# Research — Zapi reference > Every Research endpoint on Zapi, with parameters, request shape and an example response. **Base URL:** `https://api.zapi.ink` **Auth:** Send `x-api-key: YOUR_KEY` header on every request. Get a key at https://zapi.ink/dashboard/keys (free tier — 600 req/mo, no credit card). **Response envelope:** `{ status: "success" | "error", message: string, content: }` **Rate limit:** 60 req/min (free tier). Per-endpoint cache TTL is documented below. **Errors:** standard HTTP codes (`401` invalid key, `429` rate limited, `5xx` upstream). Body always has `{ status: "error", message, errors? }`. ```bash curl "https://api.zapi.ink/v1/CATEGORY:SCRAPER/ENDPOINT?param=value" \ -H "x-api-key: $ZAPI_KEY" ``` **Category page:** https://zapi.ink/category/research **Full catalog:** https://zapi.ink/apis · **Index:** https://zapi.ink/llms-full.txt --- ## DOAJ **Category:** research · **Slug:** `doaj` **Detail page:** https://zapi.ink/api/research/doaj Directory of Open Access Journals — article and journal search with full APC, licensing, peer-review and preservation metadata, plus OAI-PMH harvesting. **Tags:** doaj, open-access, journals, articles, apc ### Article By Doi DOAJ article lookup by DOI — the doi: binding over search/articles, no key. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/article-by-doi/:doi` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `doi` | string | path | yes | DOI of the article, with or without a doi.org prefix | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/article-by-doi/:doi" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/article-by-doi/:doi", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/article-by-doi/:doi", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "doi": "10.1371/journal.pone.0146294", "year": 2015, "links": [ { "url": "http://europepmc.org/articles/PMC4697834?pdf=render", "type": "fulltext", "contentType": null } ], "month": 0, "title": "A Biomechanical Comparison of Expansive Pedicle Screws for Severe Osteoporosis: The Effects of Screw Design and Cement Augmentation.", "authors": [ { "name": "Ching-Lung Tai", "orcid": null, "affiliation": null }, { "name": "Tsung-Ting Tsai", "orcid": null, "affiliation": null }, { "name": "Po-Liang Lai", "orcid": null, "affiliation": null }, { "name": "Yi-Lu Chen", "orcid": null, "affiliation": null }, { "name": "Mu-Yi Liu", "orcid": null, "affiliation": null }, { "name": "Lih-Huei Chen", "orcid": null, "affiliation": null } ], "endPage": null, "journal": { "issns": [ "1932-6203" ], "title": "PLoS ONE", "number": "12", "volume": "10", "country": "US", "language": [ "EN" ], "publisher": "Public Library of Science (PLoS)" }, "abstract": "Expansive pedicle screws significantly improve fixation strength in osteoporotic spines. However, the previous literature does not adequately address the effects of the number of lengthwise slits and the extent of screw expansion on the strength of the bone/screw interface when expansive screws are used with or without cement augmentation. Herein, four designs for expansive pedicle screws with different numbers of lengthwise slits and different screw expansion levels were evaluated. Synthetic bones simulating severe osteoporosis were used to provide a comparative platform for each screw design. The prepared specimens were then tested for axial pullout failure. Regardless of screw design, screws with cement augmentation demonstrated significantly higher pullout strength than pedicle screws without cement augmentation (p < 0.001). For screws without cement augmentation, solid screws exhibited the lowest pullout strength compared to the four expansive groups (p < 0.01). No significant differences in pullout strength were observed between the expansive screws with different designs (p > 0.05). Taken together, our results show that pedicle screws combined with cement augmentation may greatly increase screw fixation regardless of screws with or without expansion. An increase in both the number of slits and the extent of screw expansion had little impact on the screw-anchoring strength. Cement augmentation is the most influential factor for improving screw pullout strength.", "subjects": [ { "code": "R", "term": "Medicine", "scheme": "LCC" }, { "code": "Q", "term": "Science", "scheme": "LCC" } ], "articleId": "3571d4eba732417e82e9d7a9303eb0d8", "createdAt": "2016-06-10T12:12:53Z", "startPage": "e0146294", "updatedAt": "2025-08-19T21:09:39Z", "identifiers": [ { "id": "1932-6203", "type": "eissn" }, { "id": "10.1371/journal.pone.0146294", "type": "doi" } ] } ``` --- ### Article DOAJ article record by id — open JSON API, no key, rung 1 (direct) per recon. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/article/:articleId` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `articleId` | string | path | yes | DOAJ article id, 32 hex characters | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/article/:articleId" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/article/:articleId", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/article/:articleId", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "doi": "10.25057/2500672X.2038", "year": 2026, "links": [ { "url": "https://revistas.iue.edu.co/index.php/nuevoderecho/article/view/2038", "type": "fulltext", "contentType": "HTML" } ], "month": null, "title": "Responsabilidad Prospectiva Ciudadana en Sociedades Algorítmicamente Mediadas: Ética Cívica, Justicia Epistémica e Innovación Democrática", "authors": [ { "name": "Rafael Alejandro Betancourt Durango", "orcid": "https://orcid.org/0000-0002-6423-4864", "affiliation": "Universidad Pontificia Bolivariana" }, { "name": "Diego Alejandro Correa Correa", "orcid": "https://orcid.org/0000-0001-9528-2853", "affiliation": "Institución Universitaria de Envigado" }, { "name": "Conrado Giraldo Zuluaga", "orcid": "https://orcid.org/0000-0003-1885-9158", "affiliation": "Universidad Pontificia Bolivariana" }, { "name": "Eduar Antonio Rodríguez Flores", "orcid": "https://orcid.org/0000-0003-0807-6686", "affiliation": "Universidad Autónoma de Perú" } ], "endPage": null, "journal": { "title": "Nuevo Derecho", "number": "39", "volume": "22", "country": "CO", "language": [ "EN", "ES", "PT" ], "publisher": "Institución Universitaria de Envigado" }, "abstract": "\nLas democracias contemporáneas afrontan un desafío filosófico de primera magnitud: la colonización algorítmicamente mediada de la deliberación pública, la formación epistémica y la identidad cívica por sistemas cuya lógica opera de manera opaca, asimétrica y orientada a la optimización de comportamientos antes que al fortalecimiento democrático. Este artículo propone la Responsabilidad Prospectiva Ciudadana (RPC) como categoría filosófica original para conceptualizar la ciudadanía ética activa en sociedades algorítmicamente mediadas. A partir de una revisión sistemática de 127 artículos arbitrados identificados en dos bases de datos complementarias — Web of Science (A&HCI + SSCI, n = 77) y Scopus (ARTS / SOCI / COMP, n = 50) — mediante 12 ecuaciones de búsqueda para el período 2015-2026, e integrando seis tradiciones filosóficas (Jonas, Habermas, Rawls, Mouffe, Fricker y Floridi) con los marcos de democracia contestataria y poder constituyente de Mejía Quintana, Lefort, Rosanvallon y Abensour, el artículo demuestra que la literatura especializada ha producido un diagnóstico extraordinariamente sofisticado de las transformaciones algorítmicas (70% del corpus, Ejes 1-4) mientras deja dramáticamente subdesarrollada la respuesta filosófica normativa desde la perspectiva del ciudadano ordinario (30%, Ejes 5-8). El proceso de deduplicación sistemática eliminó 126 registros duplicados (96 entre bases WoS-Scopus, 29 internos de Scopus, 1 interno de WoS) de los 2.483 registros identificados, obteniendo 2.357 registros únicos para cribado. Se derivan seis principios normativos del análisis filosófico integrado: transparencia algorítmica (P1), explicabilidad y derecho de impugnación (P2), equidad epistémica (P3), participación en la gobernanza (P4), solidaridad informacional (P5) y resistencia informada (P6). Estos principios tienen implicaciones directas para el diseño de innovaciones democráticas en contextos digitales polarizados, incluidos el AI Act europeo, las recomendaciones de ética de la IA de la UNESCO y los procesos democráticos participativos de próxima generación.\n", "keywords": [ "responsabilidad prospectiva ciudadana", "mediación algorítmica", "justicia epistémica", "democracia deliberativa", "gobernanza de IA", "innovación democrática" ], "subjects": [ { "code": "K", "term": "Law", "scheme": "LCC" }, { "code": "K1-7720", "term": "Law in general. Comparative and uniform law. Jurisprudence", "scheme": "LCC" } ], "articleId": "bf9a6965797647f29ec9bc0bb4f1773b", "createdAt": "2026-07-30T16:22:40Z", "startPage": null, "updatedAt": "2026-07-30T16:22:40Z", "identifiers": [ { "id": "10.25057/2500672X.2038", "type": "doi" }, { "id": "2011-4540", "type": "pissn" }, { "id": "2500-672X", "type": "eissn" } ] } ``` --- ### Articles By Journal Every DOAJ article carrying one journal ISSN — the bibjson.journal.issns: binding over search/articles, no key. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/articles-by-journal` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `issn` | string | query | yes | Print or electronic ISSN of the journal | | `page` | number | query | no | Page number. Default 1 | | `limit` | number | query | no | Items per page. Default 10, max 100 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/articles-by-journal?issn=1932-6203&page=1&limit=10" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/articles-by-journal?issn=1932-6203&page=1&limit=10", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/articles-by-journal?issn=1932-6203&page=1&limit=10", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "issn": "1932-6203", "page": 1, "count": 3, "items": [ { "doi": "10.1371/journal.pone.0257164", "year": 2021, "links": [ { "url": "https://doi.org/10.1371/journal.pone.0257164", "type": "fulltext", "contentType": null } ], "month": 0, "title": "The PPLD has advantages over conventional regression methods in application to moderately sized genome-wide association studies.", "authors": [ { "name": "Veronica J Vieland", "orcid": null, "affiliation": null }, { "name": "Sang-Cheol Seok", "orcid": null, "affiliation": null } ], "endPage": null, "journal": { "issns": [ "1932-6203" ], "title": "PLoS ONE", "number": "9", "volume": "16", "country": "US", "language": [ "EN" ], "publisher": "Public Library of Science (PLoS)" }, "abstract": "In earlier work, we have developed and evaluated an alternative approach to the analysis of GWAS data, based on a statistic called the PPLD. More recently, motivated by a GWAS for genetic modifiers of the X-linked Mendelian disorder Duchenne Muscular Dystrophy (DMD), we adapted the PPLD for application to time-to-event (TE) phenotypes. Because DMD itself is relatively rare, this is a setting in which the very large sample sizes generally assembled for GWAS are simply not attainable. For this reason, statistical methods specially adapted for use in small data sets are required. Here we explore the behavior of the TE-PPLD via simulations, comparing the TE-PPLD with Cox Proportional Hazards analysis in the context of small to moderate sample sizes. Our results will help to inform our approach to the DMD study going forward, and they illustrate several respects in which the TE-PPLD, and by extension the original PPLD, offer advantages over regression-based approaches to GWAS in this context.", "subjects": [ { "code": "R", "term": "Medicine", "scheme": "LCC" }, { "code": "Q", "term": "Science", "scheme": "LCC" } ], "articleId": "00003499008840e299ffa0b2baec2e63", "createdAt": "2021-10-20T17:28:34Z", "startPage": "e0257164", "updatedAt": "2025-08-19T20:27:56Z", "identifiers": [ { "id": "1932-6203", "type": "eissn" }, { "id": "10.1371/journal.pone.0257164", "type": "doi" } ] }, { "doi": "10.1371/journal.pone.0059431", "year": 2013, "links": [ { "url": "http://europepmc.org/articles/PMC3632550?pdf=render", "type": "fulltext", "contentType": null } ], "month": 0, "title": "The niche-derived glial cell line-derived neurotrophic factor (GDNF) induces migration of mouse spermatogonial stem/progenitor cells.", "authors": [ { "name": "Lisa Dovere", "orcid": null, "affiliation": null }, { "name": "Stefania Fera", "orcid": null, "affiliation": null }, { "name": "Margherita Grasso", "orcid": null, "affiliation": null }, { "name": "Dante Lamberti", "orcid": null, "affiliation": null }, { "name": "Cesare Gargioli", "orcid": null, "affiliation": null }, { "name": "Barbara Muciaccia", "orcid": null, "affiliation": null }, { "name": "Anna Maria Lustri", "orcid": null, "affiliation": null }, { "name": "Mario Stefanini", "orcid": null, "affiliation": null } ], "endPage": null, "journal": { "issns": [ "1932-6203" ], "title": "PLoS ONE", "number": "4", "volume": "8", "country": "US", "language": [ "EN" ], "publisher": "Public Library of Science (PLoS)" }, "abstract": "In mammals, the biological activity of the stem/progenitor compartment sustains production of mature gametes through spermatogenesis. Spermatogonial stem cells and their progeny belong to the class of undifferentiated spermatogonia, a germ cell population found on the basal membrane of the seminiferous tubules. A large body of evidence has demonstrated that glial cell line-derived neurotrophic factor (GDNF), a Sertoli-derived factor, is essential for in vivo and in vitro stem cell self-renewal. However, the mechanisms underlying this activity are not completely understood. In this study, we show that GDNF induces dose-dependent directional migration of freshly selected undifferentiated spermatogonia, as well as germline stem cells in culture, using a Boyden chamber assay. GDNF-induced migration is dependent on the expression of the GDNF co-receptor GFRA1, as shown by migration assays performed on parental and GFRA1-transduced GC-1 spermatogonial cell lines. We found that the actin regulatory protein vasodilator-stimulated phosphoprotein (VASP) is specifically expressed in undifferentiated spermatogonia. VASP belongs to the ENA/VASP family of proteins implicated in actin-dependent processes, such as fibroblast migration, axon guidance, and cell adhesion. In intact seminiferous tubules and germline stem cell cultures, GDNF treatment up-regulates VASP in a dose-dependent fashion. These data identify a novel role for the niche-derived factor GDNF, and they suggest that GDNF may impinge on the stem/progenitor compartment, affecting the actin cytoskeleton and cell migration.", "subjects": [ { "code": "R", "term": "Medicine", "scheme": "LCC" }, { "code": "Q", "term": "Science", "scheme": "LCC" } ], "articleId": "000048ce454c4c0e9d56dbd26415ae68", "createdAt": "2016-06-14T22:51:56Z", "startPage": "e59431", "updatedAt": "2025-08-19T19:17:48Z", "identifiers": [ { "id": "1932-6203", "type": "eissn" }, { "id": "10.1371/journal.pone.0059431", "type": "doi" } ] }, { "doi": "10.1371/journal.pone.0109122", "year": 2014, "links": [ { "url": "http://europepmc.org/articles/PMC4183547?pdf=render", "type": "fulltext", "contentType": null } ], "month": 0, "title": "De novo transcriptome and small RNA analysis of two Chinese willow cultivars reveals stress response genes in Salix matsudana.", "authors": [ { "name": "Guodong Rao", "orcid": null, "affiliation": null }, { "name": "Jinkai Sui", "orcid": null, "affiliation": null }, { "name": "Yanfei Zeng", "orcid": null, "affiliation": null }, { "name": "Caiyun He", "orcid": null, "affiliation": null }, { "name": "Aiguo Duan", "orcid": null, "affiliation": null }, { "name": "Jianguo Zhang", "orcid": null, "affiliation": null } ], "endPage": null, "journal": { "issns": [ "1932-6203" ], "title": "PLoS ONE", "number": "10", "volume": "9", "country": "US", "language": [ "EN" ], "publisher": "Public Library of Science (PLoS)" }, "abstract": "Salix matsudana Koidz. is a deciduous, rapidly growing, and drought resistant tree and is one of the most widely distributed and commonly cultivated willow species in China. Currently little transcriptomic and small RNAomic data are available to reveal the genes involve in the stress resistant in S. matsudana. Here, we report the RNA-seq analysis results of both transcriptome and small RNAome data using Illumina deep sequencing of shoot tips from two willow variants(Salix. matsudana and Salix matsudana Koidz. cultivar 'Tortuosa'). De novo gene assembly was used to generate the consensus transcriptome and small RNAome, which contained 106,403 unique transcripts with an average length of 944 bp and a total length of 100.45 MB, and 166 known miRNAs representing 35 miRNA families. Comparison of transcriptomes and small RNAomes combined with quantitative real-time PCR from the two Salix libraries revealed a total of 292 different expressed genes(DEGs) and 36 different expressed miRNAs (DEMs). Among the DEGs and DEMs, 196 genes and 24 miRNAs were up regulated, 96 genes and 12 miRNA were down regulated in S. matsudana. Functional analysis of DEGs and miRNA targets showed that many genes were involved in stress resistance in S. matsudana. Our global gene expression profiling presents a comprehensive view of the transcriptome and small RNAome which provide valuable information and sequence resources for uncovering the stress response genes in S. matsudana. Moreover the transcriptome and small RNAome data provide a basis for future study of genetic resistance in Salix.", "subjects": [ { "code": "R", "term": "Medicine", "scheme": "LCC" }, { "code": "Q", "term": "Science", "scheme": "LCC" } ], "articleId": "00009c709bd4440aa6c7f7714b88f07d", "createdAt": "2016-06-15T04:11:08Z", "startPage": "e109122", "updatedAt": "2025-08-19T19:13:38Z", "identifiers": [ { "id": "1932-6203", "type": "eissn" }, { "id": "10.1371/journal.pone.0109122", "type": "doi" } ] } ], "limit": 3, "total": 367383, "hasMore": true, "nextPage": 2, "provider": "doaj" } ``` --- ### Harvest Articles DOAJ article harvest over OAI-PMH — the documented way past the JSON API's 1000-record ceiling. Pages by resumptionToken, which is a cursor and expires - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/harvest-articles` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `verb` | enum(ListRecords|ListIdentifiers) | query | no | ListRecords returns full metadata, ListIdentifiers only headers. Default ListRecords | | `metadataPrefix` | enum(oai_dc|oai_doaj) | query | no | Metadata schema. oai_doaj adds journal, volume and full-text fields. Default oai_dc | | `set` | string | query | no | setSpec from harvest-sets, restricting the harvest to one subject | | `from` | string | query | no | Lower bound on the record datestamp, YYYY-MM-DD or a UTC timestamp | | `until` | string | query | no | Upper bound on the record datestamp, YYYY-MM-DD or a UTC timestamp | | `cursor` | string | query | no | nextCursor from a previous call. When set, every other filter is ignored | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/harvest-articles?verb=ListRecords&metadataPrefix=oai_dc&set=TENDOk1pY3JvYmlvbG9neQ~~&from=2026-07-01&until=2026-07-31&cursor=eyJtIjogIm9haV9kYyJ9" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/harvest-articles?verb=ListRecords&metadataPrefix=oai_dc&set=TENDOk1pY3JvYmlvbG9neQ~~&from=2026-07-01&until=2026-07-31&cursor=eyJtIjogIm9haV9kYyJ9", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/harvest-articles?verb=ListRecords&metadataPrefix=oai_dc&set=TENDOk1pY3JvYmlvbG9neQ~~&from=2026-07-01&until=2026-07-31&cursor=eyJtIjogIm9haV9kYyJ9", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "verb": "ListRecords", "count": 300, "items": [ { "doi": "10.1136/bmjhci-2025-101636", "url": "https://doaj.org/article/ff7878e5b5d84fa59c960e2ab33d2f6e", "date": "2026-07-01T00:00:00Z", "sets": [ "TENDOkNvbXB1dGVyIGFwcGxpY2F0aW9ucyB0byBtZWRpY2luZS4gTWVkaWNhbCBpbmZvcm1hdGljcw~~" ], "type": "article", "issns": [ "2632-1009" ], "title": "Novel two-stage deep learning framework for automated pressure injury classification", "deleted": false, "sources": [ "BMJ Health & Care Informatics, Vol 33, Iss 1 (2026)" ], "creators": [ "Chien-Wei Chen", "Ting-Yu Lai", "Yi-Jiun Chou", "Chun-You Liu", "Ching-Ting Lin", "Wei-Chun Wang", "Yimin Hsu", "Ming-Li Hsieh" ], "recordId": "ff7878e5b5d84fa59c960e2ab33d2f6e", "subjects": [ "Computer applications to medicine. Medical informatics", "R858-859.7" ], "datestamp": "2026-07-31T00:40:51Z", "languages": [ "EN" ], "publisher": "BMJ Publishing Group", "relations": [ "https://informatics.bmj.com/content/33/1/e101636.full", "https://doaj.org/toc/2632-1009" ], "identifier": "oai:doaj.org/article:ff7878e5b5d84fa59c960e2ab33d2f6e", "description": "Objective The study aims to develop an artificial intelligence (AI) framework for automatic pressure injury (PI) staging directly from raw clinical images, without requiring manual lesion localisation. By integrating a two-stage deep learning approach—combining object detection and image classification—the proposed system seeks to improve diagnostic accuracy, reduce subjectivity and support consistent staging in real-world clinical workflows.Methods We conducted a retrospective study using 1807 PI images from China Medical University Hospital collected between 2020 and 2024. Lesions were annotated by five senior nurses with consensus. YOLOv9 was used for lesion detection, and DenseNet161 for staging. Performance metrics included accuracy, sensitivity, specificity, F1 score, area under the curve (AUC) and mean average precision (mAP)@0.5.Results The object detection model (YOLOv9) achieved an mAP@0.5 of 0.796. On the independent test set (n=365), the staging model demonstrated an overall accuracy of 0.775, sensitivity of 0.775, specificity of 0.955, precision of 0.779 and F1 score of 0.775.Discussion The proposed two-stage AI framework—using YOLOv9 for lesion localisation and DenseNet161 for staging—demonstrated performance comparable to or exceeding previously reported approaches, while offering improved clinical interpretability when applied to real-world clinical images. By separating detection and classification, the framework reduced background noise and improved the ability to distinguish visually similar PI stages. However, challenges remain in handling intra-wound heterogeneity, subtle early-stage boundaries and variability in image quality.Conclusions This two-stage AI system may assist clinical staff by providing standardised, reproducible PI staging from clinical images, with potential for integration into nursing workflows.", "identifiers": [ "10.1136/bmjhci-2025-101636", "2632-1009", "https://doaj.org/article/ff7878e5b5d84fa59c960e2ab33d2f6e" ] }, { "doi": "10.1136/bmjopen-2025-110435", "url": "https://doaj.org/article/070a6d2b17954a308d65ae33823293c8", "date": "2026-02-01T00:00:00Z", "sets": [ "TENDOk1lZGljaW5l" ], "type": "article", "issns": [ "2044-6055" ], "title": "Cognitive and physical exercise to improve outcomes after surgery (COPE-iOS) study: protocol for a randomised, controlled trial in the USA examining the efficacy of a combined cognitive and physical exercise programme performed before and after major surgery in improving cognitive and functional outcomes for older adults", "deleted": false, "sources": [ "BMJ Open, Vol 16, Iss 2 (2026)" ], "creators": [ "Pratik P Pandharipande", "Christopher G Hughes", "Kimberly F Rengel", "Kristin R Archer", "Jim C Jackson", "Rameela Raman", "Onur M Orun", "Terri Ellison" ], "recordId": "070a6d2b17954a308d65ae33823293c8", "subjects": [ "Medicine", "R" ], "datestamp": "2026-07-31T00:35:59Z", "languages": [ "EN" ], "publisher": "BMJ Publishing Group", "relations": [ "https://bmjopen.bmj.com/content/16/2/e110435.full", "https://doaj.org/toc/2044-6055" ], "identifier": "oai:doaj.org/article:070a6d2b17954a308d65ae33823293c8", "description": "Introduction Surgery and its resulting hospitalisation are associated with subsequent cognitive and functional decline. Interventions to reduce this decline have exhibited limited success. Prehabilitation is the process of enhancing capacity and reserve before an acute stressor to improve tolerance of the acute physiologic insult. Older adults requiring major surgery are an ideal population for prehabilitation. Prehabilitation exercise studies have mostly focused on physical training to improve physical outcomes after specific surgery types, and data on cognitive outcomes and in broader surgical populations are needed. Computerised cognitive training (CCT) has been shown to enhance memory, processing speed, attention and multitasking. Combining CCT with a physical exercise may be most effective in reducing cognitive and functional decline in older patients undergoing major surgery, but has yet to be evaluated.Methods and analysis The COgnitive and Physical Exercise to improve Outcomes after Surgery (COPE-iOS) study is a randomised, controlled, participant and assessor blinded clinical trial testing the hypothesis that a pragmatic programme combining CCT and physical exercise throughout the perioperative (ie, preoperative and postoperative) period will improve long-term cognitive and disability outcomes in older surgical patients at high risk for decline. The trial aims to randomise 250 patients who undergo major surgery for a treatment period of approximately 1 month prior to surgery and 3 months after surgery, with a follow-up period of 12 months after surgery. The primary outcome is global cognition at 3 months after surgery. Key secondary outcomes include global cognition at 12 months after surgery and disability in activities of daily living and depression at 3 and 12 months after surgery.Ethics and dissemination Trial protocol has been approved by Vanderbilt Human Research Protections Programme (#202496) and an independent Data Safety Monitoring Board. Results will be presented at scientific conferences and submitted for publication.Trial registration number ClinicalTrials.gov Registry NCT04889417.", "identifiers": [ "10.1136/bmjopen-2025-110435", "2044-6055", "https://doaj.org/article/070a6d2b17954a308d65ae33823293c8" ] }, { "doi": "10.1136/bmjopen-2025-115288", "url": "https://doaj.org/article/5c541148d88947c2a150b0d5a3ae4ff2", "date": "2026-03-01T00:00:00Z", "sets": [ "TENDOk1lZGljaW5l" ], "type": "article", "issns": [ "2044-6055" ], "title": "PRECISION study: impact of personalised cardiac anaesthesia and cerebral autoregulation on neurological outcomes in patients undergoing cardiac surgery – protocol for an international, multicentre, prospective cohort study", "deleted": false, "sources": [ "BMJ Open, Vol 16, Iss 3 (2026)" ], "creators": [ "David K Menon", "Marek Czosnyka", "Christian Schindler", "Peter Smielewski", "Erta Beqiri", "Luzius A Steiner", "Martin Siegemund", "Salome Dell-Kuster" ], "recordId": "5c541148d88947c2a150b0d5a3ae4ff2", "subjects": [ "Medicine", "R" ], "datestamp": "2026-07-31T00:26:09Z", "languages": [ "EN" ], "publisher": "BMJ Publishing Group", "relations": [ "https://bmjopen.bmj.com/content/16/3/e115288.full", "https://doaj.org/toc/2044-6055" ], "identifier": "oai:doaj.org/article:5c541148d88947c2a150b0d5a3ae4ff2", "description": "Introduction Adverse neurological complications, including postoperative delirium (POD) and stroke, remain one of the major risks after cardiac surgery. A lack of comprehensive knowledge about their causes and neuroprotective strategies has hindered the development of effective interventions to reduce these events. Personalised cerebral autoregulation (CA)-oriented blood pressure monitoring aims to identify blood pressure targets tailored to each individual patient, thereby reducing brain injury. The PRECISION study aims to assess whether perioperative duration and magnitude of mean arterial pressure (MAP) deviation from an individual’s CA limits are associated with adverse neurological complications.Methods and analysis This international, multicentre, prospective cohort study is conducted at two Swiss and one British hospital. Patients aged 65 years or older undergoing elective primary or re-operative coronary artery bypass graft and/or valvular and/or ascending aorta surgery requiring cardiopulmonary bypass are included. Preoperatively, the patient’s baseline of physical, cognitive and mental status is established. Intraoperatively, near-infrared spectroscopy (NIRS) and transcranial Doppler (TCD) are recorded in real-time to generate NIRS-derived and TCD-derived CA indices. The primary endpoint is POD, assessed daily on postoperative days 0 to 7 or up to discharge, whichever occurs earlier with the 3D-Confusion Assessment Method (3D-CAM) or CAM-Intensive Care Unit. Secondary endpoints include a composite neurological outcome of POD and overt stroke, postoperative neurocognitive disorders, major morbidity and mortality. Associations between neurologic outcomes, neurobiomarkers and genetic variation will be explored.A total of 500 participants is required to achieve 90% power to find a statistically significant effect of the area under the curve MAP<lower limit of CA (LLA) on the risk of POD at the 5% level. This includes adjustment for potential confounders and for the inability to determine the LLA.Ethics and dissemination Ethical approval has been obtained from all responsible ethics committees (Swiss lead ethics committee EKNZ 2022-01457 and Health Research Authority and Health and Care Research Wales, UK, REC 23/SW/0076). Results will be disseminated at national and international conferences and published in peer-reviewed journals.Trial registration number NCT05595954.", "identifiers": [ "10.1136/bmjopen-2025-115288", "2044-6055", "https://doaj.org/article/5c541148d88947c2a150b0d5a3ae4ff2" ] }, { "doi": "10.1136/bmjopen-2025-111860", "url": "https://doaj.org/article/9b8a6c083212461e95e275559767a72d", "date": "2026-02-01T00:00:00Z", "sets": [ "TENDOk1lZGljaW5l" ], "type": "article", "issns": [ "2044-6055" ], "title": "Start4All protocol for a Bayesian cost-effectiveness model of tuberculosis screening and diagnosis in seven high burden low-income and middle-income countries", "deleted": false, "sources": [ "BMJ Open, Vol 16, Iss 2 (2026)" ], "creators": [ "Marc Yves Romain Henrion", "Tushar Garg", "Stephen John", "Shahriar Ahmed", "Sayera Banu", "Tanjina Rahman", "Jacob Creswell", "Melissa Sander" ], "recordId": "9b8a6c083212461e95e275559767a72d", "subjects": [ "Medicine", "R" ], "datestamp": "2026-07-31T00:21:07Z", "languages": [ "EN" ], "publisher": "BMJ Publishing Group", "relations": [ "https://bmjopen.bmj.com/content/16/2/e111860.full", "https://doaj.org/toc/2044-6055" ], "identifier": "oai:doaj.org/article:9b8a6c083212461e95e275559767a72d", "description": "Introduction High costs of screening and diagnostic tests remain a major barrier to timely tuberculosis (TB) identification in resource-limited settings. Evidence on the cost-effectiveness of scalable screening algorithms is limited. Start4All is a research project aimed at developing and evaluating algorithmic approaches to TB screening and diagnosis, with the goal of optimising technical and allocative efficiency when expanding diagnostic coverage to primary healthcare and community settings.Methods and analysis Five screening and diagnostic tests will be evaluated: a capillary blood-based assay (C-reactive protein (CRP)), sputum-based rapid molecular tests (PCR; individual and pooled Xpert MTB/RIF Ultra assay (Xpert Ultra, Cepheid®, California, USA)), a lateral-flow urine-based test for lipoarabinomannan (LF-LAM), and digital chest X-rays with artificial intelligence-based computer-aided detection (CXR-CAD). A microbiological reference standard of positive culture using the mycobacteria growth indicator tube will be used to confirm TB disease.We will compare the cost and effectiveness of concurrent and sequential positive serial combinations (screening algorithms) of CRP, CXR-CAD, LF-LAM, individual and pooled Xpert Ultra. Diagnostic performance will be estimated using sensitivity, specificity, predictive values and proportions of positive results, with Bayesian inference used to derive these estimates. The analysis will include adults (15 years and older) only and will be stratified by HIV status and level of care, including facility and community-based case finding. Effectiveness will be assessed based on the number of people with TB detected. Cost analysis will be conducted from the provider perspective, incorporating commodity and implementation costs. A decision tree model will be developed to assess the cost per number of persons with confirmed TB detected across all countries. Probabilistic sensitivity analysis will be conducted to account for uncertainty in model parameters, incorporating willingness-to-pay and willingness-to-accept thresholds.Ethics and dissemination WHO ethical review committee approval ERC.0003921. Data will be available on reasonable request to the principal investigator of the consortium.Trial registration number NCT05845112.", "identifiers": [ "10.1136/bmjopen-2025-111860", "2044-6055", "https://doaj.org/article/9b8a6c083212461e95e275559767a72d" ] }, { "doi": "10.19041/APSTRACT/2023/1/1", "url": "https://doaj.org/article/edb40134422541d098d745440f2622fb", "date": "2023-06-01T00:00:00Z", "sets": [ "TENDOkFncmljdWx0dXJl", "TENDOlJlZ2lvbmFsIHBsYW5uaW5n" ], "type": "article", "issns": [ "1789-221X", "1789-7874" ], "title": "PERCEPTIONS, PROFITABILITY AND DETERMINANTS OF GRANULATED CASSAVA PACKAGING IN KUMASI METROPOLIS, GHANA", "deleted": false, "sources": [ "Apstract: Applied Studies in Agribusiness and Commerce, Vol 17, Iss 1 (2023)" ], "creators": [ "Enoch Kwame Tham-Agyekum", "Fred Nimoh", "Dora Boakye", "Abednego Yeboah", "Umar Abdul Baqi Abubakar" ], "recordId": "edb40134422541d098d745440f2622fb", "subjects": [ "Gari", "Packaging", "Gari Sellers", "Granulated Cassava", "Perception", "Profitability", "Agriculture", "S" ], "datestamp": "2026-07-31T00:19:33Z", "languages": [ "EN" ], "publisher": "University of Debrecen", "relations": [ "http://localhost:9400/apstract/article/view/10791", "https://doaj.org/toc/1789-221X", "https://doaj.org/toc/1789-7874" ], "identifier": "oai:doaj.org/article:edb40134422541d098d745440f2622fb", "description": "Packaging does not only protect a product but also provides directions for using the product, as well as relevant information about its content and nutritional value. This study was undertaken to assess Granulated Cassava (Gari) sellers’ perception, profitability and determinants of packaging in Ashanti Region. The study area was purposively selected because of the active participation and contribution of marketing activities. A structured questionnaire was administered in the form of interview to obtain primary data from the respondents. Data was generated using binary and multinomial logit regression model and Garret ranking technique. The results showed that there is 0.11% difference in the gross margin of both ventures which is also statistically significant at 1%. Years of education, legal requirement, and durability of the packaging material and cost of packaging material were the significant factors that influence sellers’ choice of packaging. Lack of technical know-how, cost of capital equipment and lack of knowledge on packaging equipment and/or material were the most limiting constraints affecting Gari packaging. The study recommends that investors should invest in the Gari packaging business since it has a relatively higher rate of returns as compared to the unpackaged one.", "identifiers": [ "10.19041/APSTRACT/2023/1/1", "1789-221X", "1789-7874", "https://doaj.org/article/edb40134422541d098d745440f2622fb" ] }, { "doi": "10.19041/APSTRACT/2025/1/1", "url": "https://doaj.org/article/c594eab4a9994dad88599954598eb3c4", "date": "2025-06-01T00:00:00Z", "sets": [ "TENDOkFncmljdWx0dXJl", "TENDOlJlZ2lvbmFsIHBsYW5uaW5n" ], "type": "article", "issns": [ "1789-221X", "1789-7874" ], "title": "FACTORS INFLUENCING FEMALE YOUTH PARTICIPATION IN AGRICULTURAL LIVELIHOOD GENERATING ACTIVITIES FOR SELF-CARE IN GWAGWALADA AREA COUNCIL, ABUJA, NIGERIA", "deleted": false, "sources": [ "Apstract: Applied Studies in Agribusiness and Commerce, Vol 19, Iss 1 (2025)" ], "creators": [ "Dutse Fidelis", "Abbas Shehu", "Hannatu Yohanna Michael", "Danladi Ezrah Bako" ], "recordId": "c594eab4a9994dad88599954598eb3c4", "subjects": [ "Youth participation", "Agricultural livelihood", "Income generating activities", "Self-care", "Perceived contribution", "Agriculture", "S", "Regional planning" ], "datestamp": "2026-07-31T00:19:31Z", "languages": [ "EN" ], "publisher": "University of Debrecen", "relations": [ "http://localhost:9400/apstract/article/view/15369", "https://doaj.org/toc/1789-221X", "https://doaj.org/toc/1789-7874" ], "identifier": "oai:doaj.org/article:c594eab4a9994dad88599954598eb3c4", "description": "This study examines female youth participation in agricultural livelihood generating activities for self-care in Gwagwalada Area Council, Abuja. The objectives were to: examine the extent of female youth participation in agricultural livelihood generating activities and the income generated, determine the levels of female youth self-care responsibilities and perceived contribution of participation in agricultural livelihood activities on their wellbeing, determine factors influencing female youth participation in agricultural livelihood activities in the study area. A multistage sampling procedure was used to select 133 female youths from 13 registered youth associations. Structured questionnaire was used to collect data while descriptive statistics and Logit regression model were used to analyze the data. The results showed that 30.1% of the respondents were engaged in crop production and generated an average income of ₦420,093.02 while only 3.0% were engaged in crop produce processing and generated ₦29,250.74. Also, almost half (47.4) of them spent money to take care of themselves of between 3-4 self-care responsibilities and about 41.5 spent an average of 130,078.95 on food per day. It also showed The logit regression results indicated that factors influencing female youth participation in agricultural livelihood generating activities include age, educational status, household size, income, occupation, and distance. While the study indicates that a significant portion of female youths is engaged in crop and poultry production, their overall participation in agricultural activities is limited. The study provides critical insights into the potential of agriculture as a viable solution to youth unemployment and is an instrument of female vulnerability reduction in Nigeria. The study recommends implementing policies to improve land access for female youths, including land reform initiatives that prioritize youth ownership and leasing options. Additionally, it suggests exploring strategies to reduce production costs through input subsidies, partnerships with agricultural suppliers, and community-based resource-sharing initiatives.", "identifiers": [ "10.19041/APSTRACT/2025/1/1", "1789-221X", "1789-7874", "https://doaj.org/article/c594eab4a9994dad88599954598eb3c4" ] }, { "doi": "10.19041/APSTRACT/2025/1/2", "url": "https://doaj.org/article/ff727ba209104a23be3c4a963f4dc9e5", "date": "2025-06-01T00:00:00Z", "sets": [ "TENDOkFncmljdWx0dXJl", "TENDOlJlZ2lvbmFsIHBsYW5uaW5n" ], "type": "article", "issns": [ "1789-221X", "1789-7874" ], "title": "THE ROLE AND IMPACT OF DIGITAL TRANSFORMATION ON THE DEVELOPMENT OF SMALL AND MEDIUM-SIZED ENTERPRISES IN HAJDÚ-BIHAR COUNTY", "deleted": false, "sources": [ "Apstract: Applied Studies in Agribusiness and Commerce, Vol 19, Iss 1 (2025)" ], "creators": [ "Mihály Bogdán", "Péter Popovics" ], "recordId": "ff727ba209104a23be3c4a963f4dc9e5", "subjects": [ "best practices", "digital best practices", "digitalization", "artificial intelligence", "efficiency", "Agriculture", "S", "Regional planning" ], "datestamp": "2026-07-31T00:19:29Z", "languages": [ "EN" ], "publisher": "University of Debrecen", "relations": [ "http://localhost:9400/apstract/article/view/15422", "https://doaj.org/toc/1789-221X", "https://doaj.org/toc/1789-7874" ], "identifier": "oai:doaj.org/article:ff727ba209104a23be3c4a963f4dc9e5", "description": "In our survey-based research, assessed the opinions of 39 small and medium-sized enterprise (SME) leaders in Hajdú-Bihar County on digitalization, how they evaluate their employees' digital skills, what digital best practices they apply, and how familiar they are with current trends in digital best practices. In the literature review, we touch on the concepts and significance of digitalization and digital transformation, the characteristics and types of best practices, benchmarking as a tool for identifying them, and the steps involved in their implementation. We introduced five currently popular digital best practices: optical character recognition, homomorphic encryption, robotic process automation, intelligent process automation, and blockchain technology. The advantages and impact of these practices on corporate efficiency are highlighted. Based on the results, we reached the following conclusions:\nThe findings show that most Hungarian companies view digitalization as an opportunity, but there are deficiencies in strategic planning and commitment. Although leaders theoretically support technological progress, 93% of companies do not have a developed digital strategy, and leaders also rate employee engagement as low. The resources allocated for digitalization investments are also low, with most companies spending only between 0-10 million HUF. The application of artificial intelligence (AI) technologies is still in its early stages, though there are positive examples. Dissatisfaction is evident regarding employees' digital competencies, particularly in problem-solving and data security. The lack of knowledge of modern digital technologies also hinders innovation. Companies' digital maturity is low, with most having only taken initial steps in this area. Often, the perceived digital intensity of the industry does not reflect reality, which can hinder development.", "identifiers": [ "10.19041/APSTRACT/2025/1/2", "1789-221X", "1789-7874", "https://doaj.org/article/ff727ba209104a23be3c4a963f4dc9e5" ] }, { "doi": "10.19041/APSTRACT/2025/1/3", "url": "https://doaj.org/article/9ac06fca05ff4cec8b3908112bcc935b", "date": "2025-06-01T00:00:00Z", "sets": [ "TENDOkFncmljdWx0dXJl", "TENDOlJlZ2lvbmFsIHBsYW5uaW5n" ], "type": "article", "issns": [ "1789-221X", "1789-7874" ], "title": "WHAT DRIVES FEMALE FARMERS’ PARTICIPATION IN OFF-FARM ACTIVITIES? THE CASE OF RURAL NIGERIA", "deleted": false, "sources": [ "Apstract: Applied Studies in Agribusiness and Commerce, Vol 19, Iss 1 (2025)" ], "creators": [ "Abbas Shehu", "Jadeera Mahmood", "Sulaiman Umar" ], "recordId": "9ac06fca05ff4cec8b3908112bcc935b", "subjects": [ "Women farmers", "Non farm enterprises", "Rural Nigeria", "Electricity", "Roads", "Agriculture", "S", "Regional planning" ], "datestamp": "2026-07-31T00:19:28Z", "languages": [ "EN" ], "publisher": "University of Debrecen", "relations": [ "http://localhost:9400/apstract/article/view/15435", "https://doaj.org/toc/1789-221X", "https://doaj.org/toc/1789-7874" ], "identifier": "oai:doaj.org/article:9ac06fca05ff4cec8b3908112bcc935b", "description": "Women often lack access to productive resources such as land and capital in most developing countries. This forces them to take part in off-farm activities to augment their little farm income. This study investigated factors that affect the involvement of women farmers in different types of off-farm entrepreneurial livelihood activities in rural Bauchi state, Nigeria. A purposive sampling method was used in selecting three local government areas in the western agricultural zone of the state and a random sampling method was used in selecting ten wards. 5% registered women farmers in each selected ward, making 134 respondents. Semi-structured questionnaires were administered to women farmers in 2017. The results revealed that food processing, farm product sales, trading and tailoring are the major off-farm livelihood activities engaged in by rural female farmers. Logit regression results revealed, as expected, that different factors affect their involvement in various types of off-farm activities. Food processing and tailoring required relatively high start-up capital and access to electricity as an investment and the use of machines was needed. Thus, access to credit or remittances and to electricity increases the probability of being involved in these activities. The requirements of trading being lower and access to market increases the probability of being involved. Provision of extension services, rural credit facilitation programmes, rural electrification, road and market structure development are instruments that are appropriate to support women farmers' involvement in off-farm activities.", "identifiers": [ "10.19041/APSTRACT/2025/1/3", "1789-221X", "1789-7874", "https://doaj.org/article/9ac06fca05ff4cec8b3908112bcc935b" ] } ], "cursor": "eyJtIjogIm9haV9kYyJ9", "hasMore": true, "provider": "doaj", "nextCursor": "eyJtIjogIm9haV9kYyIsICJ1IjogIjIwMjYtMDctMzFUMDA6NDE6MjdaIiwgIm4iOiAzMDAsICJhIjogWyIyMDI2LTA3LTMwVDIzOjAxOjE1WiIsIDFdfQ==", "metadataPrefix": "oai_dc" } ``` --- ### Harvest Journals DOAJ journal harvest over OAI-PMH. Pages by resumptionToken, which is a cursor and expires after 24h, not a page number you can jump to. The journal feed - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/harvest-journals` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `verb` | enum(ListRecords|ListIdentifiers) | query | no | ListRecords returns full metadata, ListIdentifiers only headers. Default ListRecords | | `set` | string | query | no | setSpec from harvest-sets, restricting the harvest to one subject | | `from` | string | query | no | Lower bound on the record datestamp, YYYY-MM-DD or a UTC timestamp | | `until` | string | query | no | Upper bound on the record datestamp, YYYY-MM-DD or a UTC timestamp | | `cursor` | string | query | no | nextCursor from a previous call. When set, every other filter is ignored | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/harvest-journals?verb=ListRecords&set=TENDOk1pY3JvYmlvbG9neQ~~&from=2026-07-01&until=2026-07-31&cursor=eyJtIjogIm9haV9kYyJ9" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/harvest-journals?verb=ListRecords&set=TENDOk1pY3JvYmlvbG9neQ~~&from=2026-07-01&until=2026-07-31&cursor=eyJtIjogIm9haV9kYyJ9", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/harvest-journals?verb=ListRecords&set=TENDOk1pY3JvYmlvbG9neQ~~&from=2026-07-01&until=2026-07-31&cursor=eyJtIjogIm9haV9kYyJ9", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "verb": "ListRecords", "count": 300, "items": [ { "doi": null, "url": "https://doaj.org/toc/2448-7937", "date": "2026-07-30T20:00:41Z", "sets": [ "TENDOkxhdw~~" ], "type": "journal", "issns": [ "2448-7937", "2007-4387" ], "title": "Problema: Anuario de Filosofía y Teoría del Derecho", "rights": [ "CC BY-NC" ], "deleted": false, "recordId": "8005ee2ac50e482f85c2865de2ad119f", "subjects": [ "law", "philosophy", "theory of law", "philosophy of law", "jurisprudence", "critical theory", "Law", "K" ], "datestamp": "2026-07-30T20:00:41Z", "languages": [ "EN", "ES" ], "publisher": "Universidad Nacional Autónoma de México", "relations": [ "https://revistas.juridicas.unam.mx/index.php/filosofia-derecho/tematica-y-alcance", "https://revistas.juridicas.unam.mx/index.php/filosofia-derecho", "https://revistas.juridicas.unam.mx/index.php/filosofia-derecho/about/submissions#authorGuidelines" ], "identifier": "oai:doaj.org/journal:8005ee2ac50e482f85c2865de2ad119f", "description": null, "identifiers": [ "2448-7937", "2007-4387", "https://doaj.org/toc/2448-7937" ] }, { "doi": null, "url": "https://doaj.org/toc/0120-5927", "date": "2015-06-15T20:19:50Z", "sets": [ "TENDOkVkdWNhdGlvbg~~", "TENDOlRoZW9yeSBhbmQgcHJhY3RpY2Ugb2YgZWR1Y2F0aW9u", "TENDOkVuZ2xpc2ggbGFuZ3VhZ2U~" ], "type": "journal", "issns": [ "0120-5927" ], "title": "HOW", "rights": [ "CC BY-NC-ND" ], "deleted": false, "recordId": "d6b0fb3427f84c4085c7d3f08839bb9a", "subjects": [ "education", "english as a foreign language", "teaching", "applied linguistics", "Education", "L", "Theory and practice of education", "LB5-3640" ], "datestamp": "2026-07-30T19:24:05Z", "languages": [ "EN" ], "publisher": "Asociación Colombiana de Profesores de Ingles", "relations": [ "https://howjournalcolombia.org/index.php/how/about/", "http://howjournalcolombia.org/index.php/how/about/submissions#authorGuidelines", "http://www.howjournalcolombia.org" ], "identifier": "oai:doaj.org/journal:d6b0fb3427f84c4085c7d3f08839bb9a", "description": null, "identifiers": [ "0120-5927", "https://doaj.org/toc/0120-5927" ] }, { "doi": null, "url": "https://doaj.org/toc/2590-9452", "date": "2017-11-28T17:34:16Z", "sets": [ "TENDOk1lZGljYWwgcGhpbG9zb3BoeS4gTWVkaWNhbCBldGhpY3M~", "TENDOkV0aGljcw~~" ], "type": "journal", "issns": [ "2590-9452", "1900-6896" ], "title": "Revista Colombiana de Bioética", "rights": [ "CC BY-NC-ND" ], "deleted": false, "recordId": "aca4b22eda0a493b8b6bec60d5aadfc1", "subjects": [ "bioethics", "medicine ethics", "Medical philosophy. Medical ethics", "R723-726", "Ethics", "BJ1-1725" ], "datestamp": "2026-07-30T19:12:57Z", "languages": [ "ES" ], "publisher": "Universidad El Bosque", "relations": [ "https://revistas.unbosque.edu.co/index.php/RCB/guidelines", "https://revistas.unbosque.edu.co/index.php/RCB/about", "https://revistas.unbosque.edu.co/index.php/RCB/index" ], "identifier": "oai:doaj.org/journal:aca4b22eda0a493b8b6bec60d5aadfc1", "description": null, "identifiers": [ "2590-9452", "1900-6896", "https://doaj.org/toc/2590-9452" ] }, { "doi": null, "url": "https://doaj.org/toc/2316-9095", "date": "2020-06-08T15:19:46Z", "sets": [ "TENDOkdlb2xvZ3k~" ], "type": "journal", "issns": [ "2316-9095", "1519-874X" ], "title": "Geologia USP. Série Científica", "rights": [ "CC BY-NC-SA" ], "deleted": false, "recordId": "c4f62bc181814f56bd973cd8a74ce644", "subjects": [ "general geology", "geochemistry", "environmental geology", "petrology", "isotope geology", "paleontology", "Geology", "QE1-996.5" ], "datestamp": "2026-07-30T18:36:55Z", "languages": [ "EN", "PT" ], "publisher": "Universidade de São Paulo", "relations": [ "http://www.revistas.usp.br/guspsc/about/submissions", "http://www.revistas.usp.br/guspsc", "http://www.revistas.usp.br/guspsc/about" ], "identifier": "oai:doaj.org/journal:c4f62bc181814f56bd973cd8a74ce644", "description": null, "identifiers": [ "2316-9095", "1519-874X", "https://doaj.org/toc/2316-9095" ] }, { "doi": null, "url": "https://doaj.org/toc/2410-7336", "date": "2015-11-04T09:37:12Z", "sets": [ "TENDOkluZHVzdHJpYWwgc2FmZXR5LiBJbmR1c3RyaWFsIGFjY2lkZW50IHByZXZlbnRpb24~" ], "type": "journal", "issns": [ "2410-7336", "2311-7249" ], "title": "Sučasnì Informacìjnì Tehnologìï u Sferì Bezpeki ta Oboroni", "rights": [ "CC BY-NC-ND" ], "deleted": false, "recordId": "915eea4caf0541e9ba47b7dfbf9ed089", "subjects": [ "automation", "computer-integrated technologies", "electronics", "electronic communications", "computer science", "information technology", "Industrial safety. Industrial accident prevention", "T55-55.3" ], "datestamp": "2026-07-30T15:19:10Z", "languages": [ "EN", "UK" ], "publisher": "Національний університет оборони України", "relations": [ "https://sit.nuou.org.ua/information/authors", "https://sit.nuou.org.ua/", "https://sit.nuou.org.ua/about" ], "identifier": "oai:doaj.org/journal:915eea4caf0541e9ba47b7dfbf9ed089", "description": null, "identifiers": [ "2410-7336", "2311-7249", "https://doaj.org/toc/2410-7336" ] }, { "doi": null, "url": "https://doaj.org/toc/2786-5258", "date": "2021-11-25T12:08:44Z", "sets": [ "TENDOkJpb2xvZ3kgKEdlbmVyYWwp" ], "type": "journal", "issns": [ "2786-5258", "2786-524X" ], "title": "Нотатки сучасної біології", "rights": [ "CC BY-NC" ], "deleted": false, "recordId": "d6844e73a4b94849a7a74d120308f22c", "subjects": [ "biology", "botany", "zoology", "physiology", "ecology", "biochemistry", "Biology (General)", "QH301-705.5" ], "datestamp": "2026-07-30T15:18:08Z", "languages": [ "RU", "EN", "UK" ], "publisher": "Lesya Ukrainka Volyn National University", "relations": [ "https://journalbio.vnu.edu.ua/index.php/bio/aims-and-scope", "https://journalbio.vnu.edu.ua/index.php/bio/about/submissions", "https://journalbio.vnu.edu.ua" ], "identifier": "oai:doaj.org/journal:d6844e73a4b94849a7a74d120308f22c", "description": null, "identifiers": [ "2786-5258", "2786-524X", "https://doaj.org/toc/2786-5258" ] }, { "doi": null, "url": "https://doaj.org/toc/2096-1456", "date": "2019-05-16T09:57:54Z", "sets": [ "TENDOk1lZGljaW5l" ], "type": "journal", "issns": [ "2096-1456" ], "title": "口腔疾病防治", "rights": [ "CC BY" ], "deleted": false, "recordId": "3f05e5a55308412bb70595c24a6c2fd8", "subjects": [ "prevention and treatment", "stomatological diseases", "Medicine", "R" ], "datestamp": "2026-07-30T15:12:06Z", "languages": [ "ZH" ], "publisher": "Editorial Department of Journal of Prevention and Treatment for Stomatological Diseases", "relations": [ "https://www.kqjbfz.com/EN/2096-1456/home.shtml", "https://www.kqjbfz.com/EN/column/column6.shtml", "https://www.kqjbfz.com/EN/column/column1.shtml" ], "identifier": "oai:doaj.org/journal:3f05e5a55308412bb70595c24a6c2fd8", "description": null, "identifiers": [ "2096-1456", "https://doaj.org/toc/2096-1456" ] }, { "doi": null, "url": "https://doaj.org/toc/1000-8578", "date": "2019-07-15T09:00:50Z", "sets": [ "TENDOk5lb3BsYXNtcy4gVHVtb3JzLiBPbmNvbG9neS4gSW5jbHVkaW5nIGNhbmNlciBhbmQgY2FyY2lub2dlbnM~" ], "type": "journal", "issns": [ "1000-8578" ], "title": "Zhongliu Fangzhi Yanjiu", "rights": [ "CC BY-NC" ], "deleted": false, "recordId": "50bcdbfae2de43f0bab9599b9bc87b0b", "subjects": [ "surgery", "chemotherapy", "radiotherapy", "epidemiology", "immunotherapy", "Neoplasms. Tumors. Oncology. Including cancer and carcinogens", "RC254-282" ], "datestamp": "2026-07-30T15:02:13Z", "languages": [ "ZH" ], "publisher": "Magazine House of Cancer Research on Prevention and Treatment", "relations": [ "https://www.zlfzyj.com/Instruction", "https://www.zlfzyj.com/", "https://www.zlfzyj.com/AboutJournal" ], "identifier": "oai:doaj.org/journal:50bcdbfae2de43f0bab9599b9bc87b0b", "description": null, "identifiers": [ "1000-8578", "https://doaj.org/toc/1000-8578" ] } ], "cursor": "eyJtIjogIm9haV9kYyJ9", "hasMore": true, "provider": "doaj", "nextCursor": "eyJtIjogIm9haV9kYyIsICJ1IjogIjIwMjYtMDctMzFUMDA6NDE6MzFaIiwgIm4iOiAzMDAsICJhIjogWyIyMDI2LTA3LTI0VDIzOjI5OjIzWiIsIDNdfQ==", "metadataPrefix": "oai_dc" } ``` --- ### Harvest Sets The OAI-PMH set list — every setSpec accepted by harvest-articles and harvest-journals. One shot: the upstream serves all sets without a cursor. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/harvest-sets` - **Cache TTL:** 300s **Parameters:** _No parameters._ **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/harvest-sets" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/harvest-sets", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/harvest-sets", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 526, "items": [ { "name": "LCC:1789-", "term": "1789-", "scheme": "LCC", "setSpec": "TENDOjE3ODkt" }, { "name": "LCC:Academies and learned societies", "term": "Academies and learned societies", "scheme": "LCC", "setSpec": "TENDOkFjYWRlbWllcyBhbmQgbGVhcm5lZCBzb2NpZXRpZXM~" }, { "name": "LCC:Accounting. Bookkeeping", "term": "Accounting. Bookkeeping", "scheme": "LCC", "setSpec": "TENDOkFjY291bnRpbmcuIEJvb2trZWVwaW5n" }, { "name": "LCC:Acoustics in engineering. Acoustical engineering", "term": "Acoustics in engineering. Acoustical engineering", "scheme": "LCC", "setSpec": "TENDOkFjb3VzdGljcyBpbiBlbmdpbmVlcmluZy4gQWNvdXN0aWNhbCBlbmdpbmVlcmluZw~~" }, { "name": "LCC:Acoustics. Sound", "term": "Acoustics. Sound", "scheme": "LCC", "setSpec": "TENDOkFjb3VzdGljcy4gU291bmQ~" }, { "name": "LCC:Advertising", "term": "Advertising", "scheme": "LCC", "setSpec": "TENDOkFkdmVydGlzaW5n" }, { "name": "LCC:Aesthetics", "term": "Aesthetics", "scheme": "LCC", "setSpec": "TENDOkFlc3RoZXRpY3M~" }, { "name": "LCC:Aesthetics of cities. City planning and beautifying", "term": "Aesthetics of cities. City planning and beautifying", "scheme": "LCC", "setSpec": "TENDOkFlc3RoZXRpY3Mgb2YgY2l0aWVzLiBDaXR5IHBsYW5uaW5nIGFuZCBiZWF1dGlmeWluZw~~" } ], "provider": "doaj" } ``` --- ### Journal By Issn DOAJ journal lookup by ISSN — the issn: binding over search/journals, matches print and electronic ISSN alike. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/journal-by-issn/:issn` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `issn` | string | path | yes | Print or electronic ISSN, eight characters with an optional hyphen | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/journal-by-issn/:issn" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/journal-by-issn/:issn", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/journal-by-issn/:issn", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "apc": { "max": [ { "price": 2477, "currency": "USD" } ], "url": "https://plos.org/publish/fees/", "hasApc": true }, "ref": { "journal": "https://journals.plos.org/plosone/", "aimsScope": "https://journals.plos.org/plosone/s/journal-information", "oaStatement": "https://journals.plos.org/plosone/s/journal-information#loc-open-access", "licenseTerms": "https://journals.plos.org/plosone/s/licenses-and-copyright", "authorInstructions": "https://journals.plos.org/plosone/s/submission-guidelines" }, "boai": true, "eissn": "1932-6203", "issns": [ "1932-6203" ], "pissn": null, "title": "PLoS ONE", "inDoaj": null, "ticked": true, "waiver": { "url": "https://www.plos.org/fee-assistance", "hasWaiver": true }, "oaStart": 2006, "keywords": [ "science", "medicine", "engineering", "social sciences", "multidisciplinary sciences", "humanities" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by/4.0/", "type": "CC BY" } ], "subjects": [ { "code": "R", "term": "Medicine", "scheme": "LCC" }, { "code": "Q", "term": "Science", "scheme": "LCC" } ], "copyright": { "url": "https://journals.plos.org/plosone/s/licenses-and-copyright", "authorRetains": true }, "createdAt": "2007-03-30T10:53:19Z", "editorial": { "boardUrl": "https://journals.plos.org/plosone/static/editorial-board", "reviewUrl": "https://journals.plos.org/plosone/s/editorial-and-peer-review-process", "reviewProcess": [ "Anonymous peer review" ] }, "journalId": "2fdf1470373343b7bd4f825179c685f5", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Public Library of Science (PLoS)", "country": "US" }, "updatedAt": "2026-02-24T15:59:14Z", "plagiarism": { "url": "https://journals.plos.org/plosone/s/ethical-publishing-practice#loc-plagiarism", "detection": true }, "institution": { "name": null, "country": null }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": "https://portal.issn.org/resource/ISSN/1932-6203", "services": [ "CLOCKSS", "PMC" ], "hasPreservation": true }, "depositPolicy": { "url": "https://openpolicyfinder.jisc.ac.uk/id/publication/17599", "services": [ "Open Policy Finder" ], "hasPolicy": true }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0146294" }, "lastFullReview": null, "alternativeTitle": "PLOS ONE", "lastManualUpdate": null, "publicationTimeWeeks": 29 } ``` --- ### Journal DOAJ journal record by id — open JSON API, no key, rung 1 (direct) per recon. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/journal/:journalId` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `journalId` | string | path | yes | DOAJ journal id, 32 hex characters | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/journal/:journalId" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/journal/:journalId", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/journal/:journalId", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "apc": { "max": [ { "price": 2477, "currency": "USD" } ], "url": "https://plos.org/publish/fees/", "hasApc": true }, "ref": { "journal": "https://journals.plos.org/plosone/", "aimsScope": "https://journals.plos.org/plosone/s/journal-information", "oaStatement": "https://journals.plos.org/plosone/s/journal-information#loc-open-access", "licenseTerms": "https://journals.plos.org/plosone/s/licenses-and-copyright", "authorInstructions": "https://journals.plos.org/plosone/s/submission-guidelines" }, "boai": true, "eissn": "1932-6203", "issns": [ "1932-6203" ], "pissn": null, "title": "PLoS ONE", "inDoaj": true, "ticked": true, "waiver": { "url": "https://www.plos.org/fee-assistance", "hasWaiver": true }, "oaStart": 2006, "keywords": [ "science", "medicine", "engineering", "social sciences", "multidisciplinary sciences", "humanities" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by/4.0/", "type": "CC BY" } ], "subjects": [ { "code": "R", "term": "Medicine", "scheme": "LCC" }, { "code": "Q", "term": "Science", "scheme": "LCC" } ], "copyright": { "url": "https://journals.plos.org/plosone/s/licenses-and-copyright", "authorRetains": true }, "createdAt": "2007-03-30T10:53:19Z", "editorial": { "boardUrl": "https://journals.plos.org/plosone/static/editorial-board", "reviewUrl": "https://journals.plos.org/plosone/s/editorial-and-peer-review-process", "reviewProcess": [ "Anonymous peer review" ] }, "journalId": "2fdf1470373343b7bd4f825179c685f5", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Public Library of Science (PLoS)", "country": "US" }, "updatedAt": "2026-02-24T15:59:14Z", "plagiarism": { "url": "https://journals.plos.org/plosone/s/ethical-publishing-practice#loc-plagiarism", "detection": true }, "institution": { "name": null, "country": null }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": "https://portal.issn.org/resource/ISSN/1932-6203", "services": [ "CLOCKSS", "PMC" ], "hasPreservation": true }, "depositPolicy": { "url": "https://openpolicyfinder.jisc.ac.uk/id/publication/17599", "services": [ "Open Policy Finder" ], "hasPolicy": true }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0146294" }, "lastFullReview": null, "alternativeTitle": "PLOS ONE", "lastManualUpdate": "2026-02-24T15:59:14Z", "publicationTimeWeeks": 29 } ``` --- ### Journals By Country DOAJ journals by publisher country — the bibjson.publisher.country: binding over search/journals. The upstream stores ISO 3166-1 alpha-2 codes only. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/journals-by-country` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `country` | string | query | yes | ISO 3166-1 alpha-2 country code of the publisher | | `page` | number | query | no | Page number. Default 1 | | `limit` | number | query | no | Items per page. Default 10, max 100 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/journals-by-country?country=ID&page=1&limit=10" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/journals-by-country?country=ID&page=1&limit=10", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/journals-by-country?country=ID&page=1&limit=10", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 3, "items": [ { "apc": { "url": "https://jurnal.unej.ac.id/index.php/CERiMRE/charge", "hasApc": false }, "ref": { "journal": "https://jurnal.unej.ac.id/index.php/CERiMRE", "aimsScope": "https://jurnal.unej.ac.id/index.php/CERiMRE/aimsandscopes", "oaStatement": "https://jurnal.unej.ac.id/index.php/CERiMRE/openaccess", "licenseTerms": "https://jurnal.unej.ac.id/index.php/CERiMRE/openaccess", "authorInstructions": "https://jurnal.unej.ac.id/index.php/CERiMRE/information/authors" }, "boai": true, "eissn": "2747-173X", "issns": [ "2747-173X" ], "pissn": null, "title": "Computational and Experimental Research in Materials and Renewable Energy", "inDoaj": null, "ticked": true, "waiver": { "url": null, "hasWaiver": false }, "oaStart": 2018, "keywords": [ "renewable energy", "nuclear materials", "thermoelectric materials", "ptoelectronics materials" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": true, "url": "https://creativecommons.org/licenses/by-sa/4.0/", "type": "CC BY-SA" } ], "subjects": [ { "code": "TJ807-830", "term": "Renewable energy sources", "scheme": "LCC" } ], "copyright": { "url": "https://jurnal.unej.ac.id/index.php/CERiMRE/copyright", "authorRetains": false }, "createdAt": "2022-04-18T05:11:41Z", "editorial": { "boardUrl": "https://jurnal.unej.ac.id/index.php/CERiMRE/about/editorialTeam", "reviewUrl": "https://jurnal.unej.ac.id/index.php/CERiMRE/reviewprocess", "reviewProcess": [ "Peer review" ] }, "journalId": "00087d1be705481c92efc11a6dc42b80", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Physics Department, Faculty of Mathematics and Natural Sciences University of Jember", "country": "ID" }, "updatedAt": "2026-01-15T10:34:08Z", "plagiarism": { "url": "https://jurnal.unej.ac.id/index.php/CERiMRE/sfp", "detection": true }, "institution": { "name": null, "country": null }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": null, "hasPreservation": false }, "depositPolicy": { "url": null, "hasPolicy": false }, "articleLicense": { "display": [ "No" ], "exampleUrl": null }, "lastFullReview": "2022-04-18", "alternativeTitle": "CERiMRE", "lastManualUpdate": null, "publicationTimeWeeks": 10 }, { "apc": { "url": "http://journal.um.ac.id/index.php/jptpp/about/submissions#authorGuidelines", "hasApc": false }, "ref": { "journal": "http://journal.um.ac.id/index.php/jptpp/", "aimsScope": "http://journal.um.ac.id/index.php/jptpp/about/editorialPolicies#focusAndScope", "oaStatement": "http://journal.um.ac.id/index.php/jptpp/about/editorialPolicies#openAccessPolicy", "licenseTerms": "http://journal.um.ac.id/index.php/jptpp/about/submissions#copyrightNotice", "authorInstructions": "http://journal.um.ac.id/index.php/jptpp/about/submissions#authorGuidelines" }, "boai": true, "eissn": "2502-471X", "issns": [ "2502-471X" ], "pissn": null, "title": "Jurnal Pendidikan: Teori, Penelitian, dan Pengembangan", "inDoaj": null, "ticked": true, "waiver": { "url": null, "hasWaiver": false }, "oaStart": 2016, "keywords": [ "education", "theory", "development" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": true, "url": "https://creativecommons.org/licenses/by-sa/4.0/", "type": "CC BY-SA" } ], "subjects": [ { "code": "L", "term": "Education", "scheme": "LCC" }, { "code": "L7-991", "term": "Education (General)", "scheme": "LCC" } ], "copyright": { "url": "http://journal.um.ac.id/index.php/jptpp/about/submissions#copyrightNotice", "authorRetains": true }, "createdAt": "2017-04-13T16:53:44Z", "editorial": { "boardUrl": "http://journal.um.ac.id/index.php/jptpp/about/editorialTeam", "reviewUrl": "http://journal.um.ac.id/index.php/jptpp/about/editorialPolicies#peerReviewProcess", "reviewProcess": [ "Anonymous peer review" ] }, "journalId": "000e412540f3439ea5c661e38986710a", "languages": [ "ID", "EN" ], "pidScheme": { "hasPidScheme": false }, "publisher": { "name": "Pascasarjana Universitas Negeri Malang", "country": "ID" }, "updatedAt": "2026-01-15T10:34:31Z", "plagiarism": { "url": "http://journal.um.ac.id/index.php/jptpp/about/editorialPolicies#peerReviewProcess", "detection": true }, "institution": { "name": "Universitas Negeri Malang", "country": null }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": null, "hasPreservation": false }, "depositPolicy": { "url": null, "hasPolicy": false }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "http://journal.um.ac.id/index.php/jptpp/article/view/8368" }, "lastFullReview": "2024-09-06", "alternativeTitle": null, "lastManualUpdate": null, "publicationTimeWeeks": 4 }, { "apc": { "url": "https://crjim.ub.ac.id/index.php/crjim/about", "hasApc": false }, "ref": { "journal": "https://crjim.ub.ac.id/index.php/crjim/about", "aimsScope": "https://crjim.ub.ac.id/index.php/crjim/about", "oaStatement": "https://crjim.ub.ac.id/index.php/crjim/about", "licenseTerms": "https://crjim.ub.ac.id/index.php/crjim/about", "authorInstructions": "https://crjim.ub.ac.id/index.php/crjim/about/submissions" }, "boai": true, "eissn": "2723-5122", "issns": [ "2723-5130", "2723-5122" ], "pissn": "2723-5130", "title": "Clinical and Research Journal in Internal Medicine", "inDoaj": null, "ticked": true, "waiver": { "url": null, "hasWaiver": false }, "oaStart": 2020, "keywords": [ "internal medicine", "medical education", "internist", "case reports", "review article", "clinical research" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by/4.0/", "type": "CC BY" } ], "subjects": [ { "code": "R5-920", "term": "Medicine (General)", "scheme": "LCC" } ], "copyright": { "url": "https://crjim.ub.ac.id/index.php/crjim/about/submissions", "authorRetains": false }, "createdAt": "2023-02-13T15:33:25Z", "editorial": { "boardUrl": "https://crjim.ub.ac.id/index.php/crjim/about/editorialTeam", "reviewUrl": "https://crjim.ub.ac.id/index.php/crjim/about", "reviewProcess": [ "Peer review" ] }, "journalId": "0043218855474097973a8dd5f19997b5", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Universitas Brawijaya", "country": "ID" }, "updatedAt": "2026-01-15T10:34:08Z", "plagiarism": { "url": "https://crjim.ub.ac.id/index.php/crjim/about", "detection": true }, "institution": { "name": null, "country": null }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": null, "hasPreservation": false }, "depositPolicy": { "url": null, "hasPolicy": false }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://crjim.ub.ac.id/index.php/crjim/article/view/118/104" }, "lastFullReview": "2023-02-13", "alternativeTitle": "CRJIM", "lastManualUpdate": null, "publicationTimeWeeks": 5 } ], "limit": 3, "total": 2730, "country": "ID", "hasMore": true, "nextPage": 2, "provider": "doaj" } ``` --- ### Journals By Publisher DOAJ journals by publisher name — the bibjson.publisher.name: binding over search/journals. The name is phrase-matched, so it must be spelled as DOAJ has it. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/journals-by-publisher` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `publisher` | string | query | yes | Publisher name as DOAJ records it, matched as a phrase | | `page` | number | query | no | Page number. Default 1 | | `limit` | number | query | no | Items per page. Default 10, max 100 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/journals-by-publisher?publisher=Elsevier&page=1&limit=10" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/journals-by-publisher?publisher=Elsevier&page=1&limit=10", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/journals-by-publisher?publisher=Elsevier&page=1&limit=10", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 3, "items": [ { "apc": { "max": [ { "price": 770, "currency": "USD" } ], "url": "https://www.sciencedirect.com/science/journal/24682276/publish/open-access-options", "hasApc": true }, "ref": { "journal": "https://www.sciencedirect.com/journal/scientific-african", "aimsScope": "https://www.sciencedirect.com/journal/scientific-african/about/aims-and-scope", "oaStatement": "https://www.elsevier.com/journals/scientific-african/2468-2276/open-access-journal", "licenseTerms": "https://www.sciencedirect.com/science/journal/24682276/publish/open-access-options", "authorInstructions": "https://www.sciencedirect.com/journal/scientific-african/publish/guide-for-authors" }, "boai": true, "eissn": "2468-2276", "issns": [ "2468-2276" ], "pissn": null, "title": "Scientific African", "inDoaj": null, "ticked": true, "waiver": { "url": "https://www.elsevier.com/authors/open-access/choice#waivers", "hasWaiver": true }, "oaStart": 2018, "keywords": [ "africa", "science", "health", "environment", "engineering" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by/4.0/", "type": "CC BY" }, { "by": true, "nc": true, "nd": true, "sa": false, "url": "https://creativecommons.org/licenses/by-nc-nd/4.0/", "type": "CC BY-NC-ND" } ], "subjects": [ { "code": "Q", "term": "Science", "scheme": "LCC" } ], "copyright": { "url": "https://www.sciencedirect.com/science/journal/24682276/publish/open-access-options", "authorRetains": false }, "createdAt": "2018-12-31T14:59:13Z", "editorial": { "boardUrl": "https://www.sciencedirect.com/journal/scientific-african/about/editorial-board", "reviewUrl": "https://www.sciencedirect.com/journal/scientific-african/publish/guide-for-authors", "reviewProcess": [ "Anonymous peer review" ] }, "journalId": "00d6163fb43b4d8688f414d9727bd1fd", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Elsevier", "country": "NL" }, "updatedAt": "2026-04-27T14:33:15Z", "plagiarism": { "url": null, "detection": false }, "institution": { "name": "Next Einstein Forum (NEF)", "country": "RW" }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": "https://www.elsevier.com/about/policies-and-standards/digital-archive", "services": [ "CLOCKSS", "Portico" ], "hasPreservation": true }, "depositPolicy": { "url": null, "hasPolicy": false }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://www.sciencedirect.com/science/article/pii/S2468227618300176" }, "lastFullReview": "2026-04-27", "alternativeTitle": null, "lastManualUpdate": null, "publicationTimeWeeks": 21 }, { "apc": { "max": [ { "price": 1950, "currency": "USD" } ], "url": "https://www.sciencedirect.com/science/journal/21620989/publish/open-access-options", "hasApc": true }, "ref": { "journal": "https://www.sciencedirect.com/journal/asia-pacific-journal-of-ophthalmology", "aimsScope": "https://www.sciencedirect.com/journal/asia-pacific-journal-of-ophthalmology/about/aims-and-scope", "oaStatement": "https://www.sciencedirect.com/journal/asia-pacific-journal-of-ophthalmology/publish/open-access-options", "licenseTerms": "https://www.sciencedirect.com/science/journal/21620989/publish/open-access-options", "authorInstructions": "https://www.sciencedirect.com/journal/asia-pacific-journal-of-ophthalmology/publish/guide-for-authors" }, "boai": true, "eissn": "2162-0989", "issns": [ "2162-0989" ], "pissn": null, "title": "Asia-Pacific Journal of Ophthalmology", "inDoaj": null, "ticked": true, "waiver": { "url": "https://www.elsevier.com/authors/open-access/choice#waivers", "hasWaiver": true }, "oaStart": 2019, "keywords": [ "ophthalmology", "glaucoma", "cataract", "retina", "ocular oncology", "optometry" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by/4.0/", "type": "CC BY" }, { "by": true, "nc": true, "nd": true, "sa": false, "url": "https://creativecommons.org/licenses/by-nc-nd/4.0/", "type": "CC BY-NC-ND" } ], "subjects": [ { "code": "RE1-994", "term": "Ophthalmology", "scheme": "LCC" } ], "copyright": { "url": "https://www.sciencedirect.com/science/journal/21620989/publish/open-access-options", "authorRetains": false }, "createdAt": "2020-08-05T02:43:52Z", "editorial": { "boardUrl": "https://www.sciencedirect.com/journal/asia-pacific-journal-of-ophthalmology/about/editorial-board", "reviewUrl": "https://www.sciencedirect.com/journal/asia-pacific-journal-of-ophthalmology/publish/guide-for-authors", "reviewProcess": [ "Double anonymous peer review" ] }, "journalId": "012147c22adc4cdebd1edc2c51518dc0", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Elsevier", "country": "US" }, "updatedAt": "2026-04-27T14:13:23Z", "plagiarism": { "url": "https://www.sciencedirect.com/journal/asia-pacific-journal-of-ophthalmology/publish/guide-for-authors", "detection": true }, "institution": { "name": "Asia-Pacific Academy of Ophthalmology", "country": null }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": "https://www.elsevier.com/about/policies-and-standards/digital-archive", "services": [ "CLOCKSS", "Portico" ], "hasPreservation": true }, "depositPolicy": { "url": "https://openpolicyfinder.jisc.ac.uk/id/publication/22833", "services": [ "Open Policy Finder" ], "hasPolicy": true }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://www.sciencedirect.com/science/article/pii/S2162098923000026" }, "lastFullReview": "2026-04-27", "alternativeTitle": null, "lastManualUpdate": null, "publicationTimeWeeks": 21 }, { "apc": { "max": [ { "price": 2890, "currency": "EUR" }, { "price": 3090, "currency": "USD" } ], "url": "https://www.sciencedirect.com/journal/annals-of-intensive-care/publish/open-access-options", "hasApc": true }, "ref": { "journal": "https://www.sciencedirect.com/journal/annals-of-intensive-care", "aimsScope": "https://www.sciencedirect.com/journal/annals-of-intensive-care/about/aims-and-scope", "oaStatement": "https://www.sciencedirect.com/journal/annals-of-intensive-care/publish/open-access-options", "licenseTerms": "https://www.sciencedirect.com/journal/annals-of-intensive-care/publish/open-access-options", "authorInstructions": "https://www.sciencedirect.com/journal/annals-of-intensive-care/publish/guide-for-authors" }, "boai": true, "eissn": "2110-5820", "issns": [ "2110-5820" ], "pissn": null, "title": "Annals of Intensive Care", "inDoaj": null, "ticked": true, "waiver": { "url": "https://www.elsevier.com/researcher/author/open-access/choice#2-waivers", "hasWaiver": true }, "oaStart": 2011, "keywords": [ "critical care", "intensive care medicine" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by/4.0/", "type": "CC BY" }, { "by": true, "nc": true, "nd": true, "sa": false, "url": "https://creativecommons.org/licenses/by-nc-nd/4.0/", "type": "CC BY-NC-ND" } ], "subjects": [ { "code": "RC86-88.9", "term": "Medical emergencies. Critical care. Intensive care. First aid", "scheme": "LCC" } ], "copyright": { "url": "https://www.sciencedirect.com/journal/annals-of-intensive-care/publish/open-access-options", "authorRetains": false }, "createdAt": "2012-06-11T10:09:50Z", "editorial": { "boardUrl": "https://www.sciencedirect.com/journal/annals-of-intensive-care/about/editorial-board", "reviewUrl": "https://www.sciencedirect.com/journal/annals-of-intensive-care/publish/guide-for-authors", "reviewProcess": [ "Anonymous peer review" ] }, "journalId": "014850470c6045b497d64abad23a9ccb", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Elsevier", "country": "NL" }, "updatedAt": "2026-03-23T11:44:26Z", "plagiarism": { "url": "https://www.sciencedirect.com/journal/annals-of-intensive-care/publish/guide-for-authors", "detection": true }, "institution": { "name": "Societe de reanimation de langue francaise", "country": "FR" }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": "https://www.elsevier.com/about/policies-and-standards/digital-archive", "services": [ "CLOCKSS", "PMC", "Portico" ], "hasPreservation": true }, "depositPolicy": { "url": null, "hasPolicy": false }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://www.sciencedirect.com/science/article/pii/S2110582025020291" }, "lastFullReview": "2026-03-23", "alternativeTitle": null, "lastManualUpdate": null, "publicationTimeWeeks": 13 } ], "limit": 3, "total": 853, "hasMore": true, "nextPage": 2, "provider": "doaj", "publisher": "Elsevier" } ``` --- ### Journals By Subject DOAJ journals by subject term — the bibjson.subject.term: binding over search/journals. Terms are Library of Congress Classification headings. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/journals-by-subject` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `subject` | string | query | yes | Library of Congress subject term, matched as a phrase | | `page` | number | query | no | Page number. Default 1 | | `limit` | number | query | no | Items per page. Default 10, max 100 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/journals-by-subject?subject=Medicine&page=1&limit=10" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/journals-by-subject?subject=Medicine&page=1&limit=10", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/journals-by-subject?subject=Medicine&page=1&limit=10", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 3, "items": [ { "apc": { "url": "http://mlj.goums.ac.ir/page/12/About-the-Journal", "hasApc": false }, "ref": { "journal": "http://mlj.goums.ac.ir/index.php", "aimsScope": "http://mlj.goums.ac.ir/page/14/Aims--YW_AND-amp;-Scopes", "oaStatement": "http://mlj.goums.ac.ir/page/12/About-the-Journal", "licenseTerms": "http://mlj.goums.ac.ir/page/12/About-the-Journal", "authorInstructions": "http://mlj.goums.ac.ir/page/19/Instruction-to-Authors" }, "boai": true, "eissn": "2538-4449", "issns": [ "2538-4449" ], "pissn": null, "title": "Medical Laboratory Journal", "inDoaj": null, "ticked": true, "waiver": { "url": "http://mlj.goums.ac.ir/page/12/About-the-Journal", "hasWaiver": true }, "oaStart": 2007, "keywords": [ "medical laboratory", "clinical pathology", "parasitology", "hematology", "microbiology", "virology" ], "licenses": [ { "by": true, "nc": true, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by-nc/4.0/", "type": "CC BY-NC" } ], "subjects": [ { "code": "R", "term": "Medicine", "scheme": "LCC" } ], "copyright": { "url": "http://mlj.goums.ac.ir/page/12/About-the-Journal", "authorRetains": true }, "createdAt": "2021-06-25T09:58:25Z", "editorial": { "boardUrl": "http://mlj.goums.ac.ir/page/13/Editorial-Board", "reviewUrl": "http://mlj.goums.ac.ir/page/12/About-the-Journal", "reviewProcess": [ "Double anonymous peer review" ] }, "journalId": "00023bea7c1444e9aa224df27beff895", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Golestan University of Medical Sciences", "country": "IR" }, "updatedAt": "2026-01-15T10:33:19Z", "plagiarism": { "url": "http://mlj.goums.ac.ir/content/48/Plagiarism", "detection": true }, "institution": { "name": null, "country": null }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": null, "hasPreservation": false }, "depositPolicy": { "url": null, "hasPolicy": false }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "http://mlj.goums.ac.ir/article-1-1284-en.pdf" }, "lastFullReview": "2022-03-01", "alternativeTitle": null, "lastManualUpdate": null, "publicationTimeWeeks": 4 }, { "apc": { "url": "https://crjim.ub.ac.id/index.php/crjim/about", "hasApc": false }, "ref": { "journal": "https://crjim.ub.ac.id/index.php/crjim/about", "aimsScope": "https://crjim.ub.ac.id/index.php/crjim/about", "oaStatement": "https://crjim.ub.ac.id/index.php/crjim/about", "licenseTerms": "https://crjim.ub.ac.id/index.php/crjim/about", "authorInstructions": "https://crjim.ub.ac.id/index.php/crjim/about/submissions" }, "boai": true, "eissn": "2723-5122", "issns": [ "2723-5130", "2723-5122" ], "pissn": "2723-5130", "title": "Clinical and Research Journal in Internal Medicine", "inDoaj": null, "ticked": true, "waiver": { "url": null, "hasWaiver": false }, "oaStart": 2020, "keywords": [ "internal medicine", "medical education", "internist", "case reports", "review article", "clinical research" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by/4.0/", "type": "CC BY" } ], "subjects": [ { "code": "R5-920", "term": "Medicine (General)", "scheme": "LCC" } ], "copyright": { "url": "https://crjim.ub.ac.id/index.php/crjim/about/submissions", "authorRetains": false }, "createdAt": "2023-02-13T15:33:25Z", "editorial": { "boardUrl": "https://crjim.ub.ac.id/index.php/crjim/about/editorialTeam", "reviewUrl": "https://crjim.ub.ac.id/index.php/crjim/about", "reviewProcess": [ "Peer review" ] }, "journalId": "0043218855474097973a8dd5f19997b5", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Universitas Brawijaya", "country": "ID" }, "updatedAt": "2026-01-15T10:34:08Z", "plagiarism": { "url": "https://crjim.ub.ac.id/index.php/crjim/about", "detection": true }, "institution": { "name": null, "country": null }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": null, "hasPreservation": false }, "depositPolicy": { "url": null, "hasPolicy": false }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://crjim.ub.ac.id/index.php/crjim/article/view/118/104" }, "lastFullReview": "2023-02-13", "alternativeTitle": "CRJIM", "lastManualUpdate": null, "publicationTimeWeeks": 5 }, { "apc": { "url": "https://www.russianradiology.ru/jour/about/editorialPolicies#custom-4", "hasApc": false }, "ref": { "journal": "https://www.russianradiology.ru/", "aimsScope": "https://www.russianradiology.ru/jour/about/editorialPolicies#focusAndScope", "oaStatement": "https://www.russianradiology.ru/jour/about/editorialPolicies#openAccessPolicy", "licenseTerms": "https://www.russianradiology.ru/jour/about/submissions#copyrightNotice", "authorInstructions": "https://www.russianradiology.ru/jour/about/submissions#authorGuidelines" }, "boai": true, "eissn": "2619-0478", "issns": [ "0042-4676", "2619-0478" ], "pissn": "0042-4676", "title": "Вестник рентгенологии и радиологии", "inDoaj": null, "ticked": true, "waiver": { "url": null, "hasWaiver": false }, "oaStart": 2014, "keywords": [ "radiology", "imaging", "ct", "mri", "x ray", "contrast agent" ], "licenses": [ { "by": true, "nc": true, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by-nc/4.0/", "type": "CC BY-NC" } ], "subjects": [ { "code": "R895-920", "term": "Medical physics. Medical radiology. Nuclear medicine", "scheme": "LCC" } ], "copyright": { "url": "https://www.russianradiology.ru/jour/about/submissions#copyrightNotice", "authorRetains": false }, "createdAt": "2020-08-26T16:05:15Z", "editorial": { "boardUrl": "https://www.russianradiology.ru/jour/pages/view/EditorialC", "reviewUrl": "https://www.russianradiology.ru/jour/about/editorialPolicies#custom-0", "reviewProcess": [ "Double anonymous peer review" ] }, "journalId": "004e135fffee4ef693ae38dc14193b3f", "languages": [ "RU", "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Luchevaya Diagnostika, LLC", "country": "RU" }, "updatedAt": "2026-01-15T10:33:20Z", "plagiarism": { "url": "https://www.russianradiology.ru/jour/about/editorialPolicies#custom-6", "detection": true }, "institution": { "name": "Russian Society of Radiology", "country": "RU" }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": "https://www.russianradiology.ru/jour/about/editorialPolicies#archiving", "hasPreservation": true }, "depositPolicy": { "url": "https://www.russianradiology.ru/jour/about/editorialPolicies#custom-7", "services": [ "Preprint and postprint Policy" ], "hasPolicy": true }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://www.russianradiology.ru/jour/article/view/562/330" }, "lastFullReview": "2023-03-19", "alternativeTitle": "Journal of Radiology and Nuclear Medicine", "lastManualUpdate": null, "publicationTimeWeeks": 36 } ], "limit": 3, "total": 2658, "hasMore": true, "subject": "Medicine", "nextPage": 2, "provider": "doaj" } ``` --- ### Search Articles DOAJ article search — open JSON API, no key, rung 1 (direct) per recon. Upstream caps (page × pageSize) at 1000 and says so in a 400; harvest-articles is the documented way past it. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/search-articles` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Search terms. Supports field scoping such as doi:, bibjson.title:, bibjson.author.name:, bibjson.journal.country: | | `page` | number | query | no | Page number. Default 1 | | `limit` | number | query | no | Items per page. Default 10, max 100 | | `sort` | enum(relevance|createdAt|updatedAt|title|year) | query | no | Sort field. Default relevance | | `order` | enum(asc|desc) | query | no | Sort direction. Default desc | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/search-articles?query=malaria&page=1&limit=10&sort=relevance&order=desc" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/search-articles?query=malaria&page=1&limit=10&sort=relevance&order=desc", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/search-articles?query=malaria&page=1&limit=10&sort=relevance&order=desc", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 3, "items": [ { "doi": "10.3390/idr12030022", "year": 2020, "links": [ { "url": "https://www.mdpi.com/2036-7449/12/3/22", "type": "fulltext", "contentType": "text/html" } ], "month": 12, "title": "Spontaneous Pathologic Splenic Rupture in a Patient with Plasmodium falciparum Infection, First Case Reported in Israel", "authors": [ { "name": "Yves Weinberg", "orcid": null, "affiliation": "Internal Medicine B Department, Barzilai University Medical Center, Ashkelon 7830604, Israel" }, { "name": "Arie Feldman", "orcid": null, "affiliation": "Internal Medicine B Department, Barzilai University Medical Center, Ashkelon 7830604, Israel" }, { "name": "Daniel J. Jakobson", "orcid": null, "affiliation": "Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheba 8410501, Israel" }, { "name": "Joseph Mishal", "orcid": null, "affiliation": "Internal Medicine B Department, Barzilai University Medical Center, Ashkelon 7830604, Israel" } ], "endPage": "126", "journal": { "issns": [ "2036-7430", "2036-7449" ], "title": "Infectious Disease Reports", "number": "3", "volume": "12", "country": "CH", "language": [ "EN" ], "publisher": "MDPI AG" }, "abstract": "Travelers exposed to malaria may develop severe disease and complications. A less well-known complication is spontaneous pathologic splenic rupture, which is still under-reported and has never been reported in Israel. In this paper, we report a 23 years old healthy young man presenting in the emergency department, two weeks after coming back from Sierra Leone, with intermittent fever, mild tachycardia and mild left upper quadrant abdominal pain. The patient was diagnosed with Plasmodium falciparum infection and developed rapidly after hospital admission spleen rupture. He was managed conservatively at first but ultimately underwent splenectomy after being hemodynamically unstable. In the recovery period, the patient developed acute respiratory distress syndrome and was reintubated. A high level of suspicion is recommended in every malaria patient presenting with left upper quadrant abdominal pain, even if minimal. Ultrasonography availability in the internal medicine department may be a critical diagnostic tool, especially in non-endemic areas.", "keywords": [ "malaria", "spleen rupture", "Plasmodium falciparum" ], "subjects": [ { "code": "RZ201-999", "term": "Other systems of medicine", "scheme": "LCC" } ], "articleId": "0000adb953d74750b348800878889098", "createdAt": "2020-12-09T00:02:48Z", "startPage": "121", "updatedAt": "2025-08-19T23:11:04Z", "identifiers": [ { "id": "10.3390/idr12030022", "type": "doi" }, { "id": "2036-7449", "type": "eissn" } ] }, { "doi": "10.1128/mSphere.00937-20", "year": 2020, "links": [ { "url": "https://journals.asm.org/doi/10.1128/mSphere.00937-20", "type": "fulltext", "contentType": null } ], "month": 10, "title": "Genetic Markers of Adaptation of Plasmodium falciparum to Transmission by American Vectors Identified in the Genomes of Parasites from Haiti and South America", "authors": [ { "name": "Massimiliano S. Tagliamonte", "orcid": null, "affiliation": "Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA" }, { "name": "Charles A. Yowell", "orcid": null, "affiliation": "Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA" }, { "name": "Maha A. Elbadry", "orcid": null, "affiliation": "Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA" }, { "name": "Jacques Boncy", "orcid": null, "affiliation": "Laboratoire National de Santé Publique, Ministère de la Santé Publique et de la Population, Port-au-Prince, Haiti" }, { "name": "Christian P. Raccurt", "orcid": null, "affiliation": "Department of Tropical Medicine and Infectious Diseases, Faculty of Medicine, University of Quisqueya, Port-au-Prince, Haiti" }, { "name": "Bernard A. Okech", "orcid": null, "affiliation": "Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA" }, { "name": "Erica M. Goss", "orcid": null, "affiliation": "Department of Plant Pathology, College of Agricultural and Life Sciences, University of Florida, Gainesville, Florida, USA" }, { "name": "Marco Salemi", "orcid": null, "affiliation": "Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA" } ], "endPage": null, "journal": { "issns": [ "2379-5042" ], "title": "mSphere", "number": "5", "volume": "5", "country": "US", "language": [ "EN" ], "publisher": "American Society for Microbiology" }, "abstract": "ABSTRACT The malaria parasite, Plasmodium falciparum, was introduced into Hispaniola and other regions of the Americas through the slave trade spanning the 16th through the 19th centuries. During this period, more than 12 million Africans were brought across the Atlantic to the Caribbean and other regions of the Americas. Since malaria is holoendemic in West Africa, a substantial percentage of these individuals carried the parasite. St. Domingue on Hispaniola, now modern-day Haiti, was a major port of disembarkation, and malaria is still actively transmitted there. We undertook a detailed study of the phylogenetics of the Haitian parasites and those from Colombia and Peru utilizing whole-genome sequencing. Principal-component and phylogenetic analyses, based upon single nucleotide polymorphisms (SNPs) in protein coding regions, indicate that, despite the potential for millions of introductions from Africa, the Haitian parasites share an ancestral relationship within a well-supported monophyletic clade with parasites from South America, while belonging to a distinct lineage. This result, in stark contrast to the historical record of parasite introductions, is best explained by a severe population bottleneck experienced by the parasites introduced into the Americas. Here, evidence is presented for targeted selection of rare African alleles in genes which are expressed in the mosquito stages of the parasite’s life cycle. These genetic markers support the hypothesis that the severe population bottleneck was caused by the required adaptation of the parasite to transmission by new definitive hosts among the Anopheles (Nyssorhynchus) spp. found in the Caribbean and South America. IMPORTANCE Historical data suggest that millions of P. falciparum parasite lineages were introduced into the Americas during the trans-Atlantic slave trade, which would suggest a paraphyletic origin of the extant isolates in the Western Hemisphere. Our analyses of whole-genome variants show that the American parasites belong to a well-supported monophyletic clade. We hypothesize that the required adaptation to American vectors created a severe bottleneck, reducing the effective introduction to a few lineages. In support of this hypothesis, we discovered genes expressed in the mosquito stages of the life cycle that have alleles with multiple, high-frequency or fixed, nonsynonymous mutations in the American populations which are rarely found in African isolates. These alleles appear to be in gene products critical for transmission through the anopheline vector. Thus, these results may inform efforts to develop novel transmission-blocking vaccines by identifying parasite proteins functionally interacting with the vector that are important for successful transmission. Further, to the best of our knowledge, these are the first whole-genome data available from Haitian P. falciparum isolates. Defining the genome of these parasites provides genetic markers useful for mapping parasite populations and monitoring parasite movements/introductions.", "keywords": [ "Haiti", "Plasmodium falciparum", "adaptive mutations", "evolutionary biology", "malaria", "phylogenetics" ], "subjects": [ { "code": "QR1-502", "term": "Microbiology", "scheme": "LCC" } ], "articleId": "0000e17190e246e6b2621356f3ffcae1", "createdAt": "2021-11-15T15:30:41Z", "startPage": null, "updatedAt": "2025-08-19T18:08:29Z", "identifiers": [ { "id": "10.1128/mSphere.00937-20", "type": "doi" }, { "id": "2379-5042", "type": "eissn" } ] }, { "doi": "10.4103/jfmpc.jfmpc_1169_19", "year": 2020, "links": [ { "url": "http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=5;spage=2420;epage=2425;aulast=Chowdhury", "type": "fulltext", "contentType": "html" } ], "month": null, "title": "A comparative study on knowledge and practice against malaria among Accredited Social Health Activists (ASHAs) of low and high endemic regions of Tripura, Northeast India", "authors": [ { "name": "Purvita Chowdhury", "orcid": null, "affiliation": null }, { "name": "Subrata Baidya", "orcid": null, "affiliation": null }, { "name": "Debosmita Paul", "orcid": null, "affiliation": null }, { "name": "Biraj Kalita", "orcid": null, "affiliation": null }, { "name": "Gunendra Saikia", "orcid": null, "affiliation": null }, { "name": "Sanjoy Karmakar", "orcid": null, "affiliation": null }, { "name": "Sanghita Paul", "orcid": null, "affiliation": null } ], "endPage": "2425", "journal": { "issns": [ "2249-4863", "2278-7135" ], "title": "Journal of Family Medicine and Primary Care", "number": "5", "volume": "9", "country": "IN", "language": [ "EN" ], "publisher": "Wolters Kluwer Medknow Publications" }, "abstract": "Introduction: This study was conducted to compare and evaluate the knowledge as well as the practice of community health volunteers, Accredited social health activists (ASHAs) in low and high malaria-endemic regions of Tripura, Northeast India. Materials and Methods: In this descriptive cross-sectional study, all ASHAs working in the randomly selected two blocks of each low and high malaria-endemic areas were included in the study. While ASHAs with less than 1-year experience were excluded from the study. The ASHAs were interviewed and information was gathered on knowledge and practice against malaria management. Chi-square test was used to identify differences in responses among the ASHAs. Results: Significant differences in knowledge of mixed malarial infection (P < 0.001) and early symptoms of malaria (P = 0.005) were observed when responses of high malaria-endemic ASHAs (HMEA) were compared to low endemic ASHAs (LMEA). With respect to malaria testing skills, 83.16% HMEA affirmed that they could perform Rapid diagnostic (RD) kit tests as opposed to 57.24% LMEA, (P < 0.001). Disturbingly only two HMEA could correctly describe the duration for Pf and Pv treatment. Conclusion: The study identifies major lacunae in the balance of knowledge and practices of ASHAs in both study areas of Tripura. Therefore,for a successful projected malaria elimination program, community-level ASHA volunteers need to have accurate malaria knowledge and management approaches irrespective of the endemicity. This study will help to understand the operational constraints and plan educational training for ASHA volunteers in malaria-endemic regions.", "keywords": [ "asha", "indigenous population", "knowledge and practice", "malaria endemic" ], "subjects": [ { "code": "R", "term": "Medicine", "scheme": "LCC" } ], "articleId": "0002038d8ae14f6b9835a3496862bf18", "createdAt": "2020-06-05T03:31:03Z", "startPage": "2420", "updatedAt": "2025-08-19T20:12:11Z", "identifiers": [ { "id": "2249-4863", "type": "pissn" }, { "id": "10.4103/jfmpc.jfmpc_1169_19", "type": "doi" } ] } ], "limit": 3, "query": "malaria", "total": 35766, "hasMore": true, "nextPage": 2, "provider": "doaj" } ``` --- ### Search Journals DOAJ journal search — open JSON API, no key, rung 1 (direct) per recon. Upstream caps (page × pageSize) at 1000 and says so in a 400; harvest-journals is the documented way past it. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:doaj/search-journals` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Search terms. Supports field scoping such as issn:, bibjson.title:, bibjson.publisher.name:, bibjson.publisher.country:, bibjson.subject.term: | | `page` | number | query | no | Page number. Default 1 | | `limit` | number | query | no | Items per page. Default 10, max 100 | | `sort` | enum(relevance|createdAt|updatedAt|title) | query | no | Sort field. Default relevance | | `order` | enum(asc|desc) | query | no | Sort direction. Default desc | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:doaj/search-journals?query=open%20access%20medicine&page=1&limit=10&sort=relevance&order=desc" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:doaj/search-journals?query=open%20access%20medicine&page=1&limit=10&sort=relevance&order=desc", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:doaj/search-journals?query=open%20access%20medicine&page=1&limit=10&sort=relevance&order=desc", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 3, "items": [ { "apc": { "url": "https://link.springer.com/journal/43046/how-to-publish-with-us#Fees%20and%20funding", "hasApc": false }, "ref": { "journal": "https://jenci.springeropen.com", "aimsScope": "https://jenci.springeropen.com/about", "oaStatement": "https://jenci.springeropen.com/about", "licenseTerms": "https://jenci.springeropen.com/submission-guidelines/copyright", "authorInstructions": "https://jenci.springeropen.com/submission-guidelines" }, "boai": true, "eissn": "2589-0409", "issns": [ "1110-0362", "2589-0409" ], "pissn": "1110-0362", "title": "Journal of the Egyptian National Cancer Institute", "inDoaj": null, "ticked": true, "waiver": { "url": null, "hasWaiver": false }, "oaStart": 2011, "keywords": [ "cancer", "chemotherapy", "neoplasia", "oncology" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by/4.0/", "type": "CC BY" }, { "by": true, "nc": true, "nd": true, "sa": false, "url": "https://creativecommons.org/licenses/by-nc-nd/4.0/", "type": "CC BY-NC-ND" } ], "subjects": [ { "code": "RC254-282", "term": "Neoplasms. Tumors. Oncology. Including cancer and carcinogens", "scheme": "LCC" } ], "copyright": { "url": "https://jenci.springeropen.com/submission-guidelines/copyright", "authorRetains": true }, "createdAt": "2016-05-10T11:36:34Z", "editorial": { "boardUrl": "https://jenci.springeropen.com/about/editorial-board", "reviewUrl": "https://jenci.springeropen.com/about", "reviewProcess": [ "Double anonymous peer review" ] }, "journalId": "008e9712ea7d4bd98104d89b5128953a", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "SpringerOpen", "country": "GB" }, "updatedAt": "2026-03-17T11:38:31Z", "plagiarism": { "url": "https://www.springeropen.com/get-published/editorial-policies", "detection": true }, "institution": { "name": "Cairo University, National Cancer Institute", "country": null }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": "https://www.springeropen.com/get-published/indexing-archiving-and-access-to-data/journal-archiving", "services": [ "CLOCKSS", "Portico" ], "hasPreservation": true }, "depositPolicy": { "url": "https://openpolicyfinder.jisc.ac.uk/publication/20814?from=single_hit", "services": [ "Open Policy Finder" ], "hasPolicy": true }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://jenci.springeropen.com/articles/10.1186/s43046-019-0004-1#rightslink" }, "lastFullReview": "2026-03-17", "alternativeTitle": null, "lastManualUpdate": null, "publicationTimeWeeks": 11 }, { "apc": { "max": [ { "price": 2320, "currency": "GBP" }, { "price": 3150, "currency": "USD" }, { "price": 2850, "currency": "EUR" } ], "url": "https://www.cambridge.org/core/journals/european-psychiatry/information/author-instructions/fees-and-pricing", "hasApc": true }, "ref": { "journal": "https://www.cambridge.org/core/journals/european-psychiatry", "aimsScope": "https://www.cambridge.org/core/journals/european-psychiatry/information", "oaStatement": "https://www.cambridge.org/core/journals/european-psychiatry/information/open-access", "licenseTerms": "https://www.cambridge.org/core/journals/european-psychiatry/information/open-access", "authorInstructions": "https://www.cambridge.org/core/journals/european-psychiatry/information/instructions-contributors" }, "boai": true, "eissn": "1778-3585", "issns": [ "0924-9338", "1778-3585" ], "pissn": "0924-9338", "title": "European Psychiatry", "inDoaj": null, "ticked": true, "waiver": { "url": "https://www.cambridge.org/core/journals/european-psychiatry/information/journal-policies/open-access-options", "hasWaiver": true }, "oaStart": 2020, "keywords": [ "mental health", "psychiatry", "psychological medicine", "cognitive science", "behavioural science" ], "licenses": [ { "by": true, "nc": false, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by/4.0/", "type": "CC BY" }, { "by": true, "nc": true, "nd": false, "sa": true, "url": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "type": "CC BY-NC-SA" }, { "by": true, "nc": true, "nd": true, "sa": false, "url": "https://creativecommons.org/licenses/by-nc-nd/4.0/", "type": "CC BY-NC-ND" } ], "subjects": [ { "code": "RC435-571", "term": "Psychiatry", "scheme": "LCC" } ], "copyright": { "url": "https://www.cambridge.org/core/journals/european-psychiatry/information/author-instructions/publishing-agreement", "authorRetains": true }, "createdAt": "2020-05-04T11:02:25Z", "editorial": { "boardUrl": "https://www.cambridge.org/core/journals/european-psychiatry/information/editorial-board", "reviewUrl": "https://www.cambridge.org/core/journals/european-psychiatry/information/instructions-contributors", "reviewProcess": [ "Anonymous peer review" ] }, "journalId": "00c4bb2ee62f4cf985980c7dca852c55", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Cambridge University Press", "country": "GB" }, "updatedAt": "2026-03-17T11:55:07Z", "plagiarism": { "url": null, "detection": false }, "institution": { "name": "European Psychiatric Association", "country": null }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": "https://www.cambridge.org/core/journals/european-psychiatry/information/instructions-contributors#preservation", "services": [ "CLOCKSS", "Portico" ], "hasPreservation": true }, "depositPolicy": { "url": "https://openpolicyfinder.jisc.ac.uk/publication/13242", "services": [ "Open Policy Finder" ], "hasPolicy": true }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://www.cambridge.org/core/journals/european-psychiatry/article/neutrophiltolymphocyte-ratio-a-potential-new-peripheral-biomarker-of-suicidal-behavior/A469E4B3F99B3BB452C2AAD3C99C074C#fndtn-information" }, "lastFullReview": "2026-03-17", "alternativeTitle": null, "lastManualUpdate": null, "publicationTimeWeeks": 21 }, { "apc": { "url": "https://www.intcarper.com/article-processing-charges-apc", "hasApc": false }, "ref": { "journal": "https://www.intcarper.com/", "aimsScope": "https://www.intcarper.com/aims-and-scope", "oaStatement": "https://www.intcarper.com/open-access", "licenseTerms": "https://www.intcarper.com/copyright-and-licensing", "authorInstructions": "https://www.intcarper.com/instruction-to-authors" }, "boai": true, "eissn": "3062-3227", "issns": [ "3062-3227" ], "pissn": null, "title": "Interventional Cardiology Perspectives", "inDoaj": null, "ticked": true, "waiver": { "url": null, "hasWaiver": false }, "oaStart": 2025, "keywords": [ "cardiology", "cardiovascular medicine" ], "licenses": [ { "by": true, "nc": true, "nd": false, "sa": false, "url": "https://creativecommons.org/licenses/by-nc/4.0/", "type": "CC BY-NC" } ], "subjects": [ { "code": "RC666-701", "term": "Diseases of the circulatory (Cardiovascular) system", "scheme": "LCC" } ], "copyright": { "url": "https://www.intcarper.com/copyright-and-licensing", "authorRetains": false }, "createdAt": "2026-07-06T09:58:12Z", "editorial": { "boardUrl": "https://www.intcarper.com/editorial-board", "reviewUrl": "https://www.intcarper.com/peer-review-policy", "reviewProcess": [ "Double anonymous peer review" ] }, "journalId": "00e48985497d425a96469e4e16eae614", "languages": [ "EN" ], "pidScheme": { "schemes": [ "DOI" ], "hasPidScheme": true }, "publisher": { "name": "Galenos Publishing House", "country": "TR" }, "updatedAt": "2026-07-06T09:58:12Z", "plagiarism": { "url": "https://www.intcarper.com/ethical-misconduct", "detection": true }, "institution": { "name": "Society of Cardiovascular Interventions", "country": "TR" }, "otherCharges": { "url": null, "hasOtherCharges": false }, "preservation": { "url": "https://www.intcarper.com/archiving-and-preservation", "services": [ "web archive" ], "hasPreservation": true }, "depositPolicy": { "url": null, "hasPolicy": false }, "articleLicense": { "display": [ "Embed" ], "exampleUrl": "https://www.intcarper.com/pdf/4458d962-0fb2-48a3-a23a-e35265f70f9b/articles/intercardiopers.2025.2025-9-5/87-97.pdf" }, "lastFullReview": null, "alternativeTitle": null, "lastManualUpdate": null, "publicationTimeWeeks": 17 } ], "limit": 3, "query": "open access medicine", "total": 1780, "hasMore": true, "nextPage": 2, "provider": "doaj" } ``` --- ## Europe PMC **Category:** research · **Slug:** `europepmc` **Detail page:** https://zapi.ink/api/research/europepmc Europe PMC life-science literature — search, citations, references, full text, books, supplementary files, text-mined annotations and grants. **Tags:** europepmc, literature, open-access, biomedical, citations ### Annotations By Article Text-mined entities for named articles. This replaces the retired textMinedTerms route; one unfiltered article can exceed 130 KB, so the body is read under a ceiling. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/annotations-by-article` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `articleIds` | string | query | yes | One or more SOURCE:ID pairs separated by commas, such as MED:33301246,PMC:PMC7745181. Up to 8 per call | | `type` | enum(Gene_Proteins|Chemicals|Diseases|Organisms|Accession Numbers|Gene Ontology|Sequence Ontology|Experimental Methods|Cell|Cell Line|Body Part) | query | no | Restrict to one entity type. Default all types | | `section` | enum(Title|Abstract|Introduction|Methods|Results|Discussion|Conclusion) | query | no | Restrict to one article section. Default all sections | | `annotationProvider` | string | query | no | Restrict to one annotation provider. Default all providers | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/annotations-by-article?articleIds=MED%3A33301246&type=Diseases§ion=Abstract&annotationProvider=Europe%20PMC" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/annotations-by-article?articleIds=MED%3A33301246&type=Diseases§ion=Abstract&annotationProvider=Europe%20PMC", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/annotations-by-article?articleIds=MED%3A33301246&type=Diseases§ion=Abstract&annotationProvider=Europe%20PMC", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 1, "items": [ { "id": "33301246", "count": 8, "pmcid": "PMC7745181", "source": "MED", "annotations": [ { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C3714514", "name": "infestations and infections" } ], "type": "Diseases", "exact": "infection", "prefix": "coronavirus 2 (SARS-CoV-2)", "postfix": "and the resulting", "section": "Abstract (http://purl.org/dc/terms/abstract)", "frequency": null, "annotationId": "http://europepmc.org/article/MED/33301246#europepmc-2faf2bd76e3bbc392264592dd9233545", "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C5203670", "name": "caused by sarscov2" } ], "type": "Diseases", "exact": "coronavirus disease 2019", "prefix": "and the resulting", "postfix": "disease 2019 (Covid-19)", "section": "Abstract (http://purl.org/dc/terms/abstract)", "frequency": null, "annotationId": "http://europepmc.org/article/MED/33301246#europepmc-7e5d5f7cd73d9b67569981d4a0b22dcb", "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C5203670", "name": "caused by sarscov2" } ], "type": "Diseases", "exact": "Covid-19", "prefix": "coronavirus disease 2019 (", "postfix": ") have afflicted tens", "section": "Abstract (http://purl.org/dc/terms/abstract)", "frequency": null, "annotationId": "http://europepmc.org/article/MED/33301246#europepmc-6f8bcca3fcd3b25894f64051db8fe268", "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C5203670", "name": "caused by sarscov2" } ], "type": "Diseases", "exact": "Covid-19", "prefix": "8 cases of", "postfix": "with onset at", "section": "Abstract (http://purl.org/dc/terms/abstract)", "frequency": null, "annotationId": "http://europepmc.org/article/MED/33301246#europepmc-c1eba6c1ecf105a226e8018c3198fbb9", "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C4015542", "name": "nphp19" } ], "type": "Diseases", "exact": "-19", "prefix": "effective in preventing Covid", "postfix": "(95% credible interval,", "section": "Abstract (http://purl.org/dc/terms/abstract)", "frequency": null, "annotationId": "http://europepmc.org/article/MED/33301246#europepmc-245ee7e47aba17ad0b9a8cf7dda8ce4b", "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C5203670", "name": "caused by sarscov2" } ], "type": "Diseases", "exact": "Covid-19", "prefix": "cases of severe", "postfix": "with onset after", "section": "Abstract (http://purl.org/dc/terms/abstract)", "frequency": null, "annotationId": "http://europepmc.org/article/MED/33301246#europepmc-c9b8eec0b6d3a19d870ba3396b50a621", "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C5203670", "name": "caused by sarscov2" } ], "type": "Diseases", "exact": "Covid-19", "prefix": "95% protection against", "postfix": "in persons 16", "section": "Abstract (http://purl.org/dc/terms/abstract)", "frequency": null, "annotationId": "http://europepmc.org/article/MED/33301246#europepmc-357ba54785956dff304a9d811f94e755", "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C5203670", "name": "caused by sarscov2" } ], "type": "Diseases", "exact": "Covid-19", "prefix": "e against laboratory-confirmed", "postfix": "and safety.", "section": "Abstract (http://purl.org/dc/terms/abstract)", "frequency": null, "annotationId": "http://europepmc.org/article/MED/33301246#europepmc-773e97947b1b24c615a36cd3f8f94e1f", "annotationProvider": "Europe PMC" } ], "fullTextIds": [ "PMC7745181" ] } ], "provider": "europepmc", "articleIds": [ "MED:33301246" ] } ``` --- ### Annotations By Provider Bulk annotation stream for one provider. Measured at ~820 KB per article, so the page size is capped hard and the body is read against a ceiling and the deadline. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/annotations-by-provider` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `annotationProvider` | string | query | yes | Annotation provider to stream, such as Europe PMC, IntAct or OpenTargets | | `cursor` | string | query | no | Cursor for the next slice. Start at 0 then pass nextCursor | | `limit` | number | query | no | Articles per call. Default 1, max 3 — one article averages 820 KB | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/annotations-by-provider?annotationProvider=Europe%20PMC&cursor=0&limit=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/annotations-by-provider?annotationProvider=Europe%20PMC&cursor=0&limit=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/annotations-by-provider?annotationProvider=Europe%20PMC&cursor=0&limit=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 1, "items": [ { "id": "PMC11231130", "count": 4539, "pmcid": "PMC11231130", "source": "PMC", "annotations": [ { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C0007222", "name": "Cardiovascular Disease" } ], "type": "Diseases", "exact": "Cardiovascular Disease", "prefix": null, "postfix": null, "section": null, "frequency": 43, "annotationId": null, "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C1609538", "name": "Latent Tuberculosis Infection" } ], "type": "Diseases", "exact": "Latent Tuberculosis Infection", "prefix": null, "postfix": null, "section": null, "frequency": 4, "annotationId": null, "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C0242339", "name": "dyslipidemia" } ], "type": "Diseases", "exact": "dyslipidemia", "prefix": null, "postfix": null, "section": null, "frequency": 15, "annotationId": null, "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C0011847", "name": "diabetes" } ], "type": "Diseases", "exact": "diabetes", "prefix": null, "postfix": null, "section": null, "frequency": 470, "annotationId": null, "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C0020538", "name": "hypertension" } ], "type": "Diseases", "exact": "hypertension", "prefix": null, "postfix": null, "section": null, "frequency": 452, "annotationId": null, "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C0028754", "name": "Obesity" } ], "type": "Diseases", "exact": "Obesity", "prefix": null, "postfix": null, "section": null, "frequency": 240, "annotationId": null, "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://linkedlifedata.com/resource/umls-concept/C0008679", "name": "chronic diseases" } ], "type": "Diseases", "exact": "chronic diseases", "prefix": null, "postfix": null, "section": null, "frequency": 23, "annotationId": null, "annotationProvider": "Europe PMC" }, { "tags": [ { "uri": "http://www.ebi.ac.uk/efo/EFO_0010064", "name": "pharmacotherapy" } ], "type": "Experimental Methods", "exact": "pharmacotherapy", "prefix": null, "postfix": null, "section": null, "frequency": 23, "annotationId": null, "annotationProvider": "Europe PMC" } ], "fullTextIds": [ "PMC11231130" ] } ], "limit": 1, "hasMore": true, "provider": "europepmc", "nextCursor": "28754.31123113", "annotationProvider": "Europe PMC" } ``` --- ### Article One Europe PMC record, resolved through the EXT_ID+SRC fast path of /search at resultType=core — the only shape that carries all 48 fields and the has* routing flags. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/article` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Article identifier within the source — a PMID for MED, a PMCID for PMC | | `source` | enum(MED|PMC|PPR|AGR|CBA|CTX|ETH|HIR|PAT|NBK) | query | no | Source archive the id belongs to. Default MED | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/article?id=33301246&source=MED" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/article?id=33301246&source=MED", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/article?id=33301246&source=MED", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "id": "33301246", "doi": "10.1056/nejmoa2034577", "pmid": "33301246", "inPMC": true, "pmcid": "PMC7745181", "title": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.", "grants": [ { "agency": "BioNTech and Pfizer", "acronym": null, "grantId": null, "orderIn": 0 } ], "hasPDF": true, "inEPMC": true, "source": "MED", "authMan": false, "authors": [ { "orcid": null, "fullName": "Polack FP", "initials": "FP", "lastName": "Polack", "firstName": "Fernando P", "affiliations": [ "From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.)." ], "collectiveName": null }, { "orcid": null, "fullName": "Thomas SJ", "initials": "SJ", "lastName": "Thomas", "firstName": "Stephen J", "affiliations": [ "From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.)." ], "collectiveName": null }, { "orcid": null, "fullName": "Kitchin N", "initials": "N", "lastName": "Kitchin", "firstName": "Nicholas", "affiliations": [ "From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.)." ], "collectiveName": null }, { "orcid": null, "fullName": "Absalon J", "initials": "J", "lastName": "Absalon", "firstName": "Judith", "affiliations": [ "From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.)." ], "collectiveName": null }, { "orcid": null, "fullName": "Gurtman A", "initials": "A", "lastName": "Gurtman", "firstName": "Alejandra", "affiliations": [ "From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.)." ], "collectiveName": null }, { "orcid": "0000-0002-0805-2193", "fullName": "Lockhart S", "initials": "S", "lastName": "Lockhart", "firstName": "Stephen", "affiliations": [ "From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.)." ], "collectiveName": null }, { "orcid": null, "fullName": "Perez JL", "initials": "JL", "lastName": "Perez", "firstName": "John L", "affiliations": [ "From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.)." ], "collectiveName": null }, { "orcid": null, "fullName": "Pérez Marc G", "initials": "G", "lastName": "Pérez Marc", "firstName": "Gonzalo", "affiliations": [ "From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.)." ], "collectiveName": null } ], "hasBook": false, "hasData": true, "license": null, "pubYear": 2020, "subsets": [ { "code": "IM", "name": "Index Medicus" } ], "abstract": "

Background

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently.

Methods

In an ongoing multinational, placebo-controlled, observer-blinded, pivotal efficacy trial, we randomly assigned persons 16 years of age or older in a 1:1 ratio to receive two doses, 21 days apart, of either placebo or the BNT162b2 vaccine candidate (30 μg per dose). BNT162b2 is a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. The primary end points were efficacy of the vaccine against laboratory-confirmed Covid-19 and safety.

Results

A total of 43,548 participants underwent randomization, of whom 43,448 received injections: 21,720 with BNT162b2 and 21,728 with placebo. There were 8 cases of Covid-19 with onset at least 7 days after the second dose among participants assigned to receive BNT162b2 and 162 cases among those assigned to placebo; BNT162b2 was 95% effective in preventing Covid-19 (95% credible interval, 90.3 to 97.6). Similar vaccine efficacy (generally 90 to 100%) was observed across subgroups defined by age, sex, race, ethnicity, baseline body-mass index, and the presence of coexisting conditions. Among 10 cases of severe Covid-19 with onset after the first dose, 9 occurred in placebo recipients and 1 in a BNT162b2 recipient. The safety profile of BNT162b2 was characterized by short-term, mild-to-moderate pain at the injection site, fatigue, and headache. The incidence of serious adverse events was low and was similar in the vaccine and placebo groups.

Conclusions

A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines. (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728.).", "hasSuppl": true, "language": "eng", "pageInfo": "2603-2615", "provider": "europepmc", "pubModel": "Print-Electronic", "pubTypes": [ "Clinical Trial, Phase III", "Clinical Trial, Phase II", "Research Support, Non-U.S. Gov't", "research-article", "Multicenter Study", "Randomized Controlled Trial", "Journal Article" ], "authorIds": [ { "type": "ORCID", "value": "0000-0001-6269-2354" }, { "type": "ORCID", "value": "0000-0001-9876-0267" }, { "type": "ORCID", "value": "0000-0002-0805-2193" }, { "type": "ORCID", "value": "0000-0002-4826-1790" }, { "type": "ORCID", "value": "0000-0002-7081-8348" }, { "type": "ORCID", "value": "0000-0002-8368-7682" }, { "type": "ORCID", "value": "0000-0003-1184-4711" }, { "type": "ORCID", "value": "0000-0003-1514-1685" } ], "chemicals": [ { "name": "Vaccines, Synthetic", "registryNumber": "0" }, { "name": "COVID-19 Vaccines", "registryNumber": "0" }, { "name": "BNT162 vaccine", "registryNumber": "0" }, { "name": "mRNA Vaccines", "registryNumber": "0" } ], "nihAuthMan": false, "affiliation": "From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).", "epmcAuthMan": false, "fullTextIds": [ "PMC7745181" ], "journalInfo": { "issue": "27", "volume": "383", "journal": { "essn": "1533-4406", "issn": "0028-4793", "nlmId": "0255562", "title": "The New England journal of medicine", "isoAbbreviation": "N Engl J Med", "medlineAbbreviation": "N Engl J Med" }, "journalIssueId": 3059948, "dateOfPublication": "2020 Dec", "yearOfPublication": 2020, "monthOfPublication": 12, "printPublicationDate": "2020-12-01" }, "authorString": "Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC, C4591001 Clinical Trial Group.", "citedByCount": 12438, "fullTextUrls": [ { "url": "https://www.arca.fiocruz.br/handle/icict/46039", "site": "Unpaywall", "availability": "Open access", "documentStyle": "html", "availabilityCode": "OA" }, { "url": "https://doi.org/10.1056/NEJMoa2034577", "site": "DOI", "availability": "Subscription required", "documentStyle": "doi", "availabilityCode": "S" }, { "url": "https://europepmc.org/articles/PMC7745181", "site": "Europe_PMC", "availability": "Open access", "documentStyle": "html", "availabilityCode": "OA" }, { "url": "https://europepmc.org/articles/PMC7745181?pdf=render", "site": "Europe_PMC", "availability": "Open access", "documentStyle": "pdf", "availabilityCode": "OA" } ], "hasLabsLinks": true, "isOpenAccess": true, "meshHeadings": [ { "majorTopic": false, "descriptorName": "Humans" }, { "majorTopic": false, "qualifiers": [ { "majorTopic": false, "abbreviation": "ET", "qualifierName": "etiology" } ], "descriptorName": "Headache" }, { "majorTopic": false, "qualifiers": [ { "majorTopic": false, "abbreviation": "ET", "qualifierName": "etiology" } ], "descriptorName": "Fatigue" }, { "majorTopic": false, "descriptorName": "Vaccines, Synthetic" }, { "majorTopic": false, "descriptorName": "Treatment Outcome" }, { "majorTopic": false, "descriptorName": "Immunization, Secondary" }, { "majorTopic": false, "descriptorName": "Single-Blind Method" }, { "majorTopic": false, "descriptorName": "Adolescent" } ], "dataLinksTags": [ "altmetrics", "supporting_data", "recommended_reviews" ], "hasReferences": true, "investigators": [ { "orcid": null, "fullName": "Aberg J", "initials": "J", "lastName": "Aberg", "firstName": "Judith", "collectiveName": null }, { "orcid": "0000-0003-2836-9224", "fullName": "Addo M", "initials": "M", "lastName": "Addo", "firstName": "Marylyn", "collectiveName": null }, { "orcid": null, "fullName": "Akhan S", "initials": "S", "lastName": "Akhan", "firstName": "Sıla", "collectiveName": null }, { "orcid": null, "fullName": "Albertson T", "initials": "T", "lastName": "Albertson", "firstName": "Timothy", "collectiveName": null }, { "orcid": null, "fullName": "Al-Ibrahim M", "initials": "M", "lastName": "Al-Ibrahim", "firstName": "Mohamed", "collectiveName": null }, { "orcid": null, "fullName": "Altın S", "initials": "S", "lastName": "Altın", "firstName": "Sedat", "collectiveName": null }, { "orcid": null, "fullName": "Anderson C", "initials": "C", "lastName": "Anderson", "firstName": "Corey", "collectiveName": null }, { "orcid": null, "fullName": "Andrews C", "initials": "C", "lastName": "Andrews", "firstName": "Charles", "collectiveName": null } ], "dateOfCreation": "2020-12-10", "dateOfRevision": "2026-01-27", "firstIndexDate": "2020-12-11", "hasEvaluations": false, "dateOfCompletion": "2021-01-12", "tmAccessionTypes": [ "nct" ], "hasTextMinedTerms": true, "publicationStatus": "ppublish", "commentCorrections": [ { "id": "33301245", "type": "Comment in", "source": "MED", "orderIn": 1, "reference": "N Engl J Med. 2020 Dec 31;383(27):2677-2678. doi: 10.1056/NEJMe2034717." }, { "id": "33311629", "type": "Comment in", "source": "MED", "orderIn": 2, "reference": "Nature. 2020 Dec;588(7838):377-378. doi: 10.1038/d41586-020-03542-4." }, { "id": "33478841", "type": "Comment in", "source": "MED", "orderIn": 3, "reference": "Semergen. 2021 Jan-Feb;47(1):1-3. doi: 10.1016/j.semerg.2020.12.005." }, { "id": "33480519", "type": "Comment in", "source": "MED", "orderIn": 4, "reference": "Panminerva Med. 2022 Mar;64(1):131-132. doi: 10.23736/S0031-0808.21.04286-5." }, { "id": "33524290", "type": "Comment in", "source": "MED", "orderIn": 5, "reference": "Ann Intern Med. 2021 Feb;174(2):JC15. doi: 10.7326/ACPJ202102160-015." }, { "id": "33527275", "type": "Comment in", "source": "MED", "orderIn": 6, "reference": "MMW Fortschr Med. 2021 Feb;163(2):24-25. doi: 10.1007/s15006-021-9577-4." }, { "id": "33596348", "type": "Comment in", "source": "MED", "orderIn": 7, "reference": "N Engl J Med. 2021 Apr 22;384(16):1576-1577. doi: 10.1056/NEJMc2036242." }, { "id": "33596349", "type": "Comment in", "source": "MED", "orderIn": 8, "reference": "N Engl J Med. 2021 Apr 22;384(16):1577. doi: 10.1056/NEJMc2036242." } ], "firstPublicationDate": "2020-12-10", "fullTextReceivedDate": "2025-02-03", "hasDbCrossReferences": false, "hasTMAccessionNumbers": true, "electronicPublicationDate": "2020-12-10" } ``` --- ### Book Book XML from the NCBI Bookshelf mirror. NBK1116 alone is 4.1 MB, so the byte ceiling and the deadline are load-bearing, not decoration. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/book` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `nbkId` | string | query | yes | NCBI Bookshelf identifier of the book or chapter | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/book?nbkId=NBK1116" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/book?nbkId=NBK1116", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/book?nbkId=NBK1116", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "id": "NBK1116", "bytes": 4108845, "format": "xml", "source": "NBK", "content": "geneGeneReviews®AdamMargaret PEditor-in-ChiefBickSarahMedical EditorMirzaaGhayda MMedical EditorPagonRoberta AMedical EditorWallaceStephanie EMedical EditorAmemiyaAnneGenetic Counseling Editor199320262372-0697University of Washington, SeattleSeattle (WA)Copyright © 1993-2026, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved. Test.GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (https://www.genereviews.org) and copyright (© 1993-2026 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.For questions regarding permissions or whether a specified use is allowed, contact: addmast@wu.edu

GeneReviews, an international point-of-care resource for busy clinicians, provides clinically relevant and medically actionable information for inherited conditions in a standardized journal-style format, covering diagnosis, management, and genetic counseling for patients and their families. Each chapter in GeneReviews is written by one or more experts on the specific condition or disease and goes through a rigorous editing and peer review process before being published online.

GeneReviews currently comprises more than 900 chapters and has more than 15 million users annually.

The two general formats for GeneReviews are: chapters focused on a single gene or phenotype (~95%) and overviews summarizing causes of common genetic conditions (e.g., genetic hearing loss, Alzheimer disease) (~5%).

To ensure continuing relevant and medically actionable content, each GeneReviews chapter is updated every four to five years (or as needed) by the author(s) in a formal and comprehensive process curated by the GeneReviews\neditors. Additional revisions may occur more frequently as needed to reflect significant changes in clinically relevant information.

Genetic counseling and testing terms used in GeneReviews are hyperlinked to definitions in the GeneReviews\nGlossary. Resource Materials include additional information on key genetics concepts used in GeneReviews.

GeneReviews are indexed in PubMed. Additionally, the primary author (first or last author) of a GeneReview may receive MOC Part 4 credit from the American Board of Medical Genetics and Genomics. See For Current/Prospective Authors for more information.

Note: For a variety of reasons, GeneReviews occasionally removes chapters from the active website. Click here for a list of retired chapters.

books-source-typeDatabase
1q21.1 Recurrent DeletionGuoRoseDOCone HealthGreensboro, North Carolinarose.guo@conehealth.comHaldeman-EnglertChad RMDMission Fullerton Genetics CenterAsheville, North Carolinachad.haldemanenglert@hcahealthcare.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n3-Hydroxyisobutyryl-CoA Hydrolase DeficiencySynonym: HIBCH DeficiencyAbdenurJoseMDjabdenur@choc.orgBarrickRebekahMS, CGCrebekah.barrick@choc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n3-M SyndromeSynonyms: Three M Syndrome, 3M SyndromeAkilapaRhodaBMBS, BMedScirhoda.akilapa@gstt.nhs.ukIrvingMelitaMBBS, MD(Res)melita.irving@gstt.nhs.ukHolder-EspinasseMurielMD, PhDmuriel.holder@gstt.nhs.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n3q29 Recurrent DeletionSynonyms: 3q29 Deletion Syndrome, 3q29 Microdeletion SyndromeMulleJennifer GladysMHS, PhDjennifer.mulle@rutgers.eduGambelloMichael JMD, PhDmichael.j.gambello@emory.eduSanchez RussoRossanaMDrossana.sanchez@emory.eduMurphyMelissa MPhDmelissa.murphy@emory.eduBurrellT LindseyPhDlindsey.burrell@choa.orgKlaimanCherylPhDcheryl.klaiman@emory.eduWhiteStormiPsyDstormi.pulver.white@emory.eduSaulnierCeline APhDceline@nacsatl.comWalkerElaine FPhDpsyefw@emory.eduCubellsJoseph FMD, PhDjcubell@emory.eduShultzSarahPhDsarah.shultz@emory.eduLiLongchuanPhDlongchuan.li@emory.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n7q11.23 Duplication SyndromeMervisCarolyn BPhDUniversity of LouisvilleLouisville, Kentuckycbmervis@louisville.eduMorrisColleen AMDUniversity of Nevada School of MedicineLas Vegas, Nevadacolleen.morris@unlv.eduKlein-TasmanBonita PPhDUniversity of Wisconsin-MilwaukeeMilwaukee, Wisconsinbklein@uwm.eduVellemanShelley LPhDUniversity of VermontBurlington, Vermontshelley.velleman@med.uvm.eduOsborneLucy RPhDUniversity of TorontoToronto, Ontario, Canadalucy.osborne@utoronto.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n15q13.3 Recurrent Deletionvan BonBregje WMMD, PhDbregje.vanbon@radboudumc.nlMeffordHeather CMD, PhDheather.mefford@stjude.orgde VriesBert BAMD, PhDbert.devries@radboudumc.nlSchaafChristian PMD, PhDchristian.schaaf@med.uni-heidelberg.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n16p11.2 Recurrent DeletionTaylorCora MPhDcmtaylor1@geisinger.eduSmithRebeccaMS, CGCrsmith6@geisinger.eduLehmanChristopherMScdlehman@geisinger.eduMitchelMarissa WMS, CCC-SLPmwmitchel@geisinger.eduSingerKaitlynMSkesinger@geisinger.eduWeaverW CurtisBSwcweaver@geisinger.eduChungWendyMD, PhD, FACMGwkc15@columbia.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n16p12.2 Recurrent DeletionSynonym: 16p12.1 MicrodeletionSmolenCorrineMSDepartment of Biochemistry and Molecular BiologyPennsylvania State UniversityUniversity Park, Pennsylvaniaces6136@psu.eduMyersScottMDProfessor,Department of Developmental Medicine, Geisinger College of Health Sciences, Lewisburg, PAsmyers1@geisinger.eduGirirajanSanthoshMBBS, PhDProfessor, Department of Biochemistry and Molecular BiologyDepartment of AnthropologyPennsylvania State UniversityUniversity Park, Pennsylvaniasxg47@psu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n17q12 Recurrent Deletion SyndromeMitchelMarissa WMS, CCC-SLPmwmitchel@geisinger.eduMoreno-De-LucaDanielMD, MScdaniel.morenodeluca@ualberta.caMyersScott MMDsmyers1@geisinger.eduLevyRebecca VBM BCh, MScrebecca_levy@urmc.rochester.eduTurnerStefanieMS, CGCstefturn13@gmail.comLedbetterDavid HPhD, FACMGdavid.ledbetter@jax.ufl.eduMartinChrista LPhD, FACMGclmartin1@geisinger.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n17q12 Recurrent DuplicationMeffordHeatherMD, PhDCenter for Pediatric Neurological Disease ResearchDepartment of Cellular and Molecular BiologySt Jude Children's Research HospitalMemphis, Tennesseeheather.mefford@stjude.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n21-Hydroxylase-Deficient Congenital Adrenal HyperplasiaSynonyms: 21-OHD CAH, Virilizing Adrenal HyperplasiaNimkarnSarojMDsnimkarn@gmail.comGangishettiPrasanna KMBBSprasanna252@gmail.comYauMabelMDmabel.yau@mssm.eduNewMaria IMDmaria.new@mssm.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n22q11.2 Deletion SyndromeSynonym: 22q11.2DSMcDonald-McGinnDonna MMS, LCGCmcginn@email.chop.eduHainHeather SPhD, MS, LCGChainh@email.chop.eduEmanuelBeverly SPhDbeverly@mail.med.upenn.eduZackaiElaine HMD, FACMGzackai@email.chop.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">AARS2</italic>-Related DisorderChmielaTomaszMDchmiela.tomasz@mayo.eduWszolekZbigniew KMDwszolek.zbigniew@mayo.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAbetalipoproteinemiaSynonym: Bassen-Kornzweig SyndromeBurnettJohn RMB ChB, MD, PhD, FRCPAjohn.burnett@health.wa.gov.auHooperAmanda JPhDamanda.hooper@health.wa.gov.auHegeleRobert AMD, FRCPC, FACPhegele@robarts.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAceruloplasminemiaMiyajimaHiroakiMDmiyajima@hama-med.ac.jpHosoiYasushiMDy.hosoi@hama-med.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nAchondrogenesis Type 1BSynonym: ACG1B, SLC26A2-Related AchondrogenesisUngerSheilaMDAssociate Professor, Service of Genetic MedicineLausanne University HospitalLausanne, Switzerlandsheila.unger@chuv.chSuperti-FurgaAndreaMDProfessor of PediatricsDepartment of MedicineLausanne University HospitalLausanne, Switzerlandasuperti@unil.ch\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAchondroplasiaSynonym: FGFR3-Related AchondroplasiaLegareJanet MMDjmlegare@pediatrics.wisc.eduModaffPeggyMSmodaff@waisman.wisc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAchromatopsiaKohlSusanneMSc, PhDsusanne.kohl@uni-tuebingen.deJägleHerbertMD, Dhabil, FEBOherbert.jaegle@ukr.deWissingerBerndMSc, PhDwissinger@uni-tuebingen.deZoborDittaMD, PhD, Dhabil, FEBOditta.zobor@uni-tuebingen.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAcid Sphingomyelinase DeficiencyWassersteinMelissa PMDProfessor & Chief, Division of Pediatric Genetic MedicineAlbert Einstein College of MedicineNew York, New Yorkmwassers@montefiore.orgSchuchmanEdward HPhDFrancis Crick ProfessorGenetic Disease FoundationDepartment of Genetics & Genomic SciencesIcahn School of Medicine at Mount SinaiNew York, New Yorkedward.schuchman@mssm.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ACTG2</italic> Visceral MyopathySynonyms: Berdon Syndrome, Familial Visceral MyopathyBhagwatPranjali KMTech (Pharm)pranjali.bhagwat@bcm.eduWanglerMichael FMDmw147467@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nActivated PI3K Delta SyndromeSynonyms: Activated Phosphoinositide 3-Kinase Delta (PI3Kδ) Syndrome; APDS; p110δ-Activating Mutation Causing Senescent T Cells, Lymphadenopathy, and Immunodeficiency Disease; PASLI Disease; PI3K DiseaseSaccoKeithMDThe Royal London HospitalBarts Health NHS TrustLondon, UKkeith.sacco@nhs.netUzelGulbuMDNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesda, Marylandguzel@niaid.nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReviews</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAcute Intermittent PorphyriaSynonyms: PBGD Deficiency, Porphobilinogen Deaminase DeficiencySardhElianeMD, PhDeliane.sardh@ki.seBarbaroMichelaSc, PhDmichela.barbaro@regionstockholm.se\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ADAMTSL4-</italic>Related Eye DisordersRødahlEyvindMD, PhDeyvind.rodahl@helse-bergen.noMellgrenAnne Elisabeth ChristensenMD, PhDanne.christensen@uib.noBoonstraNils-ErikMDnils-erik.boonstra@helse-bergen.noKnappskogPer MortenPhDper.morten.knappskog@helse-bergen.no\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ADCY5</italic>-Related Movement DisorderYangKathrynMBChB, FRCPCkathryn.yang@childrens.harvard.eduEbrahimi-FakhariDariusMD, PhDdarius.ebrahimi-fakhari@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAdenine Phosphoribosyltransferase DeficiencySynonyms: 2,8-Dihydroxyadeninuria; APRT DeficiencyEdvardssonVidar OrnMDDivision of Pediatric Nephrology\nChildren's Medical Center\nLandspítali –The National University Hospital of Iceland\nReykjavik, Icelandvidare@landspitali.isSahotaAmrikPhDDepartment of Genetics\nRutgers University\nPiscataway, New Jerseysahota@biology.rutgers.eduPalssonRunolfurMDDivision of Nephrology\nLandspítali –The National University Hospital of Iceland\nUniversity of Iceland\nReykjavik, Icelandrunolfur@landspitali.is\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nAdenosine Deaminase 2 DeficiencySynonyms: ADA2 Deficiency, Deficiency of Adenosine Deaminase 2 (DADA2)AksentijevichIvonaMDaksentii@arb.niams.nih.govSampaio MouraNataliaBSnatalia.sampaiomoura@nih.govBarronKarylMDkbarron@nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nAdenosine Deaminase DeficiencySynonyms: ADA Deficiency, ADA1 Deficiency, ADA-Related Immune Deficiency, Adenosine Deaminase 1 DeficiencyHershfieldMichaelMDProfessor of Medicine and BiochemistryDuke University Medical CenterDurham, North Carolinamichael.hershfield@duke.eduTarrantTeresaMDAssociate Professor of MedicineDuke University Medical CenterDurham, North Carolinateresa.tarrant@duke.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ADNP-</italic>Related Helsmoortel-Van der Aa SyndromeSynonyms: ADNP-Related Intellectual Disability and Autism Spectrum Disorder (ADNP-Related ID/ASD), ADNP Syndrome, Helsmoortel-Van der Aa Syndrome (HVDAS)HarutyunyanLusineDoctoral researcherDisability StudiesUniversity of AntwerpAntwerp, Belgiumlusine.harutyunyan@uantwerpen.beKooyR FrankPhDProfessor, Cognitive GeneticsDepartment of Medical GeneticsUniversity of AntwerpAntwerp, Belgiumfrank.kooy@uantwerpen.beD'IncalClaudio PeterPhDDoctoral researcherDepartment of Medical GeneticsUniversity of AntwerpAntwerp, Belgiumclaudio.dincal@uantwerpen.beVan DijckAnkeMD, PhDPostdoctoral Research Assistant, Disability studies University of AntwerpAntwerp, Belgiumanke.vandijck@uantwerpen.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAdult Refsum DiseaseSynonym: Classic Refsum DiseaseWaterhamHans RPhDh.r.waterham@amsterdamumc.nlWandersRonald JAPhDr.j.wanders@amsterdamumc.nlLeroyBart PMD, PhDbart.leroy@ugent.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">AFF4</italic>-Related CHOPS SyndromeIzumiKosukeMD, PhDDivision of Genetics and MetabolismDepartment of PediatricsUniversity of Texas Southwestern Medical CenterDallas, Texaskosuke.izumi@utsouthwestern.eduRaibleSaraMS, CGCPerelman School of MedicineUniversity of PennsylvaniaPhiladelphia, Pennsylvaniasarah.raible@pennmedicine.upenn.eduKrantzIanMDCohen Children’s Medical Center / Northwell HealthNew York, New Yorkikrantz@northwell.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">AFG3L2</italic>-Related Neurologic DisordersCoarelliGiuliaMD, PhDgiulia.coarelli@icm-institute.orgMourauxCharlotteMDcharlotte.mouraux@icm-institute.orgcharlotte.mouraux@chuliege.be\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAicardi-Goutières SyndromeCrowYanick JMBBS, BMedSci, MRCP, PhD\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAicardi SyndromeSuttonV ReidMDProfessor, Department of Molecular and Human GeneticsBaylor College of Medicine & Texas Children's HospitalHouston, Texasvrsutton@texaschildrens.orgVan den VeyverIgnatia BMDProfessor, Departments of Obstetrics and Gynecology and Molecular and Human GeneticsBaylor College of MedicineHouston, Texasiveyver@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">AIP</italic> Familial Isolated Pituitary AdenomasKorbonitsMártaMD, PhDDepartment of EndocrinologyBarts and the London School of MedicineQueen Mary University of LondonLondon, United Kingdomm.korbonits@qmul.ac.ukHernández-RamírezLaura CMD, PhDRed de Apoyo a la InvestigaciónCoordinación de la Investigación CientíficaUniversidad Nacional Autónoma de México e Instituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico City, Mexicolaura.hernandez@cic.unam.mx\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAlagille SyndromeSynonyms: Arteriohepatic Dysplasia, Syndromic Bile Duct PaucitySpinnerNancy BPhDspinner@chop.eduLoomesKathleen MMDloomes@chop.eduKrantzIan DMDkrantz@chop.eduGilbertMelissa APhDgilbertma@chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAlexander DiseaseSrivastavaSiddharthMDDepartment of Neurology\nBoston Children's Hospital\nBoston, Massachusettssiddharth.srivastava@childrens.harvard.eduWaldmanAmyMD, MSCEDivision of Neurology, Children's Hospital of Philadelphia;\nDepartments of Neurology and Pediatrics\nPerelman School of Medicine\nUniversity of Pennsylvania\nPhiladelphia, Pennsylvaniawaldman@email.chop.eduNaiduSakkubaiMDKennedy Krieger Institute\nPediatric Neurology and Pediatrics\nJohns Hopkins University Medical Institutions\nBaltimore, Marylandnaidu@kennedykrieger.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAlkaptonuriaSynonym: AlcaptonuriaIntroneWendy JMDStaff Clinician, Office of the Clinical DirectorNational Human Genome Research InstituteNational Institutes of HealthBethesda, Marylandwintrone@nhgri.nih.govPerryMoniqueMDStaff Clinician, Rehabilitation MedicineClinical CenterNational Institutes of HealthBethesda, Marylandmperry@cc.nih.govChenMarcusMDStaff Clinician, National Heart, Lung, and Blood InstituteNational Institutes of HealthBethesda, Marylandchenmy@nhlbi.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ALK</italic>-Related Neuroblastic Tumor SusceptibilityGreengardEmily GMDUniversity of Minnesota Masonic Children's HospitalMinneapolis, Minnesotaemilyg@umn.eduPerrinoMelissa RMDSt Jude Children's Research HospitalMemphis, Tennesseemelissa.perrino@stjude.orgParkJulie RMDSeattle Children's HospitalSeattle, Washingtonjulie.park@stjude.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAllan-Herndon-Dudley SyndromeSynonyms: MCT8 Deficiency, MCT8-Specific Thyroid Hormone Cell-Membrane Transporter DeficiencySarretCatherineMD, PhDCentre de Compétence des Leucodystrophies et Leucoencéphalopathies de Cause RareCentre Hospitalier Universitaire de Clermont-FerrandClermont-Ferrand, Francecsarret@chu-clermontferrand.frOliver PetitIsabelleMDEndocrine UnitChildren's HospitalToulouse, Franceoliver.i@chu-toulouse.frTondutiDavideMD, PhDChild Neurology UnitV Buzzi Children's HospitalMilan, Italydavidetondu@hotmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAlpha-1 Antitrypsin DeficiencySynonyms: AAT Deficiency, A1AT Deficiency, AATD, Alpha-1 Antiprotease DeficiencyStollerJames KMD, MSRespiratory and Education InstitutesCleveland ClinicCleveland, Ohiostollej@ccf.orgHupertzVeraMDPediatric GastroenterologyPediatric InstituteCleveland ClinicCleveland, Ohiohupertv@ccf.orgAboussouanLoutfi SMDRespiratory InstituteCleveland ClinicCleveland, Ohioaboussl@ccf.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAlpha-MannosidosisSynonym: α-MannosidosisFiciciogluCanMD, PhDThe Children's Hospital of Philadelphia;Division of Human Genetics and MetabolismPerelman School of Medicine at the University of PennsylvaniaPhiladelphia, Pennsylvaniaficicioglu@chop.eduStepienKarolina MMD, PhDMark Holland Metabolic UnitSalford Royal NHS Foundation TrustSalford Care OrganisationPart of the Northern Care Alliance NHS GroupSalford, United Kingdomkarolina.stepien@nca.nhs.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAlpha-ThalassemiaTamaryHannahMDHematology-Oncology DepartmentSchneider Children's Medical Center of IsraelPetah Tiqva, Israelhtamary@tauex.tau.ac.ilDganyOrlyPhDFelsenstein Medical Research CenterPetah Tiqva, Israelodgani@clalit.org.il\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAlpha-Thalassemia X-Linked Intellectual Disability SyndromeSynonym: ATR-X SyndromeStevensonRoger EMD, FACMGClinical Genetics and CytogeneticsGreenwood Genetic CenterGreenwood, South Carolinares@ggc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ALPK1-</italic>Related Autoinflammatory DiseaseSynonym: ROSAH SyndromeKozyckiChristinaMD, MPHInnate Immune Activation UnitNational Institute of Allergy and Infectious DiseasesBethesda, Marylandchristina.kozycki@nih.govKastnerDanMD, PhDInflammatory Disease SectionNational Human Genome Research InstituteNational Institutes of HealthBethesda, Marylandkastnerd@mail.nih.govHurynLaryssaMDNational Eye InstituteNational Institutes of HealthBethesda, Marylandlaryssa.huryn@nih.govKodatiShilpaMDKellogg Eye CenterDepartment of OphthalmologyUniversity of MichiganAnn Arbor, Michiganshko@umich.eduWarnerBlake MDDS, PhD, MPHNational Institute of Dental and Craniofacial ResearchNational Institutes of Healthblake.warner@nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAlport SyndromeSynonyms: Familial Nephritis, Hereditary NephritisNozuKandaiMD, PhDkandainozu@gmail.comYamamuraTomohikoMD, PhDtomohiko@med.kobe-u.ac.jpHorinouchiTomokoMD, PhDtohori@med.kobe-u.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ALS2</italic>-Related DisorderOrrellRichard WBSc, MD, FRCPUniversity Department of Clinical NeurosciencesInstitute of NeurologyUniversity College LondonLondon, United Kingdomr.orrell@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAlström SyndromePaiseyRichard BMD, FRCPrichard.paisey@nhs.netSteedsRickMDrick.steeds@uhb.nhs.ukBarrettTimMDt.g.barrett@bham.ac.ukWilliamsDeniseMDdenise.williams21@nhsnetdenise.williams@bwhct.nhs.ukGeberhiwotTarekegnMDtarekegn.geberhiwot@uhb.nhs.ukt.g.hiwot@bham.ac.ukGunay-AygunMeralMDmgunaya1@jhu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nAlzheimer Disease OverviewBirdThomas DSeattle VA Medical CenterDepartments of Neurology and MedicineUniversity of WashingtonSeattle, Washingtontomnroz@uw.edu\n\nSummary\n\n Clinical Characteristics of Alzheimer Disease\n\n Causes of Alzheimer Disease\n\n Evaluation Strategies to Identify the Genetic Cause of Alzheimer Disease in a Proband\n\n Inform Genetic Counseling of Family Members of an Individual with Alzheimer Disease\n\nResources\n\nChapter Notes\n\nReferences\n\nAmyotrophic Lateral Sclerosis OverviewSynonym: Lou Gehrig DiseaseSiddiqueNailahRN, MSNDivision of Neuromuscular MedicineDavee Department of Neurology and Clinical NeurosciencesNorthwestern University Feinberg School of MedicineChicago, Illinoisnsiddique@northwestern.eduSiddiqueTeepuMD, DSc (hc)Division of Neuromuscular MedicineDavee Department of Neurology and Clinical Neurosciences;Department of Cell and Molecular BiologyNorthwestern University Feinberg School of MedicineChicago, Illinoist-siddique@northwestern.edu\n\nSummary\n\n Clinical Characteristics of ALS\n\n Genetic Causes of ALS\n\n Evaluation Strategies to Identify the Genetic Cause of ALS in a Proband\n\n Management of ALS\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nAndersen-Tawil SyndromeSynonym: Long QT Syndrome Type 7 (LQTS Type 7)VeerapandiyanAravindhanMBBSaravindhan_veerapandiyan@urmc.rochester.eduStatlandJeffrey MMDjstatland@kumc.eduTawilRabiMDrabi_tawil@urmc.rochester.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nAndrogen Insensitivity SyndromeSynonym: Testicular FeminizationGottliebBrucePhDbruce.gottlieb@mcgill.caTrifiroMark AMDmark.trifiro@mcgill.ca\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAngelman SyndromeDagliAditi IMDMedical GeneticsOrlando Health Arnold Palmer HospitalOrlando, Floridaaditidagli@gmail.comMathewsJenniferMS, CGCDivision of Genetics and MetabolismUniversity of North Carolina at Chapel HillChapel Hill, North Carolinamuelljm@email.unc.eduWilliamsCharles AMDDivision of Genetics and MetabolismDepartment of PediatricsUniversity of Florida College of MedicineGainesville, Floridawillicx@peds.ufl.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ANKRD11</italic>-Related KBG SyndromeSynonym: ANKRD11-Related Neurodevelopmental DisorderMorel SwolsDaynaMS, CGCdmorel@med.miami.eduTekinMustafaMDmtekin@med.miami.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ANKRD17</italic>-Related Neurodevelopmental SyndromeSynonym: Chopra-Amiel-Gordon Syndrome (CAGS)SvedenAbigailMS, CGCabigail.sveden@childrens.harvard.eduGordonChristopher TPhDchris.gordon@inserm.frAmielJeanneMD, PhDjeanne.amiel@inserm.frChopraMayaMBBS, FRACPmaya.chopra@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ANKRD26</italic>-Related ThrombocytopeniaSynonym: Thrombocytopenia 2 (THC2)Perez BoteroJulianaMDjuliana.perezbotero@bcw.eduDuganStefanie NMS, CGCstefanie.dugan@ bcw.eduAndersonMatthew WMD, PhDmatthew.anderson@ bcw.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">ANO5</italic>-Related Muscle DiseaseSynonym: AnoctaminopathyPalmioJohannaMD, PhDjohanna.palmio@tuni.fiPenttiläSiniPhDsini.penttila@hus.fiJokelaManuMD, PhDmejoke@utu.fi\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAP-4-Associated Hereditary Spastic ParaplegiaSynonyms: Adaptor Protein Complex 4 Deficiency (AP-4 Deficiency), AP-4-Associated HSP, AP-4 Deficiency SyndromeAlecuJulianMD, PhDjulian.alecu@childrens.harvard.eduSchierbaumLucaMD, PhDluca.schierbaum@childrens.harvard.eduEbrahimi-FakhariDariusMD, PhDdarius.ebrahimi-fakhari@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">APC</italic>-Associated Polyposis ConditionsYenTimothyMDtimothy.yen@cuanschutz.eduStanichPeter PMDpeter.stanich@osumc.eduAxellLisenMS, CGClisen.axell@cuanschutz.eduPatelSwati GMD, MSswati.patel@cuanschutz.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nApert SyndromeSynonym: Acrocephalosyndactyly Type IWengerTara LMD, PhDtara.wenger@seattlechildrens.orgHingAnne VMDanne.hing@seattlechildrens.orgEvansKelly NMDkelly.evans@seattlechildrens.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">APOB</italic>-Related Familial HypobetalipoproteinemiaBurnettJohn RMB ChB, MD, PhD, FRCPAjohn.burnett@health.wa.gov.auHooperAmanda JPhDamanda.hooper@health.wa.gov.auHegeleRobert AMD, FRCPC, FACPhegele@robarts.ca\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nArginase DeficiencySynonyms: ARG1 Deficiency, Arginase-1 Deficiency, HyperargininemiaSunAngelaMDSeattle Children's Hospital;University of WashingtonSeattle, Washingtonangela.sun@seattlechildrens.orgCrombezEric AMDUltragenyx Pharmaceutical IncNovato, Californiaecrombez@ultragenyx.comWongDerekMDUniversity of California Los Angeles Medical CenterLos Angeles, Californiadawong@mednet.ucla.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nArgininosuccinate Lyase DeficiencySynonyms: Argininosuccinic Acid Lyase Deficiency (ASLD), Argininosuccinic Aciduria (ASA)NagamaniSandesh CSMBBS, MDnagamani@bcm.eduBurrageLindsay CMD, PhDburrage@bcm.eduLeeBrendanMD, PhDblee@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ARID1B</italic>-Related DisorderVerganoSamantha AMDsamantha.vergano@chkd.orgvan der SluijsPleuntje JMScp.j.van_der_sluijs@lumc.nlSantenGijsMD, PhDsanten@lumc.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAromatic L-Amino Acid Decarboxylase DeficiencySynonym: AADC DeficiencyBlauNenadPhDDivision of MetabolismUniversity Children's Hospital ZurichZurich, Switzerlandnenad.blau@kispi.uzh.chPearsonToni SMD, MBBSDepartments of Pediatrics and NeurologyNationwide Children's Hospital;Ohio State University College of MedicineColumbus, Ohiotoni.pearson@nationwidechildrens.orgKurianManju AMRCP, PhDDevelopmental NeurosciencesZayed Centre for Research into Rare Disease in ChildrenUCL GOS Institute of Child Health;Department of NeurologyGreat Ormond Street HospitalLondon, United Kingdommanju.kurian@ucl.ac.ukElseaSarah HPhD, FACMGDepartment. of Molecular & Human GeneticsBaylor College of MedicineHouston, Texassarah.elsea@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nArrhythmogenic Right Ventricular Cardiomyopathy OverviewMcNallyElizabethMD, PhDelizabeth.mcnally@northwestern.eduMacLeodHeatherMShmacleodgc@gmail.comDellefave-CastilloLisaMS, CGClisa.m.castillo@northwestern.edu\n\nSummary\n\n Clinical Characteristics of Arrhythmogenic Right Ventricular Cardiomyopathy\n\n Genetic Causes of Arrhythmogenic Right Ventricular Cardiomyopathy\n\n Evaluation Strategy to Identify the Genetic Cause of Arrhythmogenic Right Ventricular Cardiomyopathy\n\n Management of Arrhythmogenic Right Ventricular Cardiomyopathy\n\n Genetic Risk Assessment and Evaluation of Relatives At-Risk\n\nResources\n\nChapter Notes\n\nReferences\n\nARSACSSynonyms: Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay, Autosomal Recessive Spastic Ataxia Type 6, ATX/HSP-SACSVermeerSaschaMD, PhDsascha.vermeer@uzleuven.bevan de WarrenburgBart PMD, PhDbart.vandewarrenburg@radboudumc.nlKamsteegErik-JanPhDerik-jan.kamsteeg@radboudumc.nlBraisBernardMD, PhDbernard.brais@mcgill.caSynofzikMatthisMDmatthis.synofzik@uni-tuebingen.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nArterial Tortuosity SyndromeCallewaertBertMD, PhDbert.callewaert@ugent.beDe PaepeAnneMD, PhDanne.depaepe@ugent.beCouckePaulMD, PhDpaul.coucke@ugent.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nArylsulfatase A DeficiencySynonyms: ARSA Deficiency, Metachromatic LeukodystrophyGomez-OspinaNataliaMD, PhDAssistant ProfessorDepartment of PediatricsDivisions of Medical Genetics and Stem Cell TransplantationStanford UniversityStanford, Californiagomezosp@stanford.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ASAH1</italic>-Related DisordersDymentDavid ADPhil, MDChildren's Hospital of Eastern Ontario Research InstituteDepartment of Biochemistry, Microbiology, and ImmunologyUniversity of OttawaOttawa, Ontario, Canadaddyment@cheo.on.caBennettSteffany ALPhDDepartment of Biochemistry, Microbiology, and ImmunologyUniversity of OttawaOttawa, Ontario, Canadasteffanyann.bennett@uottawa.caMedinJeffrey APhDDepartments of Pediatrics and BiochemistryMedical College of WisconsinMilwaukee, Wisconsinjmedin@mcw.eduLevadeThierryMD, PhDLaboratoire de Biochimie MétaboliqueCHU ToulouseINSERM U1037, Centre de Recherches en Cancérologie de ToulouseUniversité Paul SabatierToulouse, Francethierry.levade@inserm.fr\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAsparagine Synthetase DeficiencySynonym: ASNS DeficiencyAlfadhelMajidMD, HHSc, SSC-Ped, ABHS(CH), FCCMGGenetics Division, Department of PediatricsKing Saud Bin Abdulaziz University for Health SciencesKing Abdulaziz Medical CityRiyadh, Saudi Arabiadralfadhelm@gmail.comEl-HattabAyman WMD, FAAP, FACMGAssociate Professor, Department of Clinical SciencesCollege of MedicineUniversity of SharjahSharjah, United Arab Emirateselhattabaw@yahoo.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAspartylglucosaminuriaSynonyms: AGA Deficiency, Aspartylglucosaminidase Deficiency, Aspartylglycosaminuria, Glycoasparaginase Deficiency, Glycosylasparaginase DeficiencyGoodspeedKimberlyMD, MSCSDepartments of Pediatrics, Neurology, and PsychiatryUniversity of Texas Southwestern Medical CenterDallas, Texaskimberly.goodspeed@utsouthwestern.eduChenXinPhDDepartment of PediatricsUniversity of Texas Southwestern Medical CenterDallas, Texasxin.chen@utsouthwestern.eduTchanMichelMBBS, PhD, BMedSc, FRACPDepartment of Genetic MedicineWestmead HospitalSydney, Australiamichel.tchan@health.nsw.gov.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ASPM</italic> Primary MicrocephalySynonyms: ASPM Microcephalia Vera, Microcephaly Primary Hereditary 5 (MCPH5)VerloesAlainMD, PhDalain.verloes@aphp.frDrunatSéverinePharmD, PhDseverine.drunat@aphp.frPassemardSandrineMD, PhDsandrine.passemard@aphp.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ASXL3</italic>-Related DisorderSynonym: Bainbridge-Ropers Syndrome (BRPS)BalasubramanianMeenaMBBS, DCH, FRCPCH, MDSheffield Children's NHS Foundation TrustUniversity of SheffieldSheffield, United Kingdommeena.balasubramanian@nhs.netSchirwaniSchaidaMBChB, MSc, MRCPSheffield Children's NHS Foundation TrustSheffield, United Kingdomschaida.schirwani@nhs.net\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAtaxia-TelangiectasiaVeenhuisStefanieMDDepartment of PediatricsAmalia Children’s HospitalRadboud University Medical CenterNijmegen, the Netherlandsstefanie.veenhuis@radboudumc.nlvan OsNienkeMD, PhDDepartment of NeurologyDonders Institute for Brain, Cognition and Behaviour;Radboud University Medical CenterNijmegen, the Netherlandsnienke.vanos@radboudumc.nlWeemaesCorryMD, PhDAmalia Children's HospitalRadboud University Medical CenterNijmegen, the Netherlandscorry.weemaes@radboudumc.nlKamsteegErik-JanMD, PhDDepartment of Human GeneticsRadboud University Medical CenterNijmegen, the Netherlandserik-jan.kamsteeg@radboudumc.nlWillemsenMichèlMD, PhDDepartment of Pediatric NeurologyDonders Institute for Brain, Cognition and Behaviour;Amalia Children's HospitalRadboud University Medical CenterNijmegen, the Netherlandsmichel.willemsen@radboudumc.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAtaxia with Oculomotor Apraxia Type 2Synonym: AOA2MoreiraMaria-CeuMSc, PhDProfessor of Molecular Biology and Geneticsmceums@hotmail.frKoenigMichelMD, PhDLaboratoire de Génétique de Maladies RaresInstitut Universitaire de Recherche CliniqueUniversité de MontpellierMontpellier, Francemichel.koenig@inserm.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAtaxia with Vitamin E DeficiencySynonyms: Ataxia with Isolated Vitamin E Deficiency, AVEDSchuelkeMarkusMDDepartment of NeuropediatricsCharité & NeuroCure Clinical Research CenterCharité - Universitätsmedizin BerlinBerlin, Germanymarkus.schuelke@charite.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ATM</italic>-Related Cancer PredispositionSchonKatherine RoseMD, PhDDepartment of Genomic MedicineNational Institute for Health ResearchCambridge Biomedical Research CentreUniversity of CambridgeCambridge, United Kingdomks339@cam.ac.ukPalTuyaMDDepartment of MedicineVanderbilt University Medical CenterVanderbilt-Ingram Cancer CenterNashville, Tennesseetuya.pal@vumc.orgStewartDouglas RMDClinical Genetics BranchDivision of Cancer Epidemiology and GeneticsNational Cancer InstituteRockville, Marylanddrstewart@mail.nih.govTischkowitzMarcMD, PhDDepartment of Genomic MedicineNational Institute for Health ResearchCambridge Biomedical Research CentreUniversity of CambridgeCambridge, United Kingdommdt33@cam.ac.ukHansonHelenMDPeninsula Clinical GeneticsRoyal Devon University Healthcare NHS Foundation Trust;Department of Clinical and Biomedical SciencesUniversity of Exeter Medical SchoolExeter, United Kingdomhelen.hanson6@nhs.net\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ATN1-</italic>Related Neurodevelopmental DisorderSynonyms: ATN1-Related Neurodevelopmental Condition; CHEDDA (Congenital Hypotonia, Epilepsy, Developmental Delay, Digit Abnormalities)WhittonChloeBMed, MDwhittonchloe@gmail.comchloe.whitton@health.nsw.gov.auPalmerElizabethPhD, MBBS, FRACPelizabeth.palmer@unsw.edu.auAlkurayaFowzanMD, ABP, ABMGGfalkuraya@kfshrc.edu.sa\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Conditions\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ATP1A3-</italic>Related DisorderBrashearAllisonMDVice President for Health Sciences;Dean, Jacobs School of Medicine and Biomedical Sciences;Professor, Neurology;University at BuffaloBuffalo, New Yorkbrashear@buffalo.eduSweadnerKathleen JPhDAssociate Professor, Cellular and Molecular PhysiologyDepartment of NeurosurgeryMassachusetts General HospitalBoston, Massachusettsksweadner@mgh.harvard.eduHaqIhtshamMDProfessor, Department of NeurologyUniversity of Miami Miller School of MedicineMiami, Floridaihaq@med.miami.eduNapoliEleonoraPhDDepartment of NeurologySchool of MedicineUniversity of California, DavisDavis, Californiaenapoli@ucdavis.eduOzeliusLauriePhDAssociate Neuroscientist, Department of NeurologyMassachusetts General HospitalBoston, Massachusettslaurie.ozelius@mgh.harvard.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ATP6V0A2</italic>-Related Cutis LaxaSynonyms: ATP6V0A2-CDG, Autosomal Recessive Cutis Laxa Type 2A (ARCL2A)Van MaldergemLionelMD, PhDCentre de génétique humaineUniversité de Franche-ComtéBesançon, Francevmald@skypro.beDobynsWilliamMDSeattle Children's Research InstituteSeattle, Washingtonwbd@uw.eduKornakUweMD, PhDInstitut für HumangenetikUniversitätsmedizin GöttingenGöttingen, Germanyuwe.kornak@med.uni-goettingen.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ATP7A</italic>-Related Copper Transport DisordersKalerStephen GMD, MPHCAPT, US Public Health Service (Ret)Professor of Pediatrics and GeneticsThe Ohio State University College of Medicine;Center for Gene TherapyAbigail Wexner Research InstituteNationwide Children’s HospitalColumbus, Ohiostephen.kaler@nationwidechildrens.orgDiStasioAndrew TPhDCenter for Gene TherapyAbigail Wexner Research InstituteNationwide Children’s HospitalColumbus, Ohioandrew.distasio@nationwidechildrens.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nATP8B1 DeficiencySynonym: FIC1 DeficiencyBullLaura NPhDLiver Center Laboratory and Institute for Human GeneticsDepartment of MedicineUniversity of California, San FranciscoSan Francisco, Californialaura.bull@ucsf.eduMorottiRaffaellaMDDepartment of PathologyYale School of MedicineNew Haven, Connecticutraffaella.morotti@yale.eduSquiresJames EMD, MSUPMC Children's Hospital of PittsburghDepartment of Pediatric Gastroenterology and HepatologyPittsburgh, Pennsylvaniajames.squires2@chp.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAu-Kline SyndromeSynonyms: HNRNPK-Related Neurodevelopmental Disorder, Au-Kline-Okamoto Syndrome, Okamoto SyndromeAuPing-Yee BillieMD, PhD, FRCPC, FCCMGbillie.au@ahs.caMcNivenVandaMD, MSc, FRCPCmcnivenv@mcmaster.caPhillipsLindsayPhDlindsay.phillips@ahs.caInnesA MicheilMD, FRCPC, FCCMGmicheil.innes@ahs.caKlineAntonie DMD, FACMG, FAAPakline@gbmc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutoimmune Lymphoproliferative SyndromeSynonym: ALPSBleesingJack JHMD, PhDProfessor of Pediatrics, Division of Bone Marrow Transplantation & Immune DeficiencyCincinnati Children's HospitalCincinnati, Ohiojack.bleesing@cchmc.orgNagarajChinmayee BMS, CGCGenetic Counselor, Division of Human GeneticsCincinnati Children's HospitalCincinnati, Ohiochinmayee.bhimarao@cchmc.orgZhangKejianMD, MBAAssociate Professor of Pediatrics, Division of Human GeneticsCincinnati Children's HospitalCincinnati, Ohiokejian.zhang@cchmc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutosomal Dominant Craniometaphyseal DysplasiaReichenbergerErnstPhDProfessor, Department of Regenerative Medicine and Skeletal DevelopmentUConn Health (UCH)Farmington, Connecticutreichenberger@uchc.eduChenI-PingDDS, MS, PhDProfessor, Department of EndodontologyUConn Health (UCH)Farmington, Connecticutipchen@uchc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutosomal Dominant Epilepsy with Auditory FeaturesSynonyms: ADEAF, Autosomal Dominant Lateral Temporal Lobe Epilepsy, Autosomal Dominant Partial Epilepsy with Auditory FeaturesMichelucciRobertoMD, PhDroberto.michelucci@isnb.itPasiniElenaMDelena.pasini@isnb.itDazzoEmanuelaPhDemanuela.dazzo@cnr.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutosomal Dominant Robinow SyndromeSynonym: Fetal Face SyndromeRoifmanMaianMDDivision of Clinical and Metabolic GeneticsDepartment of PaediatricsThe Hospital for Sick Children;Prenatal Diagnosis and Medical Genetics ProgramDepartment of Obstetrics and GynecologyMount Sinai Hospital;University of TorontoToronto, Canadamaian.roifman@gmail.comBrunnerHanMDDepartment of Human GeneticsRadboud University Medical CenterNijmegen, the Netherlandshan.brunner@radboudumc.nlLohrJamieMDDivision of Pediatric CardiologyAdult Congenital and Cardiovascular Genetics ProgramUniversity of Minnesota Amplatz Children's HospitalMinneapolis, Minnesotalohrx003@umn.eduMazzeuJulianaPhDDivision of Clinical MedicineFaculty of MedicineUniversity of BrasíliaBrasília, Braziljulianamazzeu@pq.cnpq.brChitayatDavidMDPrenatal Diagnosis and Medical Genetics ProgramDepartment of Obstetrics and GynecologyMount Sinai Hospital;Division of Clinical and Metabolic GeneticsDepartment of PaediatricsThe Hospital for Sick Children;University of TorontoToronto, Canadadchitayat@mtsinai.on.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutosomal Dominant Sleep-Related Hypermotor (Hyperkinetic) EpilepsySynonym: Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), ADSHEKurahashiHirokazuMD, PhDAichi Medical UniversityNagakute, Japankurahashi.hirokazu.736@mail.aichi-med-u.ac.jpHiroseShinichiMD, PhDFukuoka UniversityFukuoka, Japanhirose@fukuoka-u.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutosomal Dominant <italic toggle=\"yes\">TRPV4-</italic>Related DisordersMcCrayBrett AMD, PhDDepartment of NeurologyUniversity of Michigan Medical SchoolAnn Arbor, Michiganbmccray@med.umich.eduSchindlerAliceMS, CGCNational Institute of Neurological Disorders and Stroke, Neurogenetics BranchNational Institutes of HealthBethesda, Marylandschindlerab@mail.nih.govHoover-FongJulie EMD, PhDDepartment of Genetic MedicineJohns Hopkins University School of MedicineBaltimore, Marylandjhoover2@jhmi.eduSumnerCharlotte JMDDepartments of Neurology, Neuroscience, and Genetic MedicineJohns Hopkins University School of MedicineBaltimore, Marylandcsumner1@jhmi.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutosomal Dominant Tubulointerstitial Kidney Disease – <italic toggle=\"yes\">MUC1</italic>Synonyms: ADTKD-MUC1, Medullary Cystic Kidney Disease Type 1 (MCKD1), MUC1 Kidney Disease (MKD)BleyerAnthony JMD, MSableyer@wakehealth.eduŽivnáMartinaPhDmzivna@lf1.cuni.czKiddKendrahMSkkidd@wakehealth.eduKmochStanislavPhDskmoch@lf1.cuni.cz\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutosomal Dominant Tubulointerstitial Kidney Disease – <italic toggle=\"yes\">REN</italic>Synonyms: ADTKD-REN, Familial Juvenile Hyperuricemic Nephropathy Type 2 (FJHN2)ŽivnáMartinaPhDmzivna@lf1.cuni.czKiddKendrahMSkkidd@wakehealth.eduKmochStanislavPhDskmoch@lf1.cuni.czBleyerAnthony JMD, MSableyer@wakehealth.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutosomal Dominant Tubulointerstitial Kidney Disease – <italic toggle=\"yes\">UMOD</italic>Synonyms: ADTKD-UMOD, Uromodulin Kidney DiseaseBleyerAnthony JMD, MSSection on Nephrology\nWake Forest University School of Medicine\nWinston-Salem, North Carolinaableyer@wakehealth.eduKiddKendrahMSSection on Nephrology\nWake Forest University School of Medicine\nWinston-Salem, North Carolinakkidd@wakehealth.eduŽivnáMartinaPhDResearch Unit of Rare Diseases\nDepartment of Paediatrics and Inherited Metabolic Disorders\nFirst Faculty of Medicine\nCharles University\nPrague, Czech Republicmzivna@lf1.cuni.czKmochStanislavPhDResearch Unit of Rare Diseases\nDepartment of Paediatrics and Inherited Metabolic Disorders\nFirst Faculty of Medicine\nCharles University\nPrague, Czech Republicskmoch@lf1.cuni.cz\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutosomal Recessive Congenital IchthyosisRichardGabrieleMD, FACMGMedical Director, GeneDx, IncGaithersburg, Marylandgrichard@genedx.com\n\nSummary\n\n Clinical Characteristics of Autosomal Recessive Congenital Ichthyosis\n\n Genetic Causes of Autosomal Recessive Congenital Ichthyosis\n\n Differential Diagnosis of Autosomal Recessive Congenital Ichthyosis\n\n Evaluation Strategies to Identify the Genetic Cause of Autosomal Recessive Congenital Ichthyosis in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nAutosomal Recessive Polycystic Kidney Disease – <italic toggle=\"yes\">PKHD1</italic>Synonym: ARPKD-PKHD1BurgmaierKathrinMDkathrin.burgmaier@uk-koeln.deGimpelCharlotteMDcharlotte.gimpel@glkn.deSchaeferFranzMDfranz.schaefer@med.uni-heidelberg.deLiebauMaxMDmax.liebau@uk-koeln.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAutosomal Recessive <italic toggle=\"yes\">RPE65</italic>-Related Retinal DegenerationSynonyms: Autosomal Recessive RPE65-RD, RPE65 Mutation-Associated Retinal Degeneration (RPE65-IRD)KoritalaBrooke ABS, BAbkoritala@rfsw.orgPennesiMarkMD, PhDpennesi@retinafoundation.org\n\nSummary\n\nScope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nAymé-Gripp SyndromeAmudhavalliShivarajan ManickavasagamMDsamudhavalli@cmh.eduGadeaRandiMSrngadea@cmh.eduGrippKarenMDkgripp@nemours.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBachmann-Bupp SyndromeSynonym: ODC1-Related Neurodevelopmental DisorderBuppCalebMD, FACMGcaleb.bupp@spectrumhealth.orgMichaelJulianneMS, LCGCjulianne.michael@spectrumhealth.orgVanSickleElizabethMSelizabeth.vansickle@spectrumhealth.orgRajasekaranSurenderMD, MPHsurender.rajasekaran@spectrumhealth.orgBachmannAndré StephanMS, PHDbachma26@msu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBaller-Gerold SyndromeVan MaldergemLionelMD, PhDCentre de Génétique HumaineUniversité de Franche-ComtéBesançon, Francevmald@skypro.bePiardJulietteMDClinical Geneticist, Pôle Biologie et Anatomie PathologiqueCHRU de Besançon – Hôpital Saint-JacquesBesançon, Francejpiard@chu-besancon.frLarizzaLidiaMDResearch Director, Laboratory of Medical Cytogenetics and GeneticsIRCSS Istituto Auxologico ItalianoMilan, Italyl.larizza@auxologico.itWangLisa LMDAssociate Professor, Division of Hematology/OncologyDepartment of PediatricsTexas Children's HospitalBaylor College of MedicineHouston, Texasllwang@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">BAP1</italic> Tumor Predisposition SyndromeSynonyms: BAP1 Cancer Syndrome; Cutaneous/Ocular Melanoma, Atypical Melanocytic Proliferations, and Other Internal Neoplasms (COMMON Syndrome)PilarskiRobertMS, LGC, MSWrpilarski@ambrygen.comByrneLindseyMS, CGClindsey.byrne@osumc.eduCarloMaria IMDcarlom@mskcc.orgHansonHelenMDhelen.hanson6@nhs.netCebullaColleenMD, PhDcolleen.cebulla@osumc.eduAbdel-RahmanMohamedMD, PhDmohamed.abdel-rahman@osumc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBaraitser-Winter Cerebrofrontofacial SyndromeVerloesAlainMD, PhDUniversité Paris Cité;Department of GeneticsAPHP-Hôpital Robert DebréParis, Francealain.verloes@aphp.frDrunatSéverinePharmD, PhDDepartment of GeneticsAPHP-Hôpital Robert DebréParis, Franceseverine.drunat@aphp.frPilzDanielaMD, PhDInstitute of Medical GeneticsUniversity Hospital of WalesCardiff, United Kingdompilzdt@cf.ac.ukDi DonatoNataliyaMD, PhDInstitut für Klinische GenetikUniversitätsklinikum Carl Gustav CarusDresden, Germanynataliya.didonato@uniklinikum-dresden.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBardet-Biedl Syndrome OverviewForsythRaeLynnMDrforsyt2@jhmi.eduGunay-AygunMeralMDmgunaya1@jhmi.edu\n\nSummary\n\n Clinical Characteristics of Bardet-Biedl Syndrome\n\n Causes of Bardet-Biedl Syndrome\n\n Evaluation Strategies to Identify the Genetic Cause of Bardet-Biedl Syndrome in a Proband\n\n Management of Bardet-Biedl Syndrome\n\n Genetic Counseling of Family Members of an Individual with Bardet-Biedl Syndrome\n\nResources\n\nChapter Notes\n\nReferences\n\nBarth SyndromeSynonyms: 3-Methylglutaconic Aciduria Type II, BTHS, TAFAZZIN Deficiency, TAZ DeficiencyFerreiraCarlosMDUnit on Skeletal GenomicsEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institutes of HealthBethesda, Marylandferreiracr@mail.nih.govPierreGermaineMBBS, MRCPCH, MScPediatric Metabolic ConsultantBristol Royal Hospital for ChildrenBristol, United Kingdomgermaine.pierre@uhbw.nhs.ukThompsonReidMDAssociate Professor, Pediatric CardiologyJohns Hopkins UniversityBaltimore, Marylandthompson@jhmi.eduVernonHilaryMD, PhDProfessor, Departments of Genetic Medicine and PediatricsJohns Hopkins UniversityBaltimore, Marylandhvernon1@jhmi.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">BCL11A</italic>-Related Intellectual DisabilitySynonyms: Dias-Logan Syndrome, Intellectual Developmental Disorder with Persistence of Fetal HemoglobinPeronAngelaMDangela.peron@unimi.itBradburyKimberleyBA, MBBS, MAkimberley.bradbury@gosh.nhs.ukViskochilDavid HMD, PhDdave.viskochil@hsc.utah.eduDiasCristinaMD, PhDcristina.dias@kcl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBeckwith-Wiedemann SyndromeSynonyms: Wiedemann-Beckwith Syndrome, Beckwith-Wiedemann Spectrum (BWSp)ShumanCherylMS, CGCProfessor, Molecular GeneticsUniversity of TorontoToronto, Ontariocheryl.shuman@utoronto.caKalishJennifer MMD, PhDAttending PhysicianResearch ScientistChildren's Hospital of Philadelphia;Assistant Professor of Pediatrics and GeneticsPerelman School of Medicine at the University of PennsylvaniaPhiladelphia, Pennsylvaniakalishj@chop.eduWeksbergRosannaMD, PhD, FRCPC, FCCMG, FACMGGeneticist, Clinical and Metabolic GeneticsSenior Associate Scientist, Research InstituteThe Hospital for Sick Children;Professor, Department of PediatricsUniversity of TorontoToronto, Ontariorweksb@sickkids.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBestrophinopathiesMacDonaldIan MMDCM, MScDepartment of Ophthalmology\nUniversity of AlbertaEdmonton, Alberta, Canadamacdonal@ualberta.caLeeThomasMD, MScDepartment of Ophthalmology\nUniversity of OttawaOttawa, Ontario, Canadathomaslee@toh.on.caLawrenceJessicaMScAlberta Health ServicesEdmonton, Alberta, Canadajessica.lawrence2@ahs.ca\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBeta-MannosidosisSynonyms: β-Mannosidosis, Beta-Mannosidase DeficiencyMartin RiosAngelaMDStead Family Department of PediatricsUniversity of IowaIowa City, Iowaangela-martin@uiowa.eduKimonisVirginiaMDProfessor of Pediatrics, Division of Genetics and Genomic MedicineUniversity of California Irvine Medical CenterOrange, Californiavkimonis@hs.uci.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBeta-Propeller Protein-Associated NeurodegenerationSynonyms: BPAN, Neurodegeneration with Brain Iron Accumulation 5 (NBIA5)GregoryAllisonMSgregorya@ohsu.eduKurianManju APhDmanju.kurian@ucl.ac.ukHaackTobiasMDtobias.haack@helmholtz-muenchen.deHayflickSusan JMDhayflick@ohsu.eduHogarthPenelopeMDhogarthp@ohsu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBeta-ThalassemiaSynonyms: Cooley's Anemia, Mediterranean AnemiaLangerArielle LMD, MPHDirector, Thalassemia ProgramDivision of HematologyBrigham and Women's HospitalBoston, Massachusettsalanger@bwh.harvard.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBietti Crystalline DystrophySynonyms: Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline RetinopathyVargasMauricioMD, PhDvargasma@ohsu.eduMitchellAmandaMS, CGCmitcheam@ohsu.eduYangPaulMD, PhDyangp@ohsu.eduWeleberRichardMD, DABMG, FACMGweleberr@ohsu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nBiotinidase DeficiencySynonym: Late-Onset Multiple Carboxylase DeficiencyWolfBarryMD, PhDbarrywolf1@comcast.net\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBiotin-Thiamine-Responsive Basal Ganglia DiseaseSynonyms: Biotin-Responsive Basal Ganglia Disease (BBGD), BTBGD, BTRBGD, Thiamine Metabolism Dysfunction Syndrome 2, Thiamine Transporter-2 DeficiencyTabarkiBrahimMDbtabarki@hotmail.comAl-HashemAmalMDmalhashema@moh.gov.saOrtigoza-EscobarJuan DaríoMD, PhDjuandario.ortigoza@sjd.esAlsharhanHindMDhind.alsharhan@ku.edu.kwAlfadhelMajidMD, MHSc, FCCMGdralfadhelm@gmail.com\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBirt-Hogg-Dubé SyndromeSynonym: Hornstein-Knickenberg SyndromeSattlerElke CMDDepartment of Dermatology and AllergologyUniversity HospitalLMU MunichMunich, Germanyelke.sattler@med.uni-muenchen.deSteinleinOrtrud KMDInstitute of Human GeneticsUniversity HospitalLMU MunichMunich, Germanyortrud.steinlein@med.uni-muenchen.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBlepharophimosis, Ptosis, and Epicanthus Inversus SyndromeSynonyms: Blepharophimosis Syndrome, BPESMattonCharlotteMSccharlotte.matton@ugent.beThomaesArnaudBScarnaud.thomaes@ugent.beCoolsMartineMD, PhDmartine.cools@ugent.beVerdinHannahMSc, PhDhannah.verdin@ugent.beDe BaereElfrideMD, PhDelfride.debaere@ugent.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBloom SyndromeLangerKatherineBAkjl4002@med.cornell.eduCunniffChristopher MMD, FACMGcmc9039@med.cornell.eduKucineNicoleMD, MSnik9015@med.cornell.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBohring-Opitz SyndromeSynonym: Oberklaid-Danks SyndromeRussellBiancaMDCincinnati Children's HospitalCincinnati, Ohiobianca.russell@cchmc.orgTanWen-HannBMBSBoston Children's HospitalBoston, Massachusettswen-hann.tan@childrens.harvard.eduGrahamJohn MJrMD, ScDCedars Sinai Medical Center Department of PediatricsHarbor-UCLA Medical CenterEmeritus Professor of Pediatrics, David Geffen School of Medicine at UCLALos Angeles, Californiajohn.graham@cshs.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBranchiooculofacial SyndromeSynonym: BOF SyndromeHaldeman-EnglertChad RMDCone HealthGreensboro, North Carolinachad.haldemanenglert@conehealth.comLinAngela EMD, FAAP, FACMGGenetics UnitMassachusetts General Hospital for ChildrenBoston, Massachusettslin.angela@mgh.harvard.eduMilunskyJeff MMD, FACMGDirector, Clinical GeneticsSenior Director, Molecular GeneticsCo-Director, Center for Human Genetics, IncCambridge, Massachusettsjmilunsky@chginc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBranchiootorenal Spectrum DisorderSmithRichard JHMDDirector, Molecular Otolaryngology and Renal Research LaboratoriesDirector, Iowa Institute of Human GeneticsSterba Hearing Research Professor of OtolaryngologyProfessor of Otolaryngology, Pediatrics, and Internal Medicine, Division of NephrologyCarver College of MedicineUniversity of IowaIowa City, Iowarichard-smith@uiowa.eduAzaiezHelaPhDAssistant Professor, Department of Medical & Molecular GeneticsUniversity of Indiana School of MedicineIndianapolis, Indianahazaiez@iu.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">BRCA1-</italic> and <italic toggle=\"yes\">BRCA2</italic>-Associated Hereditary Breast and Ovarian CancerSynonym: BRCA1- and BRCA2-Associated HBOCPetrucelliNancieMSWayne State University School of Medicine/Detroit Medical Center;Cancer Genetic Counseling ServiceKarmanos Cancer InstituteDetroit, Michiganpetrucel@karmanos.orgDalyMary BMD, PhDChair, Department of Clinical GeneticsFox Chase Cancer CenterPhiladelphia, Pennsylvaniamary.daly@fccc.eduPalTuyaMDVanderbilt-Ingram Cancer CenterNashville, Tennesseetuya.pal@vumc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBrugada SyndromeSynonym: Sudden Unexpected Nocturnal Death SyndromeBrugadaRamonMD, PhDGirona Institute of Biomedical Research (IDIBGI), CIBERCV, and School of MedicineUniversity of GironaGirona, Spainramon@brugada.orgCampuzanoOscarBSc, PhDGirona Institute of Biomedical Research (IDIBGI) and School of MedicineUniversity of GironaGirona, Spainoscar@brugada.orgSarquella-BrugadaGeorgiaMD, PhDHospital Sant Joan de DeuBarcelona, Spaingeorgia@brugada.orgBrugadaPedroMD, PhDFree University of BrusselsBrussels, Belgiumpedro@brugada.orgBrugadaJosepMD, PhDCardiovascular InstituteHospital Clinic and University of BarcelonaBarcelona, Spainjosep@brugada.orgHongKuiMD, PhDHeart Institute of Nanchang UniversityJiangxi, Chinahongkui88@163.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nBryant-Li-Bhoj Neurodevelopmental SyndromeBryantLauraPhDlaura.bryant@nationwidechildrens.orgBhojElizabethMD, PhDbhoje@chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">BSCL2</italic>-Related Neurologic Disorders / SeipinopathyItoDaisukeMD, PhDDepartment of NeurologySchool of MedicineKeio UniversityTokyo, Japand-ito@jk9.so-net.ne.jp\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nC3 GlomerulopathySynonyms: C3G, Glomerulonephritis with Dominant C3MartínBerthaPhDMolecular Otolaryngology and Renal Research Laboratories\nAnatomy and Cell Biology Department\nUniversity of Iowa\nIowa City, IowaSmithRichard JHMDProfessor of Internal Medicine, Division of Nephrology\nSterba Hearing Research Professor of Otolaryngology\nDirector, Molecular Otolaryngology and Renal Research Laboratories\nUniversity of Iowa\nIowa City, Iowa\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">C9orf72</italic> Frontotemporal Dementia and/or Amyotrophic Lateral SclerosisSynonym: C9orf72-FTD/ALSGossyeHelenaMDhelena.gossye@uantwerpen.vib.beEngelborghsSebastiaanMD, PhDsebastiaan.engelborghs@uzbrussel.beVan BroeckhovenChristinePhD, DScchristine.vanbroeckhoven@uantwerpen.vib.bevan der ZeeJuliePhDjulie.vanderzee@uantwerpen.vib.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CACNA1C</italic>-Related DisordersNapolitanoCarloMD, PhDcarlo.napolitano@unipv.itPrioriSilvia GMD, PhDsilvia.priori@icsmaugeri.it\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCADASILSynonym: Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and LeukoencephalopathyHackRemco JMDr.j.hack@lumc.nlRuttenJulieMD, PhDj.w.rutten@lumc.nlLesnik ObersteinSaskia AJMD, PhDlesnik@lumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCaffey DiseaseSynonym: Infantile Cortical HyperostosisGuerinAndreaMD, MEd, FRCPC, FCCMGandrea.guerin@kingstonhsc.caDupuisLucieMS, MSc, CGClucie.dupuis@sickkids.caMendoza-LondonoRobertoMD, MS, FACMG, FCCMGroberto.mendoza@sickkids.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCalpainopathyAngeliniCorradoMDcorrado.angelini@unipd.it\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCampomelic DysplasiaSynonyms: Camptomelic Dysplasia, SOX9-Related Campomelic DysplasiaUngerSheilaMDMedical Genetics ServiceCentre Hospitalier Universitaire VaudoisLausanne, Switzerlandsheila.unger@chuv.chSchererGerdPhDInstitute of Human GeneticsUniversity of FreiburgFreiburg, Germanygerd.scherer@uniklinik-freiburg.deSuperti-FurgaAndreaMDLeenaards Professor of PediatricsUniversity of Lausanne;Centre Hospitalier Universitaire VaudoisLausanne, Switzerland\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCamurati-Engelmann DiseaseSynonym: Progressive Diaphyseal Dysplasia, TGFB1-Related Diaphyseal Dysplasia Camurati-EngelmannWallaceStephanie EMDDivision of Genetic MedicineUniversity of WashingtonSeattle Children's HospitalSeattle, Washingtonstephanie.wallace@seattlechildrens.orgWilcoxWilliam RMD, PhDDepartment of Human GeneticsEmory University School of MedicineAtlanta, Georgiawilliam.wilcox@emory.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCanavan DiseaseSynonyms: ASPA Deficiency, Aspartoacylase DeficiencyNagyAmandaMDanagy2@mgb.orgBleyAnnette EMDabley@uke.deEichlerFlorianMDfeichler@mgb.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCantú SyndromeGrangeDorothy KMDDivision of Genetics and Genomic MedicineDepartment of PediatricsWashington University School of Medicine;St Louis Children's HospitalSt Louis, Missourigrangedk@wustl.eduNicholsColin GPhDDirector, Center for the Investigation of Membrane Excitability DiseasesDepartment of Cell Biology and PhysiologyWashington University School of MedicineSt Louis, Missouricnichols@wustl.eduSinghGautam KMDChief of Pediatric CardiologyDepartment of PediatricsCentral Michigan University School of Medicine;Children's Hospital of MichiganDetroit, Michigangsingh3@dmc.orgGuilliamsKristinMDDepartment of NeurologyWashington University School of Medicine;St Louis Children's HospitalSt Louis, Missourikristinguilliams@wustl.eduAggarwalManishMDDivision of CardiologyDepartment of PediatricsWashington University School of Medicine;St Louis Children's HospitalSt Louis, Missourimaggarwal@wustl.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCapillary Malformation-Arteriovenous Malformation SyndromeSynonym: CM-AVM SyndromeBayrak-ToydemirPinarMD, PhD, FACMGDepartment of PathologyUniversity of UtahARUP LaboratoriesSalt Lake City, Utahpinar.bayrak-toydemir@aruplab.comStevensonDavid AMD, FACMGDivision of Medical GeneticsStanford UniversityPalo Alto, Californiadasteven@stanford.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCarbonic Anhydrase VA DeficiencySynonym: CA-VA Deficiencyvan KarnebeekClaraMD, PhDDepartment of Pediatrics\nEmma Children’s Hospital\nAmsterdam University Medical Center\nAmsterdam, the Netherlandsc.d.vankarnebeek@amsterdamumc.nlHäberleJohannesMDDivision of Metabolism\nDepartment of Pediatrics\nUniversity Children's Hospital Zurich\nZurich, Switzerlandjohannes.haeberle@kispi.uzh.ch\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCardiofaciocutaneous SyndromeSynonym: CFC SyndromeRauenKatherine AMD, PhDProfessor, Department of PediatricsDivision of Genomic MedicineUniversity of California, DavisUC Davis MIND InstituteSacramento, Californiarauen@ucdavis.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCarney ComplexSynonym: Carney SyndromeStratakisConstantine AMD, DScDirector, Human Genetics & Precision MedicineFoundation for Research & Technology HellasHeraklion, Greececastratakis@verizon.net\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCarnitine-Acylcarnitine Translocase DeficiencySynonym: CACT DeficiencyMorales CoradoJ AndresMBBSAssistant Professor, Division of Clinical GeneticsDepartment of PediatricsColumbia UniversityNew York, New Yorkjm5577@cumc.columbia.eduLeeChung UMDAssistant Professor, Division of Medical GeneticsDepartment of PediatricsStanford UniversityStanford, Californiachunglee@stanford.eduEnnsGregory MMB ChBProfessor of Pediatrics, Division of Medical GeneticsDepartment of PediatricsStanford UniversityStanford, Californiagenns@stanford.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCarnitine Palmitoyltransferase 1A DeficiencySynonyms: CPT1A Deficiency, Hepatic Carnitine Palmitoyltransferase 1 DeficiencyLeeKristenMDlekriste@med.umich.eduPritchardAmandaMDabarone@med.umich.eduAhmadAyeshaMDayeshaah@med.umich.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCarnitine Palmitoyltransferase II DeficiencySynonym: CPT II DeficiencyLoPiccoloMary KateMDAssistant Professor, Icahn School of Medicine at Mount SinaiNew York, New Yorkmary.lopiccolo@mssm.eduVockleyJerryMD, PhDProfessor, University of PittsburghPittsburgh, Pennsylvaniavockleyg@upmc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum DisordersMäkitieOutiMD, PhDouti.makitie@helsinki.fiVakkilainenSvetlanaMD, PhDsvetlana.vakkilainen@helsinki.fi\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CASK</italic> DisordersMoogUteMDInstitute of Human GeneticsHeidelberg UniversityHeidelberg, Germanyute.moog@med.uni-heidelberg.deKutscheKerstinPhDInstitute of Human GeneticsUniversity Medical Center Hamburg-EppendorfHamburg, Germanykkutsche@uke.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCatecholaminergic Polymorphic Ventricular TachycardiaSynonyms: Catecholamine-Induced Polymorphic Ventricular Tachycardia, CPVTNapolitanoCarloMD, PhDAssociate Professor, Department of Molecular Medicine\nUniversity of Pavia;\nMolecular Cardiology\nICS Maugeri\nPavia, Italycarlo.napolitano@unipv.itMazzantiAndreaMD, PhDAssistant Professor, Department of Molecular Medicine\nUniversity of Pavia;\nMolecular Cardiology\nICS Maugeri\nPavia, Italyandrea.mazzanti@icsmaugeri.itBloiseRaffaellaMDMedical Geneticist, Molecular Cardiology\nICS Maugeri\nPavia, Italyraffaella.bloise@icsmaugeri.itPrioriSilvia GMD, PhDProfessor of Cardiology, Department of Molecular Medicine\nUniversity of Pavia;\nMolecular Cardiology\nICS Maugeri\nPavia, Italysilvia.priori@icsmaugeri.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCD40 Ligand DeficiencySynonyms: CD154 Deficiency, HIGM1, X-Linked Hyper-IgM Immunodeficiency (XHIGM), X-Linked Hyper IgM SyndromeDunnClinton PMDChildren's Specialty GroupChildren's Hospital of the King's DaughtersVirginia Health Sciences at Old Dominion UniversityNorfolk, Virginiaclinton.dunn@chkd.orgde la MorenaM TeresaMDUniversity of WashingtonSeattle Children's HospitalSeattle, Washingtonmariateresa.delamorena@seattlechildrens.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CDC73</italic>-Related DisordersSkefosCatherine MMA, MSCertified Genetic Counselor, Clinical Cancer Genetics ProgramThe University of Texas MD Anderson Cancer CenterHouston, Texascbskefos@mdanderson.orgWaguespackSteven GMDProfessor, Department of Endocrine Neoplasia and Hormonal Disorders & Department of PediatricsThe University of Texas MD Anderson Cancer CenterHouston, Texasswagues@mdanderson.orgPerrierNancy DMD, FACSProfessor, Department of Surgical OncologyThe University of Texas MD Anderson Cancer CenterHouston, Texasnperrier@mdanderson.orgHuMimi IMDProfessor, Department of Endocrine Neoplasia and Hormonal DisordersThe University of Texas MD Anderson Cancer CenterHouston, Texasmhu@mdanderson.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CDK13</italic>-Related DisorderSynonyms: CDK13-Related Congenital Heart Defects, Dysmorphic Facial Features, and Intellectual Developmental Disorder; CDK13-Related CHDFIDDBostwickBretMDBaylor College of MedicineTexas Children's HospitalHouston, Texasbostwick@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCDKL5 Deficiency DisorderSynonyms: Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (CDD), CDKL5-Related Developmental and Epileptic EncephalopathyBenkeTim AMD, PhDtim.benke@cuanschutz.eduDemarestScottMDscott.demarest@cuanschutz.eduAngioneKatieMSkaitlin.angione@childrenscolorado.orgDownsJennyBAppSci, GradCertPubHlth, MSc, PhDjenny.downs@telethonkids.org.auLeonardHelenMBChB, MPHhelen.leonard@telethonkids.org.auSaldarisJacintaPhDjacinta.saldaris@telethonkids.org.auMarshEric DMD, PhDmarshe@chop.eduOlsonHeatherMD, MSheather.olson@childrens.harvard.eduHavilandIsabelMDisabel.haviland@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CDKN2A</italic> Cancer PredispositionSynonyms: CDKN2A-Related Melanoma-Astrocytoma Syndrome (MAS), Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM), Melanoma-Pancreatic Cancer SyndromeJacobsMichelle FMS, CGCmfjac@med.umich.eduMuradAndrea MMS, CGCamurad@med.umich.eduChoNicole DMS, CGCnicdcho@med.umich.eduChaKelly BMD, PhDkellycha@med.umich.eduStoffelElena MMD, MPHestoffel@med.umich.eduElseTobiasMDtelse@med.umich.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CEBPA-</italic>Associated Familial Acute Myeloid Leukemia (AML)Synonym: CEBPA-Dependent Familial Acute Myeloid LeukemiaTawanaKiranMBChB, FRCPath, PhDkiran.tawana@addenbrookes.nhs.ukFitzgibbonJudeBA, PhDj.fitzgibbon@qmul.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCeliac DiseaseSynonyms: Celiac Sprue, Cœliac Disease, Gluten-Sensitive EnteropathyTaylorAnnette KPhD, MS, FACMGAssociate VP, Strategic Director, Pharmacogenomics;Scientific Director, Molecular GeneticsLabcorpEnglewood, Coloradotayla12@labcorp.comLebwohlBenjaminMD, MSProfessor of Medicine and EpidemiologyCeliac Disease CenterColumbia UniversityNew York, New Yorkbl114@cumc.columbia.eduSnyderCara LMS, CGCCLS Genetic Consulting, LLCcara@carasnyder.comGreenPeter HRMDDirector, Celiac Disease CenterPhyllis and Ivan Seidenberg Professor of MedicineColumbia University Medical CenterNew York, New Yorkpg11@columbia.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCerebrotendinous XanthomatosisFedericoAntonioMDfederico@unisi.itGallusGian NicolaDScigallus2@unisi.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CETP</italic>-Related HyperalphalipoproteinemiaSynonyms: Cholesteryl Ester Transfer Protein (CETP) Deficiency, Primary HyperalphalipoproteinemiaBurnettJohn RMB ChB, MD, PhD, FRCPADepartment of Clinical BiochemistryRoyal Perth Hospital & Fiona Stanley Hospital NetworkPathWest Laboratory Medicine WA;Faculty of Health & Medical SciencesSchool of MedicineUniversity of Western AustraliaPerth, Australiajohn.burnett@health.wa.gov.auHooperAmanda JPhDDepartment of Clinical BiochemistryRoyal Perth Hospital & Fiona Stanley Hospital NetworkPathWest Laboratory Medicine WA;School of MedicineUniversity of Western AustraliaPerth, Australiaamanda.hooper@health.wa.gov.auHegeleRobert AMD, FRCPC, FACPDepartments of Medicine and BiochemistrySchulich School of Medicine and Robarts Research InstituteWestern UniversityLondon, Ontario, Canadahegele@robarts.ca\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCharcot-Marie-Tooth Hereditary Neuropathy OverviewSynonyms: Distal Hereditary Motor Neuropathy (dHMN), Hereditary Motor/Sensory Neuropathy (HMSN)BirdThomas DMDSeattle VA Medical Center;Departments of Neurology and MedicineUniversity of WashingtonSeattle, Washingtontomnroz@u.washington.edu\n\nSummary\n\n Clinical Characteristics of Charcot-Marie-Tooth (CMT) Hereditary Neuropathy\n\n Causes of Charcot-Marie-Tooth (CMT) Hereditary Neuropathy\n\n Evaluation Strategies to Identify the Genetic Cause of Charcot-Marie-Tooth (CMT) Hereditary Neuropathy in a Proband\n\n Management of Charcot-Marie-Tooth (CMT) Hereditary Neuropathy\n\n Genetic Counseling of Family Members of an Individual with Charcot-Marie-Tooth (CMT) Hereditary Neuropathy\n\nResources\n\nChapter Notes\n\nReferences\n\nChar SyndromeGelbBruce DMDPediatrics and Genetics and Genomic SciencesIcahn School of Medicine at Mount SinaiNew York, New Yorkbruce.gelb@mssm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CHCHD10</italic>-Related DisordersAit-El-Mkadem SaadiSamiraPhDsaadi.s@chu-nice.frChaussenotAnnabelleMDchaussenot.a@chu-nice.frBannwarthSylviePhDbannwarth.s@chu-nice.frRouzierCécileMD, PhDrouzier.c@chu-nice.frPaquis-FlucklingerVéroniqueMD, PhDpaquis@unice.fr\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CHD2</italic>-Related Neurodevelopmental DisordersCarvillGemma LPhDDepartment of NeurologyNorthwestern UniversityEvanston, Illinoisgemma.carvill@northwestern.eduMeffordHeather CMD, PhDProfessor, Center for Pediatric Neurological Disease ResearchDepartment of Cellular and Molecular BiologySt Jude Children's Research HospitalMemphis, Tennesseeheather.mefford@stjude.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CHD4</italic> Neurodevelopmental DisorderSynonyms: Sifrim-Hitz-Weiss Syndrome, SIHIWESWeissKarinMDGenetics Institute\nRambam Health Care Center;\nRuth and Bruce Rappaport Faculty of Medicine\nTechnion-Israel Institute of Technology\nHaifa, Israelk_weiss@rmc.gov.ilLachlanKatherineMDWessex Clinical Genetics Service\nUniversity Hospital Southampton NHS Trust;\nDepartment of Human Genetics and Genomic Medicine\nSouthampton University\nSouthampton, United Kingdomkatherine.lachlan@uhs.nhs.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">CHD7</italic> Disordervan Ravenswaaij-ArtsConny MMD, PhDUniversity Medical Center GroningenGroningen, the Netherlandsc.m.a.van.ravenswaaij@umcg.nlHefnerMegMSSaint Louis UniversitySt Louis, Missourimeg.hefner@health.slu.eduBlakeKimMD, MRCP, FRCPCDalhousie UniversityHalifax, Nova Scotia, Canadakblake@dal.caMartinDonna MMD, PhDUniversity of MichiganAnn Arbor, Michigandonnamm@umich.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CHD8</italic>-Related Neurodevelopmental Disorder with OvergrowthMitchelMarissa WMS, CCC-SLPmwmitchel@geisinger.eduMyersScott MMDsmyers1@geisinger.eduHeidlebaughAlexis RScM, CGCarheidlebaugh@geisinger.eduTaylorCora MPhDcmtaylor1@geisinger.eduReaHannahPhDhrea@uw.eduNeuhausEmilyPhDeneuhaus@uw.eduKurtz-NelsonEvangeline CPhDevakn@uw.eduEarlRachelPhDrearl@uw.eduBernierRaphaelPhDrab2@uw.eduLedbetterDavid HPhD, FACMGledbetter.david@ufl.eduMartinChrista LPhD, FACMGclmartin1@geisinger.eduEichlerEvan EPhDeee@gs.washington.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nChediak-Higashi SyndromeToroCamiloMDtoroc@mail.nih.govMorimotoMariePhDmarie.morimoto@nih.govMalicdanMay ChristineMD, PhDmalicdanm@mail.nih.govAdamsDavid RMD, PhDdavid.adams@nih.govIntroneWendy JMDwintrone@mail.nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CHEK2</italic>-Related Cancer PredispositionHansonHelenMDPeninsula Clinical GeneticsRoyal Devon University Healthcare NHS Foundation Trust;Department of Clinical and Biomedical SciencesUniversity of Exeter Medical SchoolExeter, United Kingdomhelen.hanson6@nhs.netPalTuyaMDDepartment of MedicineVanderbilt University Medical CenterVanderbilt-Ingram Cancer CenterNashville, Tennesseetuya.pal@vumc.orgTischkowitzMarcMD, PhDDepartment of Genomic MedicineNational Institute for Health ResearchCambridge Biomedical Research CentreUniversity of CambridgeCambridge, United Kingdommdt33@cam.ac.ukStewartDouglasMDClinical Genetics BranchDivision of Cancer Epidemiology and GeneticsNational Cancer InstituteRockville, Marylanddrstewart@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCherubismMoriceAnneMD, PhDa.morice@chu-tours.frKadlubNatachaMD, PhDnatacha.kadlub@aphp.frCoudertAméliePhDamelie.coudert@inserm.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nChildhood Ataxia with Central Nervous System Hypomyelination / Vanishing White MatterSynonyms: CACH/VWM, Leukoencephalopathy with Vanishing White Mattervan der KnaapMarjo SMD, PhDms.vanderknaap@vumc.nlFogliAnnePhDanne.fogli@inserm.u-clermont1.frBoespflug-TanguyOdileMD, PhDodile.boespflug-tanguy@rdb.aphp.frAbbinkTruus EMPhDg.abbink@vumc.nlSchiffmannRaphaelMDraphael.schiffmann@baylorhealth.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">CHKB</italic>-Related Muscular DystrophySynonym: Megaconial Congenital Muscular DystrophyChanSophelia HSMDDivision of NeurologyDepartment of Paediatrics and Adolescent MedicineSchool of Clinical MedicineLKS Faculty of MedicineUniversity of Hong KongHong Kong SAR, Chinasophehs@hku.hkNishinoIchizoMD, PhDNational Institute of NeuroscienceNational Center of Neurology and PsychiatryTokyo, Japannishino@ncnp.go.jp\n\nSummary\n\nGeneReview Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CHMP2B-</italic>Related Frontotemporal Dementia-Amyotrophic Lateral SclerosisSynonym: CHMP2B-FTD-ALSRoosPeterMD, PhDpeter.roos@regionh.dkHolmIda EMD, DMScidaholm@dadlnet.dkNielsenJørgen EMD, PhDjoergen.erik.nielsen.01@regionh.dkEjlerskovPatrickMSc, PhDpatrick.ejlerskov@regionh.dkToftAndersMD, PhDanders.toft.01@regionh.dkIsaacsAdrian MDPhila.isaacs@ucl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nChondrodysplasia Punctata 1, X-LinkedSynonym: Arylsulfatase E DeficiencyBravermanNancy EMS, MDDepartments of Pediatrics and Human Genetics\nMcGill University and Research Institute of the McGill University Health Center\nMontreal, Quebec, Canadanancy.braverman@mcgill.caBoberMichael BMD, PhDDirector, Skeletal Dysplasia Program\nAI duPont Hospital for Children\nWilmington, Delawarembober@nemours.orgBrunetti-PierriNicolaMDTelethon Institute of Genetics and Medicine;\nDepartment of Translational Medicine\nFederico II University of Naples\nNaples, Italybrunetti@tigem.itSuchySharon FPhDDirector, Inherited Metabolic Disorders\nGeneDx, Inc\nGaithersburg, Marylandssuchy@genedx.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nChondrodysplasia with Congenital Joint Dislocations, <italic toggle=\"yes\">CHST3</italic>-RelatedSynonyms: CHST3 Deficiency, CHST3-Related Skeletal Dysplasia, Recessive Larsen SyndromeSuperti-FurgaAndreaMDProfessor, Division of Genetic MedicineUniversity of Lausanne;Genetica AGLausanne, Switzerlandasuperti@unil.chUngerSheilaMDGenetica AGLausanne, Switzerlands.unger@genetica.ch\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nChoroideremiaMacDonaldIan MMD, CMmacdonal@ualberta.caHumeStaceyPhDshume@ualberta.caZhaiYiMD, PhDyzhai4@ualberta.caXuManlongMD, PhDmanlong@ualberta.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nChristianson SyndromeMorrowEric MMD, PhDDevelopmental Disorders Genetics Research ProgramEmma Pendleton Bradley HospitalThe Warren Alpert Medical SchoolDepartment of Molecular Biology, Cell Biology, and BiochemistryHassenfeld Child Health Innovation InstituteBrown UniversityProvidence, Rhode Islandemorrow@lifespan.orgPescosolidoMatthew FBADevelopmental Disorders Genetics Research ProgramEmma Pendleton Bradley HospitalThe Warren Alpert Medical SchoolBrown UniversityProvidence, Rhode Islandmatthew_pescosolido@brown.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nChronic Granulomatous DiseaseSynonym: CGDLeidingJennifer WMDDepartment of PediatricsDivision of Allergy and ImmunologyJohns Hopkins UniversityBaltimore, Marylandjleidin1@jhmi.eduHollandSteven MMDLaboratory of Clinical Microbiology and ImmunologyNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesda, Marylandsholland@niaid.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nChylomicron Retention DiseaseSynonym: Anderson DiseaseBurnettJohn RMB ChB, MD, PhD, FRCPAjohn.burnett@health.wa.gov.auHooperAmanda JPhDamanda.hooper@health.wa.gov.auHegeleRobert AMD, FRCPC, FACPhegele@robarts.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCitrin DeficiencySongYuan-ZongMD, PhDDepartment of PediatricsFirst Affiliated HospitalJinan UniversityGuangzhou, Chinasongyuanzong@vip.tom.comsongyuanzong@hotmail.comOishiKimihikoMDDepartment of PediatricsJikei University School of MedicineTokyo, Japankimihiko.oishi@jikei.ac.jpSahekiTakeyoriMD, PhDDepartment of Hygiene and Health Promotion MedicineKagoshima University Graduate School of Medical and Dental SciencesKagoshima, Japantakesah@gmail.com\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCitrullinemia Type ISynonyms: Argininosuccinate Synthetase Deficiency, Argininosuccinic Acid Synthetase Deficiency, ASS Deficiency, Classic Citrullinemia, CTLN1QuinonezShane CMDsquinon@umich.eduLeeKristen NMDlekriste@med.umich.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nClassic Ehlers-Danlos SyndromeSynonyms: Classical Ehlers-Danlos Syndrome; Ehlers-Danlos Syndrome, Classical Type; cEDSMalfaitFransiskaMD, PhDfransiska.malfait@ugent.beSymoensSofiePhDsofie.symoens@ugent.beSyxDelfienPhDdelfien.syx@ugent.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nClassic Galactosemia and Clinical Variant GalactosemiaSynonyms: Galactose-1-Phosphate Uridylyltransferase Deficiency, GALT DeficiencyBerryGerard TMD, FFACMGBoston Children's HospitalHarvard Medical SchoolBoston, Massachusettsgerard.berry@childrens.harvard.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nClassic Isovaleric AcidemiaSynonyms: Classic Isovaleric Aciduria, Isovaleryl-Coenzyme A Dehydrogenase DeficiencyMützeUlrikeMDulrike.muetze@med.uni-heidelberg.deReischl-HajiabadiAnnaMDanna.reischl-hajiabadi@med.uni-heidelberg.deKölkerStefanMDstefan.koelker@med.uni-heidelberg.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nClassic Mowat-Wilson SyndromeSynonym: Hirschsprung Disease – Intellectual Disability SyndromeAdamMargaret PMD, MS, FAAP, FACMGProfessor of Pediatrics, Division of Genetic MedicineDepartment of PediatricsUniversity of WashingtonSeattle, Washingtonmargaret.adam@seattlechildrens.orgContaJessieMS, LGCDepartment of LaboratoriesSeattle Children’s HospitalSeattle, WashingtonBeanLora JHPhD, FACMGPerkinElmer Genomics, IncPittsburgh, Pennsylvanialora.bean@perkinelmer.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CLCN2</italic>-Related LeukoencephalopathyMinRogierPhDr.min@amsterdamumc.nlDepienneChristelPhDchristel.depienne@uni-due.deSedelFredericMDfrederic.sedel@medday-pharma.comAbbinkTruus EMPhDg.abbink@amsterdamumc.nlvan der KnaapMarjo SMD, PhDms.vanderknaap@amsterdamumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CLCN4</italic>-Related Neurodevelopmental DisorderPalmerElizabeth EmmaPhD, MBBS, FRACPelizabeth.palmer@unsw.edu.auNguyenMatthew HuuBMedSc (Hons 1), MDhuu.nguyen1@health.nsw.gov.auForwoodCaitlinMBBS (Hons), BSc (Hons), FRACGP, DCHcaitlin.forwood@health.nsw.gov.auKalscheuerVeraPhDkalscheu@molgen.mpg.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CLCN7</italic>-Related OsteopetrosisSobacchiCristinaMScristina.sobacchi@humanitasresearch.itVillaAnnaMD, PhDanna.villa@humanitasresearch.itSchulzAnsgarMDansgar.schulz@uniklinik-ulm.deKornakUweMD, PhDuwe.kornak@med.uni-goettingen.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCleidocranial Dysplasia Spectrum DisorderSynonym: Cleidocranial DysostosisMacholKerenMD, PhDmachol@bcm.eduMendoza-LondonoRobertoMD, MSroberto.mendoza@sickkids.caLeeBrendanMD, PhDblee@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCLPB DeficiencySynonyms: Caseinolytic Peptidase B Deficiency, CLPB DefectWortmannSaskia BMD, PhDClinical Lead, Pediatric Metabolic DisordersDepartment of PediatricsSalzburger Landeskliniken and Paracelsus Medical UniversitySalzburg, Austrias.wortmann@salk.atWeversRon APhDTranslational Metabolic LaboratoryDepartment of Laboratory MedicineRadboud University Medical CenterNijmegen, the Netherlandsron.wevers@radboudumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CNOT1</italic>-Related Vissers-Bodmer SyndromeSynonym: CNOT1-Related Neurodevelopmental Disorderde BrouwerArjan PMPhDarjan.debrouwer@radboudumc.nlVissersLisenkaPhDlisenka.vissers@radboudumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCockayne SyndromeLaugelVincentMD, PhDLaboratory of Medical GeneticsStrasbourg, Francevincent.laugel@chru-strasbourg.fr\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCoffin-Siris SyndromeSynonym: Fifth Digit SyndromeSchrier VerganoSamanthaMDDivision of Genetic MedicineSeattle Children's HospitalSeattle, Washingtonsamantha.vergano@seattlechildrens.orgSantenGijsMD, PhDDepartment of Clinical GeneticsLeiden University Medical CenterLeiden, the Netherlandsg.w.e.santen@lumc.nlWieczorekDagmarMDInstitute of Human GeneticsMedical Faculty and University HospitalHeinrich Heine UniversityDüsseldorf, Germanydagmar.wieczorek@med.uni-duesseldorf.deMatsumotoNaomichiMD, PhDDepartment of Human GeneticsYokohama City University Graduate School of MedicineYokohama, Japannaomat@yokohama-cu.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCohen SyndromeSynonym: VPS13B-Related Neurodevelopmental DisorderWangHengMD, PhDPediatrician, Medical Director, DDC Clinic – Center for Special Needs ChildrenMiddlefield, Ohiowang@ddcclinic.orgXinBaozhongPhDResearch and Technical Director, DDC Clinic – Center for Special Needs ChildrenMiddlefield, Ohiobxin@ddcclinic.orgWenselChristineMSLicensed Genetic Counselor, Robert J Tomsich Pathology and Laboratory MedicineCleveland ClinicCleveland, Ohiowenselc@ccf.orgTraboulsiElias IMD, MEdProfessor of Ophthalmology, Cleveland Clinic Foundation and Lerner College of MedicineVice-Chair for Education and Head, Pediatric Ophthalmology and StrabismusDirector, Center for Genetic Eye DiseasesCole Eye InstituteCleveland, Ohiotraboue@ccf.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">COL1A1</italic>- and <italic toggle=\"yes\">COL1A2</italic>-Related Osteogenesis ImperfectaSynonyms: Brittle Bone Disease, OIRodriguez CelinMercedesMDmercedesrodriguezcelin@gmail.comSteinerRobert DMDrdsteiner111@gmail.comBaselDonaldMDdbasel@mcw.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">COL4A1</italic>-Related DisordersPlaisierEmmanuelleMD, PhDemmanuelle.plaisier@aphp.frRoncoPierreMD, PhDpierreronco@yahoo.fr\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCold-Induced Sweating Syndrome Including Crisponi SyndromeHahnAngelika FMD, FRCPDepartment of Clinical Neurological Sciences\nLondon Health Sciences Centre\nWestern University\nLondon, Ontario, Canadaangelika.hahn@lhsc.on.caKnappskogPer MortenPhDCenter for Medical Genetics\nHaukeland University Hospital\nBergen, Norwayper.knappskog@helse-bergen.no\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCollagen VI-Related DystrophiesSynonyms: COL6-Related Dystrophies (COL6-RDs)FoleyA ReghanMD, MD(Res)reghan.foley@nih.govMohasselPayamMDpayam.mohassel@nih.govDonkervoortSandraMS, CGCsandra.donkervoort@nih.govBolducVéroniquePhDveronique.bolduc@nih.govBönnemannCarsten GMD, habilcarsten.bonnemann@nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nComplete Plasminogen Activator Inhibitor 1 DeficiencySynonyms: Complete PAI-1 Deficiency, Homozygous PAI-1 DeficiencyHeimanMeadowMSmheiman@ihtc.orgGuptaSwetaMDsgupta@ihtc.orgLewandowskaMagdalenaMDmlewandowska@ihtc.orgShapiroAmy DMDashapiro@ihtc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">COMP</italic>-Related PseudoachondroplasiaSynonym: Pseudoachondroplasia (PSACH)BriggsMichael DPhDProfessor of Skeletal Genetics, Institute of Genetic MedicineNewcastle UniversityInternational Centre for LifeNewcastle upon Tyne, United Kingdommichael.briggs@newcastle.ac.ukWrightMichael JMB, ChB, MSc, FRCPConsultant in Clinical Genetics, Northern Genetics ServiceNewcastle upon Tyne HospitalsNewcastle upon Tyne, United Kingdommichael.wright@nuth.nhs.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCongenital Central Hypoventilation SyndromeWeese-MayerDebra EMDdweese-mayer@luriechildrens.orgd-weese-mayer@northwestern.eduRandCasey MBScrand@luriechildrens.orgKhaytinIlyaMD, PhDikhaytin@luriechildrens.orgilya.khaytin@northwestern.eduSlatterySusan MMD, MSsslattery@luriechildrens.orgsusan.slattery@northwestern.eduYapKai LeePhD FACMGklyap@luriechildrens.orgMarazitaMary LPhD, FACMGmarazita@pitt.eduBerry-KravisElizabeth MMD, PhDelizabeth_m_berry-kravis@rush.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCongenital Contractural ArachnodactylySynonyms: Beals-Hecht Syndrome, Beals SyndromeCallewaertBertMD, PhDCenter for Medical GeneticsGhent University HospitalGhent, Belgiumbert.callewaert@ugent.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCongenital Deafness with Labyrinthine Aplasia, Microtia, and MicrodontiaSynonyms: Congenital Deafness with Inner Ear Agenesis, Microtia, and Microdontia; LAMM SyndromeOrdonezJessicaMSDivision of Clinical GeneticsCenter for Genomic MedicineMiami Cancer Institute at Baptist Health South FloridaMiami, Floridajessicaord@baptisthealth.netTekinMustafaMDDr John T Macdonald FoundationDepartment of Human GeneticsJohn P Hussman Institute for Human GenomicsMiami, Floridamtekin@med.miami.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCongenital Diaphragmatic Hernia Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLYLongoniMauroMDAssistant Professor of Surgery, Harvard Medical SchoolAssistant, Massachusetts General HospitalBoston, Massachusettsmlongoni@mgh.harvard.eduPoberBarbara RMDPediatrician, MassGeneral Hospital for ChildrenProfessor Emeritus of Pediatrics, Harvard Medical SchoolBoston, Massachusettspober.barbara@mgh.harvard.eduHighFrances AMD, PhDDivision of Medical GeneticsMassGeneral Hospital for ChildrenDepartment of SurgeryBoston Children’s HospitalBoston, Massachusettsfhigh@partners.org\n\nSummary\n\n Clinical Characteristics of Congenital Diaphragmatic Hernia\n\n Genetic Causes of Congenital Diaphragmatic Hernia\n\n Evaluation Strategies to Identify the Genetic Cause of Congenital Diaphragmatic Hernia in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nCongenital Dyserythropoietic Anemia Type ITamaryHannahMDProfessor of Pediatrics\nDirector, Hematology Diagnostic and Research Laboratory\nSchneider Children's Medical Center of Israel\nPetah Tiqva, Israelhtamary@tauex.tau.ac.ilDganyOrlyPhDDirector, Pediatric Hematology Diagnostic Laboratory\nFelsenstein Medical Research Center\nBeilinson Campus\nPetah Tiqva, Israel\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCongenital Erythropoietic PorphyriaSynonym: Günther DiseaseErwinAngelikaMD, PhDerwina@ccf.orgBalwaniManishaMD, MSmanisha.balwani@mssm.eduDesnickRobert JMD, PhD, FACMGrobert.desnick@mssm.eduPorphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCongenital Fibrosis of the Extraocular Muscles OverviewSynonym: CFEOMWhitmanMary CMD, PhDmary.whitman@childrens.harvard.eduJurgensJulie APhDjulie.jurgens@childrens.harvard.eduHunterDavid GMD, PhDdavid.hunter@childrens.harvard.eduEngleElizabeth CMDelizabeth.engle@childrens.harvard.edu\n\nSummary\n\n Clinical Characteristics of Congenital Fibrosis of the Extraocular Muscles\n\n Genetic Causes of CFEOM\n\n Differential Diagnosis of CFEOM\n\n Evaluation Strategy to Identify the Genetic Cause of CFEOM in a Proband (When Possible)\n\n Management of CFEOM\n\n Genetic Counseling of Family Members of an Individual with CFEOM\n\nResources\n\nChapter Notes\n\nReferences\n\nCongenital Hepatic Fibrosis Overview ─ RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLYGunay-AygunMeralMDmgaygun@mail.nih.govGahlWilliam AMD, PhDbgahl@helix.nih.govHellerTheoMDtheller@nih.gov\n\nSummary\n\nDefinition\n\nCauses of Congenital Hepatic Fibrosis\n\nEvaluation Strategy\n\nGenetic Counseling\n\nResources\n\nManagement\n\nReferences\n\nChapter Notes\n\nCongenital Insensitivity to Pain OverviewSchonKatherine RoseMB ChB, MRCP, MADepartment of Clinical GeneticsAddenbrooke's HospitalCambridge, United Kingdomks339@cam.ac.ukParkerAlasdair Patrick JohnMBBS, MRCP, MD, MADepartment of Paediatric NeurologyAddenbrooke's HospitalCambridge, United Kingdomapjparker@gmail.comWoodsChristopher GeoffreyMB ChB, FRCP, FMedSciDepartment of Medical GeneticsThe Clinical Medical SchoolUniversity of CambridgeCambridge, United Kingdomcw347@cam.ac.uk\n\nSummary\n\n Clinical Characteristics of Congenital Insensitivity to Pain\n\n Causes of Congenital Insensitivity to Pain\n\n Evaluation Strategy to Identify the Genetic Cause of Congenital Insensitivity to Pain\n\n Management\n\n Genetic Risk Assessment\n\nResources\n\nChapter Notes\n\nReferences\n\nCongenital Mirror MovementsSynonym: Congenital Mirror Movement DisorderMéneretAurélieMD, PhDaurelie.meneret@aphp.frTrouillardOrianeBSoriane.trouillard@icm-institute.orgDunoyerMargauxMDmargaux.dunoyerdesegonzac@aphp.frDepienneChristelPhDchristel.depienne@uni-due.deRozeEmmanuelMD, PhDemmanuel.flamand-roze@aphp.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCongenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLYSparksSusan EMD, PhDSanofi GenzymeCambridge, Massachusettssusan.sparks@genzyme.comQuijano-RoySusanaMD, PhDNeuromuscular Center (GNMH)Department of PediatricsAPHP-Raymond Poincaré University HospitalUniversity of Versailles Saint Quentin-en-YvelinesGarches, Francesusana.quijano-roy@rpc.aphp.frHarperAmyMDPediatric Neuromuscular Disorders and Neurodevelopmental DisabilitiesCarolinas Pediatric Neurology Care – CharlotteLevine Children's Hospital – Carolinas Medical CenterCharlotte, North Carolinaamy.harper@carolinasheathcare.orgRutkowskiAnneMDChairman, Cure CMDOlathe, Kansasanne.rutkowski@curecmd.orgGordonErynnMS, CGCCoriell Institute for Medical ResearchCamden, New Jerseyegordon@coriell.orgHoffmanEric PPhDResearch Center for Genetic MedicineChildren's National Medical CenterWashington, DCehoffman@childrens-research.orgPegoraroElenaMD, PhDDepartment of NeurosciencesUniversity of PadovaPadova, Italyelena.pegoraro@unipd.it\n\nSummary\n\nDefinition of CMD\n\nSubtypes of CMD\n\nEstablishing the Diagnosis of a CMD Subtype\n\nGenetic Counseling\n\nResources\n\nManagement\n\nReferences\n\nChapter Notes\n\nCongenital Myasthenic Syndromes OverviewSynonym: Congenital MyastheniaAbichtAngelaMDMedical Genetics Center (MGZ);Department of NeurologyFriedrich-Baur InstituteMunich, Germanyangela.abicht@mgz-muenchen.deMüllerJuliane SPhDDepartment of Clinical NeurosciencesUniversity of CambridgeCambridge, United Kingdomjsm90@cam.ac.ukLochmüllerHannsMDChildren's Hospital of Eastern Ontario Research Institute;Division of NeurologyDepartment of MedicineThe Ottawa Hospital;Brain and Mind Research InstituteUniversity of OttawaOttawa, Canadahlochmuller@toh.ca\n\nSummary\n\n Clinical Characteristics of Congenital Myasthenic Syndromes\n\n Subtypes and Genetic Causes of Congenital Myasthenic Syndromes\n\n Differential Diagnosis of Congenital Myasthenic Syndromes\n\n Evaluation Strategies to Identify the Genetic Cause of a Congenital Myasthenic Syndrome in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nCongenital NAD Deficiency DisorderSynonym: Vertebral, Cardiac, Renal, and Limb Defects (VCRL)MarkPaulMDDepartment of PediatricsDivision of Medical GeneticsHelen DeVos Children's HospitalCorewell Health;Department of Pediatrics and Human DevelopmentCollege of Human MedicineMichigan State UniversityGrand Rapids, Michiganpaul.mark@corewellhealth.orgDunwoodieSallyPhDDevelopmental and Regenerative Biology DivisionVictor Chang Cardiac Research Institute;School of Clinical MedicineFaculty of Medicine and HealthUniversity of New South WalesSydney, New South Wales, Australia\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCongenital Stromal Corneal DystrophyRødahlEyvindMD, PhDeyvind.rodahl@helse-bergen.noKnappskogPer MPhDper.morten.knappskog@helse-bergen.noBredrupCecilieMD, PhDcecilie.bredrup@helse-bergen.noBomanHelgeMD, PhDhelge.boman@helse-bergen.no\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nCornelia de Lange SyndromeSynonyms: Brachmann-de Lange Syndrome (BDLS), CdLSDeardorffMatthew AMD, PhDDepartments of Pathology and PediatricsChildren's Hospital Los AngelesKeck School of MedicineUniversity of Southern CaliforniaLos Angeles, Californiamdeardorff@chla.usc.eduRaibleSarah EMSDivision of Human GeneticsThe Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvanianoons@email.chop.eduKrantzIan DMDDivision of Medical GeneticsSystem Vice President Department of PediatricsZucker School of Medicine – Hofstra University;Cohen Children's Medical Center / Northwell HealthGreat Neck, New Yorkikrantz@northwell.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCosteff SyndromeSynonyms: 3-Methylglutaconic Aciduria Type 3, OPA3 DefectAniksterYairMD, PhDHead of Metabolic Disease Unit\nEdmond and Lily Safra Children's Hospital\nSheba Medical Center\nTel Hashomer, Israelyair.anikster@sheba.health.gov.il\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nCranioectodermal DysplasiaSynonym: Sensenbrenner SyndromeTanWeizhenMDClinical Instructor, Harvard Medical SchoolDivision of Pediatric NephrologyMassGeneral Hospital for ChildrenBoston, Massachusettswtan2@partners.orgLinAngelaMDProfessor of Pediatrics, Harvard Medical SchoolMedical GeneticsMassGeneral Hospital for ChildrenBoston, Massachusettslin.angela@mgh.harvard.eduKeppler-NoreuilKimMDProfessor of Pediatrics, Division Chief of Genetics & MetabolismUniversity of Wisconsin School of Medicine and Public HealthMadison, Wisconsinkepplernoreu@wisc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCreatine Deficiency DisordersSynonym: Cerebral Creatine Deficiency DisordersMercimek-AndrewsSaadetMD, PhD, FCCMG, FRCPCAssociate Professor, Department of Medical GeneticsFaculty of Medicine and DentistryUniversity of AlbertaEdmonton, Alberta, Canadasaadet@ualberta.caSalomonsGajja SPhDProfessor, Department of Clinical ChemistryLaboratory Genetic Metabolic DiseasesAmsterdam University Medical CentersAmsterdam, the Netherlandsg.salomons@amsterdamumc.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CSF1R</italic>-Related DisorderDulskiJaroslawMD, PhDdulski.jaroslaw@mayo.edujaroslaw.dulski@gumed.edu.plSundalChristinaMD, PhDchristinahsundal@gmail.comWszolekZbigniew KMDwszolek.zbigniew@mayo.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CSNK2B</italic>-Related Neurodevelopmental DisorderSynonym: Poirier-Bienvenu Neurodevelopmental Syndrome (POBINDS)LippaNatalieMS, CGCDepartment of MedicineColumbia University Vagelos College of Physicians and SurgeonsNew York, NYnl2528@cumc.columbia.eduMulhernMaureenMS, MAT, CGCInter-Departmental Genetic Counseling ProgramDepartment of NeurologyPrecision Genomics LaboratoryColumbia University Vagelos College of Physicians and SurgeonsNew York, NYmm4757@cumc.columbia.eduErnst FloridoMichelleMS, CGCDepartment of Genetics & DevelopmentGenetic Counseling Graduate ProgramColumbia University Vagelos College of Physicians and SurgeonsNew York, NYme2623@cumc.columbia.eduEarleyChelseaMDFellow, Pediatric Clinical EpilepsyColumbia University Irving Medical CenterNew York, NYce2383@cumc.columbia.eduSandsTristan TMD, PhDDepartment of NeurologyColumbia University Vagelos College of Physicians and SurgeonsNew York, NYtts27@cumc.columbia.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CTCF</italic>-Related DisorderSynonyms: Autosomal Dominant Intellectual Disability 21, CTCF-Related Neurodevelopmental DisorderValverde de MoralesHannah GabrielaMDgvalverde@integragenetics.comWangHsiao-LinPhDhsiao-lin.wang@emory.eduGarberKathrynPhDkgarbe2@emory.eduCorcesVictorPhDvcorces@emory.eduLiHongMD, PhDhong.li@emory.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CTDP1</italic>-Related Congenital Cataracts, Facial Dysmorphism, and NeuropathySynonym: CTDP1-CCFDNKalaydjievaLubaMD, PhDLaboratory for Molecular GeneticsHarry Perkins Institute of Medical Research and Centre for Medical ResearchThe University of Western AustraliaPerth, Australialuba.kalaydjieva@uwa.edu.auChamovaTeodoraMD, PhDDepartment of NeurologyUniversity Hospital AlexandrovskaMedical University of SofiaSofia, Bulgariateodoratch@abv.bg\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CTNNB1</italic> Neurodevelopmental DisorderHoStephanie KLMDstephanie_kl_ho@dh.gov.hkTsangMandy HYMMScmandyhytsang@gmail.comLeeMianneMScmianne2@connect.hku.hkChengShirley SWMDshirley_s_cheng@gmail.comLukHo-mingMDlukhm@ha.org.hkLoIvan FMMDcon_cg@dh.gov.hkChungBrian HYMDbhychung@hku.hkbhychung@genomics.org.hk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">CYLD</italic> Cutaneous SyndromeSynonyms: Brooke-Spiegler Syndrome (BSS), Familial Cylindromatosis (FC), Multiple Familial Trichoepithelioma (MFT)DuboisAnnaBSc, MBChBanna.dubois@nhs.netRajanNeilMBBS, PhDneil.rajan@ncl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nCystic FibrosisSavantAdrienneMD, MSasavant1@tulane.eduLymanBenjaminDOblyman@lsuhsc.eduBojanowskiChristineMD, MSCRcbojanowski@tulane.eduUpadiaJariyaMDjupadia@tulane.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCystinosisNesterovaGalinaMDMedical Advisor, Cystinosis Research Networkgnesterova@hotmail.comGahlWilliam AMD, PhDSenior Investigator, National Human Genome Research InstituteNational Institutes of HealthBethesda, Marylandgahlw@mail.nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCystinuriaSynonyms: Cystine Nephrolithiasis, Cystine Stone Disease, Cystine UrolithiasisSpasianoAndreaMDandrea.spasiano@univr.itHalbritterJanMDjan.halbritter@charite.deFerraroPietro ManuelMD, MSc, PhD, FERApietromanuel.ferraro@univr.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nCytochrome P450 Oxidoreductase DeficiencySynonyms: POR Deficiency, PORDIdkowiakJanMD, PhDj.idkowiak@bham.ac.ukCragunDeborahMS, CGCdeborahcragun@gmail.comHopkinRobert JMDrob.hopkin@cchmc.orgArltWiebkeMD, DScw.arlt@bham.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nDanon DiseaseTaylorMatthew RGMD, PhDAdult Medical Genetics ProgramUniversity of Colorado Anschutz Medical CampusAurora, Coloradomatthew.taylor@cuanschutz.eduAdlerEric DMDDivision of CardiologyUniversity of California San DiegoSan Diego, Californiaeradler@ucsd.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDBA SyndromeSynonyms: Diamond-Blackfan Anemia (DBA), Diamond-Blackfan Syndrome (DBS)SieffColinMBBCh, FRCPathBoston Children's Hospital and Dana Farber Cancer InstituteHarvard Medical SchoolBoston, Massachusettscolin.sieff@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DCTN1</italic>-Related NeurodegenerationDulskiJaroslawMD, PhDDivision of Neurological and Psychiatric NursingFaculty of Health SciencesMedical University of Gdansk;Neurology DepartmentSt Adalbert Hospital, Copernicus PLGdansk, Polandjaroslaw.dulski@gumed.edu.plKonnoTakuyaMD, PhDDepartment of NeurologyBrain Research InstituteNiigata UniversityNiigata, Japankonno_t@bri.niigata-u.ac.jpWszolekZbigniewMDDepartment of NeurologyMayo ClinicJacksonville, Floridawszolek.zbigniew@mayo.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DCX</italic>-Related DisordersGeisTobiasMDtobias.geis@barmherzige-regensburg.deUyanikGökhanMDgoekhan.uyanik@oegk.atgoekhan.uyanik@med.sfu.ac.atAignerLudwigPhDludwig.aigner@pmu.ac.atCouillard-DespresSebastienPhDs.couillard-despres@pmu.ac.atWinklerJürgenMDjuergen.winkler@uk-erlangen.deHehrUteMDute.hehr@klinik.uni-regensburg.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DDX11</italic>-Related CohesinopathySynonyms: Warsaw Breakage Syndrome (WABS), Warsaw SyndromeAlkhunaiziEbbaMDebba.alkhunaizi@mail.mcgill.caBroshRobert MJrPhDbroshr@grc.nia.nih.govChitayatDavidMDDavid.Chitayat@sinaihealth.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DDX3X</italic>-Related Neurodevelopmental DisorderJohnson-KernerBethanyMD, PhDbethany.kerner@ucsf.eduSnijders BlokLotMDlot.snijdersblok@radboudumc.nlSuitLindseyBAlindsey.suit@ucsf.eduThomasJulianMDjulian.thomas@choc.orgKleefstraTjitskeMD, PhDtjitske.kleefstra@radboudumc.nlSherrElliott HMD, PhDelliott.sherr@ucsf.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DDX41</italic>-Associated Familial Myelodysplastic Syndrome and Acute Myeloid LeukemiaSynonyms: DDX41-Related Myeloid Neoplasia, Myeloid Neoplasms with Germline DDX41 MutationChurpekJane EMD, MSAssistant Professor, Division of Hematology, Oncology, and Palliative Care\nDepartment of Medicine\nUniversity of Wisconsin School of Medicine and Public Health\nMadison, Wisconsinjchurpek@wisc.eduSmith-SimmerKelcyMMSc, CGCGenetic Counselor, Oncology Genetics\nUniversity of Wisconsin Carbone Cancer Center\nUW Health\nAdjunct Assistant Professor, Master of Genetic Counselor Studies\nDepartment of Pediatrics\nUniversity of Wisconsin School of Medicine and Public Health\nMadison, Wisconsinksmith-simmer@uwhealth.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDeafness-Dystonia-Optic Neuronopathy SyndromeSynonyms: DDON, Mohr-Tranebjaerg SyndromeTranebjærgLisbethMD, PhDProfessor of Medical Genetics and Genetic AudiologyDepartment of Clinical GeneticsUniversity Hospital/The Kennedy CenterInstitute of Clinical Medicine;The Panum InstituteUniversity of CopenhagenCopenhagen, Denmarktranebjaerg@sund.ku.dklisbeth.tranebjaerg@regionh.dk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDent DiseaseLieskeJohn CMDlieske.john@mayo.eduMillinerDawn SMDmilliner.dawn@mayo.eduBeara-LasicLadaMDladabl@yahoo.comHarrisPeterPhDharris.peter@mayo.eduCogalAndreaBScogal.andrea@mayo.eduAbrashElizabethBAewabrash@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDeoxyguanosine Kinase DeficiencySynonyms: DGUOK Deficiency; DGUOK-Related Mitochondrial DNA Depletion Syndrome, Hepatocerebral FormEl-HattabAyman WMD, FAAP, FACMGProfessor, Department of Clinical SciencesCollege of MedicineUniversity of SharjahSharjah, United Arab Emirateselhattabaw@yahoo.comScagliaFernandoMD, FAAP, FACMGProfessor, Department of Molecular and Human GeneticsBaylor College of MedicineHouston, Texasfscaglia@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DEPDC5</italic>-Related EpilepsyBaulacStéphaniePhDstephanie.baulac@icm-institute.orgBaldassariSaraPhDsara.baldassari@icm-institute.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDFNA2 Nonsyndromic Hearing LossSmithRichard JHMDDirector, Molecular Otolaryngology Research Laboratories\nSterba Hearing Research Professor of Otolaryngology\nProfessor of Otolaryngology, Pediatrics, and Internal Medicine, Division of Nephrology\nCarver College of Medicine\nUniversity of Iowa\nIowa City, Iowarichard-smith@uiowa.eduHildebrandMichaelPhDDepartment of Medicine\nUniversity of Melbourne\nMelbourne, Australiamichael.hildebrand@unimelb.edu.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nDiabetes Mellitus, 6q24-Related Transient NeonatalSynonym: 6q24-TNDMTempleIsabel KarenMD, MBChB, FRCPikt@southampton.ac.ukMackayDeborah JGPhD, MAdjgm@southampton.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDiastrophic DysplasiaSynonym: Diastrophic Dwarfism, SLC26A2-Related Diastrophic DysplasiaUngerSheilaMDAssociate Professor, Service of Genetic MedicineLausanne University HospitalLausanne, Switzerlandsheila.unger@chuv.chSuperti-FurgaAndreaMDProfessor of Genetics, Service of Genetic MedicineLausanne University HospitalLausanne, Switzerlandasuperti@unil.ch\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DICER1-</italic>Related Tumor PredispositionSynonyms: DICER1 Pleuropulmonary Blastoma Familial Tumor Predisposition Syndrome, DICER1 SyndromeSchultzKris Ann PMDkrisann.schultz@childrensmn.orgNelsonAlexander TMDanelso13@bidmc.harvard.eduKamiharaJunneMD, PhDjunne_kamihara@dfci.harvard.eduBauerAndrew JMDbauera@chop.eduHattonJessicaMS, CGCjessica.hatton@nih.govMeridethMelissa AMD, MPHmmeridet@mail.nih.govStrattonPamelaMDstrattop@mail.nih.govHarrisAnne KMPHanne.harris@childrensmn.orgFieldAmandaMPHmandy@resourecepath.netDehnerLouis PMDdehner@wustl.eduStewartDouglas RMDdrstewart@mail.nih.govHillD AshleyMDhilldanaa@wustl.eduMessingerYoav HMDyoav.messinger@childrensmn.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDiffuse Gastric and Lobular Breast Cancer SyndromeSynonyms: DGLBCS, Hereditary Diffuse Gastric Cancer (HDGC)Barbosa-MatosRitaBSc, PhDi3S - Instituto de Investigação e Inovação em SaúdeUniversity of PortoPorto, Portugalamatos@i3s.up.ptCórdovaLilianMDDepartment of Medical GeneticsUniversity of British ColumbiaVancouver, Canadalilian.cordova@bccancer.bc.caSchraderKasmintanMBBS, PhDProgram Medical Co-Director, Hereditary CancerBC Cancer;Assistant Professor, Department of Medical GeneticsUniversity of British ColumbiaVancouver, Canadaischrader@bccancer.bc.caOliveiraCarlaPhDi3S - Instituto de Investigação e Inovação em Saúde;Institute of Molecular Pathology and Immunology;Faculty of MedicineUniversity of PortoPorto, Portugalcarlaol@i3s.up.pt\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDihydrolipoamide Dehydrogenase DeficiencySynonyms: DLD Deficiency, E3 DeficiencyQuinonezShane CMDClinical Assistant Professor\nUniversity of Michigan\nAnn Arbor, Michigansquinon@med.umich.eduThoeneJess GMDActive Emeritus Professor of Pediatrics\nUniversity of Michigan\nAnn Arbor, Michiganjthoene@med.umich.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDihydropteridine Reductase DeficiencySynonyms: DHPR Deficiency, DYT/PARK-QDPR, QDPR-Related Tetrahydrobiopterin Deficiency, Quinoid Dihydropteridine Reductase DeficiencyLongoNicolaMD, PhDDivision of Clinical GeneticsDepartment of Human GeneticsUniversity of California Los AngelesLos Angeles, Californianlongo@mednet.ucla.eduOpladenThomasMDDivision of Pediatric Neurology and Metabolic MedicineDepartment ICenter for Pediatric and Adolescent MedicineMedical Faculty HeidelbergHeidelberg UniversityHeidelberg, Germanythomas.opladen@med.uni-heidelberg.deBlauNenadPhDDivision of MetabolismUniversity Children's Hospital ZurichZurich, Switzerlandnenad.blau@kispi.uzh.ch\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDilated Cardiomyopathy OverviewHershbergerRay EMDProfessor of Medicine, Divisions of Human Genetics and Cardiovascular MedicineThe Ohio State UniversityColumbus, Ohioray.hershberger@osumc.eduJordanElizabethMS, LGCAssistant Professor, Division of Human GeneticsThe Ohio State UniversityColumbus, Ohioelizabeth.jordan@osumc.edu\n\nSummary\n\n Dilated Cardiomyopathy (DCM): Definition\n\n Dilated Cardiomyopathy (DCM): Categories\n\n Establishing (When Possible) the Specific Genetic Cause of DCM\n\n Genetic Risk Assessment and Cardiac Surveillance of At-Risk Relatives for Detection of Early Treatable Manifestations of DCM\n\nResources\n\nChapter Notes\n\nReferences\n\nDisorders of <italic toggle=\"yes\">GNAS</italic> InactivationSynonym: Gsα DeficiencyHaldeman-EnglertChad RMD, FACMGFullerton Genetics CenterAsheville, North Carolinachad.haldeman-englert@msj.orgHurstAnna CEMD, MSDepartment of GeneticsUniversity of Alabama at BirminghamBirmingham, Alabamaacehurst@uab.eduLevineMichael AMD, FAAP, FACP, MACEDepartment of Pediatrics, Division of Endocrinology and DiabetesChildren's Hospital of Philadelphia;University of Pennsylvania Perelman School of MedicinePhiladelphia, Pennsylvanialevinem@chop.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDisorders of Intracellular Cobalamin MetabolismSloanJennifer LPhD, MSjsloan@mail.nih.govCarrilloNuriaMDcarrilln@mail.nih.govAdamsDavidMD, PhDdadams1@mail.nih.govVendittiCharles PMD, PhDvenditti@mail.nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DLG4</italic>-Related SynaptopathyTümerZeynepMD, PhD, DMSczeynep.tumer@regionh.dkDyeThomas JMDPradaCarlosMDcprada@luriechildrens.orgWhite-BrownAlexandre MMScawhitebrown@cheo.on.caMacKenzieAlexMDmackenzie@cheo.on.caLevyAmanda MMScmarie.amanda.bust.levy@regionh.dk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DNAJC6</italic> Parkinson DiseaseSynonym: PARK-DNAJC6KurianManju AMRCPCH, PhDmanju.kurian@ucl.ac.ukAbelaLuciaMD, MSclucia.abela@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DNMT1</italic>-Related DisorderKleinChristopher JMDMayo ClinicRochester, Minnesotaklein.christopher@mayo.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDonnai-Barrow SyndromeSynonyms: DBS/FOAR Syndrome, Faciooculoacousticorenal Syndrome, FOAR SyndromeLongoniMauroMDAssistant Professor of Surgery, Harvard Medical SchoolAssistant, Massachusetts General HospitalBoston, Massachusettsmlongoni@mgh.harvard.eduKantarciSibelPhD, FACMGCytogenetics and GenomicsQuest Diagnostics Nichols InstituteCytogenetics and GenomicsSan Juan Capistrano, Californiasibel.x.kantarci@questdiagnostics.comDonnaiDianMDManchester Centre for Genomic MedicineUniversity of ManchesterSt Mary's HospitalManchester, United Kingdomdian.donnai@mft.nhs.ukPoberBarbara RMDPediatrician, Mass General Hospital for ChildrenHarvard Medical SchoolBoston, Massachusettspober.barbara@mgh.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDopamine Beta-Hydroxylase DeficiencyBiaggioniItaloMDProfessor, Departments of Medicine and PharmacologyVanderbilt University Medical CenterNashville, Tennesseeitalo.biaggioni@vumc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDRPLASynonym: Dentatorubral-Pallidoluysian AtrophyPradesSilviaPhDspradesabadias@ataxia.org.ukMelo de GusmaoClaudioMDGrimaldiSilviaMDShiloh-MalawskyYaelMDFeltonThomasMS, CGCHouldenHenryMD, PhDh.houlden@ucl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDuane SyndromeSynonyms: Duane Anomaly, Isolated; Duane Retraction Syndrome; Stilling-Turk-Duane SyndromeBarryBrenda JMSbrenda.barry2@childrens.harvard.eduWhitmanMary CMD, PhDmary.whitman@childrens.harvard.eduHunterDavid GMD, PhDdavid.hunter@childrens.harvard.eduEngleElizabeth CMDelizabeth.engle@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDuarte GalactosemiaSynonym: Duarte Variant GalactosemiaFridovich-KeilJudith LPhDjfridov@emory.eduGambelloMichael JMD, PhDmgambel@emory.eduSinghRani HPhD, RDrsingh@emory.eduSharerJ DanielPhDdsharer@uab.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DYNC1H1</italic>-Related DisordersMöllerBirkbmoelle2@smail.uni-koeln.deCoppolaAntoniettaMD, PhDantonietta.coppola1@gmail.comJungbluthHeinzMD, PhDheinz.jungbluth@kcl.ac.ukheinz.jungbluth@gstt.nhs.ukDafsariHormos SalimiDr medhormos.dafsari@uk-koeln.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">DYRK1A</italic> Syndromevan BonBregje WMMD, PhDbregje.vanbon@radboudumc.nlCoeBradley PPhDbcoe@u.washington.edude VriesBert BAMD, PhDbert.devries@radboudumc.nlEichlerEvan EPhDeee@gs.washington.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDysferlinopathyAokiMasashiMD, PhDDepartment of NeurologyTohoku University School of MedicineSendai, Japanaokim@med.tohoku.ac.jpTakahashiToshiakiMD, PhDDepartment of NeurologyNational Hospital Organization – Sendai-Nishitaga HospitalSendai, Japantakahashi.toshiaki.hj@mail.hosp.go.jp\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDyskeratosis Congenita and Related Telomere Biology DisordersSynonym: Zinsser-Cole-Engman SyndromeSavageSharon AMDsavagesh@mail.nih.govNiewischMarena RMDmarena.niewisch@nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDystrophic Epidermolysis BullosaSynonyms: DEB, Epidermolysis Bullosa DystrophicaLuckyAnne WMDEmeritus Professor of Dermatology and PediatricsCincinnati Children's Epidermolysis Bullosa CenterCincinnati Children's HospitalCincinnati, Ohioannewlucky@gmail.comPopeElenaMD, MScDivision of Pediatric DermatologyHospital for Sick Children;Temerty Faculty of MedicineUniversity of TorontoToronto, Ontario, Canadaelena.pope@sickkids.caCrawfordSarahMMSc, CGCGenetic CounselorDivision of Human GeneticsCincinnati Children's HospitalCincinnati, Ohiosarah.crawford2@cchmc.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDystrophinopathiesDarrasBasil TMDDirector, Neuromuscular CenterDepartment of NeurologyBoston Children’s HospitalHarvard Medical SchoolBoston, Massachusettsbasil.darras@childrens.harvard.eduUrionDavid KMDDepartment of NeurologyBoston Children’s HospitalHarvard Medical SchoolBoston, Massachusettsdavid.urion@childrens.harvard.eduGhoshPartha SMDNeuromuscular CenterDepartment of NeurologyBoston Children’s HospitalHarvard Medical SchoolBoston, Massachusettspartha.ghosh@childrens.harvard.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDYT-<italic toggle=\"yes\">GNAL</italic>Synonyms: DYT25, GNAL-Related DystoniaDeutschländerAngela BMDDepartments of Neurology, Neuroscience, and Clinical GenomicsMayo ClinicJacksonville, Floridadeutschlander.angela@mayo.eduWszolekZbigniew KMDDepartment of NeurologyMayo ClinicJacksonville, Floridawszolek.zbigniew@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nDYT-<italic toggle=\"yes\">TOR1A</italic>Synonyms: DYT1 Early-Onset Isolated Dystonia, Early-Onset Torsion Dystonia, Oppenheim DystoniaOzeliusLauriePhDDepartment of NeurologyMassachusetts General HospitalCharlestown, Massachusettsmailto:laurie.ozelius@mgh.harvard.eduLubarrNaomiMDDepartment of NeurologyMount Sinai Beth IsraelNew York, New Yorknaomi.lubarr@mountsinai.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">EBF3</italic> Neurodevelopmental DisorderSynonym: Hypotonia, Ataxia, and Delayed Development Syndrome (HADDS)NarayananDhanya LakshmiMD, DMdhanya.lakshmi@manipal.eduKutscheKerstinPhDkkutsche@uke.deGirishaKatta MMD, DMgirish.katta@manipal.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">EBP-</italic>Related X-Linked Chondrodysplasia PunctataSynonyms: Conradi-Hünermann-Happle Syndrome, X-Linked Chondrodysplasia Punctata 2 (CDPX2)KumbleSmithaMBBS, FRACPVictorian Clinical Genetics ServiceMurdoch Children's Research InstituteParkville, Victoria, Australiasmitha.kumble@vcgs.org.auSavarirayanRaviMBBS, MD, FRACP, ARCPA (Hon)Victorian Clinical Genetics ServiceMurdoch Children's Research InstituteParkville, Victoria, AustraliaThe University of MelbourneMelbourne, Australiaravi.savarirayan@vcgs.org.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">EED</italic>-Related OvergrowthSequerra Amram CohenAnaPhDAssistant Professor of PathologyUniversity of Missouri-Kansas City School of Medicine;Assistant Director, Molecular GeneticsChildren's Mercy Kansas CityKansas City, Missouriacohen1@cmh.eduGibsonWilliam ThomasMD, PhD, FRCPC, FCCMG, FACMG, FRSM (UK)Professor, UBC Department of Medical Genetics;Senior Clinician Scientist, BC Children's HospitalVancouver, British Columbia, Canadawtgibson@bcchr.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">EFEMP2</italic>-Related Cutis LaxaSynonym: Autosomal Recessive Cutis Laxa Type 1B (ARCL1B)LoeysBartMD, PhDCenter for Medical GeneticsAntwerp University HospitalAntwerp, Belgiumbart.loeys@uantwerp.beDe PaepeAnneMD, PhDCenter for Medical GeneticsGhent University HospitalGhent, Belgiumanne.depaepe@ugent.beUrbanZsoltPhDDepartment of Human GeneticsGraduate School of Public HealthUniversity of PittsburghPittsburgh, Pennsylvaniaurbanz@pitt.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ELANE</italic>-Related NeutropeniaDaleDavid CMDProfessor, Department of Medicine\nUniversity of Washington Medical Center\nSeattle, Washingtondcdale@uw.eduMakaryanVahagnMDDepartment of Medicine\nUniversity of Washington Medical Center\nSeattle, Washingtonvahagm@uw.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nEl-Hattab-Alkuraya SyndromeSynonym: WDR45B-Related Neurodevelopmental DisorderAlmannaiMohammedMD, FAAP, FACMGGenetics and Precision Medicine DepartmentKing Abdullah Specialized Children's HospitalKing Abdulaziz Medical CityMinistry of National Guard Health AffairsRiyadh, Saudi Arabiammannai81@gmail.comMarafiDanaMD, MScDepartment of PediatricsFaculty of MedicineKuwait UniversityJabriya, Kuwaitdana.marafie@ku.edu.kwEl-HattabAyman WMD, FAAP, FACMGCollege of MedicineUniversity of SharjahSharjah, United Arab Emirateselhattabaw@yahoo.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nEllis-van Creveld SyndromeSynonym: Chondroectodermal Dysplasia (Ellis-van Creveld)Da SilvaJorge DiogoMD, PhDjorge.diogo.silva@chporto.min-saude.ptTkachenkoNataliyaMDnatalia.tkachenko@chporto.min-saude.ptSoaresAna RitaMDana.rita.soares@chporto.min-saude.pt\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ELN</italic>-Related Cutis LaxaSynonym: Autosomal Dominant Cutis Laxa Type 1 (ADCL1)CallewaertBert LMD, PhDCenter for Medical GeneticsGhent University HospitalGhent, Belgiumbert.callewaert@ugent.beUrbanZsoltPhDDepartment of Human GeneticsUniversity of Pittsburgh Graduate School of Public HealthPittsburgh, Pennsylvaniaurbanz@pitt.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nEmanuel SyndromeSynonym: Supernumerary der(22)t(11;22) SyndromeEmanuelBeverly SPhD, FACMGChief Emeritus, Division of Human Genetics\nThe Children's Hospital of Philadelphia\nPhiladelphia, PennsylvaniaZackaiElaine HMD, FACMGDirector, Clinical Genetics\nDivision of Human Genetics\nThe Children's Hospital of Philadelphia\nPhiladelphia, PennsylvaniaMedneLivijaMS, CGCGenetic Counselor, Division of Human Genetics\nThe Children's Hospital of Philadelphia\nPhiladelphia, Pennsylvania\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">EMC10</italic>-Related Neurodevelopmental DisorderUmairMuhammadPhDMedical Genomics Research DepartmentKing Abdullah International Medical Research Center (KAIMRC)King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS)Ministry of National Guard Health Affairs (MNGHA)Riyadh, Saudi Arabiaumairmu@mngha.med.saAlfadhelMajidMD, MHSc, SSC-Ped, ABHS(CH), FCCMGGenetics and Precision Medicine DepartmentKing Abdullah Specialized Children Hospital (KASCH)King Abdulaziz Medical CityMinistry of National Guard Health Affairs (MNGHA)Riyadh, Saudi Arabiadralfadhelm@gmail.comfadhelma@mngha.med.sa\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nEmery-Dreifuss Muscular DystrophyBen YaouRabahMDr.benyaou@institut-myologie.orgLeturcqFranceMDfrance.leturcq@aphp.frBonneGisèlePhDgisele.bonne@inserm.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nEncephalocraniocutaneous LipomatosisSynonyms: Fishman Syndrome, Haberland SyndromeMoogUteMDInstitute of Human GeneticsHeidelberg UniversityHeidelberg, Germanyute.moog@med.uni-heidelberg.deDobynsWilliam BMDDepartment of PediatricsUniversity of MinnesotaMinneapolis, Minnesotawbdobyns@umn.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nEnlarged Parietal ForaminaSynonym: Symmetric Parietal ForaminaMavrogiannisLampros AMSc, DPhilGenetics LaboratorySt James University HospitalLeeds, United Kingdomlampros.mavrogiannis@nhs.netWilkieAndrew OMMA, DM, FRCPUniversity of OxfordOxford, United Kingdomandrew.wilkie@imm.ox.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ENTPD1</italic>-Related Neurodevelopmental DisorderSynonyms: Autosomal Recessive Spastic Paraplegia 64, HSP-ENTPD1, Spastic Paraplegia 64 (SPG64)CalameDanielMD, PhDdaniel.calame@bcm.eduHermanIsabellaMD, PhDisabellg@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">EPB42</italic>-Related Hereditary SpherocytosisKalfaTheodosia AMD, PhDCancer and Blood Diseases Institute\nDivision of Hematology\nCincinnati Children's Hospital Medical Center and University of Cincinnati Medical School\nCincinnati, Ohiotheodosia.kalfa@cchmc.orgBegtrupAmber HPhD, FACMGGeneDx, Inc\nGaithersburg, Marylandabegtrup@genedx.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">EPG5</italic>-Related DisorderDafsariHormos SalimiMDhormos.dafsari@uk-koeln.deEbrahimi-FakhariDariusMD, PhDdarius.ebrahimi-fakhari@childrens.harvard.eduSaffariAfshinMDafshin.saffari@childrens.harvard.eduDeneubourgCelineMScceline.deneubourg@kcl.ac.ukFantoManolisPhDmanolis.fanto@kcl.ac.ukJungbluthHeinzMD, PhDheinz.jungbluth@gstt.nhs.ukheinz.jungbluth@kcl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nEpidermolysis Bullosa SimplexSoJodi YBAjodiso@stanford.eduTengJoyceMD, PhDjteng3@stanford.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nEpidermolysis Bullosa with Pyloric AtresiaSynonym: EB-PALuckyAnne WMDDirector, Cincinnati Children's Epidermolysis Bullosa CenterCincinnati Children's HospitalCincinnati, Ohioannewlucky@gmail.comGorellEmilyDO, MSDermatology Resident, Department of DermatologyUniversity of Cincinnati College of MedicineCincinnati, OHgorelley@ucmail.uc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nEpimerase Deficiency GalactosemiaSynonyms: Galactosemia Type III, GALE Deficiency, UDP-Galactose-4'-Epimerase DeficiencyFridovich-KeilJudithPhDDepartment of Human GeneticsEmory University School of MedicineAtlanta, Georgiajfridov@emory.eduBeanLoraPhDPerkinElmer Genomics, IncPittsburgh, Pennsylvanialora.bean@perkinelmer.comHeMiaoPhDDepartment of Pathology and Laboratory MedicineUniversity of PennsylvaniaPhiladelphia, Pennsylvaniahem@email.chop.eduSchroerRichardMDGreenwood Genetic CenterGreenwood, South Carolinaschroer@ggc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nEpisodic Ataxia Type 1Synonym: EA1HasanSonia MPhDDepartment of Physiology\nFaculty of Medicine\nKuwait University\nKuwait City, Kuwaitsonia@hsc.edu.kwD'AdamoMaria CristinaPhDDepartment of Physiology and Biochemistry\nUniversity of Malta\nMsida, Maltacristina.dadamo@um.edu.mt\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nErythropoietic Protoporphyria, Autosomal RecessiveBalwaniManishaMD, MSmanisha.balwani@mssm.eduBloomerJosephMDjbloomer@uab.eduDesnickRobertMD, PhD, FACMGrobert.desnick@mssm.eduPorphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">ESCO2</italic> Spectrum DisorderVegaHugoMD, PhDNursing DepartmentNursing Informatics ProgramSchool of Professional StudiesCity University of New YorkNew York, New Yorkhuvega@gmail.comGordilloMiriamPhDDepartment of SurgeryWeill Cornell Medical CollegeNew York, New Yorkmig2021@med.cornell.eduJabsEthylin WangMDDepartment of Clinical GenomicsMayo ClinicRochester, Minnesotajabs.ethylin@mayo.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nEsophageal Atresia / Tracheoesophageal Fistula Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLYEA/TEF Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLYScottDaryl AMD, PhDDepartment of Molecular and Human GeneticsBaylor College of MedicineHouston, Texasdscott@bcm.edu\n\nSummary\n\n Clinical Characteristics of EA/TEF\n\n Genetic Causes of EA/TEF\n\n Evaluation Strategies to Identify the Genetic Cause of EA/TEF in a Proband\n\n Genetic Counseling\n\nResources\n\n Management of EA/TEF\n\nChapter Notes\n\nReferences\n\nEthylmalonic EncephalopathySynonym: ETHE1 DeficiencyDi MeoIvanoPhDivano.dimeo@istituto-besta.itLampertiCostanzaMDcostanza.lamperti@istituto-besta.itTirantiValeriaPhDvaleria.tiranti@istituto-besta.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ETV6-</italic>Related Thrombocytopenia and Predisposition to LeukemiaSynonyms: ETV6-Linked Leukemia / Familial Thrombocytopenia Syndrome, Thrombocytopenia 5 (THC5)PenchevaBojanaMMSc, CGCABGC Certified Genetic Counselor, Cancer Predisposition ClinicEmory University School of Medicine & Aflac Cancer and Blood Disorders CenterChildren's Healthcare of AtlantaAtlanta, Georgiabojana.borislavova.pencheva@emory.eduDi PaolaJorgeMDProfessor of Pediatrics and Molecular Genetics & GenomicsWashington University School of MedicineSt Louis Children's HospitalSt Louis, Missouridipaolaj@wustl.eduPorterChristopher CMDProfessor, Department of PediatricsEmory University School of Medicine & Aflac Cancer and Blood Disorders CenterChildren's Healthcare of AtlantaAtlanta, Georgiachris.porter@emory.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">EXOC6B</italic>-Related Spondyloepimetaphyseal Dysplasia with Joint LaxitySynonym: Spondyloepimetaphyseal Dysplasia with Joint Laxity, Type 3 (SEMDJL3)BhavaniGandham SriLakshmiMSc, PhDgsl.bhavani@manipal.eduSinghSwatiMScswatisingh0730@gmail.comGirishaKatta MohanMD, DM, PhDgirish.katta@manipal.edug.kumar@squ.edu.om\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">EXOSC3</italic> Pontocerebellar HypoplasiaSynonym: Pontocerebellar Hypoplasia Type 1B (PCH1B)BaasFrankMD, PhDf.baas@amc.uva.nlvan DijkTessaMD, PhD\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">EZH2</italic>-Related OvergrowthOcanseySharonMBBS, BSc, MScSpecialist Registrar in Clinical GeneticsSt George's University Hospital NHS Foundation TrustLondon, United KingdomTatton-BrownKatrinaBM BCh, MDProfessor and Consultant in Clinical GeneticsSt George's University of London;St George's University Hospital NHS Foundation TrustLondon, United Kingdomkatrina.tattonbrown@stgeorges.nhs.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFabry DiseaseSynonyms: Alpha-Galactosidase A Deficiency, Anderson-Fabry DiseaseMehtaAtulMA, MD, FRCP, FRCPathEmeritus Professor, Department of HaematologyUniversity College London School of MedicineLondon, United Kingdomatul.mehta1@nhs.netHughesDerralynn AMA, DPhil, FRCP, FRCPathProfessor, Experimental HaematologyLysosomal Storage Disorders UnitDepartment of HaematologyRoyal Free HospitalUniversity College LondonLondon, United Kingdomrmgvdah@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFacioscapulohumeral Muscular DystrophySynonyms: FSHD, FSH Muscular DystrophyPrestonMatthew KMDpreston4@uw.eduWangLeo HMD, PhDleowang@uw.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFactor V Leiden ThrombophiliaSynonym: Hereditary Resistance to Activated Protein CPastoriDanieleMD, PhD, FESCdaniele.pastori@uniroma1.itMenichelliDaniloMDdanilo.menichelli@uniroma1.itValerianiEmanueleMDemanuele.valeriani@uniroma1.itPignatelliPasqualeMD, PhDpasquale.pignatelli@uniroma1.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FAM111A</italic>-Related Skeletal DysplasiasChengShirleyMDshirley.cheng@ha.org.hkLoIvan FMMDcon_cg@dh.gov.hkLukHo-MingMDlukhm@ha.org.hk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFamilial Cerebral Cavernous MalformationsSynonyms: Familial Cavernous Hemangioma, Familial Cerebral Cavernous Angioma, Familial Cerebral Cavernous Malformation SyndromeFlemmingKelly DMDMayo ClinicRochester, Minnesotaflemming.kelly@mayo.eduSmithEdwardMDBoston Children's HospitalBoston, Massachusettsedward.smith@childrens.harvard.eduMarchukDouglasPhDDuke UniversityDurham, North Carolinadouglas.marchuk@duke.eduDerryW BrentPhDThe Hospital for Sick ChildrenToronto, Ontario, Canadabrent.derry@sickkids.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFamilial Combined HypolipidemiaSynonyms: Angiopoietin-Like Protein 3 (ANGPTL3) Deficiency, Familial Combined Hypobetalipoproteinemia Type 2 (FHBL2)BurnettJohn RMB ChB, MD, PhD, FRCPADepartment of Clinical BiochemistryRoyal Perth Hospital & Fiona Stanley Hospital NetworkPathWest Laboratory Medicine WA;Faculty of Health & Medical SciencesSchool of MedicineUniversity of Western AustraliaPerth, Australiajohn.burnett@health.wa.gov.auHooperAmanda JPhDDepartment of Clinical BiochemistryRoyal Perth Hospital & Fiona Stanley Hospital NetworkPathWest Laboratory Medicine WA;School of MedicineUniversity of Western AustraliaPerth, Australiaamanda.hooper@health.wa.gov.auHegeleRobert AMD, FRCPC, FACPDepartments of Medicine and BiochemistrySchulich School of Medicine and Robarts Research InstituteWestern UniversityLondon, Ontario, Canadahegele@robarts.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFamilial DysautonomiaSynonyms: Hereditary Sensory and Autonomic Neuropathy Type III (HSAN III), Riley-Day SyndromeBar-AlumaBat-ElMDPediatric Pulmonology UnitNational Center for Familial DysautonomiaEdmond and Lily Safra Children's HospitalSheba Medical Center;Sackler Faculty of MedicineTel Aviv UniversityTel Aviv, Israelbatel.baraluma@sheba.health.gov.il\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFamilial Hemiplegic MigraineJenJoanna CMD, PhDDepartment of NeurologyIcahn School of Medicine at Mount SinaiNew York, New Yorkjoanna.jen@mssm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFamilial Hemophagocytic LymphohistiocytosisSynonyms: Familial Erythrophagocytic Lymphohistiocytosis, Primary Hemophagocytic LymphohistiocytosisZhangKejianMD, MBAMount Sinai Genomics;Sema4New York, New Yorkkejian.zhang2017@gmail.comAstigarragaItziarMD, PhDDepartment of PediatricsHospital Universitario CrucesOsakidetzaIIS Biocruces BizkaiaUPV/EHUBarakaldo, Spainitziar.astigarraga@osakidetza.eusBrycesonYenanPhDDepartment of MedicineKarolinska InstitutetStockholm, Swedenyenan.bryceson@ki.seLehmbergKaiMDDepartment of Pediatric Hematology and OncologyDivision of Pediatric Stem Cell Transplantation and ImmunologyUniversity Medical Center EppendorfHamburg, Germanyk.lehmberg@uke.deMachowiczRafalMDMedical University of WarsawWarsaw, Polandr.machowicz@wp.plMarshRebeccaMDCincinnati Children's Hospital;University of CincinnatiCincinnati, Ohiorebecca.marsh@cchmc.orgSieniElenaMDMeyer Children's University HospitalFlorence, Italyelena.sieni@meyer.itWangZhaoMDDepartment of HematologyBeijing Friendship HospitalCapital Medical UniversityBeijing, Chinazhaowww263@yahoo.comNicholsKim EMDDepartment of OncologySt Jude Children's Research HospitalMemphis, Tennesseekim.nichols@stjude.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFamilial HypercholesterolemiaSynonyms: Familial Hypercholesterolæmia, Hyperlipoproteinemia Type IIAIsonHannah EMS, LCGChison@stanfordhealthcare.orgClarkeShoa LMD, PhDshoa@stanford.eduKnowlesJoshua WMD, PhDknowlej@stanford.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFamilial Lipoprotein Lipase DeficiencySynonym: Familial LPL DeficiencyBurnettJohn RMB ChB, MD, PhD, FRCPAjohn.burnett@health.wa.gov.auHooperAmanda JPhDamanda.hooper@health.wa.gov.auHegeleRobert AMD, FRCPC, FACPhegele@robarts.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nFamilial Mediterranean FeverSynonym: Recurrent PolyserositisShohatMordechaiMDmshohat@post.tau.ac.il\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFamilial Paroxysmal Nonkinesigenic DyskinesiaSynonyms: Paroxysmal Dystonic Choreoathetosis, Paroxysmal Nonkinesigenic Dyskinesia, PNKDErroRobertoMD, PhDCenter for Neurodegenerative Diseases\nDepartment of Medicine, Surgery, and Dentistry \"Scuola Medica Salernitana\"\nUniversity of Salerno\nSalerno, Italyrerro@unisa.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nFamilial Porphyria Cutanea TardaSynonyms: Familial PCT (F-PCT); Porphyria Cutanea Tarda, Type II (Type II PCT); UROD-Related Porphyria Cutanea TardaRudnickSeanMDsrudnick@wakehealth.eduPhillipsJohnPhDjohn.phillips@hsc.utah.eduBonkovskyHerbertMDhbonkovs@wakehealth.eduPorphyrias Consortium of the Rare Diseases Clinical Research Network\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFanconi AnemiaSynonym: Fanconi PancytopeniaMehtaParinda AMDProfessor, Division of Bone Marrow Transplantation and Immune DeficiencyCincinnati Children's Hospital Medical CenterCincinnati, Ohioparinda.mehta@cchmc.orgEbensChristen LMD, MPHAssociate Professor, Division of Blood and Marrow Transplant & Cellular TherapyUniversity of MinnesotaMinneapolis, Minnesotaebens012@umn.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFARS2 DeficiencyAlmannaiMohammedMD, FAAP, FACMGmalmannai@kfmc.med.saFaqeihEissaMDefaqeih@kfmc.med.saEl-HattabAyman WMD, FAAP, FACMGelhattabaw@yahoo.comWongLee-Jun CPhD, FACMGljwong@bcm.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FASTKD2</italic>-Related Combined Oxidative Phosphorylation DeficiencySynonyms: Combined Oxidative Phosphorylation (OXPHOS) Deficiency 44 (COXPD44), FASTKD2-Related Mitochondrial DiseasePatilSiddaramappa JMD, DMDivision of Medical GeneticsMazumdar Shaw Medical Centre / Narayana Hrudayalaya HospitalsBangalore, Indiadrsjpatil@gmail.comKaurNamanpreetBSc, MScThe MRC Protein Phosphorylation and Ubiquitylation UnitSchool of Life SciencesUniversity of DundeeDundee, Scotland, United Kingdomnamanpreetkaur70@gmail.comShuklaAnjuMD, DMDepartment of Medical GeneticsKasturba Medical College;Manipal Academy of Higher EducationManipal, Indiaanju.shukla@manipal.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFatty Acid Hydroxylase-Associated NeurodegenerationSynonym: Spastic Paraplegia 35 (SPG35)GregoryAllisonMSDepartment of Molecular and Medical GeneticsOregon Health & Science UniversityPortland, Oregongregorya@ohsu.eduVenkateswaranSunitaMDDepartment of NeurologyChildren's Hospital of Eastern OntarioOttawa, Ontario, Canadasvenkateswaran@cheo.on.caHayflickSusan JMDDepartments of Molecular and Medical Genetics, Pediatrics, and NeurologyOregon Health & Science UniversityPortland, Oregonhayflick@ohsu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FBLN5</italic>-Related Cutis LaxaVan MaldergemLionelMD, PhDCentre de Génétique HumaineCentre Hospitalier UniversitaireUniversité de Franche-ComtéBesançon, Francevmald@skypro.beLoeysBartMD, PhDCenter for Medical GeneticsAntwerp University HospitalEdegem, Belgiumbart.loeys@uantwerpen.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FBN1</italic>-Related Marfan SyndromeDietzHarryMDVictor A McKusick Professor, Departments of Genetic Medicine, Pediatrics, Medicine, and Molecular Biology & Genetics;Investigator, Howard Hughes Medical Institute;Johns Hopkins University School of MedicineBaltimore, Marylandhdietz@jhmi.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FBXL4</italic>-Related Encephalomyopathic Mitochondrial DNA Depletion SyndromeSynonyms: FBXL4 Deficiency; FBXL4-Related Early-Onset Mitochondrial Encephalopathy; Mitochondrial DNA Depletion Syndrome 13 (MTDPS13), Encephalomyopathic TypeAlmannaiMohammedMD, FAAP, FACMGMedical Genetics and Metabolic Consultant, Section of Medical GeneticsKing Fahad Medical CityRiyadh, Saudi Arabiamalmannai@kfmc.med.saDaiHongzhengPhDClinical Molecular Genetics and Genomics Fellow, Department of Molecular & Human GeneticsBaylor College of MedicineHouston, Texashongzheng.dai@bcm.eduEl-HattabAyman WMD, FAAP, FACMGAssociate Professor, Department of Clinical SciencesCollege of MedicineUniversity of SharjahSharjah, United Arab Emirateselhattabaw@yahoo.comWongLee-Jun CPhD, FACMGProfessor, Department of Molecular and Human GeneticsBaylor College of MedicineHouston, Texasljwong@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nFeingold Syndrome 1Synonyms: Oculodigitoesophagoduodenal Syndrome, ODED SyndromeMarcelisCarlo LMMDDepartment of Human GeneticsRadboud University Nijmegen Medical CenterNijmegen, The Netherlandscarlo.marcelis@radboudumc.nlde BrouwerArjan PMPhDAssistant Professor, Department of Human GeneticsRadboud University Nijmegen Medical CenterNijmegen, The Netherlandsarjan.debrouwer@radboudumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FGD1</italic>-Related Faciogenital Dysplasia (Aarskog-Scott Syndrome)Synonyms: Aarskog-Scott Syndrome, Aarskog Syndrome, Faciogenital DysplasiaJeanneMédéricMD, PhDPRISME Division for Congenital and Developmental DisordersDepartment of GeneticsHôpital de l'EstranAvranches, Francem.jeanne@ch-estran.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FGFR1</italic>-Related Hartsfield SyndromeDhamijaRadhikaMD, FAAPDepartment of Clinical GenomicsMayo ClinicPhoenix, Arizonadhamija.radhika@mayo.eduBabovic-VuksanovicDusicaMDDepartment of Clinical GenomicsMayo ClinicRochester, Minnesotadbabovic@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FGFR</italic> Craniosynostosis Syndromes OverviewSynonym: FGFR AcrocephalosyndactylyWengerTaraMD, PhDtara.wenger@seattlechildrens.orgMillerDannyMD, PhDdanny.miller@seattlechildrens.orgEvansKellyMDkelly.evans@seattlechildrens.org\n\nSummary\n\n Clinical Characteristics of <italic toggle=\"yes\">FGFR</italic> Craniosynostosis Syndromes\n\n Causes of <italic toggle=\"yes\">FGFR</italic> Craniosynostosis\n\n Evaluation Strategies to Identify the Genetic Cause of an <italic toggle=\"yes\">FGFR</italic> Craniosynostosis Syndrome in a Proband\n\n Management of Individuals with an <italic toggle=\"yes\">FGFR</italic> Craniosynostosis Syndrome\n\n Genetic Risk Assessment\n\nResources\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FH</italic> Tumor Predisposition SyndromeSynonyms: Fumarate Hydratase Tumor Predisposition Syndrome (FHTPS), Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), Multiple Cutaneous and Uterine Leiomyomatosis (MCL/MCUL), Reed's SyndromeKamiharaJunneMD, PhDDana-Farber Cancer Institute;Boston Children's HospitalBoston, Massachusettsjunne_kamihara@dfci.harvard.eduSchultzKris AnnMDChildren's MinnesotaMinneapolis, Minnesotakrisann.schultz@childrensmn.orgRanaHuma QMD, MPHDana-Farber Cancer InstituteBoston, Massachusettshumaq_rana@dfci.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFibrodysplasia Ossificans ProgressivaSynonyms: Myositis Ossificans Progressiva, Progressive Ossifying Myositis, ACVR1-Related Fibrodysplasia Ossificans ProgressivaAkessonLauren SMBBS (Hons), PhD, FRACP, FRCPAUniversity of TasmaniaHobart, Tasmania, Australialauren.akesson@utas.edu.auSavarirayanRaviMBBS, MD, FRACP, ARCPA (Hon)Victorian Clinical Genetics Services;Murdoch Children's Research Institute;University of MelbourneParkville, Victoria, Australiaravi.savarirayan@vcgs.org.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFibrous Dysplasia / McCune-Albright SyndromeSynonym: FD/MASSzymczukVivianMDvivian.szymczuk@nih.govFlorenzanoPabloMDpablo.florenzano@nih.govde CastroLuis FPhDluis.fernandezdecastrodiaz@nih.govCollinsMichael TMDmcollins@dir.nidcr.nih.govBoyceAlison MMDboyceam@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FKBP14</italic> Kyphoscoliotic Ehlers-Danlos SyndromeSynonym: kEDS-FKBP14GiuntaCeciliaPhDcecilia.giunta@kispi.uzh.chRohrbachMarianneMD, PhDmarianne.rohrbach@kispi.uzh.chFauthChristineMDchristine.fauth@i-med.ac.atBaumannMatthiasMDmatthias.baumann@tirol-kliniken.at\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nFLNA DeficiencyChenMing HuiMD, MMScBoston Children's HospitalBoston, Massachusettsminghui.chen@cardio.chboston.orgWalshChristopher AMD, PhDBoston Children's HospitalHoward Hughes Medical InstituteHarvard Medical SchoolBoston, Massachusettschristopher.walsh@childrens.harvard.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FLNA</italic>-Related Otopalatodigital Spectrum DisordersSynonyms: Otopalatodigital Spectrum Disorders (OPDSD); X-Linked Otopalatodigital Spectrum DisordersRobertsonStephenFRACP, DPhilDepartment of Paediatrics and Child HealthDunedin School of MedicineUniversity of OtagoDunedin, New Zealandstephen.robertson@otago.ac.nzWadeEmmaPhDDepartment of Obstetrics, Gynaecology and Women's HealthDunedin School of MedicineUniversity of OtagoDunedin, New Zealandemma.wade@otago.ac.nz\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FLNB-</italic>Related DisordersRobertsonStephenFRACP, DPhilProfessor of Paediatric GeneticsDepartment of Paediatrics and Child HealthDunedin School of MedicineUniversity of OtagoDunedin, New Zealandstephen.robertson@otago.ac.nzMeiraJoannaMD, MScProfessor, State University of Bahia (UNEB)Salvador, Bahia, Braziljoannagcm@gmail.com\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FMR1</italic> DisordersHunterJessica EzzellPhDCenter for Health ResearchKaiser Permanente NorthwestPortland, Oregonjessica.e.hunter@kpchr.orgBerry-KravisElizabethMD, PhDDepartments of Pediatrics, Neurological Sciences, and BiochemistryRush University Medical CenterChicago, Illinoiselizabeth_berry-kravis@rush.eduHippHeatherMDDivision of Reproductive Endocrinology and InfertilityEmory University School of MedicineAtlanta, Georgiahhipp@emory.eduToddPeter KMD, PhDDepartment of NeurologyUniversity of Michigan Medical SchoolAnn Arbor, Michiganpetertod@med.umich.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FOLR1</italic>-Related Cerebral Folate Transport DeficiencySynonyms: Folate Receptor-Alpha Deficiency, FOLR1 Deficiency, FOLRα Deficiency, FRα DeficiencyGoldmanI DavidMDDepartments of Medicine and Molecular PharmacologyAlbert Einstein College of MedicineBronx, New Yorki.david.goldman@einsteinmed.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FOXG1</italic> SyndromeSynonyms: FOXG1-Related Disorder, FOXG1-Related Encephalopathy, FOXG1-Related Neurodevelopmental DisorderBrockmannKnutMDInterdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic DisordersChildren's Hospital,University Medical CenterGöttingen, Germanyknut.brockmann@med.uni-goettingen.deStaudtMartinMDCenter for Pediatric Palliative CareDr von Hauner Children's HospitalUniversity HospitalLMU MunichMunich, Germanymartin.staudt@med.uni-muenchen.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFOXP1 SyndromeSynonyms: FOXP1 Haploinsufficiency, FOXP1-Related Neurodevelopmental DisorderRappoldGudrunPhDgudrun.rappold@med.uni-heidelberg.deSiperPaigePhDpaige.siper@mssm.eduKosticAnaPhDana.kostic@mssm.eduBradenRuthPhDbraden.r@unimelb.edu.auMorganAngelaPhDangela.morgan@mcri.edu.auKoeneSaskiaMD, PhDs.koene@lumc.nlKolevzonAlexanderMDalexander.kolevzon@mssm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FOXP2-</italic>Related Speech and Language DisorderMorganAngelaBSpPath (Aud Hons), PhDHead, Speech & Language,Murdoch Children's Research Institute;Professor, Department of Audiology and Speech PathologyUniversity of Melbourne;Director, Genetics of Speech ClinicRoyal Children’s HospitalMelbourne, Victoria, Australiaamor@unimelb.edu.auFisherSimon EDPhilLanguage and Genetics DepartmentMax Planck Institute for Psycholinguistics;Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegen, the Netherlandssimon.fisher@mpi.nlSchefferIngridMBBS, PhD, FRACP, FAAEpilepsy Research CentreDepartment of Medicine and PaediatricsUniversity of Melbourne;Austin HealthMelbourne, Victoria, Australiai.scheffer@unimelb.edu.auHildebrandMichaelPhDEpilepsy Research CentreMelbourne Brain CentreDepartment of MedicineUniversity of Melbourne;Austin Health;Neuroscience GroupMurdoch Children's Research InstituteMelbourne, Victoria, Australiamichael.hildebrand@unimelb.edu.au\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFree Sialic Acid Storage DisorderAdamsDavidMD, PhDdadams1@mail.nih.govHuizingMarjanPhDmhuizing@mail.nih.govWassersteinMelissaMDmwassers@montefiore.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FREM1</italic> Autosomal Recessive DisordersLiChumeiMD, PhD, FRCPC, FCCMGMcMaster Children's HospitalDepartment of PediatricsMcMaster UniversityHamilton, Ontario, Canadalichum@mcmaster.caSlavotinekAnneMBBS, PhDDepartment of PediatricsDivision of GeneticsUniversity of California, San FranciscoSan Francisco, Californiaanne.slavotinek@cchmc.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFriedreich AtaxiaSynonym: FRDABidichandaniSanjay IMBBS, PhDProfessor of Pediatrics, University of Oklahoma Health Sciences CenterOklahoma City, Oklahomasanjay-bidichandani@ouhsc.eduDelatyckiMartin BMBBS, FRACP, PhDProfessor and Clinical Geneticist, Victorian Clinical Genetics Services;Co-Director, Bruce Lefroy Centre for Genetic Health ResearchMurdoch Children's Research InstituteVictoria, Australiamartin.delatycki@vcgs.org.auNapieralaMarekPhD, DScProfessor of Neurology, University of Texas Southwestern Medical Center;O’Donnell Brain InstituteDallas, Texasmarek.napierala@utsouthwestern.eduDuquetteAntoineMD, MSc, FRCP(C)Associate Clinical Professor, Department of NeurosciencesCentre hospitalier de l'Université de MontréalMontréal, Canadaantoine.duquette@umontreal.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">FRMD7</italic>-Related Infantile NystagmusSynonyms: NYS1, X-Linked Idiopathic Infantile NystagmusThomasMervyn GBSc (Hons), MB ChB, PhDmt350@le.ac.ukMaconachieGailBSc, PhDHisaundMichaelBScGottlobIreneMD, Univ Doz, FRCOphthig15@le.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFructose-1,6-Bisphosphatase DeficiencySynonyms: FBP1 Deficiency; FBPase Deficiency; Fructose 1,6 Diphosphatase DeficiencyBijarnia-MahaySunitaMBBS, DCH, DNBbijarnia@gmail.comBhatiaSameerMBBS, MDdrsameerbhatia@gmail.comAroraVeronicaMBBS, MS, DNB (OBG)veronicaarora@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFryns SyndromeSlavotinekAnneMBBS, PhDProfessor of Human GeneticsDivision of Human GeneticsDepartment of PediatricsCincinnati Children's Hospital Medical Centeranne.slavotinek@cchmc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFucosidosisSynonyms: Α-L-Fucosidase Deficiency, Alpha-L-Fucosidase Deficiency, Mucopolysaccharidosis Type FStepienKarolina MMD, PhDkarolina.stepien@nca.nhs.ukJonesSimonMDsimon.jones@mft.nhs.ukWangRaymondMDrawang@choc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFukuyama Congenital Muscular DystrophySynonym: FCMDSaitoKayokoMD, PhDEmeritus Professor, Tokyo Women's Medical UniversityTokyo, Japansaito.kayoko@twmu.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nFumarate Hydratase DeficiencySynonyms: Fumarase Deficiency (FMRD), Fumaric AciduriaComanDavidMBBS, MPhil, FRACProfessor, Department of Metabolic MedicineQueensland Children's HospitalBrisbane, Australiadavid.coman@health.qld.gov.auKrancKamil RMD, DPhilLaboratory of Haematopoietic Stem Cell & Leukaemia BiologyCentre for Haemato-OncologyBarts Cancer InstituteQueen Mary University of LondonLondon, United Kingdomkamil.kranc@qmul.ac.ukChristodoulouJohnMBBS, PhDDirector, Genetics ResearchMurdoch Children's Research Institute;Chair of Genomic Medicine, Department of PaediatricsUniversity of MelbourneMelbourne, Australiajohn.christodoulou@mcri.edu.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nG6PC3 DeficiencySynonym: Ubiquitous Glucose-6-Phosphatase DeficiencyBankaSiddharthMD, MRCPCH, PhDManchester Centre for Genomic Medicine - Institute of Human DevelopmentFaculty of Medical and Human SciencesUniversity of Manchester;Manchester Centre for Genomic Medicine - Saint Mary's HospitalCentral Manchester University Hospitals NHS Foundation Trust;Manchester Academic Health Science CentreManchester, United Kingdomsiddharth.banka@manchester.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGAA-<italic toggle=\"yes\">FGF14</italic>-Related AtaxiaSynonyms: Spinocerebellar Ataxia 27B (SCA27B), FGF14 (GAA)n-Mediated Ataxia, GAA-FGF14 Ataxia, GAA-FGF14 Disease, GAA-FGF14-Related Disease, SCA27B/ATX-FGF14PellerinDavidMD, MSc, FRCPCdavid.pellerin.21@ucl.ac.ukDanziMattPhDm.danzi@med.miami.eduRenaudMathildeMD, PhDm.renaud2@chru-nancy.frHouldenHenryMD, PhDh.houlden@ucl.ac.ukSynofzikMatthisMDmatthis.synofzik@uni-tuebingen.deZuchnerStephanMD, PhDszuchner@med.miami.eduBraisBernardMDCM, MPhil, PhD, FRCPCbernard.brais@mcgill.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGabriele-de Vries SyndromeSynonym: YY1 Intellectual Disability SyndromeNabais SáMaria JMD, MPH, PhDmaria.nabaissa@radboudumc.nlGabrieleMicheleMS, PhDmichele.gabriele@ieo.itTestaGiuseppeMD, PhD, MAgiuseppe.testa@unimi.itgiuseppe.testa@ieo.itde VriesBert BAMD, PhDbert.devries@radboudumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GAN</italic>-Related NeurodegenerationOpalPuneetMD, PhDDepartment of NeurologyNorthwestern UniversityFeinberg School of MedicineChicago, Illinoisp-opal@northwestern.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GARS1</italic>-Associated Axonal NeuropathyMarkovitzRebeccaMD, PhDrebecca.markovitz@bcm.eduGhoshRajarshiPhDrajarshi.ghosh@nih.govLotzeTimothyMDtlotze@bcm.eduPotockiLorraineMDlpotocki@bcm.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GATA1</italic>-Related CytopeniaTakasakiKaoruMDInstructor, Department of PediatricsDivision of HematologyChildren's Hospital of PhiladelphiaPhiladelphia, Pennsylvaniatakasakik@chop.eduKacenaMelissa APhDProfessor and Vice Chair for Research, Department of Orthopaedic SurgeryIndiana University School of MedicineIndianapolis, Indianamkacena@iupui.eduRaskindWendy HMD, PhDProfessor, Departments of Medicine and Psychiatry and Behavioral SciencesUniversity of Washington Medical CenterSeattle, Washingtonwendyrun@uw.eduWeissMitchell JMD, PhDMember and Chairman,Department of HematologySt Jude Children's Research HospitalMemphis, Tennesseemitch.weiss@stjude.orgChouStella TMDAssociate Professor, Department of PediatricsUniversity of Pennsylvania School of Medicine;Division of HematologyChief, Division of Transfusion MedicineChildren's Hospital of PhiladelphiaPhiladelphia, Pennsylvaniachous@chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGaucher DiseaseSynonyms: Glucocerebrosidase Deficiency, Glucosylceramidase DeficiencyHughesDerralynn AMA, DPhil, FRCP, FRCPathProfessor of Experimental HaematologyDepartment of Academic HaematologyUniversity College Medical SchoolLondon, United Kingdomderralynnhughes@nhs.netPastoresGregory MMDClinical Professor, Medicine (Genetics)University CollegeDublin, Ireland\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GBE1</italic> Adult Polyglucosan Body DiseaseAkmanH OrhanPhDhoa2101@cumc.columbia.eduLossosAlexanderMDalos@hadassah.org.ilKakhlonOrPhDork@hadassah.org.il\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGeleophysic DysplasiaMarzinPaulineMDpauline.marzin@aphp.frCormier-DaireValérieMD, PhDvalerie.cormier-daire@inserm.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGeneralized Arterial Calcification of InfancySynonyms: GACI, Idiopathic Infantile Arterial Calcification (IIAC)ZieglerShira GMD, PhDsgziegler@jhmi.eduFerreiraCarlos RMDferreiracr@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGenetic Atypical Hemolytic-Uremic SyndromeSynonym: Familial Atypical Hemolytic-Uremic SyndromeNorisMarinaPhDmarina.noris@marionegri.itBresinElenaMDelena.bresin@marionegri.itMeleCaterinaBiol Sci Dcaterina.mele@marionegri.itRemuzziGiuseppeMDgiuseppe.remuzzi@marionegri.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGenetic Hearing Loss OverviewShearerA EliotMD, PhDeliot.shearer@childrens.harvard.eduHildebrandMichael SPhDmichael.hildebrand@unimelb.edu.auOdellAmanda MMS, LGCamanda-odell@uiowa.eduSmithRichard JHMDrichard-smith@uiowa.edu\n\nSummary\n\n Audiometric and Clinical Aspects of Hearing Loss\n\n Causes of Genetic Hearing Loss\n\n Differential Diagnosis of Genetic Hearing Loss\n\n Evaluation Strategy\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nGenetic Prion DiseaseZerrIngaMDingazerr@med.uni-goettingen.deSchmitzMatthiasMDmatthias.schmitz@med.uni-goettingen.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGenetic Steroid-Resistant Nephrotic Syndrome OverviewLipska-ZiętkiewiczBeata SMD, PhDCenter for Rare Diseases;Department of Biology and Medical GeneticsClinical Genetics UnitMedical University of GdańskGdańsk, Polandb.lipska@gumed.edu.pl\n\nSummary\n\n Clinical Characteristics of Genetic Steroid-Resistant Nephrotic Syndrome\n\n Causes of Genetic Steroid-Resistant Nephrotic Syndrome\n\n Evaluation Strategies to Identify the Cause of Genetic Steroid-Resistant Nephrotic Syndrome in a Proband\n\n Phenocopies of Genetic Steroid-Resistant Nephrotic Syndrome\n\n Management of Genetic Steroid-Resistant Nephrotic Syndrome\n\n Risk Assessment and Surveillance of At-Risk Relatives for Early Detection and Treatment of Genetic Steroid-Resistant Nephrotic Syndrome\n\nResources\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GJB1</italic> Disorders: Charcot-Marie-Tooth Neuropathy (CMT1X) and Central Nervous System PhenotypesAbramsCharles KMD, PhDDepartment of Neurology and RehabilitationUniversity of Illinois at Chicago College of MedicineChicago, Illinoiscabrams1@uic.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GJB2</italic>-Related Autosomal Recessive Nonsyndromic Hearing LossSmithRichard JHMDrichard-smith@uiowa.eduAzaiezHelaMS, PhDhela-azaiez@uiowa.eduBoothKevinPhDkevbooth@iu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GLB1-</italic>Related DisordersRegierDebra SMD, PhDMedical Director, Rare Disease InstituteChildren's National HospitalWashington, DCdregier@childrensnational.orgTifftCynthia JMD, PhDDeputy Clinical Director, National Human Genome Research InstituteNational Institutes of HealthBethesda, Marylandctifft@nih.govRothermelCaroline EBANational Human Genome Research InstituteNational Institutes of HealthBethesda, Marylandcaroline.rothermel@nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GLI3</italic>-Related Greig Cephalopolysyndactyly SyndromeBieseckerLeslie GMDlesb@mail.nih.govJohnstonJennifer JPhDjjohnsto@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GLI3</italic>-Related Pallister-Hall SyndromeBieseckerLeslie GMDCenter for Precision Health ResearchNational Human Genome Research InstituteNational Institutes of HealthBethesda, Marylandlesb@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGlucose Transporter Type 1 Deficiency SyndromeSynonyms: De Vivo Disease, Glut1 Deficiency Syndrome, Glut1DS, Glut1-DSWangDongMDdwang666888@gmail.comSandsTristanMD, PhDtts27@cumc.columbia.eduTangMaoxuePhDmt2877@cumc.columbia.eduMonaniUmraoPhDum2105@cumc.columbia.eduDe VivoDarrylMDdcd1@cumc.columbia.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGlutaric Acidemia Type 1Synonyms: GA-1, GCDH Deficiency, Glutaric Aciduria Type 1, Glutaryl-CoA Dehydrogenase DeficiencyLarsonAustinMDaustin.larson@childrenscolorado.orgCoughlinCurtisIIPhD, MScurtis.coughlin@childrenscolorado.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGlycogen Storage Disease Type IBaliDeeksha SPhDdbali@duke.eduEl-GharbawyAreegMDareeg.el-gharbawy@duke.eduAustinStephanieMS, MA, CGCsaustin@amicusrx.comPendyalSurekhaMSc, MEd, RD, FANDsurekha.pendyal@duke.eduKishnaniPriya SMDpriya.kishnani@duke.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGlycogen Storage Disease Type IIISynonyms: Cori Disease, Debrancher Deficiency, Forbes Disease, Glycogen Debranching Enzyme (GDE) DeficiencySchreuderAndrea BMD, PhDa.b.schreuder@umcg.nlRossiAlessandroMDalessandro.rossi@unina.itGrünertSarah CMDsarah.gruenert@uniklinik-freiburg.deDerksTerry GJMD, PhDt.g.j.derks@umcg.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGlycogen Storage Disease Type IVSynonyms: Andersen Disease, Glycogen Branching Enzyme Deficiency, Glycogen Storage Disease IV, GSD IVMagoulasPilar LMS, CGCBaylor College of MedicineTexas Children's HospitalHouston, Texasmagoulas@bcm.eduEl-HattabAyman WMD, FAAP, FACMGAssociate Professor, Department of Clinical SciencesCollege of MedicineUniversity of SharjahSharjah, United Arab Emirateselhattabaw@yahoo.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nGlycogen Storage Disease Type VSynonyms: Glycogenosis Type V, GSDV, McArdle Disease, Muscle Glycogen Phosphorylase Deficiency, Myophosphorylase Deficiency, PYGM DeficiencyMartínMiguel APhDmamcasanueva.imas12@h12o.esLuciaAlejandroMD, PhDalejandro.lucia@universidadeuropea.esArenasJoaquinPhDjoaquin.arenas@salud.madrid.orgAndreuAntonio LMD, PhDtoniandreu.bcn@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGlycogen Storage Disease Type VISynonym: GSD VISallagoJulieta BonvinMD, MSjbonvinsallago@connecticutchildrens.orgWeinsteinDavid AMD, MMScweinstein@uchc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGM2 Activator DeficiencySynonyms: GM2 Gangliosidosis, AB Variant; Hexosaminidase Activator Deficiency; Tay-Sachs Variant ABXiaoChangruiMDchangrx@hs.uci.eduToroCamiloMDtoroc@mail.nih.govTifftCyndiMD, PhDcynthiat@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGM3 Synthase DeficiencySynonyms: Amish Infantile Epilepsy Syndrome, Salt and Pepper Developmental Regression Syndrome, ST3GAL5-CDG, ST3GAL5 DeficiencyCruzVincentMD, MSvcruz@ddcclinic.orgXinBaozhongPhDbxin@ddcclinic.orgWangHengMD, PhDwang@ddcclinic.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GNAI1</italic>-Related Neurodevelopmental DisorderBonkowskiEmilyScM, CGCemily.bonkowski@stjude.orgFathiEsmatPhDesmat.fathi@stjude.orgMeffordHeather CMD, PhDheather.mefford@stjude.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GNAO1</italic>-Related DisorderSynonyms: GNAO1-Associated Disorder, GNAO1-Associated Epileptic Encephalopathy and Movement DisorderBriereLaurenMSlbriere@mgh.harvard.eduThielMoritzMDmoritz.thiel@uk-koeln.deSweetserDavid AMD, PhDdsweetser@mgh.harvard.eduKoyAnneMDanne.koy@uk-koeln.deAxeenErikaMDeta2h@virginia.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GNB1</italic> EncephalopathyRevah-PolitiAnyaMS, CGCar3594@cumc.columbia.eduSandsTristan TMD, PhDtts27@cumc.columbia.eduColomboSophieMS, PhDGoldsteinDavid BPhDAnyane-YeboaKwameMD, FACMGka8@cumc.columbia.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GNB5</italic>-Related Neurodevelopmental DisorderSynonyms: Intellectual Developmental Disorder with Cardiac Arrhythmia (IDDCA) Syndrome, Language Delay and ADHD / Cognitive Impairment with or without Cardiac Arrhythmia (LADCI)PokeGemmaBSc, MBBSgemma.poke@otago.ac.nzSadleirLynette GrantMBChBlynette.sadleir@otago.ac.nzMerlaGiuseppegiuseppe.merla@unina.itde Valles-IbáñezGuillemBSc, MSc, PhDguille.devallesibanez@otago.ac.nzSkinnerJonathan RobertMB ChB, MRCP(UK), FRACP, FHRS, MDjskinner@adhb.govt.nz\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GNE</italic> MyopathySynonyms: Distal Myopathy with Rimmed Vacuoles (DMRV), Hereditary Inclusion Body Myopathy (HIBM), Inclusion Body Myopathy Type 2 (IBM2), Nonaka Myopathy, Quadriceps-Sparing MyopathyCarrilloNuriaMDcarrilln@mail.nih.govMalicdanMay ChristineMD, PhDmaychristine.malicdan@nih.govHuizingMarjanPhDmhuizing@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GNPTAB</italic>-Related DisordersLeroyJules GMD, PhDCatheySara SMD, FACMGFriezMichael JPhD\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GRIA2</italic>-Related Neurodevelopmental DisorderEfthymiouStephanieMSc, PhDs.efthymiou@ucl.ac.ukRumbos SiuranaElisaMScelisa.siurana.17@ucl.ac.ukSalpietroVincenzoMDv.salpietro@ucl.ac.ukBayatAllanabaya@filadelfia.dkHouldenHenryMD, PhDh.houlden@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GRIN1</italic>-Related Neurodevelopmental DisorderSynonym: GRIN1-Related Developmental and Epileptic EncephalopathyPlatzerKonradMDkonrad.platzer@medizin.uni-leipzig.deLemkeJohannes RMDjohannes.lemke@medizin.uni-leipzig.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GRIN2A</italic>-Related DisordersStrehlowVincentMDvincent.strehlow@medizin.uni-leipzig.deMyersKenneth AMD, PhD, FRCPCsfu.ken1@gmail.comMorganAngela TBSpPath(Aud Hons), PhD, CPSPamor@unimelb.edu.auSchefferIngrid EMBBS, PhD, FRACP, FAA, FAHMS, FRSi.scheffer@unimelb.edu.auLemkeJohannes R.MDjohannes.lemke@medizin.uni-leipzig.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GRIN2B</italic>-Related Neurodevelopmental DisorderSynonym: GRIN2B EncephalopathyPlatzerKonradMDkonrad.platzer@medizin.uni-leipzig.deLemkeJohannes RMDjohannes.lemke@medizin.uni-leipzig.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GRIN2D</italic>-Related Developmental and Epileptic EncephalopathyPlatzerKonradMDkonrad.platzer@medizin.uni-leipzig.deKreyIlonaMDilona.krey@medizin.uni-leipzig.deLemkeJohannes RMDjohannes.lemke@medizin.uni-leipzig.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GRN</italic> Frontotemporal DementiaSynonym: FTD-GRNHsiungGing-Yuek RobinMD, MHSc, FRCPCAssociate Professor, Division of NeurologyFaculty of MedicineUniversity of British Columbia and Providence Health CareVancouver, British Columbia, Canadahsiung@mail.ubc.caFeldmanHoward HMD, CM, FRCPCProfessor, Division of NeurologyFaculty of MedicineUniversity of British ColumbiaVancouver, British Columbia, Canadahoward.feldman@ubc.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nGTP Cyclohydrolase 1-Deficient Dopa-Responsive DystoniaSynonyms: Autosomal Dominant Dopa-Responsive Dystonia, Autosomal Dominant Segawa Syndrome, DYT5a, Hereditary Progressive Dystonia with Marked Diurnal FluctuationFurukawaYoshiakiMD, PhDChairman, Department of NeurologyVice President, Juntendo Tokyo Koto Geriatric Medical CenterProfessor, Department of NeurologyFaculty of MedicineJuntendo UniversityTokyo, Japanfurukawa@juntendo.gmc.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">HAMP</italic>- and <italic toggle=\"yes\">HJV</italic>-Related HemochromatosisMarianiRaffaellaMD, PhDraffaella.mariani@irccs-sangerardo.itBertolaFrancescaPhDfrancescadaniela.bertola@irccs-sangerardo.itPipernoAlbertoMDalberto.piperno@unimib.it\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHand-Foot-Genital SyndromeSynonyms: HFGS, HFG SyndromeInnisJeffrey WMD, PhDProfessor, Human Genetics, Pediatrics and Internal MedicineDirector, Division of Pediatric Genetics, Metabolism and Genomic MedicineUniversity of MichiganDirector, Michigan Medical Genetics LaboratoriesAnn Arbor, Michiganinnis@umich.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nHaploinsufficiency of A20Synonym: HA20DeuitchNatalie TMS, CGCnatalie.deuitch@nih.govSchwartzDaniella MMDdaniella.schwartz@pitt.eduAksentijevichIvonaMDaksentii@arb.niams.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHemophilia ASynonym: Factor VIII DeficiencyKonkleBarbara AMDDirector, Bleeding Disorders LaboratoryBloodworks Northwest; Hematologist, Washington Center for Bleeding Disorders;Professor Emeritus of MedicineUniversity of WashingtonSeattle, Washingtonkonkleb@uw.eduNakaya FletcherShelleyBSManager, Bleeding Disorders LaboratoryBloodworks NorthwestSeattle, Washingtonshelleyn@bloodworksnw.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHemophilia BSynonyms: Christmas Disease, Factor IX DeficiencyKonkleBarbara AMDDirector, Bleeding Disorders LaboratoryBloodworks Northwest; Hematologist, Washington Center for Bleeding Disorders;Professor Emeritus of MedicineUniversity of WashingtonSeattle, Washingtonkonkleb@uw.eduNakaya FletcherShelleyBSManager, Bleeding Disorders LaboratoryBloodworks NorthwestSeattle, Washingtonshelleyn@bloodworksnw.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nKey Sections in this <italic toggle=\"yes\">GeneReview</italic>\n\nReferences\n\nHepatic Veno-Occlusive Disease with ImmunodeficiencySynonym: VODIWongMelanieMBBS, FRACP, FRCPA, PhDClinical Immunologist and ImmunopathologistThe Children's Hospital at WestmeadSydney, Australiamelanie.wong@health.nsw.gov.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHepatoerythropoietic PorphyriaSynonym: UROD-Related Hepatoerythropoietic PorphyriaRudnickSeanMDsrudnick@wakehealth.eduPhillipsJohnPhDjohn.phillips@hsc.utah.eduBonkovskyHerbertMDhbonkovs@wakehealth.eduPorphyrias Consortium of the Rare Diseases Clinical Research Network\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Ataxia OverviewPerlmanSusanMDDavid Geffen School of MedicineUniversity of California Los AngelesLos Angeles, Californiasperlman@mednet.ucla.edu\n\nSummary\n\n Clinical Characteristics of Primary Hereditary Ataxia\n\n Causes of Hereditary Ataxia\n\n Evaluation Strategies to Identify the Genetic Cause of Hereditary Ataxia in a Proband\n\n Management of Hereditary Ataxia\n\n Genetic Counseling of Family Members of an Individual with Hereditary Ataxia\n\nResources\n\nChapter Notes\n\nLiterature Cited\n\nHereditary CoproporphyriaWangBruceMDUniversity of California San Francisco\nSan Francisco, Californiabruce.wang@ucsf.eduBissellD MontgomeryMDUniversity of California San Francisco\nSan Francisco, Californiamontgomery.bissell@ucsf.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Distal Renal Tubular AcidosisSynonyms: Classic Renal Tubular Acidosis, Type 1 RTAAlexanderR ToddMD, PhDUniversity of AlbertaEdmonton, Canadatodd2@ualberta.caGil-PeñaHelenaPhDHospital Universitario Central de Asturias;Instituto de Investigación Sanitaria del Principado de AsturiasOviedo, Spainhelena.gil@sespa.esGreenbaumLarry AMD, PhDEmory University;Children’s Healthcare of AtlantaAtlanta, Georgialgreen6@emory.eduSantosFernandoMD, PhDUniversity of Oviedo;Hospital Universitario Central de AsturiasOviedo, Spainfsantos@uniovi.es\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Fibrosing Poikiloderma with Tendon Contractures, Myopathy, and Pulmonary FibrosisSynonym: POIKTMPMercierSandraMD, PhDsandra.mercier@chu-nantes.frKürySébastienDVM, PhDsebastien.kury@chu-nantes.frBarbarotSébastienMD, PhDsebastien.barbarot@chu-nantes.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Folate MalabsorptionSynonym: Congenital Folate MalabsorptionGoldmanI DavidMDDepartments of Medicine, Oncology, and Molecular PharmacologyAlbert Einstein College of MedicineBronx, New Yorki.david.goldman@einsteinmed.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Fructose IntoleranceGaughanSommerRD, CSPChildren's Hospital ColoradoAurora, Coloradosommer.gaughan@childrenscolorado.orgAyresLachlanMB, ChB, MRCPUniversity Hospitals DorsetDorset, United Kingdomlachlan.ayres@uhd.nhs.ukBakerPeter RIIMD, FAAP, FACMGChildren's Hospital Colorado;University of Colorado School of MedicineAurora, Coloradopeter.baker@childrenscolorado.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Hemorrhagic TelangiectasiaSynonyms: HHT, Osler-Weber-Rendu DiseaseMcDonaldJamieMS, CGCDepartment of PathologyUniversity of Utah Medical CenterSalt Lake City, Utahjamie.mcdonald@hsc.utah.eduGossageJames RMDAugusta UniversityAugusta, Georgiajgossage@augusta.eduStevensonDavid AMDDivision of Medical GeneticsDepartment of PediatricsStanford UniversityStanford, Californiadasteven@stanford.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Hyperekplexia OverviewBalintBettinaMDb.balint@ucl.ac.ukThomasRhysPhD, FRCPrhys.thomas@ncl.ac.uk\n\nSummary\n\n Hereditary Hyperekplexia: Clinical Characteristics\n\n Hereditary Hyperekplexia: Causes\n\n Hereditary Hyperekplexia: Evaluation Strategy to Identify the Genetic Cause in a Proband\n\n Hereditary Hyperekplexia: Management\n\n Hereditary Hyperekplexia: Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nHereditary Motor and Sensory Neuropathy with Agenesis of the Corpus CallosumSynonyms: Agenesis of Corpus Callosum with Peripheral Neuropathy (ACCPN), Andermann SyndromeGauvreauClaudieMD, MScNeurology resident, CHU de Québec – Enfant-JésusLaval UniversityQuebec City, Canadaclaudie.gauvreau.2@ulaval.caBrissonJean-DenisMD, FRCP(C)Neurologist, Groupe de Recherche Interdisciplinaire sur les Maladies NeuromusculairesCentre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-Saint-Jean;Sherbrooke UniversityQuebec, Canadajean-denis.brisson@usherbrooke.caDupréNicolasMD, MSc, FRCP(C)Neurologist, Neurogenetics ClinicDepartment of Neurological SciencesCHA – Enfant-JésusQuebec City, Canadanicolas.dupre@chudequebec.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Multiple OsteochondromasSynonyms: Bessel-Hagen Disease, Diaphyseal Aclasis, Hereditary Multiple Exostoses (HME), Multiple Cartilaginous Exostoses, Multiple Hereditary Exostoses (MHE)SefcikRyanMDryan.sefcik@childrenscolorado.orgEarlDawnARNPdawn.earl@seattlechildrens.orgThorpeStevenMDsteven.thorpe@childrenscolorado.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Myopathy with Early Respiratory FailureSynonyms: HMERF, MFM-Titinopathy, Myofibrillar Myopathy with Early Respiratory FailurePfefferGeraldMD, CM, FRCPC, PhDHotchkiss Brain InstituteUniversity of CalgaryCalgary, Canadagerald.pfeffer@ucalgary.caChinneryPatrick FBMedSci, MBBS, PhD, FRCPath, FRCP, FMedSciDepartment of Clinical NeurosciencesUniversity of CambridgeCambridge, United Kingdompfc25@medschl.cam.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Nephrogenic Diabetes InsipidusKnoersNineMD, PhDDepartment of GeneticsUniversity Medical Center GroningenGroningen, the Netherlandsv.v.a.m.knoers@umcg.nlLemminkHennyPhDDepartment of GeneticsUniversity Medical CenterGroningen, the Netherlandsh.h.lemmink@umcg.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Neuropathy with Liability to Pressure PalsiesSynonym: HNPPChrestianNicolasMD, FRCPC, CSCNCHU Laval–CHU de Québec;Centre de Recherche du CHUQuébec City, Québec, Canadanicolas.chrestian.1@ulaval.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Paraganglioma-Pheochromocytoma SyndromesElseTobiasMDAssociate Professor, Division of Metabolism, Endocrinology, and DiabetesDepartment of Internal MedicineUniversity of MichiganAnn Arbor, Michigantelse@med.umich.eduGreenbergSamanthaMS, MPH, CGCDirector, UT Southwestern Genetic Counseling Program;Assistant Professor, Department of Health Care SciencesUT Southwestern Medical CenterDallas, Texassamantha.greenberg@utsouthwestern.eduFishbeinLaurenMD, PhD, MTRAssociate Professor, Division of Endocrinology, Metabolism and Diabetes;Department of Medicine; Department of Biomedical InformaticsUniversity of Colorado School of MedicineAurora, Coloradolauren.fishbein@cuanschutz.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Sensory and Autonomic Neuropathy Type IISynonyms: Hereditary Sensory and Autonomic Neuropathy Type 2 (HSAN2), HSANIIKurthIngoMDInstitute of Human GeneticsUniklinik RWTH AachenAachen, Germanyikurth@ukaachen.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHereditary Transthyretin AmyloidosisSynonyms: ATTRv Amyloidosis, Familial Amyloid Polyneuropathy, Familial Transthyretin Amyloidosis, hATTR, Hereditary Amyloidogenic Transthyretin Amyloidosis, Hereditary ATTR Amyloidosis, Hereditary Transthyretin-Mediated AmyloidosisSekijimaYoshikiMD, PhDsekijima@shinshu-u.ac.jpNakamuraKatsuyaMD, PhDkatsuya@shinshu-u.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHeritable Pulmonary Arterial Hypertension OverviewGeigerHanabihanabi.u.geiger@vanderbilt.eduTinkerRory JMDrory.tinker@mssm.eduTalbertJanetMS, CGCjanet.talbert@vumc.orgPhillipsJohn AIIIMD no PhDjohn.a.phillips@vumc.orgAustinEric DMD, MSCIeric.austin@vumc.org\n\nSummary\n\n Clinical Characteristics of Heritable Pulmonary Arterial Hypertension\n\n Genetic Causes of Heritable Pulmonary Arterial Hypertension\n\n Differential Diagnosis of Heritable Pulmonary Arterial Hypertension\n\n Evaluation Strategies to Identify the Genetic Cause of Heritable Pulmonary Arterial Hypertension in a Proband\n\n Management of Heritable Pulmonary Arterial Hypertension\n\n Genetic Risk Assessment\n\nResources\n\nChapter Notes\n\nReferences\n\nHeritable Thoracic Aortic Disease OverviewMilewiczDianna MMD, PhDdianna.m.milewicz@uth.tmc.eduCecchiAlana CMS, CGCalana.c.cecchi@uth.tmc.edu\n\nSummary\n\n Clinical Characteristics of Thoracic Aortic Disease\n\n Causes of Heritable Thoracic Aortic Disease\n\n Evaluation and Genetic Risk Assessment for Heritable Thoracic Aortic Disease in a Proband\n\n Management\n\n Genetic Risk Assessment and Cascade Testing in Family Members of a Proband\n\nResources\n\nChapter Notes\n\nReferences\n\nHermansky-Pudlak SyndromeIntroneWendy JMDwintrone@nhgri.nih.govHuizingMarjanPhDmhuizing@mail.nih.govMalicdanMay Christine VMD, PhDmaychristine.malicdan@nih.govO'BrienKevin JRN, MS-CRNPobrienke@mail.nih.govGahlWilliam AMD, PhDgahlw@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">HEXA</italic> DisordersSynonyms: Beta-Hexosaminidase A Deficiency; GM2 Gangliosidosis, Type I; Tay-Sachs DiseaseToroCamiloMDtoroc@mail.nih.govShirvanLeilaBAleila.shirvan@nih.govTifftCynthiaMD, PhDcynthiat@mail.nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">HFE-</italic>Related HemochromatosisSynonym: HFE-Associated HemochromatosisBartonJames CMDUniversity of Alabama at Birmingham;Southern Iron Disorders CenterBirmingham, Alabamabartonjames336@gmail.comParkerCharles JMDDivision of Hematology and Hematologic MalignanciesUniversity of Utah School of MedicineSalt Lake City, Utahcharles.parker@hsc.utah.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHidrotic Ectodermal Dysplasia 2Synonym: Clouston SyndromeMellerioJemimaBSc, MB BS, MD, FRCPjemima.mellerio@kcl.ac.ukGreenblattDanielleMB ChB, FRCPdanielle.greenblatt@gstt.nhs.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHirschsprung Disease Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLYSynonyms: Aganglionic Megacolon, HSCRParisiMelissa AMD, PhDEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institutes of HealthBethesda, Marylandparisima@mail.nih.gov\n\nSummary\n\nDefinition\n\nCauses\n\nEvaluation Strategy\n\nGenetic Counseling\n\nResources\n\nManagement\n\nReferences\n\nChapter Notes\n\nHIST1H1E SyndromeSynonym: Rahman SyndromeBurkardtDeepikaDOburkardtdd@nih.govTatton-BrownKatrinaMDk.tattonbrown@nhs.net\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">HNRNPH2</italic>-Related Neurodevelopmental DisorderSynonyms: Bain Type Syndromic Intellectual Disability; X-Linked Syndromic Intellectual Developmental Disorder, Bain TypeMadhokSehajvirMDChild NeurologyNew York-PresbyterianColumbia University Irving Medical CenterNew York, New Yorksm5168@cumc.columbia.eduBainJenniferMD, PhDColumbia University Irving Medical CenterNew York, New Yorkjb3634@cumc.columbia.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">HNRNPU</italic>-Related Neurodevelopmental DisorderSynonyms: Developmental and Epileptic Encephalopathy 54, Early Infantile Epileptic Encephalopathy Type 54BalasubramanianMeenaMBBS, DCH, FRCPCH, MDSenior Clinical Lecturer, Department of Oncology & MetabolismUniversity of SheffieldConsultant Clinical Geneticist, Sheffield Clinical Genetics ServiceLead Consultant, OI-Genetics ServiceHighly Specialised Severe, Complex & Atypical OI ServiceSheffield Children's NHS Foundation Trustmeena.balasubramanian@nhs.netm.balasubramanian@sheffield.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHoloprosencephaly OverviewTekendo-NgongangCedrikMDcedrik.ngongang@nih.govMuenkeMaximilianMD, FACMGmmuenke@acmg.netKruszkaPaulMD, MPHpaul.kruszka@nih.gov\n\nSummary\n\n Clinical Characteristics of Holoprosencephaly\n\n Genetic Causes of Holoprosencephaly\n\n Evaluation Strategies to Identify the Genetic Cause of Holoprosencephaly in a Proband\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nHolt-Oram SyndromeSynonym: Heart-Hand SyndromeVanlerbergheClémenceMD, PhDclemence.vanlerberghe@chu-lille.frPetitFlorenceMD, PhDflorence.petit@chu-lille.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHomocystinuria due to Cystathionine Beta-Synthase DeficiencySynonym: Classic HomocystinuriaSacharowStephanie JMDstephanie.sacharow@childrens.harvard.eduLevyHarvey LMDharvey.levy@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHomocystinuria due to Deficiency of N(5,10)-Methylenetetrahydrofolate Reductase ActivitySynonym: Homocystinuria due to MTHFR DeficiencyUmairMuhammadMS, PhDMedical Genomics Research DepartmentKing Abdullah International Medical Research Center (KAIMRC)King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS)Ministry of National Guard Health Affairs (MNGHA)Riyadh, Saudi Arabiaumairmu@mngha.med.saAlfadhelMajidMD, MHSc, SSC-Ped, ABHS(CH), FCCMGGenetics and Precision Medicine DepartmentKing Abdullah Specialized Children Hospital (KASCH)King Abdulaziz Medical CityMinistry of National Guard Health Affairs (MNGHA)Riyadh, Saudi Arabiadralfadhelm@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">HOXA1</italic>-Related DisordersJacobPrinceMSc, PhDDepartment of Medical GeneticsJSS Medical College and JSS HospitalJSS Academy of Higher Education and ResearchMysuru, Indiaprincejacob@jssuni.edu.inBhatVenkatramanMDDepartment of RadiologyMazumdar Shaw Medical Centre / Narayana Hrudayalaya HospitalsBangalore, Indiabvenkatraman@gmail.comPatilSiddaramappa JMD, DMDivision of Medical GeneticsMazumdar Shaw Medical Centre / Narayana Hrudayalaya HospitalsBangalore, Indiadrsjpatil@gmail.com\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">HPRT1</italic> DisordersSynonyms: HGprt Deficiency, HPRT Deficiency, Hypoxanthine-Guanine Phosphoribosyltransferase DeficiencyJinnahHyder AMD, PhDProfessor, Departments of Neurology & Human Genetics\nEmory University School of Medicine\nAtlanta, Georgiahjinnah@emory.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">HRAS</italic>-Related Costello SyndromeGrippKaren WMD, FAAP, FACMGkgripp@nemours.orgWeaverK NicoleMD, FAAP, FACMGkathryn.weaver@cchmc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">HTRA1</italic> DisorderSynonym: CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy)OnoderaOsamuMD, PhDonodera@bri.niigata-u.ac.jpNozakiHiroakiMD, PhDnozak@bri.niigata-u.ac.jpFukutakeToshioMD, PhDfukutake.toshio@kameda.jp\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHuntington DiseaseSynonym: Huntington ChoreaCaldeira BrásInêsPhDibras@cmmt.ubc.caDawsonJessicaPhDjdawson@cmmt.ubc.caKayChrisPhDckay@cmmt.ubc.caCaronNicholas SPhDncaron@cmmt.ubc.caHaydenMichael RMB, ChB, PhD, FRCP(C), FRSCmrh@cmmt.ubc.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHuntington Disease-Like 2AndersonDavid GMBBCh, FCN, MMed, PhDConsultant NeurologistQueen Elizabeth University Hospital;Honorary Senior LecturerUniversity of GlasgowGlasgow, Scotland, United Kingdomdave.anderson.2@glasgow.ac.ukKrauseAmandaMBBCh, PhDHead, Division of Human GeneticsNational Health Laboratory Service and School of PathologyFaculty of Health SciencesUniversity of the WitwatersrandJohannesburg, South Africaamanda.krause@wits.ac.zaMargolisRussell LMDABCD Charitable Trust Professor of SchizophreniaProfessor of Psychiatry and NeurologyLaboratory of Genetic NeurobiologyDivision of NeurobiologyDepartment of PsychiatryJohns Hopkins University School of MedicineBaltimore, Marylandrmargoli@jhmi.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHuppke-Brendel SyndromeParayil SankaranBinduMD, DM, FRACP, PhDbindu.parayilsankaran@health.nsw.gov.audpsbindu@yahoo.co.inChiplunkarShwethaMBBS, PhD, MRCGPVandanaVPPhDNagappaMadhuMD, DMGovindarajPeriyasamyPhDTalyABMD, DM\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHutchinson-Gilford Progeria SyndromeGordonLeslie BMD, PhDDepartment of PediatricsAlpert Medical School of Brown UniversityProvidence, Rhode Islandlgordon@progeriaresearch.orgBrownW TedMD, PhDInstitute for Basic Research in Developmental DisabilitiesStaten Island, New Yorkwtbibr@aol.comCollinsFrancis SMD, PhDSenior Investigator, National Institutes of HealthBethesda, Marylandfrancis.collins@nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHYAL2 DeficiencySynonym: Orofacial Clefting and Cor Triatriatum Sinister SyndromeFashamJamesBSc, MBChB, PhDj.fasham@exeter.ac.ukWengerOlivia KMDowenger@newleafclinic.orgCrosbyAndrew HBSc,PhDa.h.crosby@exeter.ac.ukBapleEmma LBSc, MBBS, MRCPCH, PhDe.baple@exeter.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHyaline Fibromatosis SyndromeSynonyms: ANTXR2-Related Hyaline Fibromatosis Syndrome, Inherited Systemic HyalinosisShiehJoseph TCMD, PhDDivision of Medical GeneticsDepartment of PediatricsBenioff Children’s HospitalUniversity of California San FranciscoSan Francisco, Californiajoseph.shieh2@ucsf.eduHoymeH EugeneMDDepartment of PediatricsSanford School of MedicineUniversity of South DakotaSanford Children's HospitalSioux Falls, South DakotaArbourLaura TMDDepartment of Medical GeneticsIsland Medical ProgramUniversity of British ColumbiaVictoria, British Columbia, Canada\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHyperkalemic Periodic ParalysisSynonyms: HyperKPP, HyperPP, HYPPWeberFrankMD, PhDDepartment of NeurologyGerman Air Force Center of Aviation MedicineFürstenfeldbruck, Germanyfrankweber@bundeswehr.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHypermanganesemia with Dystonia 1Synonyms: Dystonia/Parkinsonism, Hypermanganesemia, Polycythemia, and Chronic Liver Disease; HMNDYT1TuschlKarinMDk.tuschl@ucl.ac.ukClaytonPeter TMDpeter.clayton@ucl.ac.ukGospeSidney MJrMD, PhDsgospe@uw.eduMillsPhilippa BPhDp.mills@ucl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHypermobile Ehlers-Danlos SyndromeSynonyms: Ehlers-Danlos Syndrome Hypermobility Type, Ehlers-Danlos Syndrome Type III, hEDSHakimAlanBA, MBBChir, MAThe Harley Street ClinicHCA HealthcareLondon UKalan.hakim@ehlers-danlos.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHyperornithinemia-Hyperammonemia-Homocitrullinuria SyndromeSynonym: HHH Syndrome, ORNT1 DeficiencyCamachoJoseMDLoma Linda University HealthLoma Linda, Californiajocamacho@llu.eduRioseco-CamachoNataliaBAnrioseco@hotmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHyperphosphatemic Familial Tumoral CalcinosisSynonyms: Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome (FTC/HHS), HFTC, Hyperostosis-Hyperphosphatemia Syndrome, Primary Hyperphosphatemic Tumoral CalcinosisRamnitzMary ScottMDramnitzms@nidcr.nih.govGafniRachel IMDgafnir@nidcr.nih.govCollinsMichael TMDmcollins@dir.nidcr.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nHypochondroplasiaBoberMichael BMD, PhDAlfred I duPont Hospital for ChildrenWilmington, Delawaremichael.bober@nemours.orgmikebbober@yahoo.comBellusGary AMD, PhDGeisinger Health SystemDanville, Pennsylvaniagbellus@geisinger.eduCheungMoira SMD, PhDGreat Ormond Street HospitalLondon, United Kingdommoira.cheung@gosh.nhs.ukJainMahimMD, PhDNemours Children’s HospitalWilmington, Delawaremahim.jain@nemours.orgNikkelSarah MMDBC Women’s and Children’s HospitalVancouver, Canadasarah.nikkel@cw.bc.caTillerGeorge EMD, PhDSouthern California Permanente Medical GroupLos Angeles, Californiageorge.e.tiller@kp.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHypohidrotic Ectodermal DysplasiaSynonyms: Anhidrotic Ectodermal Dysplasia, Christ-Siemens-Touraine SyndromeWrightJ TimothyDDS, MSDistinguished Bawden Professor, Department of Pediatric DentistryUniversity of North CarolinaChapel Hill, North Carolinatim_wright@unc.eduGrangeDorothy KMDProfessor of Pediatrics, Division of Genetics and Genomic MedicineDepartment of PediatricsWashington University School of MedicineSt Louis, Missourigrangedk@wustl.eduFeteMaryMSN, RN, CCMExecutive Director, National Foundation for Ectodermal DysplasiasMascoutah, Illinoismary@nfed.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHypokalemic Periodic ParalysisSynonyms: HOKPP, HypoPPWeberFrankMD, PhDDepartment of NeurologyGerman Air Force Institute of Aviation MedicineFürstenfeldbruck, Germanyfrankweber@bundeswehr.orgLehmann-HornFrankMD, PhD, MSNeurophysiologyUlm UniversityUlm, Germanyfrank.lehmann-horn@uni-ulm.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nHypomyelination and Congenital CataractWolfNicole IMD, PhDn.wolf@amsterdamumc.nlBiancheriRobertaMD, PhDZaraFedericoPhDBrunoClaudioMD, PhDGazzerroElisabettaMDRossiAndreaMDvan der KnaapMarjo SMD, PhDMinettiCarloMD\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nHypophosphatasiaDahirKathryn MMDProgram for Metabolic Bone DisordersVanderbilt University Medical CenterNashville, Tennesseekathryn.dahir@vumc.orgNunesMark EMDDirector of Genetics, Genomics, and MetabolismCure 4 the Kids FoundationLas Vegas, Nevadamnunes@cure4thekids.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nIDEDNIK SyndromeSynonyms: Intellectual Disability, Enteropathy, Deafness, Peripheral Neuropathy, Ichthyosis, and Keratoderma Syndrome; Keratitis-Ichthyosis-Deafness, Autosomal Recessive (KIDAR) Syndrome; MEDNIK Syndrome; MEDNIK-like SyndromeAlsaifHessa SMScAdvanced Diagnostics and Therapeutics InstituteHealth SectorKing Abdulaziz City for Science and Technology (KACST)Riyadh, Saudi Arabiahalsaif@kacst.gov.saAlkurayaFowzan SMDDepartment of Translational GenomicsCenter for Genomic MedicineKing Faisal Specialist Hospital and Research CenterRiyadh, Saudi ArabiaFAlKuraya@kfshrc.edu.sa\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nIMAGe SyndromeSynonym: Intrauterine Growth Restriction, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, and Genital AnomaliesSchrier VerganoSamantha AMDDivision of Medical Genetics and Metabolism\nDepartment of Pediatrics\nChildren’s Hospital of the King’s Daughters\nEastern Virginia Medical School\nNorfolk, Virginiasamantha.vergano@chkd.orgDeardorffMatthew AMD, PhDDepartments of Pathology and Pediatrics\nChildren's Hospital Los Angeles\nUniversity of Southern California\nKeck School of Medicine\nLos Angeles, Californiamdeardorff@chla.usc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nInclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal DementiaSynonyms: IBMPFD, Inclusion Body Myopathy with Early-Onset Paget Disease of Bone and/or Frontotemporal Dementia, Multisystem ProteinopathyKimonisVirginiaMDProfessor of Pediatrics, Division of Genetics and Genomic MedicineUniversity of California Irvine Medical CenterOrange, Californiavkimonis@uci.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nIncontinentia PigmentiSynonym: Bloch-Sulzberger SyndromeScheuerleAngela EMD, FAAP, FACMGDivision of Genetics and MetabolismDepartment of PediatricsUniversity of Texas Southwestern Medical CenterDallas, Texasangela.scheuerle@utsouthwestern.eduUrsiniMatilde ValeriaPhDDepartment of Molecular and Human GeneticsInstitute of Genetics and BiophysicsNational Research CouncilNaples, Italyursini@igb.cnr.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">INPPL1</italic>-Related OpsismodysplasiaHuangSamuelMDMarshfield ClinicMarshfield, Wisconsinhuang.samuel@marshfieldclinic.orgEarlDawnARNPSeattle Children's HospitalSeattle, Washingtondawn.earl@seattlechildrens.orgWhiteKlaneMDChildren's Hospital of ColoradoAurora, Coloradoklane.white@childrenscolorado.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">INSR</italic>-Related Severe Insulin Resistance SyndromeMesikaAvivavivmasika@gmail.comKlarAharonMDaklar@inter.net.ilFalik ZaccaiTzipora CMDfalikmd.genetics@gmail.com\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nIPEX SyndromeSynonym: Immunodeficiency, Polyendocrinopathy, and Enteropathy X-Linked SyndromeTanQueenie K-GMD, PhDtan.khoongheequeenie@mayo.eduLouieRaymond JPhDrlouie@ggc.orgSleasmanJohn WMDjohn.sleasman@duke.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">IRF2BPL</italic>-Related DisorderSynonyms: NEDAMSS (Neurodevelopmental Disorder With Regression, Abnormal Movements, Loss of Speech, and Seizures); IRF2BPL Mutation SyndromeVanagunasTomasMD, PhDtomas.vanagunas2@emory.eduUlm SeiwertElizabethMS, CGCelizabeth.ulm@cchmc.orgLarshTravis RMDtravis.larsh@cchmc.orgMarcogliesePaul CPhDpaul.marcogliese@umanitoba.caPenaLoren DMMD, PhDloren.pena@alumni.duke.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">IRF6</italic>-Related DisordersSchutteBrian CPhDDepartment of Microbiology and Molecular Genetics\nDepartment of Pediatrics and Human Development\nMichigan State University\nEast Lansing, Michiganschutteb@msu.eduSaalHoward MMD, FACMGDivision of Human Genetics\nCincinnati Children’s Hospital Medical Center;\nDepartment of Pediatrics\nUniversity of Cincinnati\nCincinnati, Ohiohoward.saal@cchmc.orgGoudyStevenMD, FACS, FAAPDepartment of Otolaryngology\nVanderbilt University\nNashville, Tennesseesteven.goudy@vanderbilt.eduLeslieElizabeth JPhDAssistant Professor\nDepartment of Human Genetics\nEmory University\nAtlanta, Georgiaejlesli@emory.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ISCA1</italic>-Related Multiple Mitochondrial Dysfunctions SyndromeSynonym: Multiple Mitochondrial Dysfunctions Syndrome 5ShuklaAnjuMD, DMAssociate Professor, Department of Medical Genetics\nKasturba Medical College\nManipal Academy of Higher Education\nManipal, Indiaanju.shukla@manipal.eduNarayananDhanya LakshmiMD, DMAssistant Professor, Department of Medical Genetics\nKasturba Medical College\nManipal Academy of Higher Education\nManipal, Indiadhanya.lakshmi@manipal.eduKaurParneetMScPhD Student, Department of Medical Genetics\nKasturba Medical College\nManipal Academy of Higher Education\nManipal, Indiaparneetkaurgenetics@gmail.comGirishaKatta MohanMD, DMProfessor, Department of Medical Genetics\nKasturba Medical College\nManipal Academy of Higher Education\nManipal, Indiagirish.katta@manipal.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ISCA2</italic>-Related Mitochondrial DisorderSynonym: Multiple Mitochondrial Dysfunction Syndrome 4Al-HassnanZuhair NMDzhassnan@kfshrc.edu.saKayaNamikPhDnkaya@kfshrc.edu.sa\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nIsolated and Classic Cutis Marmorata Telangiectatica CongenitaSynonym: Van Lohuizen SyndromeTamburroJoanDODepartment of DermatologyCleveland ClinicCleveland, Ohiotamburj@ccf.orgTraboulsiElias IMD, MEdProfessor of Ophthalmology, Cleveland Clinic Lerner College of MedicineCase Western Reserve UniversityCleveland, Ohiotraboue@ccf.orgPatelMillan SMD, MScClinical Professor, Department of Medical GeneticsUniversity of British ColumbiaVancouver, British Columbia, Canadampatel@cw.bc.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nIsolated Gonadotropin-Releasing Hormone (GnRH) DeficiencySynonyms: Idiopathic Hypogonadotropic Hypogonadism, Isolated Hypogonadotropic HypogonadismBalasubramanianRavikumarMD, PhDInstructor, Harvard Medical SchoolReproductive Endocrine UnitMassachusetts General HospitalBoston, Massachusettsrbalasubramanian@partners.orgCrowleyWilliam FJrMDProfessor of Medicine, Harvard Medical SchoolChief, Reproductive Endocrine Unit of the Department of MedicineMassachusetts General HospitalBoston, Massachusettswcrowley@partners.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nIsolated Methylmalonic AcidemiaSynonym: Isolated Methylmalonic AciduriaManoliIriniMD, PhDmanolii@mail.nih.govSloanJennifer LPhDjsloan@mail.nih.govVendittiCharles PMD, PhDvenditti@mail.nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nIsolated Sulfite Oxidase DeficiencySynonym: SulfocysteinuriaSankaranBindu ParayilMD, DMdrpsbindu@yahoo.co.inNagappaMadhuMD, DMmadhu_nagappa@yahoo.co.inBharathRose DawnDMdrrosedawn@yahoo.comTalyArun BMD, DMabtaly@yahoo.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nJervell and Lange-Nielsen SyndromeSynonym: JLNSTranebjærgLisbethMD, PhDlisbeth.tranebjaerg@regionh.dktranebjaerg@sund.ku.dkSamsonRicardo AMDrsamson@childrensheartcenter.comGreenGlenn EdwardMDgegreen@med.umich.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nJoubert SyndromeSynonyms: JBTS, Joubert Syndrome and Related Disorders (JSRD)GlassIan AMB ChB, MDDivision of Genetic MedicineSeattle Children's HospitalUniversity of WashingtonSeattle, Washingtonianglass@uw.eduDempseyJennifer CMPHDivision of Genetic Medicine University of Washington Seattle, Washingtondempseyj@uw.eduParisiMelissaMD, PhDEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institutes of HealthBethesda, Marylandparisima@mail.nih.govDohertyDanMD, PhDDivisions of Developmental Medicine and Genetic MedicineSeattle Children's HospitalUniversity of WashingtonSeattle, Washingtonddoher@uw.edu\n\nSummary\n\n Clinical Characteristics of Joubert Syndrome\n\n Genetic Causes of Joubert Syndrome\n\n Evaluation Strategies to Identify the Genetic Cause of Joubert Syndrome in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nJunctional Epidermolysis BullosaPfendnerEllen GPhDDirector, EBDx Program\nGeneDx, Inc\nGaithersburg, Marylandellen@genedx.comLuckyAnne WMDDirector, Cincinnati Children's Epidermolysis Bullosa Center\nCincinnati Children's Hospital\nCincinnati, Ohioanne.lucky@cchmc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nJuvenile Polyposis SyndromeLarsen HaidleJoyMS, CGCNorth Memorial Health Cancer CenterRobbinsdale, Minnesotajoy.larsen.haidle@northmemorial.comMacFarlandSuzanne PMDDepartment of PediatricsDivision of OncologyChildren's Hospital of Philadelphia;University of PennsylvaniaPhiladelphia, Pennsylvaniamacfarlands@chop.eduHoweJames RMDDepartment of SurgeryUniversity of Iowa Hospitals and ClinicsIowa City, Iowajames-howe@uiowa.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nKabuki SyndromeSynonyms: Kabuki Make-Up Syndrome, Niikawa-Kuroki SyndromeAdamMargaret PMD, MS, FAAP, FACMGDepartment of PediatricsUniversity of WashingtonSeattle, Washingtonmargaret.adam@seattlechildrens.orgHannibalMarkMD, PhDDivision of GeneticsDepartment of Pediatrics and Communicable DiseasesUniversity of Michigan Medical SchoolAnn Arbor, Michiganhannibal@umich.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders<!-- {\\*\\bkmkstart_Differential_Diagnosis} -->\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nKagami-Ogata SyndromeSynonym: KOS14OgataTsutomuMD, PhDDepartment of PediatricsHamamatsu University School of MedicineHamamatsu, Japantomogata@hama-med.ac.jpKagamiMasayoMD, PhDDepartment of Molecular EndocrinologyNational Research Institute for Child Health and DevelopmentTokyo, Japankagami-ms@ncchd.go.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KAT6B</italic> DisordersLemireGabrielleMD, FRCPCg.lemire-therien@umontreal.caCampeauPhilippe MMD, FRCPCp.campeau@umontreal.caLeeBrendan HMD, PhDblee@bcm.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nKaufman Oculocerebrofacial SyndromeSynonym: Blepharophimosis-Ptosis-Intellectual Disability (BPID) SyndromeBrabbing-GoldsteinDanaMDdanabr2@clalit.org.ilBasel-SalmonLinaMD, PhDbasel@tauex.tau.ac.il\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KCNC1-</italic>Related DisordersGinnNatalieMGC, CGCginnn@chop.eduGoldbergEthan MMD, PhDgoldberge@chop.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KCNK9</italic> Imprinting SyndromeSynonym: Birk-Barel SyndromeZadehNedaMDDivision of Medical GeneticsCHOC Children’s HospitalGenetics CenterOrange, Californianzadeh@choc.orgDeardorffMatthewMD, PhDPathology and Laboratory MedicineKeck School of MedicineUniversity of Southern CaliforniaLos Angeles, Californiamdeardorff@chla.usc.eduCousinMargotPhDMayo ClinicRochester, Minnesotacousin.margot@mayo.eduGrahamJohn MJrMD, ScDDepartment of PediatricsHarbor-UCLA Medical CenterCedars-Sinai Medical CenterTorrance, CaliforniaEmeritus Professor of Pediatrics, David Geffen School of Medicine at UCLALos Angeles, Californiajohn.graham@cshs.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KCNQ2</italic>-Related DisordersMiceliFrancescoPhDfrmiceli@unina.itSoldovieriMaria VirginiaPhDmariavirginia.soldovieri@unimol.itWeckhuysenSarahMD, PhDsarah.weckhuysen@uantwerpen.beCooperEdwardMD, PhDecc1@bcm.eduTaglialatelaMaurizioMD, PhDmaurizio.taglialatela@unina.it\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KCNQ3</italic>-Related DisordersMiceliFrancescoPhDDivision of PharmacologyDepartment of NeuroscienceUniversity of Naples Federico IINaples, Italyfrmiceli@unina.itSoldovieriMaria VirginiaPhDDepartment of Health ScienceUniversity of MoliseCampobasso, Italymariavirginia.soldovieri@unimol.itWeckhuysenSarahMD, PhDApplied & Translational Neurogenomics GroupVIB Center for Molecular NeurologyUniversity of Antwerp;Neurology DepartmentUniversity HospitalAntwerp, Belgiumsarah.weckhuysen@uantwerpen.vib.beCooperEdward CMD, PhDDepartments of Neurology, Neuroscience, and Molecular and Human GeneticsBaylor College of MedicineHouston, Texasecc1@bcm.eduTaglialatelaMaurizioMD, PhDDivision of PharmacologyDepartment of NeuroscienceUniversity of Naples Federico IINaples, Italymtaglial@unina.it\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KCNT1</italic>-Related EpilepsyGertlerTracyMD, PhDDepartment of PediatricsAnn and Robert H Lurie Children's Hospital of ChicagoChicago, IllinoisBeardenDavidMD, MSCEDepartment of NeurologyDivision of Child NeurologyUniversity of Rochester School of MedicineRochester, New YorkBhattacharjeeArinPhDDepartment of PharmacologyUniversity of BuffaloBuffalo, New YorkCarvillGemmaPhDDepartment of NeurologyFeinberg School of MedicineNorthwestern UniversityChicago, Illinois\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KCTD7</italic>-Related Progressive Myoclonic EpilepsySynonym: Epilepsy, Progressive Myoclonic 3, With or Without Intracellular Inclusions (EPM3)YoganathanSangeethaMD, DMPediatric Neurology UnitDepartment of Neurological SciencesChristian Medical CollegeVellore, Tamil Nadu, Indiadoc_ys@yahoo.co.inJainPuneetMD, DMStaff Physician, Division of NeurologyHospital for Sick Children;Department of Pediatrics, University of TorontoToronto, Ontario, Canadapuneet.jain@sickkids.caCostainGregoryMD, PhD, FRCPCDivision of Clinical & Metabolic GeneticsHospital for Sick Children;Department of PediatricsUniversity of TorontoToronto, Ontario, Canadagregory.costain@sickkids.caWhitneyRobynMD, FRCPC, CSCN (EEG)Division of NeurologyDepartment of PediatricsMcMaster UniversityHamilton, Ontario, Canadawhitner@mcmaster.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KIF1A</italic>-Related Neurodevelopmental DisorderSynonyms: Complex KAND, Neurodegeneration and Spasticity With or Without Cerebellar Atrophy or Cortical Visual Impairment (NESCAV) SyndromeChungWendyMD, PhD, FACMGChief, Department of PediatricsBoston Children's Hospital;Mary Ellen Avery Professor of PediatricsHarvard Medical SchoolBoston, Massachusettswendy.chung@childrens.harvard.eduBoyleLiaMD, PhDResident, Department of Pediatrics and Medical GeneticsUniversity of MichiganAnn Arbor, Michiganliabo@med.umich.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nKindler SyndromeSynonym: Congenital Bullous PoikilodermaYoussefianLeilaPhDleila.youssefian@jefferson.eduVahidnezhadHassanPhDhassan.vahidnezhad@jefferson.eduUittoJouniMD, PhDjouni.uitto@jefferson.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nKleefstra SyndromeSynonyms: 9q34.3 Microdeletion Syndrome, 9qSTDS, 9q Subtelomeric Deletion SyndromeKleefstraTjitskeMD, PhDtjitske.kleefstra@radboudumc.nlde LeeuwNicolePhDnicole.deleeuw@radboudumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KMT2B</italic>-Related DisordersAbelaLuciaMD, PhDDepartment of Child NeurologyUniversity Children's Hospital ZurichZurich, Switzerlandlucia.abela@kispi.uzh.chKurianManju AnnMA, MBBChir, PhDDevelopmental Neurosciences ProgrammeUCL-Institute of Child HealthLondon, United Kingdommanju.kurian@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KMT2E</italic>-Related Neurodevelopmental DisorderSynonym: O'Donnell-Luria-Rodan Syndrome (ODLURO)PaisLynnMSc, MS, CGClynn.pais@childrens.harvard.eduRodanLanceMDlance.rodan@childrens.harvard.eduO'Donnell-LuriaAnneMD, PhDanne.odonnell@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nKoolen-de Vries SyndromeSynonym: KdVSKoolenDavid AMD, PhDdavid.koolen@radboudumc.nlMorganAngelaProf, PhDangela.morgan@mcri.edu.aude VriesBert BAMD, PhDbert.devries@radboudumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">KPTN</italic>-Related DisorderSynonym: Macrocephaly, Autistic Features, Seizures, Developmental Delay (MASD) SyndromeRawlinsLettie EBSc, MBChB, MRCP, PhDl.rawlins@exeter.ac.ukCrinoPeter BBA, MD, PhDpcrino@som.umaryland.eduIfflandPhilip HBA, MA, PhDpiffland@som.umaryland.eduCrosbyAndrew HBSc, PhDa.h.crosby@exeter.ac.ukBapleEmma LBSc, MBBS, MRCPCH, PhDe.baple@exeter.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nKrabbe DiseaseSynonyms: Galactocerebrosidase Deficiency, GALC Deficiency, Globoid Cell LeukodystrophyOrsiniJoseph JPhDjoseph.orsini@health.ny.govEscolarMaria LMD, MSmaria.escolar@chp.eduWassersteinMelissa PMDmwassers@montefiore.orgCagganaMicheleScDmichele.caggana@health.ny.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nL1 SyndromeSynonym: L1 DiseaseStumpelConnieMD, PhDDepartment of Clinical Genetics\nAcademic Hospital Maastricht and School for Oncology & Developmental Biology (GROW);\nMaastricht University and University Hospital Maastricht (MUMC+)\nMaastricht, the Netherlandsc.stumpel@mumc.nlVosYvonne JPhDDepartment of Genetics\nUniversity Medical Center Groningen\nGroningen, the Netherlandsy.j.vos@umcg.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLaing Distal MyopathySynonym: Laing Early-Onset Distal MyopathyLamontPhillipaMBBS, PhDProfessor, Department of Neurology\nRoyal Perth Hospital\nPerth, Western Australiaphillipa.lamont@health.wa.gov.auLaingNigel GPhDProfessor, NH & MRC Principal Research Fellow, Harry Perkins Institute for Medical Research\nUniversity of Western Australia\nNedlands, Western Australianigel.laing@perkins.uwa.edu.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">LAMA2</italic> Muscular DystrophySynonym: Laminin α2 Chain-DeficiencyOliveiraJorgeMSc, PhDjmoliveira@ibmc.up.ptParente FreixoJoãoMDjoao.freixo@ibmc.up.ptSantosManuelaMDmanuela.a.santos@gmail.comCoelhoTeresaMD, PhDtcoelho@netcabo.pt\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nLathosterolosisSynonyms: Sterol C-5 Desaturase Deficiency, Sterol-C5-Desaturase Deficiency, SC5D DeficiencyPrasunPankajMDdrpankajprasun@gmail.comGaneshJayaMDjaya.ganesh@mssm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLeber Hereditary Optic NeuropathySynonyms: Leber's Disease, Leber's Hereditary Optic Neuropathy, Leber's Optic Atrophy, Leber's Optic Neuropathy, LHONYu-Wai-ManPatrickBMedSci, MBBS, PhD, FRCPath, FRCOphthpy237@cam.ac.ukChinneryPatrick FBMedSci, MBBS, PhD, FRCPath, FRCP, FMedScipfc25@cam.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLegius SyndromeSynonym: Neurofibromatosis Type 1-Like SyndromeStevensonDavidMDStanford UniversityStanford, Californiadasteven@stanford.eduLegiusEricMD, PhDUniversity of LeuvenLeuven, Belgiumeric.legius@uzleuven.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLeukodystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLYVanderverAdelineMDChildren's Hospital of PhiladelphiaPhiladelphia, Pennsylvaniavandervera@email.chop.eduTondutiDavideMDDepartment of Child Neurology and Psychiatry, IRCCS CMondino Institute of Neurology FoundationPavia, Italydavidetondu@hotmail.comSchiffmannRaphaelMDInstitute of Metabolic DiseaseBaylor Research InstituteDallas, Texasp15099@baylorhealth.eduSchmidtJohannaMPH, MGC, CGCDepartment of Neurology & Center for Genetic Medicine ResearchChildren's National Medical CenterWashington, DCjloewens@childrensnational.orgvan der KnaapMarjo SMD, PhDDepartment of Child NeurologyVrije Universiteit Medical CenterAmsterdam, Netherlandsms.vanderknaap@vumc.nl\n\nSummary\n\nDefinition of Leukodystrophy\n\nClinical Manifestations of Leukodystrophies\n\nPrevalence of Leukodystrophies\n\nDifferential Diagnosis of Leukodystrophies\n\nEvaluation Strategy for an Individual with a Leukodystrophy\n\nGenetic Counseling\n\nResources\n\nManagement\n\nReferences\n\nChapter Notes\n\nLeukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate ElevationSynonyms: LBSL, Mitochondrial Aspartyl-tRNA Synthetase DeficiencyEngelenMarcMD, PhDm.engelen@amsterdamumc.nlAbbinkTruus EMPhDg.abbink@amsterdamumc.nlSalomonsGajja SPhDg.salomons@amsterdamumc.nlvan der KnaapMarjo SMD, PhDms.vanderknaap@amsterdamumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLi-Fraumeni SyndromeSchneiderKatherineMPHkatherine_schneider@dfci.harvard.eduZelleyKristinMS, LGCzelleyk@chop.eduNicholsKim EMDkim.nichols@stjude.orgSchwartz LevineAlisonMS, CGCalison_schwartz@dfci.harvard.eduGarberJudyMD, MPHjudy_garber@dfci.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLimb-Girdle Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLYSynonym: LGMDPegoraroElenaMD, PhDDepartment of NeurosciencesUniversity of PadovaPadova, Italyelena.pegoraro@unipd.itHoffmanEric PPhDResearch Center for Genetic MedicineChildren's National Medical CenterWashington, DCehoffman@childrens-research.org\n\nSummary\n\nDefinition\n\nCauses\n\nEvaluation Strategy\n\nGenetic Counseling\n\nResources\n\nManagement\n\nReferences\n\nChapter Notes\n\nLipoid ProteinosisSynonyms: Hyalinosis Cutis et Mucosae, Urbach-Wiethe DiseaseVahidnezhadHassanPhDhassan_vahidnezhad@yahoo.comYoussefianLeilaPhDleila.youssefian@jefferson.eduUittoJouniMD, PhDjouni.uitto@jefferson.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">LMNA</italic>-Related Dilated CardiomyopathyHershbergerRay EMDProfessor of Medicine, Divisions of Human Genetics and Cardiovascular Medicine\nThe Ohio State University\nColumbus, Ohioray.hershberger@osumc.eduJordanElizabethMMSc, CGCAssistant Professor, Division of Human Genetics\nThe Ohio State University\nColumbus, Ohioelizabeth.jordan@osumc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">LMNB1</italic>-Related Autosomal Dominant LeukodystrophySynonyms: Adult-Onset Autosomal Dominant Leukodystrophy with Autonomic Symptoms, Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy, Autosomal Dominant Leukodystrophy with Autonomic Symptoms, LMNB1-Related ADLDRaininkoRailiMD, PhDraili.raininko@radiol.uu.seGoskyMichaelBS, MSmdg75@pitt.eduPadiathQuasar SMBBS, PhDqpadiath@pitt.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLoeys-Dietz SyndromeSynonym: Loeys-Dietz Aortic Aneurysm SyndromeLoeysBart LMD, PhDCenter of Medical GeneticsAntwerp University HospitalAntwerp, Belgiumbart.loeys@uantwerp.beDietzHarry CMDVictor A McKusick Professor of Medicine and GeneticsDepartment of Genetic MedicineDepartments of Pediatrics, Medicine, and Molecular Biology and GeneticsJohns Hopkins University School of MedicineBaltimore, Marylandhdietz@jhmi.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLong-Chain Hydroxyacyl-CoA Dehydrogenase Deficiency / Trifunctional Protein DeficiencyPrasunPankajMDpankaj.prasun@mssm.eduLoPiccoloMary KateMDmary.lopiccolo@mssm.eduGinevicIlonaRDIlona.ginevic@mssm.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLong QT Syndrome OverviewGroffenAlexander JPhDa.groffen@amsterdamumc.nlBikkerHenniePhDh.bikker@amsterdamumc.nlChristiaansImkePhD, MDi.christiaans@umcg.nl\n\nSummary\n\n Clinical Characteristics of Long QT Syndrome\n\n Genetic Causes of Long QT Syndrome\n\n Differential Diagnosis of Long QT Syndrome\n\n Evaluation Strategies to Identify the Genetic Cause of Long QT Syndrome in a Proband\n\n Management\n\n Genetic Risk Assessment and Evaluations of At-Risk Relatives for Early Detection and Treatment of Long QT Syndrome\n\nResources\n\nChapter Notes\n\nReferences\n\nLowe SyndromeSynonyms: Oculocerebrorenal Syndrome, Oculocerebrorenal Syndrome of LoweLewisRichard AlanMD, MSProfessor, Departments of Molecular and Human Genetics, Ophthalmology, Medicine, and Pediatrics\nBaylor College of Medicine\nHouston, Texasrlewis@bcm.eduNussbaumRobert LMDChief Medical Officer, Invitae Corporation\nSan Francisco, Californiarobert.nussbaum@invitae.comBrewerEileen DMDProfessor, Pediatric Renal Section\nBaylor College of Medicine\nMedical Director, Renal Transplantation\nTexas Children's Hospital\nHouston, Texasebrewer@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">LPIN2</italic>-Related Majeed SyndromeNarayananDhanya LakshmiMD, DMdhanya.lakshmi@manipal.eduGogineniKishore SaiMSckishoresai88@gmail.comBadigerVaishnavi AshokMScbadigervaishnavi2@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">LRRK2-</italic>Related Parkinson DiseaseSynonym: PARK-LRRK2WiseAdinaMDadina.wise@mountsinai.orgRaymondDeborahMSdeborah.raymond@mountsinai.orgSaunders-PullmanRachelMD, MPHrachel.saunders-pullman@mountsinai.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">LTBP4</italic>-Related Cutis LaxaSynonyms: Autosomal Recessive Cutis Laxa Type 1C (ARCL1C), Urban-Rifkin-Davis Syndrome (URDS)CallewaertBert LMD, PhDCenter for Medical GeneticsGhent University HospitalGhent, Belgiumbert.callewaert@ugent.beUrbanZsoltPhDDepartment of Human GeneticsUniversity of Pittsburgh Graduate School of Public HealthPittsburgh, Pennsylvaniaurbanz@pitt.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLymphedema-Distichiasis SyndromeMansourSaharFRCPConsultant Geneticist, SW Thames Regional Genetics DepartmentSt George's, University of LondonLondon, United Kingdomsmansour@sgul.ac.ukBriceGlen WRGN, BSc (Hons)SW Thames Regional Genetics DepartmentSt George's, University of LondonLondon, United Kingdomgbrice@sgul.ac.ukJefferyStevePhDDivision of Medical GeneticsSt George's, University of LondonLondon, United Kingdomsggt100@sgul.ac.ukMortimerPeterMD, FRCPDepartment of Cardiac and Vascular Sciences (Dermatology)St George's, University of LondonLondon, United Kingdommortimer@sgul.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nLynch SyndromeIdosGregoryMD, MSgidos@coh.orgValleLauraPhDlvalle@idibell.cat\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLysinuric Protein IntoleranceNunesVirginiaPhDProfessor of Genetics, Genetics UnitPhysiological SciencesFaculty of Medicine – Bellvitge CampusUniversity of BarcelonaSenior Investigator, Molecular Genetics LaboratoryInstituto de Investigación Biomédica de BellvitgeCoordinator of the Genes Disease and Therapy Program at IDIBELLChief, Centro de Investigación Biomédica en Red de Enfermedades Raras U730Barcelona, Spainvnunes@ub.eduvnunes@idibell.catNiinikoskiHarriMD, PhDProfessor of Nutrition in MedicineUniversity of TurkuPediatric EndocrinologistTurku University HospitalTurku, Finlandharri.niinikoski@tyks.fi\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nLysosomal Acid Lipase DeficiencySynonyms: Acid Lipase Deficiency, LAL Deficiency (LAL-D)BalwaniManishaMD, MSIcahn School of Medicine at Mount SinaiNew York, New Yorkmanisha.balwani@mssm.eduVijaySureshFRCPCHBirmingham Children's HospitalNHS Foundation TrustBirmingham, United Kingdomsuresh.vijay1@nhs.net\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">LZTR1</italic>- and <italic toggle=\"yes\">SMARCB1</italic>-Related SchwannomatosisDhamijaRadhikaMDDepartment of Clinical Genomics and NeurologyMayo ClinicRochester, Minnesotadhamija.radhika@mayo.eduPlotkinScottMD, PhDDepartment of NeurologyHarvard Medical School;Massachusetts General HospitalBoston, Massachusettssplotkin@mgh.harvard.eduGomesAliciaMS, LCGCDepartment of Clinical and Diagnostics SciencesUniversity of Alabama at BirminghamBirmingham, Alabamaagomes@uabmc.eduBabovic-VuksanovicDusicaMDDepartment of Clinical GenomicsMayo ClinicRochester, Minnesotadbabovic@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMandibulofacial Dysostosis with MicrocephalySynonym: Mandibulofacial Dysostosis, Guion-Almeida Type (MFDGA), EFTUD2-Related Mandibulofacial Dysostosis with Microcephaly (Guion-Almeida Type)LinesMatthewMDmatthew.lines@albertahealthservices.caHartleyTailaMScthartley@cheo.on.caMacDonaldStella KBScsmacdonald@cheo.on.caBoycottKym MPhD, MDkboycott@cheo.on.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMaple Syrup Urine DiseaseSynonyms: BCKD Deficiency, Branched-Chain Ketoacid Dehydrogenase Deficiency, Maple Syrup Disease, MSUDStraussKevin AMDkstrauss@clinicforspecialchildren.orgPuffenbergerErik GPhDepuffenberger@clinicforspecialchildren.orgCarsonVincent JMDvcarson@clinicforspecialchildren.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MAPT-</italic>Related Frontotemporal DementiaRohrerJonathanFRCP, PhDProfessor of Neurology, UCL Queen Square Institute of NeurologyLondon, United Kingdomj.rohrer@ucl.ac.ukRyanBrigidPhDResearch Fellow, Centre for Brain Research and Department of Anatomy and Medical ImagingUniversity of AucklandAuckland, New Zealandb.ryan@auckland.ac.nzAhmedRebekahFRACP, PhDClinical Associate Professor and NHMRC Early Career Fellow, Sydney Medical SchoolUniversity of SydneySydney, Australiarebekah.ahmed@sydney.edu.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMarinesco-Sjögren SyndromeAnttonenAnna-KaisaMD, PhDMedical and Clinical GeneticsUniversity of Helsinki and Helsinki University HospitalHelsinki, Finlandanna-kaisa.anttonen@hus.fi\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMaternal 15q Duplication SyndromeLuskLainaMMSc, CGCChildren’s Hospital of PhiladelphiaPhiladelphia, Pennsylvanialuskl@email.chop.eduVogel-FarleyVanessaBADup15q AllianceHighland Park, Illinoisvanessa.vogelfarley@dup15q.orgDiStefanoCharlottePhDUniversity of California Los AngelesLos Angeles, Californiacdistefano@mednet.ucla.eduJesteShafaliMDChief of NeurologyChildren's Hospital Los AngelesLos Angeles, Californiasjeste@chla.usc.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMaternal Effect Gene-Related Multilocus Imprinting DisturbancesTümerZeynepMD, PhD, DMSczeynep.tumer@regionh.dkEggermannThomasPhDteggermann@ukaachen.deMaasSaskiaMDs.m.maas@amsterdamumc.nlBliekJetPhDj.bliek@amc.uva.nlMackayDeborahPhDdjgm@soton.ac.uk\n\nSummary\n\n Genomic Imprinting\n\n Review of Imprinting Disorders in Which Multilocus Imprinting Disturbances Have Been Observed\n\n Genes of Interest in Maternal Effect Gene-Related Multilocus Imprinting Disturbances\n\n\n<!-- {\\*\\bkmkstart_Hlk156998694} -->Evaluation Strategies to Identify the Genetic Cause of Maternal Effect Gene-Related Multilocus Imprinting Disturbances in a Family\n\n Genetic Counseling\n\nChapter Notes\n\nReferences\n\nMaturity-Onset Diabetes of the Young OverviewSynonym: MODY OverviewNaylorRochelleMDrnaylor@bsd.uchicago.eduKnight JohnsonAmyMS, CGCaknightjohnson@bsd.uchicago.edudel GaudioDanielaPhDddelgaudio@bsd.uchicago.edu\n\nSummary\n\n Clinical Characteristics of MODY\n\n Genetic Causes of MODY\n\n Evaluation Strategy to Identify the Genetic Cause of MODY in a Proband\n\n Management of MODY Based on Genetic Cause\n\n Risk Assessment and Surveillance of At-Risk Relatives for Early Detection and Treatment of MODY\n\nResources\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MBD5</italic> HaploinsufficiencySynonym: 2q23.1 Microdeletion SyndromeMullegamaSureni VPhDsvm013@shsu.eduMendoza-LondonoRobertoMDroberto.mendoza@sickkids.caElseaSarah HPhDelsea@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MBTPS1</italic>-Related Spondyloepimetaphyseal Dysplasia with Elevated Lysosomal EnzymesSynonym: Spondyloepiphyseal Dysplasia, Kondo-Fu Type (SEDKF)WangHuaMD, PhDSchool of MedicineLoma Linda UniversityLoma Linda, Californiahuawang@llu.eduWierengaAndreaPhDSIVOTEC BioinformaticsBoca Raton, Floridaawierenga@gena.techPrabhuSandeepMDDepartment of RadiologyUniversity of OklahomaOklahoma City, Oklahomasandeep-prabhu@ouhsc.eduWierengaKlaasMDDepartment of Clinical GenomicsMayo Clinic FloridaJacksonville, Floridawierenga.klaas@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMcKusick-Kaufman SyndromeSlavotinekAnne MMB, BS, PhDDepartment of PediatricsUniversity of California, San FranciscoSan Francisco, Californiaanne.slavotinek@ucsf.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMcLeod Neuroacanthocytosis SyndromeJungHans HMDDepartment of Neurology\nUniversity Hospital Zurich\nZurich, Switzerlandhans.jung@usz.chDanekAdrianMDDepartment of Neurology\nUniversity Hospital LMU Munich\nMunich, Germanydanek@lmu.deWalkerRuth HMD,ChB, PhDDepartment of Neurology\nVeterans Affairs Medical Center\nBronx, New Yorkruth.walker@mssm.eduFreyBeat MMDBlood Transfusion Service\nSwiss Red Cross\nSchlieren/Zürich, Switzerlandbm.frey@zhbsd.chPeikertKevinMDTranslational Neurodegeneration Section \"Albrecht-Kossel\"\nDepartment of Neurology\nUniversity Medical Center Rostock\nRostock, Germanykevin.peikert@med.uni-rostock.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MCM8</italic>/<italic toggle=\"yes\">MCM9</italic>-Related SyndromesSynonyms: MCM8 Deficiency Syndrome, MCM9 Deficiency SyndromeHeldermanNoah CMD, PhDn.c.helderman@lumc.nlBen YahiaSalwaMDs.ben_yahia@lumc.nlRajkovicAleksandarMD, PhDaleks.rajkovic@ucsf.eduGoldbergYaelMDyaelgo43@gmail.comNielsenMaartjeMD, PhDm.nielsen@lumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MECP2</italic> DisordersKaurSimranpreetMSc, M PhilBrain and Mitochondrial Research GroupMurdoch Children’s Research Institute;Department of PaediatricsUniversity of MelbourneParkville, Victoria, Australiasimran.kaur@mcri.edu.auChristodoulouJohnMBBS, PhD, FRACP, FFSc, FRCPA, FAHMSProfessor, Pediatrics and Biochemical, Molecular, and Human GeneticsTheme Director, Genetics ResearchMurdoch Children’s Research Institute;Chair of Genomic Medicine, Department of PediatricsUniversity of MelbourneMelbourne, Victoria, Australiajohn.christodoulou@mcri.edu.au\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MECP2</italic> Duplication SyndromeVan EschHildeMD, PhDCenter for Human GeneticsUniversity Hospitals LeuvenLeuven, Belgiumhilde.vanesch@uzleuven.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MECR</italic>-Related Neurologic DisorderSynonym: Mitochondrial Enoyl CoA Reductase Protein-Associated Neurodegeneration (MEPAN)HeimerGaliMD, PhDgalih.md@gmail.comGregoryAllisonMSgregorya@ohsu.eduHogarthPenelopeMDhogarthp@ohsu.eduHayflickSusanMDhayflick@ohsu.eduBen ZeevBruriaMD, Profbruria.benzeev@sheba.health.gov.il\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MED12</italic>-Related DisordersLyonsMichael JMD, FAAP, FACMGAssociate Clinical Geneticist, Greenwood Genetic CenterCharleston, South Carolinamlyons@ggc.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MED13L</italic> SyndromeSynonyms: MED13L Haploinsufficiency Syndrome, MED13L-Related Intellectual DisabilityCampbellAlicia NicolePhDcampbe26@rowan.eduBainJenniferMD, PhDJb3634@cumc.columbia.eduDoyleSteven JamesPhD, DOdoyles5@rowan.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMedium-Chain Acyl-Coenzyme A Dehydrogenase DeficiencySynonym: MCAD DeficiencyChangIrene JMD, MScAssistant ProfessorUniversity of California at San FranciscoSan Francisco, Californiairene.chang@ucsf.eduLamChristinaMDAssociate ProfessorUniversity of Washington;Seattle Children's HospitalSeattle, Washingtonchristina.lam@seattlechildrens.orgVockleyJerryMD, PhDProfessorUniversity of PittsburghPittsburgh, Pennsylvaniavockleyg@upmc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MEF2C</italic>-Related DisorderSynonyms: MEF2C Deficiency; MEF2C Haploinsufficiency Syndrome (MCHS); MEF2C-Related Neurodevelopmental Disorder; MEF2C-Related Syndrome; Neurodevelopmental Disorder with Hypotonia, Stereotypic Hand Movements, and Impaired Language (NEDHSIL)Cooley ColemanJessicaPhDjcoleman@ggc.orgSkinnerSteven AMDsas@ggc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMegacystis-Microcolon-Intestinal Hypoperistalsis Syndrome OverviewSynonyms: Berdon Syndrome, MMHSAmbartsumyanLusineMDSeattle Children's HospitalSeattle, Washingtonlusine.ambartsumyan@seattlechildrens.org\n\nSummary\n\n Clinical Characteristics of Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome\n\n Genetic Causes of Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome\n\n Evaluation Strategy to Identify the Genetic Cause of Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome\n\n Management of Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome\n\n Genetic Counseling of Family Members of an Individual with Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome\n\nResources\n\nChapter Notes\n\nReferences\n\nMegalencephalic Leukoencephalopathy with Subcortical CystsSynonym: Van der Knaap DiseaseMinRogierPhDr.min@amsterdamumc.nlAbbinkTruus EMPhDg.abbink@amsterdamumc.nlvan der KnaapMarjo SMD, PhDms.vanderknaap@amsterdamumc.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMELASEl-HattabAyman WMD, FAAP, FACMGelhattabaw@yahoo.comAlmannaiMohammedMD, FAAP, FACMGmalmannai@kfmc.med.saScagliaFernandoMD, FAAP, FACMGfscaglia@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMERRFSynonym: Myoclonic Epilepsy Associated with Ragged Red FibersVelez-BartolomeiFrancesMDfvelez@stanford.eduLeeChungMDchunglee@stanford.eduEnnsGregoryMB, ChBgenns@stanford.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MFN2</italic> Hereditary Motor and Sensory NeuropathySynonyms: MFN2 Charcot-Marie-Tooth Neuropathy, MFN2-HMSNZüchnerStephanMD, PhDDepartment of Human GeneticsUniversity of Miami Miller School of MedicineMiami, Floridaszuchner@med.miami.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMicrocephalic Osteodysplastic Primordial Dwarfism Type IISynonyms: Majewski Osteodysplastic Primordial Dwarfism Type II, MOPDII, PCNT-Related Microcephalic Osteodysplastic Primordial DwarfismDukerAngelaMSNemours Children's HealthWilmington, Delawareaduker@nemours.orgJacksonAndrewMBBS, PhDMRC Institute of Genetics and CancerUniversity of EdinburghEdinburgh, United Kingdomandrew.jackson@ed.ac.ukBoberMichael BMD, PhDNemours Children’s HealthWilmington, Delawarembober@nemours.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMicrocephaly-Capillary Malformation SyndromeSynonym: MIC-CAP SyndromeCarterMelissa TMSc, MD, FRCPCmcarter@cheo.on.caMirzaaGhaydaMD, FAAP, FACMGghayda.mirzaa@seattlechildrens.orgMcDonellLaura MMD, PhDlaura.mcdonell@nshealth.caBoycottKym MPhD, MD, FRCPC, FCCMGkboycott@cheo.on.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMicrophthalmia/Anophthalmia/Coloboma Spectrum – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLYBardakjianTanyaMS, LCGCGeneDxGaithersburg, MarylandWeissAveryMDDepartment of OphthalmologyChildren's Hospital and Regional Medical CenterSeattle, WashingtonSchneiderAdeleMD, FACMGDepartment of GeneticsEinstein Medical CenterPhiladelphia, Pennsylvania\n\nSummary\n\nDefinition\n\nCauses\n\nEvaluation Strategy\n\nGenetic Counseling\n\nResources\n\nManagement\n\nReferences\n\nChapter Notes\n\nMicrophthalmia with Linear Skin Defects SyndromeSynonyms: Microphthalmia, Dermal Aplasia, and Sclerocornea (MIDAS) Syndrome; MLS SyndromeMorleoManuelaPhDmorleo@tigem.itFrancoBrunellaMDfranco@tigem.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">MID1</italic>-Related Opitz G/BBB SyndromeSynonyms: X-Linked Opitz Syndrome (XLOS), X-Linked Opitz G/BBB SyndromeMeroniGermanaPhDDepartment of Life SciencesUniversity of TriesteTrieste, Italygmeroni@units.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMilroy DiseaseSynonym: Hereditary Lymphedema Type IVan ZantenMalouPhDSenior Clinical Research Practitioner, Molecular and Clinical Sciences Research InstituteSt George's, University of LondonLondon, United Kingdommvanzant@sgul.ac.ukMansourSaharFRCPProfessor of Clinical Genetics, SW Thames Regional Genetics DepartmentSt George's, University of LondonLondon, United Kingdomsmansour@sgul.ac.ukOstergaardPiaPhDProfessor of Human Genetics, Molecular and Clinical Sciences Research InstituteSt George's, University of LondonLondon, United Kingdomposterga@sgul.ac.ukMortimerPeterMD, FRCPProfessor of Dermatological Medicine, Molecular and Clinical Sciences Research InstituteSt George's, University of LondonLondon, United Kingdommortimer@sgul.ac.ukGordonKristianaMD, FRCPConsultant and Reader in Dermatology & Lymphovascular MedicineSt George's University HospitalsNHS Foundation TrustLondon, United Kingdomkristiana.gordon@stgeorges.nhs.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMIRAGE SyndromeSynonym: Myelodysplasia, Infection, Restriction of Growth, Adrenal Hypoplasia, Genital Phenotypes, and EnteropathyTanase-NakaoKanakoMD, PhDnakao-k@ncchd.go.jpOlsonTimothy SMD, PhDolsont@chop.eduNarumiSatoshiMD, PhDnarumi-s@ncchd.go.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMitochondrial DNA-Associated Leigh Syndrome SpectrumSynonym: mtDNA-Associated Leigh Syndrome SpectrumBallMeganMDmegan.ball@mcri.edu.auThorburnDavid RPhD, FHGSA, FFSc(RCPA)david.thorburn@mcri.edu.auRahmanShamimaPhD, FRCP, FRCPCHshamima.rahman@ucl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMitochondrial DNA Maintenance Defects OverviewEl-HattabAyman WMD, FAAP, FACMGelhattabaw@yahoo.comCraigenWilliam JMD, PhD, FACMGwcraigen@bcm.eduWongLee-Jun CPhD, FACMGljwong@bcm.eduScagliaFernandoMD, FAAP, FACMGfscaglia@bcm.edu\n\nSummary\n\n Mitochondrial DNA Maintenance Defects\n\n Causes of mtDNA Maintenance Defects\n\n Clinical Characteristics of mtDNA Maintenance Defects\n\n Evaluation Strategies to Diagnose mtDNA Maintenance Defects and to Establish a Genetic Cause in a Proband\n\n Management of Individuals with mtDNA Maintenance Defects\n\n Genetic Counseling\n\nChapter Notes\n\nReferences\n\nMitochondrial Membrane Protein-Associated NeurodegenerationSynonym: Neurodegeneration with Brain Iron Accumulation 4 (NBIA4)GregoryAllisonMS, CGCGenetic Counselor and Research Instructor, Oregon Health & Science UniversityPortland, Oregongregorya@ohsu.eduKlopstockThomasMDProfessor of Neurology, Friedrich Baur InstituteDepartment of NeurologyUniversity Hospital, LMU MunichMunich, Germanythomas.klopstock@med.lmu.deKmiecTomaszMDAssociate Professor, NeurologyChildren's Memorial Health InstituteWarsaw, Polanddr.tomaszkmiec@gmail.comHogarthPenelopeMDAssociate Professor, Molecular and Medical GeneticsOregon Health & Science UniversityPortland, Oregonhogarthp@ohsu.eduHayflickSusan JMDProfessor and Chair, Molecular and Medical GeneticsProfessor, Pediatrics and NeurologyOregon Health & Science UniversityPortland, Oregonhayflick@ohsu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMitochondrial Neurogastrointestinal Encephalopathy DiseaseSynonyms: Mitochondrial Neurogastrointestinal Encephalopathy Syndrome, MNGIE Syndrome, Thymidine Phosphorylase DeficiencyHiranoMichioMDH Houston Merritt Center\nDepartment of Neurology\nColumbia University Medical Center\nNew York, New Yorkmh29@columbia.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMitochondrial Short-Chain Enoyl-CoA Hydratase DeficiencySynonyms: ECHS1D, ECHS1 Deficiency, Mitochondrial Short-Chain Enoyl-CoA Hydratase 1 Deficiency, SCEH DeficiencyGanetzkyRebeccaMDAssociate Professor of PediatricsDivision of Human GeneticsChildren's Hospital of PhiladelphiaPhiladelphia, Pennsylvaniaganetzkyr@email.chop.eduKongChristineBAPerelman School of MedicineUniversity of PennsylvaniaPhiladelphia, Pennsylvaniachristine.kong@pennmedicine.upenn.eduElsharkawiIbrahimMDAssistant Professor of Genetics and Genomic SciencesIcahn School of Medicine at Mount SinaiNew York, New Yorkibrahim.elsharkawi@mssm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MN1</italic> C-Terminal Truncation SyndromeMakChristopher CYMBChB, PhDccymak@connect.hku.hkFungJasmine LFBBiomedScjasflf@connect.hku.hkLeeMianneMScmianne@hku.hkLinAngela EMDalin@partners.orgAmielJeanneMD, PhDjeanne.amiel@inserm.frDohertyDanMD, PhDddoher@uw.eduGordonChristopher TPhDchris.gordon@inserm.frChungBrian HYMDbhychung@hku.hk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMolybdenum Cofactor DeficiencyMiskoAlbertMD, PhDamisko@mgh.harvard.eduMahtaniKarishmaBSck.mahtani@smd18.qmul.ac.ukAbbottJessicajessicaabbott113@gmail.comSchwarzGuentergschwarz@uni-koeln.deAtwalPaldeepMDdra@atwalclinic.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMonogenic Isolated Dystonia OverviewLohmannKatjaPhDkatja.lohmann@uni-luebeck.deLangeLaraMDla.lange@uni-luebeck.deKleinChristineMDchristine.klein@neuro.uni-luebeck.deZechMichaelMDmichael.zech@mri.tum.de\n\nSummary\n\n Clinical Characteristics of Monogenic Isolated Dystonia\n\n Causes of Monogenic Isolated Dystonia\n\n Differential Diagnosis of Monogenic Isolated Dystonia\n\n Evaluation Strategies to Identify the Cause of Monogenic Isolated Dystonia in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nMonogenic Parkinson Disease OverviewMorrisHuwPhD, FRCPUCL Queen Square Institute of NeurologyLondon, United Kingdomh.morris@ucl.ac.ukLimShen-YangMD, FRACPUniversity of Malaya Medical CentreKuala Lumpur, Malaysiasylim@ummc.edu.my\n\nSummary\n\n Clinical Characteristics of Parkinson Disease\n\n Monogenic Causes of Parkinson Disease\n\n Differential Diagnosis of Monogenic Parkinson Disease\n\n Evaluation Strategies to Identify the Genetic Cause of Parkinson Disease in a Proband\n\n Participation in Targeted Therapeutic Clinical Trials\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nMonosomy 7 Predisposition Syndromes OverviewOlsonTimothy SMD, PhDolsont@chop.eduDickersonKathryn EMDkathryn.dickerson@utsouthwestern.eduNakanoTaizo AMDtaizo.nakano@childrenscolorado.orgWlodarskiMarcinMD, PhDmarcin.wlodarski@stjude.org\n\nSummary\n\n Clinical Characteristics of Monosomy 7 Predisposition Syndromes\n\n Causes of Monosomy 7 Predisposition Syndromes\n\n Evaluation Strategies to Identify the Genetic Cause of Monosomy 7 Predisposition in a Proband\n\n Differential Diagnosis of Monosomy 7 Predisposition Syndromes\n\n Management: To Inform (When Possible) Medical Management of Monosomy 7 Based on Genetic Cause\n\n Risk Assessment and Surveillance of At-Risk Relatives for Early Detection and Treatment of Monosomy 7 Predisposition Syndromes\n\nChapter Notes\n\nReferences\n\nMosaic <italic toggle=\"yes\">EPAS1</italic> Gain-of-Function SpectrumAlkaissiHussamMD, MShussam.alkaissi@nih.govPacakKarelMD, DSc, FACE, Dhckarel@mail.nih.govZhuangZhengpingMD, PhDzhengping.zhuang@nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMPPH SyndromeSynonym: Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus SyndromeMirzaaGhaydaMD, FAAP, FACMGSeattle Children's Research InstituteSeattle, Washingtonghayda.mirzaa@seattlechildrens.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MPV17-</italic>Related Mitochondrial DNA Maintenance DefectSynonyms: Mitochondrial DNA Depletion Syndrome 6 (MTDPS6), Hepatocerebral Type; MPV17 Deficiency; MPV17 Hepatocerebral Mitochondrial DNA Depletion SyndromeEl-HattabAyman WMD, FAAP, FACMGelhattabaw@yahoo.comWangJuliaBSjulia.wang@bcm.eduDaiHongzhengPhDhongzheng.dai@bcm.eduAlmannaiMohammedMD, FAAP, FACMGmalmannai@kfmc.med.saScagliaFernandoMD, FAAP, FACMGfscaglia@bcm.eduCraigenWilliam JMD, PhD, FACMGwcraigen@bcm.eduWongLee-Jun CPhD, FACMGljwong@bcm.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMucolipidosis III GammaSynonyms: MLIII Gamma, ML IIIγ, Mucolipidosis Type III GammaRaas-RothschildAnnickMDannick.rein@sheba.health.org.ilSpiegelRonenMDspiegel_ro@clalit.org.il\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMucolipidosis IVMiskoAlbertMD, PhDDepartment of NeurologyMassachusetts General HospitalHarvard Medical SchoolBoston, Massachusettsamisko@mgh.harvard.eduGrishchukYuliaPhDDepartment of NeurologyMassachusetts General HospitalCenter for Genomic MedicineHarvard Medical SchoolBoston, Massachusettsygrishchuk@mgh.harvard.eduGoldinEhudPhDSection on Molecular NeurogeneticsMedical Genetics BranchNational Human Genome Research InstituteNational Institutes of HealthBethesda, Marylandgoldine@mail.nih.govSchiffmannRaphaelMD, MHScBaylor Scott & White Research InstituteDallas, Texasraphael.schiffmann@bswhealth.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMucopolysaccharidosis Type IISynonyms: Hunter Syndrome, Iduronate-2-Sulfatase Deficiency, MPS IIScarpaMaurizioMD, PhDRegional Coordinating Center for Rare DiseasesUniversity Hospital of UdineUdine Italymaurizio.scarpa@asufc.sanita.fvg.itLampeChristinaMDCenter for Rare DiseasesDepartment of Pediatric NeurologyMuscular Diseases and Social PediatricsUniversity of GiessenGiessen, Germanychristina.lampe@paediat.med.uni-giessen.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMucopolysaccharidosis Type IIISynonyms: MPS III, Sanfilippo SyndromeWagnerVictoria FMS, CGCvictoria.wagner@uth.tmc.eduNorthrupHopeMDhope.northrup@uth.tmc.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nMucopolysaccharidosis Type ISynonyms: Alpha-L-Iduronidase Deficiency, IDUA Deficiency, MPS IClarkeLorne AMDProfessor, Medical GeneticsUniversity of British ColumbiaVancouver, BC, Canadalorne.clarke@ubc.ca\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMucopolysaccharidosis Type IVASynonyms: Morquio A Disease, Morquio Syndrome Type A, MPS IVARegierDebra SMD, PhDdregier@childrensnational.orgOetgenMatthewMDmoetgen@childrensnational.orgTanpaiboonPranootMDptanpaib@childrensnational.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMucopolysaccharidosis Type VIISynonyms: Beta-Glucuronidase Deficiency, MPS7, Sly SyndromeSunAngelaMDWangRaymondMDrawang@choc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMuenke SyndromeKruszkaPaulMD, MPHpkruszka@genedx.comRolleMyronMDmrolle@partners.orgKahleKristopher TMD, PhDkahle.kristopher@mgh.harvard.eduMuenkeMaximilianMD, FACMGmaxmuenke@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMulticentric Osteolysis Nodulosis and ArthropathySynonyms: Torg Syndrome, Torg-Winchester Syndrome, MMP2-Related Multicentric Osteolysis, Nodulosis, and ArthropathyBhavaniGandham SriLakshmiMSc, PhDgsl.bhavani@manipal.eduShahHiteshMShiteshshah12@gmail.comShuklaAnjuMD, DManju.shukla@manipal.eduGirishaKatta MohanMD, DMgirish.katta@manipal.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMultiple Acyl-CoA Dehydrogenase DeficiencySynonyms: Electron Transfer Flavoprotein Dehydrogenase Deficiency, Glutaric Acidemia II, Glutaric Aciduria II, MADDPrasunPankajMDIcahn School of Medicine at Mount SinaiNew York, New Yorkpankaj.prasun@mssm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMultiple Endocrine Neoplasia Type 1Synonyms: MEN1, MEN1 Syndrome, Multiple Endocrine Adenomatosis, Wermer SyndromeGiustiFrancescaMD, PhDfrancesca.giusti@unifi.itMariniFrancescaPhDfrancesca.marini@unifi.itBrandiMaria LuisaMD, PhDmarialuisa@marialuisabrandi.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMultiple Endocrine Neoplasia Type 2Synonyms: MEN2, MEN2 SyndromeEngCharisMD, PhD, FACPengc@ccf.orgPlittGilmanMDplittg@ccf.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMultiple Endocrine Neoplasia Type 4Synonyms: MEN4, CDKN1B-Related Multiple Endocrine NeoplasiaBrockPamelaMS, CGCpamela.brock@osumc.eduKirschnerLawrenceMD, PhDlawrence.kirschner@osumc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMultiple Epiphyseal Dysplasia, Autosomal DominantBriggsMichael DPhDProfessor of Skeletal Genetics, Institute of Genetic MedicineNewcastle UniversityInternational Centre for LifeNewcastle upon Tyne, United Kingdommichael.briggs@newcastle.ac.ukWrightMichael JMB, ChB, MSc, FRCPConsultant Clinical Geneticist, Northern Genetics ServiceInstitute of Human GeneticsNewcastle upon Tyne, United Kingdommichael.wright19@nhs.netMortierGeert RMD, PhDChairman, Department of Clinical GeneticsDepartment of Human GeneticsKU LeuvenLeuven, Belgiumgeert.mortier@uzleuven.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMultiple Sulfatase DeficiencySchlotawaLarsMDlars.schlotawa@med.uni-goettingen.deAdangLauraMD, PhDadangl@email.chop.eduDe CastroMauricioMDmauricio.j.decastropretelt.mil@mail.milAhrens-NicklasRebeccaMD, PhDahrensnicklasr@email.chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMusculocontractural Ehlers-Danlos SyndromeSynonyms: mcEDS; Adducted Thumb-Clubfoot Syndrome (ATCS); Dündar Syndrome; Ehlers-Danlos Syndrome, Kosho Type (EDS-KT)KoshoTomokiMD, PhDDepartment of Medical GeneticsShinshu University School of Medicine;Center for Medical GeneticsShinshu University Hospital;Division of Clinical SequencingShinshu University School of Medicine;Research Center for Supports to Advanced ScienceShinshu University;BioBank ShinshuShinshu University HospitalMatsumoto, Japanktomoki@shinshu-u.ac.jpYamaguchiTomomiPhDDepartment of Medical GeneticsShinshu University School of Medicine;Center for Medical GeneticsShinshu University Hospital;Division of Clinical SequencingShinshu University School of MedicineMatsumoto, Japant_yamaguchi@shinshu-u.ac.jpMizumotoShujiPhDDepartment of PathobiochemistryFaculty of PharmacyMeijo UniversityNagoya, Japanmizumoto@meijo-u.ac.jpMendoza-LondonoRobertoMD, MS, FACMG, FCCMGDivision of Clinical and Metabolic GeneticsDepartment of PædiatricsThe Hospital for Sick Children and University of TorontoToronto, Canadaroberto.mendoza@sickkids.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MUTYH</italic> PolyposisSynonyms: Multiple Colorectal Adenomas, Autosomal Recessive; MUTYH-Associated Polyposis (MAP)NielsenMaartjeMDDepartment of Clinical GeneticsLeiden University Medical CenterLeiden, Netherlandsm.nielsen@lumc.nlInfanteElenaMS, CGCDepartment of PediatricsDivision of Medical GeneticsUPMC Children’s Hospital of PittsburghPittsburgh, Pennsylvaniainfanteem@upmc.eduBrandRandallMDDepartment of MedicineDivision of Gastroenterology, Hepatology, and NutritionUniversity of PittsburghPittsburgh, Pennsylvaniabrandre@pitt.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MYH9</italic>-Related DiseaseSavoiaAnnaPhDDepartment of Medical SciencesInstitute for Maternal and Child Health – IRCCS Burlo GarofoloUniversity of TriesteTrieste, Italyanna.savoia@burlo.trieste.itPecciAlessandroMD, PhDIRCCS Policlinico San Matteo Foundation;Department of Internal MedicineUniversity of PaviaPavia, Italyalessandro.pecci@unipv.it\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMyhre SyndromeSynonym: Myhre-LAPS SyndromeLinAngela EMDalin@mgb.orgBrunetti-PierriNicolaMDbrunetti@tigem.itLindsayMark EMD, PhDlindsay.mark@mgh.harvard.eduSchimmentiLisa AMDschimmenti.lisa@mayo.eduStarrLois JMD, PhDlstarr@unmc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMyotonia CongenitaDunøMortenPhDMolecular Genetic LaboratoryDepartment of Clinical GeneticsRigshospitaletUniversity of CopenhagenCopenhagen, Denmarkmorten.dunoe@regionh.dkVissingJohnMD, DMSciNeuromuscular Clinic and Research UnitDepartment of NeurologyRigshospitaletUniversity of CopenhagenCopenhagen, Denmarkjohn.vissing@regionh.dk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMyotonic Dystrophy Type 1Synonym: Steinert's DiseaseBirdThomas DMDSeattle VA Medical Center;Departments of Neurology and MedicineUniversity of WashingtonSeattle, Washingtontomnroz@uw.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nMyotonic Dystrophy Type 2Synonym: Proximal Myotonic Myopathy (PROMM)KleefeldFelixMDfelix.kleefeld@bergmannsheil.deErdmannHannesMD, MSchannes.erdmann@med.uni-muenchen.deSchoserBenediktMDbenedikt.schoser@med.uni-muenchen.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">MYRF</italic>-Related Cardiac Urogenital SyndromeKaplanJulie DMDCleveland Clinic FoundationCleveland, Ohiokaplanj3@ccf.orgStewartBlytheUniversity of EdinburghEdinburgh, United Kingdomb.stewart-6@sms.ed.ac.ukPrasovLevMD, PhDUniversity of Michigan Medical SchoolAnn Arbor, Michiganlprasov@umich.eduPyleTucker Louise CMD, PhDChildren's National Medical CenterWashington, DClpyle@cnmc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNail-Patella SyndromeSynonym: LMX1B-Related Nail-Patella SyndromeHoover-FongJulie EMD, PhDProfessor, McKusick-Nathans Department of Genetic Medicine; Director, Greenberg Center for Skeletal DysplasiasJohns Hopkins UniversityBaltimore, Marylandjhoover2@jhmi.eduMcIntoshIainPhDPresident, Bendel Camus Medical Education, Inc.iain@bendelcamus.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NARS1</italic>-Related Neurologic DisordersEfthymiouStephanieMSc, PhDs.efthymiou@ucl.ac.ukNagySaraMD, MScs.nagy@ucl.ac.ukAynekinBusraPhDb.aynekin@ucl.ac.ukHouldenHenryMD, PhDh.houlden@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NDP-</italic>Related RetinopathiesScruggsBrittni AMD, PhDSenior Associate ConsultantVitreoretinal Surgery & DiseasesDepartment of OphthalmologyMayo ClinicRochester, Minnesotascruggs.brittni@mayo.eduRedingMadeline QMS, MPH, CGCGenetic Counselor, Clinical GenomicsMayo ClinicRochester, Minnesotareding.madeline@mayo.eduSchimmentiLisa AMDCo-Director, Medical Scientist Training Program (MD/PhD)Assistant Dean, MD/PhD Affairs MCGSBSProfessor, Pediatrics Consultant, Departments of Clinical Genomics, Otorhinolaryngology, Head and Neck Surgery, Ophthalmology, and Biochemistry and Molecular BiologyMayo Clinic School of MedicineRochester, Minnesotaschimmenti.lisa@mayo.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNephronophthisis-Related CiliopathiesSynonym: NPHP-RCStokmanMarijnMD, PhDDepartment of Human GeneticsRadboud University Medical CentreNijmegen, the Netherlandsmarijn.stokman@radboudumc.nlLilienMarcMD, PhDDepartment of Pediatric NephrologyWilhelmina Children's HospitalUniversity Medical Center UtrechtUtrecht, the Netherlandsm.lilien@umcutrecht.nlKnoersNineMD, PhDDepartment of GeneticsUniversity Medical Center GroningenGroningen, the Netherlandsv.v.a.m.knoers@umcg.nl\n\nSummary\n\n Clinical Characteristics of Nephronophthisis-Related Ciliopathies\n\n Genetic Causes of Nephronophthisis-Related Ciliopathies\n\n Differential Diagnosis of Nephronophthisis-Related Ciliopathies\n\n Evaluation Strategies to Identify the Genetic Cause of a Nephronophthisis-Related Ciliopathy in a Proband\n\n Management of Nephronophthisis-Related Ciliopathies\n\n Genetic Counseling of Nephronophthisis-Related Ciliopathies\n\nResources\n\nChapter Notes\n\nReferences\n\nNeurocutaneous Disorders due to Mitochondrial Proline Synthesis DefectsFischer-ZirnsakBjörnDr. rer. medicInstitute for Medical Genetics and Human GeneticsCharité-Universitaetsmedizin BerlinBerlin, Germanybjoern.fischer@charite.deCallewaertBert LMD, PhDCenter for Medical GeneticsGhent University Hospital;Department of Biomolecular MedicineGhent UniversityGhent, Belgiumbert.callewaert@ugent.beGardeitchikThatjanaMDDepartment of Human GeneticsRadboudumc Medical CenterNijmegen, the Netherlandsthatjana.gardeitchik@radboudumc.nlKornakUweMD, PhDInstitute of Human GeneticsUniversity Medical CenterGöttingen, Germanyuwe.kornak@med.uni-goettingen.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNeurodegeneration with Brain Iron Accumulation Disorders OverviewGregoryAllisonMS, CGCgregorya@ohsu.eduKurianManju AMA, MBBChir, PhDmanju.kurian@ucl.ac.ukWilsonJennyMDwilsjen@ohsu.eduHayflickSusanMDhayflick@ohsu.edu\n\nSummary\n\n Clinical Characteristics of Neurodegeneration with Brain Iron Accumulation\n\n Genetic Causes of Neurodegeneration with Brain Iron Accumulation\n\n Differential Diagnosis of Neurodegeneration with Brain Iron Accumulation\n\n Evaluation Strategies to Identify the Genetic Cause of Neurodegeneration with Brain Iron Accumulation in a Proband\n\n Management of Neurodegeneration with Brain Iron Accumulation\n\n Genetic Counseling of Family Members of an Individual with Neurodegeneration with Brain Iron Accumulation\n\nResources\n\nChapter Notes\n\nReferences\n\nNeuroferritinopathySynonym: Hereditary FerritinopathyChinneryPatrick FBMedSci, MBBS, PhD, FRCPath, FRCP, FMedSciDepartment of Clinical NeurosciencesUniversity of CambridgeCambridge, United Kingdompfc25@medschl.cam.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNeurofibromatosis 1Synonyms: NF1, Von Recklinghausen Disease, Von Recklinghausen's NeurofibromatosisFriedmanJan MMD, PhDDepartment of Medical GeneticsUniversity of British ColumbiaVancouver, Canadajan.friedman@ubc.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNeuronal Ceroid Lipofuscinoses OverviewSynonyms: Batten Disease, CLN Disease, NCLMalikKristinaMDkristina.malik@childrenscolorado.orgSantucciKourtneyMDkourtney.santucci@childrenscolorado.orgSrembaLeighannMSleighann.sremba@childrenscolorado.orgSteenariMaijaMDmsteenari@choc.orgMieleAndreaPhDandrea.miele@childrenscolorado.orgDemarestScottMD, MSCSscott.demarest@childrenscolorado.orgWhitemanInekaPhDresearch@bdsraaustralia.org\n\nSummary\n\n Clinical Characteristics of Neuronal Ceroid Lipofuscinoses\n\n Genetic Causes of Neuronal Ceroid Lipofuscinoses\n\n Evaluation Strategies to Identify the Genetic Cause of a Neuronal Ceroid Lipofuscinosis in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nNevoid Basal Cell Carcinoma SyndromeSynonyms: Basal Cell Nevus Syndrome (BCNS), Gorlin Syndrome, NBCCSEvansD GarethMD, FRCPGenomic MedicineDivision of Evolution, Infection and GenomicsManchester Academic Health Science Centre;Consultant in Medical GeneticsSt Mary's Hospital and Christie Hospital;Professor of Medical Genetics and Cancer EpidemiologyUniversity of ManchesterManchester, United Kingdomgareth.evans@mft.nhs.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NF2</italic>-Related SchwannomatosisSynonyms: Neurofibromatosis 2, Neurofibromatosis Type IIEvansD GarethMD, FRCPDirector, Neurofibromatosis ClinicManchester University Hospitals;Foundation NHS Trust Regional Genetic ServiceSt Mary's HospitalManchester, United Kingdomgareth.evans@mft.nhs.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NFIA</italic>-Related DisorderSynonym: NFIA HaploinsufficiencySenaratneT NiroshiniPhDPathology and Laboratory MedicineClinical Genomics CenterDavid Geffen School of MedicineUniversity of California, Los AngelesLos Angeles, Californiatsenaratne@mednet.ucla.eduQuintero-RiveraFabiolaMDProfessor, Pathology and Laboratory MedicineSchool of MedicineUniversity of California, IrvineOrange, Californiafabiolaq@hs.uci.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NFIX</italic>-Related Malan SyndromeSynonyms: Sotos-Like Syndrome, Sotos Syndrome 2PrioloManuelaMDOperative Unit of Medical Genetics and Laboratory of GeneticsAORN A CardarelliNaples, Italymanuela.priolo@aocardarelli.itprioloma@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NGLY1</italic>-Related Congenital Disorder of DeglycosylationSynonyms: NGLY1-CDDG, NGLY1 Deficiency, NGLY1-Related DisorderLamChristinaMD, FACMGUniversity of WashingtonSeattle Children's HospitalSeattle, Washingtonctlam2@uw.eduWolfeLynneMS, CRNPNational Institutes of HealthBethesda, Marylandwolfela@mail.nih.govNeedAnnaPhDImperial College LondonLondon, United Kingdoma.need@imperial.ac.ukShashiVandanaMDDuke UniversityDurham, North Carolinavandana.shashi@duke.eduEnnsGregoryMD, FACMGStanford UniversityStanford, Californiagenns@stanford.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNiemann-Pick Disease Type CSynonym: Niemann-Pick Type C Disease (NPCD)Bremova-ErtlTatianaMDDepartment of Neurology, University Hospital Bern (Inselspital),Switzerlandtatiana.bremova-ertl@insel.chPattersonMarcMDEmeritus Professor, Neurology, Pediatrics and Medical GeneticsMayo ClinicRochester, Minnesotapatterson.marc@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNijmegen Breakage SyndromeVaronRaymondaPhDInstitute of Medical and Human GeneticsCharité – Universitätsmedizin BerlinBerlin, Germanyraymonda.varon-mateeva@charite.deDemuthIljaPhDDepartment of Endocrinology and Metabolic Diseases (including Division of Lipid Metabolism), Biology of Aging Working GroupCharité – Universitätsmedizin BerlinBerlin, GermanyIlja.demuth@charite.deChrzanowskaKrystyna HMD, PhDChildren's Memorial Health InstituteWarsaw, Polandk.chrzanowska@ipczd.pl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NKX2-1</italic>-Related DisordersPatelNeepa JayantMDAssociate ProfessorDivision of Movement DisordersDepartment of Neurological SciencesRUSH University Medical CenterChicago, Illinoisneepa_patel@rush.eduJankovicJosephMDProfessor of NeurologyDistinguished Chair in Movement DisordersDirector, Parkinson's Disease Center and Movement Disorders ClinicDepartment of NeurologyBaylor College of MedicineHouston, Texasjosephj@bcm.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NKX6-2</italic>-Related DisorderSynonyms: NKX6-2-Related Spastic Ataxia with Hypomyelination, SPAX8ChelbanVioricaMDv.chelban@ucl.ac.ukKayaNamikPhDnkaya@kfshrc.edu.saAlkurayaFowzanMDfalkuraya@kfshrc.edu.saHouldenHenryMD, PhDh.houlden@ucl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNonketotic HyperglycinemiaSynonym: NKHVan HoveJohan LKMD, PhDjohan.vanhove@childrenscolorado.orgCoughlinCurtisIIMS, MBecurtis.coughlin@childrenscolorado.orgSwansonMichaelPhDmike.swanson@ucdenver.eduHennermannJulia BMD, PhDjulia.hennermann@unimedizin-mainz.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNonsyndromic 46,XX Testicular Disorders/Differences of Sex DevelopmentSynonym: 46,XX Testicular DSDDélotEmmanuèle CPhDedelot@childrensnational.orgVilainEric JMD, PhD, FACMGevilain@childrensnational.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNonsyndromic Disorders of Testicular Development OverviewMohnachLaurenMSlmohnach@umich.eduFechnerPatricia YMDpatricia.fechner@seattlechildrens.orgKeeganCatherine EMD, PhDkeeganc@med.umich.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\n Clinical Characteristics of Nonsyndromic Disorders of Testicular Development\n\n Causes of Nonsyndromic Disorders of Testicular Development\n\n Evaluation Strategies to Identify the Genetic Cause of Nonsyndromic Disorders of Testicular Development\n\n Management\n\n Genetic Risk Assessment\n\nResources\n\nChapter Notes\n\nReferences\n\nNonsyndromic Genetic Hyperinsulinism OverviewSynonyms: Congenital Hyperinsulinism (CHI), Familial Hyperinsulinism, Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)GillisDavidMDHadassah Hebrew University HospitalJerusalem, Israeldgillis@hadassah.org.il\n\nSummary\n\n Clinical Characteristics of Nonsyndromic Genetic Hyperinsulinism\n\n Causes of Nonsyndromic Genetic Hyperinsulinism\n\n Evaluation Strategies to Identify the Genetic Cause of Nonsyndromic Genetic Hyperinsulinism in a Proband\n\n Medical Management of Nonsyndromic Genetic Hyperinsulinism Based on Genetic Cause\n\n Risk Assessment and Surveillance of At-Risk Relatives for Early Detection and Treatment of Nonsyndromic Genetic Hyperinsulinism\n\nResources\n\nChapter Notes\n\nReferences\n\nNonsyndromic Hearing Loss and Deafness, MitochondrialUsamiShin-ichiMD, PhDProfessor and Chairman, Department of Otorhinolaryngology\nShinshu University School of Medicine\nMatsumoto, Japanusami@shinshu-u.ac.jpNishioShin-yaPhDAssistant Professor, Department of Otorhinolaryngology\nShinshu University School of Medicine\nMatsumoto, Japannishio@shinshu-u.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNonsyndromic Hypertrophic Cardiomyopathy OverviewCirinoAllison LMS, CGCChannaouiNadineMS, CGCHoCarolynMD\n\nSummary\n\n Clinical Characteristics of Hypertrophic Cardiomyopathy\n\n Genetic Causes of Nonsyndromic Hypertrophic Cardiomyopathy\n\n Differential Diagnosis of Nonsyndromic Hypertrophic Cardiomyopathy\n\n Evaluation Strategy to Identify (when Possible) the Genetic Cause of Hypertrophic Cardiomyopathy\n\n Management of Hypertrophic Cardiomyopathy\n\n Genetic Counseling of Family Members of an Individual with Nonsyndromic Hypertrophic Cardiomyopathy\n\nResources\n\nChapter Notes\n\nReferences\n\nNonsyndromic Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy OverviewSynonyms: EOSRD, LCAKumaranNerubanBSc, MBBS, PhD, FRCOphthn.kumaran@nhs.netPennesiMark EMD, PhDpennesi@retinafoundation.orgYangPaulMD, PhDyangp@ohsu.eduTrzupekKarmen MMS, CGCktrzupek@informeddna.comMichaelidesMichelBSc, MBBS, MD(Res), FRCOphth, FACSmichel.michaelides@ucl.ac.uk\n\nSummary\n\n Clinical Characteristics of Nonsyndromic Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy\n\n Causes of Nonsyndromic Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy\n\n Differential Diagnosis of Nonsyndromic Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy\n\n Evaluation Strategies to Identify the Genetic Cause of Nonsyndromic Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy in a Proband\n\n Management of Nonsyndromic Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy Based on Genetic Cause\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nNonsyndromic Malignant Hyperthermia SusceptibilitySynonym: Malignant HyperpyrexiaRiaziSheilaMDProfessor, Department of AnesthesiaUniversity of TorontoToronto, Ontariosheila.riazi@uhn.caBieseckerLeslie GMDCenter for Precision Health ResearchNational Human Genome Research InstituteNational Institutes of HealthBethesda, Marylandlesb@mail.nih.govRosenbergHenryMDPresident Emeritus of MHAUS and Courtesy Clinical Professor of AnesthesiologyUniversity of FloridaGainesville, Floridahenryrosenberg@yahoo.comDirksenRobert TPhDProfessor, Department of Pharmacology and PhysiologyUniversity of Rochester Medical CenterRochester, New Yorkrobert_dirksen@urmc.rochester.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNonsyndromic Retinitis Pigmentosa OverviewFahimAbigail TMD, PhDKellogg Eye CenterUniversity of Michigan Medical SchoolAnn Arbor, Michiganahteich@med.umich.eduDaigerStephen PPhDProfessor, Human Genetics CenterSchool of Public HealthRuiz Department of Ophthalmology and Visual ScienceUniversity of Texas Health Science CenterHouston, Texasstephen.p.daiger@uth.tmc.eduWeleberRichard GMD, DABMG, FACMGProfessor, Department of Ophthalmology and Molecular and Medical GeneticsOregon Retinal Degeneration CenterCasey Eye InstituteOregon Health Sciences UniversityPortland, Oregonweleberr@ohsu.edu\n\nSummary\n\n Clinical Characteristics of Nonsyndromic Retinitis Pigmentosa\n\n Causes of Nonsyndromic Retinitis Pigmentosa\n\n Evaluation Strategy to Identify the Genetic Cause of Nonsyndromic Retinitis Pigmentosa in a Proband\n\n Management of Nonsyndromic Retinitis Pigmentosa\n\n Genetic Risk Assessment\n\nResources\n\nChapter Notes\n\nReferences\n\nNonsyndromic Tooth Agenesis OverviewLetraAriadneDDS, MS, PhDariadne.m.letra@uth.tmc.eduChiquetBrettDDS, PhDbrett.t.chiquet@uth.tmc.eduHansen-KissEmilyMS, MA, CGCemily.hansenkiss@uth.tmc.eduMenezesSimoneBSsimone.a.menezes@uth.tmc.eduHunterElizabethBSelizabeth.c.hunter@uth.tmc.edu\n\nSummary\n\n Clinical Characteristics of Nonsyndromic Tooth Agenesis\n\n Causes of Nonsyndromic Tooth Agenesis\n\n Evaluation Strategies to Identify the Genetic Cause of Nonsyndromic Tooth Agenesis in a Proband\n\n Management\n\n Genetic Risk Assessment\n\nResources\n\nChapter Notes\n\nReferences\n\nNoonan SyndromeRobertsAmy EMDCo-Director, Center for Cardiovascular GeneticsDepartment of Cardiology and Division of GeneticsDepartment of PediatricsBoston Children's HospitalBoston, Massachusettsamy.roberts@cardio.chboston.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nNoonan Syndrome with Multiple LentiginesSynonyms: LEOPARD Syndrome, Multiple Lentigines SyndromeGelbBruce DMDDepartments of Pediatrics and Genetics and Genomic SciencesMindich Child Health and Development InstituteIcahn School of Medicine at Mount SinaiNew York, New Yorkbruce.gelb@mssm.eduTartagliaMarcoPhDGenetics and Rare Disease Research DivisionBambino Gesú Children’s Hospital IRCSSRome, Italymarco.tartaglia@opbg.net\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NOTCH3</italic>-Related Lateral Meningocele SyndromeSynonym: Lehman SyndromeEjazReshamMD, FRCPCDivision of GeneticsDepartment of PediatricsMcMaster Children’s HospitalHamilton, Ontario, Canadaejazr@mcmaster.caCarterMelissaMD, MScThe Children’s Hospital of Eastern OntarioOttawa, Canadamcarter@cheo.on.caGrippKarenMDAlfred I DuPont Hospital for ChildrenWilmington, Delawarekaren.gripp@nemours.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NR0B1-</italic>Related Adrenal Hypoplasia CongenitaAchermannJohn CMB, MD, PhD, FRCPCHGenetics and Genomic Medicine\nUCL Great Ormond Street Institute of Child Health\nUniversity College London\nLondon, United Kingdomj.achermann@ucl.ac.ukVilainEric JMD, PhD, FACMGCenter for Genetic Medicine Research\nChildren's National Medical Center\nWashington, DCevilain@childrensnational.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">NR2F1</italic>-Related Neurodevelopmental DisorderSynonym: Bosch-Boonstra-Schaaf Optic Atrophy Syndrome (BBSOAS)SchaafChristian PMD, PhDchristian.schaaf@med.uni-heidelberg.deYu-Wai-ManPatrickBMedSci, MBBS, PhD, FRCPath, FRCOphthpy237@cam.ac.ukValentinIliaMDilia.valentin@med.uni-heidelberg.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NSDHL</italic>-Related DisordersKurbanMazenMDTenured Professor of DermatologyBiochemistry and Molecular GeneticsAmerican University of Beirut Medical CenterBeirut, Lebanonmk104@aub.edu.lbEl FeghalyJiniaMDAssistant Professor of Dermatology and PediatricsUniversity of Rochester Medical CenterRochester, New Yorkjiniaelfeghalymd@gmail.comHamieLamiaaMD, MScSpecialist DermatologistMediclinic Middle EastDubai, United Arab Emiratesdr.lamiaahamie@outlook.com\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NTHL1</italic> Tumor SyndromeSynonym: NTHL1-Associated PolyposisDe VoerRicharda MPhDricharda.devoer@radboudumc.nlNielsenMaartjeMD, PhDm.nielsen@lumc.nlGaoWeilunMDalan.gao@mh.org.auKuiperRoland PPhDr.kuiper@prinsesmaximacentrum.nlHoogerbruggeNicolineMD, PhDnicoline.hoogerbrugge@radboudumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">NTRK1</italic> Congenital Insensitivity to Pain with AnhidrosisSynonym: Hereditary Sensory and Autonomic Neuropathy Type IV (HSAN IV)IndoYasuhiroMD, PhDDepartment of PediatricsKumamoto University HospitalKumamoto, Japanyindo@kumamoto-u.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nNuclear Gene-Encoded Leigh Syndrome Spectrum OverviewRahmanShamimaFRCP, FRCPCH, PhDshamima.rahman@ucl.ac.ukThorburnDavid RPhDdavid.thorburn@mcri.edu.auBallMeganMDmegan.ball@mcri.edu.au\n\nSummary\n\n Clinical Characteristics of Nuclear Gene-Encoded Leigh Syndrome Spectrum\n\n Causes of Nuclear Gene-Encoded Leigh Syndrome Spectrum\n\n Differential Diagnosis of Nuclear Gene-Encoded Leigh Syndrome Spectrum\n\n Evaluation Strategies to Identify the Genetic Cause of Nuclear Gene-Encoded Leigh Syndrome Spectrum in a Proband\n\n Management of Nuclear Gene-Encoded Leigh Syndrome\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nOculocutaneous Albinism and Ocular Albinism OverviewThomasMervyn GMBChB, PhD, FRCOphthUlverscroft Eye UnitCollege of Life SciencesSchool of Psychology and Vision SciencesUniversity of LeicesterLeicester, UKmt350@le.ac.ukZippinJonathanMD, PhDDepartment of DermatologyJoan and Sanford I Weill Medical College of Cornell UniversityNew York, New Yorkjhzippin@med.cornell.eduBrooksBrian PMD, PhDOphthalmic Genetics and Visual Function BranchNational Eye InstituteNational Institutes of HealthBethesda, Marylandbrooksb@nei.nih.gov\n\nSummary\n\n Clinical Characteristics of Oculocutaneous Albinism and Ocular Albinism\n\n Genetic Causes of Oculocutaneous Albinism and Ocular Albinism\n\n Differential Diagnosis of Ocular Findings in Oculocutaneous Albinism and Ocular Albinism\n\n Evaluation Strategies to Identify the Genetic Cause of Oculocutaneous Albinism or Ocular Albinism in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nOculocutaneous Albinism Type 4Synonyms: OCA4, SLC45A2-Related Oculocutaneous AlbinismSuzukiTamioMD, PhDtamsuz@med.id.yamagata-u.ac.jpOkamuraKenMD, PhDk-okamura@med.id.yamagata-u.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nOculopharyngeal Muscular DystrophySynonym: OPMDTrolletCapucinePhDcapucine.trollet@upmc.frBoulinguiezAlexisPhDalexis.boulinguiez@inserm.frRothFannyPhDfanny.roth0106@gmail.comStojkovicTanyaMDstojkovic.tanya@aphp.frButler-BrowneGillianPhDgillian.butler-browne@upmc.frEvangelistaTeresinhaMDt.evangelista@institut-myologie.orgLacau St GuilyJeanMDjean.lacau@aphp.frRichardPascalePharmD, PhDpascale.richard@aphp.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nOkur-Chung Neurodevelopmental SyndromeSynonym: CSNK2A1-Related Neurodevelopmental SyndromeChungWendyMD, PhD, FACMGDepartments of Pediatrics and MedicineColumbia UniversityNew York, New Yorkwkc15@columbia.eduOkurVolkanMD, FACMGNew York Genome CenterNew York, New Yorkvokur@nygenome.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nOral-Facial-Digital Syndrome Type ISynonyms: OFD1, Orofaciodigital Syndrome IFrancoBrunellaMDPrincipal Investigator, Telethon Institute of Genetics and Medicine;Professor, Medical GeneticsDepartment of Translational Medical SciencesUniversity of Naples Federico IINaples, Italyfranco@tigem.itBruelAnge-LinePhDResearch Engineer, Genetics of Disorders of Development TeamUniversity of BurgundyDijon, Franceangeline.bruel@gmail.comThauvin-RobinetChristelMD, PhDAssistant and Research Investigator, University Hospital Federation - Translational Medicine and Developmental Anomalies;Professor, Medical GeneticsChildren's Hospital Genetic CenterGenetics of Disorders of Development TeamUniversity of BurgundyDijon, Francechristel.thauvin@chu-dijon.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nOrnithine Transcarbamylase DeficiencySynonyms: Ornithine Carbamoyltransferase Deficiency, OTC DeficiencyLichter-KoneckiUtaMD, PhDuta.lichterkonecki@chp.eduCaldovicLjubicaPhDMorizonoHirokiPhDSimpsonKaraMS, CGCAh MewNicholasMDMacLeodErinPhD, RD, LD\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nOsteoglophonic DysplasiaSynonyms: FGFR1-Related Osteoglophonic Dysplasia, Osteoglophonic Dwarfism, Fairbank-Keats SyndromeOthmanAmna AMBBChamna.othman@nih.govBabcockHolly EMSholly.babcock@nih.govFerreiraCarlos RMDcarlos.ferreira@nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nOsteopathia Striata with Cranial SclerosisSynonyms: Horan-Beighton Syndrome, OS-CS, AMER1-Related Osteopathia Striata with Cranial SclerosisGearRussellMBChBrussellgear@hotmail.comSavarirayanRaviMBBS, MD, FRACP, ARCPA (Hon)ravi.savarirayan@mcri.edu.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">OTOF</italic>-Related Hearing LossSynonyms: DFNB9, Otoferlin-Related Hearing LossAzaiezHelaPhDhazaiez@iu.eduThorpeRyan KMDryan-thorpe@uiowa.eduOdellAmanda MMS, LGCamanda-odell@uiowa.eduSmithRichard JHMDrichard-smith@uiowa.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPachyonychia CongenitaSmithFrances JDPhDPachyonychia Congenita ProjectSchool of Life SciencesUniversity of DundeeDundee, Scotland, United Kingdomfrances.smith@pachyonychia.orgHansenC DavidMDDepartment of DermatologyUniversity of UtahSalt Lake City, Utahdavid.hansen@hsc.utah.eduHullPeter RMD, PhD, FRCPCDivision of Clinical Dermatology and Cutaneoous ScienceDalhousie UniversityHalifax, Nova Scotia, Canadapeter.hull@dal.caKasparRoger LPhDTransderm, IncSanta Cruz, Californiaroger.kaspar@transderminc.comMcLeanWH IrwinDSc, FRSEDivision of Biological Chemistry and Drug DiscoverySchool of Life SciencesUniversity of DundeeDundee, Scotland, United Kingdomw.h.i.mclean@dundee.ac.ukO’TooleEdelMD, PhD, FRCPI, FRCPCentre for Cutaneous ResearchBarts & the London School of Medicine and DentistryQueen Mary University of LondonLondon, England, United Kingdome.a.otoole@qmul.ac.ukSprecherEliMD, PhDDepartment of DermatologyTel Aviv Medical CenterTel Aviv, Israelelisp@tlvmc.gov.il\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PACS1</italic> Neurodevelopmental DisorderSynonym: Schuurs-Hoeijmakers SyndromeLuskLainaMMSc, CGCluskl@email.chop.eduSmithSimoneMScshsmith1@geisinger.eduMartinChristaPhD, FACMGclmartin1@geisinger.eduTaylorCoraPhDcmtaylor1@geisinger.eduChungWendyMD, PhD, FACMGwkc15@columbia.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PAFAH1B1</italic>-Related Lissencephaly / Subcortical Band HeterotopiaSynonym: LIS1-Related Lissencephaly / Subcortical Band HeterotopiaBrockStefanieMDDepartment of PathologyUniversitair Ziekenhuis Brussel;Neurogenetics Research GroupVrije UniversiteitBrussels, Belgiumstefanie.brock@uzbrussel.beDobynsWilliam BMDDepartment of Pediatrics (Genetics)University of MinnesotaMinneapolis, Minnesotawbdobyns@umn.eduJansenAnnaMD, PhDPediatric Neurology UnitDepartment of PediatricsUniversitair Ziekenhuis Brussel;Neurogenetics Research GroupVrije UniversiteitBrussels, Belgiumanna.jansen@uzbrussel.be\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPancreatitis OverviewSheltonCelestePhD, CGCClinical Variant Scientist, Ariel Precision MedicinePittsburgh, Pennsylvaniacshelton@arielmedicine.comLaRuschJessicaPhDLead Genetic Scientist, Ariel Precision MedicinePittsburgh, Pennsylvanialarusch@arielmedicine.comWhitcombDavid CMD, PhDDepartments of Medicine, Cell Biology & Physiology, and Human GeneticsDivision of Gastroenterology, Hepatology, and NutritionUniversity of Pittsburgh & University of Pittsburgh Medical CenterPittsburgh, Pennsylvaniawhitcomb@pitt.edu\n\nSummary\n\n Pancreatitis: Definitions\n\n Risk Factors and Etiologies of Recurrent Acute Pancreatitis / Chronic Pancreatitis\n\n Evaluation Strategies to Identify Genetic Risk Factors in a Proband with Pancreatitis\n\n Medical Management of Pancreatitis\n\n Genetic Risk Assessment\n\nResources\n\nChapter Notes\n\nReferences\n\nPantothenate Kinase-Associated NeurodegenerationSynonym: PKANGregoryAllisonMS, CGCGenetic Counselor and Assistant ProfessorOregon Health & Science UniversityPortland, Oregongregorya@ohsu.eduHayflickSusan JMDProfessor and Chair, Molecular and Medical GeneticsProfessor, Pediatrics and NeurologyOregon Health & Science UniversityPortland, Oregonhayflick@ohsu.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nParkin Type of Early-Onset Parkinson DiseaseSynonyms: PARK-Parkin, PRKN Parkinson DiseaseBrüggemannNorbertMDnorbert.brueggemann@neuro.uni-luebeck.deKleinChristineMDchristine.klein@neuro.uni-luebeck.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">PAX2</italic>-Related DisorderSynonyms: Papillorenal Syndrome, Renal Coloboma SyndromeBowerMatthew AMSDivision of Genetics and MetabolismUniversity of Minnesota Medical Center, FairviewMinneapolis, Minnesotambower1@fairview.orgSchimmentiLisa AMDProfessor, PediatricsSenior Associate Consultant, Otorhinolaryngology and Clinical GenomicsMayo ClinicRochester, Minnesotaschimmenti.lisa@mayo.eduEcclesMichael RPhDProfessor and Chair in Cancer Pathology, Department of PathologyDunedin School of MedicineUniversity of OtagoDunedin, New Zealand\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PAX6</italic> Aniridia SyndromeKitVivienneBSc, MBBS, FRCOphthOphthalmology Registrar, North Thames DeaneryNHS EnglandLondon, United Kingdomvivienne.kit@nhs.netOluonyeNgoziMBBS, MRCPCH, MScConsultant Neurodevelopmental PaediatricianGreat Ormond Street Hospital;Moorfields Eye HospitalLondon, United Kingdomn.oluonye@nhs.netMoosajeeMariyaMBBS, BSc, PhD, FRCOphthConsultant OphthalmologistProfessor of Molecular OphthalmologyMoorfields Eye Hospital;UCL Institute of OphthalmologyLondon, United Kingdomm.moosajee@ucl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPediatric Genetic Cholestatic Liver Disease OverviewAmendolaMariaMDDepartment of PediatricsUPMC Children's Hospital of PittsburghPittsburgh, Pennsylvaniamaria.lanyi@chp.eduSquiresJames EMD, MSDepartment of Pediatric Gastroenterology and HepatologyUPMC Children's Hospital of PittsburghPittsburgh, Pennsylvaniajames.squires2@chp.edu\n\nSummary\n\n Clinical Characteristics of Genetic Cholestatic Liver Disease\n\n Causes of Genetic Cholestatic Liver Disease\n\n Evaluation Strategies to Identify the Cause of a Genetic Cholestatic Liver Disease in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nPelizaeus-Merzbacher-Like Disease 1Synonyms: Hypomyelinating Leukodystrophy 2 (HLD2), PMLD1NahhasNorahMDnnahhas@childrensnational.orgConantAlexBSaconant@childrensnational.orgOrthmann-MurphyJenniferMD, PhDjorthma1@jhmi.eduVanderverAdelineMDavanderv@cnmc.orgvandervera@email.chop.eduHobsonGracePhDghobson@nemours.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nPeriodontal Ehlers-Danlos SyndromeSynonyms: EDS Type VIII, pEDSKapferer-SeebacherInesDMDines.kapferer@i-med.ac.atvan DijkFleur SMD, PhDfleur.dijk@nhs.netZschockeJohannesMD, PhDjohannes.zschocke@i-med.ac.at\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPermanent Neonatal Diabetes MellitusDe LeónDiva DMD, MSCEProfessor of PediatricsChildren's Hospital of Philadelphia;Perelman School of Medicine at University of PennsylvaniaPhiladelphia, Pennsylvaniadeleon@chop.eduPinneySara EMD, MSTRAssociate Professor of PediatricsChildren's Hospital of Philadelphia;Perelman School of Medicine at University of PennsylvaniaPhiladelphia, Pennsylvaniapinneys@chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPerrault Syndrome OverviewLiTianyiMD, PhDdr_lty@cqmu.edu.cnFaridiRabiaPhDrabia.faridi@nih.govNewmanWilliam GMD, PhDwilliam.newman@manchester.ac.ukFriedmanThomas BPhDfriedman@nidcd.nih.gov\n\nSummary\n\n Clinical Characteristics of Perrault Syndrome\n\n Genetic Causes of Perrault Syndrome\n\n Differential Diagnosis of Perrault Syndrome\n\n Evaluation Strategies to Identify the Genetic Cause of Perrault Syndrome in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nPeters Plus SyndromeSynonym: PTRPLSReisLinda MMS, LCGCDepartment of OphthalmologyMedical College of WisconsinMilwaukee, Wisconsinlreis@mcw.eduLevinAlex VMD, MHScDepartments of Ophthalmology and PediatricsFlaum Eye InstituteGolisano Children's HospitalUniversity of RochesterRochester, New Yorkalex_levin@urmc.rochester.eduBaselDonaldMDChief, Pediatric GeneticsMedical College of Wisconsin;Children's WisconsinMilwaukee, Wisconsindbasel@mcw.eduSeminaElena VPhDMarjorie and Joseph Heil Professor of Ophthalmology & Visual SciencesDepartments of Ophthalmology, Pediatrics, and Cell Biology, Neurobiology, and AnatomyMedical College of WisconsinMilwaukee, Wisconsinesemina@mcw.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPeutz-Jeghers SyndromeSynonym: PJSMcGarrityThomas JMDDepartment of Medicine\nMilton S Hershey Medical Center\nHershey, Pennsylvaniatmcgarrity@psu.eduAmosChristopher IPhDDepartment of Medicine\nBaylor College of Medicine\nHouston, Texaschris.amos@bcm.eduBakerMaria JPhDDepartment of Medicine\nMilton S Hershey Medical Center;\nPenn State Hershey Cancer Institute\nHershey, Pennsylvaniambaker@pennstatehealth.psu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PEX7-</italic>Related Rhizomelic Chondrodysplasia PunctataSynonyms: PEX7-Rhizomelic CDP, Rhizomelic Chondrodysplasia Punctata Type 1BravermanNancy EMS, MDnancy.braverman@mcgill.caCarrollRickiMD, MBEricki.carroll@nemours.orgMussCandacePA-C, LCGCcandace.muss@nemours.orgFallatahWedadMD, MAS, PhDfallatah@kennedykrieger.orgJainMahimMD, PhDmahim.jain@nemours.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPhelan-McDermid Syndrome-<italic toggle=\"yes\">SHANK3</italic> RelatedSynonym: 22q13.3 Deletion SyndromePhelanKatyPhD, FACMGDirector of GeneticsFlorida Cancer Specialists and Research InstituteFort Myers, Floridakphelan@flcancer.comRogersR CurtisMD, FACMGSenior Clinical GeneticistRCR GeneticsGreenville, South Carolinarcrgenetics@gmail.comBoccutoLuigiMDClinical Associate ProfessorClemson UniversityClemson, South Carolinalboccut@clemson.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPhenylalanine Hydroxylase DeficiencySynonyms: Hyperphenylalaninemia, PAH Deficiency, Phenylketonuria (PKU)ArnoldGeorgianneMDVirtual Medical PracticeUniversity of PittsburghPittsburgh, Pennsylvaniaglarnold2757@gmail.comVockleyJerryMD, PhDUniversity of PittsburghPittsburgh, Pennsylvaniavockleyg@upmc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPhosphoribosylpyrophosphate Synthetase DeficiencySynonym: PRS Deficiencyde BrouwerArjan PMPhDDepartment of Human GeneticsRadboud UniversityNijmegen Medical CenterNijmegen, the Netherlandsarjan.debrouwer@radboudumc.nlChristodoulouJohnMBBS, PhDDirector and Genomic Medicine Theme and Group Co-LeaderBrain and Mitochondrial Research GroupMurdoch Children's Research Institute;Chair of Genomic MedicineDepartment of PaediatricsUniversity of MelbourneMelbourne, Australiajohn.christodoulou@mcri.edu.au\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPhosphoribosylpyrophosphate Synthetase Superactivityde BrouwerArjan PMPhDDepartment of Human GeneticsRadboud University Nijmegen Medical CenterNijmegen, the Netherlandsarjan.debrouwer@radboudumc.nlChristodoulouJohnMBBS, PhDDirector and Genetics Theme/Group Co-Leader, Brain and Mitochondrial Research GroupMurdoch Children's Research InstituteChair in Genomic Medicine, Department of PædiatricsUniversity of MelbourneMelbourne, Australiajohn.christodoulou@mcri.edu.au\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPhosphorylase Kinase DeficiencySynonyms: Glycogen Storage Disease Type IX, GSDIX, PhK Deficiency, Phosphorylase b Kinase DeficiencyHerbertMruduMD, MPHDepartment of PediatricsUniversity of KentuckyLexington, Kentuckymrudu.herbert@uky.eduGoldsteinJennifer LPhDDepartment of GeneticsUniversity of North Carolina - Chapel HillChapel Hill, North Carolinagoldjen@email.unc.eduRehderCatherinePhDMolecular Genetics LaboratoryDuke University Medical CenterDurham, North Carolinacatherine.rehder@duke.eduAustinStephanieMS, MA, CGCAmicus Therapeutics, IncPhildelphia, Pennsylvaniasaustin@amicusrx.comKishnaniPriya SMDClinical GeneticsDepartment of PediatricsDuke University Medical CenterDurham, North Carolinapriya.kishnani@duke.eduBaliDeeksha SPhDBiochemical Genetics LaboratoryDuke University Medical CenterDurham, North Carolinadbali@duke.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PI4KA</italic>-Related DisorderBapleEmma LBSc, MBBS, MRCPCH, PhDe.baple@exeter.ac.ukSalterClaireBMedSci, BMBS, PGCert, MRCPCHc.salter@exeter.ac.ukUhligHolmholm.uhlig@ndm.ox.ac.ukWolfNicole IMD, PhDn.wolf@amsterdamumc.nlCrosbyAndrew HBSc, PhDa.h.crosby@exeter.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PIK3CA</italic>-Related Overgrowth SpectrumSynonym: PROSMirzaaGhaydaMD, FAAP, FACMGSeattle Children's Research InstituteSeattle, Washingtonghayda.mirzaa@seattlechildrens.orgGrahamJohn MJrMD, ScDCedars Sinai Medical CenterLos Angeles, Californiajohn.graham@cshs.orgKeppler-NoreuilKimMD, FAAP, FACMGUniversity of Wisconsin School of Medicine and Public HealthMadison, Wisconsinkepplernoreu@wisc.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PIK3R1</italic>-Related SHORT SyndromeInnesA MicheilMD, FRCPC, FCCMGDepartment of Medical GeneticsUniversity of Calgary;Alberta Children's Hospital Research Institute for Child and Maternal HealthCalgary, Alberta, Canadamicheil.innes@albertahealthservices.caNeufeldStanleyPhD, MDDepartment of Medical GeneticsUniversity of CalgaryCalgary, Alberta, Canadastanley.neufeld@albertahealthservices.caDymentDavid ADPhil, MD, FRCPC, FCCMGDepartment of GeneticsChildren's Hospital of Eastern Ontario Research InstituteOttawa, Ontario, Canadaddyment@cheo.on.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PINK1</italic> Type of Young-Onset Parkinson DiseaseSynonym: PARK-PINK1LangeLara MMDla.lange@uni-luebeck.deKleinChristineMDchristine.klein@uni-luebeck.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPitt-Hopkins SyndromeSynonym: TCF4-Related Pitt-Hopkins SyndromeSweetserDavid AMD, PhDDivision of Medical Genetics and MetabolismMassGeneral for Children;Center for Genomic MedicineBoston, Massachusettsdsweetser@mgh.harvard.eduGipsonKevin SMD, MSDivision of Pediatric Pulmonology and Sleep MedicineMassGeneral for ChildrenBoston, Massachusettskgipson@mgh.harvard.eduZar-KesslerClaireMD, MPHDivision of Pediatric Gastroenterology and NutritionMassGeneral for ChildrenBoston, Massachusettsczarkessler@mgh.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PLA2G6</italic>-Associated NeurodegenerationSynonyms: NBIA2, PLA2G6-Related Disorders, PLANGregoryAllisonMS, CGCMolecular & Medical GeneticsOregon Health & Science UniversityPortland, Oregongregorya@ohsu.eduKurianManju AMA, MRCPCH, PhDMolecular NeurosciencesDevelopmental NeurosciencesUCL-Great Ormond Street Institute of Child HealthLondon, United Kingdommanju.kurian@ucl.ac.ukSooAudrey KSBSc, MBBS, MRCPCH, PhDPaediatric NeurologyGreat Ormond Street Hospital for Children;UCL-Great Ormond Street Institute of Child HealthLondon, United Kingdoma.soo@ucl.ac.ukWilsonJenny LMDPediatric NeurologyOregon Health & Science UniversityPortland, Oregonwilsjen@ohsu.eduHogarthPenelopeMDNeurology and Molecular & Medical GeneticsOregon Health & Science UniversityPortland, Oregonhogarthp@ohsu.eduHayflickSusan JMDMolecular & Medical Genetics, Pediatrics, and NeurologyOregon Health & Science UniversityPortland, Oregonhayflick@ohsu.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PLOD1</italic>-Related Kyphoscoliotic Ehlers-Danlos SyndromeSynonyms: Ehlers-Danlos Syndrome Type VIA (EDS VIA), Lysyl-Hydroxylase 1 Deficiency, PLOD1-kEDSRohrbachMarianneMD, PhDmarianne.rohrbach@kispi.uzh.chGiuntaCeciliaPhDcecilia.giunta@kispi.uzh.ch\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PLP1-</italic>Related DisordersWolfNicole IMD, PhDDepartment of Child NeurologyAmsterdam University Medical CenterAmsterdam, The Netherlandsn.wolf@amsterdamumc.nlvan SpaendonkRosalina MLPhDDepartment of Human GeneticsAmsterdam University Medical CenterAmsterdam, The Netherlandsr.vervenne@amsterdamumc.nlHobsonGrace MPhDNemours Biomedical ResearchNemours Hospital for ChildrenWilmington, Delawareghobson@nemours.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPLPBP DeficiencySynonyms: PLPHP Deficiency, PROSC Deficiency, Pyridoxal 5'-Phosphate Homeostasis Protein Deficiency, Pyridoxal 5'-Phosphate-Binding Protein Deficiency, PDE-PLPBPAl-ShekailiHilalPhDCentre for Molecular Medicine and TherapeuticsBC Children's Hospital Research InstituteUniversity of British ColumbiaVancouver, Canadahalshekaili@bcchr.caCiapaiteJolitaPhDDepartment of GeneticsUniversity Medical Center UtrechtUtrecht, the Netherlandsj.ciapaite@umcutrecht.nlvan KarnebeekClaraMD, PhDDepartments of Pediatrics and Human GeneticsEmma Center for Personalized MedicineAmsterdam University Medical CentersAmsterdam, the Netherlandsc.d.vankarnebeek@amsterdamumc.nlPenaIzabellaPhDScientist, CHEO Research Institute;Assistant Professor, Faculty of Medicine, University of OttawaOttawa, Canadaipena@cheo.on.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPMM2-CDGSynonyms: CDG-Ia, Congenital Disorder of Glycosylation Type 1a (CDG1a), Phosphomannomutase 2 DeficiencyLamChristinaMDUniversity of Washington;Seattle Children’s Research InstituteSeattle, Washingtonctlam2@uw.eduKrasnewichDonna MMD, PhDNational Institutes of HealthBethesda, Marylanddkras@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PNPLA6</italic> DisordersSynofzikMatthisMDDepartment of Neurodegenerative DiseasesHertie Institute for Clinical Brain ResearchUniversity of TübingenTübingen, Germanymatthis.synofzik@uni-tuebingen.deHufnagelRobert BMD, PhDNational Eye InstituteNational Institutes of HealthBethesda, Marylandrobert.hufnagel@nih.govZüchnerStephanMD, PhDDr John T Macdonald Foundation Department of Human GeneticsJohn P Hussman Institute for Human GenomicsUniversity of Miami Miller School of MedicineMiami, Floridaszuchner@med.miami.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPNPO DeficiencySynonym: Pyridox(am)ine 5'-Phosphate Oxidase DeficiencyPleckoBarbaraMDProfessor of PediatricsService for Child Neurology and Inherited Metabolic DisordersDivision of General PediatricsDepartment of Pediatrics and Adolescent MedicineMedical University of GrazGraz, Austriabarbara.plecko@medunigraz.atMillsPhilippaPhDProfessor of Inherited Metabolic DiseasesUniversity College LondonGreat Ormond Street Institute of Child HealthLondon, United Kingdomp.mills@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPoikiloderma with NeutropeniaSynonym: Clericuzio-Type Poikiloderma with NeutropeniaWangLisaMDDepartment of PediatricsHematology/OncologyBaylor College of MedicineHouston, Texasllwang@bcm.eduClericuzioCarolMDEmeritus Professor of PediatricsDivision of Pediatric GeneticsUniversity of New Mexico School of MedicineAlbuquerque, New Mexicocclericuzio@salud.unm.eduLarizzaLidiaMDResearch Laboratory of Medical Cytogenetics & GeneticsIRCSS Istituto Auxologico ItalianoMilan, Italyl.larizza@auxologico.itConcolinoDanielaMDChief of PediatricsUniversity \"Magna Graecia\"Catanzaro, Italydconcolino@unicz.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">POLG</italic>-Related DisordersCohenBruce HMDNeuroDevelopmental Science Center and the Rebecca D Considine Research InstituteAkron Children's HospitalNortheast Ohio Medical UniversityAkron, Ohiobcohen@akronchildrens.orgChinneryPatrick FBMedSci, MBBS, PhD, FRCPath, FRCP, FMedSciDepartment of Clinical Neurosciences & MRC Mitochondrial Biology UnitUniversity of CambridgeCambridge, United Kingdompfc25@cam.ac.ukCopelandWilliam CPhDMitochondrial DNA Replication GroupGenome Integrity and Structural Biology LaboratoryNational Institute of Environmental Health Sciences / NIHResearch Triangle Park, North Carolinacopelan1@niehs.nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPOLR3-Related LeukodystrophySynonym: 4H LeukodystrophyBernardGenevièveMD, MSc, FRCPcDepartments of Neurology and Neurosurgery and Pediatrics, McGill UniversityDepartment of Medical Genetics, McGill University Health CenterChild Health and Human Development Program, Research Institute of the McGill University Health CenterMontreal, Quebec, Canadagenevieve.bernard@mcgill.caVanderverAdelineMDDivision of NeurologyChildren's Research InstituteChildren's Hospital of PhiladelphiaPhiladelphia, Pennsylvaniavandervera@email.chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPolycystic Kidney Disease, Autosomal DominantSynonym: ADPKDHarrisPeter CPhDharris.peter@mayo.eduTorresVicente EMD, PhDtorres.vicente@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPolycystic Lipomembranous Osteodysplasia with Sclerosing LeukoencephalopathySynonyms: Nasu-Hakola Disease, PLOSLPalonevaJuhaMD, PhDOulu University Hospital;University of OuluOulu, Finlandjuha.paloneva@fimnet.fiAuttiTainaMD, PhDUniversity of HelsinkiHelsinki Medical Imaging CenterHelsinki, Finlandtaina.autti@hus.fiSoljeEinoMD, PhDUniversity of Eastern Finland; Kuopio University HospitalKuopio, Finlandeino.solje@uef.fiHaltiaMatti JMD, PhDDepartment of PathologyHaartman InstituteUniversity of HelsinkiHelsinki, Finlandmatti.j.haltia@helsinki.fi\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPolymicrogyria Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLYStutterdChloe AMBBS, FRACPMurdoch Children's Research InstituteDepartment of PaediatricsUniversity of MelbourneRoyal Children's HospitalMelbourne, Australiachloe.stutterd@mcri.edu.auDobynsWilliam BMDDepartments of Pediatrics and NeurologyUniversity of WashingtonCenter for Integrative Brain ResearchSeattle Children's Research InstituteSeattle, Washingtonwbd@uw.eduJansenAnnaMD, PhDPediatric Neurology UnitUZ BrusselNeurogenetics Research GroupVrije Universiteit BrusselBrussels, Begiumanna.jansen@uzbrussel.beMirzaaGhaydaMDCenter for Integrative Brain ResearchSeattle Children's Research InstituteSeattle, Washingtongmirzaa@uw.eduLeventerRichard JMBBS, BMedSci, PhD, FRACPDepartment of NeurologyRoyal Children's HospitalMurdoch Children's Research InstituteDepartment of PaediatricsUniversity of MelbourneMelbourne, Australiarichard.leventer@rch.org.au\n\nSummary\n\n Definition and Clinical Characteristics of Polymicrogyria\n\n Genetic Causes of Polymicrogyria\n\n Evaluation Strategy to Identify the Genetic Cause of PMG in a Proband\n\n Genetic Counseling of Family Members of an Individual with PMG\n\nResources\n\nChapter Notes\n\nReferences\n\nPompe DiseaseSynonyms: Acid Alpha-Glucosidase Deficiency, Acid Maltase Deficiency, GAA Deficiency, Glycogenosis Type II, Glycogen Storage Disease Type II (GSD II)SperryEthanMD, PhDethan.sperry@cchmc.orgLeslieNancyMDnancy.leslie@cchmc.orgBerryLisaMSlisa.berry@cchmc.orgPenaLorenMD, PhDloren.pena@alumni.duke.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PORCN</italic>-Related Developmental DisordersSynonyms: Focal Dermal Hypoplasia, Goltz Syndrome, Goltz-Gorlin SyndromeSuttonV ReidMDProfessor, Department of Molecular and Human GeneticsBaylor College of MedicineHouston, Texasvrsutton@texaschildrens.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">POT1</italic> Tumor PredispositionAccardoMarie-LouiseMS, CGCmvhenry@med.umich.eduOsborneJenaeMS, CGCjenaej@med.umich.eduElseTobiasMDtelse@med.umich.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPotocki-Lupski SyndromeSynonyms: Duplication 17p11.2 Syndrome, PTLSPotockiLorraineMD, FACMGlpotocki@bcm.eduNeira-FresnedaJuanitaMDjuanita.neira@bcm.eduYuanBoPhDby2@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">PPP1R12A</italic>-Related Urogenital and/or Brain Malformation SyndromeAlkhunaiziEbbaMDDepartment of Clinical GeneticsNorth York General HospitalToronto, Ontario, Canadaebba.alkhunaizi@mail.mcgill.caChitayatDavidMDThe Prenatal Diagnosis and Medical Genetics ProgramDepartment of Obstetrics and GynecologyMount Sinai Hospital;Division of Clinical and Metabolic GeneticsDepartment of PediatricsThe Hospital for Sick ChildrenUniversity of TorontoToronto, Ontario, Canadadavid.chitayat@sinaihealth.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PPP1R21</italic>-Related El-Hattab-Schmidts SyndromeSynonyms: El-Hattab-Schmidts Syndrome; Neurodevelopmental Disorder with Hypotonia, Facial Dysmorphism, and Brain Abnormalities (NEDHFBA)AlmannaiMohammedMD, FAAP, FACMGGenetics and Precision Medicine Department (GPM)King Abdullah Specialized Children's Hospital (KASCH)King Abdulaziz Medical CityMinistry of National Guard Health Affairs (MNG-HA)Riyadh, Saudi Arabiammannai81@gmail.comMarafiDanaMD, MScAssistant Professor, Department of PediatricsCollege of MedicineKuwait UniversityKuwait City, Kuwaitdana.marafie@ku.edu.kwEl-HattabAyman WMD, FAAP, FACMGProfessor, Department of Clinical SciencesCollege of MedicineUniversity of SharjahSharjah, United Arab Emirateselhattabaw@yahoo.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PPP2R1A</italic>-Related Neurodevelopmental DisorderDouzgouSofiaMD, PhDsofia.douzgou.houge@helse-bergen.noJanssensVeerlePhDveerle.janssens@kuleuven.beHougeGunnarMD, PhDgunnar.douzgos.houge@helse-bergen.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PPP2R5D</italic>-Related Neurodevelopmental DisorderSynonyms: Jordan's Syndrome, PPP2 Syndrome Type R5DMirzaaGhaydaMDUniversity of WashingtonSeattle, Washingtonghayda.mirzaa@seattlechildrens.orgFossKimberlyMS, CGCUniversity of North Carolina at Chapel HillChapel Hill, North Carolinakimberly_foss@med.unc.eduSudnawaKhemikaMDPhramongkutklao Hospital; Phramongkutklao College of MedicineBangkok, Thailandk.sudnawa@pcm.ac.thChungWendy KMD, PhDBoston Children's Hospital;Harvard Medical SchoolBoston, Massachusettswendy.chung@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPrader-Willi SyndromeSynonym: Prader-Labhart-Willi SyndromeDriscollDaniel JMD, PhD, FFACMGG, FAAPProfessor of Pediatrics and GeneticsHayward Professor of Genetics ResearchUniversity of Florida College of MedicineGainesville, Floridadriscdj@peds.ufl.eduMillerJennifer LMD, MS, FAAPProfessor of PediatricsDivision of Pediatric EndocrinologyUniversity of Florida College of MedicineGainesville, Floridamillejl@peds.ufl.eduCassidySuzanne BMD, FFACMGGClinical Professor of PediatricsDivision of Medical GeneticsUniversity of California, San FranciscoSan Francisco, Californiasuzannecassidy@comcast.net\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PRICKLE1</italic>-Related DisordersMastrangeloMarioMD, PhDmario.mastrangelo@uniroma1.itCaputiCaterinaMDcaterina.caputi@uniroma1.itEspositoDarioMDdario.esposito@uniroma1.itLeuzziVincenzoMDvincenzo.leuzzi@uniroma1.it\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPrimary Carnitine DeficiencySynonyms: Carnitine Deficiency, Carnitine Transport Defect (CTD), Carnitine Uptake Defect (CUD), Systemic Primary Carnitine DeficiencyEl-HattabAyman WMD, FAAP, FACMGProfessor, Department of Clinical SciencesCollege of MedicineUniversity of SharjahSharjah, United Arab Emirateselhattabaw@yahoo.comAlmannaiMohammedMD, FAAP, FACMGGenetics and Precision Medicine department (GPM)King Abdullah Specialized Children's Hospital (KASCH)King Abdulaziz Medical CityMinistry of National Guard Health Affairs (MNG-HA)Riyadh, Saudi Arabiammannai81@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPrimary Ciliary DyskinesiaSynonyms: Immotile Cilia Syndrome, Kartagener SyndromeZariwalaMaimoona AMSc, PhD, FACMGDepartment of PediatricsMarsico Lung InstituteUniversity of North Carolina at Chapel HillChapel Hill, North Carolinazariwala@med.unc.eduDespotesKatherine AMDDepartment of PediatricsPediatric PulmonaryDepartment of MedicinePulmonary and Critical Care MedicineUniversity of North Carolina at Chapel HillChapel Hill, North Carolinakatherine.despotes@unchealth.unc.eduDavisStephanie DMDUNC Children’s;Department of PediatricsUniversity of North Carolina at Chapel HillChapel Hill, North Carolinastephanie_davis@med.unc.edu\n\nSummary\n\n Clinical Characteristics of Primary Ciliary Dyskinesia\n\n Causes of Primary Ciliary Dyskinesia\n\n Differential Diagnosis of Primary Ciliary Dyskinesia\n\n Evaluation Strategy to Identify the Genetic Cause of Primary Ciliary Dyskinesia\n\n Management\n\n Genetic Counseling of Family Members of an Individual with Primary Ciliary Dyskinesia\n\nResources\n\nChapter Notes\n\nReferences\n\nPrimary Coenzyme Q<sub>10</sub> Deficiency OverviewSynonym: Primary Ubiquinone DeficiencySalviatiLeonardoMD, PhDleonardo.salviati@unipd.itTrevissonEvaMD, PhDeva.trevisson@unipd.itAgostoCaterinaMDcaterina.agosto@aopd.veneto.itDoimoMaraPhDmara.doimo@unipd.itNavasPlacidoPhDpnavas@upo.es\n\nSummary\n\n Clinical Characteristics of Primary Coenzyme Q<sub>10</sub> Deficiency\n\n Genetic Causes of Primary Coenzyme Q<sub>10</sub> Deficiency\n\n Differential Diagnosis of Primary Coenzyme Q<sub>10</sub> Deficiency\n\n Evaluation Strategies to Identify the Genetic Cause of Primary Coenzyme Q<sub>10</sub> Deficiency in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nPrimary Familial and Congenital ErythrocytosisSynonyms: ECYT1, Familial Erythrocytosis Type 1, Primary Familial and Congenital PolycythemiaPrchalJosefMDUniversity of Utah; Huntsman Cancer Center;VA Health CareSalt Lake City, Utahjosef.prchal@hsc.utah.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPrimary Familial Brain Calcification OverviewBalckAlexanderMDalexander.balck@uni-luebeck.deKleinChristineMDchristine.klein@uni-luebeck.deWestenbergerAnaPhDana.westenberger@uni-luebeck.de\n\nSummary\n\n Clinical Characteristics of Primary Familial Brain Calcification\n\n Genetic Causes of Primary Familial Brain Calcification\n\n Differential Diagnosis of Primary Familial Brain Calcification\n\n Evaluation Strategies to Identify the Genetic Cause of Primary Familial Brain Calcification in a Proband\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nPrimary Hyperoxaluria Type 1MillinerDawn SMDmilliner.dawn@mayo.eduHarrisPeter CPhDharris.peter@mayo.eduSasDavid JDOsas.david@mayo.eduCogalAndrea GBScogal.andrea@mayo.eduLieskeJohn CMDlieske.john@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPrimary Hyperoxaluria Type 2Synonym: Glyoxylate Reductase/Hydroxypyruvate Reductase DeficiencyRumsbyGillPhD, FRCPathConsultant Clinical Scientist, Clinical BiochemistrUniversity College London HospitalsLondon, United Kingdomgill.rumsby@nhs.netHultonSally-AnneMD, FRCP, FRCPCH, MBBChConsultant Nephrologist, Birmingham Children’s HospitalNHS Foundation TrustBirmingham, United Kingdomsally.hulton@bch.nhs.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPrimary Hyperoxaluria Type 3MillinerDawn SMDmilliner.dawn@mayo.eduHarrisPeter CPhDharris.peter@mayo.eduSasDavid JDOsas.david@mayo.eduLieskeJohn CMDlieske.john@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPrimary Mitochondrial Disorders OverviewChinneryPatrick FBMedSci, MBBS, PhD, FRCPath, FRCP, FMedSciDepartment of Clinical NeurosciencesUniversity of CambridgeCambridge, United Kingdompfc25@medschl.cam.ac.uk\n\nSummary\n\n Clinical Characteristics of Mitochondrial Disorders\n\n Evaluation Strategies to Identify the Genetic Cause of a Mitochondrial Disorder in a Proband\n\n Patient Care Guidelines\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nPrimary Pyruvate Dehydrogenase Complex Deficiency OverviewSynonyms: PDH Deficiency (PDHD), PDHC Deficiency, Pyruvate Dehydrogenase Complex Deficiency Disease (PDCDD), Pyruvate Dehydrogenase DeficiencyGanetzkyRebeccaMDganetzkyr@chop.eduMcCormickElizabeth MMS, LCGCmccormicke@chop.eduFalkMarni JMDfalkm@chop.edu\n\nSummary\n\n Clinical Characteristics of Primary Pyruvate Dehydrogenase Complex Deficiency\n\n Causes of Primary Pyruvate Dehydrogenase Complex Deficiency\n\n Differential Diagnosis of Primary Pyruvate Dehydrogenase Complex Deficiency\n\n Evaluation Strategies to Identify the Genetic Cause of Primary Pyruvate Dehydrogenase Complex Deficiency in a Proband\n\n Management of Pyruvate Dehydrogenase Complex Deficiency Based on Genetic Cause\n\n Genetic Risk Assessment of Family Members of a Proband with Primary Pyruvate Dehydrogenase Complex Deficiency\n\nResources\n\nChapter Notes\n\nReferences\n\nPrimary TrimethylaminuriaSynonyms: Fish Odor Syndrome, FMO3 Deficiency, TMAU, TMAuriaPhillipsIan RPhDEmeritus Professor of Molecular BiologySchool of Biological and Chemical SciencesQueen Mary, University of LondonVisiting Professor, Division of BiosciencesUniversity College LondonLondon, United Kingdomi.r.phillips@qmul.ac.uki.r.phillips@ucl.ac.ukShephardElizabeth AMSc, PhDProfessor of Molecular BiologyDepartment of Structural and Molecular BiologyUniversity College LondonLondon, United Kingdome.shephard@ucl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPrimrose SyndromeAroraVeronicaMDveronicaarora@gmail.comFerreiraCarlos RMD, FACMGcarlos.ferreira@nih.govDua PuriRatnaMDratnadpuri@gmail.comVermaIshwar ChandarMDicverma@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nLiterature Cited\n\nProgressive Myoclonic Epilepsy Type 1Synonyms: EPM1, Unverricht-Lundborg Disease (ULD)LehesjokiAnna-ElinaMD, PhDFolkhälsan Research Center and University of HelsinkiHelsinki, Finlandanna-elina.lehesjoki@helsinki.fiKälviäinenReettaMD, PhDKuopio Epilepsy CenterKuopio University HospitalMember, EpiCARE ERNUniversity of Eastern FinlandKuopio, Finlandreetta.kalviainen@kuh.fi\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nProgressive Myoclonus Epilepsy, Lafora TypeSynonyms: Lafora Body Disease, Lafora Disease, Progressive Myoclonic Epilepsy Type 2 (EPM2)MinassianBergeMDUniversity of Texas SouthwesternDallas, Texasberge.minassian@utsouthwestern.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nProgressive Pseudorheumatoid DysplasiaSynonyms: Progressive Pseudorheumatoid Arthropathy of Childhood, Spondyloepiphyseal Dysplasia Tarda with Progressive ArthropathyBhavaniGandham SriLakshmiMSc, PhDgslbhavani2016@gmail.comAl RashdiSamiyaMScsamiya7@squ.edu.omShahHiteshMSHitesh.shah@manipal.eduShuklaAnjuMD, DManju.shukla@manipal.eduDalalAshwinMD, DMadalal@cdfd.org.inGirishaKatta MohanMD, DM, PhDg.kumar@squ.edu.om\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nProlidase DeficiencyRossignolFrancisMDfrancis.rossignol@nih.govWangHengMD, PhDwang@ddcclinic.orgFerreiraCarlosMDcarlos.ferreira@nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PROP1</italic>-Related Combined Pituitary Hormone DeficiencySynonym: PROP1-Related CPHDCarvalhoLuciani RenataMD, PhDluciani.carvalho@hc.fm.usp.brNishiMirian YumiePhDminishi@usp.brCorreaFernanda AzevedoMDfernandacorrea@usp.brMoreira MarquesJulianaPhDjulianamoreira@usp.brArnholdIvo Jorge PradoMDiarnhold@usp.brMendoncaBerenice BMDberemen@usp.br\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPropionic AcidemiaGalarreta AimaCarolina IMDcarolina.galarretaaima@nih.govShchelochkovOleg AMDoleg.shchelochkov@nih.govJerves SerranoTeodoroMDteodoro.jervesserrano@yale.eduVendittiCharles PMD, PhDvenditti@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nProteus SyndromeBieseckerLeslie GMDlesb@mail.nih.govSappJulie CScMsappj@mail.nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nProthrombin ThrombophiliaSynonym: Prothrombin G20210A ThrombophiliaKujovichJody LMDAssistant Professor of Pediatrics and Medicine, Department of Pediatric Hematology/Oncology\nOregon Health and Science University\nPortland, Oregonkujovich@ohsu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PRRT2</italic>-Related DisorderYangKathrynMD, FRCPCkathryn.yang@childrens.harvard.eduQuirozVincenteMDvicente.quiroz@childrens.harvard.eduEbrahimi-FakhariDariusMD, PhDdarius.ebrahimi-fakhari@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PRSS1</italic>-Related Hereditary PancreatitisWhitcombDavid CMD, PhDMedicine, Cell Biology & Physiology, and Human GeneticsUniversity of Pittsburgh & University of Pittsburgh Medical CenterPittsburgh, Pennsylvaniawhitcomb@pitt.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPseudohypoaldosteronism Type IISynonyms: Familial Hyperkalemic Hypertension, Gordon's Syndrome, PHAIIEllisonDavid HMDOregon Health & Science UniversityPortland, Oregonellisond@ohsu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nPseudoxanthoma ElasticumSynonym: PXETerrySharon FMAPXE InternationalWashington, DCsterry@pxe.orgUittoJouniMD, PhDThomas Jefferson UniversityPhiladelphia, Pennsylvaniajouni.uitto@jefferson.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PTDSS1</italic>-Related Lenz-Majewski Hyperostotic DysplasiaSynonyms: Lenz-Majewski Hyperostotic Dwarfism, Lenz-Majewski Hyperostotic Dysplasia, Lenz-Majewski SyndromeBuasriKochakornMDkochakorn.buasri@cchmc.orgSlavotinekAnnePhD, MBBSanne.slavotinek@cchmc.orgWattanasirichaigoonDuangrurdeeMDduangrurdee.wat@mahidol.ac.th\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PTEN</italic> Hamartoma Tumor SyndromeSynonym: PHTSYehiaLamisPhDGenomic Medicine InstituteCleveland ClinicCleveland, Ohioyehial@ccf.orgEngCharisMD, PhDGenomic Medicine InstituteCleveland Clinic;Department of Genetics & Genome SciencesCase Western Reserve University School of MedicineCleveland, Ohioengc@ccf.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PTH1R</italic>-Related Jansen Metaphyseal ChondrodysplasiaSynonyms: Jansen Disease; Jansen Metaphyseal Dysplasia; Murk Jansen Metaphyseal Chondrodysplasia; PTH1R-Related Metaphyseal Dysplasia, Jansen TypeObiezuFionaMDfiona.obiezu@nih.govBoyceAlisonMDalison.boyce@nih.govJüppnerHaraldMDhjueppner@mgh.harvard.eduJhaSmitaMDsmita.jha@nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PTS</italic>-Related Tetrahydrobiopterin Deficiency (PTPSD)Synonyms: 6-Pyruvoyl-Tetrahydropterin Synthase Deficiency, PTS DeficiencyOpladenThomasMDCenter for Pediatric and Adolescent MedicineDepartment IDivision of Pediatric Neurology and Metabolic MedicineMedical Faculty HeidelbergHeidelberg UniversityHeidelberg, Germanythomas.opladen@med.uni-heidelberg.deLongoNicolaMD, PhDDivision of Clinical GeneticsDepartment of Human GeneticsUniversity of California Los AngelesLos Angeles, Californianlongo@mednet.ucla.eduBlauNenadPhDDivision of MetabolismUniversity Children's Hospital ZurichZurich, Switzerlandnenad.blau@kispi.uzh.ch\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPulmonary Fibrosis Predisposition OverviewGarciaChristine KimMD, PhDColumbia University Medical CenterNew York, New Yorkckg2116@cumc.columbia.eduTalbertJanet LMS, CGC, LGCVanderbilt University Medical CenterNashville, Tennesseejanet.talbert@vumc.org\n\nSummary\n\n Clinical Characteristics of Pulmonary Fibrosis\n\n Genetic Causes of Pulmonary Fibrosis\n\n Differential Diagnosis of Pulmonary Fibrosis\n\n Evaluation Strategies to Identify the Genetic Cause of Pulmonary Fibrosis in a Proband\n\n Management of Pulmonary Fibrosis\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">PURA-</italic>Related Neurodevelopmental DisordersSynonym: PURA-Related Developmental and Epileptic EncephalopathyReijndersMargot RFMD, PhDm.r.f.reijnders@erasmusmc.nlLeventerRichard JMBBS, BMedSci, PhD, FRACPrichard.leventer@rch.org.auLeeBo HoonMDbohoon_lee@urmc.rochester.eduBaralleDianaMBBS, MD, FRCPd.baralle@soton.ac.ukSelberPauloMD, SBOT, FRACSselberpoffice@hss.eduPaciorkowskiAlex RMD, FACMGalex_paciorkowski@urmc.rochester.eduSt JohnMiyaBSc, MAppLing, MspPath, PhDmiya.stjohn@mcri.edu.auMorganAngela TBSpPath (AudHons), PhDangela.morgan@mcri.edu.auAndersonMelBEdPGDipmel.anderson@purafoundation.auHildebrandMichael SPhDmichael.hildebrand@unimelb.edu.auSanchezL DengleMDlauren.sanchez@utsouthwestern.eduHuntDavidMBBS, PhD, MRCPdavid.hunt2@uhs.nhs.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPycnodysostosisSynonyms: Pyknodysostosis, Toulouse-Lautrec Syndrome, CTSK-Related PyknodysostosisLeBlancShannonMBBSshannon.leblanc@vcgs.org.auSavarirayanRaviMBBS, MD, FRACP, ARCPA (Hon)ravi.savarirayan@vcgs.org.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPyridoxine-Dependent Epilepsy – <italic toggle=\"yes\">ALDH7A1</italic>Synonyms: AASADH Deficiency, ALDH7A1 Deficiency, Alpha Aminoadipic Semialdehyde (α-AASA) Dehydrogenase Deficiency, Antiquitin (ATQ) Deficiency, PDE-ALDH7A1GospeSidney MJrMD, PhDsgospe@uw.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nPyruvate Carboxylase DeficiencyDuque LasioMaria LauraMDlduque@wustl.eduLehmanApril NMDapril.lehman2@nationwidechildrens.orgAhmadAyeshaMDayeshaah@med.umich.eduBedoyanJirair KMD, PhDjbedoyan@pitt.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nRAB18 DeficiencyHandleyMarkPhDm.handley@leeds.ac.ukSheridanEamonnMDe.sheridan@leeds.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">RAB32</italic>-Related Parkinson DiseaseSynonym: PARK-RAB32ChmielaTomaszMD, PhDchmiela.tomasz@mayo.edutchmiela@sum.edu.plWszolekZbigniew KMDwszolek.zbigniew@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">RERE</italic>-Related DisordersSynonym: Neurodevelopmental Disorder with or without Anomalies of the Brain, Eye, or Heart (NEDBEH)ScottDaryl AMD, PhDMolecular & Human Genetics, Molecular Physiology & Biophysics\nBaylor College of Medicine\nHouston, Texasdscott@bcm.eduSherrElliott HMD, PhDDepartments of Neurology & Pediatrics\nWeill Institute of Neuroscience & Institute of Human Genetics\nUniversity of California, San Francisco\nSan Francisco, Californiaelliott.sherr@ucsf.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nRetinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic ManifestationsSynonyms: Cerebroretinal Vasculopathy (CRV); Hereditary Endotheliopathy, Retinopathy, Nephropathy, and Stroke (HERNS); Hereditary Systemic Angiopathy (HSA); Hereditary Vascular Retinopathy (HVR); Retinal Vasculopathy with Cerebral Leukodystrophy (RVCL); RVCL-Sde BoerIreneMDideboer@lumc.nlPelzerNadineMD, PhDn.pelzer@lumc.nlTerwindtGiselaMD, PhDg.m.terwindt@lumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nRetinoblastomaLohmannDietmar RMDProfessor, Eye Oncogenetics Research GroupInstitute of Human GeneticsUniversity Hospital EssenEssen, Germanydlohmann@me.comGallieBrenda LMDProfessor, University of TorontoRetinoblastoma ProgramHospital for Sick ChildrenToronto, Ontario, Canadabrenda@gallie.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">RFC1</italic> CANVAS / Spectrum DisorderCorteseAndreaMD, PhDandrea.cortese@ucl.ac.ukReillyMary MMB, Bch, BAO, MDm.reilly@ucl.ac.ukHouldenHenryMD, PhDh.houlden@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nRhabdoid Tumor Predisposition SyndromeSynonyms: Rhabdoid Predisposition Syndrome, RTPSNemesKarolinaMD, PhDkarolina.nemes@uk-augsburg.deBensSusanneMDsusanne.bens@uni-ulm.deBourdeautFranckMD, PhDfranck.bourdeaut@curie.frJohannPascalMDpascal.johann@uk-augsburg.deKordesUweMDkordes@uke.deSiebertReinerMD, Profreiner.siebert@uni-ulm.deFrühwaldMichael CMD, PhD, Profmichael.fruehwald@uk-augsburg.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nRiboflavin Transporter DeficiencyCaliElisaMDe.cali@ucl.ac.ukDominikNataliaBSc, MScn.dominik@ucl.ac.ukManoleAndreeaBSc, PhDandreea.manole.13@ucl.ac.ukHouldenHenryMD, PhDh.houlden@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nRitscher-Schinzel SyndromeSynonyms: 3C Syndrome, Cranio-Cerebello-Cardiac DysplasiaElliottAlison MPhD, MS, CGCUniversity of British ColumbiaVancouver, British Columbia, Canadaaelliott@bcchr.caChudleyAlbertMDUniversity of ManitobaWinnipeg, Manitoba, Canadaabchudley@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">RNU4-2</italic>–Related Autosomal Dominant Neurodevelopmental DisorderSynonym: ReNU SyndromeBarbosaMafaldaMD, PhD, FACMGDivision of Medical Genetics and GenomicsDepartment of Genetics and Genomic SciencesThe Mindich Child Health and Development InstituteIcahn School of Medicine at Mount SinaiNew York, New Yorkmafalda.barbosa@mssm.eduChopraMayaMBBS, FRACPRosamund Stone Zander Translational Neuroscience CenterBoston Children's HospitalBoston, Massachusettsmaya.chopra@childrens.harvard.eduTurroErnestPhDDepartment of Genetics and Genomic SciencesIcahn School of Medicine at Mount SinaiNew York, New Yorkernest.turro@mssm.eduValenzuela PalafollIreneMSc, MDClinical and Molecular Genetics AreaVall d'Hebron Hospital; Medicine Genetics GroupVall d'Hebron Research Institute (VHIR)Barcelona, Spainirene.valenzuela@vallhebron.cat\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nRNU4atac-opathySynonym: RNU4ATAC Spectrum DisorderDukerAngelaMSaduker@nemours.orgVelascoDanitaMDdvelasco@unmc.eduRobertsonNicMRCPCH, PhDnic.robertson@ed.ac.ukJacksonAndrewMRCP, PhDandrew.jackson@ed.ac.ukDeFeliceMageeMDmagee.defelice@nemours.orgBoberMichael BMD, PhDmbober@nemours.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">ROR2</italic>-Related Robinow SyndromeSynonym: Fetal Face SyndromeBacinoCarlos AMDDepartment of Molecular and Human Genetics\nBaylor College of Medicine\nHouston, Texascbacino@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nRothmund-Thomson SyndromeWangLisa LMDAssociate Professor, Division of Hematology/Oncology\nDepartment of Pediatrics\nTexas Children's Cancer Center\nTexas Children's Hospital\nBaylor College of Medicine\nHouston, Texasllwang@bcm.eduPlonSharon EMD, PhD, FACMGProfessor, Departments of Pediatrics and Molecular and Human Genetics\nTexas Children's Hospital\nBaylor College of Medicine\nHouston, Texassplon@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nRotor SyndromeSynonym: Rotor-Type HyperbilirubinemiaJirsaMilanMD, PhDInstitute for Clinical and Experimental MedicinePrague, Czech Republicmiji@ikem.czKniselyASMDZLP - Zentrum für Leber- und PankreaspathologieSt Pölten, Austriaasknisely@gmail.comSchinkelAlfredPhDNetherlands Cancer InstituteAmsterdam, the Netherlandsa.schinkel@nki.nlKmochStanislavPhDDepartment of Pediatrics and Inherited Metabolic DisordersCharles UniversityPrague, Czech Republicskmoch@lf1.cuni.cz\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">RPS6KA3</italic>-Related Intellectual DisabilityRogersR CurtisMDSenior Clinical GeneticistGreenwood Genetic CenterGreenville, South Carolinacrogers@ggc.orgAbidiFatima EPhD, MS, FACMGAssociate Director, Molecular Diagnostic LaboratoryGreenwood Genetic CenterGreenwood, South Carolinafatimaabidi@ggc.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">RRM2B</italic> Mitochondrial DNA Maintenance DefectsLimAlbert ZMBBS (Hons), MRCPCHalbert.lim@ncl.ac.ukMcFarlandRobertMA, MBBS, PhDrobert.mcfarland@ncl.ac.ukTaylorRobert WPhD, FRCPathrobert.taylor@ncl.ac.ukGormanGráinne SMB BCh, BAO (NUI), LRCP&SI (Hons), PhDgrainne.gorman@ncl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nRubinstein-Taybi SyndromeSynonym: Broad Thumb-Hallux SyndromeStevensCathy AMDDirector, Medical GeneticsProfessor, PediatricsUniversity of Tennessee College of MedicineChattanooga, Tennesseecathy.stevens@erlanger.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">RUNX1</italic> Familial Platelet Disorder with Associated Myeloid MalignanciesSynonyms: Familial Platelet Disorder / Acute Myeloid Leukemia (FPD/AML), RUNX1 Familial Platelet Disorder (FPD)DeuitchNatalieMS, CGCnatalie.deuitch@nih.govBroadbridgeElizabethBSliesl.broadbridge@nih.govCunninghamLeaMDlea.cunningham@nih.govLiuPaulMD, PhDpliu@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSaethre-Chotzen SyndromeSynonym: Acrocephalosyndactyly Type IIIGallagherEmily RMD, MPHChildren's Craniofacial Center\nSeattle Children's Hospital;\nDepartment of Pediatrics\nUniversity of WashingtonSeattle, Washingtonegalla@uw.eduRatisoontornChootimaDDS, PhDDepartment of Operative Dentistry\nChulalongkorn UniversityBangkok, ThailandCunninghamMichael LMD, PhDMedical Director, Children's Craniofacial Center\nSeattle Children's Hospital;\nDepartments of Pediatrics, Biological Structure, Pediatric Dentistry, and Oral Biology\nUniversity of Washington Schools of Medicine and DentistrySeattle, Washingtonmcunning@uw.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSalih MyopathyHackmanPeterPhDpeter.hackman@helsinki.fiSavareseMarcoPhDmarco.savarese@helsinki.fiDi FeoMaria FrancescaMDmariafrancesca.difeo@helsinki.fiUddBjarneMD, PhDbjarne.udd@pshp.fiSalihMustafa AMB BS, MPCH, MD, Dr Med Sci, FRCPCH, FAANmustafa_salih05@yahoo.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SALL1</italic>-Related Townes-Brocks SyndromeGrazianoClaudioMDU.O. Genetica MedicaAzienda USL della RomagnaRavenna, Italyclaudio.graziano2@auslromagna.itOlivucciGiuliaMDIRCCS Azienda Ospedaliero-Universitaria di BolognaBologna, Italygiulia.olivucci2@unibo.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SALL4</italic>-Related DisordersKohlhaseJürgenMDSYNLAB Center for Human Genetics\nFreiburg, Germanyjuergen.kohlhase@synlab.com\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SAMD9L</italic> Ataxia-Pancytopenia SyndromeSynonym: SAMD9L-ATXPC SyndromeRaskindWendy HMD, PhDwendyrun@uw.eduChenDong-HuiMD, PhDcdhui@uw.eduBirdThomasMDtomnroz@uw.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSandhoff DiseaseSynonym: Type II GM2 GangliosidosisXiaoChangruiMDchangrui.xiao@nih.govTifftCynthiaMD, PhDcynthiat@mail.nih.govToroCamiloMDtoroc@mail.nih.gov\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SATB2-</italic>Associated SyndromeSynonyms: 2q32 Deletion Syndrome, 2q33.1 Microdeletion Syndrome, Glass SyndromeZarateYuri AMDyuri.zarate@uky.eduBosankoKatherineMSkbbosanko@uams.eduFishJenniferPhDjennifer_fish@uml.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSaul-Wilson SyndromeSynonym: Microcephalic Osteodysplastic DysplasiaFerreiraCarlosMDMedical Genomics and Metabolic Genetics BranchNational Human Genome Research InstituteNational Institutes of HealthBethesda, Marylandcarlos.ferreira@nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SCARB2</italic>-Related Action Myoclonus – Renal Failure SyndromeXiaoChangruiMDchangrx@hs.uci.eduAhnHaejunMDhcahn@stanford.eduKibromSaraMDskibrom@stanford.eduToroCamiloMDtoroc@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSchaaf-Yang SyndromeSynonym: Chitayat-Hall SyndromeSchaafChristian PMD, PhDchristian.schaaf@med.uni-heidelberg.deMarbachFelixMDfelix.marbach@med.uni-heidelberg.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSchimke Immunoosseous DysplasiaSynonyms: SMARCAL1-Related Immuno-osseous Dysplasia (Schimke Type)LippnerElizabethMDelippner@luriechildrens.orgLückeThomasMD, PhDluecke.thomas@ruhr-uni-bochum.deSalgadoCarlosMDsalgado1@stanford.eduBoerkoelCorneliusMD, PhDcornelius.boerkoel@ubc.caLewisDavid BMDdblewis@stanford.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSchinzel-Giedion SyndromeDuisJessicaMD, MSChildren's Hospital Colorado;University of Colorado Anschutz Medical CampusAurora, Coloradojduis@sequencemd.comvan BonBregje WMMD, PhDDepartment of Human GeneticsRadboud University Medical CenterNijmegen, the Netherlandsbregje.vanbon@radboudumc.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSchmid Metaphyseal ChondrodysplasiaSynonyms: Metaphyseal Chondrodysplasia Type Schmid (MCDS); Metaphyseal Dysplasia Schmid (MCS), COL10A1-RelatedRichmondChristopher MarkBBiomedSc, MBBS, FRACPchris.richmond@health.qld.gov.auSavarirayanRaviMBBS, MD, FRACP, ARCPA (Hon)ravi.savarirayan@vcgs.org.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SCN1A</italic> Seizure DisordersMillerIan OMDMedical Director, Comprehensive Epilepsy ProgramNicklaus Children's HospitalMiami, Floridaian.miller@mchdocs.comSotero de MenezesMarcio AMDDirector, Genetic Epilepsy Clinic and TSC ClinicPediatric Neuroscience CenterSwedish Neuroscience InstituteSeattle, Washingtonmarcio.soterodemenezes@swedish.org\n\nSummary\n\nGeneReview Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SCN3A-</italic>Related Neurodevelopmental DisorderHelbigKatherine LMS, CGCThe Epilepsy Neurogenetics InitiativeDivision of NeurologyDepartment of PediatricsThe Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvaniahelbigk@email.chop.eduGoldbergEthan MMD, PhDThe Epilepsy Neurogenetics InitiativeDivision of NeurologyDepartment of PediatricsThe Children's Hospital of Philadelphia;Departments of Neurology and NeuroscienceThe University of Pennsylvania Perelman School of MedicinePhiladelphia, Pennsylvaniagoldberge@email.chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SCN8A</italic>-Related Epilepsy and/or Neurodevelopmental DisordersHammerMichael FPhDProfessor of NeurologyBIO5 InstituteUniversity of ArizonaTucson, Arizonamfh@email.arizona.eduXiaMayaBACOMBINEDBrainBrentwood, Tennesseemaya@combinedbrain.orgSchreiberJohn MMDChildren's National HospitalWashington, DCjschreib@childrensnational.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SCN9A</italic> Neuropathic Pain SyndromesHisamaFuki MMDDivision of Genetics\nDepartment of Medicine\nUniversity of Washington\nSeattle, Washingtonfmh2@uw.eduDib-HajjSulayman DPhDSenior Research Scientist, Center for Neuroscience and Regeneration Research\nDepartment of Neurology\nYale University School of Medicine\nNew Haven, Connecticutsulayman.dib-hajj@yale.eduWaxmanStephen GMD, PhDProfessor, Center for Neuroscience and Regeneration Research\nDepartment of Neurology\nYale University School of Medicine\nNew Haven, Connecticutstephen.waxman@yale.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nSepiapterin Reductase DeficiencySynonyms: Dopa-Responsive Hypersomnia, DYT-SPR, SPR DeficiencyFriedmanJenniferMDClinical Professor, Neurosciences and PediatricsRady Children’s Institute for Genomic MedicineUniversity of California San Diego / Rady Children’s Hospital San DiegoSan Diego, Californiajrfriedman@ucsd.eduGalosiSerenaMD, PhDDepartment of Human NeuroscienceSapienza UniversityRome, Italyserena.galosi@uniroma1.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSERAC1 DeficiencyWortmannSaskia BMD, PhDExpertise Centre for Inborn Metabolic DiseaseUniversity Children's HospitalParacelsus Private Medical UniversitySalzburg, Austrias.wortmann@salk.atde BrouwerArjan PMPhDDepartment of Human GeneticsRadboud University Nijmegen Medical CenterNijmegen, the Netherlandsarjan.debrouwer@radboudumc.nlWeversRon APhDTranslational Metabolic LaboratoryDepartment of Human GeneticsRadboud University Nijmegen Medical CenterNijmegen, the Netherlandsron.wevers@radboudumc.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSerine Deficiency DisordersSynonyms: Serine Biosynthesis Disorders, Serine Synthesis Disordersvan der CrabbenSaskia NMD, PhDs.n.vandercrabben@amsterdamumc.nlde KoningTom JMD, PhDtom.j_de_koning@med.lu.se\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SETBP1</italic> Haploinsufficiency DisorderSynonym: SETBP1 DisorderMorganAngelaPhDMurdoch Children’s Research InstituteUniversity of MelbourneRoyal Children’s HospitalMelbourne, Australiaangela.morgan@mcri.edu.auSrivastavaSiddharthMDDepartment of NeurologyBoston Children’s HospitalBoston, Massachusettssiddharth.srivastava@childrens.harvard.eduDuisJessicaMD, MSChildren's Hospital ColoradoUniversity of Colorado Anschutz Medical CampusAurora, Coloradojessica.duis@childrenscolorado.orgvan BonBregjeMD, PhDRadboud University Medical CenterNijmegen, the Netherlandsbregje.vanbon@radboudumc.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SETD1B</italic>-Related Neurodevelopmental DisorderRostonAlexandraMDDepartment of Medical GeneticsUniversity of British ColumbiaVancouver, British Columbiaalexandra.roston@phsa.caGibsonWilliamMD, PhDUBC Senior Clinician Scientist, Department of Medical GeneticsBC Children's Hospital Research InstituteVancouver, British Columbiawtgibson@bcchr.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SETD2</italic> Neurodevelopmental DisordersPappasJohnMD, MSAssociate Professor, Grossman School of MedicineNew York UniversityNew York, New Yorkjohn.pappas@nyulangone.orgRabinRachelMSGrossman School of MedicineNew York UniversityNew York, New Yorkrachel.rabin@nyulangone.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SGCE</italic> Myoclonus-DystoniaSynonyms: Dystonia 11 (DYT11), DYT-SGCERaymondDeborahMSdraymond@mountsinai.orgSaunders-PullmanRachelMD, MPHrachel.saunders-pullman@mountsinai.orgOzeliusLauriePhDlozelius@partners.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">SH3TC2</italic>-Related Hereditary Motor and Sensory NeuropathySynonyms: Charcot-Marie-Tooth Disease Type 4C, CMT4C, SH3TC2-HMSN, SH3TC2-Related Charcot-Marie-Tooth NeuropathyAzzedineHamidPhDInstitute of Pathology and Neuropathology\nAcademic Medical Center\nAmsterdam, the Netherlandsazzedine.hamid@yahoo.frSalihMustafa AMD, Dr Med Sci, FRCPCH, FAANDivision of Pediatric Neurology\nCollege of Medicine\nKing Saud University\nRiyadh, Saudi Arabia\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nShashi-Pena SyndromeSynonym: SHAPNSPorterJulie MMD, PhDjulie.lander@hsc.utah.eduPenaLoren DMMD, PhDloren.pena@alumni.duke.eduSpillmannRebecca CMS, CGCrebecca.crimian@duke.eduJohnsonAmandaamanda@arrefoundation.orgShashiVandanaMDvandana.shashi@duke.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nShort-Chain Acyl-CoA Dehydrogenase DeficiencySynonyms: SCADD, SCAD DeficiencyWolfeLynneMS, CRNP, BCNational Human Genome Research InstituteNational Institutes of HealthBethesda, Marylandlynne.wolfe@nih.govJethvaReenaMDHackensack University Medical CenterHackensack, New Jerseyreena.jethva@hmhn.orgOglesbeeDevinPhDMayo ClinicRochester, Minnesotaoglesbee.devin@mayo.eduVockleyJerryMD, PhDUniversity of PittsburghPittsburgh, Pennsylvaniagerard.vockley@chp.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSHOX Deficiency DisordersBinderGerhardMDPediatric EndocrinologyUniversity Children's HospitalTübingen, Germanygerhard.binder@med.uni-tuebingen.deRappoldGudrun APhDMolecular GeneticsUniversity of HeidelbergHeidelberg, Germanygudrun.rappold@med.uni-heidelberg.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nShprintzen-Goldberg SyndromeGreallyMarie TMD, MSc, FACMGConsultant Clinical Geneticist, Department of Clinical GeneticsOur Lady's Children's Hospital, CrumlinDublin, Irelandmarie.greally@yahoo.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nShwachman-Diamond SyndromeSynonym: Shwachman-Bodian-Diamond SyndromeNelsonAdamMBBSDirector, Bone Marrow Transplant and Cellular TherapyKids Cancer CentreSydney Children's HospitalSydney, Australiaadam.nelson@health.nsw.gov.auMyersKasianiMDAssociate Professor of Pediatrics, Division of Blood and Marrow Transplantation and Immune DeficiencyThe Cancer and Blood Diseases InstituteCincinnati Children's Hospital Medical CenterCincinnati, Ohiokasiani.myers@cchmc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSickle Cell DiseaseBenderMAMD, PhDmbender@fredhutch.orgCarlbergKatieMDkatie.carlberg@seattlechildrens.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSilver-Russell SyndromeSynonym: Russell-Silver SyndromeSaalHoward MMDDirector of Clinical Genetics, Division of Human GeneticsCincinnati Children's Hospital Medical Center;Professor of PediatricsUniversity of Cincinnati College of MedicineCincinnati, Ohiosaalhm@cchmc.orgHarbisonMadeleine DMDIcahn School of Medicine at Mount SinaiNew York, New Yorkmadeleine.harbison@mssm.eduNetchineIreneMD, PhDSorbonne Université, INSERM, UMR_S 938;Centre de Recherche Saint Antoine APHP, Hôpital Armand Trousseau;Explorations Fonctionnelles EndocriniennesParis, Franceirene.netchine@aphp.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSimpson-Golabi-Behmel Syndrome Type 1NisbetAlex FBSnisbeta@chop.eduHathawayEvan RMS, LCGChathawaye@chop.eduKalishJennifer MMD, PhDkalishj@chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSingle Large-Scale Mitochondrial DNA Deletion SyndromesSynonyms: mtDNA Deletion Syndromes, SLSMDSGoldsteinAmyMDgoldsteina@chop.eduFalkMarni JMDfalkm@chop.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSitosterolemiaSynonyms: Beta-Sitosterolemia, Phytosterolæmia, Phytosterolemia, SitosterolæmiaMyrieSemone BPhDmyrie@cc.umanitoba.caSteinerRobert DMDrdsteiner111@gmail.comMyminDavidMBBCh, FRCPdmymin@cc.umanitoba.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SLC12A5</italic>-Related Epilepsy of Infancy with Migrating Focal SeizuresSynonyms: Early-Infantile Epileptic Encephalopathy 34 (EIEE34), SLC12A5-EIMFSMcTagueAmyMBChBa.mctague@ucl.ac.ukKurianManju APhDmanju.kurian@ucl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SLC19A1</italic>-Related Folate Transport DeficiencyGoldmanI DavidMDDepartments of Medicine, Oncology and Molecular PharmacologyAlbert Einstein College of MedicineBronx, New Yorki.david.goldman@einsteinmed.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SLC25A19</italic>-Related Thiamine Metabolism DysfunctionSynonym: SLC25A19 DeficiencyTabarkiBrahimMDbtabarki@hotmail.comThabetFarahMDthabetfarah@yahoo.frAlfadhelMajidMD, FCCMGdralfadhelm@gmail.com\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SLC25A24</italic> Fontaine Progeroid SyndromeVelascoDanitaMD, FAAP, FACMGClinical Geneticist and Assistant Professor, Pediatrics and Munroe-Meyer Institute for Genetics & RehabilitationUniversity of Nebraska Medical CenterOmaha, Nebraskadvelasco@unmc.eduOlneyAnn HaskinsMD, FACMGClinical Geneticist and Professor, Pediatrics and Munroe-Meyer Institute for Genetics & RehabilitationUniversity of Nebraska Medical CenterOmaha, Nebraskaaolney@unmc.eduStarrLoisMD, PhD, FAAP, FACMGClinical Geneticist and Associate Professor, Pediatrics and Munroe-Meyer Institute for Genetics & RehabilitationUniversity of Nebraska Medical CenterOmaha, Nebraskalstarr@unmc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SLC26A2</italic>-Related AtelosteogenesisSuperti-FurgaAndreaMDProfessor of Pediatrics, Department of PediatricsLausanne University HospitalLausanne, Switzerlandasuperti@unil.chUngerSheilaMD, FRCPCDivision of Genetic MedicineUniversity of LausanneLausanne, Switzerlandsheila.unger@chuv.ch\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SLC26A2</italic>-Related Multiple Epiphyseal DysplasiaSynonym: SLC26A2-Related Recessive MED (SLC26A2-rMED)UngerSheilaMDAssociate Professor of GeneticsUniversity of Lausanne;Lausanne University HospitalLausanne, Switzerlandsheila.unger@chuv.chSuperti-FurgaAndreaMDProfessor of Pediatrics and GeneticsUniversity of Lausanne;Lausanne University HospitalLausanne, Switzerlandasuperti@unil.ch\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SLC26A4</italic>-Related Sensorineural Hearing LossSmithRichard JHMDSterba Hearing Research Professor of Otolaryngology;Director, Molecular Otolaryngology and Renal Research LaboratoriesDepartment of Otolaryngology – Head & Neck SurgeryCarver College of MedicineUniversity of IowaIowa City, Iowarichard-smith@uiowa.eduAzaiezHelaMS, PhDMolecular Otolaryngology and Renal Research LaboratoriesDepartment of Otolaryngology – Head & Neck SurgeryCarver College of MedicineUniversity of IowaIowa City, Iowahela-azaiez@uiowa.eduOdellAmanda MMS, LGCGenetic Counselor,Molecular Otolaryngology and Renal Research LaboratoriesDepartment of Otolaryngology – Head & Neck SurgeryCarver College of MedicineUniversity of IowaIowa City, Iowaamanda-odell@uiowa.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSLC39A14 DeficiencySynonyms: Hypermanganesemia with Dystonia 2 (HMNDYT2); SLC39A14-Related Early-Onset Dystonia-ParkinsonismTuschlKarinMD, PhDk.tuschl@ucl.ac.ukGregoryAllisonMS, CGCgregorya@ohsu.eduMeyerEstherPhDesther.meyer@nbt.nhs.ukClaytonPeter TMDpeter.clayton@ucl.ac.ukHayflickSusan JMDhayflick@ohsu.eduMillsPhilippa BPhDp.mills@ucl.ac.ukKurianManju APhDmanju.kurian@ucl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSLC39A8-CDGSynonyms: CDG-IIn, Congenital Disorder of Glycosylation Type IIn (CDG2N), SLC39A8 DeficiencyParkJulien HDr. med.Klinik für Kinder- und Jugendmedizin – Allgemeine PädiatrieUniversitätsklinikum Münster (UKM)julien.park@ukmuenster.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SLC6A1</italic>-Related Neurodevelopmental DisorderSynonyms: SLC6A1-Related Disorder, SLC6A1 Deficiency DisorderGoodspeedKimberlyMD, MSCSkimberly.goodspeed@utsouthwestern.eduDemarestScottMD, MSCSscott.demarest@childrenscolorado.orgJohannesenKatrineMD, PhDkatrine.johannesen@regionh.dkKangJingqiongPhDjingqiong.kang@vumc.orgLalDennisPhDlald@ccf.orgAngioneKatieMSkaitlin.angione@childrenscolorado.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SLC6A3</italic>-Related Dopamine Transporter Deficiency SyndromeSynonym: DAT DeficiencySpaullRobert VVMA, MBBSr.spaull@ucl.ac.ukKurianManju AMA, MBBChir, PhDmanju.kurian@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SMARCA2-</italic>Related Nicolaides-Baraitser SyndromeSynonym: NCBRSAbdul-RahmanOmarMDDepartment of PediatricsWeill Cornell MedicineNew York, NYoma4009@med.cornell.eduMayFrancisMDMemorial Sloan Kettering Cancer Center;NewYork-Presbyterian/Weill Cornell Medical CenterNew York, NYfjm4001@nyp.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSmith-Kingsmore SyndromePradaCarlos EMDcprada@luriechildrens.orgRaskiCarolyn RMScraski@luriechildrens.orgMirzaaGhaydaMDghayda.mirzaa@seattlechildrens.orgBestermanAaronMDabesterman@ucsd.eduKruegerDarcy AMD, PhDkrueger_darcy@cchmc.orgLiuAndrew CPhDandrew.liu@ufl.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSmith-Lemli-Opitz SyndromeSynonym: SLOSNowaczykMalgorzata JMMD, MFA, FRCPC, FCCMG, FACMGProfessor, Molecular Medicine & Pathology and PediatricsPediatrician and Clinical GeneticistMcMaster UniversityHamilton, Canadanowaczyk@hhsc.caWassifChristopher APhDStaff Scientist, Section of Molecular DysmorphologyNICHDBethesda, Marylandwassifc@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSmith-Magenis SyndromeSynonym: del(17)(p11.2)SmithAnn CMMA, DSc (hon), CGCacmsmith@mail.nih.govBerensJohnMD, FAAP, FACPjohn.berens@bcm.eduBoydKerry EMD, FRCP(C)kboyd@mcmaster.caBrennanChristinePhD, CCC-SLPchristine.brennan@colorado.eduGropmanAndreaMD, FAAP, FACMG, FANA, FAAN, FCNSandrea.gropman@stjude.orgHaas-GivlerBarbaraMEd, BCBAbahaasgivler@geisinger.eduVlangosChristopherPhD, FACMGchris.vlangos@tempus.comFosterRebeccaPhDrebecca.foster@bjc.orgFranciskovichRachelMS, CGCrwills@bcm.eduGirirajanSanthoshMBBS, PhDsxg47@psu.eduRaitano LeeNancyPhDnrl39@drexel.eduTaylorCoraPhDcmtaylor1@geisinger.eduTurnaciogluSinan OmerMDsturnaci@childrensnational.orgElseaSarah HPhD, FACMGelsea@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSnyder-Robinson SyndromeSynonym: Spermine Synthase DeficiencySchwartzCharles EPhDcharles.schwartz224@gmail.comBuppCalebMDcaleb.bupp@corewellhealth.orgKutlerMary JoDOmaryjo.kutler@snyder-robinson.orgPeronAngelaMD, PhDangela.peron@unifi.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SOST</italic>-Related Sclerosing Bone DysplasiasAppelman-DijkstraNatashaMD, PhDn.m.appelman-dijkstra@lumc.nlVan LieropAntoonMD, PhDavlierop@flevoziekenhuis.nlPapapoulosSocratesMD, PhDs.e.papapoulos@lumc.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSotos SyndromeOcanseySharonMBBS, BSc, MScSpecialist Registrar in Clinical GeneticsSt George's University Hospital NHS Foundation TrustLondon, United Kingdomsharon.ocansey@stgeorges.nhs.ukColeTrevor RPMB ChBConsultant and Honorary Reader in Clinical GeneticsClinical Genetics UnitBirmingham Women's HospitalBirmingham, United Kingdomtrevor.cole@bham-womens.thenhs.comRahmanNazneenBM BCh, PhDProfessor and Honorary Consultant in Medical GeneticsCancer Genetics Section Institute of Cancer ResearchLondon, United Kingdomnazneen.rahman@icr.ac.ukTatton-BrownKatrinaBM BCh, MDConsultant in Clinical GeneticsSouth West Thames Regional Genetics Service;Professor in Clinical Genetics and Genomic EducationSt George's University of LondonLondon, United Kingdomktattonbrown@nhs.net\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SOX2</italic> DisorderWilliamsonKathleen APhDkathy.williamson@igmm.ed.ac.ukYatesT MichaelMBChB, MRCP (Edin)michael.yates@igmm.ed.ac.ukFitzPatrickDavid RMD, FMedScidavid.fitzpatrick@ed.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpastic Paraplegia 11StevaninGiovanniPhDInstitut du Cerveau et de la Moelle EpinièreINSERM, CNRSSorbonne University;École Pratique des Hautes ÉtudesParis Sciences et Lettres Research UniversityHôpital Pitié-SalpêtrièreParis, Francegiovanni.stevanin@upmc.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpastic Paraplegia 15Synonyms: Hereditary Spastic Paraplegia Type 15, HSP-ZFYVE26, SPG15, ZFYVE26-Related Hereditary Spastic ParaplegiaEbrahimi-FakhariDariusMD, PhDdarius.ebrahimi-fakhari@childrens.harvard.eduAlecuJulian Ejulian.alecu@childrens.harvard.eduBlackstoneCraigMD, PhDcblackstone@mgh.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpastic Paraplegia 3ASynonyms: ATL1-HSP, SPG3AHederaPeterMD, PhDDepartment of NeurologyUniversity of LouisvilleLouisville, Kentuckyphederabna@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpastic Paraplegia 4Synonyms: SPAST-HSP, SPG4ParodiLiviaPhDlivia.parodi@icm-institute.orgRydningSiri LynneMDs.l.rydning@medisin.uio.noTallaksenChantalMD, PhDchantal.tallaksen@medisin.uio.noDurrAlexandraMD, PhDalexandra.durr@icm-institute.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpastic Paraplegia 8Synonym: SPG8MeijerInge AMD, PhDCHU Sainte-Justine\nUniversité de Montréal\nMontreal, Quebec, Canadainge.meijer@umontreal.caValdmanisPaul NPhDDivision of Medical Genetics\nDepartment of Medicine\nUniversity of Washington\nSeattle, Washingtonpaulnv@uw.eduRouleauGuy AMD, PhDMontreal Neurological Hospital and Institute\nMcGill University\nMontreal, Quebec, Canadaguy.rouleau@mcgill.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SPG7</italic>-Related Neurologic DisorderHederaPeterMD, PhD, FACMGDepartment of NeurologyUniversity of Louisville, Louisville, Kentuckypeter.hedera@louisville.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSphingosine Phosphate Lyase Insufficiency SyndromeSynonyms: Familial Steroid-Resistant Nephrotic Syndrome with Adrenal Insufficiency; NPHS14; Renal, Endocrine, Neurological, and Immune (RENI) Syndrome; SGPL1 Deficiency; Steroid-Resistant Nephrotic Syndrome Type 14WeaverKathryn NicoleMDkathryn.weaver@cchmc.orgSullivanBonnieMDbrsullivan@cmh.eduHildebrandtFriedhelmMDfriedhelm.hildebrandt@childrens.harvard.eduStroberJonathanMDjonathan.strober@ucsf.eduPrasadRathiMBBS, PhDrathi.prasad1@nhs.netSabaJulieMD, PhDjulie.saba@ucsf.eduSamuelMaryiaBSc, MScmaryia.samuel@ucsf.eduHegeleRobertMD, FRCPChegele@robarts.caMcIntyreAdamBScamcintyre@robarts.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinal and Bulbar Muscular AtrophySynonyms: Kennedy's Disease, SBMA, X-Linked Spinal and Bulbar Muscular AtrophyLa SpadaAlbertMD, PhDUniversity of California Irvine School of MedicineIrvine, Californiaalaspada@hs.uci.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinal Muscular AtrophyPriorThomas WPhD, FACMGthomas.prior@uhhospitals.orgLeachMeganne EMSN, PNPleachm@ohsu.eduFinangerErika LMDfinanger@ohsu.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinal Muscular Atrophy, X-Linked InfantileSynonyms: SMAX2, XL-SMABaumbach-ReardonLisaPhD, FACMGAssociate Professor, Dr Kiran C Patel College of MedicineTampa Bay CampusClearwater, Floridalreardon@nova.eduHunterJMPhD, FACMGClinical Lab Director, Institute for Genomic MedicineNationwide Children's HospitalColumbus, Ohiojeshnt@gmail.comAhearnMary EllenMSResearch Operations Manager, Translational Genomics Research InstitutePhoenix, Arizonameahearn@tgen.orgPfautschMirandaDO candidateDr Kiran C Patel College of MedicineTampa Bay CampusClearwater, Floridamp2771@mynsu.nova.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 10Synonym: SCA10MatsuuraTohruMDDivision of NeurologyDepartment of Internal MedicineJichi Medical UniversityTochigi, Japantohrum@jichi.ac.jpAshizawaTetsuoMDDirector, Neuroscience Research ProgramHouston Methodist Research InstituteHouston, Texastashizawa@houstonmethodist.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 11Synonym: SCA11ChenZhongboMA, BM BCh, MRCPzhongbo.chen@ucl.ac.ukPuzriakovaArinaBSc, MScarina.puzriakova.18@ucl.ac.ukHouldenHenryMD, PhDh.houlden@ucl.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nSpinocerebellar Ataxia Type 13Synonym: SCA13WatersMichael FMD, PhDProfessor of Neurology\nBarrow Neurological Institute\nPhoenix, Arizonamichael.waters@dignityhealth.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 14Synonym: SCA14ChenDong-HuiMD, PhDDepartment of Neurology\nUniversity of Washington Medical Center\nSeattle, Washingtoncdhui@uw.eduBirdThomas DMDDepartments of Neurology and Medicine\nUniversity of Washington;\nSeattle VA Medical Center\nSeattle, Washingtontomnroz@uw.eduRaskindWendy HMD, PhDProfessor, Departments of Medicine and Psychiatry and Behavioral Sciences\nUniversity of Washington Medical Center\nSeattle, Washingtonwendyrun@uw.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 17Synonyms: Huntington Disease-Like 4, SCA17ToyoshimaYasukoMD, PhDDepartment of NeurologyBrain Disease CenterAgano HospitalAgano, Japantoyoshima@agano.or.jpOnoderaOsamuMD, PhDProfessor, Department of NeurologyBrain Research InstituteNiigata UniversityNiigata, Japanonodera@bri.niigata-u.ac.jpYamadaMitsunoriMD, PhDProfessor, Division of NeuropathologyDepartment of Brain Disease ResearchShinshu University School of MedicineMatsumoto, Japannori@shinshu-u.ac.jpTsujiShojiMD, PhDProfessor, Department of NeurologyUniversity of Tokyo Graduate School of MedicineTokyo, Japantsuji@m.u-tokyo.ac.jpTakahashiHitoshiMD, PhDExecutive Vice-President for ResearchNiigata UniversityNiigata, Japanhitoshi@bri.niigata-u.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 1Synonym: SCA1OpalPuneetMD, PhDDirector, Ataxia ClinicDepartment of NeurologyNorthwestern Feinberg School of MedicineChicago, Illinoisp-opal@northwestern.eduAshizawaTetsuoMDDirector, Neuroscience Research ProgramHouston Methodist Research InstituteHouston, Texastashizawa@houstonmethodist.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 20Synonym: SCA20StoreyElsdonDPhil, FRACPDirector, Van Cleef Roet Centre for Nervous DiseasesHead, Department of NeuroscienceDepartment of Medicine (Neuroscience)Monash University (Alfred Hospital Campus)Neurologist to Neurogenetics ClinicsAlfred, Saint Vincent's, and Royal Melbourne HospitalsMelbourne, Victoria, Australiaelsdon.storey@med.monash.edu.auGardnerRJMMB ChB, FCCMGClinical Genetics GroupUniversity of OtagoDunedin, New Zealandmacgardner@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 2Synonym: SCA2PulstStefan MMDDepartment of Neurology\nUniversity of Utah\nSalt Lake City, Utahstefan.pulst@hsc.utah.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nSpinocerebellar Ataxia Type 37Synonyms: SCA37Matilla-DueñasAntoniBSc, MSc, PhDNeurogenetics UnitNeuroscience DepartmentGermans Trias i Pujol Research Institute (IGTP)Badalona, Spainamatilla@igtp.catVolpiniVictorMD, PhDMolecular Genetics CenterBellvitge Biomedical Research Institute (IDIBELL)L'Hospitalet de LlobregatBarcelona, Spainvvolpini@idibell.cat\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 38BruscoAlfredoPhDAssociate Professor in Medical Genetics, Department of Medical SciencesUniversity of TurinTurin, Italyalfredo.brusco@unito.itDi GregorioEleonoraPhDBiologist, Città della Salute e della Scienza University HospitalTurin, Italyele.digregorio@gmail.comBorroniBarbaraMDAssociate Professor of Neurology, Neurology UnitDepartment of Clinical and Experimental SciencesUniversity of BresciaBrescia, Italybarbara.borroni@unibs.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 3Synonyms: Machado-Joseph Disease, SCA3PaulsonHenryMD, PhDProfessor, Department of NeurologyUniversity of Michigan Medical SchoolAnn Arbor, Michiganhenryp@umich.eduShakkottaiVikramMD, PhDAssociate Professor, Departments of Neurology and of Molecular and Integrative PhysiologyUniversity of Michigan Medical SchoolAnn Arbor, Michiganvikramsh@med.umich.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 4Synonyms: SCA4, Spinocerebellar Ataxia 4PuschmannAndreasMD, PhDandreas.puschmann@med.lu.seDoblougSigurdMDsigurd.dobloug@med.lu.seWalleniusJoelMScjoel.wallenius@skane.seWictorinKlasMD, PhDklas.wictorin@skane.seGorcencoSorinaMD, PhDsorina.gorcenco@med.lu.se\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia Type 6Synonym: SCA6CaseyHannah LBShannahcasey@neurology.bsd.uchicago.eduGomezChristopher MMD, PhDcgomez@neurology.bsd.uchicago.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nSpinocerebellar Ataxia Type 7Synonym: SCA7La SpadaAlbert RMD, PhDDistinguished Professor and Vice Chair, Departments of Pathology & Laboratory Medicine and Neurology\nDirector, UCI Institute for Neurotherapeutics\nUniversity of California Irvine School of Medicine\nIrvine, Californiaalaspada@uci.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nSpinocerebellar Ataxia Type 8Synonym: SCA8ClearyJohn DouglasPhDCenter for NeuroGeneticsDepartment of Molecular Genetics & MicrobiologyCollege of MedicineUniversity of FloridaGainesville, Floridajohn.cleary@ufl.eduSubramonySHMDDepartment of NeurologyUniversity of FloridaGainesville, Floridas.subramony@neurology.ufl.eduRanumLaura PWPhDCenter for NeuroGeneticsDepartment of Molecular Genetics & MicrobiologyDepartment of NeurologyGenetics InstituteCollege of MedicineUniversity of FloridaGainesville, Floridaranum@ufl.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpinocerebellar Ataxia with Axonal Neuropathy Type 1Synonym: SCAN1, TDP1-Related Spinocerebellar Ataxia with Axonal NeuropathySalihMustafa AMMD, Dr Med Sci, FRCPCHDivision of Pediatric NeurologyCollege of MedicineKing Saud UniversityRiyadh, Saudi Arabiamustafa_salih05@yahoo.comTakashimaHiroshiMD, PhDDepartment of Neurology and GeriatricsKagoshima University Graduate School of Medical and Dental SciencesKagoshima, Japanthiroshi@m3.kufm.kagoshima-u.ac.jpBoerkoelCornelius FMD, PhDProvincial Medical Genetics ProgramChild and Family Research InstituteDepartment of Medical GeneticsUniversity of British ColumbiaVancouver, Canadaboerkoel@interchange.ubc.cacornelius.boerkoel@ubc.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpondylocostal Dysostosis, Autosomal RecessiveSynonyms: Costovertebral Dysplasia, Spondylocostal DysplasiaTurnpennyPeter DBSc, MB, ChB, FRCP, FRCPCH, FRCPathpeter.turnpenny@nhs.netSlomanMelissaBSc, DipRCPathmelissa.sloman@nhs.netDunwoodieSallyBSc, PhDs.dunwoodie@victorchang.edu.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSpondylometaphyseal Dysplasia, Corner Fracture TypeSynonym: Spondylometaphyseal Dysplasia SutcliffeEnglandJadeMD, MScjade.england@umontreal.caCampeauPhilippe MMDp.campeau@umontreal.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SPTBN4</italic> DisorderSynonym: Neurodevelopmental Disorder with Hypotonia, Neuropathy, and Deafness (NEDHND)Ortiz-GonzalezXilmaMD, PhDChildren's Hospital of PhiladelphiaPhiladelphia, Pennsylvaniaortizgonzalez@chop.eduWierengaKlaasMDMayo Clinic FloridaJacksonville, Floridawierenga.klaas@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SPTLC1</italic>-Related Hereditary Sensory NeuropathySynonyms: Hereditary Sensory and Autonomic Neuropathy Type IA, Hereditary Sensory Neuropathy Type IA, HSAN1A, HSN1ANicholsonGarth AMBBS, PhDDepartment of Medicine\nUniversity of Sydney\nHereditary Neuropathies Clinic and Molecular Medicine Laboratory\nConcord Hospital\nSydney, Australiagarth.nicholson@sydney.edu.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSqualene Synthase DeficiencyComanDavidMBBS, MPhil, FRACPDepartment of Metabolic MedicineQueensland Children’s HospitalBrisbane, Australiadavid.coman@health.qld.gov.auVissersLisenkaPhDDepartment of Human GeneticsDonders Institute for Brain, Cognition and BehaviorRadboud University Medical CenterNijmegen, the Netherlandslisenka.vissers@radboudumc.nlWaterhamHansPhDLaboratory Genetic Metabolic DiseasesAcademic Medical CenterUniversity of AmsterdamAmsterdam, the Netherlandsh.r.waterham@amc.uva.nlChristodoulouJohnMBBS, PhDDirector, Genetics Research ThemeMurdoch Children’s Research InstituteChair of Genomic Medicine, Department of PaediatricsUniversity of MelbourneMelbourne, Australiajohn.christodoulou@mcri.edu.auWeversRon APhDTranslational Metabolic LaboratoryDepartment of Laboratory MedicineRadboud University Medical CenterNijmegen, the Netherlandsron.wevers@radboudumc.nlPittJamesPhDVictorian Clinical Genetics ServicesMurdoch Children's Research InstituteMelbourne, Australiajames.pitt@vcgs.org.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SRCAP-</italic>Related Floating-Harbor SyndromeNowaczykMalgorzata JMMD, FRCPC, FCCMG, FACMGDepartment of Pathology and Molecular MedicineMcMaster UniversityHamilton, Ontario, Canadanowaczyk@hhsc.caNikkelSarah MMD, FRCPC, FCCMGDepartment of Medical GeneticsBC Women's and Children's HospitalVancouver, British Columbia, Canadasarah.nikkel@cw.bc.caWhiteSusan MMD, FRACPVictorian Clinical Genetics ServiceMurdoch Children's Research InstituteRoyal Children's HospitalVictoria, Australiasue.white@vcgs.org.au\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">STAC3</italic> DisorderSynonym: Native American MyopathyWebbBryn DMDbryn.webb@mssm.eduManoliIriniMD, PhDmanolii@mail.nih.govJabsEthylin WangMDethylin.jabs@mssm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">STAT3</italic> Hyper IgE SyndromeSynonyms: Job Syndrome, STAT3-Deficient Hyper-IgE Syndrome, STAT3 Deficiency, STAT3-HIES, STAT3 Loss-of-Function Hyper-IgE Syndrome (STAT3 LOF HIES)HsuAmy PBAtwins@niaid.nih.govDavisJoiePNP-BC, APNGjdavis@niaid.nih.govPuckJennifer MMDpuckj@peds.ucsf.eduHollandSteven MMDsholland@niaid.nih.govFreemanAlexandra FMDfreemaal@niaid.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nStickler SyndromeSynonym: ArthroophthalmopathyMortierGeertMD, PhDCenter for Human GeneticsUniversity Hospitals LeuvenLeuven, Belgiumgeert.mortier@uzleuven.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">STRC</italic>-Related Autosomal Recessive Hearing LossSynonym: STRC-Related Sensorineural Hearing LossRedfieldShelbyMS, CGCshelby.redfield@childrens.harvard.eduShearerA EliotMD, PhDeliot.shearer@childrens.harvard.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nStrømme SyndromeSynonyms: Apple Peel Syndrome with Microcephaly and Ocular Anomalies, Jejunal Atresia with Microcephaly and Ocular AnomaliesHoStephanie KLMDstephanie_kl_ho@dh.gov.hkLeungLai TingMDmo_cg1@dh.gov.hkLukHo-mingMDlukhm@ha.org.hkLoIvan FMMDcon_cg@dh.gov.hk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">STXBP1</italic> Encephalopathy with EpilepsySynonyms: Early-Infantile Epileptic Encephalopathy 4 (EIEE4), STXBP1 Epileptic Encephalopathy, STXBP1-Related Developmental and Epileptic Encephalopathy (STXBP1-DEE)Mercimek-AndrewsSaadetMD, PhD, FCCMG, FRCPCDepartment of Medical GeneticsFaculty of Medicine and DentistryUniversity of AlbertaAlberta Health ServicesEdmonton, Alberta, Canadasaadet@ualberta.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSuccinic Semialdehyde Dehydrogenase DeficiencySynonyms: 4-Hydroxybutyric Aciduria, Gamma-Hydroxybutyric Aciduria, SSADH DeficiencyTokatly LatzerItayMDitay.tokatlylatzer@childrens.harvard.eduPearlPhillip LMDphillip.pearl@childrens.harvard.eduRoulletJean-BaptistePhDj.roullet@wsu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SUCLA2</italic>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic AciduriaSynonym: SUCLA2 DeficiencyEl-HattabAyman WMD, FAAP, FACMGProfessor, Department of Clinical SciencesCollege of MedicineUniversity of SharjahSharjah, United Arab Emirateselhattabaw@yahoo.comScagliaFernandoMD, FAAP, FACMGProfessor, Department of Molecular and Human GeneticsBaylor College of MedicineHouston, Texasfscaglia@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SUCLG1</italic>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic AciduriaSynonyms: SUCLG1 Deficiency, SUCLG1-Related Succinyl-CoA Ligase DeficiencyEl-HattabAyman WMD, FAAP, FACMGAssociate Professor, Department of Clinical SciencesCollege of MedicineUniversity of SharjahSharjah, United Arab Emirateselhattabaw@yahoo.comScagliaFernandoMD, FAAP, FACMGDepartment of Molecular and Human GeneticsBaylor College of MedicineHouston, Texasfscaglia@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">SYNCRIP</italic>-Related Neurodevelopmental DisorderSynonym: HNRNPQ-Related Neurodevelopmental DisorderBalasubramanianMeenaMBBS, DCH, FRCPCH, MD, FHEAProfessor of Medical Genetics, Division of Clinical Medicine, University of Sheffield;Honorary Consultant Clinical Geneticist, Sheffield Clinical Genomics Service;Director of Research, Sheffield Children's NHS Foundation TrustSheffield, United Kingdomem.balasubramanian@sheffield.ac.ukBainJennifer MMD, PhD, FCNSAssociate Professor of Neurology and PediatricsColumbia University Irving Medical CenterNew York, New Yorkjb3634@cumc.columbia.eduGillentineMadelyn APhDScientific Director, HNRNP Family Foundation;Clinical Genomics Scientist, Baylor GeneticsHouston, Texasmaddie@hnrnp.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nSYNE1 DeficiencyBeaudinMarieMDmarie.beaudin.1@ulaval.caGamachePierre-LucMD, PhDpierre-luc.gamache.1@ulaval.caGros-LouisFrançoisPhDfrancois.gros-louis@fmed.ulaval.caDupréNicolasMD, MScnicolas.dupre.cha@ssss.gouv.qc.ca\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\n<italic toggle=\"yes\">SYNGAP1</italic>-Related Intellectual DisabilitySynonym: SYNGAP1-Related Developmental and Epileptic EncephalopathyHolderJ LloydJrMD, PhDholder@bcm.eduHamdanFadi FPhDfadi.hamdan@recherche-ste-justine.qc.caMichaudJacques LMDjacques.michaud@recherche-ste-justine.qc.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TAF8</italic>-Related Neurodevelopmental DisorderSynonym: TAF8 DeficiencyFalik ZaccaiTzipora CMDfalikmd.genetics@gmail.comtzipora.falik-zaccai@biu.ac.ilMesikaAvivavivmaskia@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTangier DiseaseSynonyms: Analphalipoproteinemia, Familial High-Density Lipoprotein Deficiency 1, Primary Hypoalphalipoproteinemia 1BurnettJohn RMB ChB, MD, PhD, FRCPAjohn.burnett@health.wa.gov.auHooperAmanda JPhDamanda.hooper@health.wa.gov.auMcCormickSally PAPhDsally.mccormick@otago.ac.nzHegeleRobert AMD, FRCPC, FACPhegele@robarts.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nTANGO2 DeficiencySynonyms: TANGO2 Deficiency Disorder, TANGO2-Related Metabolic Encephalopathy and ArrhythmiasMiyakeChristina YMD, MScymiyake@bcm.eduBurrageLindsayMD, PhDburrage@bcm.eduGlintonKevinMD, PhDKevin.Glinton@bcm.eduHouckKimberlyMDkmhouck@texaschildrens.orgHoyos-MartinezAlfonsoMDaxhoyosm@texaschildrens.orgGrahamBrettMD, PhDbregraha@iu.eduYangYapingPhDyapingy@ailifeus.comRawls-CastilloBrandyMS, RD, LDblrawls@texaschildrens.orgScagliaFernandoMDfscaglia@bcm.eduSoler-AlfonsoClaudiaMDsoler@bcm.eduLalaniSeema RMDseemal@bcm.tmc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TARDBP</italic>-Related Amyotrophic Lateral Sclerosis-Frontotemporal DementiaSynonyms: TARDBP-ALS-FTD, TDP-43 Proteinopathy, TDP-43-Linked ALS-FTDManoharVaishnaviMTechvaishnavi.1.manohar@kcl.ac.ukCrowleyLeonMScleon.crowley@kcl.ac.ukSreedharanJemeenBSc, MBBS, MRCP, PhDjemeen.sreedharan@kcl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTatton-Brown-Rahman SyndromeSynonym: DNMT3A Overgrowth SyndromeOstrowskiPhilip JMDSpecialist Registrar in Clinical Genetics, St George's University Hospitals NHS Foundation Trust;Great Ormond Street Hospital for Children NHS Foundation TrustLondon, United Kingdomphil.ostrowski@nhs.netTatton-BrownKatrinaMDConsultant Clinical Geneticist, St George's University Hospitals NHS Foundation Trust;Professor of Clinical Genetics and Genomic Medicine, St George's University of LondonLondon, United Kingdomk.tattonbrown@nhs.net\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TBC1D24</italic>-Related DisordersBalestriniSimonaMD, PhDsimona.balestrini@meyer.itCampeauPhilippe MMDp.campeau@umontreal.caMeiDavideMScdavide.mei@meyer.itGuerriniRenzoMD, FRCPrenzo.guerrini@meyer.itSisodiyaSanjayMD, PhD, FRCPs.sisodiya@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TBCK</italic>-Related Neurodevelopmental DisorderSynonyms: Infantile Hypotonia with Psychomotor Retardation and Characteristic Facies-3 (IHPRF3), TBCK Encephaloneuronopathy, TBCK SyndromeOrtiz-GonzalezXilmaMD, PhDortizgonzalez@chop.eduDubbsHollyMS, LCGCdubbsh@chop.eduKellerKierstinMS, LCGCkellerk@chop.eduDurhamEmilyPhDdurhame@chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TCIRG1</italic>-Related OsteopetrosisJodehWadeMDwade.jodeh@utoledo.eduAlamImranulPhDialam@iu.eduEconsMichaelMDmecons@iu.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TECPR2</italic>-Related Hereditary Sensory and Autonomic Neuropathy with Intellectual DisabilitySynonyms: Hereditary Sensory and Autonomic Neuropathy Type IX with Developmental Delay (HSAN9), Hereditary Spastic Paraplegia Type 49 (SPG49)HeimerGaliMD, PhDgalih.md@gmail.comNeuserSonjaMDsonja.neuser@medizin.uni-leipzig.deBen-ZeevBruriaMDbruria.benzeev@sheba.health.gov.ilbruria.benzeev@gmail.comEbrahimi-FakhariDariusMD, PhDdarius.ebrahimi-fakhari@childrens.harvard.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TEK</italic>-Related Venous MalformationsSerontEmmanuelMD, PhDInstitut Roi Albert IIDepartment of Medical OncologyCliniques universitaires Saint-LucUniversité catholique de LouvainBrussels, Belgiumemmanuel.seront@saintluc.uclouvain.beBoonLaurence MMD, PhDCenter for Vascular AnomaliesDivision of Plastic SurgeryCliniques universitaires Saint-LucUniversité catholique de LouvainBrussels, Belgiumlaurence.boon@saintluc.uclouvain.beVikkulaMiikkaMD, PhDHuman Molecular Geneticsde Duve InstituteUniversité catholique de LouvainBrussels, Belgiummiikka.vikkula@uclouvain.be\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTemple SyndromeSynonym: TS14GazdaghGabriellaMD, PGCert, FRCPCHgabriella.gazdagh@uhs.nhs.ukJuriaansAliciaMD, PhDa.f.juriaans@soton.ac.ukKerkhofGertheMD, PhDg.kerkhof@erasmusmc.nlDaviesJustin HMBBCh, MRCP, FRCPCH, MDjustin.davies@uhs.nhs.ukTempleKaren IMB ChB, MD, FRCPi.k.temple@soton.ac.ukMackayDeborah JGMA, PhDd.j.g.mackay@soton.ac.ukOgawaTomoeMDyamaguchi-t@ncchd.go.jpOgataTsutomuMD, PhDtomogata@hama-med.ac.jpKagamiMasayoMD, PhDkagami-ms@ncchd.go.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TET3</italic>-Related Beck-Fahrner SyndromeSynonyms: TET3-BEFAHRS, TET3 DeficiencyFahrnerJill AMD, PhDDepartment of Genetic MedicineDepartment of PediatricsJohns Hopkins School of MedicineBaltimore, Marylandjfahrne1@jhmi.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TFR2</italic>-Related HemochromatosisDe GobbiMarcoMD, PhDProfessor of Internal MedicineDepartment of Clinical and Biological SciencesUniversity of Torino;Azienda Ospedaliera San LuigiOrbassano, Turin, Italymarco.degobbi@unito.itRoettoAntonellaPhDAssistant Professor in Medical GeneticsDepartment of Clinical and Biological SciencesUniversity of Torino;Azienda Ospedaliera San LuigiOrbassano. Turin, Italyantonella.roetto@unito.it\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nThanatophoric DysplasiaFrenchTeganBMBSVictorian Clinical Genetics ServicesMurdoch Children's Research InstituteRoyal Children's HospitalMelbourne, Australiategan.french@vcgs.org.auSavarirayanRaviMBBS, MD, FRACP, ARCPA (Hon)Victorian Clinical Genetics ServicesMurdoch Children's Research InstituteRoyal Children's Hospital;University of MelbourneMelbourne, Australiaravi.savarirayan@vcgs.org.au\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nThiamine-Responsive Megaloblastic Anemia SyndromeSynonyms: Rogers Syndrome, TRMASakoShuheiMDTsunogaiToshikiMDOishiKimihikoMDkimihiko.oishi@jikei.ac.jp\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">THOC6</italic> Intellectual Disability SyndromeSynonym: Beaulieu-Boycott-Innes SyndromeLemireGabrielleMD, FRCPCChildren's Hospital of Eastern Ontario Research InstituteUniversity of OttawaOttawa, Canadaglemire@cheo.on.caInnesA MicheilMD, FRCPCDepartment of Medical GeneticsAlberta Children's Hospital Research InstituteUniversity of CalgaryCalgary, Canadamicheil.innes@albertahealthservices.caBoycottKym MMD, PhD, FRCPCDepartment of GeneticsChildren's Hospital of Eastern OntarioUniversity of OttawaOttawa, Canadakboycott@cheo.on.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nThrombocytopenia Absent Radius SyndromeSynonym: TAR SyndromePetitFlorenceMD, PhDflorence.petit@chu-lille.frBoussionSimonMDsimon.boussion@chu-lille.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TK2</italic>-Related Mitochondrial DNA Maintenance Defect, Myopathic FormSynonyms: Mitochondrial DNA Depletion Syndrome 2 (MTDPS2), Myopathic Type; TK2 DeficiencyWangJuliaBSjulia.wang@bcm.eduEl-HattabAyman WMD, FAAP, FACMGelhattabaw@yahoo.comWongLee-Jun CPhD, FACMGljwong@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTNF Receptor-Associated Periodic Fever SyndromeSynonyms: TNF Receptor-Associated Periodic Syndrome (TRAPS), Tumor Necrosis Factor Receptor-Associated Periodic SyndromeDeuitchNatalieMS, CGCnatalie.deuitch@nih.govCudriciCorneliaMDcornelia.cudrici@nih.govOmbrelloAmandaMDamanda.ombrello@nih.govAksentijevichIvonaMD, FACMGaksentii@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TNXB</italic>-Related Classical-Like Ehlers-Danlos SyndromeSynonyms: Classical-Like Ehlers-Danlos syndrome (clEDS) Type 1, TNXB-Related clEDS, TNXB-Related Classic-Like Ehlers-Danlos Syndromevan DijkFleur SMD, PhDfleur.dijk@nhs.netGhaliNeetiMBChB, MDneeti.ghali@nhs.netDemirdasSerwetMD, PhDs.demirdas@erasmusmc.nlBakerDuncanMSc\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TP63</italic>-Related DisordersSuttonV ReidMDProfessor, Department of Molecular and Human Genetics\nBaylor College of Medicine;\nTexas Children's Hospital\nHouston, Texasvrsutton@texaschildrens.orgvan BokhovenHansPhDProfessor, Molecular Neurogenetics\nDepartment of Human Genetics\nRadboud University Medical Center\nNijmegen, the Netherlandshans.vanbokhoven@radboudumc.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TPK1</italic>-Related Thiamine Metabolism Dysfunction SyndromeSynonyms: Thiamine Metabolism Dysfunction Syndrome 5 (TMDS5), Thiamine Pyrophosphokinase Deficiency, TPK1 DeficiencyMascarenhasSelindaMScmascarenhasselinda@gmail.comPaulMaimuna SaliPhDmaimuna.paul@manipal.eduBhatVivekanandaDNB, DMbhat.vivekananda@manipal.eduShuklaAnjuMD, DManju.shukla@manipal.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTreacher Collins SyndromeSynonyms: Mandibulofacial Dysostosis, Treacher Collins-Franceschetti SyndromeBarbosaMafaldaMD, PhD, FACMGDepartment of Genetics and Genomic SciencesIcahn School of Medicine at Mount SinaiNew York, New Yorkmafalda.barbosa@mssm.eduJabsEthylin WangMDDepartment of Clinical GenomicsMayo Clinic, Rochester, Minnesotajabs.ethylin@mayo.eduHustonSaraMSDepartment of PediatricsFeinberg School of MedicineNorthwestern University;Lurie Children’s HospitalChicago, Illinoisshuston@luriechildrens.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTrichohepatoenteric SyndromeSynonyms: Phenotypic Diarrhea of Infancy, Syndromic Diarrhea/Tricho-Hepato-Enteric Syndrome (SD/THE), THESFabreAlexandreMD, PhDalexandre.fabre@ap-hm.frBourgeoisPatricePhDpatrice.bourgeois@ap-hm.frChaixCharlènecharlene.chaix@ap-hm.frBertauxKarinePhDkarine.bertaux@ap-hm.frGouletOlivierMD, PhDolivier.goulet@aphp.frBadensCatherinePharmD, PhDcatherine.badens@ap-hm.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTrichorhinophalangeal SyndromeSynonym: Tricho-Rhino-Phalangeal Syndrome (TRPS)TüysüzBeyhanMD, PhDbeyhan@istanbul.edu.trGüneşNilayMDnilay.gunes@istanbul.edu.trAlkayaDilek UludağMD, PhDduludagalkaya@istanbul.edu.tr\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TRIO</italic>-Related Neurodevelopmental DisorderVarvagiannisKonstantinosMDkonstantinosv@cing.ac.cyknsvarv@ath.forthnet.grVissersLisenka ELMPhDlisenka.vissers@radboudumc.nlBaralleDianaBSc, MBBS, MD, FRCPd.baralle@soton.ac.ukde VriesBert BAMD, PhDbert.devries@radboudumc.nlGazdaghGabriellaMD, MRCPCHgabriella.gazdagh@uhs.nhs.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTRMU DeficiencySynonyms: TRMU-Related Reversible Infantile Respiratory Chain Deficiency, TRMU-Related Mitochondrial Hepatopathy, TRMU-Related Reversible Infantile Liver FailureReinhartMichaelaMDreinhartmb@chop.eduMurareskuColleenMS, LCGCclarkec@chop.eduGanetzkyRebeccaMDganetzkyr@chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTroyer SyndromeSynonyms: SPART-Related Hereditary Spastic Paraplegia (SPART-HSP); SPG20BapleEmmaMBBS, MRCPCH, PhDe.baple@exeter.ac.ukDayJacobMRCP, BM BCh, BAJ.Day8@exeter.ac.ukNewmanAllisonMScian545@exeter.ac.ukCrosbyAndrewPhDa.h.crosby@exeter.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TRPM3</italic>-Related Neurodevelopmental DisorderDymentDavidDPhil, MD, FRCPCddyment@cheo.on.caLinesMatthewMSc, MD, FRCPCmatthew.lines@albertahealthservices.caInnesA MicheilMD, FRCPCmicheil.innes@albertahealthservices.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TSEN54</italic> Pontocerebellar Hypoplasiavan DijkTessaMDt.van_dijk@lumc.nlBaasFrankMD, PhDf.baas@lumc.nl\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TUBB4A</italic>-Related Neurologic DisordersGavazziFrancescoMD, PhDgavazzif@chop.eduPizzinoAmyMSpizzinoa@chop.eduBallyJulien FMDjulien.bally@chuv.chFraserJamieMD, PhDjfraser@childrensnational.orgSimonsCasPhDc.simons@imb.uq.edu.auWolfNicole IMD, PhDn.wolf@amsterdamumc.nlvan der KnaapMarjoMD, PhDms.vanderknaap@vumc.nlVanderverAdelineMDvandervera@email.chop.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTuberous Sclerosis ComplexSynonym: Bourneville DiseaseNorthrupHopeMD, FACMGhope.northrup@uth.tmc.eduKoenigMary KayMDmary.k.koenig@uth.tmc.eduPearsonDeborah APhDdeborah.a.pearson@uth.tmc.eduAuKit SingPhDkit-sing.au@uth.tmc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTubulinopathies OverviewBahi-BuissonNadiaMD, PhDnadia.bahi-buisson@aphp.frMaillardCamillePhD\n\nSummary\n\n Clinical Characteristics of Tubulinopathies\n\n Genetic Causes of Tubulinopathies\n\n Differential Diagnosis of Tubulinopathies\n\n Evaluation Strategies to Identify the Genetic Cause of Tubulinopathy in a Proband\n\n General Medical Management of Tubulinopathies\n\n Genetic Counseling of Family Members of an Individual with a Tubulinopathy\n\nResources\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">TXNL4A</italic>-Related Craniofacial DisordersLüdeckeHermann-JosefPhDhermann-josef.luedecke@uni-duesseldorf.deWieczorekDagmarMDdagmar.wieczorek@uni-duesseldorf.dedagmar.wieczorek@hhu.de\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nType II Collagen Disorders OverviewGregersenPernille AxélMD, PhDDepartment of Clinical Genetics;Centre for Rare Diseases;Pediatrics and Adolescent MedicineAarhus University HospitalAarhus, Denmarkperngreg@rm.dkSavarirayanRaviMBBS, MD, FRACP, ARCPA (Hon)Victorian Clinical Genetics Service;Murdoch Children's Research Institute;University of Melbourne, ParkvilleMelbourne, Australiaravi.savarirayan@vcgs.org.au\n\nSummary\n\n Clinical Characteristics of Type II Collagen Disorders\n\n Evaluation Strategies to Identify the Genetic Cause of a Type II Collagen Disorder in a Proband\n\n Differential Diagnosis of Type II Collagen Disorders\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nTyrosine Hydroxylase DeficiencyFurukawaYoshiakiMD, PhDVice-President, Juntendo Tokyo Koto Geriatric Medical CenterProfessor, Department of Neurology, Juntendo University Graduate School of MedicineTokyo, Japanfurukawa@juntendo.gmc.ac.jpKishStephenPhDProfessor, Departments of Psychiatry and PharmacologyUniversity of TorontoHead, Human Brain LaboratoryResearch Imaging CentreCentre for Addiction and Mental HealthToronto, Ontario, Canadastephen.kish@camh.ca\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTyrosinemia Type IISynonyms: Oculocutaneous Tyrosinemia, Richner-Hanhart Syndrome, TAT Deficiency, Tyrosine Aminotransferase DeficiencyBayzaeiZahraPhDz.beyzaei@gmail.comDehghaniSeyed MohsenMD, MPHdehghanism@gmail.comGeramizadehBitaMD, APCPgeramib@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nTyrosinemia Type ISynonyms: FAH Deficiency, Fumarylacetoacetase Deficiency, Fumarylacetoacetate Hydrolase Deficiency, Hepatorenal Tyrosinemia Type 1 (HT-1)FiciciogluCanMD, PhDThe Children's Hospital of Philadelphia;Division of Human Genetics and MetabolismPerelman School of Medicine at the University of PennsylvaniaPhiladelphia, Pennsylvaniaficicioglu@chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nUdd Distal Myopathy – Tibial Muscular DystrophySynonym: Udd MyopathyUddBjarneMD, PhD, Profbjarne.udd@netikka.fiHackmanPeterPhD, Docpeter.hackman@helsinki.fi\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nUNC80 DeficiencyBramswigNuria CMDCentre of Medical GeneticsDepartment of Medical GeneticsUniversity of Münster and University Hospital MünsterMünster, Germanynuria.braemswig@ukmuenster.deZakiMaha SMD, PhDProfessor of Clinical GeneticsNational Research CentreCairo, Egyptdr_mahazaki@yahoo.comdr.mahazaki@nrc.nci.eg\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nUncomplicated (Pure) Hereditary Spastic Paraplegia OverviewSynonyms: Strumpell-Lorrain Syndrome, Uncomplicated Hereditary Spastic ParaparesisHederaPeterMD, PhD, FACMGDepartment of NeurologyUniversity of LouisvilleLouisville, Kentuckypeter.hedera@louisville.edu\n\nSummary\n\n Clinical Characteristics of Uncomplicated Hereditary Spastic Paraplegia\n\n Causes of Uncomplicated Hereditary Spastic Paraplegia\n\n Differential Diagnosis of Uncomplicated Hereditary Spastic Paraplegia\n\n Evaluation Strategies to Identify the Genetic Cause of Uncomplicated Hereditary Spastic Paraplegia in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nUrea Cycle Disorders OverviewSimpsonKara LMS, CGCksimpson@childrensnational.orgMacLeodErin LPhD, RDemacleod@childrensnational.orgKakajiwalaAadilMDakakajiwal@childrensnational.orgGropmanAndrea LMDmailto:agropman@childrensnational.organdrea.gropman@stjude.orgAh MewNicholasMDnahmew@childrensnational.org\n\nSummary\n\n Clinical Characteristics of Urea Cycle Disorders\n\n Genetic Causes of Urea Cycle Disorders\n\n Differential Diagnosis of Urea Cycle Disorders\n\n Evaluation Strategies to Identify the Genetic Cause of a Urea Cycle Disorder in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nUrofacial SyndromeSynonym: Ochoa SyndromeNewmanWilliam GMA, PhD, FRCPwilliam.newman@manchester.ac.ukWoolfAdrian SMA, MDadrian.woolf@manchester.ac.ukBeamanGlenda MPhDglenda.beaman@manchester.ac.ukRobertsNeil APhDneil.roberts-2@manchester.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nUsher Syndrome Type IISynonym: USH2KoenekoopRobertMD, PhD, FARVOPediatric Surgery, Human Genetics and Adult OphthalmologyMcGill University Health CenterMontreal, Quebec, Canadarobert.koenekoop@mcgill.caArriagaMoisesMD, MBA, FACSOtolaryngology and NeurosurgeryLouisiana State University Health Sciences CenterNew Orleans, Louisianamaa@neurotologic.comTrzupekKarmen MMS, CGCOcular & Rare Disease Genetics ServicesInformed DNASt Petersburg, Floridaktrzupek@informeddna.comLentzJenniferPhDNeuroscience Center of ExcellenceLouisiana State University HealthSciences CenterNew Orleans, Louisianajlentz@lsuhsc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nUsher Syndrome Type ISynonyms: Usher Syndrome Type 1, USH1, USH Type 1KoenekoopRobert KMD, PhD, FACSPediatric Surgery, Human Genetics, and Adult OphthalmologyMcGill University Health CenterMontreal, Quebec, Canadarobert.koenekoop@mcgill.caArriagaMoises AMD, MBA, FACSOtolaryngology and NeurosurgeryLouisiana State University Health Sciences CenterNew Orleans, Louisianamaa@neurotologic.comGilliesNickyMSHuman Development CenterLouisiana State University Health Sciences CenterNew Orleans, Louisianangilli@lsuhsc.eduTrzupekKarmen MMS, CGCOcular & Rare Disease Genetics ServicesInformedDNASt Petersburg, Floridaktrzupek@informeddna.comLentzJennifer JPhDNeuroscience Center of ExcellenceLouisiana State University Health Sciences CenterNew Orleans, Louisianajlentz@lsuhsc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">USP7</italic>-Related Hao-Fountain SyndromeSynonym: USP7-Related Neurodevelopmental DisorderSchaafChristianMD, PhDMedical Director and Chairman, Institute of Human GeneticsHeidelberg UniversityHeidelberg, Germanychristian.schaaf@med.uni-heidelberg.deSailerSebastianMDInstitute of Human GeneticsHeidelberg UniversityHeidelberg, Germanysebastian.sailer@med.uni-heidelberg.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nVariegate PorphyriaSynonym: Porphyria VariegataSingalAshwani KMD, MScUniversity of South Dakota Sanford School of Medicine\nSioux Falls, South Dakotaaksingal@uab.eduAndersonKarl EMDUniversity of Texas Medical Branch\nGalveston, Texaskanderso@utmb.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nVascular Ehlers-Danlos SyndromeSynonyms: EDS Type IV; Ehlers-Danlos Syndrome, Vascular Type; vEDSByersPeter HMDDepartment of Laboratory Medicine and Pathology;Department of Medicine, Division of Medical GeneticsUniversity of WashingtonSeattle, Washingtonpbyers@uw.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">VCAN</italic>-Related VitreoretinopathyRothschildPierre-RaphaelMD, PhDInstitut Parisien d’ophjtalmologie et Groupe PauchetParis, Francepierreraphaelrothschild@hotmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nVery Long-Chain Acyl-Coenzyme A Dehydrogenase DeficiencySynonyms: Very Long-Chain Acyl-CoA Dehydrogenase Deficiency, VLCAD DeficiencyLeslieNancy DMDProfessor of Clinical PediatricsDivision of Human GeneticsCincinnati Children's Hospital Medical CenterCincinnati, Ohionancy.leslie@cchmc.orgSaenz-AyalaSofiaMDCincinnati Children's Hospital Medical CenterCincinnati, Ohio\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nVEXAS SyndromeSynonym: Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic SyndromeHadjadjJeromeMD, PhDjerome.hadjadj@nyulangone.orgBeckDavidMD, PhDdavid.beck@nyulangone.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">VLDLR</italic> Cerebellar HypoplasiaSynonym: Cerebellar Ataxia, Mental Retardation, and Dysequilibrium Syndrome 1 (CAMRQ1)BoycottKym MPhD, MDDepartment of GeneticsChildren's Hospital of Eastern OntarioProfessor of PediatricsUniversity of OttawaOttawa, Ontario, Canadakboycott@cheo.on.caMacDonaldStella KBScClinical Research Associate, Department of GeneticsChildren's Hospital of Eastern OntarioOttawa, Ontario, Canadasmacdonald@cheo.on.caParboosinghJillian SPhDMolecular Diagnostic LaboratoryAlberta Children's HospitalAssociate Professor of Medical GeneticsUniversity of CalgaryCalgary, Alberta, Canadajillian.parboosingh@albertaprecisionlabs.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nVon Hippel-Lindau SyndromeSynonyms: VHL Disease, VHL Syndrome, Von Hippel-Lindau Diseasevan LeeuwaardeRachel SMD, PhDr.vanLeeuwaarde@umcutrecht.nlAhmadSayaBScvan NesselrooijBernadetteMD, PhDb.p.m.vannesselrooij@umcutrecht.nlZandeeWouterMD, PhDw.zandee@umcg.nlGilesRachel HPhDrachelhelengiles@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nVon Willebrand DiseaseSynonym: Von Willebrand Factor DeficiencyJohnsenJillMDDivision of Hematology and Oncology, Department of Medicine;Institute for Stem Cell & Regenerative Medicine;Center for Cardiovascular BiologyUniversity of WashingtonSeattle, Washingtonjjohnsen@uw.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">VPS13A</italic> DiseaseSynonyms: Chorea-Acanthocytosis (ChAc), ChoreoacanthocytosisPeikertKevinMDkevin.peikert@med.uni-rostock.deDobson-StoneCarolDPhilcarol.dobson-stone@sydney.edu.auRampoldiLucaPhDrampoldi.luca@hsr.itMiltenberger-MiltenyiGabrielMDgmiltenyi@medicina.ulisboa.ptNeimanAaronPhDaaron.neiman@stonybrook.eduDe CamilliPietroPhDpietro.decamilli@yale.eduHermannAndreasMD, PhDandreas.hermann@med.uni-rostock.deWalkerRuth HMB, ChB, PhDruth.walker@mssm.eduMonacoAnthony PMD, PhDanthony.monaco@tufts.eduDanekAdrianMDdanek@lmu.de\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">VPS13D</italic> Movement DisorderSynonyms: Spinocerebellar Ataxia, Recessive, Type 4 (SCAR4); Spinocerebellar Ataxia with Saccadic Intrusion (SCASI); VPS13D Hyperkinetic Movement DisorderMeijerInge AMD, PhDCHU Sainte-JustineUniversité de MontréalMontréal, Québec, Canadainge.meijer@umontreal.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">VPS35</italic>-Related Parkinson DiseaseSynonyms: PARK17, PARK-VPS35DulskiJaroslawMD, PhDdulski.jaroslaw@mayo.eduRossOwen APhDross.owen@mayo.eduWszolekZbigniew KMDwszolek.zbigniew@mayo.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nWaardenburg Syndrome Type IMilunskyJeff MarkMDDirector, Clinical GeneticsSenior Director, Molecular GeneticsCo-Director, Center for Human Genetics, IncCambridge, Massachusettsjmilunsky@chginc.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">WAC</italic>-Related Intellectual DisabilityVarvagiannisKonstantinosMDknsvarv@ath.forthnet.grde VriesBert BAMD, PhDbert.devries@radboudumc.nlVissersLisenka ELMPhDlisenka.vissers@radboudumc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nWAGR Spectrum DisorderSynonyms: WAGR Complex, WAGRO Syndrome, WAGR SyndromeGeorgeAndrew MBSgeorgeam@chop.eduKatzZoeMS, LCGCkatzz1@chop.eduHathawayEvan RMS, LCGChathawaye@chop.eduAdamsSylvie ABAadamss9@chop.eduBerlantZacharyMDberlantz@chop.eduDukiBamelak TesfayeBAdukib@chop.eduViswanathanAravindBAviswanatha@chop.eduTroutKelly LBSN, RNkelly.trout@wagr.orgMacFarlandSuzanne PMDmacfarlands@chop.eduKalishJennifer MMD, PhDkalishj@chop.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nWARS2 DeficiencyMroczekMagdalenaMDm.mroczek888@gmail.comBusraAynekinPhDbusraynekin@gmail.comHouldenHenryMD, PhDh.houlden@ucl.ac.ukEfthymiouStephanieMSc, PhDs.efthymiou@ucl.ac.ukNagySaraMD, MScs.nagy@ucl.ac.uk\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">WAS</italic>-Related DisordersChandraSharatMDAssociate Professor, Division of Bone Marrow Transplantation and Immune DeficiencyCincinnati Children's Hospital Medical Center;University of Cincinnati College of MedicineCincinnati, Ohiosharat.chandra@cchmc.orgNagarajChinmayee BMSGenetic Counselor, Division of Human GeneticsCincinnati Children's Hospital Medical CenterCincinnati, Ohiochinmayee.bhimarao@cchmc.orgSunMiaoPhDAssociate Professor of Clinical PathologyDivision of Genomic MedicineDepartment of Pathology and Laboratory MedicineChildren's Hospital Los Angeles;Keck School of Medicine of USCLos Angeles, Californiamiaosun@chla.usc.eduChandrakasanShanmuganathanMDAssociate Professor and DirectorImmune dysregulation / Immunohematology and Immune Defects Transplant ProgramsAflac Cancer and Blood Disorders CenterChildren's Healthcare of Atlanta;Emory University School of MedicineAtlanta, Georgiaschan31@emory.eduZhangKejianMD, MBAProfessor and DirectorMolecular Genetics LaboratoryDivision of Diagnostic Genetics and GenomicsDepartment of Pathology and Clinical LaboratoriesMichigan MedicineUniversity of MichiganAnn Arbor, Michigankejian.zhang2017@gmail.comkejian@med.umich.edu\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">WDR26</italic>-Related Intellectual DisabilitySkrabanCara MMDskrabanc@email.chop.eduGrandKatheryn LMSgrandk@email.chop.eduDeardorffMatthew AMD, PhDmdeardorff@chla.usc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">WDR62</italic> Primary MicrocephalySynonyms: Autosomal Recessive Primary Microcephaly 2 With or Without Cortical Malformations, MCPH2VerloesAlainMD, PhDalain.verloes@aphp.frRuaudLyseMD, PhDlyse.ruaud@aphp.frDrunatSéverinePharmD, PhDseverine.drunat@aphp.frPassemardSandrineMD, PhDsandrine.passemard@aphp.fr\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nWeill-Marchesani SyndromeMarzinPaulineMDpauline.marzin@aphp.frCormier-DaireValérieMD, PhDvalerie.cormier-daire@inserm.frTsilouEkateriniMDekaterini.tsilou@fda.hhs.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nWeiss-Kruszka SyndromeSynonym: ZNF462 DisorderKruszkaPaulMD, MPHNational Human Genome Research Institute\nNational Institutes of Health\nBethesda, Marylandpaul.kruszka@nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nWerner SyndromeOshimaJunkoMD, PhDDepartment of PathologyUniversity of WashingtonSeattle, Washingtonpicard@uw.eduHisamaFuki MMDDivision of Medical Genetics, Department of PediatricsUniversity of California Irvine,Orange, Californiafhisama@hs.uci.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">WFS1</italic> Spectrum DisorderBarrettTimothyMB BS, PhDProfessor of Pædiatrics, Institute of Cancer and Genomic SciencesUniversity of BirminghamBirmingham, United Kingdomt.g.barrett@bham.ac.ukTranebjærgLisbethMD, PhDProfessor of Medical Genetics and Genetic Audiology, Department of Clinical GeneticsUniversity Hospital / Kennedy Center;Institute of Clinical MedicinePanum InstituteUniversity of CopenhagenCopenhagen, Denmarktranebjaerg@sund.ku.dklisbeth.tranebjaerg@regionh.dkGuptaRajatMDDepartment of NeurologyBirmingham Women's and Children's HospitalBirmingham, United Kingdomrajatgupta@nhs.netMcCarthyLiamMDDepartment of UrologyBirmingham Women's and Children's HospitalBirmingham, United Kingdomliammccarthy@nhs.netRendtorffNanna DahlPhDDepartment of Clinical GeneticsUniversity Hospital / Kennedy CenterCopenhagen, Denmarknanna.dahl.rendtorff@regionh.dkWilliamsDeniseMDDepartment of Medical GeneticsBirmingham Women's and Children's HospitalBirmingham, United Kingdomdenise.williams21@nhs.netWrightBenjaminMDDepartment of NeurologyUniversity Hospitals BirminghamBirmingham, United Kingdombenjamin.wright@uhb.nhs.ukDiasRenukaPhDDepartment of EndocrinologyBirmingham Women's and Children's HospitalBirmingham, United Kingdomr.dias1@nhs.net\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nWhite-Sutton SyndromeSynonym: POGZ-Related Intellectual Disability SyndromeAssia BatzirNuritMDPediatric Genetics ClinicSchneider Children's Medical Center of IsraelPetah Tikva, Israelnurita3@clalit.org.ilWhiteJansonPhDInvitae CorporationSan Francisco, Californiajanson.white@invitae.comSuttonV ReidMDProfessor, Molecular & Human GeneticsBaylor College of Medicine;Texas Children's HospitalHouston, Texasvrsutton@texaschildrens.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nWiedemann-Steiner SyndromeSynonym: KMT2A-Related Neurodevelopmental DisorderSheppardSarah EMD, PhDUnit on Vascular MalformationsDivision of Intramural ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentBethesda, Marylandsarah.sheppard@nih.govQuintero-RiveraFabiolaMDDivision of Genetic and Genomic MedicineDepartments of Pathology, Laboratory Medicine, and PediatricsSchool of MedicineUniversity of California, Irvine;UC Irvine HealthOrange, Californiafabiolaq@hs.uci.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nWilliams SyndromeSynonym: Williams-Beuren SyndromeMorrisColleen AMD, FACMG, FAAPcolleen.morris@unlv.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nWilms Tumor PredispositionTurnerJoyce TMSjturner@childrensnational.orgBrzezinskiJackMD, PhDjack.brzezinski@sickkids.caDomeJeffrey SMD, PhDjdome@childrensnational.org\n\nSummary\n\n Clinical Characteristics of Wilms Tumor\n\n Mechanisms of Predisposition to Wilms Tumor\n\n Evaluation Strategy to Identify the Genetic Cause of Wilms Tumor in a Proband\n\n Management\n\n Genetic Counseling\n\nResources\n\nChapter Notes\n\nReferences\n\nWilson DiseaseSynonym: Hepatolenticular DegenerationWeissKarl HeinzMDInternal MedicineSalem Medical CenterHeidelberg, Germanykarlheinz.weiss@stadtmission-hd.deSchilskyMichaelMDYale University School of MedicineNew Haven, Connecticutmichael.schilsky@yale.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nWoodhouse-Sakati SyndromeSynonym: Hypogonadism, Alopecia, Diabetes Mellitus, Intellectual Disability, and Extrapyramidal SyndromeBohlegaSaeed AMD, FRCPC, FAANProfessor and Consultant, Department of Neurosciences\nKing Faisal Specialist Hospital and Research Center\nRiyadh, Saudi Arabiaboholega@kfshrc.edu.saAbusrairAliMDNeurologist, Department of Neurosciences\nKing Faisal Specialist Hospital and Research Center\nRiyadh, Saudi Arabiaaabusrair@moh.gov.sa\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">WT1</italic> DisorderLipska-ZiętkiewiczBeata SMD, PhDCentre for Rare DiseasesClinical Genetics UnitDepartment of Biology and GeneticsMedical University of GdańskGdańsk, Polandb.lipska@gumed.edu.pl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nXeroderma PigmentosumKraemerKenneth HMDkraemerk@nih.govDiGiovannaJohn JMDjdigiova@mail.nih.govTamuraDeborahRNtamurad@mail.nih.gov\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nXia-Gibbs SyndromeChanderVarunaMSvaruna.chander@bcm.eduWanglerMichaelMDmw147467@bcm.eduGibbsRichardPhDagibbs@bcm.eduMurdockDavidMDdmurdock@gmail.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nX-Linked AcrogigantismSynonyms: Chromosome Xq26.3 Duplication Syndrome, X-LAG, XLAGIacovazzoDonatoMDd.iacovazzo@qmul.ac.ukKorbonitsMártaMD, PhDm.korbonits@qmul.ac.uk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nX-Linked AdrenoleukodystrophySynonym: X-ALDRaymondGerald VMDgraymon4@jhmi.eduMoserAnn BBAmosera@kennedykrieger.orgFatemiAliMDfatemi@kennedykrieger.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nX-Linked AgammaglobulinemiaSynonyms: Bruton's Agammaglobulinemia, BTK Deficiency, XLASmithCI EdvardMD, PhDKarolinska InstitutetStockholm, Swedenedvard.smith@ki.seBerglöfAnnaVMD, PhDKarolinska InstitutetStockholm, Swedenanna.berglof@ki.se\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nX-Linked Congenital RetinoschisisSynonym: X-Linked RetinoschisisSievingPaul AMD, PhDProfessor of OphthalmologyDirector of the Center for Ocular Regenerative Therapy (CORT)University of California, DavisSacramento, Californiapasieving@ucdavis.eduMacDonaldIan MMD, CMProfessor, Department of Ophthalmology and Visual SciencesUniversity of AlbertaRoyal Alexandra HospitalEdmonton, Alberta, Canadamacdonal@ualberta.caHoangStephanieMScGenetic Counselor, Department of Medical GeneticsUniversity of Alberta HospitalEdmonton, Alberta, Canadastephanie.hoang@albertahealthservices.ca\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nX-Linked Congenital Stationary Night BlindnessSynonym: X-Linked CSNBMacDonaldIan MMD, CMDepartments of Ophthalmology and Medical Genetics\nUniversity of Alberta\nEdmonton, Alberta, Canadamacdonal@ualberta.caHoangStephanieMScAlberta Health Services\nEdmonton, Alberta, Canadastephanie.hoang@albertapubliclabs.caTuupanenSariPhDBlueprint Genetics\nHelsinki, Finlandsari.tuupanen@blueprintgenetics.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nX-Linked Dystonia-ParkinsonismSynonyms: DYT3, DYT-TAF1, LubagEvidenteVirgilio Gerald HMDDirector, Movement Disorders\nCenter of Arizona\nScottsdale, Arizonavevidente@movementdisorders.us\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nX-Linked HypophosphatemiaSynonyms: X-Linked Hypophosphatemic Rickets (XLHR); X-Linked Vitamin D-Resistant Rickets; Hypophosphatemic Rickets, PHEX-RelatedLaurentMichaël RMD, PhDCentre for Metabolic Bone DiseasesUniversity Hospitals LeuvenLeuven, Belgiummichael.laurent@uzleuven.beHarvengtPolPhDXLH BelgiumBelgian Association of Patients with XLH (A member of the International XLH Alliance)Waterloo, Belgiumpol.harvengt@gmail.comMortierGeert RMD, PhDCentre for Human GeneticsUniversity Hospitals LeuvenLeuven, Belgiumgeert.mortier@uzleuven.beBöckenhauerDetlefMD, PhDPaediatric NephrologyUniversity Hospitals LeuvenLeuven, Belgiumdetlef.bockenhauer@uzleuven.be\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nX-Linked Lymphoproliferative DiseaseMeyerLaurenMD, PhDDepartment of PediatricsUniversity of WashingtonSeattle, Washingtonlauren.meyer@seattlechildrens.orgHinesMelissaMDDivision of Critical Care MedicineSt Jude Children's Research HospitalMemphis, Tennesseemelissa.hines@stjude.orgZhangKejianMD, MBAGoBroad Healthcare GroupBeijing, Chinakejian.zhang2017@gmail.comNicholsKim EMDDepartment of OncologySt Jude Children's Research HospitalMemphis, Tennesseekim.nichols@stjude.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nX-Linked Myotubular MyopathySynonyms: Myotubular Myopathy (MTM), XLCNM, X-Linked Centronuclear Myopathy, XLMTMDowlingJames JMD, PhDDivision of Neurology\nProgram for Genetics and Genome Biology\nHospital for Sick Children\nToronto, Ontario, Canadajames.dowling@sickkids.caLawlorMichael WMD, PhDDepartment of Pathology and Laboratory Medicine and Neuroscience Research Center\nMedical College of Wisconsin\nMilwaukee, Wisconsinmlawlor@mcw.eduDasSomaPhDDepartment of Human Genetics\nUniversity of Chicago\nChicago, Illinoissdas@genetics.uchicago.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nReferences\n\nChapter Notes\n\nX-Linked ProtoporphyriaBalwaniManishaMD, MS, FACMGmanisha.balwani@mssm.eduDesnickRobertMD, PhD, FACMGrobert.desnick@mssm.eduPorphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nX-Linked Severe Combined ImmunodeficiencySynonyms: SCID-X1, X-Linked SCID (X-SCID)AllenspachEric JMD, PhDeric.allenspach@seattlechildrens.orgRawlingsDavid JMDdrawling@uw.eduPetrovicAleksandraMDaleksandra.petrovic@seattlechildrens.orgChenKarinMDkarin.chen@seattlechildrens.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nX-Linked Spondyloepiphyseal Dysplasia TardaSynonyms: TRAPPC2-Related SED Tarda, X-Linked (SED-XL); TRAPPC2-Related X-Linked Spondyloepiphyseal Dysplasia TardaTillerGeorge EMD, PhDDepartment of GeneticsSouthern California Permanente Medical GroupLos Angeles, Californiageorge.e.tiller@kp.org\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nXq28 Duplication Syndrome, Int22h1/Int22h2 MediatedSynonym: Xq28 Int22h-1/Int22h-2 Duplication SyndromeBalloutRami AMDClinical Fellow, Medical Genetics and Genomic Medicine Training ProgramNational Human Genome Research Institute (NHGRI)National Institutes of Health (NIH)Bethesda, Marylandrami-ballout@hotmail.comEl-HattabAyman WMD, FAAP, FACMGProfessor, Department of Clinical SciencesCollege of MedicineUniversity of SharjahSharjah, United Arab Emirateselhattabaw@yahoo.comSchaafChristian PMD, PhDProfessor and Chairman, Institute of Human GeneticsHeidelberg UniversityHeidelberg, Germanychristian.schaaf@med.uni-heidelberg.deCheungSau WaiPhD, MBA, FACMGProfessor, Department of Molecular and Human GeneticsBaylor College of MedicineHouston, Texasscheung@bcm.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nYARS1 DeficiencySynonyms: Autosomal Recessive YARS1-Related Disorder, Tyrosyl-tRNA Synthetase 1 Deficiency (TyrRS 1 Deficiency)AverdunkLuisaMDluisasusan.averdunk@med.uni-duesseldorf.deluisa.aver@gmail.comWangHuaMD, PhDhuawang@llu.eduHoytema van KonijnenburgEva MMMDe.m.m.hoytemavankonijnenburg-2@umcutrecht.nlFuchsSabine AMDs.fuchs@umcutrecht.nlNasser SamraNadranadran@ziv.gov.ilMandelHannaMDhmandel2637@gmail.comKwokAnne Mei-KwunMBBS(HK), FHKCPkwokmk@ha.org.hk\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nY Chromosome InfertilitySynonym: Y Chromosome-Related AzoospermiaFanYutingMDSilberSherman JMDsilber@infertile.com\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">YIF1B</italic>-Related Neurodevelopmental DisorderSynonym: Kaya-Barakat-Masson Syndrome (KABAMAS)Medico-SalsenchEvaMSce.medicosalsench@erasmusmc.nlKayaNamikPhDnkaya@kfshrc.edu.saBarakatTahsin StefanMD, PhD, MSct.barakat@erasmusmc.nl\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nZAP70 DeficiencySynonyms: ZAP70 Combined Immunodeficiency, ZAP-70 DeficiencyOwensJoshua WMDUPMC Children's Hospital of PittsburghPittsburgh, Pennsylvaniaowensjw@upmc.eduGrunebaumEyalMDCo-director, Food Allergy and Anaphylaxis ProgramDivision of Immunology and AllergySickKidsToronto, Canadaeyal.grunebaum@sickkids.caChongHey JinMD, PhD, FAAAAIDivision Director, Allergy & ImmunologyDirector, Pittsburgh Immunogenetics Discovery CenterAssociate Professor of PediatricsUPMC Children’s Hospital of PittsburghPittsburgh, Pennsylvaniahey.chong@chp.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nZellweger Spectrum DisorderSynonym: ZSDSteinbergSteven JPhDARUP LaboratoriesSalt Lake City, Utahsteven.steinberg@aruplab.comRaymondGerald VMDDepartment of Genetic MedicineJohns Hopkins HospitalBaltimore, Marylandgraymon4@jhmi.eduBravermanNancy EMS, MDDepartments of Pediatrics and Human GeneticsMcGill University and Research Institute of the McGill University Health CenterMontreal, Quebec, Canadanancy.braverman@mcgill.caMoserAnn BBAThe Peroxisomal Diseases LaboratoryKennedy Krieger InstituteDepartment of NeurologyJohns Hopkins University School of MedicineBaltimore, Marylandmosera@kennedykrieger.org\n\nSummary\n\n<italic toggle=\"yes\">GeneReview</italic> Scope\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\nZhu-Tokita-Takenouchi-Kim SyndromeSynonyms: SON Deficiency Syndrome, SON-Related Neurodevelopmental Disorder, SON-Related Zhu-Tokita-Takenouchi-Kim Syndrome, ZTTK SyndromeMoriMariMDmari.mori@emory.eduLemaireMathieuMD, PhDmathieu.lemaire@sickkids.caRainesGraceMDgraceraines@uabmc.eduStoneBrandon SMDbrandon.stone@nationwidechildrens.orgAhnEun-Young ErinPhDeyahn@uabmc.edu\n\nSummary\n\nDiagnosis\n\nClinical Characteristics\n\nGenetically Related (Allelic) Disorders\n\nDifferential Diagnosis\n\nManagement\n\nGenetic Counseling\n\nResources\n\nMolecular Genetics\n\nChapter Notes\n\nReferences\n\n<italic toggle=\"yes\">GeneReviews</italic> Glossary\n\n
", "complete": true, "provider": "europepmc" } ``` --- ### Citations Articles citing one Europe PMC record. Upstream pages by offset, not cursor. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/citations` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Article identifier within the source — a PMID for MED, a PMCID for PMC | | `source` | enum(MED|PMC|PPR|AGR|CBA|CTX|ETH|HIR|PAT|NBK) | query | no | Source archive the id belongs to. Default MED | | `page` | number | query | no | Page number. Default 1 | | `limit` | number | query | no | Items per page. Default 25, max 100 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/citations?id=33301246&source=MED&page=1&limit=25" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/citations?id=33301246&source=MED&page=1&limit=25", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/citations?id=33301246&source=MED&page=1&limit=25", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "id": "33301246", "page": 1, "count": 3, "items": [ { "id": "PPR1298176", "doi": null, "essn": null, "issn": null, "issue": null, "title": "A full-flow microfluidic platform for synthesis, purification and concentrating of lipid nanoparticles (LNPs)", "source": "PPR", "volume": null, "pubYear": 2026, "pageInfo": null, "authorString": "Tao J, Zhao J, Liu Y, Hu L, Zhou H, Wang B, Kang Y.", "citationType": "preprint", "citedByCount": 0, "externalLink": null, "journalAbbreviation": null }, { "id": "42595948", "doi": null, "essn": null, "issn": null, "issue": null, "title": "Exploring the Polyethylene Glycol-Modified Drug Patent Landscape by Deep Learning.", "source": "MED", "volume": null, "pubYear": 2026, "pageInfo": null, "authorString": "Zhang T, Deng D, Zhang X, Chen W, Wang P, Li X, Cong J, Wei B, Liu K.", "citationType": "journal article", "citedByCount": 0, "externalLink": null, "journalAbbreviation": "Ther Innov Regul Sci" }, { "id": "42594644", "doi": null, "essn": null, "issn": null, "issue": null, "title": "Implications for future pandemics from a living systematic review and critical evaluation of observational studies of the effectiveness of COVID-19 vaccination against the Omicron variant.", "source": "MED", "volume": "90", "pubYear": 2026, "pageInfo": "128993", "authorString": "Kazi F, Shapland CY, Spiga F, Villanueva G, Cornish RP, Henschke N, Cogo E, Sebastianski M, Aarabi M, Bergman H, Buckley B, Clayton GL, French CE, Liu J, Madley-Dowd P, Pelone F, Petkovic J, Probyn K, Saulle R, Savović J, Wilson R, Beck CR, Higgins JPT.", "citationType": "journal article", "citedByCount": 0, "externalLink": null, "journalAbbreviation": "Vaccine" } ], "limit": 3, "total": 12080, "source": "MED", "hasMore": true, "nextPage": 2, "provider": "europepmc" } ``` --- ### Database Links Cross-references from one Europe PMC record into the molecular databases (UniProt, PDB, ENA, ChEBI …). Upstream names the filter `database`. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/database-links` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Article identifier within the source — a PMID for MED, a PMCID for PMC | | `source` | enum(MED|PMC|PPR|AGR|CBA|CTX|ETH|HIR|PAT|NBK) | query | no | Source archive the id belongs to. Default MED | | `database` | string | query | no | Restrict to one database, such as EMBL, UNIPROT, PDB, CHEBI, OMIM, PRIDE | | `page` | number | query | no | Page number. Default 1 | | `limit` | number | query | no | Items per page. Default 25, max 100 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/database-links?id=18407985&source=MED&database=EMBL&page=1&limit=25" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/database-links?id=18407985&source=MED&database=EMBL&page=1&limit=25", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/database-links?id=18407985&source=MED&database=EMBL&page=1&limit=25", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "id": "18407985", "page": 1, "count": 0, "items": [], "limit": 3, "total": null, "source": "MED", "hasMore": false, "database": "EMBL", "nextPage": null, "provider": "europepmc" } ``` --- ### Full Text JATS full-text XML for one open-access PMC record. Non-JSON upstream, so this is a flat single object; the body is read against a byte ceiling and the 60s wall. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/full-text` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `pmcid` | string | query | yes | PMC identifier of an article whose full text is in Europe PMC | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/full-text?pmcid=PMC3258128" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/full-text?pmcid=PMC3258128", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/full-text?pmcid=PMC3258128", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "id": "PMC3258128", "bytes": 94004, "format": "xml", "source": "PMC", "content": "
4narNucleic Acids ResearchNucleic Acids ResOxford University PressPMC3258128325812832581282193751110.1093/nar/gkr715Hepato-specific microRNA-122 facilitates accumulation of newly synthesized miRNA through regulating PRKRALiShuai1ZhuJuanjuan1,2FuHanjiang1WanJing1HuZheng1LiuShanshan1LiJie1,2TieYi1XingRuiyun1ZhuJie1SunZhixian1ZhengXiaofei1*1Beijing Institute of Radiation Medicine, Beijing 100850 and 2Anhui Medical University, Hefei 230032, P. R. China

*To whom correspondence should be addressed. Tel: +86 10 68214653; Fax: +86 10 68214653; Email: xfzheng100@126.com

The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.

2192011402884884–8911712012© The Author(s) 2011. Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Abstract

microRNAs (miRNAs) are a versatile class of non-coding RNAs involved in regulation of various biological processes. miRNA-122 (miR-122) is specifically and abundantly expressed in human liver. In this study, we employed 3′-end biotinylated synthetic miR-122 to identify its targets based on affinity purification. Quantitative RT-PCR analysis of the affinity purified RNAs demonstrated a specific enrichment of several known miR-122 targets such as CAT-1 (also called SLC7A1), ADAM17 and BCL-w. Using microarray analysis of affinity purified RNAs, we also discovered many candidate target genes of miR-122. Among these candidates, we confirmed that protein kinase, interferon-inducible double-stranded RNA-dependent activator (PRKRA), a Dicer-interacting protein, is a direct target gene of miR-122. miRNA quantitative-RT–PCR results indicated that miR-122 and small interfering RNA against PRKRA may facilitate the accumulation of newly synthesized miRNAs but did not detectably affect endogenous miRNAs levels. Our findings will lead to further understanding of multiple functions of this hepato-specific miRNA. We conclude that miR-122 could repress PRKRA expression and facilitate accumulation of newly synthesized miRNAs.

statusreleaseddisplay-pdfyesis-olfnois-manuscriptnois-preprintnois-journal-matternois-scannednois-retractedno

Received 2010 Dec 13; Revised 2011 Aug 14; Accepted 2011 Aug 18; Issue date 2012 Jan; Collection date 2012 Jan.

INTRODUCTION

MicroRNAs (miRNAs) are small conserved RNAs of ∼22 nt which negatively modulate gene expression in animals and plants, primarily through base paring to the 3′-untranslated region (UTR) of target messenger RNAs (mRNAs). This leads to mRNA cleavage and/or translation repression (1). miRNAs are primarily transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by Drosha ribonuclease III enzyme to produce an ∼70-nt stem–loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA. The mature miRNA is incorporated into an RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA. Bioinformatic analysis predicts that each miRNA may regulate hundreds of target genes, suggesting that miRNAs may play a role in almost every biological pathway (2). Indeed, miRNAs have been implicated in the regulation of various cellular processes, including cell proliferation, apoptosis and stress responses (3–6).

One of the first clues of the existence of miRNAs in mammals came from studies on genetic alterations in woodchuck liver tumors. In 1989, a gene rearrangement of c-myc and an unusual transcript, named hcr, was described in one of these tumors. This transcript was characterized as liver specific, essentially non-coding, specifically nuclear and processed by endonucleases (7). Furthermore, hcr was proposed to be the precursor for miR-122. In the current understanding, the part of the hcr transcript encompassing the so-called ‘pri-miRNA’ is predicted to be processed to form a 66-nt long ‘pre-miRNA’, which presents a hairpin structure with 79% base pairing, and which will ultimately be cleaved by the endonuclease Dicer to form the mature miR-122 (8). Recent works on tissue-specific miRNAs has demonstrated miRNAs participation in tissue specification and cell lineage decisions (9–11). Among these tissue-specific miRNAs, miR-122 is one which is specifically expressed in adult liver and constitutes 70% of the total miRNA population (12–14). Recent studies showed that miR-122 could modulate lipid metabolism (15,16), hepatitis C virus (HCV) replication (17–19), apoptosis (20) and play a role in hepatocellular carcinoma (HCC) (21–23). To better understand the role of this liver-specific miRNA, the identification of the target genes of miR-122 is necessary.

In the present study, we employed 3′-end biotinylated synthetic miR-122 to identify its target genes based on affinity purification as described previously (24,25). Quantitative reverse transcriptase–polymerase chain reaction (RT–PCR) analysis of the affinity purified RNAs demonstrated a specific enrichment of several reported miR-122 targets, such as CAT-1 (13), ADAM17 (22) and BCL-w (20). By microarray, many candidate target genes of miR-122 were identified. We also verified that PRKRA, which showed a high of enrichment in affinity purification assay, was a new target gene of miR-122. Furthermore, the over-expression of miR-122 could facilitate the accumulation of newly synthesized miRNA.

MATERIALS AND METHODSCell lines and cultures

HepG2 and HeLa cell lines were cultured in DMEM (GIBCO BRL, Grand Island, NY, USA) containing 10% FBS with 100 U/ml penicillin and 100 mg/ml streptomycin at 37°C with 5% CO2.

Affinity purification experiments

To identify mRNAs associated with miRNA-122, affinity purification experiments were performed as described previously (Supplementary Figure S1, see Supplementary Methods for details) (24,25). Synthetic miRNA-122 duplexes were produced carrying a biotin group attached to the 3′-end of the miRNA sense strand (TaKaRa, Dalian, China) and transfected into HepG2 cells. Cells were harvested 48 h after transfection. The isolated RNA was ready for downstream qRT–PCR or microarray analysis.

Real-time qRT–PCR for mRNA

Total RNA was isolated using TRI Reagent (Sigma-Aldrich, St Louis, USA). cDNA was generated by reverse transcription using 1 μg of total RNA and ImProm-IITM Reverse Transcription System (Promega, Madison, WI, USA). Quantitative real-time PCR was performed on the MX 3000PTM PCR Instrument (Stratagene, La Jolla, USA) using SYBR Premix EX TaqTM (TaKaRa). Forward (F) and reverse (R) primers used were as follows: GAPDH-F 5′-tcagtggtggacctgacctg-3′, GAPDH-R 5′-tgctgtagccaaattcgttg-3′; BCL-w -F 5′-tttggttcggctttatcagg-3′, BCL-w-R 5′-gaggactgcgagttccaaag-3′; CAT-1-F 5′-ggctgtcctctggtgagaag-3′, CAT-1-R 5′-ggccaccagatcaaaagtgt-3′; ADAM-17-F 5′-ctgtggtgcaaaagcagaaa-3′, ADAM-17-R 5′-tgccaaatgcctcatattca-3′; PRKRA-F 5′-acgaatacggcatgaagacc-3′, PRKRA-R 5′-tggaagggtcaggcattaag-3′; A20-F 5′-gagagcacaatggctgaaca-3′, A20-R 5′-tccagtgtgtatcggtgcat-3′.

Microarray hybridization

RNA from affinity purification experiments was linear amplified (Two-Cycle Eukaryotic Target Labeling Kit, P/N 900494, Affymetrix, Inc., Santa Clara, CA, USA) and analyzed on Affymetrix human u133 plus 2.0 microarrays, which include a set of human maintenance genes to facilitate the normalization and scaling of array experiments. This set of genes serves as a tool to normalize and scale the data prior to performing data comparisons.

miRNA target site analysis

Affymetrix probe set identifiers were mapped to Ensembl transcripts using the Ensembl Biomart system. The 3′-UTR sequences were extracted from Ensembl using Biomart utilities. UltraEdit software was used to search candidate 3′-UTR for seed matches (perfect Watson–Crick matches between the 6-mer from bases 2 to 7 of the miRNA from the 5′-end) with none or one of three kinds of extensions: (i) an A across from nucleotide 1 in the miRNA (seedM+t1A), (ii) an additional match between the site and nucleotide 8 in the miRNA (seedM+m8M) and (iii), the combination of (i) and (ii) (seedM+m8M+t1A). TargetScan software (www.targetscan.org) was used to search for conserved miR-122-binding sites.

Plasmid construction

For the expression of miR-122, miR-133 or miR-30a, genomic fragment of Homo sapiens miR-122, miR-133 or miR-30a precursor was amplified and cloned into pcDNA3.0 (Invitrogen, Carlsbad, CA, USA). PRKRA 3′-UTR segment was subcloned into the pGL3 Control vector (Promega) immediately downstream of the stop codon of the luciferase gene. PCR with the appropriate primers also generated inserts with point substitutions in the miRNA complementary sites. Wild-type and mutant inserts were confirmed by sequencing.

miRNA qRT–PCR

For miRNA detection, total RNA was polyadenylated by poly (A) polymerase (Ambion, Austin, USA). An amount of 50 μl polyadenylation reaction was set up with 10 μg total RNA and 1 μl (2U) poly (A) polymerase according to the manufacturer's protocol. After incubation at 37°C for 60 min, poly (A)-tailed total RNA was recovered by phenol/chloroform extraction and ethanol precipitation. RT reaction was performed using 1 μg poly (A) tailed total RNA and 1 μg RT primer [5′-gcgagcacagaattaatacgatcactatagg(t)18VN-3′] with 1 μl ImProm-IITM Reverse Transcriptase (Promega) according to the manufacturer's protocol. qPCR was performed as described in the method of Quantitect SYBR Green PCR Kit (Qiagen, Hilden, Germany) with Mx3000pTM (Stratagene) supplied with analytical software. One primer of miRNA amplification is miRNA specific (miR-122 5′-tggagtgtgacaatggtgtttg-3′; miR-16 5′-tagcagcacgtaaatattggcg-3′; miR-24 5′-tggctcagttcagcaggaacag-3′; miR-133 5′-tttggtccccttcaaccagctg-3′; miR-30a 5′-tgtaaacatcctcgactggaag-3′), and the other is a universal primer (5′-gcgagcacagaattaatacgac-3′). U6 snRNA levels were used for normalization (U6-F 5′-cgcttcggcagcacatatacta-3′; U6-R 5′-cgcttcacgaatttgcgtgtca-3′).

miRNAs, small interfering RNAs and transfection

The miR-122 duplex and PRKRA small interfering RNAs (siRNAs) were designed and synthesized by GenePharma (GenePharma, Shanghai, China). The sequences of miRNA duplex and siRNAs were presented in Supplementary Table S1. siRNAs and miRNAs were transfected using Lipofectamine 2000 (Invitrogen). In brief, cells were cultured in a six-well plate to 50% confluence. For each well, 5 μl siRNA (20 μM) or miRNA (20 μM) was added into 250 μl Opti-MEM medium (GIBCO BRL), 4 μl of Lipofectamine 2000 into 250 μl Opti-MEM medium and then mixed siRNA or miRNA with Lipofectamine 2000 after 5 min incubation. After 20 min, the mixture was added to cells and incubated for 6 h before replacing the medium. Total RNA and protein were prepared 48 or 72 h after transfection and were used for qRT–PCR or western blotting analysis.

Western blot

Total cell lysate was prepared in 1× SDS buffer. Proteins at the same amount were separated by SDS–PAGE and transferred onto PVDF membranes. After probing with anti-PRKRA (10771-1-AP; Protein Tech Group, Inc., Chicago, USA) or anti-β-actin antibody (Beijing Zhongshan Biotechnology, Beijing, China) and incubating with proper secondary antibody, antigen–antibody complex was visualized by enhanced chemiluminescence's reagents Supersignal (Pierce, Rochford, IL, USA).

Luciferase reporter assay

Adherent HepG2 cells were grown in DMEM with 10% FBS to 80–90% confluency in 24-well plates. Cells were co-transfected with 100 ng of firefly luciferase reporter vector containing the PRKRA 3′-UTR (named pGL3-PRKRA-3′-UTR) or PRKRA mutant (named pGL3-PRKRA-3′-UTRmut) and 8 ng of the control vector containing Renilla luciferase, pRL-TK (Promega), in a final volume of 0.5 ml using Lipofectamine 2000 (Invitrogen). Firefly and Renilla luciferase activities were measured consecutively using the Dual-luciferase assays (Promega) 48 h after transfection.

Statistic analysis

All data are presented as means ± SD. Differences were assessed by two-tailed Student's t-test using Excel software. P < 0.05 was considered to be statistically significant.

RESULTSAffinity purification of miR-122 target mRNAs

To identify mRNA targets of miR-122, we employed an affinity-based target-identification procedure in which miR-122 is synthesized with a 3′-biotin group allowing for subsequent purification with streptavidin (Supplementary Figure S1). This technique has been previously verified for affinity purification of miRNA targets in Drosophila melanogaster cells and human neuronal cells (24,25). We validated the technique using a biotin-tagged miR-122 targeting several reported targets such as CAT-1 (13), ADAM17 (22) and BCL-w (20). Affinity purification experiments in HepG2 cells resulted in a 2- to 19-fold enrichment of these endogenous targets (Figure 1).\n

Affinity purification with biotin-tagged miR-122 from human hepatoma HepG2 cells and quantitative RT–PCR for its endogenous target CAT-1, ADAM17 and BCL-w. HepG2 cells were treated with cell lysis buffer 48 h after transfection. Data were normalized to the level of GAPDH mRNA. Results of the mean of triplicate quantitative PCR assays with standard deviation of the mean are presented. *P < 0.05.

To identify more targets of miR-122, RNAs from affinity purification experiment were linear amplified and analyzed on microarrays. Microarray results showed that 1474 genes were enriched >2-fold by 3′-biotin modified miR-122 (output) compared with total RNA (input) (Supplementary Table 2). We examined the 3′-UTRs for the presence of the 6-nt sequence CACTCC, which is the reverse complement of the nucleotides 2–7 seed in the mature miR-122 sequence. About 39% of the enriched mRNAs having at least one miR-122 recognition sequence, while the seed match frequency in all annotated human 3′-UTRs was only 25%, implying that a significant pool of the enriched mRNAs correspond to direct miR-122 targets in the liver (P < 0.001, Figure 2B and Supplementary Table S3). Detailed studies indicate that the presence of extended seed matches increases the likelihood that a given message is regulated by a miRNA (26,27). We therefore examined the identified seed matches for the presence of an A anchor corresponding to the 5′ most nucleotide of miR-122, as well as for an extended match to base 8 of miR-122 as described by Lewis et al. (26). Both the 7-nt and the 8-nt seed matches were significantly enriched in our microarray data (Figure 2Aand B; Supplementary Table S3). Moreover, about one-third of the conserved targets predicted by TargetScan software showed >2-fold of enrichment by biotin modified miR-122 (38 out of 124, Supplementary Table S2).\n

A significant enrichment of miR-122 targets by biotin-tagged miR-122. (A) Different seed types of miR-122. (B) The occurrence of miR-122 6-, 7- or 8-nt seed sequence matches in biotin-miR-122 enriched mRNAs (grey columns) and in all human annotated genes (white columns).

The GO analysis revealed that the enriched genes were over represented in gene categories involved in cellular functions associated with the regulation of transcription and RNA splicing, as well as development and cell cycle (Supplementary Table S4 and See Supplementary Table S5 for details).

Interaction between miR-122 and the 3′-UTR of PRKRA mRNA

In previously mentioned affinity purification experiment, PRKRA showed a high-level enrichment (∼45-fold) and harbored one putative binding site for miR-122 in its mRNA's 3′-UTR which was conserved across various species (Figure 3A). To investigate the potential miRNA:mRNA interaction, the human PRKRA 3′-UTR was subcloned after the firefly luciferase open reading frame (ORF) and cotransfected into HepG2 cells with the miR-122 duplex, which could mimic miR-122 molecule. miR-122 duplex could lead to a 60% decrease of relative luciferase activity compared with Negative Control transfected cells (Figure 3B). An analogous reporter with point substitutions disrupting the target sites (as illustrated, Figure 3A) was also contransfected with miR-122 duplex. There was no decrease of relative luciferase activity in miR-122 duplex transfected cells compared with Negative Control transfected cells (Figure 3B).\n

miR-122 inhibits PRKRA expression. (A upper panel) The target site of miR-122 in PRKRA 3′-UTR is conserved among mammalian species. (A lower panel) Predicted duplex formation between miR-122 and the targeted PRKRA 3′-UTR. The PRKRA 3′-UTR mutant is identical with the wild-type except that its three point substitutions disrupting pairing to miR-122 seed. (B) pGL3-PRKRA-3′-UTR reporter plasmid in which the luciferase-coding sequence had been fused to the 3′-UTR of PRKRA was cotransfected into HepG2 cells with Negative Control (grey columns) or miR-122 duplex (white columns). Luciferase activity was normalized relative to a simultaneously transfected Renilla expression plasmid. 3′-UTR-Mut indicates the introduction of alterations into the seed complementary sites shown in Figure 3A. Results of the mean of quadruplicate assays with standard deviation of the mean are presented. *P < 0.05. (C) Western blots of PRKRA from HepG2 cells. Cells were transfected with Negative Control or miR-122 duplex. Cells were harvested 48 h later, and 30 μg of whole-cell lysate was added into each lane. A β-actin antibody was used in a reprobing as a loading control. (D) Real-time RT–PCR of PRKRA in HepG2 cells transfected with the Negative Control or miR-122 duplex for 48 h. Data were normalized to the level of GAPDH mRNA. Results of the mean of triplicate qPCR assays with standard deviation of the mean are presented. *P < 0.05.

PRKRA is a potential target of miR-122

To learn whether miR-122 can affect endogenous PRKRA, we examined the impact of this miR-122 on PRKRA protein expression in cultured cells. Western blot from protein extracts obtained from the HepG2 cells revealed dramatically reduction in PRKRA protein level after miR-122 duplex transfection (Figure 3C). In contrast, negative control-transfected cells showed no reduction in PRKRA protein level. Because inhibition of expression by miRNA may also be mediated by mRNA degradation (28,29), we examined whether the PRKRA mRNA levels might be affected by miR-122. Figure 3D showed the PRKRA mRNA level was dramatically reduced by miR-122 duplex (42% reduction). Taken together, affinity purification experiment, luciferase data, immunoassay and real-time qRT–PCR assay provided strong evidences that PRKRA is a target of miR-122.

miR-122 facilitates accumulation of newly synthesized miRNA through downregulate PRKRA

PRKRA (PACT) cDNA was cloned by virtue of its interaction with PKR (30). PRKRA is a human cellular protein that heterodimerizes with PKR through its double-stranded RNA-binding domains (dsRBDs) and activates PKR pathway in vitro and in vivo in the absence of dsRNA. In contrast to PRKRA, the human immunodeficiency virus transactivating response RNA-binding protein (TRBP), another dsRBD protein with 42% identity to PRKRA, has an inhibitory effect on PKR (31). The opposite effects of PRKRA and TRBP on PKR activity are mediated by the C-terminal dsRBDs, which are devoid of detectable dsRNA-binding properties (31). PRKRA and TRBP have been demonstrated recently to interact with RNase III Dicer, a key enzyme involving in miRNA maturation, through their C-terminal dsRBDs (32–35). By using siRNA against TRBP, Chendrimada et al. (32) found that TRBP knockdown reduced endogenous miRNA levels in cell culture, whereas Haase et al. (33) saw no such reduction.

To assess the potential role of PRKRA in miRNA pathway, we transfected HeLa cells with miR-122 duplex or siRNAs against PRKRA. Via miRNA-RT–qPCR, we found the endogenous levels of miR-16 and miR-24 changed only slightly after the depletion of PRKRA (Figure 4A and B). This supports the previous observation that mature miRNA is highly stable in cells and therefore the changes in the steady-state level of mature miRNA may be difficult to detect (36–38). Then we cotransfected miR-133 expressing vector (pcDNA3.0-miR133) with miR-122 duplex or siRNAs against PRKRA into HeLa cells. Results from miRNA-RT–qPCR indicated that miR-122 duplex, siPRKRA-1 and siPRKRA-2 could facilitate accumulation of newly synthesized miR-133 (Figure 4C). We also found that PRKRA siRNAs could also facilitate accumulation of newly synthesized miR-122 when HeLa cells were cotransfected with miR-122 expressing vector (pcDNA3.0-miR122) (Figure 4D). Similar results were observed in HepG2 cell line (data not shown). To monitor PKR activity, we analysis the expression of Tnfaip3 (A20) which could be induced by PKR activation through NF-κB pathway (39,40). Real time qRT–PCR results showed that downregulation of PRKRA by siRNA has no effect on A20 expression (Supplementary Figure S3). Our findings that PRKRA knockdown facilitated accumulation of newly synthesized miRNA support the hypothesis that PRKRA and TRBP have opposite effects on miRNA maturation just like the situation in PKR pathway (Figure 5).\n\n

miR-122 facilitates the accumulation of newly synthesized miRNA through regulating PRKRA. (A and B) miRNA-RT–qPCR detected the expression of miR-16 and miR-24. HeLa cells were transfected with the Negative Control siRNA, miR-122 duplex, siPRKRA-1 or siPRKRA-2 for 48 h. (C) miRNA-RT–qPCR detected the expression of miR-133. HeLa cells were cotransfected with miR-133 expressing vector (pcDNA3.0-miR133) and Negative Control siRNA, miR-122 duplex, siPRKRA-1 or siPRKRA-2 for 48 h. (D) The same experiment as described in (C), except for cotransfecting HeLa cells with miR-122 expressing vector (pcDNA3.0-miR122) and Negative Control siRNA, siPRKRA-1 or siPRKRA-2 for 48 h. Total RNA was poly-A tailed, reverse transcripted and then real-time PCR tested. Data were normalized to the level of U6 RNA. Results of the mean of triplicate quantitative PCR assays with standard deviation of the mean are presented.

The regulation of miRNA maturation and PKR pathway by TRBP and PRKRA. PRKRA and TRBP involved in the regulation of PKR pathway and the maturation of miRNAs through interacting with PKR or Dicer, respectively.

DISCUSSION

The present study shows that PRKRA could be enriched by 3′-biotin modified miR-122. It is also shown that PRKRA is negatively regulated by miR-122 via a specific target site within the 3′-UTR. Moreover, we showed that miR-122 facilitates accumulation of newly synthesized miRNA through downregulating PRKRA expression. The identification of miR-122 as an important regulator of miRNA maturation emphasizes an essential role of this liver-specific miRNA.

Sophisticated mechanisms regulating RNA may explain the gap between the great complexity of cellular functions and the limited number of primary transcripts. Regulation by miRNAs underscores this possibility, as each miRNA is believed to bind directly to many mRNAs to regulate their translation or stability and thereby control a wide range of activities. Despite their biological importance, determining the targets of miRNAs is a major challenge. Attention has largely been laid on computational predictions of targets based on the observation that many miRNAs can recognize their targets by binding to motifs in the 3′-UTR sequences complementary to bases 2–8 of the miRNA (the seed region) (41). Whereas these algorithms have been instrumental in many studies of individual miRNA:mRNA interactions, unbiased approaches to study miRNA target recognition are important to discover new features of miRNAs. In this study, we used a direct affinity-based procedure to isolate target mRNAs bound by miR-122. These results will help us to understand the function of this liver-specific miRNA. While preparing this manuscript one group has published a paper demonstrating miR-122 targeting CUTL1 (CUX1) during liver development, which is also enriched by biotin-tagged miR-122 (Supplementary Table S2) (42).

The affinity-based target-identification procedure was performed following Orom et al. (24,25) with some modification. The non-specific binding of RNAs to streptavidin–agarose beads was unavoidable even we washed the beads four times with cell lysis buffer. Therefore, GAPDH with no putative target site of miR-122 was chosen to serve as an internal control. If one gene is the target of miR-122, the output would contain more mRNA/GAPDH than the Input. To validate our results, we also normalize mRNA with β-actin (no putative target site of miR-122 in its 3′-UTR). Results from real-time PCR showed that miR-122's known target gene had enrichment in Ouput when normalized to GAPDH or β-actin (Figure 1 and Supplementary Figure S4).

miRNAs are generated by a two-step processing pathway. Primary miRNAs are processed to pre-miRNAs by Drosha. These pre-miRNAs are cleaved by Dicer to generate mature miRNAs (43–45). In human cells, Drosha exists as part of a protein complex called the Microprocessor complex, which contains the dsRNA-binding protein DGCR8 (also called Pasha). DGCR8 is essential for Drosha activity and capable of binding single-stranded fragments of the pri-miRNA that are required for proper processing (46,47). Dicer also exists as part of a protein complex which contains two dsRNA-binding proteins, TRBP and PRKRA (32–35). It was reported that TRBP knockdown reduced endogenous miRNA levels in cell culture (32). Here, we found that PRKRA knockdown by miR-122 duplex or siRNAs against PRKRA could facilitate accumulation of newly synthesized miRNA. Thus dsRNA-binding protein such as DGCR8, TRBP and PRKRA could affect the miRNAs processing pathway by interacting with Drosha or Dicer.

However, our finding that PRKRA is a negative regulator of miRNA processing is in direct conflict with the finding of Lee et al. (34). They demonstrated that the reduction of PRKRA protein results in reduced miRNA accumulation. The contradictory results probably reflect the different methodologies. Lee et al. depleted PRKRA by RNAi from a HeLa cell line that expresses pri-miR-30a from the tetracycline-inducible promoter. After incubation with siRNA, the cell line was exposed to doxycycline, the derivative of tetracycline, for induction of pri-miR-30a. By using northern blotting on miR-30a, they found that reduction of PRKRA protein levels results in reduced miRNA accumulation. While we co-transfected siRNA and miRNA-expressing vector into HeLa cell line. By using miRNA quantitative-RT–PCR, we found that PRKRA siRNAs could facilitate the accumulation of miRNA. Moreover, we co-transfected PRKRA siRNAs and miR-30a-expressing vector (the specific miRNA investigated by Lee et al.) into HeLa cell line. Forty-eight hours after transfection, we employed miRNA quantitative-RT–PCR to detect miR-30a expression and found that PRKRA siRNAs could also facilitate the accumulation of miR-30a (Supplementary Figure S5).

An interesting paradox exists between TRBP and PRKRA, which shares 42% amino acid sequence identity. TRBP inhibits the dsRNA-activated PKR, whereas PRKRA activates this protein—both using their C-terminal domains for these functions (31). TRBP and PRKRA could interact with Dicer, raising the intriguing possibility that TRBP and PRKRA modulate PKR differentially in response to dsRNAs in the cytoplasm. For instance, it would be disadvantageous to the cell to have miRNA precursors activating PKR, as this may ultimately lead to cell death. Thus, our findings suggest that TRBP and PRKRA might be responsible for keeping the balance between PKR pathway and pre-miRNA processing (Figure 5).

In conclusion, miR-122, a hepato-specific miRNA, inhibits the expression of Dicer-interacting PRKRA gene by binding to the 3′-UTR of PRKRA mRNA and thereby facilitates the accumulation of newly synthesized miRNA.

SUPPLEMENTARY DATA

Supplementary Data are available at NAR Online: Supplementary material, Supplementary tables, Supplementary figures 1–5.

FUNDING

Chinese State Key Projects for Basic Research (2010CB912801, 2007CB914601); partially by grants from Chinese Key Project for the Infectious Diseases (2008ZX10002-016); and Chinese National Natural Science Foundation (30870529, 30873008). Funding for open access charge: Chinese State Key Projects for Basic Research (2010CB912801).

Conflict of interest statement. None declared.

Supplementary MaterialSupplementary DataREFERENCESBartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. doi: 10.1016/s0092-8674(04)00045-5.Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. Combinatorial microRNA target predictions. Nat. Genet. 2005;37:495–500. doi: 10.1038/ng1536.Xu P, Guo M, Hay BA. MicroRNAs and the regulation of cell death. Trends Genet. 2004;20:617–624. doi: 10.1016/j.tig.2004.09.010.Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33:1290–1297. doi: 10.1093/nar/gki200.Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl Acad. Sci. USA. 2005;102:18081–18086. doi: 10.1073/pnas.0506216102.Dresios J, Aschrafi A, Owens GC, Vanderklish W, Edelman GM, Mauro VP. Cold stress-induced protein Rbm3 binds 60S ribosomal subunits, alters microRNA levels, and enhances global protein synthesis. Proc. Natl Acad. Sci. USA. 2005;102:1865–1870. doi: 10.1073/pnas.0409764102.Moroy T, Etiemble J, Bougueleret L, Hadchouel M, Tiollais P, Buendia MA. Structure and expression of hcr, a locus rearranged with c-myc in a woodchuck hepatocellular carcinoma. Oncogene. 1989;4:59–65.Chang J, Provost P, Taylor JM. Resistance of human hepatitis delta virus RNAs to dicer activity. J. Virol. 2003;77:11910–11917. doi: 10.1128/JVI.77.22.11910-11917.2003.Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007;8:166. doi: 10.1186/1471-2164-8-166.Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006;38:228–233. doi: 10.1038/ng1725.Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433:769–773. doi: 10.1038/nature03315.Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002;12:735–739. doi: 10.1016/s0960-9822(02)00809-6.Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2004;1:106–113. doi: 10.4161/rna.1.2.1066.Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, Landthaler M, Landgraf P, Kan S, Lindenbach BD, et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl Acad. Sci. USA. 2007;104:12884–12889. doi: 10.1073/pnas.0704894104.Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with ‘antagomirs’. Nature. 2005;438:685–689. doi: 10.1038/nature04303.Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006;3:87–98. doi: 10.1016/j.cmet.2006.01.005.Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science. 2005;309:1577–1581. doi: 10.1126/science.1113329.Henke JI, Goergen D, Zheng J, Song Y, Schuttler CG, Fehr C, Junemann C, Niepmann M. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 2008;27:3300–3310. doi: 10.1038/emboj.2008.244.Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010;327:198–201. doi: 10.1126/science.1178178.Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun. 2008;375:315–320. doi: 10.1016/j.bbrc.2008.07.154.Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J. Cell Biochem. 2006;99:671–678. doi: 10.1002/jcb.20982.Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009;49:1571–1582. doi: 10.1002/hep.22806.Bai S, Nasser MW, Wang B, Hsu SH, Datta J, Kutay H, Yadav A, Nuovo G, Kumar P, Ghoshal K. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J. Biol. Chem. 2009;284:32015–32027. doi: 10.1074/jbc.M109.016774.Orom UA, Lund AH. Isolation of microRNA targets using biotinylated synthetic microRNAs. Methods. 2007;43:162–165. doi: 10.1016/j.ymeth.2007.04.007.Orom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell. 2008;30:460–471. doi: 10.1016/j.molcel.2008.05.001.Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20. doi: 10.1016/j.cell.2004.12.035.Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell. 2007;27:91–105. doi: 10.1016/j.molcel.2007.06.017.Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433:769–773. doi: 10.1038/nature03315.Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell. 2005;122:553–563. doi: 10.1016/j.cell.2005.07.031.Patel RC, Sen GC. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 1998;17:4379–4390. doi: 10.1093/emboj/17.15.4379.Gupta V, Huang X, Patel RC. The carboxy-terminal, M3 motifs of PACT and TRBP have opposite effects on PKR activity. Virology. 2003;315:283–291. doi: 10.1016/s0042-6822(03)00589-0.Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436:740–744. doi: 10.1038/nature03868.Haase AD, Jaskiewicz L, Zhang H, Laine S, Sack R, Gatignol A, Filipowicz W. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 2005;6:961–967. doi: 10.1038/sj.embor.7400509.Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN. The role of PACT in the RNA silencing pathway. EMBO J. 2006;25:522–532. doi: 10.1038/sj.emboj.7600942.Kok KH, Ng MH, Ching YP, Jin DY. Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J. Biol. Chem. 2007;282:17649–17657. doi: 10.1074/jbc.M611768200.Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415–419. doi: 10.1038/nature01957.Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003;17:3011–3016. doi: 10.1101/gad.1158803.Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science. 2004;303:95–98. doi: 10.1126/science.1090599.Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000;289:2350–2354. doi: 10.1126/science.289.5488.2350.Donze O, Deng J, Curran J, Sladek R, Picard D, Sonenberg N. The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J. 2004;23:564–571. doi: 10.1038/sj.emboj.7600078.Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233. doi: 10.1016/j.cell.2009.01.002.Xu H, He JH, Xiao ZD, Zhang QQ, Chen YQ, Zhou H, Qu LH. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology. 2010;52:1431–1442. doi: 10.1002/hep.23818.Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, Baillie DL, Fire A, Ruvkun G, Mello CC. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell. 2001;106:23–34. doi: 10.1016/s0092-8674(01)00431-7.Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science. 2001;293:834–838. doi: 10.1126/science.1062961.Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 2001;15:2654–2659. doi: 10.1101/gad.927801.Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature. 2004;432:231–235. doi: 10.1038/nature03049.Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK, Sohn SY, Cho Y, Zhang BT, Kim VN. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell. 2006;125:887–901. doi: 10.1016/j.cell.2006.03.043.Associated DataSupplementary MaterialsSupplementary Data
", "complete": true, "provider": "europepmc" } ``` --- ### Grants GRIST grant records. The upstream folds its whole query string into one path segment and mangles any parameter it does not know, so order and set are fixed. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/grants` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Free text, or a GRIST field expression such as gr.gid eq "23942" or pi.fn eq "Smith" | | `resultType` | enum(lite|core) | query | no | Field depth per record. Default core, which carries the abstract and amount | | `page` | number | query | no | Page number. Default 1. Upstream fixes the page at 25 records | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/grants?query=malaria&resultType=core&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/grants?query=malaria&resultType=core&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/grants?query=malaria&resultType=core&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 25, "items": [ { "grant": { "doi": "10.3030/101231026", "type": "Consolidator Grant", "alias": "101231026", "title": "Evolution of Mechanisms for Sex Chromosome Dosage Compensation and Gene Regulation (EMERGE)", "amount": 1999177, "funder": { "name": "European Research Council", "fundRefId": "https://doi.org/10.13039/501100000781", "searchTerm": "European Research Council" }, "stream": "Frontier Research", "endDate": "2031-07-31", "grantId": "101231026", "abstract": "There is a remarkable diversity of phenotypes among multicellular animals, including differences between males and females. A major driver of phenotypic variation stems from differences in gene regulation. The evolution of these regulatory mechanisms is a central, yet unresolved question in biology. Sex chromosome dosage compensation (SCDC) is an epigenetic process that equalizes sex chromosomal gene expression between males and females. EMERGE uses SCDC as a model to uncover how and why epigenetic mechanisms evolve and function across animals. We will employ a taxonomic gradient from (1) molecular studies in malaria mosquitos to (2) comparative mechanistic analyses across multiple insects, and finally to (3) a broad investigation across all animal clades. First, we will determine how a novel SCDC pathway in malaria mosquitos evolved to specifically regulate the X chromosome. To achieve this, we will use heterologous expressions, alongside in vitro biochemistry and proximity proteomics. Second, we will assess the physiological relevance of SCDC to determine why its absence is lethal in only certain contexts and species. We will test how proteome homeostasis, transcriptional noise, and critical genes influence essentiality. Third, we will explore the diversity of SCDC mechanisms across dozens of animal species with heteromorphic sex chromosomes, including unexplored phyla such as Cnidaria or Mollusca. Employing microscopy, transcriptomics, proteomics, and epigenome profiling, we will study SCDC patterns, conserved and lineage-specific adaptations, as well as regulatory mechanisms. Our findings are expected to reveal general principles of how chromatin controls gene expression, responds to dosage imbalances, and evolves across the animal tree of life. By comprehensively investigating both sexes, EMERGE will at the same time shed light on the regulatory and physiological differences between males and females, a heavily overlooked aspect in research and healthcare.", "category": "Horizon Europe", "currency": "EUR", "startDate": "2026-08-01", "abstractType": "scientific", "abstractLanguage": "en" }, "person": { "orcid": "0000-0003-4135-5927", "title": "Dr", "initials": "C", "givenName": "Claudia", "familyName": "Keller Valsecchi" }, "institution": { "name": "University of Basel", "rorId": "02s6k3f65", "department": null, "officialName": "University of Basel" } }, { "grant": { "doi": null, "type": "Research Grant", "alias": "UKRI3660", "title": "Mining the Cryptosporidium kinome: using kinobead technology to reveal novel biology and potential therapeutic targets", "amount": 1211707, "funder": { "name": "Medical Research Council", "fundRefId": "https://doi.org/10.13039/501100000265", "searchTerm": "Medical Research Council" }, "stream": "MRC: Apr 2025: research: infections and immunity: responsive mode", "endDate": null, "grantId": "UKRI3660", "abstract": "Diarrhoeal disease is a leading cause of morbidity and mortality for young children. The WHO estimates that 10% of the deaths of children under the age of five globally are due to diarrheal disease. In 2013 the Global Enteric Multicentre Study identified the pathogens responsible for deadly diarrhoeal disease. Surprisingly, cryptosporidiosis caused by infection with Cryptosporidium parasites, was revealed as second only to Rotavirus in causing deadly disease. Diarrhoea from cryptosporidiosis is severe, but self-limiting in immune-competent people. However, for young, malnourished children and the immunocompromised, the disease can be fatal. Annually there are an estimated 7.5 million cases of cryptosporidiosis, resulting in >200,000 deaths. Recurrent diarrhoeal episodes associated with cryptosporidiosis alters gut morphology, leading to growth stunting, delayed development, and impaired cognitive function. The greatest impact of the disease occurs in Low and Middle-Income Countries. However, waterborne outbreaks threaten public health in High-Income Countries including the USA and UK. Waterborne outbreaks also carry significant economic impact. Unfortunately, there is no vaccine and no effective treatment for cryptosporidiosis. New drugs are desperately needed. Phosphorylation, the addition of a phosphate group to a molecule or protein, is mediated by kinases. Kinases are key regulators of cell signalling and play a crucial role in modulating almost all cellular events. Therefore, it is no surprise that kinase inhibitors have become one of the pharmaceutical industry’s most important drug target classes with ~30% of drug discovery efforts worldwide directed at the kinase superfamily. Despite the fact that little is known about the function of kinases in Cryptosporidium, they are gaining traction as exploitable drug targets. The two compounds currently in development for cryptosporidiosis specifically target kinases. In addition, compounds known to inhibit kinases kill Cryptosporidium parasites, although the details about how the compounds do this are unknown. In order to leverage these promising compounds as treatments for cryptosporidiosis, it is critical to identify which specific kinase, or kinases they target (Cryptosporidium have >100 kinases). This information will strengthen current drug discovery projects and help initiate new ones. Unfortunately, many of the tools and reagents available to identify the targets of kinase inhibitors are optimised for human kinases and are considerably less effective for the study of kinases in other organisms. Similarly, compared to other related parasites, like Plasmodium and Toxoplasma (which cause malaria and toxoplasmosis respectively), our understanding of the basic biology of Cryptosporidium is limited. To address this knowledge gap, we will adopt an interdisciplinary approach that combines chemistry, proteomics (the study of proteins), biology, and genetics. To better understand the role of kinases in Cryptosporidium biology we will: 1] develop Cryptosporidium-centric chemical tools; 2] use these tools, in combination with proteomics, to identify the protein targets of kinase inhibitors capable of killing Cryptosporidium parasites and 3] interrogate the biology and function(s) of these biologically significant Cryptosporidium kinases. This research will improve our fundamental understanding of Cryptosporidium biology and will lay the foundations for the future exploitation of kinases for anti-cryptosporidial drug discovery. Effective drugs for cryptosporidiosis will lead to improvements to the health and welfare of children and immune-compromised patients world-wide.", "category": null, "currency": "GBP", "startDate": "2026-06-30", "abstractType": "scientific", "abstractLanguage": "en" }, "person": { "orcid": null, "title": null, "initials": "SW", "givenName": "Susan", "familyName": "Wyllie" }, "institution": { "name": "University of Dundee", "rorId": "03h2bxq36", "department": null, "officialName": "University of Dundee" } }, { "grant": { "doi": null, "type": "Discretionary Award", "alias": [ "351995", "351995/Z/26/Z" ], "title": "Establishment of Climate and Health Science and Policy Consortium in Eastern Africa", "amount": 20000, "funder": { "name": "Wellcome Trust", "fundRefId": "https://doi.org/10.13039/100010269", "searchTerm": "Wellcome Trust" }, "stream": "Population and Public Health", "endDate": "2026-10-14", "grantId": "351995", "abstract": "Climate change is already intensifying health risks across Eastern Africa. The 2020–2022 Horn of Africa drought left more than 30 million people in Ethiopia, Kenya and Somalia facing drought-related food insecurity, and climate change is projected to cause 123 million additional malaria cases and 532,000 additional malaria deaths across Africa between 2024 and 2050. These risks intersect with climate-sensitive livelihoods, food and water insecurity, population mobility, fragile infrastructure and uneven adaptive capacity, increasing vulnerability across the region. However, Eastern Africa’s climate- health response remains constrained by a critical systems gap: fragmented research, weak cross-sector coordination, uneven technical capacity, limited community and policy engagement, and inadequate mechanisms for translating evidence into decisions and practice. This proposal development grant will address this gap by supporting the co-design of an African-led Climate and Health Science and Policy Consortium in Eastern Africa, led by Ifakara Health Institute. The grant will support country and stakeholder mapping, partner consultations, priority-setting, governance design, capacity strengthening, sustainability planning and collaborative proposal writing. The outcome will be a credible regional consortium capable of generating policy-relevant evidence, strengthening regional capacity, supporting evidence-informed decision-making and enabling practical climate-health action. Keywords: climate change; health; Eastern Africa; science-policy consortium; capacity strengthening.", "category": null, "currency": "GBP", "startDate": "2026-06-15", "abstractType": "scientific", "abstractLanguage": "en" }, "person": { "orcid": null, "title": "Dr", "initials": "HM", "givenName": "Honorati", "familyName": "Masanja" }, "institution": { "name": "Ifakara Health Institute", "rorId": "04js17g72", "department": null, "officialName": "Ifakara Health Institute" } }, { "grant": { "doi": null, "type": "Early-Career Award", "alias": [ "324519", "324519/Z/25/Z" ], "title": "Mechanisms of Emergence and Spread of Artemisinin and MultiDrug Resistance (AMRED) Malaria Parasites in West Africa", "amount": 1067792.92, "funder": { "name": "Wellcome Trust", "fundRefId": "https://doi.org/10.13039/100010269", "searchTerm": "Wellcome Trust" }, "stream": "Genetics and Genomics", "endDate": "2031-05-15", "grantId": "324519", "abstract": "The recent emergence and spread of artemisinin resistant Plasmodium falciparum parasites in Africa pose grave threats to control/elimination programs utilising artemisinin combination therapies (ACTs), the last stronghold for malaria treatments. Over 10 mutations in the parasite’s Kelch 13 gene, K13, have been associated with artemisinin resistance in Africa; particularly, West African parasites harbouring K13 resistant markers also show reduced ex vivo susceptibility to artemisinin. The typical high parasite transmission/recombination rates in West African parasites could rapidly expand these resistant markers on diverse genetic backgrounds, associated with multidrug resistance to partner drugs, and the former first-line treatments, chloroquine and sulphadoxine-pyrimethamine. We are not well equipped, and lack critical knowledge in the evolutionary mechanisms underlying the emergence/spread of these resistant markers, to forestall containment measures in West Africa; how do artemisinin- and multidrug resistant (AMRED) marker combinations influence heterogenous susceptibilities to ACTs in contemporary infections? This study aims to investigate these questions in Ghana, a low- high transmission setting, with ideal parasite populations that harbour resistance markers to most antimalarials. It will innovate genetic tools and approaches to unravel the complexity in resistance evolution and build local capacity in functional genetics studies to detect, track and stop artemisinin resistance.", "category": null, "currency": "GBP", "startDate": "2026-05-15", "abstractType": "scientific", "abstractLanguage": "en" }, "person": { "orcid": null, "title": "Dr", "initials": "CA", "givenName": "Charles", "familyName": "Narh" }, "institution": { "name": "University of Ghana", "rorId": "01r22mr83", "department": null, "officialName": "University of Ghana" } }, { "grant": { "doi": null, "type": "Fellowship", "alias": "UKRI3394", "title": "Advancing epidemiological methods for evaluation of malaria vaccine effectiveness and impact", "amount": 1848767, "funder": { "name": "Medical Research Council", "fundRefId": "https://doi.org/10.13039/501100000265", "searchTerm": "Medical Research Council" }, "stream": "MRC: Apr 2025: career development award", "endDate": null, "grantId": "UKRI3394", "abstract": "Each year, malaria kills nearly half a million children in sub-Sharan Africa. Currently, several effective malaria control interventions including chemoprevention and insecticide-treated nets are implemented across the region. Recently, World Health Organisation recommended the introduction of two novel malaria vaccines, administered in a four-dose schedule. The Malaria Vaccine Implementation Pilot study in Ghana, Kenya, and Malawi showed that coverage was relatively high for the first three doses(63-75%) among vaccine-eligible children, but only 40% received the fourth dose. As of 2025, seventeen countries have introduced these vaccines as part of their national childhood immunisation program using either age-based or pre-transmission season schedules. While many countries follow the four-dose regimen with or without malaria chemoprevention, others like Mali have opted for a five-dose schedule. Since the protective efficacy of these vaccines declines gradually over time; continuous monitoring is essential to optimise their long-term impact. This calls for methodological advancement to assess how the vaccines, in combination with other malaria interventions, perform when deployed at scale and their impact at the population level. This project aims to develop and evaluate novel epidemiological methods for measuring the effectiveness of malaria control interventions rapidly and cost-effectively. It will specifically measure the effectiveness and impact of the malaria vaccines implemented through national immunisation programs. The specific aims and objectives are: Aim 1: Develop and validate novel methods tor evaluate malaria vaccine effectiveness using a test-negative case-control design. 1.1 Replicate the efficacy of malaria vaccines, as reported in randomised controlled trials using a test-negative case-control study design applied to the clinical trial data. 1.2 To develop methods to detect, minimise, and quantify biases when estimating vaccine effectiveness using a test-negative design in routinely collected clinical data. Aim 2: Evaluate the effectiveness of malaria vaccines when delivered through the routine immunisation programs. 2.1 Measure the effectiveness of the malaria vaccines delivered through routine systems with or without chemoprevention, and assess how effectiveness varies with age-based versus season-based schedules, intervals between doses, and the use of seasonal malaria chemoprevention. 2.2 Assess the protection against clinical malaria provided by the fourth and fifth doses. Aim 3: Evaluate the population-level impact of malaria vaccines when implemented at scale through national immunisation programs. 3.1 Measure the impact of the malaria vaccination program on malaria burden, all-cause mortality, and uptake of other malaria interventions and childhood vaccines. 3.2 Adapt mathematical models to simulate the impact of the vaccination program on malaria burden, using vaccine effectiveness and coverage measured in routinely collected data. 3.3 Investigate the impact of climatic factors on the spatial and temporal distribution of malaria burden. The project will use existing clinical trial data collected over 15 years, Monte Carlo simulations, prospective studies in Burkina Faso, Guinea, and Mali, data from the routine surveillance system, and mathematical modelling. To support implementation of these methods, I and my team will develop user-friendly software tools and guidelines and establish a vaccine effectiveness consortium across several African countries. This work will inform optimum strategies for monitoring malaria vaccines effectiveness, and broader public heath impact. It will also help identify factors influencing vaccine effectiveness and impact, and generate evidence to guide policy decision on the best combinations of vaccination schedule and doses, ultimately improving health outcomes for children and maximising value for money. Furthermore, the methods can be applied to evaluate effectiveness of other vaccines.", "category": null, "currency": "GBP", "startDate": "2026-05-01", "abstractType": "scientific", "abstractLanguage": "en" }, "person": { "orcid": null, "title": null, "initials": "MA", "givenName": "M Sanni", "familyName": "Ali" }, "institution": { "name": "London School of Hygiene and Tropical Medicine", "rorId": "00a0jsq62", "department": null, "officialName": "London School of Hygiene & Tropical Medicine" } }, { "grant": { "doi": null, "type": "Career Development Award", "alias": [ "328051", "328051/Z/25/Z" ], "title": "Spatio-clinal distribution of Microsporidia MB and assessing thermal fitness of its transmission, modulation of Plasmodium refractoriness and its impact on the efficacy of malaria vectors control tools", "amount": 603989, "funder": { "name": "Wellcome Trust", "fundRefId": "https://doi.org/10.13039/100010269", "searchTerm": "Wellcome Trust" }, "stream": "Pathogen Biology and Disease Transmission", "endDate": "2031-03-31", "grantId": "328051", "abstract": "The discovery of Microsporidia MB (herafter MB), a promising biological agent which inhibits Plasmodium development in malaria vectors has opened another door for malaria control, which if properly exploited may prove as successful as Wolbachia and Bacillus thuringiensis, which are used worldwide for control of mosquito vectors. This is crucially important because, unlike chemical insecticides, biological control agents are more environmentally friendly and less susceptible to resistance. However, information about the frequency of MB in the major malaria vectors Anopheles gambiae s.s. and An. coluzzii is still lacking. Also, it remains to be known how environmental variables, such as temperature and humidity impact the fitness of MB in the field. This study aims to map the prevalence of MB along ecological gradients of increasing aridity, spanning Nigeria and Niger Republic, investigate the impact of temperature on MB survival and effectiveness in blocking Plasmodium transmission, and explore its potential modulation of insecticide resistance in malaria mosquitoes. By generating primary data on the environmental resilience of MB and its interaction with insecticides, this study will provide critical insights into the feasibility of sustainably integrating this biological agent into existing vector control programs, potentially revolutionizing malaria vector control in regions heavily affected.", "category": null, "currency": "GBP", "startDate": "2026-04-01", "abstractType": "scientific", "abstractLanguage": "en" }, "person": { "orcid": null, "title": "Dr", "initials": "L", "givenName": "Lamine", "familyName": "Mahaman Moustapha" }, "institution": { "name": "Université André Salifou", "rorId": null, "department": null, "officialName": null } }, { "grant": { "doi": null, "type": "Research Grant", "alias": "UKRI3658", "title": "MKP1 modulating host defence: pathogen-specific innate immune regulation", "amount": 1005469, "funder": { "name": "Medical Research Council", "fundRefId": "https://doi.org/10.13039/501100000265", "searchTerm": "Medical Research Council" }, "stream": "MRC: Apr 2025: research: infections and immunity: responsive mode", "endDate": null, "grantId": "UKRI3658", "abstract": "Mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP1) plays a crucial role in the regulation of immune responses and the body’s defence mechanisms against infections. MKP1 is involved in modulating the activity of MAPKs, which are vital for transducing signals from microbial pathogens. During infection, MKP1 acts as a ‘regulatory brake’ on the inflammatory response, as excessive or prolonged inflammation can lead to tissue damage and chronic inflammatory diseases. MKP1 fine-tune’s this response by deactivating MAPKs, thereby reducing the production of pro-inflammatory cytokines. This action is critical for preventing tissue damage and promoting resolution of inflammation, demonstrating a dual role for MKP1 in infections acting as a critical modulator of the immune response. While the functional role of MKP1 has been studied in bacterial infections, no studies have investigated its role in fungal infections. Fungi kill ~2.5 million individuals each year, five times more than malaria or influenza, and are deadlier than most bacterial infections. Candida spp. cause ~1 million deaths from invasive/bloodstream infections and >150 million mucosal infections annually. As such, Candida infections are a serious medical problem and an immense burden to human health. Given this, the World health Organisation recently cited C. albicans in the ‘critical’ group (highest) in the ‘fungal priority pathogens’ list. Thus, identifying biological and immunological mechanisms that advance our understanding of C. albicans infection and lead to disease prevention is now a recognised priority. MKP1 is strongly activated in epithelial cells and neutrophils during C. albicans infection. Importantly, using a MKP1 knockout (KO) mouse, MKP1 deletion resulted in protection against mucosal and systemic C. albicans infection. These findings are in stark contrast to bacterial studies, where the MKP1 KO dramatically increases morbidity and mortality. This dichotomy between fungal and bacterial responses is highly intriguing and highlights the complexity of MKP1's role in immune regulation. Therefore, our objectives are twofold. First, to determine why MKP1 deletion is protective in fungal disease but detrimental in bacterial disease. Second, to determine the cell-type specific functional role of MKP1 in C. albicans infection, which will reveal new mechanisms by which fungal diseases outcome could be improved through targeted immunostimulatory therapy. The work will considerably enhance our understanding of immune regulation during fungal and bacterial infection and will identify new therapeutic opportunities that may arise from manipulating MKP1 pathways to improve microbial infection resolution, especially as adjunctive therapy during antimicrobial resistance. This work will have multiple academic beneficiaries in the fields of general and innate immunology, fungal and bacterial pathogenesis, cellular signalling, and host-pathogen interactions. An integral part of this research proposal involves the creation of conditional MKP1 knockout mouse models, which will create invaluable and powerful research tools that will enhance the impact and significance of this research proposal and be of considerable value to the wider scientific community (broader ranging infection studies, immunology, MAPK biology). In addition, this proposal has potential commercial beneficiaries, as our findings could be exploited at several levels in the longer term to improve human health and quality of life.", "category": null, "currency": "GBP", "startDate": "2026-02-03", "abstractType": "scientific", "abstractLanguage": "en" }, "person": { "orcid": null, "title": null, "initials": "JN", "givenName": "Julian", "familyName": "Naglik" }, "institution": { "name": "King's College London", "rorId": "ror.org/0220mzb33", "department": null, "officialName": null } }, { "grant": { "doi": null, "type": "Early-Career Award", "alias": "324238", "title": "Vertical and horizontal transmission mechanisms of a Plasmodium-blocking symbiont in Anopheles mosquitoes", "amount": 818363.49, "funder": { "name": "Wellcome Trust", "fundRefId": "https://doi.org/10.13039/100010269", "searchTerm": "Wellcome Trust" }, "stream": "Pathogen Biology and Disease Transmission", "endDate": "2031-01-31", "grantId": "324238", "abstract": "Microsporidia MB, a symbiont that inhibits Plasmodium transmission in An. arabiensis, has the potential to be developed into a transformative symbiont- based malaria control strategy. It spreads naturally through vector populations via vertical (mother-to-offspring) and horizontal (sexual) transmission. However, our previous research has demonstrated inefficiencies in these transmission routes, which can limit its application as a malaria control tool. In the proposed study, the mechanistic basis of variations in vertical transmission rates will be investigated by determining symbiont infection dynamics across mosquito developmental stages. Also, horizontal transmission mechanisms will be assessed by determining how Microsporidia MB is transmitted during mating. To achieve these aims, high-resolution microscopy imaging will be applied to track Microsporidia MB’s interaction with An. arabiensis at the tissue and cellular level. Host and symbiont factors mediating or inhibiting symbiont colonization and transmission will be investigated using gene expression studies while symbiont transmission efficiencies will be assessed using experimental bioassays. Understanding vertical and horizontal transmission mechanisms and efficiencies of Microsporidia MB will establish the stability of Microsporidia MB infections, determine the specificity of host-symbiont interactions, and establish transmission bottlenecks. This knowledge will be the foundation for developing optimized Microsporidia MB-Anopheles symbioses for deployment as a novel malaria control strategy.", "category": null, "currency": "GBP", "startDate": "2026-02-01", "abstractType": "scientific", "abstractLanguage": "en" }, "person": { "orcid": null, "title": "Dr", "initials": "TO", "givenName": "Thomas", "familyName": "Onchuru" }, "institution": { "name": "International Centre of Insect Physiology and Ecology", "rorId": "03qegss47", "department": null, "officialName": "International Centre of Insect Physiology and Ecology" } } ], "limit": 25, "query": "malaria", "total": 1683, "hasMore": true, "nextPage": 2, "provider": "europepmc", "resultType": "core" } ``` --- ### Labs Links External provider links (Altmetric, Publons, BioStudies, Faculty Opinions …) for one Europe PMC record. Upstream returns the whole provider set in one call. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/labs-links` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Article identifier within the source — a PMID for MED, a PMCID for PMC | | `source` | enum(MED|PMC|PPR|AGR|CBA|CTX|ETH|HIR|PAT|NBK) | query | no | Source archive the id belongs to. Default MED | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/labs-links?id=33301246&source=MED" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/labs-links?id=33301246&source=MED", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/labs-links?id=33301246&source=MED", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "id": "33301246", "count": 4, "items": [ { "name": "Publons", "links": [ { "url": "https://publons.com/p/35654943/", "title": "Read 1 peer review on Publons", "imageUrl": null }, { "url": "https://publons.com/review/create/post/35654943/", "title": "Add a post publication review on Publons", "imageUrl": null } ], "frontTab": false, "linksCount": 2, "providerId": 1529, "description": "Our mission is to speed up science by working with peer reviewers, publishers, and research institutions to make peer review a rewarding activity." }, { "name": "BioStudies: supplemental material and supporting data", "links": [ { "url": "http://www.ebi.ac.uk/biostudies/studies/S-EPMC7745181?xr=true", "title": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.", "imageUrl": null } ], "frontTab": false, "linksCount": 1, "providerId": 1518, "description": "Database of biological studies" }, { "name": "Altmetric", "links": [ { "url": "https://www.altmetric.com/details/95765100", "title": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine", "imageUrl": "https://api.altmetric.com/v1/donut/95765100_64.png" }, { "url": "https://www.altmetric.com/details/130496611", "title": "Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022", "imageUrl": "https://api.altmetric.com/v1/donut/130496611_64.png" } ], "frontTab": false, "linksCount": 2, "providerId": 1562, "description": "Discover the attention surrounding your research" }, { "name": "Faculty Opinions", "links": [ { "url": "https://connect.h1.co/prime/739182803#eval793581854", "title": "Faculty Opinions recommendation of Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.", "imageUrl": null } ], "frontTab": false, "linksCount": 1, "providerId": 1837, "description": "Expert Recommended Research Articles" } ], "source": "MED", "provider": "europepmc" } ``` --- ### Profile Hit counts for one query, faceted by source, publication type and subset — the cheapest way to size a search before paging it. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/profile` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Search terms, same grammar as the search endpoint | | `synonym` | enum(true|false) | query | no | Expand the query with MeSH and UniProt synonyms. Default false | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/profile?query=malaria&synonym=false" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/profile?query=malaria&synonym=false", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/profile?query=malaria&synonym=false", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 15, "items": [ { "name": "AGR", "count": 489, "group": "source" }, { "name": "CBA", "count": 117, "group": "source" }, { "name": "CTX", "count": 9, "group": "source" }, { "name": "ETH", "count": 1024, "group": "source" }, { "name": "HIR", "count": 4, "group": "source" }, { "name": "MED", "count": 254752, "group": "source" }, { "name": "PAT", "count": 2254, "group": "source" }, { "name": "CIT", "count": 0, "group": "source" } ], "query": "malaria", "provider": "europepmc" } ``` --- ### References The reference list of one Europe PMC record. Upstream pages by offset, not cursor. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/references` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Article identifier within the source — a PMID for MED, a PMCID for PMC | | `source` | enum(MED|PMC|PPR|AGR|CBA|CTX|ETH|HIR|PAT|NBK) | query | no | Source archive the id belongs to. Default MED | | `page` | number | query | no | Page number. Default 1 | | `limit` | number | query | no | Items per page. Default 25, max 100 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/references?id=33301246&source=MED&page=1&limit=25" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/references?id=33301246&source=MED&page=1&limit=25", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/references?id=33301246&source=MED&page=1&limit=25", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "id": "33301246", "page": 1, "count": 3, "items": [ { "id": "18797453", "doi": null, "essn": "1525-0024", "issn": "1525-0016", "issue": "11", "title": "Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.", "source": "MED", "volume": "16", "matched": true, "pubYear": 2008, "pageInfo": "1833-1840", "citedOrder": 1, "authorString": "Kariko K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, Weissman D.", "citationType": "JOURNAL ARTICLE", "externalLink": null, "journalAbbreviation": "Mol Ther", "unstructuredInformation": null }, { "id": "31828291", "doi": null, "essn": "1537-6591", "issn": "1058-4838", "issue": "7", "title": "Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.", "source": "MED", "volume": "71", "matched": true, "pubYear": 2020, "pageInfo": "1704-1714", "citedOrder": 2, "authorString": "Cowling BJ, Perera RAPM, Valkenburg SA, Leung NHL, Iuliano AD, Tam YH, Wong JHF, Fang VJ, Li APY, So HC, Ip DKM, Azziz-Baumgartner E, Fry AM, Levine MZ, Gangappa S, Sambhara S, Barr IG, Skowronski DM, Peiris JSM, Thompson MG.", "citationType": "JOURNAL ARTICLE", "externalLink": null, "journalAbbreviation": "Clin Infect Dis", "unstructuredInformation": null }, { "id": "33053279", "doi": null, "essn": "1533-4406", "issn": "0028-4793", "issue": "25", "title": "Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.", "source": "MED", "volume": "383", "matched": true, "pubYear": 2020, "pageInfo": "2439-2450", "citedOrder": 3, "authorString": "Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Tureci O, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, Sahin U, Gruber WC.", "citationType": "JOURNAL ARTICLE", "externalLink": null, "journalAbbreviation": "N Engl J Med", "unstructuredInformation": null } ], "limit": 3, "total": 7, "source": "MED", "hasMore": true, "nextPage": 2, "provider": "europepmc" } ``` --- ### Search Post Europe PMC searchPOST — the same index as `search`, reached with a form body so a query too long for a URL still fits. Same cursor-walk pagination, same envelope. - **Method:** `POST` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/search-post` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | body | yes | Search terms. Supports the field grammar SRC:, EXT_ID:, DOI:, PUB_YEAR:, AUTHORID:, JOURNAL:, AFF:, GRANT_AGENCY:, HAS_FT:, OPEN_ACCESS:, LICENSE: | | `resultType` | enum(idlist|lite|core) | body | no | Field depth per record. Default lite, core carries all 48 fields | | `page` | number | body | no | Page number. Default 1, max 10 — pass cursor for anything deeper | | `cursor` | string | body | no | Cursor for unbounded deep paging. Start with * then pass nextCursor. Overrides page | | `limit` | number | body | no | Items per page. Default 25, max 100 | | `sort` | enum(relevance|dateAsc|dateDesc|citedAsc|citedDesc|author|title) | body | no | Sort order. Default relevance | | `synonym` | enum(true|false) | body | no | Expand the query with MeSH and UniProt synonyms. Default false | **cURL:** ```bash curl -X POST "https://api.zapi.ink/v1/research:europepmc/search-post" \ -H "x-api-key: YOUR_API_KEY" \ -H "Content-Type: application/json" \ -d '{ "query": "SRC:MED AND PUB_YEAR:2020 AND malaria", "resultType": "lite", "page": "1", "cursor": "*", "limit": "25", "sort": "citedDesc", "synonym": "false" }' ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/search-post", { method: "POST", headers: { "x-api-key": process.env.ZAPI_KEY, "Content-Type": "application/json" }, body: JSON.stringify({ "query": "SRC:MED AND PUB_YEAR:2020 AND malaria", "resultType": "lite", "page": "1", "cursor": "*", "limit": "25", "sort": "citedDesc", "synonym": "false" }) }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.post("https://api.zapi.ink/v1/research:europepmc/search-post", headers={"x-api-key": "YOUR_API_KEY"}, json={ "query": "SRC:MED AND PUB_YEAR:2020 AND malaria", "resultType": "lite", "page": "1", "cursor": "*", "limit": "25", "sort": "citedDesc", "synonym": "false" }) data = r.json() ``` **Example response:** ```json { "page": null, "count": 3, "items": [ { "id": "33069326", "doi": "10.1016/s0140-6736(20)30925-9", "pmid": "33069326", "inPMC": true, "pmcid": "PMC7567026", "title": "Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.", "hasPDF": false, "inEPMC": true, "source": "MED", "authMan": null, "hasBook": false, "hasData": null, "license": null, "pubYear": 2020, "abstract": null, "hasSuppl": true, "language": null, "pageInfo": "1204-1222", "pubModel": null, "pubTypes": [ "research-article; journal article" ], "nihAuthMan": null, "affiliation": null, "epmcAuthMan": null, "fullTextIds": [ "PMC7567026" ], "journalInfo": { "issue": "10258", "volume": "396", "journal": { "essn": null, "issn": "0140-6736; 1474-547x; ", "nlmId": null, "title": "Lancet", "isoAbbreviation": null, "medlineAbbreviation": null }, "journalIssueId": null, "dateOfPublication": null, "yearOfPublication": null, "monthOfPublication": null, "printPublicationDate": null }, "authorString": "GBD 2019 Diseases and Injuries Collaborators.", "citedByCount": 14449, "hasLabsLinks": true, "isOpenAccess": true, "hasReferences": true, "dateOfCreation": null, "dateOfRevision": null, "firstIndexDate": "2020-10-20", "hasEvaluations": null, "dateOfCompletion": null, "tmAccessionTypes": [ "doi" ], "hasTextMinedTerms": true, "publicationStatus": null, "firstPublicationDate": "2020-10-01", "fullTextReceivedDate": null, "hasDbCrossReferences": false, "hasTMAccessionNumbers": true, "electronicPublicationDate": null }, { "id": "32029601", "doi": "10.1126/science.aau6977", "pmid": "32029601", "inPMC": true, "pmcid": "PMC7717626", "title": "The biology, function, and biomedical applications of exosomes.", "hasPDF": true, "inEPMC": true, "source": "MED", "authMan": null, "hasBook": false, "hasData": null, "license": null, "pubYear": 2020, "abstract": null, "hasSuppl": false, "language": null, "pageInfo": "eaau6977", "pubModel": null, "pubTypes": [ "research support, non-u.s. gov't; research-article; review; journal article; research support, n.i.h., extramural" ], "nihAuthMan": null, "affiliation": null, "epmcAuthMan": null, "fullTextIds": [ "PMC7717626" ], "journalInfo": { "issue": "6478", "volume": "367", "journal": { "essn": null, "issn": "0036-8075; 1095-9203; ", "nlmId": null, "title": "Science", "isoAbbreviation": null, "medlineAbbreviation": null }, "journalIssueId": null, "dateOfPublication": null, "yearOfPublication": null, "monthOfPublication": null, "printPublicationDate": null }, "authorString": "Kalluri R, LeBleu VS.", "citedByCount": 8274, "hasLabsLinks": true, "isOpenAccess": false, "hasReferences": true, "dateOfCreation": null, "dateOfRevision": null, "firstIndexDate": "2020-02-09", "hasEvaluations": null, "dateOfCompletion": null, "tmAccessionTypes": [ "nct", "doi" ], "hasTextMinedTerms": true, "publicationStatus": null, "firstPublicationDate": "2020-02-01", "fullTextReceivedDate": null, "hasDbCrossReferences": false, "hasTMAccessionNumbers": true, "electronicPublicationDate": null }, { "id": "32738937", "doi": "10.1016/s0140-6736(20)30367-6", "pmid": "32738937", "inPMC": true, "pmcid": "PMC7392084", "title": "Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.", "hasPDF": true, "inEPMC": true, "source": "MED", "authMan": null, "hasBook": false, "hasData": null, "license": null, "pubYear": 2020, "abstract": null, "hasSuppl": true, "language": null, "pageInfo": "413-446", "pubModel": null, "pubTypes": [ "review-article; review; journal article" ], "nihAuthMan": null, "affiliation": null, "epmcAuthMan": null, "fullTextIds": [ "PMC7392084" ], "journalInfo": { "issue": "10248", "volume": "396", "journal": { "essn": null, "issn": "0140-6736; 1474-547x; ", "nlmId": null, "title": "Lancet", "isoAbbreviation": null, "medlineAbbreviation": null }, "journalIssueId": null, "dateOfPublication": null, "yearOfPublication": null, "monthOfPublication": null, "printPublicationDate": null }, "authorString": "Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N.", "citedByCount": 7936, "hasLabsLinks": true, "isOpenAccess": true, "hasReferences": true, "dateOfCreation": null, "dateOfRevision": null, "firstIndexDate": "2020-08-09", "hasEvaluations": null, "dateOfCompletion": null, "tmAccessionTypes": [ "doi" ], "hasTextMinedTerms": true, "publicationStatus": null, "firstPublicationDate": "2020-07-30", "fullTextReceivedDate": null, "hasDbCrossReferences": false, "hasTMAccessionNumbers": true, "electronicPublicationDate": null } ], "limit": 3, "query": "SRC:MED AND PUB_YEAR:2020 AND malaria", "total": 13355, "hasMore": true, "nextPage": null, "provider": "europepmc", "nextCursor": "AoJQ8AMoNDIwMTUxNDc=", "resultType": "lite" } ``` --- ### Search Europe PMC REST search — open JSON, no key, rung 1 (direct) per recon. Measured 2026-08-29: upstream ignores `page` and paginates by cursorMark alone, so a - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/search` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Search terms. Supports the field grammar SRC:, EXT_ID:, DOI:, PUB_YEAR:, AUTHORID:, JOURNAL:, AFF:, GRANT_AGENCY:, HAS_FT:, OPEN_ACCESS:, LICENSE: | | `resultType` | enum(idlist|lite|core) | query | no | Field depth per record. Default lite, core carries all 48 fields | | `page` | number | query | no | Page number. Default 1, max 10 — pass cursor for anything deeper | | `cursor` | string | query | no | Cursor for unbounded deep paging. Start with * then pass nextCursor. Overrides page | | `limit` | number | query | no | Items per page. Default 25, max 100 | | `sort` | enum(relevance|dateAsc|dateDesc|citedAsc|citedDesc|author|title) | query | no | Sort order. Default relevance | | `synonym` | enum(true|false) | query | no | Expand the query with MeSH and UniProt synonyms. Default false | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/search?query=SRC%3AMED%20AND%20PUB_YEAR%3A2020%20AND%20malaria&resultType=lite&page=1&cursor=*&limit=25&sort=citedDesc&synonym=false" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/search?query=SRC%3AMED%20AND%20PUB_YEAR%3A2020%20AND%20malaria&resultType=lite&page=1&cursor=*&limit=25&sort=citedDesc&synonym=false", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/search?query=SRC%3AMED%20AND%20PUB_YEAR%3A2020%20AND%20malaria&resultType=lite&page=1&cursor=*&limit=25&sort=citedDesc&synonym=false", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": null, "count": 3, "items": [ { "id": "33069326", "doi": "10.1016/s0140-6736(20)30925-9", "pmid": "33069326", "inPMC": true, "pmcid": "PMC7567026", "title": "Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.", "hasPDF": false, "inEPMC": true, "source": "MED", "authMan": null, "hasBook": false, "hasData": null, "license": null, "pubYear": 2020, "abstract": null, "hasSuppl": true, "language": null, "pageInfo": "1204-1222", "pubModel": null, "pubTypes": [ "research-article; journal article" ], "nihAuthMan": null, "affiliation": null, "epmcAuthMan": null, "fullTextIds": [ "PMC7567026" ], "journalInfo": { "issue": "10258", "volume": "396", "journal": { "essn": null, "issn": "0140-6736; 1474-547x; ", "nlmId": null, "title": "Lancet", "isoAbbreviation": null, "medlineAbbreviation": null }, "journalIssueId": null, "dateOfPublication": null, "yearOfPublication": null, "monthOfPublication": null, "printPublicationDate": null }, "authorString": "GBD 2019 Diseases and Injuries Collaborators.", "citedByCount": 14449, "hasLabsLinks": true, "isOpenAccess": true, "hasReferences": true, "dateOfCreation": null, "dateOfRevision": null, "firstIndexDate": "2020-10-20", "hasEvaluations": null, "dateOfCompletion": null, "tmAccessionTypes": [ "doi" ], "hasTextMinedTerms": true, "publicationStatus": null, "firstPublicationDate": "2020-10-01", "fullTextReceivedDate": null, "hasDbCrossReferences": false, "hasTMAccessionNumbers": true, "electronicPublicationDate": null }, { "id": "32029601", "doi": "10.1126/science.aau6977", "pmid": "32029601", "inPMC": true, "pmcid": "PMC7717626", "title": "The biology, function, and biomedical applications of exosomes.", "hasPDF": true, "inEPMC": true, "source": "MED", "authMan": null, "hasBook": false, "hasData": null, "license": null, "pubYear": 2020, "abstract": null, "hasSuppl": false, "language": null, "pageInfo": "eaau6977", "pubModel": null, "pubTypes": [ "research support, non-u.s. gov't; research-article; review; journal article; research support, n.i.h., extramural" ], "nihAuthMan": null, "affiliation": null, "epmcAuthMan": null, "fullTextIds": [ "PMC7717626" ], "journalInfo": { "issue": "6478", "volume": "367", "journal": { "essn": null, "issn": "0036-8075; 1095-9203; ", "nlmId": null, "title": "Science", "isoAbbreviation": null, "medlineAbbreviation": null }, "journalIssueId": null, "dateOfPublication": null, "yearOfPublication": null, "monthOfPublication": null, "printPublicationDate": null }, "authorString": "Kalluri R, LeBleu VS.", "citedByCount": 8274, "hasLabsLinks": true, "isOpenAccess": false, "hasReferences": true, "dateOfCreation": null, "dateOfRevision": null, "firstIndexDate": "2020-02-09", "hasEvaluations": null, "dateOfCompletion": null, "tmAccessionTypes": [ "nct", "doi" ], "hasTextMinedTerms": true, "publicationStatus": null, "firstPublicationDate": "2020-02-01", "fullTextReceivedDate": null, "hasDbCrossReferences": false, "hasTMAccessionNumbers": true, "electronicPublicationDate": null }, { "id": "32738937", "doi": "10.1016/s0140-6736(20)30367-6", "pmid": "32738937", "inPMC": true, "pmcid": "PMC7392084", "title": "Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.", "hasPDF": true, "inEPMC": true, "source": "MED", "authMan": null, "hasBook": false, "hasData": null, "license": null, "pubYear": 2020, "abstract": null, "hasSuppl": true, "language": null, "pageInfo": "413-446", "pubModel": null, "pubTypes": [ "review-article; review; journal article" ], "nihAuthMan": null, "affiliation": null, "epmcAuthMan": null, "fullTextIds": [ "PMC7392084" ], "journalInfo": { "issue": "10248", "volume": "396", "journal": { "essn": null, "issn": "0140-6736; 1474-547x; ", "nlmId": null, "title": "Lancet", "isoAbbreviation": null, "medlineAbbreviation": null }, "journalIssueId": null, "dateOfPublication": null, "yearOfPublication": null, "monthOfPublication": null, "printPublicationDate": null }, "authorString": "Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N.", "citedByCount": 7936, "hasLabsLinks": true, "isOpenAccess": true, "hasReferences": true, "dateOfCreation": null, "dateOfRevision": null, "firstIndexDate": "2020-08-09", "hasEvaluations": null, "dateOfCompletion": null, "tmAccessionTypes": [ "doi" ], "hasTextMinedTerms": true, "publicationStatus": null, "firstPublicationDate": "2020-07-30", "fullTextReceivedDate": null, "hasDbCrossReferences": false, "hasTMAccessionNumbers": true, "electronicPublicationDate": null } ], "limit": 3, "query": "SRC:MED AND PUB_YEAR:2020 AND malaria", "total": 13355, "hasMore": true, "nextPage": null, "provider": "europepmc", "nextCursor": "AoJQ8AMoNDIwMTUxNDc=", "resultType": "lite" } ``` --- ### Supplementary Files The supplementary-material archive for one PMC record. Upstream serves application/zip, so the handler resolves and sizes it and hands back the URL. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:europepmc/supplementary-files` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `pmcid` | string | query | yes | PMC identifier of an article with supplementary material | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:europepmc/supplementary-files?pmcid=PMC7654321" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:europepmc/supplementary-files?pmcid=PMC7654321", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:europepmc/supplementary-files?pmcid=PMC7654321", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "id": "PMC7654321", "url": "https://www.ebi.ac.uk/europepmc/webservices/rest/PMC7654321/supplementaryFiles", "bytes": 100956, "format": "zip", "source": "PMC", "complete": true, "filename": "PMC7654321_SupplementaryFiles.zip", "provider": "europepmc" } ``` --- ## Garuda **Category:** research · **Slug:** `garuda` **Detail page:** https://zapi.ink/api/research/garuda Garba Rujukan Digital — Indonesian scholarly articles, journals, authors and publishers with direct publisher PDF links. **Tags:** garuda, indonesia, jurnal, artikel, akademik ### Areas Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search
is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/areas` - **Cache TTL:** 300s **Parameters:** _No parameters._ **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/areas" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/areas", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/areas", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 40, "items": [ { "name": "Education", "areaId": "97" }, { "name": "Social Sciences", "areaId": "190" }, { "name": "Humanities", "areaId": "24" }, { "name": "Economics, Econometrics & Finance", "areaId": "95" }, { "name": "Other", "areaId": "500" }, { "name": "Languange, Linguistic, Communication & Media", "areaId": "135" }, { "name": "Religion", "areaId": "1" }, { "name": "Computer Science & IT", "areaId": "60" } ], "provider": "garuda" } ``` --- ### Author Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/author/:authorId` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `authorId` | string | path | yes | Garuda author id, taken from the authors of a document | | `page` | number | query | no | Page number, 10 documents per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/author/:authorId?page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/author/:authorId?page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/author/:authorId?page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "name": "Mudma'inah", "page": 1, "count": 1, "items": [ { "doi": "10.33023/jikep.v11i1.2302", "year": 2025, "issue": "1", "title": "Analisa diskriptif peran kader malaria terhadap penemuan dini kasus malaria di wilayah pembangunan Ibu Kota Nusantara (IKN) dan daerah endemis Kelurahan Sotek: Descriptive analysis the role of malaria cadres on early discovery of malaria cases in the area of National Capital City (IKN) development and endemic areas of Sotek Village", "volume": "11", "authors": [ { "name": "Mudma'inah", "authorId": "8365817" }, { "name": "Sulistyarini, Wahyu Dewi", "authorId": "2045587" } ], "abstract": "Malaria disebabkan oleh parasit Plasmodium dan ditularkan melalui gigitan nyamuk Anopheles betina, masih menjadi masalah kesehatan signifikan di Kabupaten Penajam Paser Utara, khususnya di daerah endemis Kelurahan Sotek. Keberadaan kader diperlukan karena wilayah endemis yang jauh dari sarana prasarana kesehatan dan kegiatan survey migrasi. Penelitian ini bertujuan untuk menggambarkan peran kader malaria di wilayah Pembangunan IKN dan Kelurahan Sotek serta menganalisis kontribusi mereka dalam pengendalian penyakit. Penelitian kuantitatif ini menggunakan metode deskriptif analitik dengan sampel total dari 40 kader malaria di daerah tersebut. Variabel penelitian adalah peran kader malaria, yang dianalisis secara univariat dengan distribusi frekuensi. Hasil menunjukkan bahwa sebagian besar kegiatan kader dilaksanakan secara optimal, meskipun ada satu kegiatan, yaitu pemberian obat malaria, yang belum sepenuhnya optimal. Secara keseluruhan, peran kader malaria di wilayah Pembangunan IKN dan Kelurahan Sotek adalah baik dan optimal. Untuk selanjutnya dapat direncanakan pelaksanaan pelatihan kader malaria terutama tata cara pemberian obat anti malaria dan penatalaksanaannya pada wilayah Pembangunan IKN.", "publisher": "UPPM STIKES Pemkab Jombang", "sourceUrl": "https://journal.stikespemkabjombang.ac.id/index.php/jikep/article/view/2302/1217", "documentId": "4957784", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Analisa+diskriptif+peran+kader+malaria+terhadap+penemuan+dini+kasus+malaria+di+wilayah+pembangunan+Ibu+Kota+Nusantara+IKN+dan+daerah+endemis+Kelurahan+Sotek+Descriptive+analysis+the+role+of+malaria+cadres+on+early+discovery+of+malaria+cases+in+the+area+of+National+Capital+City+IKN+development+and+endemic+areas+of+Sotek+Village\"", "downloadUrl": "https://journal.stikespemkabjombang.ac.id/index.php/jikep/article/download/2302/1217", "journalTitle": "Jurnal Ilmiah Keperawatan (Scientific Journal of Nursing)" } ], "limit": 10, "total": 1, "pIndex": 0.23, "hasMore": false, "authorId": "8365817", "journals": [ { "title": "Jurnal Ilmiah Keperawatan (Scientific Journal of Nursing)", "journalId": "12855" } ], "nextPage": null, "provider": "garuda", "subjects": [ "Health Professions", "Medicine & Pharmacology", "Nursing", "Public Health" ], "affiliation": null } ``` --- ### Document Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/document/:documentId` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `documentId` | string | path | yes | Garuda document id, taken from a documents search result | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/document/:documentId" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/document/:documentId", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/document/:documentId", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "doi": null, "year": 2025, "issue": "1", "title": "Analisa diskriptif peran kader malaria terhadap penemuan dini kasus malaria di wilayah pembangunan Ibu Kota Nusantara (IKN) dan daerah endemis Kelurahan Sotek: Descriptive analysis the role of malaria cadres on early discovery of malaria cases in the area of National Capital City (IKN) development and endemic areas of Sotek Village", "risUrl": "https://garuda.kemdiktisaintek.go.id/citation/site/RIS/4957784", "volume": "11", "authors": [ { "name": "Mudma'inah", "authorId": "8365817", "affiliation": null }, { "name": "Sulistyarini, Wahyu Dewi", "authorId": "2045587", "affiliation": null } ], "journal": { "areas": [ { "name": "Health Professions", "areaId": "125" }, { "name": "Medicine & Pharmacology", "areaId": "170" }, { "name": "Nursing", "areaId": "177" }, { "name": "Public Health", "areaId": "185" } ], "title": "Jurnal Ilmiah Keperawatan (Scientific Journal of Nursing)", "abbrev": "jikep", "website": "https://journal.stikespemkabjombang.ac.id/index.php/jikep", "journalId": "12855", "publisher": "STIKES Pemkab Jombang", "description": "Jurnal Ilmiah Keperawatan (Scientifics Journal of Nursing) is a place of publication for researchers in the field of nursing and health care. Jurnal Ilmiah Keperwatan are peer-reviewer journals published semi-annually twice in a year. Jurnal Ilmiah Keperawatan published by STIKES Pemkab Jombang. The ...", "publisherId": "999" }, "abstract": "Malaria disebabkan oleh parasit Plasmodium dan ditularkan melalui gigitan nyamuk Anopheles betina, masih menjadi masalah kesehatan signifikan di Kabupaten Penajam Paser Utara, khususnya di daerah endemis Kelurahan Sotek. Keberadaan kader diperlukan karena wilayah endemis yang jauh dari sarana prasarana kesehatan dan kegiatan survey migrasi. Penelitian ini bertujuan untuk menggambarkan peran kader malaria di wilayah Pembangunan IKN dan Kelurahan Sotek serta menganalisis kontribusi mereka dalam pengendalian penyakit. Penelitian kuantitatif ini menggunakan metode deskriptif analitik dengan sampel total dari 40 kader malaria di daerah tersebut. Variabel penelitian adalah peran kader malaria, yang dianalisis secara univariat dengan distribusi frekuensi. Hasil menunjukkan bahwa sebagian besar kegiatan kader dilaksanakan secara optimal, meskipun ada satu kegiatan, yaitu pemberian obat malaria, yang belum sepenuhnya optimal. Secara keseluruhan, peran kader malaria di wilayah Pembangunan IKN dan Kelurahan Sotek adalah baik dan optimal. Untuk selanjutnya dapat direncanakan pelaksanaan pelatihan kader malaria terutama tata cara pemberian obat anti malaria dan penatalaksanaannya pada wilayah Pembangunan IKN.", "provider": "garuda", "bibtexUrl": "https://garuda.kemdiktisaintek.go.id/citation/site/bib/4957784", "sourceUrl": "https://journal.stikespemkabjombang.ac.id/index.php/jikep/article/view/2302/1217", "documentId": "4957784", "issueLabel": "Vol. 11 No. 1 (2025): JiKep | Februari 2025", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Analisa+diskriptif+peran+kader+malaria+terhadap+penemuan+dini+kasus+malaria+di+wilayah+pembangunan+Ibu+Kota+Nusantara+IKN+dan+daerah+endemis+Kelurahan+Sotek+Descriptive+analysis+the+role+of+malaria+cadres+on+early+discovery+of+malaria+cases+in+the+area+of+National+Capital+City+IKN+development+and+endemic+areas+of+Sotek+Village\"", "downloadUrl": "https://journal.stikespemkabjombang.ac.id/index.php/jikep/article/download/2302/1217", "publishDate": "29 Mar 2025", "journalTitle": "Jurnal Ilmiah Keperawatan (Scientific Journal of Nursing)", "copyrightYear": 2025 } ``` --- ### Documents By Abstract Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/documents-by-abstract` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Keyword matched against the document abstract only. The site refuses anything under 3 characters | | `page` | number | query | no | Page number, 10 documents per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/documents-by-abstract?query=malaria&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/documents-by-abstract?query=malaria&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/documents-by-abstract?query=malaria&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "doi": "10.33024/jkm.v8i4.7464", "year": 2022, "issue": "4", "title": "Knowledge And Attitude Of Pregnant Women About Malaria With Behavior To Seek Malaria Treatment", "volume": "8", "authors": [ { "name": "Pasnel Parna Wemy Gultom", "authorId": "5463014" }, { "name": "Jenie Palupi", "authorId": "2533648" }, { "name": "Yuniasih Purwaningrum", "authorId": "349738" }, { "name": "Syiska Atik Maryanti", "authorId": "3869240" } ], "abstract": "Belakang: Papua merupakan daerah endemik malaria dengan tingginya kasus malaria pada anak balita dan ibu hamil. Namun, kurangnya sosialisasi dan minat mencari tahu tentang malaria dan cara pengobatannya membuat penyakit malaria masih dianggap sebagai penyakit yang biasa oleh masyarakat di wilayah endemis malaria. Kasus malaria secara global mencapai 219 juta pada tahun 2017, dengan 435.000 kasus dikaitkan dengan malaria, di Indonesia, Profil Kesehatan Kabupaten Sarmi tahun 2017, 31.068 kasus pasien malaria. Kabupaten Sarmi kasus ibu hamil yang terinfeksi Malaria pada tahun 2010 sebanyak 260 orang (1,5% ) dengan jumlah penduduk 41.515 jiwa.Tujuan: Studi ini dilakukan untuk mengetahui hubungan pengetahuan dan sikap tentang malaria dengan perilaku ibu hamil untuk mencari pengobatan malaria dalam kehamilan di Puskesmas Samanente Kabupaten Sarmi.Metode: yang digunakan dalam penelitian ini yaitu metode analitik korelasional dengan pendekatan desain penelitian cross-sectional dengan menggunakan teknik simple random sampling sebanyak 30 orang. Instrumen penelitian yang digunakan yaitu menggunakan kuesioner. population in this study 30 people, this research used sampling technique Total Sampling with sampling 30 people. Inclusion criteria on this research is Willing to be a respondent, Mothers who are pregnant and currently or have suffered from malaria, Can read and write. Criteria exclusions in this study are Pregnant women who are sick at the time of the study, Pregnant women with Auto Immune, Pregnant women with pregnancy complicationsHasil: didapatkan responden dengan pengetahuan sedang yang tidak memiliki kebiasaan berobat malaria pada kehamilan adalah 56,3% dan kelompok responden dengan pengetahuan baik yang tidak memiliki kebiasaan berobat malaria pada kehamilan adalah 71,4%. Hal ini menunjukkan bahwa semakin tinggi tingkat informasi dapat meningkatkan proporsi perilaku tidak mencari pengobatan malaria selama kehamilan yaitu sebesar 15,1%. Hasil analisis menunjukkan bahwa tidak ada hubungan antara tingkat pengetahuan dan perilaku ibu hamil dalam mencari pengobatan malaria (P > 0.05). Ada hubungan antara sikap ibu hamil tentang malaria dan perilaku ibu hamil dalam mencari pengobatan malaria (P < 0.05). Kesimpulan: Meningkatnya pengetahuan dapat meningkatkan kesadaran ibu tentang penyakit malaria dan sikap yang baik dapat meningkatkan kewaspadaan terhadap penyakit malaria.Saran: menganjurkan ibu hamil untuk rutin melakukan kunjungan kehamilannya di Puskesmas agar dapat meningkatkan pengetahuan dan sikap tentang malaria dengan perilaku mencari pengobatan malaria dalam kehamilan. Kata Kunci : Malaria dalam kehamilan Pengetahuan, Pengobatan malaria sikap dan perilaku, ABSTRACT Background: Papua is a malaria endemic area with high malaria cases among children under five years and pregnant women. However, the lack of socialization and interest in finding out about malaria and how to medicate it makes malaria still considered a common disease by the people in malaria endemic areas. Malaria cases globally reached 219 million in 2017, with 435,000 cases attributed to malaria, in Indonesia, the Sarmi District Health Profile in 2017, 31,068 cases of malaria patients.Sarmi Regency cases of pregnant women infected with Malaria in 2010 were 260 people (1.5%) with a total population of 41,515 residents.Method: To ascertain the association between knowledge and attitudes about malaria and the behavior of pregnant women to seek treatment for malaria in pregnancy at Samanente Public Health Center, Sarmi Regency, a cross-sectional, correlational analysis study was carried out. The instrument was a questionnaire, with a sample size of 30 respondents, obtained using a simple random sampling method. population in this study 30 people, this research used sampling technique Total Sampling with sampling 30 people. Inclusion criteria on this research is Willing to be a respondent, Mothers who are pregnant and currently or have suffered from malaria, Can read and write. Criteria exclusions in this study are Pregnant women who are sick at the time of the study, Pregnant women with Auto Immune, Pregnant women with pregnancy complicationsResults: it was found that respondents with moderate knowledge who did not have the habit of seeking malaria treatment in pregnancy were 56.3% and the group of respondents with good knowledge who did not have the habit of seeking malaria treatment in pregnancy was 71.4%. This indicates that having a greater degree of information can improve the proportion of behavior for not seeking malaria treatment during pregnancy, which is 15.1%. The study found no correlation between pregnant women's knowledge level and behavior in seeking treatment for malaria (P>0.05). On the contrary, there was a significant correlation between pregnant women's attitudes toward malaria and their behavior in seeking malaria treatment (P<0.05).Conclusion: Improved knowledge is associated with increased maternal awareness of malaria, and positive attitudes can help raise awareness of malaria. It is to be expected that pregnant women who seek treatment for malaria will have a greater understanding of the disease and a more positive attitude toward it.Suggestion: We propose that pregnant women should be required to regularly visit the health center for prenatal care examinations in order to enhance their understanding and attitudes toward malaria by obtaining malaria medication during pregnancy. Keywords : Malaria in pregnancy, Malaria treatment, Knowledge, attitude and behavior", "publisher": "Program Studi Kebidanan Fakultas Ilmu Kesehatan Universitas Malahayati", "sourceUrl": "http://ejurnalmalahayati.ac.id/index.php/kebidanan/article/view/7464/pdf", "documentId": "3072471", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Knowledge+And+Attitude+Of+Pregnant+Women+About+Malaria+With+Behavior+To+Seek+Malaria+Treatment\"", "downloadUrl": "http://ejurnalmalahayati.ac.id/index.php/kebidanan/article/download/7464/pdf", "journalTitle": "JKM (Jurnal Kebidanan Malahayati)" }, { "doi": null, "year": 2025, "issue": "3", "title": "Efficacy safety of chemoprophylactic plasmodium falciparum and sporozoite vaccines for malaria prevention: a systematic review and meta- analysis", "volume": "3", "authors": [ { "name": "I N Kamila, Alya", "authorId": "9295418" }, { "name": "S Chandrarini, Aqilla", "authorId": "9295419" }, { "name": "S Devi, Rossi", "authorId": "9295420" } ], "abstract": "PfSPZ-CVac, an innovative vaccine, aims to combat malaria by using live, weakened Plasmodium falciparum sporozoites in combination with chloroquine. This approach employs the whole parasite, triggering a strong immune response and potentially providing long-term protection. The objective of this study is to assess the efficacy and safety of the PfSPZ- Chemoprophylaxis Vaccine (PfSPZ-CVac) for malaria prevention. A systematic review following PRISMA guidelines was conducted, focusing on randomized controlled trials (RCTs) that assessed the efficacy and safety of the vaccine. Seven eligible studies were selected from eight electronic databases. The quality was assessed using the Cochrane Risk of Bias tool, and data analysis was performed using Review Manager 5.4. PfSPZ-CVac combines live sporozoites with chloroquine, which prevents the parasite from entering the liver and enhance the body’s immune response, particularly T-cell activation, to provide long- lasting protection against malaria. The meta-analysis revealed a significant reduction in parasitemia (P<0.00001, I²=35%, MD=0.38). Local solicited adverse events did not show a significant increase (MD=0.73, P=0.45, I²=0%). Similarly, systemic solicited adverse events and unsolicited adverse events demonstrated minimal risks (MD=0.89, P=0.56, I²=23%; MD=0.65, P=0.20, I²=0%). Although PfSPZ-CVac exhibits high efficacy, its administration is complex, and it carries a slight of rare adverse reactions. PfSPZ-CVac demonstrates potential for providing strong, long-term protection against malaria , with a positive safety profile, making it a promising candidate for widespread use in high-transmission regions. DOI : 10.35990/amhs.v3n3.p178-189 REFERENCES World Health Organization. World malaria report 2022 [Internet]. Geneva: WHO; 2022 [cited 2023 Mar 5]. Available from: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022. World Health Organization. Malaria [Internet]. WHO; 2023 [cited 2023 Mar 5]. Available from: https://www.who.int/news-room/fact-sheets/detail/malaria. Berman J. Chemotherapy against malaria. Br Med Bull. 2000;54(2):459–70. https://doi.org/10.1258/0007142001903250. Cowman AF, Healer J, Marapana D, Marsh K. Malaria: Biology and disease. Cell. 2016;167(3):610–24. https://doi.org/10.1016/j.cell.2016.07.055. RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: Final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386(9988):31–45. https://doi.org/10.1016/S0140-6736(15)60721-8. Ghana Health Service. Ghana becomes first country to approve malaria vaccine [Internet]. Accra: GHS; 2023 [cited 2023 Apr 1]. Available from: https://www.ghanahealthservice.org. Laurens MB. RTS,S/AS01 vaccine (Mosquirix™): An overview. Hum Vaccin Immunother. 2020;16(3):480–9. https://doi.org/10.1080/21645515.2019.1669415. World Health Organization. WHO recommends groundbreaking malaria vaccine for children at risk [Internet]. WHO; 2021 [cited 2023 Mar 6]. Available from: https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk. Programme for Immunization. WHO recommends the R21/Matrix-M malaria vaccine [Internet]. WHO; 2023 [cited 2023 Apr 1]. Available from: https://www.who.int/news/item/02-10-2023-who-recommends-r21-matrix-m-malaria-vaccine. Datoo MS, Natama HM, Somé A, Traoré O, Rouamba T, Bellamy D, et al. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: A randomised controlled trial. Lancet. 2021;397(10287):1809–18. https://doi.org/10.1016/S0140-6736(21)00943-0. gov. Study to evaluate efficacy, immunogenicity and safety of the R21/Matrix-M vaccine (MAL-ED) [Internet]. 2023 [cited 2023 Apr 2]. Available from: https://clinicaltrials.gov/ct2/show/NCT04868604. Mahamar A, Issiaka D, Barry A, Kone DT, Traore F, Sissoko M, et al. Safety and immunogenicity of the R21/Matrix-M malaria vaccine administered seasonally in children in Mali: A randomised, controlled, phase 1/2 trial. Lancet Infect Dis. 2022;22(4):590–8. https://doi.org/10.1016/S1473-3099(21)00559-1. University of Oxford. R21/Matrix-M vaccine shows high-level efficacy of 77% over 12 months of follow-up [Internet]. Oxford; 2022 [cited 2023 Apr 2]. Available from: https://www.ox.ac.uk/news/2022-09-07. R21/Matrix-M malaria vaccine receives WHO recommendation [Internet]. UNICEF; 2023 [cited 2023 Apr 2]. Available from: https://www.unicef.org. World Health Organization. R21/Matrix-M malaria vaccine: WHO recommendation [Internet]. WHO; 2023 [cited 2023 Apr 3]. Available from: https://www.who.int/publications/i/item/9789240072056. Malaria vaccine implementation programme (MVIP) [Internet]. PATH; 2022 [cited 2023 Apr 3]. Available from: https://www.path.org/resources/malaria-vaccine-implementation-programme-mvip. Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, et al. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med. 2011;365(20):1863–75. https://doi.org/10.1056/NEJMoa1102287. Otieno L, Akhwale W, Nzila A, Hunt R, Ochola S, Tetteh KKA, et al. Protective efficacy of RTS,S/AS01 malaria vaccine in children 5 to 17 months of age in Kenya and Tanzania: A phase 3, randomized, controlled trial. Lancet Infect Dis. 2016;16(11):1339–48. https://doi.org/10.1016/S1473-3099(16)30227-3. Olotu A, Fegan G, Wambua J, Nyangweso G, Leach A, Lievens M, et al. Seven-year efficacy of RTS,S/AS01 malaria vaccine among young African children. N Engl J Med. 2016;374(26):2519–29. https://doi.org/10.1056/NEJMoa1515257. White MT, Verity R, Griffin JT, Asante KP, Owusu-Agyei S, Greenwood B, et al. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: Secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect Dis. 2015;15(12):1450–8. https://doi.org/10.1016/S1473-3099(15)00239-X. Penny MA, Verity R, Bever CA, Galactionova K, Flasche S, White MT, et al. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: A systematic comparison of predictions from four mathematical models. Lancet. 2016;387(10016):367–75. https://doi.org/10.1016/S0140-6736(15)00725-4. Ehreth J. The global value of vaccination. Vaccine. 2003;21(7–8):596–600. https://doi.org/10.1016/S0264-410X(02)00623-0. Vaccine investment strategy [Internet]. Gavi, the Vaccine Alliance; 2023 [cited 2023 Apr 3]. Available from: https://www.gavi.org. Advancing the malaria vaccine pipeline [Internet]. PATH; 2022 [cited 2023 Apr 3]. Available from: https://www.path.org/articles/advancing-malaria-vaccine-pipeline. United Nations. Goal 3: Ensure healthy lives and promote well-being for all at all ages [Internet]. UN; 2022 [cited 2023 Apr 3]. Available from: https://sdgs.un.org/goals/goal3. The Global Fund. Malaria and the global fund [Internet]. 2023 [cited 2023 Apr 3]. Available from: https://www.theglobalfund.org/en/malaria. European Medicines Agency. First malaria vaccine receives positive scientific opinion from EMA [Internet]. EMA; 2015 [cited 2023 Apr 4]. Available from: https://www.ema.europa.eu/en/news. UNICEF Supply Division. Vaccine procurement and delivery [Internet]. UNICEF; 2022 [cited 2023 Apr 4]. Available from: https://www.unicef.org/supply. Bill & Melinda Gates Foundation. Malaria strategy overview [Internet]. Gates Foundation; 2023 [cited 2023 Apr 4]. Available from: https://www.gatesfoundation.org. Malaria: Developing better prevention and treatment [Internet]. Wellcome Trust; 2023 [cited 2023 Apr 4]. Available from: https://wellcome.org/what-we-do/our-work/malaria. What is the malaria vaccine pipeline? [Internet]. PATH; 2023 [cited 2023 Apr 4]. Available from: https://www.path.org/articles. RTS,S Clinical Trials Partnership. Long-term safety and efficacy of RTS,S/AS01 malaria vaccine in African infants and children: An open-label 4-year extension study of a phase 3 randomized controlled trial. Lancet Infect Dis. 2021;21(10):1404–16. https://doi.org/10.1016/S1473-3099(20)30779-8. Datoo MS, Natama HM, Somé A, Traoré O, Rouamba T, Bellamy D, et al. Efficacy of the R21/Matrix-M malaria vaccine with seasonal administration in children in Burkina Faso: A double-blind, randomized, controlled trial. Lancet Infect Dis. 2023;23(1):1–10. https://doi.org/10.1016/S1473-3099(22)00541-X. WHO Strategic Advisory Group of Experts on Immunization. WHO SAGE roadmap for prioritizing uses of malaria vaccines [Internet]. WHO; 2022 [cited 2023 Apr 4]. Available from: https://www.who.int/publications. Deeks JJ, Higgins JPT, Altman DG, editors. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane; 2021. Available from: training.cochrane.org/handbook. Mordmüller B, Surat G, Lagler H, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445–60. https://doi.org/10.1038/nature21060. Camponovo F, Campo JJ, Le TQ, Oberai A, Hung C, Pablo JV, et al. Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults. eLife. 2020;9:e53080. https://doi.org/10.7554/eLife.53080. Skelly CL, Cassagnol M, Munakomi S. Adverse effects of vaccines. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Apr 4]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538239/. Ibanez J, Fendel R, Lorenz FR, et al. Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens. NPJ Vaccines. 2022;7:59. https://doi.org/10.1038/s41541-022-00473-1. Healy SA, Murphy SC, Hume JCC, Shelton L, Kuntz S, Voorhis WCV, et al. Chemoprophylaxis vaccination: Phase I study to explore stage-specific immunity to Plasmodium falciparum in US adults. Clin Infect Dis. 2020;71(6):1481–90. https://doi.org/10.1093/cid/ciz1010. Mwakingwe-Omari A, Healy SA, Lane J, et al. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity. Nature. 2021;595:289–94. https://doi.org/10.1038/s41586-021-03684-z. Sulyok Z, Fendel R, Eder B, et al. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. Nat Commun. 2021;12:2518. https://doi.org/10.1038/s41467-021-22740-w. Jongo SA, Urbano V, Church LWP, Olotu A, Manock SR, Schindler T, Mtoro A, et al. Immunogenicity and protective efficacy of radiation-attenuated and chemo-attenuated PfSPZ vaccines in Equatoguinean adults. Am J Trop Med Hyg. 2021;104(1):283–93. https://doi.org/10.4269/ajtmh.20-0435.", "publisher": "ACTA Medical Health Sciences", "sourceUrl": "http://amhs.unjani.ac.id/index.php/acta_medica/article/view/84/60", "documentId": "5693929", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Efficacy+safety+of+chemoprophylactic+plasmodium+falciparum+and+sporozoite+vaccines+for+malaria+prevention+a+systematic+review+and+meta-+analysis\"", "downloadUrl": "http://amhs.unjani.ac.id/index.php/acta_medica/article/download/84/60", "journalTitle": "ACTA Medical Health Sciences" }, { "doi": "10.22435/mpk.v21i4 Des.79.", "year": 2011, "issue": "4", "title": "Respon Klinis dan Parasitologis Dihidroartemisinin - Piperakuin pada Subyek Malaria Falsiparum dan Malaria Vivaks pada Hari Ke-3 Kunjungan Ulang", "volume": "21", "authors": [ { "name": "Risniati, Yenni", "authorId": "1142250" }, { "name": "Hasugian, Armedy Ronny", "authorId": "278494" }, { "name": "Siswantoro, Hadjar", "authorId": "382325" }, { "name": "Avrina, Rossa", "authorId": "1142251" }, { "name": "Tjitra, Emiliana", "authorId": "404296" }, { "name": "-, Delima", "authorId": "530965" } ], "abstract": "Background: Clinical and parasitological response of malaria treatment on day 3 follow-up (D3) is a crucial condition to predict the successful of treatment. D3 is a period time that Early Treatment Failure may happen which may cause severe or complicated malaria. Moreover, if the asexual parasitemia is still detected more than 10% study subjects, it is assumed parasites resistance against artemisinin. Methods: Analysis used data from Monitoring Drug Resistance In Subject With P.falciparum And P.vivax Malaria In Kalimantan And Sulawesi. Clinical data was gotten from anamnesis to identify clinical symptoms and physical examination including vital and clinical signs that was notified in case report form (CRF). Parasitological data was cross check examination from NIHRD microscopist for parasite density, and PCR examination result for Plasmodium detection and speciation that were recorded in log book and/or CRF. Clinical and parasitological response of DHP was examined with compared the condition of falciparum and vivax malaria on D0 (before treatment) and D3 (after 3 days treatment with completed dose). Result: Total malaria subject that were analyzed 206 subject, that were 119 falciparum malaria and 87 vivax malaria. Proportion subject falciparum and vivax malaria with clinical symptoms deceased significantly on D3 (p<0.05), accepted diarrhea on subject with vivax malaria. Proportion clinical signs also decreased significantly on D3, accepted dyspneu on falciparum malaria subject. From 206 malaria subject, only 1 subject (0,8%) with falciparum malaria that still was found asexual parasite with low density (10/ul). Proportion subject with gametocyte also decreased significantly on falciparum malaria (p=0,000) and vivax malaria (p=0,000). Conclusion: Clinical and parasitological response of DHP in falciparum and vivax subjects was excellent by D3. Only one falciparum malaria subject (0,8%) was still detected asexual parasitemia with the density of 10/ul. DHP has rapid action and no clear signs artemisinin resistance.AbstrakLatar belakang: Respon klinis dan parasitologis pengobatan malaria pada hari ke 3 kunjungan ulang (H3), merupakan keadaan yang penting untuk memprediksi keberhasilan pengobatan. H3 merupakan kurun waktu yang memungkinkan terjadinya kegagalan pengobatan dini (Early Treatment Failure) yang dapat megakibatkan malaria berat atau malaria dengan komplikasi. Selain itu apabila parasitemia masih terdeteksi pada H3 sebanyak ?10% dapat sebagai tanda sudah terjadi resisten parasit terhadap derivat artemisinin. Metode: Analisis menggunakan data Monitoring Pengobatan malaria dengan DHP di Kalimantan dan Sulawesi. Data klinis merupakan hasil anamnesis untuk mengidentifikasi gejala klinis, dan pemeriksaan fisik termasuk tanda vital dan tanda klinis yang tercatat di formulir rekam medis subyek. Sedangkan data parasitologis merupakan data hasil pemeriksaan cek silang mikroskopis untuk kepadatan parasit, dan hasil PCR untuk deteksi dan spesiasi Plasmodium yang tercatat di log book dan/atau di formulir rekam medis subyek. Respon klinis dan respon parasitologis DHP dinilai dengan membandingkan keadaan subyek malaria falsiparum dan malaria vivaks pada H0 (sebelum pengobatan) dengan H3 (pada hari setelah pengobatan dengan dosis lengkap 3 hari). Hasil: Jumlah subyek malaria yang dianalisis adalah 206 yaitu 119 malaria falsiparum dan 87 malaria vivaks. Gejala klinis subyek malaria falsiparum dan malaria vivaks yang mendapat pengobatan DHP berkurang proporsinya secara bermakna pada H3 (p<0,05), kecuali diare pada subyek malaria vivaks. Demikian pula tanda klinis berkurang proporsinya secara bermakna pada H3 (p<0,05), kecuali sesak nafas pada subyek malaria falsiparum. Dari total 206 subyek malaria, hanya satu kasus (0,8%) malaria falsiparum yang masih terdeteksi parasit aseksualnya dengan kepadatan rendah (10/ul). Proporsi subyek dengan gametositemia juga menurun bermakna pada malaria falsiparum (p=0,000) dan malaria vivaks (p=0,000). Kesimpulan: Respon klinis dan parasitologis DHP pada subyek malaria falsiparum dan malaria vivaks sangat baik di H3. Hanya satu subyek malaria falsiparum (0,8%) yang masih terdeteksi aseksual parasitemia dengan kepadatan 10/ul. DHP cepat kerjanya dan belum ada tanda yang jelas parasit resisten artemisinin", "publisher": "Badan Penelitian dan Pengembangan Kesehatan", "sourceUrl": "http://ejournal.litbang.depkes.go.id/index.php/MPK/article/view/79", "documentId": "1135920", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Respon+Klinis+dan+Parasitologis+Dihidroartemisinin+-+Piperakuin+pada+Subyek+Malaria+Falsiparum+dan+Malaria+Vivaks+pada+Hari+Ke-3+Kunjungan+Ulang\"", "downloadUrl": null, "journalTitle": "Media Penelitian dan Pengembangan Kesehatan" }, { "doi": "10.22146/jkki.v4i2.36100", "year": 2015, "issue": "2", "title": "Kebijakan Penggunaan Batas Wilayah Epidemiologi dalam Pengendalian Penyakit Malaria (Studi Kasus di Puskesmas Kokap II Kabupaten Kulon Progo, DIY)", "volume": "4", "authors": [ { "name": "Sutjipto Sutjipto", "authorId": "2969295" }, { "name": "Hari Kusnanto", "authorId": "2969296" }, { "name": "Laksono Trisnantoro", "authorId": "5830850" }, { "name": "Lutfan Lazuardi", "authorId": "2969297" }, { "name": "Indwiani Astuti", "authorId": "235973" } ], "abstract": "Background: There are 396 endemic districts from the total of 495 districts in Indonesia, with an estimated 45% of the population live in the areas that are at risk of infected malaria disease. Kulon Progo Regency is one of regencies in Yogyakarta (DIY), which until now has not declared elimination of malaria. PHC Kokap II located in Kokap sub-district, is the largest contributor of positive malaria cases in Kulon Progo regency due to the potential for outbreaks of malaria, during the period 1997-2004, when the number of malaria positive patients in the PHC Kokap II ranged between 26% - 55% of patients of the total positive malaria cases in Kulon Progo. This study aims to produce epidemiological information that is important in the region of PHC Kokap II associated with the distribution and determinants of malaria that affects the possibility of local transmission. Methods: The study design was a descriptive study, to get an overview of the distribution and determinants of malaria. The observation unit is the population in the form of correlation studies population and a time series. To determine the pattern of malaria transmission we use secondary data between 2009- 2012 malaria cases. Malaria incidence patterns were analyzed by person, place and time. To determine the clusters of malaria we use clustering analysis with the data of malaria cases in the region PHC Kokap II year 2012. To determine the spread of malaria in the cross-border area between PHC Kokap II and PHC Kaligesing we use secondary data year 2010-2012. Results: In the area of PHC Kokap II, we found import cases every year. Even more, in the year 2009 the proportion of import cases was 82% compared with all patients that were found malaria positive. Clusters of malaria is in the west region of PHC Kokap II, which is bordering to the Subdistrict Kaligesing, Purworejo, Central Java Province. Region PHC Kokap II is an area of high vulnerability, the potential to get the risk of transmission of imported cases of malaria is due to the entry of patients or infective vectors from high transmission areas to low transmission. Conclusion: The focus of malaria transmission in the area of PHC Kokap II is at the western part bordering the sub-district Kaligesing, Purworejo. PHC Kokap II is the region of high vulnerability. Policies need to be made use of epidemiological boundaries in the malaria control program in the cross-border region. Latar belakang: Di Indonesia masih terdapat 396 Kabupaten endemis dari 495 Kabupaten yang ada, dengan perkiraan seki- tar 45% penduduk berdomisili di daerah yang berisiko tertular malaria. Kabupaten Kulon Progo merupakan salah satu kabupa- ten di Daerah Istimewa Yogyakarta (DIY), yang sampai saat ini belum dinyatakan eliminasi. Wilayah Puskesmas Kokap II yang berada di Kecamatan Kokap, merupakan penyumbang terbesar penderita positip malaria untuk wilayah Kabupaten Kulon Progo diantaranya karena potensi terjadinya KLB malaria, selama periode tahun 1997-2004, range jumlah penderita positip ma- laria di wilayah Puskesmas Kokap II berkisar antara 26% - 55% penderita positip malaria di Kabupaten Kulon Progo. Pe- nelitian ini bertujuan untuk menghasilkan informasi epidemiologi yang penting di wilayah Puskesmas Kokap II terkait dengan distribusi dan determinan penyakit malaria yang sangat berpe- ngaruh terhadap kemungkinan terjadinya penularan setempat. Metode: Rancangan penelitian ini adalah studi deskriptif untuk mendapatkan gambaran distribusi dan determinan penyakit malaria, unit pengamatan adalah populasi dalam bentuk studi korelasi populasi dan rangkaian berkala. Untuk mengetahui pola penularan malaria digunakan data sekunder kasus ma- laria tahun 2009-2012, dianalisis pola kejadian malaria menurut orang, tempat dan waktu. Untuk mengetahui kluster penderita malaria dilakukan analisis klustering menggunakan data kasus malaria di wilayah Puskesmas Kokap II tahun 2012. Untuk mengetahui penyebaran penderita malaria di daerah lintas batas antara Puskesmas Kokap II Kabupaten Kulon Progo dan Pus- kesmas Kaligesing Kabupaten Purworejo digunakan data sekunder tahun 2010-2012. Hasil: Di wilayah Puskesmas Kokap II setiap tahun selalu dike- temukan kasus import, bahkan dalam tahun 2009 kasus import proporsinya adalah 82% dibandingkan dengan seluruh pen- derita positif malaria yang diketemukan. Kluster penderita ma- laria berada di bagian barat wilayah Puskesmas Kokap II, yaitu berbatasan langsung dengan Kecamatan Kaligesing Kabupaten Purworejo, Provinsi Jawa Tengah. Wilayah Puskesmas Kokap II merupakan daerah vulnerebilitas tinggi, potensial untuk menda- patkan risiko penularan kasus import karena masuknya pende- rita malaria atau vektor yang infektif dari daerah penularan tinggi ke penularan rendah. Kesimpulan: Fokus penularan penyakit malaria di wilayah Puskesmas Kokap II berada pada wilayah bagian barat berba- tasan dengan wilayah administratif Kecamatan Kaligesing, Ka- bupaten Purworejo. Puskesmas Kokap II adalah wilayah vulnerabilitas tinggi, perlu dibuat kebijakan penggunaan batas wilayah epidemiologi dalam program penanggulangan malaria di wilayah lintas batas.", "publisher": "Center for Health Policy and Management", "sourceUrl": "https://journal.ugm.ac.id/jkki/article/view/36100/21114", "documentId": "688195", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Kebijakan+Penggunaan+Batas+Wilayah+Epidemiologi+dalam+Pengendalian+Penyakit+Malaria+Studi+Kasus+di+Puskesmas+Kokap+II+Kabupaten+Kulon+Progo+DIY\"", "downloadUrl": "https://journal.ugm.ac.id/jkki/article/download/36100/21114", "journalTitle": "Jurnal Kebijakan Kesehatan Indonesia" }, { "doi": "10.22435/mpk.v21i3 Sept.93.", "year": 2011, "issue": "3", "title": "HUBUNGAN KEPADATAN PARASIT DENGAN MANIFESTASI KLINIS PADA MALARIA Plasmodium FALCIPARUM DAN Plasmodium VIVAX", "volume": "21", "authors": [ { "name": "Avrina, Rossa", "authorId": "1142251" }, { "name": "Risniati, Yenni", "authorId": "1142250" }, { "name": "Siswantoro, Hadjar", "authorId": "382325" }, { "name": "Hasugian, Armedy Ronny", "authorId": "278494" }, { "name": "Tjitra, Emiliana", "authorId": "404296" }, { "name": "-, Delima", "authorId": "530965" } ], "abstract": "Malaria is still a public health problem in Indonesia. The clinical manifestation of malaria is varied, and many factors may influence its clinical manifestation. Despite the species of malaria, density of parasitemia is known related to the severity or malignancy of malaria. It is worth to analyse the clinical and laboratory data of malaria cases in monitoring dihydroartemisinin-piperaquine (DHP) treatment. The extended analysed was done to assess the relationship between density of parasitemia and clinical manifestations. A subset data of monitoring DHP treatment in subjects with uncomplicated falciparum and vivax malaria in Kalimantan and Sulawesi which were consist of clinical and laboratory day-0 data was used in analysing. Clinical data were recorded through anamnesis and physical examination. Parasite density was counted by health centre microscopist and then cross-checked by certified microscopists of the Natiional Institute of Health Reseach and Development. Haemoglobin level was also measured by health centre analyst using the existing Sahli hemoglobinmeter. For parasite density category, median is used for cut off point. In P.falciparum malaria, the cut off point is 5588/µl and in P.vivax malaria is 3375/µl. The relationship between parasite density and clinical manifestation in falciparum and vivax malaria was determined by bivariate and multivariate analysis with logistic regression using SPSS 17 software. The most of subject with P.falciparum and P.vivax malaria are children (<15 yeras old), male, and non indigenous. From analysis bivariate, variabels that can be analyzed by multivariate in P.falciparum malaria (p<0,25) are children under 15 years old (p=0,0 12) and Sulawesi island where subject live(p=0,163) and In P.vivax malaria is children under 15 years old (p=0,218). Because of other variables are considered biologicaly related to parasite density, therefore all variabel are analyzed with multivariate. From multivariate analysis, there is significant relationship between parasite density and chidren under 15 years old in P.falciparum malaria (OR = 0,4, CI95%= 0,2-1,0). In P.vivax malaria, parasite density is related to children under 15 years old (OR = 0,6, CI 95% =0,2-1,9), haemoglobin level under 11gr/dl (OR= 1,4, CI 95%= 0,5-3,8), non indigenous OR= 0,3, CI 95%= 0,1-1,2) and the sum of clinical symptom <7 (OR=0,7, CI 95%=0,3-1,9). Parasite density is not related with clinical manifestation in P.falciparum malaria.. Parasite density is related to children under 15 years old significantly in P.falciparum malaria. In P.vivax malaria, parasite density are related to children under 15 years old, anemia, non indigenous, and the sum of clinical symptom <7. But the relationship isn?t significant. AbstrakMalaria merupakan salah satu masalah kesehatan di Indonesia. Gejala/manifetasiklinis malaria bervariasi dan banyak faktor yang dapat mempengaruhi beratnya manifestasi tersebut. Selain spesies dari malaria, kepadatan parasit diketahui berhubungan dengan berat atau keparahan malaria. Untuk itu penting menaganalisa data klinik dan laboratorium dari subyek malaria pada monitoring pengobatan DHP. Bagian Data dari Monitoring drug resistance in subject with P.falciparum and P.vivax malaria in Kalimantan and Sulawesi, Indonesia yang terdiri dari klinis dan laboratorium hari 0 dianalisa. Data klinis diambil melaluli anamnesa dan pemeriksaan fisik. Kepadatan parasit diperiksa oleh petugas mikroskopis Puskesmas dan di cek silang oleh petugas mikroskopis bersertifikasi di Badan Litbangkes. Data laboratorium lain yaitu kadar hemoglobin diperiksa oleh analis di Puskesmas menggunakan hemogobinmeter Sahli. Untuk pengelompokkan variabel kepadatan parasit , nilai median diambil sebagai cut off. Pada malaria P.falciparum cut off nya adalah 5588/µl, dan pada malaria P.vivax adalah 3375/µl. Hubungan antara kepadatan parasit dan manifestasi klinis pada malaria P.falciparum dan P.vivax ditentukan dengan analisis bivariat dan multivariat menggunakan regresi logistik dengan program SPSS 17.Subyek terbanyak pada malaria P.falciparum dan P.vivax adalah anak-anak (<15tahun), berjenis kelamin laki-laki, dan merupakan pendatang. Pada analisis bivariat, variabel yang dapat dianalisis multivariat pada malaria P.falciparum (p<0,25) adalah anak-anak yang berusia kurang 15 tahun (p=0,012) dan pulau Sulawesi sebagai tempat tinggal subyek (p=0,163), sedangkan pada malaria P.vivax adalah anak-anak yang berusia kurang dari 15 tahun(p= 0,218). Namun karena variabel-variabel lainnya dianggap berpengaruh secara biologis terhadap kepadatan parasit, maka semua variabel masuk kedalam analisis multivariat. Hasil dari analisis multivariat terlihat bahwa kepadatan parasit pada malaria P.falciparum berhubungan signifikan dengan anak ?anak yang berusia kurang dari 15 tahun (OR = 0,4, CI95%= 0,2-1,0). Pada malaria P.vivax, kepadatan parasit berhubungan dengan anak ?anak yang berusia kurang dari 15 tahun (OR = 0,6, CI 95% =0,2-1,9), kadar hemoglobin kurang dari 11gr/dl (OR= 1,4, CI 95%= 0,5-3,8), pendatang (OR= 0,3, CI 95%= 0,1-1,2) dan jumlah gejala klinik sedikit (OR=0,7, CI 95%=0,3-1,9). Namun hubungannya tidak bermakna. Pada malaria P.falciparum, kepadatan parasit tidak berhubungan dengan manifestasi klinis. Kepadatan parasit behubungan bermakna dengan anak- anak yang berusia kurang dari 15 tahun pada malaria P.falciparum. Pada malaria P.vivax, kepadatan parasit berhubungan dengan anak-anak yang berusia kurang dari 15 tahun, anemia, pendatang, dan jumlah gejala klinik. Namun hubungan variabel-variabel tersebut tidak bermakna.", "publisher": "Badan Penelitian dan Pengembangan Kesehatan", "sourceUrl": "http://ejournal.litbang.depkes.go.id/index.php/MPK/article/view/93", "documentId": "1135956", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"HUBUNGAN+KEPADATAN+PARASIT+DENGAN+MANIFESTASI+KLINIS+PADA+MALARIA+Plasmodium+FALCIPARUM+DAN+Plasmodium+VIVAX\"", "downloadUrl": null, "journalTitle": "Media Penelitian dan Pengembangan Kesehatan" }, { "doi": "10.22146/jcoemph.38309", "year": 2018, "issue": "1", "title": "Prevalensi malaria di Asmat, Papua: Gambaran situasi terkini di daerah endemik tinggi", "volume": "1", "authors": [ { "name": "Josephine Debora", "authorId": "4317038" }, { "name": "Hanggoro Tri Rinonce", "authorId": "4317039" }, { "name": "Maria Fransiska Pudjohartono", "authorId": "4317040" }, { "name": "Pritania Astari", "authorId": "4317041" }, { "name": "Monica Gisela Winata", "authorId": "4317042" }, { "name": "Fadli Kasim", "authorId": "433860" } ], "abstract": "ABSTRAK Malaria merupakan salah satu penyakit yang terus endemik di beberapa daerah di Indonesia walaupun pemerintah telah melakukan berbagai usaha untuk mengobati dan mencegah malaria. World Health Organization (WHO) menargetkan insidensi kasus malaria pada tahun 2030 dapat turun hingga 90% dibandingkan tahun 2015.Asmat merupakan salah satu daerah endemik tinggi dan menjadi salah satu daerah target program eliminasi malaria, namun belum ada publikasi data rinci terkait malaria di Asmat, Papua. Penelitian ini bertujuan untuk mengetahui prevalensi malaria di Asmat pada tahun 2017 dan melihat tren kejadian malaria yang merupakan salah satu indikator evaluasi program eliminasi malaria di Indonesia. Penelitian ini merupakan penelitian deskriptif observasional yang dilakukan selama pelaksanaan kegiatan Kuliah Kerja Nyata - Peduli Bencana (KKN-PB) Universitas Gadjah Mada (UGM), pada tanggal 17 Maret hingga 30 April 2018 di Asmat, Papua. Penelitian dilakukan dengan analisis data sekunder dan observasi. Data sekunder diambil dari Dinas Kesehatasn Kabupaten Asmat, kemudian dianalisis dan dipaparkan secara deskriptif. Dilakukan pula observasi lingkungan di Distrik Agats, Atsj, dan Sawaerma untuk mengetahui kemungkinan faktor-faktor risiko malaria. Pada tahun 2017, prevalensi malaria di kabupaten Asmat yaitu 12,37% dengan 7,90 % kasus malaria klinis dan 4,46% kasus malaria yang telah tegak diagnosisnya berdasarkan hasil pemeriksaan laboratorium. Prevalensi tersebut meningkat dibandingkan tahun 2016. Pusat Kesehatan Masyarakat (Puskesmas) Atsj merupakan puskesmas dengan prevalensi malaria tertinggi, yaitu sebesar 27,70%. Kejadian malaria ini kemungkinan dipengaruhi oleh lingkungan fisik (suhu, kelembaban, kerapatan dinding rumah, pengunaan kawat kassa, curah hujan), lingkungan biologi (adanya semak dan rawa), lingkungan kimia (salinitas dan pH), serta kebiasaan masyarakat. Hasil penelitian ini menunjukkan bahwa penanganan malaria di Asmat masih menjadi tantangan besar bagi petugas kesehatan dan pemerintah. Diperlukan penelitian lebih lanjut untuk mengetahui faktor penyebab masih tingginya kejadian malaria agar kebijakan yang diambil lebih tepat. KATA KUNCI prevalensi; malaria; endemik; Asmat; Papua ABSTRACT Malaria is still an endemic disease in Indonesia, despite years of government efforts to cure and prevent malaria. World Health Organization (WHO) has a goal to reduce malaria case incidence globally at least 90% in 2030 compared with 2015.Asmat is one of the high endemic areas in Indonesia, making Asmat one of the target areas for malaria elimination programs. However, the published data regarding malaria in Asmat is limited. This study aimed to investigate the prevalence of malaria in Asmat in 2017 and assess the trend of malaria prevalence, as an indicator in evaluating malaria elimination programs. This study was descriptive observational research which was performed from March 17th until April 30th 2018, as part of Kuliah Kerja Nyata - Peduli Bencana (KKN-PB) Universitas Gadjah Mada (UGM), in Asmat Regency. This study was using secondary data analysis and environmental observation. Secondary data was obtained from Department of Health in Asmat Regency and presented descriptively. Environmental observation in Agats, Atsj, and Sawaerma District was also conducted to find out the possible risk factors of malaria. In 2017, malaria prevalence in Asmat was 12.37% with 7.9% cases being clinically diagnosed malaria, and the other 4.46% laboratory diagnosed malaria. The prevalence in 2017 was higher than in 2016. Among all the districts in Asmat, Atsj had the highest prevalence (27.70%). Malaria prevalence was possibly affected by multiple factors, such as physical environment (temperature, humidity, houses’ wall density, and the use of wire net), biological environment (house surrounded by bush or swamp), chemical environment (pH and salinity), and habits in community. These findings suggest that malaria control is still a big challenge for health-care workers and government. Further research is needed to study the exact causes of high malaria prevalence in Asmat, so that more appropriate policies can be done to overcome the problem.KEYWORDS prevalence; malaria; endemic; Asmat; Papua", "publisher": "Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada", "sourceUrl": "https://jurnal.ugm.ac.id/jcoemph/article/view/38309/22894", "documentId": "1300018", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Prevalensi+malaria+di+Asmat+Papua+Gambaran+situasi+terkini+di+daerah+endemik+tinggi\"", "downloadUrl": "https://jurnal.ugm.ac.id/jcoemph/article/download/38309/22894", "journalTitle": "Journal of Community Empowerment for Health" }, { "doi": "10.33024/jkpm.v7i6.14784", "year": 2024, "issue": "6", "title": "Pemberdayaan Kader dalam Usaha Penemuan Kasus Malaria melalui Kegiatan MBS (Mass Blood Survey) Sebagai Hasil Implementasi Pelatihan di Desa Lempasing Wilayah Kerja Puskesmas Hanura", "volume": "7", "authors": [ { "name": "Ujiani, Sri", "authorId": "1498948" }, { "name": "Sulistianingsih, Eka", "authorId": "1223993" }, { "name": "Nuraini, Sri", "authorId": "602856" } ], "abstract": "ABSTRAK Desa Lempasing terletak di daerah lahan berawa dan ditumbuhi banyak semak yang memungkinkan untuk tempat berkembangbiaknya vektor malaria. Desa Lempasing merupakan salah satu wilayah kerja Puskesmas Hanura yang berada di Kecamatan Pesawaran. Berdasarkan data dinas Kesehatan provinsi Lampung, pada Desa Lempasing terdapat kasus malaria terbanyak di provinsi Lampung. Untuk itu diperlukan partisipasi sivitas akademik Poltekkes Tanjungkarang, kader dan masyarakat untuk berperan serta serta membantu mengatasi permasalahan malaria melalui upaya promotif, preventif, berupa kegiatan Pengabdian Kepada masyarakat, salah satunya usaha penemuan (skrining) kasus malaria untuk menekan penularan dalam membantu penanggulangan malaria dengan memberdayakan kader malaria yang terlatih. Selain itu edukasi masyarakat terkait malaria masih harus terus menerus dilakukan. Pada kegiatan pengabdian kepada msyarakat ini telah dilakukan edukasi malaria pada masyarakat desa Lempasing, melakukan penemuan kasus malaria melalui kegiatan Mass Blood Survey (MBS), memberikan obat malaria bagi masyarakat yang positif malaria. Capaian program pada kegiatan pengabdian kepada masyarakat ini adalah 77% terdapat peningkatan pengetahuan masyarakat desa Lempasing tentang malaria, dilaksanakannya kegiatan penemuan kasus (skrining) malaria pada 522 masyarakat desa Lempasing dengan hasil 26 positif malaria, dan pemberian obat pada 26 masyarakat yang mengalami malaria. Target luaran pada kegiatan pengabdian kepada masyarakat ini adalah publikasi kegiatan pengabmas melalui Jurnal Poltekkes Tanjungkarang “Beguai Jejama”. Kata Kunci: Malaria, Kader Malaria, Mass Blood Survey (MBS) ABSTRACT Lempasing Village is located in a marshy area with abundant bushes, which provide a suitable environment for the breeding of malaria vectors. Lempasing Village is one of the working areas of Hanura Community Health Center located in Pesawaran District. According to data from the Lampung Provincial Health Office, Lempasing Village has the highest number of malaria cases in Lampung Province. Therefore, the participation of academic community of Tanjungkarang Health Polytechnic, cadres, and the community is necessary to assist in addressing the malaria problem through promotive and preventive efforts, such as community service activities, one of which is the effort to detect (screen) malaria cases to reduce transmission in supporting malaria control by empowering trained malaria cadres. In addition, educating the community about malaria must continue to be carried out. In this community service activity, malaria education has been conducted in Lempasing Village, malaria cases have been detected through Mass Blood Survey (MBS) activities, and malaria medication has been provided to positive cases. The achievements of the program in this community service activity are a 77% increase in knowledge among Lempasing Village residents about malaria, the implementation of malaria case detection (screening) activities for 522 residents of Lempasing Village resulting in 26 positive malaria cases, and the provision of medication to 26 individuals with malaria. The output target of this community service activity is the publication of community service activities through the Politeknik Kesehatan Tanjungkarang Journal \"Beguai Jejama.\" Keywords: Malaria, Malaria Cadres, Mass Blood Survey (MBS)", "publisher": "Universitas Malahayati Lampung", "sourceUrl": "https://ejurnalmalahayati.ac.id/index.php/kreativitas/article/view/14784/Download%20Artikel", "documentId": "4500967", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Pemberdayaan+Kader+dalam+Usaha+Penemuan+Kasus+Malaria+melalui+Kegiatan+MBS+Mass+Blood+Survey+Sebagai+Hasil+Implementasi+Pelatihan+di+Desa+Lempasing+Wilayah+Kerja+Puskesmas+Hanura\"", "downloadUrl": "https://ejurnalmalahayati.ac.id/index.php/kreativitas/article/download/14784/Download%20Artikel", "journalTitle": "Jurnal Kreativitas Pengabdian Kepada Masyarakat (PKM)" }, { "doi": "10.56922/phc.v5i12.2427", "year": 2026, "issue": "12", "title": "Edukasi kesehatan tentang malaria sebagai upaya mendukung program eliminasi malaria", "volume": "5", "authors": [ { "name": "Thoyibah, Zurriyatun", "authorId": "2270967" }, { "name": "Haryani, Haryani", "authorId": "277329" }, { "name": "Mardani, Raden Ahmad Dedy", "authorId": "506661" }, { "name": "Metri, Ni Ketut", "authorId": "631967" }, { "name": "Hajri, Zuhratul", "authorId": "1411313" } ], "abstract": "Background: Malaria remains a public health problem in Indonesia, particularly in endemic and hypoendemic areas. Although the national elimination target was set for 2030, malaria cases were still reported as of 2024, including in West Lombok Regency, West Nusa Tenggara. Bukit Tinggi Village, the working area of ​​the Penimbung Community Health Center, faces environmental risk factors, population mobility, and suboptimal preventive behaviors. Limited public knowledge is a major challenge in supporting malaria elimination. Purpose: To increase public knowledge, awareness, and understanding of malaria and its prevention as part of malaria elimination efforts. Method: This community service activity was carried out in September 2024 in Batu Kemalik Hamlet, Bukit Tinggi Village, Penimbung District, West Lombok Regency. The activity was attended by 20 community members and Batu Kemalik Hamlet officials. The target of the activity was community knowledge about malaria and maintaining the environment of Batu Kemalik Hamlet so that it does not become a malaria endemic. The activity was carried out with a community participation-based education approach. Measurement of knowledge levels used questionnaires with direct interviews given before the educational activity (pre-test) and after the educational activity (post-test). Observation activities were carried out in October 2024 as an evaluation in assessing program implementation in Batu Kemalik Hamlet. Descriptive evaluation was carried out by looking at changes in the knowledge and understanding scores of participants before the educational activity (pre-test) and after the educational activity (post-test). Results: The level of knowledge of participants before the educational activity was 2 (10.0%) in the good category, 4 (20.0%) in the sufficient category, and 14 (70.0%) in the poor category. There was an increase in knowledge of participants after the educational activity, with 18 (90.0%) in the good category and 2 (10.0%) in the sufficient category. This increase in knowledge was also demonstrated by the practical efforts undertaken after receiving education on malaria prevention. Conclusion: Community service activities through health education using an interactive and participatory approach have had a significant impact on increasing public knowledge and understanding of malaria. The increased public knowledge through these activities also increased community motivation and awareness to implement malaria management and prevention measures in their communities as an effort to end the malaria endemic. Suggestion: Strengthening sustainable education programs through empowering health cadres and establishing malaria awareness groups is recommended, with regular and continuous health education implementation to enable the community to play an active role as agents of change in malaria prevention. It is hoped that similar community service activities can become a model for sustainable community-based health education and contribute significantly to supporting the achievement of the malaria elimination target in West Lombok Regency. Keywords: Community health; Health education; Malaria; Malaria elimination; Malaria prevention Pendahuluan: Malaria masih menjadi masalah kesehatan masyarakat di Indonesia, terutama di wilayah endemis dan hipoendemis. Meskipun target eliminasi nasional ditetapkan pada 2030, kasus malaria masih dilaporkan hingga 2024, termasuk di Kabupaten Lombok Barat, Nusa Tenggara Barat. Desa Bukit Tinggi, wilayah kerja Puskesmas Penimbung, memiliki faktor risiko lingkungan, mobilitas penduduk, serta perilaku pencegahan yang belum optimal. Keterbatasan pengetahuan masyarakat menjadi tantangan utama dalam mendukung eliminasi malaria. Tujuan: Untuk meningkatkan pengetahuan, kesadaran, dan pemahaman masyarakat tentang malaria dan pencegahannya sebagai upaya eliminasi malaria. Metode: Kegiatan pengabdian kepada masyarakat ini dilaksanakan pada bulan September 2024.di Dusun Batu Kemalik, Desa Bukit Tinggi, Kecamatan Penimbung, Kabupaten Lombok Barat. Kegiatan dikuti oleh 20 orang warga masyarakat dan aparatur Dusun Batu Kemalik. Sasaran kegiatan adalah pengetahuan masyarakat tentang malaria dan menjaga lingkungan Dusun Batu Kemalik agar tidak menjadi endemi malaria. Kegiatan dilaksanakan dengan pendekatan edukasi berbasis partisipasi masyarakat. Pengukuran tingkat pengetahuan menggunakan kuesioner dengan wawancara langsung yang diberikan sebelun kegiatan edukasi (pre-test) dan sesudah kegiatan edukasi (post-test). Kegiatan observasi dilakukan pada bulan Oktober 2024 sebagai evaluasi dalam memberikan penilaian pelaksanaan program di Dusun Batu Kemalik. Evaluasi secara deskriptif dilakukan dengan melihat perubahan nilai pengetahuan dan pemahaman peserta sebelum kegiatan edukasi (pre-test) dan sesudah kegiatan edukasi (post-test). Hasil: menunjukkan bahwa tingkat pengetahuan peserta sebelum kegiatan edukasi adalah sebanyak 2 orang (10.0%) dalam kategori baik, sebanyak 4 orang (20.0%) dalam kategori cukup, dan sebanyak 14 orang (70.0%) dalam kategori kurang. Terdapat peningkatan pengetahuan peserta setelah kegiatan edukasi menjadi sebanyak 18 orang (90.0%) dalam kategori baik dan sebanyak 2 orang (10.0%) dalam kategori cukup. Peningkatan pengetahuan peserta juga ditunjukkan dengan upaya praktik yang dilakukan setelah menerima edukasi dalam pencegahan malaria. Simpulan: Kegiatan pengabdian masyarakat melalui edukasi kesehatan dengan pendekatan interaktif dan partisipatif meberikan dampak nyata dalam meningkatkan pengetahuan dan pemahaman masyarakat tentang malaria. Meningkatnya pengetahuan masyarakat dalam kegiatan ini juga meningkatkan motivasi masyarakat dan kesadaran komunitas untuk melakukan penatalaksanaan dan langkah pencegahan malaria di lingkungan sebagai upaya memutus endemi kejadian malaria. Saran: Diharapkan adanya penguatan program edukasi berkelanjutan melalui pemberdayaan kader kesehatan dan pembentukan kelompok peduli malaria, dengan pelaksanaan pendidikan kesehatan secara rutin dan berkesinambungan agar masyarakat dapat berperan aktif sebagai agen perubahan dalam pencegahan malaria. Diharapkan kegiatan pengabdian serupa dapat menjadi model edukasi kesehatan berbasis masyarakat yang berkelanjutan dan berkontribusi nyata dalam mendukung tercapainya target eliminasi malaria di Kabupaten Lombok Barat.", "publisher": "Indonesian Public Health-Observer Information Forum (IPHORR) Kerja sama dengan: Unit Penelitian dan Pengabdian Kep Akademi Keperawatan Baitul Hikmah", "sourceUrl": "https://e-jurnal.iphorr.com/index.php/phc/article/view/2427/3021", "documentId": "5995433", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Edukasi+kesehatan+tentang+malaria+sebagai+upaya+mendukung+program+eliminasi+malaria\"", "downloadUrl": "https://e-jurnal.iphorr.com/index.php/phc/article/download/2427/3021", "journalTitle": "JOURNAL of Public Health Concerns" } ], "limit": 10, "query": "malaria", "total": 4464, "hasMore": true, "nextPage": 2, "provider": "garuda" } ``` --- ### Documents By Author Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/documents-by-author` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Keyword matched against the author name only. The site refuses anything under 3 characters | | `page` | number | query | no | Page number, 10 documents per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/documents-by-author?query=Sulistyarini&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/documents-by-author?query=Sulistyarini&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/documents-by-author?query=Sulistyarini&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "doi": null, "year": 2019, "issue": "9", "title": "PENGGUNAAN PBL UNTUK MENINGKATKAN HASIL BELAJAR PPKn SISWA KELAS X SMA MUJAHIDIN PONTIANAK", "volume": "8", "authors": [ { "name": "Jasmine, Khariza Arnita", "authorId": "1151081" }, { "name": "Sulistyarini, Sulistyarini", "authorId": "391358" }, { "name": "Atmaja, Thomy Sastra", "authorId": "6575567" } ], "abstract": "Abstract                                                            This research aims to improve student learning result by using the Problem Based Learning (PBL) learning model in Civic Education subjects. This is a classroom action research with the descriptive method. The research was conducted at the senior high school Mujahidin Pontianak, enaging 31 of 10th -grade Social 3 students as the research subject. Data collection techniques used were measurement techniques, direct observation techniques, and documentary study techniques with data collection tools used were learning result tests and observation sheets. The collected data were analyzed by calculating the average and the percentage. Each cycle consists of 4 stages, named planning, implementation, observation and reflection. The results showed that, in the Cycle I, the average student learning result was only 63,22 with the number of students reach the minimum completeness criteria (KKM) was 3 students or 9.67%.respectively, the average result in Cyle II and Cycle III are 71,29 and 85,28 with the number of students passing the KKM as many as 13 and 27 or 42,00% and 87,00% in percentage. Based on the analysis, it shows that PBL model can improve learning result to the 10th –grade student of Social 3 in Senior High School Mujahidin Pontianak in Civic Education subject.Keyword: Learning Result, PBL, Used", "publisher": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa", "sourceUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/view/35704/75676582962", "documentId": "1514108", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"PENGGUNAAN+PBL+UNTUK+MENINGKATKAN+HASIL+BELAJAR+PPKn+SISWA+KELAS+X+SMA+MUJAHIDIN+PONTIANAK\"", "downloadUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/download/35704/75676582962", "journalTitle": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa" }, { "doi": null, "year": 2019, "issue": "12", "title": "PEMANFAATAN BUKU TEKS SEBAGAI SUMBER BELAJAR DALAM PEMBELAJARAN SOSIOLOGI KELAS XI SMAN 2 MENYUKE", "volume": "8", "authors": [ { "name": "Siska, Siska", "authorId": "382133" }, { "name": "Sulistyarini, Sulistyarini", "authorId": "391358" }, { "name": "Ulfah, Maria", "authorId": "407450" } ], "abstract": "AbstractThis study aims to study textbooks in sociology as a source of learning textbooks can help as a source of learning and teaching sociology because there are materials, and various evaluations, looking for learning objectives can help optimally.The first choice of textbook criteria matches the relevance of the material contained in the textbook to the curriculum structure. The data source of this study were students of class XI IIS 1 and sociology teacher of SMAN 2 Menyuke and the results of interviews and observations. The results of this study indicate the study of sociology textbooks as a source of learning in sociology learning so that it is relevant to the learning objectives and other learning components can help improve learning efficiency and support learning goals, increase positive values in the learning process, in accordance with interactions and learning strategies that have been designed orbeing implemented. Factors that influence the development of sociology learning textbooks as a source of learning in the development of sociology learning technology. Keywords: Textbooks, Learning Resources, sociology learningÂ", "publisher": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa", "sourceUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/view/37888/75676584251", "documentId": "1514167", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"PEMANFAATAN+BUKU+TEKS+SEBAGAI+SUMBER+BELAJAR+DALAM+PEMBELAJARAN+SOSIOLOGI+KELAS+XI+SMAN+2+MENYUKE\"", "downloadUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/download/37888/75676584251", "journalTitle": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa" }, { "doi": null, "year": 2019, "issue": "11", "title": "PENGARUH HASIL BELAJAR KEWIRAUSAHAAN TERHADAP MINAT BERWIRAUSAHA KELAS XI SMK PANCA BHAKTI KUBU RAYA", "volume": "8", "authors": [ { "name": "Rhosa, Eliya", "authorId": "1416536" }, { "name": "Sulistyarini, Sulistyarini", "authorId": "391358" }, { "name": "Sumartono, Bambang Genjik", "authorId": "392150" } ], "abstract": "AbstractThe title of this research is the Effect of Learning Outcomes of Entrepreneurship on Entrepreneurial Interest in Class XI Students of SMK Panca Bhakti Sungai Raya Kubu Raya Regency. A general problem in this study is how the effect of entrepreneurial learning outcomes on entrepreneurial interest in class XI students of SMK Panca Bhakti Sungai Raya, Kubu Raya Regency. The purpose of this study was to determine the learning outcomes of entrepreneurship subjects in class XI Vocational High School Panca Bhakti Sungai Raya, to determine the entrepreneurial interest of students in class XI Vocational School Panca Bhakti and to determine the effect of entrepreneurial learning outcomes on entrepreneurial interest in class XI Vocational School Panca Bhakti. The method used is a descriptive method with the form of a study of relationship studies that aims to determine the effect of entrepreneurial learning outcomes on student entrepreneurial interest. The results of this study stated that the effect of entrepreneurial learning outcomes on student entrepreneurial interest in the amount of 26.7% included in the low category and the remaining 73.3% was influenced by other factors such as motivation and background of students' parents who were not reviewed in this study. Keywords:Learning Outcomes, Entrepreneurship Interest", "publisher": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa", "sourceUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/view/37881/75676584246", "documentId": "1514183", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"PENGARUH+HASIL+BELAJAR+KEWIRAUSAHAAN+TERHADAP+MINAT+BERWIRAUSAHA+KELAS+XI+SMK+PANCA+BHAKTI+KUBU+RAYA\"", "downloadUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/download/37881/75676584246", "journalTitle": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa" }, { "doi": null, "year": 2019, "issue": "9", "title": "PENGARUH PENGGUNAAN MODEL PEMBELAJARAN SCRAMBLE TERHADAP HASIL BELAJAR SISWA PADA MATA PELAJARAN PPKn", "volume": "8", "authors": [ { "name": "Kalsum, Umi", "authorId": "221209" }, { "name": "Sulistyarini, Sulistyarini", "authorId": "391358" }, { "name": "Achmadi, Achmadi", "authorId": "218730" } ], "abstract": "AbstractThis study aims to determine the effect of using scramble learning model for students' learning outcomes in Civic Education subject at class XII of SMA Negeri 5 Pontianak. The method of research is the experimental method using Quasi Experimental Design, Nonequivalent Control Group Design. The subject of this research was the class XII Science 2 (as experimental class) and XII Science 3 (as control class). This research instrument consist of multiple choice with 20 questions. The student learning outcomes of experiment class before and after treatment with scramble learning model, the averages pre-tests and post-test is 66.25 and 84.58. While the results of the student learning control class before and after given treatment conventional learning, the averages pre-test and post-test is 64.30 and 78.33. Based on the paired sample ttest on the value 0.000<0.005 therefore, Ho was rejected and Ha is accepted. Based on the calculation of the effect size experiment class is 3.317>1.00 and for control class is 1.98>1.00. In conclusion, theres is an effect in the use of scramble learning model towards students learning outcomes in Civic Education in class XII Science 2, compared with an effect of conventional learning models in class XII Science 3. Keywords: Learning Model Scramble, Learning Outcomes, Civic Education", "publisher": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa", "sourceUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/view/35781/75676583012", "documentId": "1513902", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"PENGARUH+PENGGUNAAN+MODEL+PEMBELAJARAN+SCRAMBLE+TERHADAP+HASIL+BELAJAR+SISWA+PADA+MATA+PELAJARAN+PPKn\"", "downloadUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/download/35781/75676583012", "journalTitle": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa" }, { "doi": null, "year": 2020, "issue": "1", "title": "ANALISIS MOTIVASI SISWA DALAM PEMBELAJARAN EKONOMI DI KELAS XI IIS 2 SMA SANTUN UNTAN PONTIANAK", "volume": "9", "authors": [ { "name": "Akfatulilah, Rizvi", "authorId": "1416353" }, { "name": "Sulistyarini, Sulistyarini", "authorId": "391358" }, { "name": "Warneri, Warneri", "authorId": "1151056" } ], "abstract": "AbstractThis purpose of this research is to know the student motivation to learn Economic for class XI IIS 2 SMA Santun Untan pontianak. Metodelogy of this rearch is descriptive metothodology eith qualitative approach. Souces of this research are observation and direct communcation with interview and study documentation wcih is paper. The result of this research show that analysis of student motivation to learn economis for class class XI IIS 2 SMA Santun Untan pontianak have 2 indicatoin: 1)instrinsic learning motivation possessed by students of class XI IIS 2 shows that the desire and itention to succeed lack student motivation for learn economic and the encouragment dan needs, hopes and aspirations of the future in economic learnig. 2) Extrinsic learning motivation of student of class XI IIS 2 shows that intersting activities less motivating student to learn economis as well as from rewards in studing and a conducive learning environment that skill makes students less motivated. Keywords: Student Motivation, Economic Learning.", "publisher": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa", "sourceUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/view/39200", "documentId": "1513957", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"ANALISIS+MOTIVASI+SISWA+DALAM+PEMBELAJARAN+EKONOMI+DI+KELAS+XI+IIS+2+SMA+SANTUN+UNTAN+PONTIANAK\"", "downloadUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/download/39200/75676585078", "journalTitle": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa" }, { "doi": null, "year": 2019, "issue": "9", "title": "IMPLEMENTASI NILAI-NILAI KEPRAMUKAAN PADA SISWA SMP NEGERI 7 SUNGAI RAYA KABUPATEN KUBU RAYA", "volume": "8", "authors": [ { "name": "Pranata, Eka", "authorId": "1416355" }, { "name": "Sulistyarini, Sulistyarini", "authorId": "391358" }, { "name": "Supriadi, Supriadi", "authorId": "4346786" } ], "abstract": "AbstractThe title of this thesis is \"Implementation of Scouting Values for Students in SMP Negeri 7 Sungai Raya, Kubu Raya Regency\". The general problem of this research is how to implement Scouting values in students at SMP Negeri 7 Sungai Raya, Kubu Raya Regency, with sub-problems (1) how to implement Scouting values in the form of courageous and loyal discipline, (2) how to implement Scouting values polite and knightly patriot forms, (3) how the Scouting Implementation values are responsible and trustworthy forms. The method used is a qualitative method with descriptive analysis. Data collection tools use observation guidelines, interview guidelines and documentation. The results showed that. (1) The implementation of the values of scouting forms of brave and loyal discipline is very good. This is evidenced when scouting activities, scout coaches apply the values of scouting, scout coaches provide advice by reminding students about the importance of scouting values in forming good personalities, (2) The implementation of scouting values in a polite patriot form is good enough. This is proven by the scout builder of good behavior to all students so that students and vice versa. (3) Implementation of the values of scouting forms is responsible and can be trusted very well. This is proven by the scoutmaster who is responsible for the success of his students in the school environment. Keywords : Implementation, Scouting, Values", "publisher": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa", "sourceUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/view/35791", "documentId": "1513959", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"IMPLEMENTASI+NILAI-NILAI+KEPRAMUKAAN+PADA+SISWA+SMP+NEGERI+7+SUNGAI+RAYA+KABUPATEN+KUBU+RAYA\"", "downloadUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/download/35791/75676583019", "journalTitle": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa" }, { "doi": null, "year": 2019, "issue": "11", "title": "PENGARUH KEAKTIFAN BELAJAR SISWA TERHADAP HASIL BELAJAR PRAKTIK PEMBELAJARAN MESIN BISNIS", "volume": "8", "authors": [ { "name": "Gayatri, Gayatri", "authorId": "279138" }, { "name": "Sulistyarini, Sulistyarini", "authorId": "391358" }, { "name": "Sumartono, Bambang Genjik", "authorId": "392150" } ], "abstract": "Abstract This studi aims to study “active learning towards machine learning in class XI Marketing SMK Negeri 8 Pontianak”. the method used is a quantitative descriptive method with the form of a study of relationship studies. Data collection techniques used are direct communication, indirect questionnaires, interview guidelines, and documentational.the sampel in the study showed that there was a positive influence on student’ learning activeness on learning outcomes indicated by the correlation coefficient of 0.135. the coefficient of determination in this study shows the contribution of the dependent variable (X), namely the effect of student learning activeness on the dependent variable (Y), namely the learning outcomes of 0.135 or 13,5%. While the rest is influenced by other variable not explained in this study. With simple lenear regression calculation obtained equation Y = 90.426+0.21 X, which means the constant value of 90.426 if the effect of student learning activeness is zero (0), then the learning outcomes of 0.221, this mean that an increase in student learning activeness by 1 then the learning outcomes will increase y 0.221.Keywords:Student Learning Activeness, Learning Outcomes", "publisher": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa", "sourceUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/view/38149/75676584375", "documentId": "1514020", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"PENGARUH+KEAKTIFAN+BELAJAR+SISWA+TERHADAP+HASIL+BELAJAR+PRAKTIK+PEMBELAJARAN+MESIN+BISNIS\"", "downloadUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/download/38149/75676584375", "journalTitle": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa" }, { "doi": null, "year": 2017, "issue": "11", "title": "PERSEPSI MASYARAKAT TERHADAP ETIKA PERGAULAN MAHASISWA KOST DI RT 03 KELURAHAN BANSIR DARAT KECAMATAN PONTIANAK TENGGARA", "volume": "6", "authors": [ { "name": "Febriyani, Devi", "authorId": "1349125" }, { "name": "Sulistyarini, Sulistyarini", "authorId": "391358" }, { "name": "Rustiyarso, Rustiyarso", "authorId": "1388662" } ], "abstract": "AbstractThesis title \"Societys? Perception on the Social Ethics of the College Students Live in Dormitory at RT 03 Kelutahan Bansir Darat Kecamatan Pontianak Tenggara\". The main problem in this research is how is societys? perception towards social ethics of the college students who live at dormitory. This research uses qualitative approach with descriptive method. Technique data collection used are observation techniques, interviews, and documentation study. The results showed that: (1) Societys? appraisement towards social ethics of the college students showed that students who are sociable proven fairly with greeting and smile, interaction with society has not been good yet because interaction occurs only when there is needs (2) Forms of violation have done by the college students are coming home over time which it has to be not later than 11 pm and guest of the opposite sex visiting hours which it has to be not later than 10 pm (3) The control towards college students showed that the preventive and repressive controls done by society leader and the dorm owner towards college students is quite good because the prevention through rules and repressive reprimand in the form of warning, punishment in the form of expelling and advice in the form of calling students who violated the rules have been conducted.Keywords: Perception, Social Ethics, College students live in dormitory", "publisher": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa", "sourceUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/view/22890", "documentId": "1559743", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"PERSEPSI+MASYARAKAT+TERHADAP+ETIKA+PERGAULAN+MAHASISWA+KOST+DI+RT+03+KELURAHAN+BANSIR+DARAT+KECAMATAN+PONTIANAK+TENGGARA\"", "downloadUrl": "http://jurnal.untan.ac.id/index.php/jpdpb/article/download/22890/18142", "journalTitle": "Jurnal Pendidikan dan Pembelajaran Khatulistiwa" } ], "limit": 10, "query": "Sulistyarini", "total": 803, "hasMore": true, "nextPage": 2, "provider": "garuda" } ``` --- ### Documents By Doi Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/documents-by-doi` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Keyword matched against the DOI only, which must be complete — a bare prefix matches nothing | | `page` | number | query | no | Page number, 10 documents per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/documents-by-doi?query=10.33023%2Fjikep.v11i1.2302&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/documents-by-doi?query=10.33023%2Fjikep.v11i1.2302&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/documents-by-doi?query=10.33023%2Fjikep.v11i1.2302&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 1, "items": [ { "doi": "10.33023/jikep.v11i1.2302", "year": 2025, "issue": "1", "title": "Analisa diskriptif peran kader malaria terhadap penemuan dini kasus malaria di wilayah pembangunan Ibu Kota Nusantara (IKN) dan daerah endemis Kelurahan Sotek: Descriptive analysis the role of malaria cadres on early discovery of malaria cases in the area of National Capital City (IKN) development and endemic areas of Sotek Village", "volume": "11", "authors": [ { "name": "Mudma'inah", "authorId": "8365817" }, { "name": "Sulistyarini, Wahyu Dewi", "authorId": "2045587" } ], "abstract": "Malaria disebabkan oleh parasit Plasmodium dan ditularkan melalui gigitan nyamuk Anopheles betina, masih menjadi masalah kesehatan signifikan di Kabupaten Penajam Paser Utara, khususnya di daerah endemis Kelurahan Sotek. Keberadaan kader diperlukan karena wilayah endemis yang jauh dari sarana prasarana kesehatan dan kegiatan survey migrasi. Penelitian ini bertujuan untuk menggambarkan peran kader malaria di wilayah Pembangunan IKN dan Kelurahan Sotek serta menganalisis kontribusi mereka dalam pengendalian penyakit. Penelitian kuantitatif ini menggunakan metode deskriptif analitik dengan sampel total dari 40 kader malaria di daerah tersebut. Variabel penelitian adalah peran kader malaria, yang dianalisis secara univariat dengan distribusi frekuensi. Hasil menunjukkan bahwa sebagian besar kegiatan kader dilaksanakan secara optimal, meskipun ada satu kegiatan, yaitu pemberian obat malaria, yang belum sepenuhnya optimal. Secara keseluruhan, peran kader malaria di wilayah Pembangunan IKN dan Kelurahan Sotek adalah baik dan optimal. Untuk selanjutnya dapat direncanakan pelaksanaan pelatihan kader malaria terutama tata cara pemberian obat anti malaria dan penatalaksanaannya pada wilayah Pembangunan IKN.", "publisher": "UPPM STIKES Pemkab Jombang", "sourceUrl": "https://journal.stikespemkabjombang.ac.id/index.php/jikep/article/view/2302/1217", "documentId": "4957784", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Analisa+diskriptif+peran+kader+malaria+terhadap+penemuan+dini+kasus+malaria+di+wilayah+pembangunan+Ibu+Kota+Nusantara+IKN+dan+daerah+endemis+Kelurahan+Sotek+Descriptive+analysis+the+role+of+malaria+cadres+on+early+discovery+of+malaria+cases+in+the+area+of+National+Capital+City+IKN+development+and+endemic+areas+of+Sotek+Village\"", "downloadUrl": "https://journal.stikespemkabjombang.ac.id/index.php/jikep/article/download/2302/1217", "journalTitle": "Jurnal Ilmiah Keperawatan (Scientific Journal of Nursing)" } ], "limit": 10, "query": "10.33023/jikep.v11i1.2302", "total": 1, "hasMore": false, "nextPage": null, "provider": "garuda" } ``` --- ### Documents By Title Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/documents-by-title` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Keyword matched against the document title only. The site refuses anything under 3 characters | | `page` | number | query | no | Page number, 10 documents per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/documents-by-title?query=malaria&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/documents-by-title?query=malaria&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/documents-by-title?query=malaria&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "doi": "10.33023/jikep.v11i1.2302", "year": 2025, "issue": "1", "title": "Analisa diskriptif peran kader malaria terhadap penemuan dini kasus malaria di wilayah pembangunan Ibu Kota Nusantara (IKN) dan daerah endemis Kelurahan Sotek: Descriptive analysis the role of malaria cadres on early discovery of malaria cases in the area of National Capital City (IKN) development and endemic areas of Sotek Village", "volume": "11", "authors": [ { "name": "Mudma'inah", "authorId": "8365817" }, { "name": "Sulistyarini, Wahyu Dewi", "authorId": "2045587" } ], "abstract": "Malaria disebabkan oleh parasit Plasmodium dan ditularkan melalui gigitan nyamuk Anopheles betina, masih menjadi masalah kesehatan signifikan di Kabupaten Penajam Paser Utara, khususnya di daerah endemis Kelurahan Sotek. Keberadaan kader diperlukan karena wilayah endemis yang jauh dari sarana prasarana kesehatan dan kegiatan survey migrasi. Penelitian ini bertujuan untuk menggambarkan peran kader malaria di wilayah Pembangunan IKN dan Kelurahan Sotek serta menganalisis kontribusi mereka dalam pengendalian penyakit. Penelitian kuantitatif ini menggunakan metode deskriptif analitik dengan sampel total dari 40 kader malaria di daerah tersebut. Variabel penelitian adalah peran kader malaria, yang dianalisis secara univariat dengan distribusi frekuensi. Hasil menunjukkan bahwa sebagian besar kegiatan kader dilaksanakan secara optimal, meskipun ada satu kegiatan, yaitu pemberian obat malaria, yang belum sepenuhnya optimal. Secara keseluruhan, peran kader malaria di wilayah Pembangunan IKN dan Kelurahan Sotek adalah baik dan optimal. Untuk selanjutnya dapat direncanakan pelaksanaan pelatihan kader malaria terutama tata cara pemberian obat anti malaria dan penatalaksanaannya pada wilayah Pembangunan IKN.", "publisher": "UPPM STIKES Pemkab Jombang", "sourceUrl": "https://journal.stikespemkabjombang.ac.id/index.php/jikep/article/view/2302/1217", "documentId": "4957784", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Analisa+diskriptif+peran+kader+malaria+terhadap+penemuan+dini+kasus+malaria+di+wilayah+pembangunan+Ibu+Kota+Nusantara+IKN+dan+daerah+endemis+Kelurahan+Sotek+Descriptive+analysis+the+role+of+malaria+cadres+on+early+discovery+of+malaria+cases+in+the+area+of+National+Capital+City+IKN+development+and+endemic+areas+of+Sotek+Village\"", "downloadUrl": "https://journal.stikespemkabjombang.ac.id/index.php/jikep/article/download/2302/1217", "journalTitle": "Jurnal Ilmiah Keperawatan (Scientific Journal of Nursing)" }, { "doi": "10.58623/aspirator.v15i1.74", "year": 2024, "issue": "1", "title": "Inovasi program pengendalian malaria menuju eliminasi malaria di Kabupaten Fakfak, Papua Barat: Malaria Control Program Innovation Towards Malaria Elimination in Fakfak District, West Papua", "volume": "15", "authors": [ { "name": "Rina Marina", "authorId": "3162745" }, { "name": "Shinta", "authorId": "2128803" }, { "name": "Helper Sahat P Manalu", "authorId": "8825207" }, { "name": "Alfons M. Letelay", "authorId": "8825208" }, { "name": "Muhammad Fajri Rokhmad", "authorId": "8825209" }, { "name": "Tri Isnani", "authorId": "3519237" } ], "abstract": "Malaria control in Indonesia has been facing various challenges and obstacles, especially in Eastern Indonesia. Several strategies have been carried out to achieve national elimination by 2030. This study aims to explore innovative strategies for controlling malaria in Fakfak Regency, West Papua Province which is one of the malaria endemic areas in eastern Indonesia. This type of research is a qualitative study using in-depth interviews with malaria program managers (n=6). The interview process was recorded through the zoom-meeting application and then transcription of the interview results was used to conduct content analysis. The results showed that the Bela Kaca Innovation (Bebas Malaria Kampung Bercahaya), which was initiated by the Fakfak Regency Health Office, hassucceeded significantly in reducing malaria cases in the last 5 years. This program fights malaria from village to village by involving all parties in the Malaria Center. The innovation of Bela Kaca is carried out by attacking and defending strategies. The attacks are carried out intensively in villages that had 5 or more malaria cases within two months by mass screening, indoor residual spraying (IRS), surveys of insecticide-treated mosquito nets and vector control until cases become zero. The survival strategy is carried out if there are no malaria cases, then surveillance is carried out strictly, if cases are found, then the 1-2-5 method is used. In conclusion, Bela Kaca control innovation can be one of the efforts to accelerate malaria elimination that is supported by the community and stakeholders", "publisher": "Perkumpulan Entomologi Kesehatan Indonesia", "sourceUrl": "https://jurnal.peki.or.id/index.php/aspirator/article/view/74/7", "documentId": "5099587", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Inovasi+program+pengendalian+malaria+menuju+eliminasi+malaria+di+Kabupaten+Fakfak+Papua+Barat+Malaria+Control+Program+Innovation+Towards+Malaria+Elimination+in+Fakfak+District+West+Papua\"", "downloadUrl": "https://jurnal.peki.or.id/index.php/aspirator/article/download/74/7", "journalTitle": "Aspirator" }, { "doi": "10.47539/jktp.v8i1.431", "year": 2025, "issue": "1", "title": "Paparan malaria maternal dan bayi berat lahir rendah: studi kasus-kontrol di daerah endemik malaria Papua, Indonesia: Maternal malaria exposure and low birth weight: a case-control study in malaria-endemic Papua, Indonesia", "volume": "8", "authors": [ { "name": "Masrif", "authorId": "9859880" }, { "name": "I Rai Ngardita", "authorId": "10294168" }, { "name": "Muhamad Sahiddin", "authorId": "10294169" }, { "name": "Mustika Pramestiyani", "authorId": "10294170" }, { "name": "Harlyanti Mashar", "authorId": "10294171" }, { "name": "Itma Annah", "authorId": "10294172" } ], "abstract": "Malaria selama kehamilan merupakan salah satu faktor risiko utama terjadinya malnutrisi pada bayi. Hubungan malaria dan kejadian BBLR di daerah endemik tinggi malaria seperti Papua perlu dikaji sebagai upaya mengatasi kedua masalah kesehatan tersebut. Penelitian ini bertujuan untuk mengevaluasi hubungan antara paparan malaria selama kehamilan dan kejadian BBLR di Papua. Penelitian ini menggunakan desain case-control yang dilakukan tahun 2024 di Papua pada 21 puskesmas. Sampel penelitian berjumlah 288 responden, terdiri dari 96 kasus (BBLR) dan 192 kontrol (bayi dengan berat lahir normal) dipilih dengan simple random sampling. Pengumpulan data dilakukan dengan pemeriksaan rekam medis dan wawancara terstruktur menggunakan kuesioner. Analisis data dilakukan menggunakan uji chi-square dan regresi logistik untuk analisis multivariat. Hasil penelitian jenis plasmodium yang paling banyak ditemukan adalah Plasmodium vivax (malaria tertiana) (45,9%) dan diikuti oleh Plasmodium falciparum (malaria tropika) (41,0%). Selama kehamilan paparan malaria paling banyak terjadi pada trimester kedua (39,3%). Kejadian malaria selama kehamilan (OR adjusted= 2,09; CI 95%: 1,14–3,84) dan tidak menggunakan kelambu anti nyamuk pada masa kehamilan (OR adjusted= 1,83; CI 95%: 1,09–3,08) merupakan faktor risiko BBLR. Selain itu, karakteristik usia ibu yang berada pada kategori berisiko juga menunjukkan hubungan signifikan dengan kejadian BBLR (OR adjusted= 2,18; CI 95%: 1,24–3,86). Paparan malaria selama kehamilan dan usia ibu yang berisiko merupakan faktor yang memengaruhi kejadian BBLR di Papua. Intervensi kesehatan masyarakat yang terfokus pada pencegahan malaria, seperti penggunaan kelambu berinsektisida, dan pengobatan antimalaria yang aman untuk mengurangi risiko BBLR di wilayah endemik tinggi malaria. Malaria during pregnancy is one of the primary risk factors for infant malnutrition. The association between malaria and LBW incidence in high malaria-endemic regions such as Papua needs further examination to address these two health issues. This study aims to evaluate the relationship between malaria exposure during pregnancy and LBW incidence in Papua. The study used a case-control design conducted in 2024 across 21 community health centers (puskesmas) in Papua. The sample consisted of 288 respondents, including 96 cases (LBW) and 192 controls (infants with normal birth weight), selected through simple random sampling. Data were collected through medical record reviews and structured interviews using questionnaires. Data analysis was performed using chi-square tests and multivariate logistic regression. The results showed that the most frequently identified Plasmodium species were Plasmodium vivax (tertian malaria) (45.9%), followed by Plasmodium falciparum (tropical malaria) (41.0%). Malaria exposure during pregnancy most commonly occurred in the second trimester (39.3%). Malaria during pregnancy (adjusted OR = 2.09; 95% CI: 1.14–3.84) and non-use of insecticide-treated bed nets during pregnancy (adjusted OR = 1.83; 95% CI: 1.09–3.08) were identified as risk factors for LBW. Additionally, maternal age in the high-risk category was significantly associated with LBW incidence (adjusted OR = 2.18; 95% CI: 1.24–3.86). Malaria exposure during pregnancy and high-risk maternal age were factors influencing LBW incidence in Papua. Public health interventions focused on malaria prevention, such as the use of insecticide-treated bed nets and safe antimalarial treatment, are essential to reduce LBW risk in high malaria-endemic regions.", "publisher": "Poltekkes Kemenkes Jayapura", "sourceUrl": "https://jktp.jurnalpoltekkesjayapura.com/index.php/jktp/article/view/431/221", "documentId": "6367719", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Paparan+malaria+maternal+dan+bayi+berat+lahir+rendah+studi+kasus-kontrol+di+daerah+endemik+malaria+Papua+Indonesia+Maternal+malaria+exposure+and+low+birth+weight+a+case-control+study+in+malaria-endemic+Papua+Indonesia\"", "downloadUrl": "https://jktp.jurnalpoltekkesjayapura.com/index.php/jktp/article/download/431/221", "journalTitle": "JURNAL KEPERAWATAN TROPIS PAPUA" }, { "doi": null, "year": 2017, "issue": "tions", "title": "The Effectiveness of The Malaria Cadres on Drug Intake Supervision, The Use of Mosquito Net and Environmental Modification on Malaria Sufferers at Malaria Endemic Area of Public Health Center of Waipukang, Lembata District, Nusa Tenggara Timur Province", "volume": "1", "authors": [ { "name": "Kristina, Ragu Harming", "authorId": "300492" }, { "name": "Subekti, Sri", "authorId": "387158" }, { "name": "Dachlan, Yoes Prijatna", "authorId": "2278001" }, { "name": "Martini, Santi", "authorId": "316597" } ], "abstract": "Background & objectives: Environmental risk factors, both physical and biological (e.g. ecology of vegetation/plants, forest), equally serve as the risk factors for Anopheles mosquitos breeding. This study was designed to determine a model of spatial mapping for the ecology of vegetation and the potential habitats for the Anopheles mosquitos. Methods: Descriptive epidemiological research was employed to carry out the project, supported with a cross-sectional design. The research took place in Kupang regency, Oesao village, lasting for 2 months from October to November 2014. The ecology of the vegetation and all habitats of the mosquitos in Oesao village were regarded as the population of the research. They were purposively sampled. Results: The vegetation mapping revealed that the land area for rice fields is 169 ha, coconut and banana tress 56.68 ha, maize 67.03 ha, vegetable plants 59.53 ha, forages 21.52 ha, and forests 16.24 ha. The results of the mapping also revealed that the mosquitos breeding sites entail paddy fields, swamps, irrigation channels, and damps. Interpretation & conclution: The ecology of all types of plants mapped serves as potential habitats for the Anopheles mosquitos breeding sites. Plant ecology is quite varied in the Oesao Village, as well as extensive areas of the plant that are closely linked to inadequate growth and development of mosquitoes  and  specific species of Anopheles,  An. vagus and An. annularis. Keywords:  Ecological vegetation mapping; Breeding sites; Malaria mosquitos", "publisher": "Humanistic Network for Science and Technology (Address: Cemara street 25, Ds/Kec Sukorejo, Ponorogo, East Java, Indonesia 63453)", "sourceUrl": "http://heanoti.com/index.php/hn/article/view/hn1325", "documentId": "761074", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"+The+Effectiveness+of+The+Malaria+Cadres+on+Drug+Intake+Supervision+The+Use+of+Mosquito+Net+and+Environmental+Modification+on+Malaria+Sufferers+at+Malaria+Endemic+Area+of+Public+Health+Center+of+Waipukang+Lembata+District+Nusa+Tenggara+Timur+Province\"", "downloadUrl": "http://heanoti.com/index.php/hn/article/download/hn1325/55", "journalTitle": "Health Notions" }, { "doi": "10.33846/hn.v1i3.60", "year": 2017, "issue": "tions", "title": "The Effectiveness of The Malaria Cadres on Drug Intake Supervision, The Use of Mosquito Net and Environmental Modification on Malaria Sufferers at Malaria Endemic Area of Public Health Center of Waipukang, Lembata District, Nusa Tenggara Timur Province, Indonesia", "volume": "1", "authors": [ { "name": "Ragu Harming Kristina", "authorId": "2815152" }, { "name": "Sri Subekti", "authorId": "387158" }, { "name": "Yoes Prijatna Dachlan", "authorId": "2278001" }, { "name": "Santi Martini", "authorId": "316597" } ], "abstract": "Malaria was a disease that caused many mortalities in developing countries. In solving this problem, it was needed a focused and directed mentoring continuously. This study aimed to determine the effectiveness of malaria cadres on drug intake supervision, the use of mosquito net and environmental modification on malaria sufferers at Public Health Center of Waipukang. This research was analytic observational research with cross sectional study design. The results showed that the average knowledge of malaria cadres was still low. Malaria cadres in Public Health Center of Waipukang were less effective in monitoring the consuming of malaria drugs, mosquito nets usage, and environmental modification in their areas. Furthermore, there were 78% of people who used mosquito net properly and 54% of families obediently did environmental modification efforts. Keywords: Malaria, Malaria cadre, Drug intake supervision, Environmental development, Mosquito net", "publisher": "Humanistic Network for Science and Technology (HNST)", "sourceUrl": "http://heanoti.com/index.php/hn/article/view/hn1325/55", "documentId": "874584", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"The+Effectiveness+of+The+Malaria+Cadres+on+Drug+Intake+Supervision+The+Use+of+Mosquito+Net+and+Environmental+Modification+on+Malaria+Sufferers+at+Malaria+Endemic+Area+of+Public+Health+Center+of+Waipukang+Lembata+District+Nusa+Tenggara+Timur+Province+Indonesia\"", "downloadUrl": "http://heanoti.com/index.php/hn/article/download/hn1325/55", "journalTitle": "Health Notions" }, { "doi": "10.32539/Hummed.V4l2.148", "year": 2024, "issue": "2", "title": "Penyuluhan masyarakat dalam upaya peningkatan pengetahuan mengenai malaria dan nyamuk vektor malaria serta screening dini malaria di Kelurahan Kemelak RT 01 Kabupaten Baturaja", "volume": "5", "authors": [ { "name": "Azhari, Dalilah", "authorId": "7290970" }, { "name": "Handayani, Dwi", "authorId": "274037" }, { "name": "Prasasty, Gita Dwi", "authorId": "1050181" }, { "name": "Amalia, Ella", "authorId": "608698" }, { "name": "Pariyana, Pariyana", "authorId": "1237079" }, { "name": "Theresy, Elzabet", "authorId": "7291007" }, { "name": "Irnanda, Andi", "authorId": "7291008" } ], "abstract": "Malaria is caused by a parasite of the genus Plasmodium that is transmitted to humans through the bite of a female Anopheles mosquito. Indonesia is the second highest ranked region in Asia with 214 regencies/cities in Indonesia that are still malaria endemic spread from Sumatra to Papua. Knowledge is one of the important components in preventing malaria transmission. The purpose of this service was to assist and screen for malaria in the context of early detection of malaria in the community and to increase public knowledge about malaria and malaria mosquito vectors. Activities were carried out by providing pretests followed by education and socialization of malaria and early screening of malaria cases with Rapid Diagnostic Test (RDT) examination. Education and socialization events were held at RT 01 Kemelak Baturaja using LCD projector media as well as posters and pamphlets. A total of 83 people attended the counseling event consisting of 37 men and 46 women and 50 people carried out early detection of malaria RDT examination. Pretest results obtained knowledge that was still lacking in knowledge of malaria and malaria vectors by 78% and good knowledge by 22%. There was an increase in knowledge in the posttest held after counseling and education where lack of knowledge was 44% and good knowledge to 56%. On examination with RDT found no positive cases of malaria. Education and socialization in the community about the symptoms of malaria and its vectors can increase awareness of the disease and prevent malaria vector mosquito bites. Therefore, education and assistance are an important part of efforts to prevent and reduce cases that support malaria elimination.", "publisher": "Fakultas Kedokteran Universitas Sriwijaya", "sourceUrl": "https://hummed.ejournal.unsri.ac.id/index.php/HummedJ/article/view/148/83", "documentId": "4268440", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Penyuluhan+masyarakat+dalam+upaya+peningkatan+pengetahuan+mengenai+malaria+dan+nyamuk+vektor+malaria+serta+screening+dini+malaria+di+Kelurahan+Kemelak+RT+01+Kabupaten+Baturaja\"", "downloadUrl": "https://hummed.ejournal.unsri.ac.id/index.php/HummedJ/article/download/148/83", "journalTitle": "Jurnal Pengabdian Masyarakat: Humanity and Medicine" }, { "doi": "10.33024/jkpm.v7i7.15163", "year": 2024, "issue": "7", "title": "Pelatihan dan Penyegaran Kader Malaria Melalui Petugas Kesehatan tentang Skrining Pemeriksaan Malaria melalui Pemeriksaan Rapid Diagnostic Test (RDT) dan Slide Malaria", "volume": "7", "authors": [ { "name": "Bahrah, Bahrah", "authorId": "1508369" }, { "name": "Erawati, Deasy", "authorId": "4093043" } ], "abstract": "ABSTRAK Pada beberapa Puskesmas di daerah endemis dengan jumlah penderita malaria yang tinggi, seringkali dilakukan skrening malaria pada masyarakat yang melibatkan kader dari masyarakat setempat untuk pemeriksaan RDT dan membuat sediaan apusan darah. Berdasarkan studi pendahuluan yang telah dilakukan oleh pengabdi Puskesmas Amban pada Tahun 2024 Puskesmas Amban belum memiliki kader Malaria dan studi wawancara pada petugas penangung jawab program malaria, sebagian besar mengatakan bahwa belum pernah mendapatkan pelatihan tentang cara pembuatan hapusan darah. Tujuan dari pelatihan ini adalah meningkatkan pengetahuan dan keterampilan petugas kesehatan dalam melakukan diagnosis malaria menggunakan RDT dan pembuatan hapusan darah tepi. Metode dalam pengabdian ini adalah dengan melakukan pelatihan dan penyegaran kader malaria melalui petugas kesehatan dengan kegiatan penyuluhan dan pendampingan pemeriksaan RDT dan pembuatan slide malaria atau hapusan darah menggunakan media bantu media audiovisual yang dilakukan selama 3 hari. Setelah dilakukan pelatihan dan penyegaran akan dievaluasi hasil pelatihan yang telah diberikan dengan menggunakan lembar observasi atau lembar cheklist cara melakukan pemeriksaan RDT dan pembuatan hapusan darah. Hasil nilai rata-rata skor keterampilan petugas kesehatan tentang pemeriksaan RDT sebelum diberikan pelatihan yaitu 85,3 dan meningkat menjadi 97,2 sedangkan skor keterampilan petugas kesehatan tentang pengambilan hapusan darah tepi sebelum pelatihan yaitu 75 dan setelah pelatihan meningkat menjadi 93,7 setelah diberikan pelatihan. Kesimpulan penyegaran dan pelatihan petugas kesehatan efektif menggunakan media bantu video dan demonstrasi dapat meningkatkan keterampilan petugas kesehatan dalam melakukan pemeriksaan RDT dan pembuatan hapusan darah tepi. Kata Kunci: Kader Malaria, Petugas Kesehatan, Skrining Pemeriksaan Malaria, Rapid Diagnostic Test (RDT) dan Slide Malaria ABSTRACT In several Community Health Centers in endemic areas with a high number of malaria sufferers, malaria screening is often carried out in the community involving cadres from the local community for RDT examinations and making blood smear preparations. Based on a preliminary study conducted by Amban Community Health Center staff in 2024, Amban Community Health Center does not yet have Malaria cadres and interview studies of officers in charge of the malaria program, the majority said that they had never received training on how to make blood smears. The aim of this training is to increase the knowledge and skills of health workers in diagnosing malaria using RDT and making peripheral blood smears. The method of this service is to carry out training and refreshment of malaria cadres through health workers with outreach activities and assistance with RDT examinations and making malaria slides or blood smears using audiovisual media which is carried out for 3 days. After training and refreshment, the results of the training provided will be evaluated using an observation sheet or checklist on how to carry out RDT examinations and make blood smears. The average value of the skill score of health workers regarding RDT examination before being given training was 85.3 and increased to 97.2, while the skill score of health workers regarding taking peripheral blood smears before training was 75 and after training increased to 93.7 after being given training . Conclusion: Refreshing and training health workers effectively using video media and demonstrations can improve the skills of health workers in carrying out RDT examinations and making peripheral blood smears. Keywords: Malaria Cadres, Health Workers, Malaria Screening, Rapid Diagnostic Test (RDT) and Malaria Slides", "publisher": "Universitas Malahayati Lampung", "sourceUrl": "https://ejurnalmalahayati.ac.id/index.php/kreativitas/article/view/15163/Download%20Artikel", "documentId": "4596800", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Pelatihan+dan+Penyegaran+Kader+Malaria+Melalui+Petugas+Kesehatan+tentang+Skrining+Pemeriksaan+Malaria+melalui+Pemeriksaan+Rapid+Diagnostic+Test+RDT+dan+Slide+Malaria\"", "downloadUrl": "https://ejurnalmalahayati.ac.id/index.php/kreativitas/article/download/15163/Download%20Artikel", "journalTitle": "Jurnal Kreativitas Pengabdian Kepada Masyarakat (PKM)" }, { "doi": null, "year": 2002, "issue": "3", "title": "GAMBARAN KLINIK PENDERITA MALARIA YANG DIRAWAT DI RSU BANYUMAS TAHUN 2OOO. MEI 2OO2 CLINICAL FEATARES OF MALARIA PATIENTS THAT HOSPITALIZED IN BANYAMAS GENERAL HOSPITAL 2OOO-MAY 2OO2", "volume": "2", "authors": [ { "name": "Arjadi, Fitranto", "authorId": "436774" }, { "name": "Hadiantoro, Felix", "authorId": "436773" }, { "name": "SDL, Agung", "authorId": "437032" } ], "abstract": "Malaria masih merupakan masalah kesehatan yang penting di Indonesia.D i Jawa Tengah terdapat beberapa daerah endemic malaria dan tak termasuk Banyumas Tapi sejak tahun 2000, kasus malaria di Banyumas sangat meningkat sehingga menjadikan Banyumas sebagai daerah endemis baru. Tujuan penelitianu ntuk mengetahui pola klinik penderita malaria yang dirawat di Rumah Sakit Umum Banyumas. Penelitian bersifat deskriptif retrospektif dengan mencatat data rekam medis penderita malaria yang dirawat dari Januari 2000 - Mei 2002. Selama periode 29 bulan, tercatat 223 penderita malaria yang dirawat di RSU Banyumas yang terdiri dari 130 pria (58%) dan 93 wanita( 42%). Usia p odukrif (l5-44 tahun) adalah yang sering terjangkit malaria (52%). Lebih dari 90% (102) pasien dari Kabupaten Banyurnas dan sisanya dari Kabupaten sekitarnya. Insidens terbanyak terjadi pada bulan Desember 2001. Empat besar manifestasi klinik adalah demam (100%), menggigil (47Vo), sakit kepala 29 (33%) dan mual 22 (25%). H asil laboratorium adalah sebagian besar penderita anemia 63 (75%). Penyebab terbanyak adalah Plasmodium falciparum ll4 (49%). Fansidar adalah terapi tunggal yang terbanyak (8%) dan Chloroquin Primaquin sebagai terapi kombinasi yang terbanyak (38%).", "publisher": "Pembangunan Pedesaan", "sourceUrl": "http://journal.lppm.unsoed.ac.id/ojs/index.php/Pembangunan/article/view/41", "documentId": "308324", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"GAMBARAN+KLINIK+PENDERITA+MALARIA+YANG+DIRAWAT+DI+RSU+BANYUMAS+TAHUN+2OOO+MEI+2OO2+CLINICAL+FEATARES+OF+MALARIA+PATIENTS+THAT+HOSPITALIZED+IN+BANYAMAS+GENERAL+HOSPITAL+2OOO-MAY+2OO2\n\"", "downloadUrl": "http://journal.lppm.unsoed.ac.id/ojs/index.php/Pembangunan/article/download/41/40", "journalTitle": "Pembangunan Pedesaan" } ], "limit": 10, "query": "malaria", "total": 2582, "hasMore": true, "nextPage": 2, "provider": "garuda" } ``` --- ### Documents Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/documents` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Search keyword. The site refuses anything under 3 characters | | `field` | enum(title|abstract|author|doi) | query | no | Restrict the keyword to one field. Default searches every field | | `publisher` | string | query | no | Publisher name filter, 3 characters or more | | `pdfOnly` | enum(true|false) | query | no | Keep only documents with a downloadable PDF. Default false | | `yearFrom` | number | query | no | Earliest publication year | | `yearTo` | number | query | no | Latest publication year | | `page` | number | query | no | Page number, 10 documents per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/documents?query=malaria&field=title&publisher=universitas&pdfOnly=true&yearFrom=2020&yearTo=2024&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/documents?query=malaria&field=title&publisher=universitas&pdfOnly=true&yearFrom=2020&yearTo=2024&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/documents?query=malaria&field=title&publisher=universitas&pdfOnly=true&yearFrom=2020&yearTo=2024&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "field": "title", "items": [ { "doi": "10.56338/pjkm.v11i2.2026", "year": 2021, "issue": "2", "title": "The Peran Kader Malaria di Wilayah Kerja Puskesmas Bagaiserwar Sarmi Timur: The Role of Malaria Cadres in the Work Area of Health Centers in Bagaiserwar East Sarmi", "volume": "11", "authors": [ { "name": "Lappra, Karenina Gabriela", "authorId": "2124692" }, { "name": "Untung Sudharmono", "authorId": "2551438" } ], "abstract": "Malaria adalah penyakit endemik yang sampai saat ini belum dapat diselesaikan. Kasus malaria banyak terjadi di provinsi Papua hal ini dikarenakan kondisi lingkungan fisik daerah Papua yang panas dan lembab. Pemerintah daerah mengupayakan pengendalian dan penanganan malaria melalui program pelatihan bagi kader malaria. Tujuan penelitian ini adalah untuk melihat peran kader malaria di wilayah kerja Puskesmas Bagaiserwar Sarmi Timur. Metode penelitian yang digunakan adalah deskriptif retrospektif. Populasi dan sampel adalah kader malaria yang berjumlah 11 orang di area kerja Puskesmas Bagaiserwas. Hasil penelitian yang didapatkan adalah terdapat 11 orang kader yang rata-rata berpendidikan SMA dengan jenis kelamin perempua dan rentang usia 36- 45 tahun. Kasus malaria tahun 2019 sebanyak 582 orang dan tahun 2020 sebanyak 1054 orang. Penderita malaria didapati lebih banyak laki-laki dengan rentang usia 15-64 tahun. Diagnosa jenis malaria dilakukan dengan metode Rapid Diagnostic Test didapati jenis terbanyak pada tahun 2019 dan 2020 adalah P.Falciparum sebanyak 397 orang dan 546 orang. Peran pendistribusian obat dan pengawasan obat dilakukan selama 14 hari dengan obat Artimisin Combination Therapy dan primaquine, serta dilakukan pengendalian vector malaria. Tahun 2019 menunjukkan penurunan angka tetapi tahun 2020 terjadi kenaikan akibat dari pandemik Covid-19 sehingga peran kader tidak dilakukan dengan maksimal.", "publisher": "Fakultas Kesehatan Masyarakat, Universitas Muhammadiyah Palu", "sourceUrl": "https://jurnal.unismuhpalu.ac.id/index.php/PJKM/article/view/2026/1710", "documentId": "2391788", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"The+Peran+Kader+Malaria+di+Wilayah+Kerja+Puskesmas+Bagaiserwar+Sarmi+Timur+The+Role+of+Malaria+Cadres+in+the+Work+Area+of+Health+Centers+in+Bagaiserwar+East+Sarmi\"", "downloadUrl": "https://jurnal.unismuhpalu.ac.id/index.php/PJKM/article/download/2026/1710", "journalTitle": "Promotif : Jurnal Kesehatan Masyarakat" }, { "doi": "10.56338/mppki.v4i4.1827", "year": 2021, "issue": "4", "title": "Analisis Strategi Pengendalian Vektor Malaria di Kabupaten Bangka Barat: Analysis of Malaria Vector Control Strategies in West Bangka Regency", "volume": "4", "authors": [ { "name": "Asmiani", "authorId": "4084656" }, { "name": "Yuanita Windusari", "authorId": "4084657" }, { "name": "Hamzah Hasyim", "authorId": "278540" } ], "abstract": "Kabupaten Bangka Barat merupakan satu-satunya kabupaten di Provinsi Kepulauan Bangka Belitung yang belum mencapai eliminasi malaria. Hal ini disebabkan karena masih ditemukan kasus malaria indigenous di Kabupaten Bangka Barat. Data pelaporan E-SISMALpada tahun 2020 di Kabupaten Bangka Barat menunjukkan bahwa kasus malaria indigenous berjumlah 8 kasus dan data pengendalian vektor malaria yang kosong atau tidak ada laporan. Penelitian ini bertujuan untuk menganalisis strategi pengendalian vektor malaria di Kabupaten Bangka Barat dalam rangka eliminasi malaria. Penelitian ini jenis penelitian kualitatif. Penelitian dilakukan di Kabupaten Bangka Barat pada bulan Mei sampai dengan Juni 2021. Penentuan informan penelitian dilakukan secara purposive. Pengumpulan data dilakukan melalui di focus group discussion, wawancara mendalam, observasi partisipatif dan photovoice. Validasi data yang digunakan berupa triangulasi metode dan sumber. Selanjutnya, dianalisis menggunakan aplikasi Nvivo 12 Plus for windows. Faktor-Faktor yang sering ditekankan oleh informan dalam penelitian sebanyak 8 Faktor. Faktor perilaku penambang (26 references), topografi wilayah (14 references), adaya pertemuan lintas sektor (6 references), dukungan lintas sektor, lintas program (5 references), kerjasama TNI/polri (5 references), keterbatasan SDM entomologi dan epidemiologi (18 references), keterbatasan dana (20 references) dan terbatasnya perlengkapan IRS (13 references). Penelitian ini menyimpulkan bahwa pelaksanaan strategi pengendalian vektor malaria di Kabupaten Bangka Tengah belum maksimal. Hal ini disebabkan beberapa faktor yaitu topografi wilayah, perilaku penambang, pertemuan lintas sektor yang belum berdampak langsung pada program malaria, advokasi kepada TNI dan Polri, keterbatasan SDM entomology dan epidemiologi, dana dan perlengkapan IRS.", "publisher": "Fakultas Kesehatan Masyarakat, Universitas Muhammadiyah Palu", "sourceUrl": "https://jurnal.unismuhpalu.ac.id/index.php/MPPKI/article/view/1827/1677", "documentId": "2483574", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Analisis+Strategi+Pengendalian+Vektor+Malaria+di+Kabupaten+Bangka+Barat+Analysis+of+Malaria+Vector+Control+Strategies+in+West+Bangka+Regency\"", "downloadUrl": "https://jurnal.unismuhpalu.ac.id/index.php/MPPKI/article/download/1827/1677", "journalTitle": "Media Publikasi Promosi Kesehatan Indonesia (MPPKI)" }, { "doi": "10.25026/mpc.v14i1.562", "year": 2021, "issue": null, "title": "Pola Penggunaan Antimalaria pada Pasien Malaria di Instalasi Rawat Inap RSUD Jayapura Periode Januari–Desember 2020: Pattern of Antimalarial Drug in Malaria Patients in the Jayapura Hospital Inpatient Installation During January – Desember 2020", "volume": "14", "authors": [ { "name": "Kornelius Yustico Trimedya Purba", "authorId": "4295866" }, { "name": "Vita Olivia Siregar", "authorId": "5557455" }, { "name": "Niken Indriyanti", "authorId": "4295845" } ], "abstract": "The Jayapura city is one of the endemic areas of malaria in the province of Papua. The use of antimalarial medicine in hospitals has adjusted to a pattern of successful therapy in previous years. The study aims to know the pattern of antimalarial use in malarial patients at the jayapura hospital installation in January - December 2020. The method of research used is a non-experimental study with a descriptive design from the retrospective data that sources the data of the treatment records of malaria patients. Studies show that the age of 17-25 became the most common age to develop malaria by 38 patients (38%). The male group became dominant compared with the female population of 60 (60%). Students are the primary target of malaria with 38 patients (38%). Tropical malaria is the most common of 62 patients (62%). Combination of primaquine + artesunate therapy reaches (66%). For precise indications and precise intervals of time entering into the precision of the treatment of malaria with accuracy (100%) while for right the medicine has a percentage (92%) and the right dosage has a percentage (99%) so it can be maximized in the future.", "publisher": "Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia", "sourceUrl": "https://prosiding.farmasi.unmul.ac.id/index.php/mpc/article/view/562/488", "documentId": "2490737", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Pola+Penggunaan+Antimalaria+pada+Pasien+Malaria+di+Instalasi+Rawat+Inap+RSUD+Jayapura+Periode+JanuariDesember+2020+Pattern+of+Antimalarial+Drug+in+Malaria+Patients+in+the+Jayapura+Hospital+Inpatient+Installation+During+January++Desember+2020\"", "downloadUrl": "https://prosiding.farmasi.unmul.ac.id/index.php/mpc/article/download/562/488", "journalTitle": "Proceeding of Mulawarman Pharmaceuticals Conferences" }, { "doi": "10.22146/jkesvo.47741", "year": 2020, "issue": "1", "title": "Pemanfaatan UKS dalam Pencegahan Anemia pada Anak Sekolah Dasar di Daerah Endemik Malaria", "volume": "5", "authors": [ { "name": "Khairunnisa Khairunnisa", "authorId": "3780066" }, { "name": "Rostika Flora", "authorId": "2409619" }, { "name": "Haerawati Idris", "authorId": "2028254" }, { "name": "Nurlaili Nurlaili", "authorId": "454269" }, { "name": "Ikhsan Ikhsan", "authorId": "285575" } ], "abstract": "Latar Belakang: Usia yang rawan terkena penyakit terjadi pada anak-anak dan remaja. Pemerintah berusaha menciptakan lingkungan sehat, menyebarkan pengetahuan kesehatan dan menyediakan fasilitas layanan kesehatan melalui UKS. Di daerah endemik malaria, anak sekolah dasar rentan mengalami anemia. Kondisi lingkungan endemik dan kurangnya asupan nutrisi meningkatkan terjadinya anemia. Di Kabupaten Seluma tahun 2019 didapatkan 21,08% dari 137 anak sekolah dasar menderita anemia.Tujuan: Melakukan analisis pemanfaatan UKS dalam pencegahan anemia pada anak sekolah dasar di daerah endemik malaria.Metode: Penelitian kualitatif, pemilihan informan secara purposive. Pengambilan data dengan wawancara mendalam kepada 10 informan, observasi dan telaah dokumen. Triangulasi sumber, metode dan data. Analisis data dengan cara mereduksi, menyajikan, menarik kesimpulan dan memverifikasi.Hasil: Pemanfaatan UKS melalui pendidikan kesehatan dilakukan dengan memberikan informasi kesehatan oleh guru dan petugas kesehatan. Pemanfaatan UKS dalam pelayanan kesehatan untuk mencegah anemia dengan memantau status gizi anak sekolah dasar dan pemeriksaan konjungtiva, namun belum maksimal karena hanya dilakukan sekali setahun dan belum ada pengecekan kadar hemoglobin. Sarana dan prasarana program UKS untuk pemantauan anemia belum lengkap dan pemanfaatannya terbatas.Kesimpulan: Pemanfaatan UKS dalam pencegahan anemia belum optimal. Sekolah diharapkan meningkatkan pemahaman guru tentang pencegahan anemia melalui kerjasama dengan Puskesmas.", "publisher": "Sekolah Vokasi Universitas Gadjah Mada", "sourceUrl": "https://jurnal.ugm.ac.id/jkesvo/article/view/47741/27172", "documentId": "1483384", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Pemanfaatan+UKS+dalam+Pencegahan+Anemia+pada+Anak+Sekolah+Dasar+di+Daerah+Endemik+Malaria\"", "downloadUrl": "https://jurnal.ugm.ac.id/jkesvo/article/download/47741/27172", "journalTitle": "Jurnal Kesehatan Vokasional" }, { "doi": "10.12928/dpphj.v14i1.1813", "year": 2020, "issue": "1", "title": "Faktor Sikap dan Perilaku yang Berhubungan dengan Malaria di Wilayah Kerja Puskesmas Banjarmangu I Banjarnegara", "volume": "14", "authors": [ { "name": "Siti, Zulaikhah Thomas", "authorId": "1456755" }, { "name": "Sahariyani, Menik", "authorId": "368359" }, { "name": "H, Prasetyo Bhakti", "authorId": "1456756" }, { "name": "M, David Akbar", "authorId": "1456757" }, { "name": "Rani, Mustika", "authorId": "1419828" } ], "abstract": "Background: Malaria is an infectious disease caused by Plasmodium and transmitted to humans through the bite of infected female Anopheles. Characteristics of a person affecting the pattern of life that can contribute to the occurrence, attitudes and behaviors that is less attention to environmental related to Anopheles population can contribute to the malaria. In Indonesia, malaria is found in almost all regions. Some provinces are still malaria endemic areas, both low, medium and high. The number of malaria-based illnesses in API in Central Java in 2014 was recorded at 0.05 per 1000 population, and indigenous cases were still found in 5 districts, namely Purworejo, Banjarnegara, Purbalingga, Banyumas and Kebumen. Banjarnegara is one of the district in Central Java which is an endemic area of malaria, the patients as many 247, of that 102 patients in Puskesmas Banjarmangu I, Banjarmangu. This study aims to related factors attitude and behavior to the malaria. Method: The research was observasional analytic with case control design. The sample of 34 cases and 34 controls, with simple random sampling. Attitudes and behaviors were examined using logistic regression. Results: The result of study showed that attitude (p = 0,015; OR = 3,656; 95% CI = 1,292-10,344) and behavior (p = 0,031; OR = 2,962; 95% CI = 1,104-7,942) were significance relationship with malaria. Conclusion: Attitude and behavior related to the malaria in working area of Banjarmangu I, Banjarnegara. The dominant factors was attitude.", "publisher": "Universitas Ahmad Dahlan", "sourceUrl": "http://journal2.uad.ac.id/index.php/dpphj/article/view/1813/pdf", "documentId": "1590402", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Faktor+Sikap+dan+Perilaku+yang+Berhubungan+dengan+Malaria+di+Wilayah+Kerja+Puskesmas+Banjarmangu+I+Banjarnegara\"", "downloadUrl": "http://journal2.uad.ac.id/index.php/dpphj/article/download/1813/pdf", "journalTitle": "Disease Prevention and Public Health Journal" }, { "doi": "10.20473/ijph.v15i1.2020.71-80", "year": 2020, "issue": "1", "title": "ANALYSIS OF THE ROLE OF OFFICERS IN IMPORT MALARIA CONTROL IN PANDEAN PUSKESMAS DISTRICT TRENGGALEK", "volume": "15", "authors": [ { "name": "Rike Dwi Anggraini", "authorId": "3108053" }, { "name": "R Azizah", "authorId": "3108057" } ], "abstract": "ABSTRACKMalaria remains a health problem in the world. In Indonesia, malaria is one of the causes of the outbreak in the province of East Java. Pandean is a public health center thatcounted for large numbers in cases of malaria in Trenggalek. Although Pandean public health center has conducted treatment of imported malaria, the cases are still high. The purpose of this research is to analyze the role of officers in the implementation of discovery and treatment program of imported malaria, including the availability of human resources, training, knowledge and understanding of the auth. This research is a descriptive observational research. Respondents in the study were 8 people, including Program Managers Of Malaria, 2 Microscopic and 5 JMD in Pandean public health center area. Data retrieval was implemented with interviews against the respondents and secondary data searches in Pandean. The results showed they have the good availability of human resources, but there is no the head of JMD yet. Officer of the discovery and treatment of malaria have had a good knowledge, they have received training, and also have a good working understanding of auth, malaria program officer Role has been good, but they need to keep the improvements including recruitment of the head of JMD to avoid duplicate tasks so that the control of imported malaria can run optimally. Keywords: Malaria import control, The role of officers, Public Health Center", "publisher": "Universitas Airlangga", "sourceUrl": "https://e-journal.unair.ac.id/IJPH/article/view/8257/pdf", "documentId": "1609416", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"ANALYSIS+OF+THE+ROLE+OF+OFFICERS+IN+IMPORT+MALARIA+CONTROL+IN+PANDEAN+PUSKESMAS+DISTRICT+TRENGGALEK\"", "downloadUrl": "https://e-journal.unair.ac.id/IJPH/article/download/8257/pdf", "journalTitle": "The Indonesian Journal of Public Health" }, { "doi": "10.26714/jkmi.15.1.2020.35-41", "year": 2020, "issue": "1", "title": "Pengasapan Kandang Ternak: Perilaku Potensial Peningkatan Risiko Gigitan Anopheles pada Penduduk Daerah Endemik Malaria", "volume": "ume", "authors": [ { "name": "Husniyatun Nisrina", "authorId": "2901667" }, { "name": "Didik Sumanto", "authorId": "5710496" }, { "name": "Sri Widodo", "authorId": "2574014" } ], "abstract": "Latar Belakang: Vektor malaria terverifikasi di Purworejo adalah Anopheles aconitus dan Anopheles maculatus. Vektor bersifat zooantropofilik yang lebih menyukai darah kambing dibandingkan manusia. Kondisi ini menjadi peluang positif bagi upaya pengendalian malaria melalui pengalihan serangan gigitan Anopheles dari manusia ke ternak. Tujuan: Untuk mengeksplorasi kebiasaan pengelolaan ternak pada masyarakat endemik malaria. Metode: Survei dilakukan pada penduduk sekitar domisili penderita malaria di daerah endemik malaria Desa Jatirejo Kaligesing Purworejo. Variabel pengamatan yaitu jarak kandang dengan pemukiman, jumlah kambing dalam kandang, perilaku pengusiran nyamuk. Etik penelitian dikeluarkan oleh Komisi Etik Penelitian Kesehatan Fakultas Kesehatan Masyarakat Universitas Muhammadiyah Semarang. Hasil: Seluruh kandang ternak berjarak lebih dari 10 m dari tempat tinggal. Jumlah kambing etawa tiap kandang berkisar antara 2 – 3 ekor. Tidak ada yang membalurkan insektisida pada hewan ternak untuk mencegah serangan nyamuk. Perilaku pengusiran nyamuk dengan membakar jerami di sekitar kandang ternak 75.3%. Simpulan : Upaya pengalihan serangan gigitan Anopheles yang dilakukan adalah memelihara ternak kambing ditempatkan pada kandang berjarak lebih 10 meter dari rumah hunian. Pengusiran nyamuk metode pengasapan dengan membakar jerami atau rumput kering di malam hari potensial efektif meminimalkan serangan pada ternak namun perlu diwaspadai berbaliknya nyamuk ke area pemukiman penduduk.", "publisher": "Universitas Muhammadiyah Semarang", "sourceUrl": "https://jurnal.unimus.ac.id/index.php/jkmi/article/view/5834/4860", "documentId": "1692258", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Pengasapan+Kandang+Ternak+Perilaku+Potensial+Peningkatan+Risiko+Gigitan+Anopheles+pada+Penduduk+Daerah+Endemik+Malaria\"", "downloadUrl": "https://jurnal.unimus.ac.id/index.php/jkmi/article/download/5834/4860", "journalTitle": "Jurnal Kesehatan Masyarakat Indonesia Volume 15. No. 1. Tahun 2020" }, { "doi": "10.34312/jebj.v2i2.2590", "year": 2020, "issue": "2", "title": "Effectiveness Test Of Rambusa (Passiflora foetida L.) Fruit Extract As A Liquid Anti- Mosquito On The Development Vector Of Malaria Mosquito (Anopheles sp.)", "volume": "2", "authors": [ { "name": "Gregorius Olla", "authorId": "3388492" }, { "name": "Thobias Hasan", "authorId": "3388493" }, { "name": "Anggreini D.N Rupidara", "authorId": "1571157" } ], "abstract": "Rambusa (Passiflora foetida L.) (Passifloraceae) is a plant that contains larvicide bioactive compounds, namely acetogenin, polyphenols, ethanol, citric acid, alkaloids, tannins, coumarin, procyanidin, triterpenoids, flavonoids, and saponins (Kaerati dkk, 2015). The purpose of this research was to determine the effectiveness of rambusa (Passiflora foetida L.) plant extract as liquid mosquito repellent against the development vector of malaria mosquitoes (Anopheles sp.) and to determine the most effective concentration to produce liquid scale insecticide LAB products.This research was conducted at LAB. Undana Bio-Science Kupang uses a simple experimental RAL method with 4 treatments and 3 replications to obtain 15 experimental units. Variation in concentration of 0% (negative / positive control) 10%, 20%, 40% of 1000 ppm. Data analysis using BSLT probit analysis to determine the LC50 value. The results showed that the administration of rambusa (Passiflora foetida L.) fruit extract effectively killed larva at concentrations 100 ppm by 23,3% from 10 larva, concentration of 200 ppm at 65,7%, from 10 larva, concentration of 400 ppm at 100% of 10 larva. The results of probit analysis obtained a relationship curve log concentration to the probit value with a linear curve equation y = 8,4x – 13,79. The LC50 value obtained was 173,78 ppm with a significance value of 0,212 0,05 so that the concentration of 173,78 ppm was most effectively used as a liquid insecticide on the LAB scale.", "publisher": "Fakultas MIPA Universitas Negeri Gorontalo", "sourceUrl": "https://ejurnal.ung.ac.id/index.php/edubiosfer/article/view/2590/2109", "documentId": "1731944", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"Effectiveness+Test+Of+Rambusa+Passiflora+foetida+L+Fruit+Extract+As+A+Liquid+Anti-+Mosquito+On+The+Development+Vector+Of+Malaria+Mosquito+Anopheles+sp\"", "downloadUrl": "https://ejurnal.ung.ac.id/index.php/edubiosfer/article/download/2590/2109", "journalTitle": "Jambura Edu Biosfer Journal" } ], "limit": 10, "query": "malaria", "total": 39, "yearTo": 2024, "hasMore": true, "pdfOnly": true, "nextPage": 2, "provider": "garuda", "yearFrom": 2020, "publisher": "universitas" } ``` --- ### Journal Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/journal/:journalId` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `journalId` | string | path | yes | Garuda journal id, taken from a journals search result | | `page` | number | query | no | Page number, 10 documents per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/journal/:journalId?page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/journal/:journalId?page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/journal/:journalId?page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "issn": null, "page": 1, "areas": [ { "name": "Medicine & Pharmacology", "areaId": "170" }, { "name": "Public Health", "areaId": "185" } ], "count": 10, "eissn": "2549225X", "items": [ { "doi": "10.26618/aimj.v1i2.2758", "year": 2018, "issue": "2", "title": "REGENERASI DENDRIT SEL GANGLION RETINA: PERAN INSULIN UNTUK MENGEMBALIKAN PENGLIHATAN PADA GLAUKOMA", "volume": "1", "authors": [ { "name": "Nurul Azizah", "authorId": "3850491" }, { "name": "Sisca Sisca", "authorId": "3850492" }, { "name": "Rasiha Rasiha", "authorId": "3850493" } ], "abstract": "Glaukoma is a leading cause of irreversible blindness worldwide. This disease is associated with characteristic damage to the optic nerve and permanent retinal ganglion cell (RGC) degeneration. A crucial step towards circuit repair in glaucoma is to promote damaged RGCs to regenerate not only axons, but also dendrites to successfully reconnect with their synaptic partners. The latest research showed that insulin signalling has the capacity to regenerate dendrites dan injured synapses, therefore the use of insulin raises a new paradigm as a new pro-regenerative therapeutic target for the disease of glaucoma. This literature review is made using literature searching of valid journals with inclusion and exclusion criteria. On the experiment of insulin’s effectivity, it is valued using 4 indicators; promote dendrite regeneration, restore synaptic density, rescue retinal function, robust neuronal survival. Based on in vivo experiment, insulin endowed with the ability to effectively restore dendritic morphology thus enhancing the function and survival of RGC through mTORC1 (mammalian target of rapamycin complex 1) and mTORC2 (mammalian target of rapamycin complex 2) signalling, this supports that that it can be promising therapeutic targets to counter progressive RGC neurodegeneration and vision loss in glaucoma.", "publisher": "Journal Medical Universitas muhammadiyah Makassar", "sourceUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/view/2758/2188", "documentId": "1839899", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"REGENERASI+DENDRIT+SEL+GANGLION+RETINA+PERAN+INSULIN+UNTUK+MENGEMBALIKAN+PENGLIHATAN+PADA+GLAUKOMA\"", "downloadUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/download/2758/2188", "journalTitle": "Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran" }, { "doi": "10.26618/aimj.v3i1.2745", "year": 2019, "issue": "1", "title": "POTENSI SEL T MOBIL HER2 SPESIFIK MODIFIKASI CRISPR / CAS9 PD-1 / PD-L1 PEMBLOKIRAN SEBAGAI INOVASI TERAPI UVEAL MELANOMA", "volume": "2", "authors": [ { "name": "Muhammad AH Khoiruddin", "authorId": "3850497" }, { "name": "Yusi Windya Febriyanti", "authorId": "3850498" }, { "name": "Nafia Amalia", "authorId": "3850499" } ], "abstract": "Uveal Melanoma (UM) is the primary intraocular tumor most commonly found in adults. The combination of therapy, Brachytherapy, surgery, Tranpupillary Thermal Therapy (TTT), Proton Beam Theraphy has not produced satisfactory results. The discovery of HER2 receptors expressed by UM cells can be used as a specific antigen target for the treatment of CAR T-celss. However, the effectiveness of CAR T-cell immunotherapy in tumors results in immunosuppressive T cells caused by an increase in Programmed cell Death Ligand-1 (PD-L1). This literature review demonstrates the success of HER2-specific CART T Cells as UM therapeutic efforts capable of eliminating tumor cells. In addition, CRSPR / Cas9 PD-1 / PD-L1-blocking modified HER2-specific CAR T cells can be a gene innovation in UM sufferers. Further clinical trials are needed to prove the effectiveness of CRISPR / Cas9 PD-1 / PD-L1-Blocking modified HER2-specific CAR T Cells in the treatment of UM patients.Keywords: Uveal melanoma, CAR T cell, reseptor HER", "publisher": "Journal Medical Universitas muhammadiyah Makassar", "sourceUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/view/2745/2179", "documentId": "1839900", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"POTENSI+SEL+T+MOBIL+HER2+SPESIFIK+MODIFIKASI+CRISPR++CAS9+PD-1++PD-L1+PEMBLOKIRAN+SEBAGAI+INOVASI+TERAPI+UVEAL+MELANOMA\"", "downloadUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/download/2745/2179", "journalTitle": "Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran" }, { "doi": "10.26618/aimj.v3i1.4154", "year": 2020, "issue": "1", "title": "FREMANEZUMAG (FREMANEZUMAB DAN MAGNESIUM) SEBAGAI INOVASI DALAM PENCEGAHAN SERANGAN MIGRAIN", "volume": "3", "authors": [ { "name": "Putri Windiana Rahman", "authorId": "3850517" }, { "name": "Safira Qalbissilmi", "authorId": "3850532" } ], "abstract": "Migrain adalah penyakit yang dirasakan seumur hidup, sering berulang dan menghambat aktivitas penderitanya. Patogenesis migrain dispekulasikan berada pada sistem trigeminal dengan aktivitas neurotransmitter seperti CGRP, glutamat, serotonin dan nitrit oksida, vasodilatasi arteri serebri serta inflamasi neurogenic. Tata laksana migrain dengan konsumsi triptan didapatkan efek samping yang tak terduga antara penggunaan obat tersebut dengan kejadian iskemik serebrovaskular, jantung coroner dan hipertensi berat. Saat ini, telah ditemukan tata laksana terbaru dan sudah diakui untuk penyakit migrain. Pengobatan yang berhubungan dengan CGRP dan senyawa magnesium menawarkan manfaat yang cukup besar dibandingkan obat-obatan yang sudah ada.", "publisher": "Journal Medical Universitas muhammadiyah Makassar", "sourceUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/view/4154/pdf", "documentId": "1839901", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"FREMANEZUMAG+FREMANEZUMAB+DAN+MAGNESIUM+SEBAGAI+INOVASI+DALAM+PENCEGAHAN+SERANGAN+MIGRAIN\"", "downloadUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/download/4154/pdf", "journalTitle": "Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran" }, { "doi": "10.26618/aimj.v1i1.2769", "year": 2018, "issue": "1", "title": "PENGARUH TERAPI BEKAM TERHADAP PENURUNAN KADAR KOLESTEROL PADA PASIEN HYPERCHOLESTEROLEMIA DI RUMAH SEHAT AL-HIJAMAAH TAHUN 2014/2015", "volume": "1", "authors": [ { "name": "Sitti Aulia Hidayat", "authorId": "3850534" }, { "name": "Salsa Anggeraini", "authorId": "3850535" }, { "name": "TaufiQul Hidayat", "authorId": "3850536" } ], "abstract": "To know the effect of cupping therapy to decrease cholesterol levels in patients at Home Healthy hiperkolestrolemia Al-hijamaah in the year 2014/2015. Research observational analytic-numerical categorical pairs. Samples were hypercholesterolemic patients at Home Healthy Al-hijamaah in 2014/2015. Taken by using non-probability sampling technique with purposive sampling method. The primary data obtained directly from respondents, and analyzed by paired T test. The number of samples involved in this study were 45 respondents. Most of the samples were aged 20-45 years were 28 respondents (62.2%), female 27 respondents (60%), and average cholesterol levels before cupping therapy of 262.84 mg / dl and the average after cupping therapy 239.53 mg / dl. In this study, the results of Test Independent t test t test = 2.64 with p = 0,010 (p 0.05) which means that there are significant differences in cholesterol levels before and after cupping therapy", "publisher": "Journal Medical Universitas muhammadiyah Makassar", "sourceUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/view/2769/2195", "documentId": "1839902", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"PENGARUH+TERAPI+BEKAM+TERHADAP+PENURUNAN+KADAR+KOLESTEROL+PADA+PASIEN+HYPERCHOLESTEROLEMIA+DI+RUMAH+SEHAT+AL-HIJAMAAH+TAHUN+20142015\"", "downloadUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/download/2769/2195", "journalTitle": "Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran" }, { "doi": "10.26618/aimj.v1i2.2750", "year": 2018, "issue": "2", "title": "GLYCOLYTIC 2-DEOXY-D-GLUCOSE PERIOCULAR INHIBITOR SEBAGAI TERAPI ADJUVANT PADA RETINOBLASTOMA", "volume": "1", "authors": [ { "name": "Demara, Yedhi Azlia", "authorId": "3850546" }, { "name": "Laily Annisa Kusumastuti", "authorId": "3850547" }, { "name": "Daffa Abhista Wicaksana", "authorId": "3850548" } ], "abstract": "Retinoblastoma is the most common intraocular tumor in children. Retinoblastoma tumors consist of areas with high angiogenic activity and other areas with low oxygen pressure conditions. Tumor cells that survive in this hypoxic region have been shown to be resistant to chemotherapy and radiation, namely standard retinoblastoma therapy which selectively targets rapidly dividing cell populations, so that therapy is needed that can reach up to the hypoxic cells. 2-deoxy-D-glucose (2-DG) has been shown to be effective in reducing hypoxic areas in tumors, reducing tumor buds, and inhibiting angiogenesis. to discuss the glycolytic 2-DG inhibitors as adjuvant therapy in retinoblastoma. The authors searched for medical articles in the PubMed and ResearchGate literature databases with the keywords treatment, 2-deoxy-D-glucose, 2-DG, retinoblastoma, and cancer. The words are combined with OR or AND using Boolean logic. Based on the selection according to the inclusion and exclusion criteria, 4 articles were used as the main reference for writing this review literature. 2-DG will disregulate (inhibit) the process of angiogenesis through upregulation of Estrogen Receptor 1 Nuclear (ESR 1), ubiquitin, jun activation domain binding protein 1 (JAB1), G-protein alpha S, and CAPER in the apical part of the tumor and B3GNT1 upregulation , CEPT1, PABPC1, myotrophin, HAX1 in the postero-lateral part of the tumor. H3, DTX1, RPL12, and bone morphogenic (BMP) histones are also upregulated so that hypoxia can be inhibited. With this mechanism, the tumor burden can be suppressed. Glycolytic 2-DG inhibitors with anti-angiogenesis and anti-hypoxic abilities can be developed as adjuvant therapy for advanced retinoblastoma patients.", "publisher": "Journal Medical Universitas muhammadiyah Makassar", "sourceUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/view/2750/2184", "documentId": "1839903", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"GLYCOLYTIC+2-DEOXY-D-GLUCOSE+PERIOCULAR+INHIBITOR+SEBAGAI+TERAPI+ADJUVANT+PADA+RETINOBLASTOMA\"", "downloadUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/download/2750/2184", "journalTitle": "Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran" }, { "doi": "10.26618/aimj.v3i2.4160", "year": 2020, "issue": "2", "title": "ANALISIS POTENSI TERAPI SELULER MENGGUNAKAN ADIPOSE-DERIVED STEM CELLS DAN PLATELET-RICH PLASMA DALAM PENANGANAN PENYAKIT ALZHEIMER", "volume": "3", "authors": [ { "name": "Rejoel Mangasa Siagian", "authorId": "3850549" }, { "name": "Grady Krisandi", "authorId": "3850550" } ], "abstract": "Alzheimer sebagai penyakit penyebab utama dari kasus demensia pada lansia terus meningkat seiring dengan pertumbuhan jumlah penduduk usia lanjut. Diagnosis, pencegahan, dan secara khusus penanganan penyakit Alzheimer perlu diteliti lebih lanjut. Penelitian terapi seluler dengan menggunakan sel punca adipose-derived stem cell (ADSC) serta penggunaan bioteknologi platelet-rich plasma (PRP) menunjukkan sebuah penanganan dengan metode baru dan potensial oleh karennya dibutuhkan kajian analisis terkait potensi sebagai kandidat terapi Alzheimer. Kajian dilakukan sesuai dengan panduan PRISMA dari sejumlah database yang diakses daring. Dari hasil analisis studi literatur, ADSC dan PRP penurunan konsentrasi peptida amiloid beta (Aβ), pertumbuhan neuron dan sinaptogenesis, aktivasi mikroglia dengan fenotipe antiinflamasi, peningkatan produksi sitokin antiinflamasi, peningkatan stabilitas sinaps dan dendrit, peningkatan viabilitas neuron, peningkatan neurogenesis, dan penurunan neurodegenerasi.dan peningkatan kognitif. Potensi ADSC dan PRP cukup menjanjikan walaupun PRP masih belum banyak yang meneliti potensinya pada penyakit Alzheimer. Studi lebih lanjut mengenai kedua faktor bioaktif tersebut diperlukan untuk meningkatkan potensi serta kemungkinan kombinasi terapi ADSC dan PRP untuk penyakit Alzheimer.", "publisher": "Journal Medical Universitas muhammadiyah Makassar", "sourceUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/view/4160/pdf", "documentId": "1839904", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"ANALISIS+POTENSI+TERAPI+SELULER+MENGGUNAKAN+ADIPOSE-DERIVED+STEM+CELLS+DAN+PLATELET-RICH+PLASMA+DALAM+PENANGANAN+PENYAKIT+ALZHEIMER\"", "downloadUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/download/4160/pdf", "journalTitle": "Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran" }, { "doi": "10.26618/aimj.v2i2.3958", "year": 2019, "issue": "2", "title": "HUBUNGAN MOTIVASI INTRINSIK TERHADAP PELAKSANAAN PEMBELAJARAN LANGSUNG DI FAKULTAS KEDOKTERAN HALU OLEO UNIVERSITAS KENDARI", "volume": "2", "authors": [ { "name": "Ashaeryanto Ashaeryanto", "authorId": "3850554" }, { "name": "Satrio Wicaksono", "authorId": "3850555" }, { "name": "Juminten Saimin", "authorId": "2638034" }, { "name": "Rezki Fitrianti", "authorId": "3850556" } ], "abstract": "Self-Directed Learning (SDL) is a student-centered learning in which the process and experience of learning are individually regulated and controlled by the student. The implementation of SDL is an interaction of several aspects, including self-motivation, self-control, and self-monitoring skills. Students with strong motivation in the learning process will have more consistency in implementing the SDL. Inner self-motivation will give better impacts than that obtained from the outside. This study aimed to analyze the correlation of intrinsic motivation to SDL implementation in the Faculty of Medicine of Halu Oleo University. The study was quantitative research using a cross-sectional design. Subjects were 91 sophomores of the Faculty of Medicine of Halu Oleo University (UHO). Data were collected using a total sampling method. SDL implementation and intrinsic motivation were measured using Self-Directed Learning Readiness Scale (SDLRS) and Intrinsic Motivation Inventory (IMI) questionnaires, respectively. Data were statistically analyzed using Pearson’s correlation. Second-year of medical students of UHO showed a high intrinsic motivation and SDL implementation. Students with high intrinsic motivation were found to apply high implementation of SDL. Moreover, students with moderate intrinsic motivation also showed high implementation of SDL. There is a significant correlation between intrinsic motivation to SDL implementation among medical students of UHO. Further research is required to investigate other factors that affect the SDL implementation of medical students.", "publisher": "Journal Medical Universitas muhammadiyah Makassar", "sourceUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/view/3958/pdf", "documentId": "1839905", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"HUBUNGAN+MOTIVASI+INTRINSIK+TERHADAP+PELAKSANAAN+PEMBELAJARAN+LANGSUNG+DI+FAKULTAS+KEDOKTERAN+HALU+OLEO+UNIVERSITAS+KENDARI\"", "downloadUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/download/3958/pdf", "journalTitle": "Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran" }, { "doi": "10.26618/aimj.v1i1.2764", "year": 2018, "issue": "1", "title": "OBESITAS TERHADAP TINGKAT INSIDENSI HIPERKOLESTEROLEMIA PADA KARYAWAN DPRD PROVINSI SULAWESI SELATAN DESEMBER 2014", "volume": "1", "authors": [ { "name": "Juliani Ibrahim", "authorId": "848509" }, { "name": "Andi Ridha Annisa Rahmat", "authorId": "3850559" }, { "name": "A.Tenri Padad", "authorId": "5799422" } ], "abstract": "To determine the relationship of obesity to incidence rate of hypercholesterolemia on the employees of DPRD Office of South Sulawesi Province. Methods: Analytic observational study with cross sectional design. Samples were employees of the DPRD Office of South Sulawesi Province December 2014. The data were obtained from the primary data through direct examination to determine body mass index and blood cholesterol levels and through a questionnaire and analyzed using SPSS (Statistical Product and Service Solutions) for windows version 21 with Pearson Chi Square test. Results: The number of samples involved in this study were 100 respondents. Most of the samples were classified as obese as many as 81 people (81.0%) and as many as 5 people (5.0%) were classified as non-obese. In as many as 83 people found respondents (83.0%) were hypercholesterolemia and normal only 17 people (17.0%). Conclusion: In this study, the results of a statistical test with a p-value of 0.000. This means that there is a relationship of obesity to incidence rate of hypercholesterolemia on the employees of the DPRD office of South Sulawesi Province December 2014.", "publisher": "Journal Medical Universitas muhammadiyah Makassar", "sourceUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/view/2764/2192", "documentId": "1839906", "scholarUrl": "http://scholar.google.com/scholar?q=%2Bintitle%3A\"OBESITAS+TERHADAP+TINGKAT+INSIDENSI+HIPERKOLESTEROLEMIA+PADA+KARYAWAN+DPRD+PROVINSI+SULAWESI+SELATAN+DESEMBER+2014\"", "downloadUrl": "https://journal.unismuh.ac.id/index.php/aimj/article/download/2764/2192", "journalTitle": "Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran" } ], "limit": 10, "title": "Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran", "total": 128, "abbrev": "aimj", "oaiUrl": "https://journal.unismuh.ac.id/index.php/aimj/oai", "hasMore": true, "website": "https://journal.unismuh.ac.id/index.php/aimj", "coverUrl": "https://garuda.kemdiktisaintek.go.id/imageview/journal?id=19466&size=", "nextPage": 2, "provider": "garuda", "doiPrefix": "10.26618", "journalId": "19466", "publisher": "Universitas Muhammadiyah Makassar", "coreSubject": "Health", "description": "Journal of Medicine and Health Indonesia is a peer-reviewed journal of medicine and health. This journal is designed as a forum for disseminating information and knowledge which is published twice a year. It publishes original articles, review articles, and case reports. It comprises biomedical science, clinical medicine, public health science, and medical science education. This journal has been established since 2018 (Print ISSN 2085-4145, ISSN Online 2527-2950) which is managed by the Faculty of Medicine, University of Muhammadiyah Makassar.", "arjunaSubject": "Kedokteran - Kedokteran (Lain-Lain)" } ``` --- ### Journals Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/journals` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Journal name, abbreviation, ISSN or EISSN. Omit to list every journal | | `page` | number | query | no | Page number, 10 journals per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/journals?query=kedokteran&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/journals?query=kedokteran&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/journals?query=kedokteran&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "issn": null, "type": "JOURNAL", "areas": [ { "name": "Medicine & Pharmacology", "areaId": "170" }, { "name": "Public Health", "areaId": "185" } ], "eissn": "2549225X", "title": "Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran", "coverUrl": "https://garuda.kemdiktisaintek.go.id/imageview/journal?id=19466&size=m", "journalId": "19466", "publisher": "Universitas Muhammadiyah Makassar" }, { "issn": "24775231", "type": "JOURNAL", "areas": [ { "name": "Dentistry", "areaId": "85" }, { "name": "Health Professions", "areaId": "125" }, { "name": "Medicine & Pharmacology", "areaId": "170" }, { "name": "Nursing", "areaId": "177" }, { "name": "Public Health", "areaId": "185" } ], "eissn": "25028715", "title": "AVERROUS: Jurnal Kedokteran dan Kesehatan Malikussaleh", "coverUrl": "https://garuda.kemdiktisaintek.go.id/imageview/journal?id=18432&size=m", "journalId": "18432", "publisher": "Universitas Malikussaleh" }, { "issn": "23015454", "type": "JOURNAL", "areas": [ { "name": "Dentistry", "areaId": "85" } ], "eissn": "26547643", "title": "B-Dent, Jurnal Kedokteran Gigi Universitas Baiturrahmah", "coverUrl": "https://garuda.kemdiktisaintek.go.id/imageview/journal?id=13753&size=m", "journalId": "13753", "publisher": "Universitas Baiturrahmah" }, { "issn": "02151936", "type": "JOURNAL", "areas": [ { "name": "Nursing", "areaId": "177" }, { "name": "Public Health", "areaId": "185" } ], "eissn": "26148412", "title": "Berita Kedokteran Masyarakat", "coverUrl": "https://garuda.kemdiktisaintek.go.id/imageview/journal?id=26728&size=m", "journalId": "26728", "publisher": "Universitas Gadjah Mada" }, { "issn": null, "type": "JOURNAL", "areas": [ { "name": "Medicine & Pharmacology", "areaId": "170" } ], "eissn": "29886791", "title": "Berkala Ilmiah Kedokteran dan Kesehatan Masyarakat", "coverUrl": "https://garuda.kemdiktisaintek.go.id/imageview/journal?id=41487&size=m", "journalId": "41487", "publisher": "Universitas Islam Indonesia" }, { "issn": "24609684", "type": "JOURNAL", "areas": [ { "name": "Biochemistry, Genetics & Molecular Biology", "areaId": "35" }, { "name": "Health Professions", "areaId": "125" }, { "name": "Immunology & microbiology", "areaId": "130" }, { "name": "Medicine & Pharmacology", "areaId": "170" }, { "name": "Public Health", "areaId": "185" } ], "eissn": "24768863", "title": "Berkala Ilmiah Kedokteran Duta Wacana", "coverUrl": "https://garuda.kemdiktisaintek.go.id/imageview/journal?id=10784&size=m", "journalId": "10784", "publisher": "Universitas Kristen Duta Wacana" }, { "issn": "14120550", "type": "JOURNAL", "areas": [ { "name": "Biochemistry, Genetics & Molecular Biology", "areaId": "35" }, { "name": "Health Professions", "areaId": "125" }, { "name": "Immunology & microbiology", "areaId": "130" }, { "name": "Medicine & Pharmacology", "areaId": "170" }, { "name": "Public Health", "areaId": "185" } ], "eissn": "25485660", "title": "Berkala Kedokteran", "coverUrl": "https://garuda.kemdiktisaintek.go.id/imageview/journal?id=9373&size=m", "journalId": "9373", "publisher": "Universitas Lambung Mangkurat" }, { "issn": "28289994", "type": "JOURNAL", "areas": [ { "name": "Biochemistry, Genetics & Molecular Biology", "areaId": "35" }, { "name": "Health Professions", "areaId": "125" }, { "name": "Medicine & Pharmacology", "areaId": "170" }, { "name": "Nursing", "areaId": "177" }, { "name": "Public Health", "areaId": "185" } ], "eissn": "28289994", "title": "Buletin Kedokteran dan Kesehatan Prima", "coverUrl": "https://garuda.kemdiktisaintek.go.id/imageview/journal?id=26147&size=m", "journalId": "26147", "publisher": "Universitas Prima Indonesia" } ], "limit": 10, "query": "kedokteran", "total": 105, "hasMore": true, "nextPage": 2, "provider": "garuda" } ``` --- ### Publishers Garuda (Kemdiktisaintek) — server-rendered HTML; /suggest?term= answers with a full page, not JSON, so the search is the entire API contract. garuda.kemdikbud.go.id and garuda.ristekbrin.go.id are DEAD hostnames: a 0-19ms connect - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:garuda/publishers` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Publisher name. Omit to list every publisher | | `page` | number | query | no | Page number, 10 publishers per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:garuda/publishers?query=universitas&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:garuda/publishers?query=universitas&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:garuda/publishers?query=universitas&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "name": "Universitas Negeri Semarang", "abbrev": "UNNES", "logoUrl": "https://garuda.kemdiktisaintek.go.id/imageview/publisher/?id=18&logo=png", "website": "https://unnes.ac.id", "publisherId": "18", "journalCount": 351 }, { "name": "Universitas Negeri Surabaya", "abbrev": "UNESA", "logoUrl": "https://garuda.kemdiktisaintek.go.id/imageview/publisher/?id=118&logo=png", "website": "http://unesa.ac.id", "publisherId": "118", "journalCount": 204 }, { "name": "Universitas Diponegoro", "abbrev": "UNDIP", "logoUrl": "https://garuda.kemdiktisaintek.go.id/imageview/publisher/?id=7&logo=jpg", "website": "http://undip.ac.id", "publisherId": "7", "journalCount": 200 }, { "name": "Universitas Negeri Padang", "abbrev": "UNP", "logoUrl": "https://garuda.kemdiktisaintek.go.id/imageview/publisher/?id=53&logo=jpg", "website": "http://www.unp.ac.id", "publisherId": "53", "journalCount": 191 }, { "name": "Universitas Negeri Makassar", "abbrev": "UNM", "logoUrl": "https://garuda.kemdiktisaintek.go.id/imageview/publisher/?id=112&logo=jpeg", "website": "http://www.unm.ac.id/", "publisherId": "112", "journalCount": 191 }, { "name": "Universitas Halu Oleo", "abbrev": "UHO", "logoUrl": "https://garuda.kemdiktisaintek.go.id/imageview/publisher/?id=351&logo=png", "website": "http://uho.ac.id", "publisherId": "351", "journalCount": 182 }, { "name": "Universitas Pendidikan Indonesia", "abbrev": "UPI", "logoUrl": "https://garuda.kemdiktisaintek.go.id/imageview/publisher/?id=85&logo=jpeg", "website": "http://www.upi.edu/", "publisherId": "85", "journalCount": 174 }, { "name": "Universitas Brawijaya", "abbrev": "UB", "logoUrl": "https://garuda.kemdiktisaintek.go.id/imageview/publisher/?id=28&logo=jpg", "website": "http://www.ub.ac.id/", "publisherId": "28", "journalCount": 164 } ], "limit": 10, "query": "universitas", "total": 823, "hasMore": true, "nextPage": 2, "provider": "garuda" } ``` --- ## Google Maps Reviews **Category:** research · **Slug:** `google-maps-reviews` **Detail page:** https://zapi.ink/api/research/google-maps-reviews Ambil ulasan Google Maps berdasarkan kata kunci/nama tempat. Mengembalikan detail tempat (rating, total ulasan, alamat, kategori) plus daftar ulasan publik (penulis, rating bintang, waktu, teks, foto, balasan pemilik). Mendukung paginasi & sortir (relevan/terbaru/tertinggi/terendah). **Tags:** google, maps, reviews, ulasan, places, rating, scraper ### Search Places by Keyword Cari tempat di Google Maps by kata kunci. Balikin daftar tempat yang cocok (nama, rating, kategori, alamat, ftid/cid/url). Untuk detail + semua ulasan, pakai endpoint reviews dengan query=ftid/cid/url. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:google-maps-reviews/search` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Kata kunci pencarian tempat. Paling akurat kalau sebut jenis + area (mis. 'kopi senayan', 'apotek bandung'). | | `limit` | number | query | no | Maksimum jumlah tempat. Default 20, max 40. | | `language` | string | query | no | Kode bahasa hasil (hl=). Default en. | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:google-maps-reviews/search?query=coffee%20shop%20menteng%20jakarta&limit=20&language=id" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:google-maps-reviews/search?query=coffee%20shop%20menteng%20jakarta&limit=20&language=id", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:google-maps-reviews/search?query=coffee%20shop%20menteng%20jakarta&limit=20&language=id", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "hint": "Untuk detail lengkap + semua ulasan, panggil endpoint `reviews` dengan query = ftid/cid/url salah satu tempat di atas.", "count": 10, "query": "coffee shop menteng jakarta", "places": [ { "cid": "7935521876300476942", "url": "https://maps.google.com/?cid=7935521876300476942", "ftid": "0x2e69f418b10da37f:0x6e20a31a303b320e", "name": "1/15 Coffee, Menteng", "rating": 4.5, "address": "Jl. Dr. Kusuma Atmaja No.79 10, RT.10/RW.4", "category": "Coffee shop", "reviewCount": null }, { "cid": "8767492921603617647", "url": "https://maps.google.com/?cid=8767492921603617647", "ftid": "0x2e69f4151ceb7767:0x79ac645c2aef736f", "name": "Giyanti Coffee Roastery", "rating": 4.6, "address": "", "category": "Coffee shop", "reviewCount": null }, { "cid": "5511039473957957695", "url": "https://maps.google.com/?cid=5511039473957957695", "ftid": "0x2e69f5321b8d4f91:0x4c7b2533ec6b703f", "name": "LUC Coffee - Menteng", "rating": 4.9, "address": "Jl. Teuku Cik Ditiro No.3, RT.8/RW.2", "category": "Coffee shop", "reviewCount": null }, { "cid": "16405461092859573733", "url": "https://maps.google.com/?cid=16405461092859573733", "ftid": "0x2e69f5e230652957:0xe3abe7f1b062f5e5", "name": "Ombé Kofie Menteng", "rating": 4.5, "address": "", "category": "Coffee shop", "reviewCount": null }, { "cid": "2763188331139820129", "url": "https://maps.google.com/?cid=2763188331139820129", "ftid": "0x2e69f414485a7db5:0x2658d125ad17ea61", "name": "Anomali Coffee Menteng", "rating": 4.5, "address": "Jl. Teuku Cik Ditiro No.52, RT.10/RW.5", "category": "Coffee shop", "reviewCount": null }, { "cid": "15650491436840511292", "url": "https://maps.google.com/?cid=15650491436840511292", "ftid": "0x2e69f33d3ff98109:0xd931b70abd2be73c", "name": "Nwansa Coffee, Menteng", "rating": 4.8, "address": "toko sebelum lampu merah, Jl. Surabaya No. 2, Kec. Menteng. Kel. Menteng, Jakarta Pusat (2, RT.16/RW.5", "category": "Coffee shop", "reviewCount": null }, { "cid": "14721771199065890163", "url": "https://maps.google.com/?cid=14721771199065890163", "ftid": "0x2e69f57291b199d5:0xcc4e3ce800e61d73", "name": "Agreya Coffee Menteng - Cafe & Coffee Shop Jakarta Pusat: WFC, Meeting Room, dan Smoking Indoor", "rating": 4.9, "address": "masjid Sunda Kelapa, Jl. Taman Sunda Kelapa, RT.6/RW.4", "category": "Coffee shop", "reviewCount": null }, { "cid": "1761403448671480868", "url": "https://maps.google.com/?cid=1761403448671480868", "ftid": "0x2e69f51c1a2dfbeb:0x1871c31ab0362c24", "name": "Kurasu Menteng", "rating": 4.7, "address": "Jl. Latuharhary No.9, RT.11/RW.7", "category": "Coffee shop", "reviewCount": null } ] } ``` --- ### Reviews by Keyword Cari tempat via kata kunci/nama (atau URL Maps/CID), lalu ambil ulasan publiknya: penulis, rating, waktu, teks, foto. Paginasi + sortir. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:google-maps-reviews/reviews` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `place` | string | query | yes | ID tempat Google Maps: CID (angka), ftid (0x..:0x..), atau URL Google Maps tempat. Ambil dari endpoint `search` (field cid/ftid/url). | | `pages` | number | query | no | Jumlah halaman ulasan (1 halaman = ~10 ulasan). Default 2, max 8. | | `sort` | enum(relevant|newest|highest|lowest) | query | no | Urutan ulasan: relevant (default) \| newest \| highest \| lowest. | | `language` | string | query | no | Kode bahasa hasil (hl=). Default en. Contoh: id, en. | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:google-maps-reviews/reviews?place=8767492921603617647&pages=2&sort=newest&language=en" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:google-maps-reviews/reviews?place=8767492921603617647&pages=2&sort=newest&language=en", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:google-maps-reviews/reviews?place=8767492921603617647&pages=2&sort=newest&language=en", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "sort": "newest", "count": 20, "place": { "cid": "8767492921603617647", "url": "https://maps.google.com/?cid=8767492921603617647", "ftid": "0x0:0x79ac645c2aef736f", "name": "Giyanti Coffee Roastery", "rating": 4.6, "address": "Surabaya St No.20, RT.15/RW.5, Menteng, Central Jakarta City, Jakarta 10310, Indonesia", "category": "Cafe", "plusCode": "RR2Q+CQ Menteng, Central Jakarta City, Jakarta, Indonesia", "coordinates": { "lat": -6.1988778, "lng": 106.8394721 }, "totalReviews": 4278 }, "reviews": [ { "id": "Ci9DQUlRQUNvZENodHljRjlvT2pSQ2NpMUdUMmc0ZVU5TE5XbHZhRXBKZWxSSFRFRRAB", "text": "Giyanti Coffee Menteng is a true gem for coffee enthusiasts. The café offers a warm, inviting atmosphere that makes you feel at home. Their Picollo stands out, expertly crafted, smooth, and full of flavor. It’s the kind of coffee that lingers in memory long after the last sip. Highly recommended for anyone seeking quality coffee in Menteng.", "author": { "id": "117944858386343515815", "name": "Biav", "avatar": "https://lh3.googleusercontent.com/a/ACg8ocJO-9ghde51eXlk-DDdt7sW4MYygf8DYG5XMqXfJqx5p8ZLIA=s120-c-rp-mo-ba12-br100", "profileUrl": "https://www.google.com/maps/contrib/117944858386343515815/reviews?hl=en", "reviewCount": 15, "isLocalGuide": true }, "photos": [], "rating": 5, "language": "en", "timestamp": 1781264113505, "relativeTime": "15 hours ago", "timestampIso": "2026-06-12T11:35:13.505Z", "ownerResponse": null }, { "id": "Ci9DQUlRQUNvZENodHljRjlvT25SWE0ySTVjRzQ0TFV4c2VVbEZPVWhLZDNjMlRsRRAB", "text": "Giyanti Coffee Roastery is still that girl.\n\nTucked away in the middle of Jakarta, this place has such a warm and homey vibe that makes you want to stay longer than planned. The moment you walk in, the aroma of freshly roasted coffee hits different.\n\nOrdered a cup of black coffee and it was exactly what you’d expect from a roastery that’s been respected for years. clean, flavorful, and beautifully balanced. No unnecessary gimmicks, just great coffee and solid execution.\n\nThe space feels intimate and charming, with that old Jakarta character that makes it stand out from newer cafés. Perfect for slow mornings, catching up with friends, or simply enjoying a proper coffee break.\n\nHonestly, Giyanti is one of those places that reminds you why specialty coffee became a thing in the first place. Great beans, great atmosphere, and timeless vibes. Definitely worth coming back to.", "author": { "id": "108087582026663315656", "name": "Garry Akbar Prakaza", "avatar": "https://lh3.googleusercontent.com/a-/ALV-UjUuQqA6cdJ0OuCJWzLCC0CG-fIEu2mb-NaIzyzjYSFpDQL6TSz3aQ=s120-c-rp-mo-ba12-br100", "profileUrl": "https://www.google.com/maps/contrib/108087582026663315656/reviews?hl=en", "reviewCount": 263, "isLocalGuide": true }, "photos": [ "https://lh3.googleusercontent.com/grass-cs/ANxoTn0zoNiKF6-jVhS1cqXklRK2pb7S2fm1QO-xog4SjT-rSIb17haU03swkMRyCVTAyzSoXLuoAJDMwQRAxUTOWBthm8nO_UTkh_JD7kA1OGM1_bdhoqjUvVmzVQtH2ivNvahQfm-ZfiJYA0ho=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn3wM0AwEAI68OlK4Z7oiW5_-lIcKMBameOhwFCyHWKl7L9KcL5Sq8cac-F_hCF9ZSU3upR7XljZ2CQv9pF3Z3Z75OfHEinuZ5msQKgAOKxTGnzdKeu6HMze8wBg0q9Tr9uf8vxhPwFySsv_=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn2wXz0IAbsFv6mjtNORa_Cf7T67taGr1GfeLapzIhuURmFE38eSKKrleZPPKpPXpeoLgryCBmpp9QdgAsLfnrMU8n6_mP_AnoAT7C4KyfIaURVeLtLdPq-lJxWS0WIm4Fdm-3V3bi8ceVo=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn0vDScoZ2x6MVStA--mmOCm8_LrVIo3XL2TZWW4HsZdii281ixZXV2f329CzBqcLJe5DA3I8chockudKhkJ5qSenCqeG5BbyzFvm7avqRG5zLRhWLD484twuQJ6owdtXy8LCZGutz0NHaUT=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn2wSchk_c1tbs9NeQEW5wHG4qa1da6VR6Y95sb1Yu3Ot2vmfEj0LN9PSWRWCIt_IjFyvQUaZ0MueXK3dzkNoMLG9cwouzttdUIn_ttkwLOD5iZxOx4L2Z7okFH1MhMhk18JUp-XkZ_zOmhK=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn21ef9ELrSEAZxsdQtZPex0DbpXDWY__Vz7o9S0-dplh43q0v8XgFiNB0KZNzIxIvUCswnsVg8eTI0TiCxjcwH39Xw2P_ifcKFceebgKS5Yc-zNbSIJZlLpA_vQmf36lFr3mVA7Y05gqwUI=k-no" ], "rating": 5, "language": "en", "timestamp": 1781200186217, "relativeTime": "a day ago", "timestampIso": "2026-06-11T17:49:46.217Z", "ownerResponse": null }, { "id": "Ci9DQUlRQUNvZENodHljRjlvT2xkc2IxbzBZbTFPYzJwVFNIWnhWa0ZTTVc1WlZtYxAB", "text": "Finally, touch down to this place.\n\nAtmosphere:\nVintage with many ornament surrounding. Full enough but not noise.\n\nService: the crew are the best.\n\nFood:\nWe just order their lite bites and they are nice.\n\nCoffee:\nThey dont provide manual brew, only espresso based with classic characters. They sells the beans as well, but enough pricy.\n\nWell, recommended coffee shop when you are around menteng area.", "author": { "id": "104307678784843976506", "name": "Aldi Syah", "avatar": "https://lh3.googleusercontent.com/a-/ALV-UjUMnfoElgxwOMQJn_dAAgbqCsi9uiTSl9RvnBS7ap1BQuo1FDc6=s120-c-rp-mo-ba12-br100", "profileUrl": "https://www.google.com/maps/contrib/104307678784843976506/reviews?hl=en", "reviewCount": 236, "isLocalGuide": true }, "photos": [ "https://lh3.googleusercontent.com/grass-cs/ANxoTn1WpshSkm0VFWmvUjdRh0pcDHeQspHX_g8_J1jbKGiDg-MHU7YQ8SuU2td3LuIfSWEEXpNDDyOlhSibxK7vBwve5kikvrz4d9eCQtjupxXscB6DNYd6MXK_i-VVvSklG4Ctj-wkhWero6Kr=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn3__NVo_dnYl2kKxQ8jloy_HGX5zxwjK62FuiGAndlaLPCHyMdfseyp-7d6B4wVcRUKIyBwVQE4xlN4hV-ZiIzTnXqWo_17STgdlJHLVEBzLFJdyUj0Tcr9lymY1Mt0QGXL6K6f1lQjO5E=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn2TfQDzaY_BnHMvIk5NTM-MI-u3fcgRgM_ZXbB_2rHOGXrYFRtxlRd63MbeDLnji0-dohdL8tanP4coBfooDBTo7_b42iN2PH0zp5rZ2wD6UeNnVR-SfJCxHsZ_ZV_Vdw0pjRszLTsPjP8=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn1nMOfhNVvbcw-RMPiynNISbyLWXeHLld-frdZ3Q_0zbvhqnaAJDeQKfC61hohyW2d7fSYj4ghKO8sk-wl5vu7w_Uq3tt-ij9i-ZH3f-AaGZwBY6RkDcFYju6K61lqV8Kx1SlxGXk7owTA=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn2bznSEZk_zGhSbcGfd_vHI2alH7TxXRCfxqlV1OzhEXXTCURIT2hrSPcCvsbI8j5G1KrOW9FgSFnhNJbzPGilxYy2saiBTc1y8_SVMUii9wsSe1vJ-qJdA_Km_4klrBeAUQML-yfpGG6g=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn1GCQFxKz7gvhrNhaEgK4PwVY-C5SyeI1YgwW01JkfUXd3cCEQ6BdcXysOqqCkg72qfnzbsVpxDHgvCMPiNSGUi_cVwBbSqzQ37ijtudCS82jV_VlyCrAdIR8gfp_SioQu-57_i5UULOOi4=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn2uoWClIDEiaE9YeYUHxlfyg5s3aOdNXkxVSHlKLrv9SfoIomqxKWvnsC1nL7QN20X4UPx98jUr6mJTmJ2Hqmyk80ac6Aob0BnS-YmJJN_8Fa3ddGPnqWWWxIbfOtZ2kWeI1dyM0qA4D9gV=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn3V35qynrzW1FbBvsAVe0k1EWzXv7MgoEEi5dD-GdZ6KVCnIMZivaSRAstlpAklKigW7UyU23RGXEu17LGAwCqj_Cj5iZxibHdkDhs3nXZZEeAZ13wB9tgrxD-vSLb2r-ppVu9ADMX9HmY=k-no" ], "rating": 5, "language": "en", "timestamp": 1781014048598, "relativeTime": "3 days ago", "timestampIso": "2026-06-09T14:07:28.598Z", "ownerResponse": null }, { "id": "Ci9DQUlRQUNvZENodHljRjlvT25sZlgyZE1TMDQ1UVc1dkxVeFVXVTh6VlZsVkxXYxAB", "text": "Tidak sebaik di fotonya. Ini adalah pemanfaatan sisi samping property untuk dijadikan cafe, jadi entrynya ada di samping kiri rumah.\nParkir terbatas dan dipungut 10k\nKopi so so, cenderung over roasted (mungkin mereka pakai dark roast?).", "author": { "id": "104203617720259409145", "name": "Babi Go", "avatar": "https://lh3.googleusercontent.com/a-/ALV-UjXk94NsjlD7YH-OLejT5G3F9x4IapqC5jpBuhgty9VfIVNAVtGT=s120-c-rp-mo-ba12-br100", "profileUrl": "https://www.google.com/maps/contrib/104203617720259409145/reviews?hl=en", "reviewCount": 101, "isLocalGuide": true }, "photos": [], "rating": 2, "language": "id", "timestamp": 1780980907722, "relativeTime": "3 days ago", "timestampIso": "2026-06-09T04:55:07.722Z", "ownerResponse": null }, { "id": "Ci9DQUlRQUNvZENodHljRjlvT21aVlVXZG9NVWRLYjJWa2RYSkplR1I1YjJnM1JXYxAB", "text": null, "author": { "id": "103057356919313131415", "name": "Mohamed Naamy", "avatar": "https://lh3.googleusercontent.com/a-/ALV-UjWlWsyHJgJDloMooNXZv5jO4IxN-PfdrgLg5ndj7S6aemzzYcWT8A=s120-c-rp-mo-ba12-br100", "profileUrl": "https://www.google.com/maps/contrib/103057356919313131415/reviews?hl=en", "reviewCount": 5, "isLocalGuide": true }, "photos": [], "rating": 5, "language": null, "timestamp": 1780886227322, "relativeTime": "5 days ago", "timestampIso": "2026-06-08T02:37:07.322Z", "ownerResponse": null }, { "id": "Ci9DQUlRQUNvZENodHljRjlvT25kNGFYSkZTMGRqVUZsNU1YcENMVWxNVFdoU2FuYxAB", "text": "One of my favorite coffee shop 🤩", "author": { "id": "116880101873532629647", "name": "Danica Prima", "avatar": "https://lh3.googleusercontent.com/a-/ALV-UjU-g1wR0hGU8G1XLo0GdshCKMwd8lHQLDmW6FG4aN2CnHWjAdmh=s120-c-rp-mo-ba12-br100", "profileUrl": "https://www.google.com/maps/contrib/116880101873532629647/reviews?hl=en", "reviewCount": 53, "isLocalGuide": true }, "photos": [ "https://lh3.googleusercontent.com/grass-cs/ANxoTn1mx5eu2hEZCQJUgLby2hXWnl4o0NglX06tl6ZStVBL9ZuOvvF3Ybgm3719lcp206lPzhYG0pzwM-ffA6GuuBd6w7Pi2Zt52aqjUUEkZR0dpk3UAkvyYB73DErOq22TAZdpNejggVQuT8e5=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn2ARdGOao3kLQQeXM08d0eIk5z5XBbyavIg1vByVcwg4Lq57qZegQsH51yaujFhNYzIa0TFChpPonGxgp639Qh9a4Cyjg8nenUrUqPdxRVKDZtgEQgoQ7sZK4RZx5NJ3OxhnGZrvAz0y3Rd=k-no" ], "rating": 5, "language": "en", "timestamp": 1780825226790, "relativeTime": "5 days ago", "timestampIso": "2026-06-07T09:40:26.790Z", "ownerResponse": null }, { "id": "Ci9DQUlRQUNvZENodHljRjlvT2tOb1FsZDZTbXRyUlV0WlN6aGhjRFJMVTFoSGVtYxAB", "text": "Another lovely coffee shop that we should visit in town! Kopi camelnya enak ga bikin deg2an n mual, soalnya aku suka zonk kadang kalo minum kopi but this very good\n\nTempatnya fotogenic banget, estetik makanya kita foto2 terus nih, kamar mandi juga bersih oke banget, pelayanan ramah minta tolong foto ma mbaknya gercep, kokonya ramah, talk like we know each other before..kurangnya cuma gak ada tempat shalat doang sih\n\nSukses terus ya, til we meet again Giyanti", "author": { "id": "103104313316227656732", "name": "Dini Probojati", "avatar": "https://lh3.googleusercontent.com/a-/ALV-UjUidA-yWeJc6CfsZIUR1utTpy7eMG2FU9k_R8t7dxxenK2IMLNx=s120-c-rp-mo-ba12-br100", "profileUrl": "https://www.google.com/maps/contrib/103104313316227656732/reviews?hl=en", "reviewCount": 452, "isLocalGuide": true }, "photos": [ "https://lh3.googleusercontent.com/grass-cs/ANxoTn1XKRFYCfRrTNLN-U11UxCD6OuFUBQAqcX2EQp8s5iHYGKFYnQZ9TqtLbJmadhwJugYZyuPcD67AdhfhcJHC9W-ODSQuB9KFIbF-j5lJH-6qxT9_54C7OwW1sIh5KUlgpmtHAv9KFIjZNMs=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn1K_wO_mDMc6kXXjURqDIOQ7ib4jpcWXq7ZPAHazcRd59UJOGGN_eQXoGJv7J1grIQQ8PD3cmveLvs03QDYTP1MxECZ_StMnmCN2--NMw0anAp9pWxG3y_S7OBGfOnD2JcjLO16pOpR7eKm=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn3tEzXwQH1KbENq1peS1e7X_VYjw8VoN27V3JQM05oragehrm_o3VaLAXqPOVJ_xBTvki7vAp-OGH5G4RH1ulYawCQtduvjPQTzIEmH-x1CN4GMTt1DvGpS2BGeF43aQEnDWz7dvMJLCZ9c=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn3IIklTZIwxSsIKgYEwQFbhyH7lO3Y-GnHEYyu1XxF0-_Oyt-IB50-_BNWutsB8qTkitJxVhgNFIaLB9WusovWpGtzwNxp3YVqq_KQ7EEKtJCYm0SygA1dVad4fVelApyuYEpdHuM-zS-S8=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn3Li7I3v5rxht_I79crQz8nDkll8qYh8p3KojNgSeTzZaLCHTsJ8EJZsIH6ASafjX8nGUiIz4CflBARuWQQAN33FScisRAUiViQMhHU2qmymZHGiWYB4TSo2wKdjexFHxF-daNXV2bOtM9o=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn34I-zOfeOSuqvfGoFsvOtjGoFMvipJuJk23ojeZ8U3dVVITNkjU6-vlK2TM3TT1t9Plx6auO75QccskTjy5_T8vYSm0uFwEM0o-xP3F6nCxG-AWvjTGs3eEBAoauXHUJmfrGRaNqqvfPE=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn3nwi-zf32wtikrplWw-TIYDK7Yt1ZDup4phuH19NiwwrlCdssoIAxV5x3EXWUUotRm8sEZhjVPNqmm81XFzSIH9_SexkYDrF4T3TGBI8aat6_tm5YJRUuWv9kWzjet4iliyTPTG4RroaLL=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn11-AtX7dhWJunyNRkTiBg3AfrQhP2Cmc3V15r29-e0wffoDNAYQowgYq3Uv6AXp00uErdIyxmxrdbS5p0yzoikga8YIea7wLTcDTBSnXTFrM_Ox70FzJpCkphWqpeeXoV4QUFADdj-IVc=k-no" ], "rating": 5, "language": "id", "timestamp": 1780611728923, "relativeTime": "a week ago", "timestampIso": "2026-06-04T22:22:08.923Z", "ownerResponse": null }, { "id": "Ci9DQUlRQUNvZENodHljRjlvT2t0MmEwTXpVak13ZEd4NU1tOTVMV2hRYW1wWVpIYxAB", "text": null, "author": { "id": "109216557088268113962", "name": "bodelz", "avatar": "https://lh3.googleusercontent.com/a-/ALV-UjWhZssUH3pSR5mBvnhFB6X0yNvExa-OQnnK49-1-kayfkC9pmc=s120-c-rp-mo-ba12-br100", "profileUrl": "https://www.google.com/maps/contrib/109216557088268113962/reviews?hl=en", "reviewCount": 28, "isLocalGuide": true }, "photos": [ "https://lh3.googleusercontent.com/grass-cs/ANxoTn0HDRnTwhB2NBbEzVFM2nI_-1BRN1H7EqL5boyNpZyA9ZhtQLJPJkPle-GVkge_SE00OdqoysPgMQTluRZQUrEa7E3LcT9N24sI64TBD4SR4iZQKSSg8JR575Jvm6ZN2Lh8Uh4e5qqPBy4=k-no", "https://lh3.googleusercontent.com/grass-cs/ANxoTn0fUlkvLRy-DZnWfQ9UYQwW1k4yJfUruDNMet8zuKgwV-09LQZCuNQT49ZBIkpT_Cg-2JjVJVB0-7Xx0e_F7uv389j_uD4C8SiqmDWXHOFKTa2x8iLGo3JTAGeMmpjiw_JPRwSeM8NyOcb9=k-no" ], "rating": 5, "language": null, "timestamp": 1780595804558, "relativeTime": "a week ago", "timestampIso": "2026-06-04T17:56:44.558Z", "ownerResponse": null } ] } ``` --- ### Foto & Metadata Galeri foto/video sebuah tempat di Google Maps beserta metadata (tipe, sumber, tanggal upload, ukuran). - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:google-maps-reviews/photos` - **Cache TTL:** 600s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `place` | string | query | yes | ID tempat Google Maps: CID (angka), ftid (0x..:0x..), atau URL Google Maps tempat. Ambil dari endpoint `search` (field cid/ftid/url). | | `limit` | number | query | no | Maksimum jumlah foto yang dikembalikan. Default 30, max 80. | | `type` | enum(all|photo|video|street_view) | query | no | Filter jenis media: all (default) \| photo \| video \| street_view. | | `size` | number | query | no | Lebar maksimum (px) URL foto utama. Default 1024, max 2048. | | `language` | string | query | no | Kode bahasa hasil (hl=). Default en. Contoh: id, en. | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:google-maps-reviews/photos?place=14770901448424878510&limit=30&type=photo&size=1024&language=en" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:google-maps-reviews/photos?place=14770901448424878510&limit=30&type=photo&size=1024&language=en", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:google-maps-reviews/photos?place=14770901448424878510&limit=30&type=photo&size=1024&language=en", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "type": "all", "count": 30, "place": { "cid": "14770901448424878510", "url": "https://maps.google.com/?cid=14770901448424878510", "ftid": "0x0:0xccfcc89b95aaf1ae", "name": "Grand Indonesia", "rating": 4.7, "address": "Jl. MH Thamrin No.1, Menteng, Kec. Menteng, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta 10310, Indonesia", "category": "Shopping mall", "coordinates": { "lat": -6.1953681, "lng": 106.8204181 }, "totalReviews": 103008 }, "photos": [ { "id": "CIABIhD2VFbWuNsQRtjWWaeiJs0x", "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHxCaRIJ9Pb6TP5VJBBp0rAUZhQMQ-GI7H_3Qhu6Oo9iryTABGFzM_NX-ryzb2LKjtzfGTfcp9MjbavskrCur5YRD8NRRrHpxPyeZVDEe3-OdEfJM3LF_6r5DKK3GkImhyUE7UvLukCjKeP=w1024-h768-k-no", "type": "photo", "urls": { "large": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHxCaRIJ9Pb6TP5VJBBp0rAUZhQMQ-GI7H_3Qhu6Oo9iryTABGFzM_NX-ryzb2LKjtzfGTfcp9MjbavskrCur5YRD8NRRrHpxPyeZVDEe3-OdEfJM3LF_6r5DKK3GkImhyUE7UvLukCjKeP=w1600-h1200-k-no", "thumb": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHxCaRIJ9Pb6TP5VJBBp0rAUZhQMQ-GI7H_3Qhu6Oo9iryTABGFzM_NX-ryzb2LKjtzfGTfcp9MjbavskrCur5YRD8NRRrHpxPyeZVDEe3-OdEfJM3LF_6r5DKK3GkImhyUE7UvLukCjKeP=w256-h192-k-no", "medium": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHxCaRIJ9Pb6TP5VJBBp0rAUZhQMQ-GI7H_3Qhu6Oo9iryTABGFzM_NX-ryzb2LKjtzfGTfcp9MjbavskrCur5YRD8NRRrHpxPyeZVDEe3-OdEfJM3LF_6r5DKK3GkImhyUE7UvLukCjKeP=w800-h600-k-no", "original": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHxCaRIJ9Pb6TP5VJBBp0rAUZhQMQ-GI7H_3Qhu6Oo9iryTABGFzM_NX-ryzb2LKjtzfGTfcp9MjbavskrCur5YRD8NRRrHpxPyeZVDEe3-OdEfJM3LF_6r5DKK3GkImhyUE7UvLukCjKeP=s0" }, "width": 5712, "height": 4284, "source": "photos:gmm_ios_review_post", "caption": "Grand Indonesia", "typeLabel": "Photo", "uploadDate": { "day": 3, "hour": 19, "year": 2026, "month": 6 }, "uploadDateIso": "2026-06-03" }, { "id": "CIHM0ogKEICAgIDkj5a6RQ", "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHduF1jN0HYF1EAhMxH1-MWwf86Y6Rv2k33dChA11RUnSxkwsJaOJR2BKDrt8N0htuEQhVpqaWXt5wjjloKO782hnmVr5rk6zQBKemc_OlPbhSjJIiKEI7XJWUHJEihfcs2HC90=w1024-h576-k-no", "type": "video", "urls": { "large": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHduF1jN0HYF1EAhMxH1-MWwf86Y6Rv2k33dChA11RUnSxkwsJaOJR2BKDrt8N0htuEQhVpqaWXt5wjjloKO782hnmVr5rk6zQBKemc_OlPbhSjJIiKEI7XJWUHJEihfcs2HC90=w1600-h1200-k-no", "thumb": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHduF1jN0HYF1EAhMxH1-MWwf86Y6Rv2k33dChA11RUnSxkwsJaOJR2BKDrt8N0htuEQhVpqaWXt5wjjloKO782hnmVr5rk6zQBKemc_OlPbhSjJIiKEI7XJWUHJEihfcs2HC90=w256-h192-k-no", "medium": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHduF1jN0HYF1EAhMxH1-MWwf86Y6Rv2k33dChA11RUnSxkwsJaOJR2BKDrt8N0htuEQhVpqaWXt5wjjloKO782hnmVr5rk6zQBKemc_OlPbhSjJIiKEI7XJWUHJEihfcs2HC90=w800-h600-k-no", "original": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHduF1jN0HYF1EAhMxH1-MWwf86Y6Rv2k33dChA11RUnSxkwsJaOJR2BKDrt8N0htuEQhVpqaWXt5wjjloKO782hnmVr5rk6zQBKemc_OlPbhSjJIiKEI7XJWUHJEihfcs2HC90=s0" }, "width": 1920, "height": 1080, "source": "photos:gmm_android", "caption": "Grand Indonesia", "typeLabel": "Video", "uploadDate": { "day": 11, "hour": 16, "year": 2019, "month": 7 }, "uploadDateIso": "2019-07-11", "videoVariants": [ { "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHduF1jN0HYF1EAhMxH1-MWwf86Y6Rv2k33dChA11RUnSxkwsJaOJR2BKDrt8N0htuEQhVpqaWXt5wjjloKO782hnmVr5rk6zQBKemc_OlPbhSjJIiKEI7XJWUHJEihfcs2HC90=m18", "width": 640, "height": 360 }, { "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHduF1jN0HYF1EAhMxH1-MWwf86Y6Rv2k33dChA11RUnSxkwsJaOJR2BKDrt8N0htuEQhVpqaWXt5wjjloKO782hnmVr5rk6zQBKemc_OlPbhSjJIiKEI7XJWUHJEihfcs2HC90=m37", "width": 1920, "height": 1080 }, { "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHduF1jN0HYF1EAhMxH1-MWwf86Y6Rv2k33dChA11RUnSxkwsJaOJR2BKDrt8N0htuEQhVpqaWXt5wjjloKO782hnmVr5rk6zQBKemc_OlPbhSjJIiKEI7XJWUHJEihfcs2HC90=m22", "width": 1280, "height": 720 }, { "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHduF1jN0HYF1EAhMxH1-MWwf86Y6Rv2k33dChA11RUnSxkwsJaOJR2BKDrt8N0htuEQhVpqaWXt5wjjloKO782hnmVr5rk6zQBKemc_OlPbhSjJIiKEI7XJWUHJEihfcs2HC90=mm,dash", "width": 1920, "height": 1080 }, { "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAHduF1jN0HYF1EAhMxH1-MWwf86Y6Rv2k33dChA11RUnSxkwsJaOJR2BKDrt8N0htuEQhVpqaWXt5wjjloKO782hnmVr5rk6zQBKemc_OlPbhSjJIiKEI7XJWUHJEihfcs2HC90=mm,hls?ibw=750000", "width": 1920, "height": 1080 } ] }, { "id": "CIABIhCFfRGfEgYpVwuzRCmwRMQw", "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAEu7OB4lDDmJiyLmhO5e7KzxcWgo7ai8Xy_QomYqyKunjcRv1OyX3sHmQzVr1Xc4-IbDNZAep7XOAHyPQJgBgr3eSsp7jXkXazH4j_K8MjUyKMEBDR4j1fhjx_uRZWhlD7VxihXtpv2XwKx=w1024-h768-k-no", "type": "photo", "urls": { "large": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAEu7OB4lDDmJiyLmhO5e7KzxcWgo7ai8Xy_QomYqyKunjcRv1OyX3sHmQzVr1Xc4-IbDNZAep7XOAHyPQJgBgr3eSsp7jXkXazH4j_K8MjUyKMEBDR4j1fhjx_uRZWhlD7VxihXtpv2XwKx=w1600-h1200-k-no", "thumb": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAEu7OB4lDDmJiyLmhO5e7KzxcWgo7ai8Xy_QomYqyKunjcRv1OyX3sHmQzVr1Xc4-IbDNZAep7XOAHyPQJgBgr3eSsp7jXkXazH4j_K8MjUyKMEBDR4j1fhjx_uRZWhlD7VxihXtpv2XwKx=w256-h192-k-no", "medium": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAEu7OB4lDDmJiyLmhO5e7KzxcWgo7ai8Xy_QomYqyKunjcRv1OyX3sHmQzVr1Xc4-IbDNZAep7XOAHyPQJgBgr3eSsp7jXkXazH4j_K8MjUyKMEBDR4j1fhjx_uRZWhlD7VxihXtpv2XwKx=w800-h600-k-no", "original": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAEu7OB4lDDmJiyLmhO5e7KzxcWgo7ai8Xy_QomYqyKunjcRv1OyX3sHmQzVr1Xc4-IbDNZAep7XOAHyPQJgBgr3eSsp7jXkXazH4j_K8MjUyKMEBDR4j1fhjx_uRZWhlD7VxihXtpv2XwKx=s0" }, "width": 5712, "height": 4284, "source": "photos:gmm_ios_review_post", "caption": "Grand Indonesia", "typeLabel": "Photo", "uploadDate": { "day": 3, "hour": 19, "year": 2026, "month": 6 }, "uploadDateIso": "2026-06-03" }, { "id": "CIABIhAH3meAZhIy_SbmR0cPvdeU", "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFeit5o95xOa8PyXWNNmb1CFsZ_Zg-aqXjk2TJJW9E0D5t8BVOWD0DPuNf2w6pslU_i9Frp2c1zg14DysM_oC8NaXAKddVhW-sxeXdo32MMahtpK8W5MbCvt6GZl_YwfL_vNeALw_nHfKE=w1024-h768-k-no", "type": "photo", "urls": { "large": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFeit5o95xOa8PyXWNNmb1CFsZ_Zg-aqXjk2TJJW9E0D5t8BVOWD0DPuNf2w6pslU_i9Frp2c1zg14DysM_oC8NaXAKddVhW-sxeXdo32MMahtpK8W5MbCvt6GZl_YwfL_vNeALw_nHfKE=w1600-h1200-k-no", "thumb": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFeit5o95xOa8PyXWNNmb1CFsZ_Zg-aqXjk2TJJW9E0D5t8BVOWD0DPuNf2w6pslU_i9Frp2c1zg14DysM_oC8NaXAKddVhW-sxeXdo32MMahtpK8W5MbCvt6GZl_YwfL_vNeALw_nHfKE=w256-h192-k-no", "medium": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFeit5o95xOa8PyXWNNmb1CFsZ_Zg-aqXjk2TJJW9E0D5t8BVOWD0DPuNf2w6pslU_i9Frp2c1zg14DysM_oC8NaXAKddVhW-sxeXdo32MMahtpK8W5MbCvt6GZl_YwfL_vNeALw_nHfKE=w800-h600-k-no", "original": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFeit5o95xOa8PyXWNNmb1CFsZ_Zg-aqXjk2TJJW9E0D5t8BVOWD0DPuNf2w6pslU_i9Frp2c1zg14DysM_oC8NaXAKddVhW-sxeXdo32MMahtpK8W5MbCvt6GZl_YwfL_vNeALw_nHfKE=s0" }, "width": 4096, "height": 3072, "source": "photos:gmm_android", "caption": "Grand Indonesia", "typeLabel": "Photo", "uploadDate": { "day": 12, "hour": 11, "year": 2026, "month": 2 }, "uploadDateIso": "2026-02-12" }, { "id": "CIABIhABb0iT3Niyov838mphdBnn", "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAF6ogwNPdh9KzKR39Xl_GR0sujrWbHuqxWVRU47fUhFfexLdtTE4nse3FSIhPXXwYWQih0wpJTHAjtbBTvSx66_oCWC5J4_2ShJ0zd_2Z_T_kCalMbhahkHHQx3V7TUv_5emGdfr1bEEffR=w1024-h1365-k-no", "type": "photo", "urls": { "large": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAF6ogwNPdh9KzKR39Xl_GR0sujrWbHuqxWVRU47fUhFfexLdtTE4nse3FSIhPXXwYWQih0wpJTHAjtbBTvSx66_oCWC5J4_2ShJ0zd_2Z_T_kCalMbhahkHHQx3V7TUv_5emGdfr1bEEffR=w1600-h1200-k-no", "thumb": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAF6ogwNPdh9KzKR39Xl_GR0sujrWbHuqxWVRU47fUhFfexLdtTE4nse3FSIhPXXwYWQih0wpJTHAjtbBTvSx66_oCWC5J4_2ShJ0zd_2Z_T_kCalMbhahkHHQx3V7TUv_5emGdfr1bEEffR=w256-h192-k-no", "medium": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAF6ogwNPdh9KzKR39Xl_GR0sujrWbHuqxWVRU47fUhFfexLdtTE4nse3FSIhPXXwYWQih0wpJTHAjtbBTvSx66_oCWC5J4_2ShJ0zd_2Z_T_kCalMbhahkHHQx3V7TUv_5emGdfr1bEEffR=w800-h600-k-no", "original": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAF6ogwNPdh9KzKR39Xl_GR0sujrWbHuqxWVRU47fUhFfexLdtTE4nse3FSIhPXXwYWQih0wpJTHAjtbBTvSx66_oCWC5J4_2ShJ0zd_2Z_T_kCalMbhahkHHQx3V7TUv_5emGdfr1bEEffR=s0" }, "width": 3024, "height": 4032, "source": "photos:gmm_android", "caption": "Grand Indonesia", "typeLabel": "Photo", "uploadDate": { "day": 29, "hour": 15, "year": 2025, "month": 8 }, "uploadDateIso": "2025-08-29" }, { "id": "CIABIhAyxqR9VYfSaEsAWuE-lPNW", "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFiKIFX8GPaa01nKDOxDFxJTHd-8AtyHFcqNAM3ccKajUbE2-Jh7RwsBMkMIox-Df1bwVStImc-kq7j8GCKi5urY2Z0W9604xcbLVHKF9J9GqtQtls6JvsZZcIW4_Luvb5UCCd2_gSGCg8=w1024-h768-k-no", "type": "photo", "urls": { "large": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFiKIFX8GPaa01nKDOxDFxJTHd-8AtyHFcqNAM3ccKajUbE2-Jh7RwsBMkMIox-Df1bwVStImc-kq7j8GCKi5urY2Z0W9604xcbLVHKF9J9GqtQtls6JvsZZcIW4_Luvb5UCCd2_gSGCg8=w1600-h1200-k-no", "thumb": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFiKIFX8GPaa01nKDOxDFxJTHd-8AtyHFcqNAM3ccKajUbE2-Jh7RwsBMkMIox-Df1bwVStImc-kq7j8GCKi5urY2Z0W9604xcbLVHKF9J9GqtQtls6JvsZZcIW4_Luvb5UCCd2_gSGCg8=w256-h192-k-no", "medium": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFiKIFX8GPaa01nKDOxDFxJTHd-8AtyHFcqNAM3ccKajUbE2-Jh7RwsBMkMIox-Df1bwVStImc-kq7j8GCKi5urY2Z0W9604xcbLVHKF9J9GqtQtls6JvsZZcIW4_Luvb5UCCd2_gSGCg8=w800-h600-k-no", "original": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFiKIFX8GPaa01nKDOxDFxJTHd-8AtyHFcqNAM3ccKajUbE2-Jh7RwsBMkMIox-Df1bwVStImc-kq7j8GCKi5urY2Z0W9604xcbLVHKF9J9GqtQtls6JvsZZcIW4_Luvb5UCCd2_gSGCg8=s0" }, "width": 4096, "height": 3072, "source": "photos:gmm_android_review_post", "caption": "Grand Indonesia", "typeLabel": "Photo", "uploadDate": { "day": 5, "hour": 3, "year": 2025, "month": 9 }, "uploadDateIso": "2025-09-05" }, { "id": "CIABIhBA5roWoB2LcN95b2xFo1Nf", "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFZIMXD4ZNWFfVbcfZh3QHRISDmOZsNjREcaOPokINiDLrNTl8S7-91BfnhvOJ1Ax7dUAJYxMkxLVCiqKtLpz1gEkbLIx6W0CF043xFtyi7Ho4Mg1X84udV78RgeHqAktAqOnJWh_hLAF3W=w1024-h768-k-no", "type": "photo", "urls": { "large": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFZIMXD4ZNWFfVbcfZh3QHRISDmOZsNjREcaOPokINiDLrNTl8S7-91BfnhvOJ1Ax7dUAJYxMkxLVCiqKtLpz1gEkbLIx6W0CF043xFtyi7Ho4Mg1X84udV78RgeHqAktAqOnJWh_hLAF3W=w1600-h1200-k-no", "thumb": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFZIMXD4ZNWFfVbcfZh3QHRISDmOZsNjREcaOPokINiDLrNTl8S7-91BfnhvOJ1Ax7dUAJYxMkxLVCiqKtLpz1gEkbLIx6W0CF043xFtyi7Ho4Mg1X84udV78RgeHqAktAqOnJWh_hLAF3W=w256-h192-k-no", "medium": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFZIMXD4ZNWFfVbcfZh3QHRISDmOZsNjREcaOPokINiDLrNTl8S7-91BfnhvOJ1Ax7dUAJYxMkxLVCiqKtLpz1gEkbLIx6W0CF043xFtyi7Ho4Mg1X84udV78RgeHqAktAqOnJWh_hLAF3W=w800-h600-k-no", "original": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAFZIMXD4ZNWFfVbcfZh3QHRISDmOZsNjREcaOPokINiDLrNTl8S7-91BfnhvOJ1Ax7dUAJYxMkxLVCiqKtLpz1gEkbLIx6W0CF043xFtyi7Ho4Mg1X84udV78RgeHqAktAqOnJWh_hLAF3W=s0" }, "width": 5712, "height": 4284, "source": "photos:gmm_ios_review_post", "caption": "Grand Indonesia", "typeLabel": "Photo", "uploadDate": { "day": 2, "hour": 14, "year": 2026, "month": 1 }, "uploadDateIso": "2026-01-02" }, { "id": "CIHM0ogKEICAgIDStrGbVA", "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAGHx2X0kv5CrdH8SCzFrRhW7k2r7TtoIxk8c1knPSWPfz_iEl3TVm3rzME976vTC1ZiNXEfibTgT1S4Xz0FMbXg83lGq7wbTdNf-6qNLLMYk-4oEAq_3teCcn5k05clfMKJotxN=w1024-h576-k-no", "type": "video", "urls": { "large": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAGHx2X0kv5CrdH8SCzFrRhW7k2r7TtoIxk8c1knPSWPfz_iEl3TVm3rzME976vTC1ZiNXEfibTgT1S4Xz0FMbXg83lGq7wbTdNf-6qNLLMYk-4oEAq_3teCcn5k05clfMKJotxN=w1600-h1200-k-no", "thumb": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAGHx2X0kv5CrdH8SCzFrRhW7k2r7TtoIxk8c1knPSWPfz_iEl3TVm3rzME976vTC1ZiNXEfibTgT1S4Xz0FMbXg83lGq7wbTdNf-6qNLLMYk-4oEAq_3teCcn5k05clfMKJotxN=w256-h192-k-no", "medium": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAGHx2X0kv5CrdH8SCzFrRhW7k2r7TtoIxk8c1knPSWPfz_iEl3TVm3rzME976vTC1ZiNXEfibTgT1S4Xz0FMbXg83lGq7wbTdNf-6qNLLMYk-4oEAq_3teCcn5k05clfMKJotxN=w800-h600-k-no", "original": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAGHx2X0kv5CrdH8SCzFrRhW7k2r7TtoIxk8c1knPSWPfz_iEl3TVm3rzME976vTC1ZiNXEfibTgT1S4Xz0FMbXg83lGq7wbTdNf-6qNLLMYk-4oEAq_3teCcn5k05clfMKJotxN=s0" }, "width": 1920, "height": 1080, "source": "photos:gmm_android", "caption": "Grand Indonesia", "typeLabel": "Video", "uploadDate": { "day": 24, "hour": 23, "year": 2020, "month": 12 }, "uploadDateIso": "2020-12-24", "videoVariants": [ { "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAGHx2X0kv5CrdH8SCzFrRhW7k2r7TtoIxk8c1knPSWPfz_iEl3TVm3rzME976vTC1ZiNXEfibTgT1S4Xz0FMbXg83lGq7wbTdNf-6qNLLMYk-4oEAq_3teCcn5k05clfMKJotxN=m18", "width": 640, "height": 360 }, { "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAGHx2X0kv5CrdH8SCzFrRhW7k2r7TtoIxk8c1knPSWPfz_iEl3TVm3rzME976vTC1ZiNXEfibTgT1S4Xz0FMbXg83lGq7wbTdNf-6qNLLMYk-4oEAq_3teCcn5k05clfMKJotxN=m37", "width": 1920, "height": 1080 }, { "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAGHx2X0kv5CrdH8SCzFrRhW7k2r7TtoIxk8c1knPSWPfz_iEl3TVm3rzME976vTC1ZiNXEfibTgT1S4Xz0FMbXg83lGq7wbTdNf-6qNLLMYk-4oEAq_3teCcn5k05clfMKJotxN=m22", "width": 1280, "height": 720 }, { "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAGHx2X0kv5CrdH8SCzFrRhW7k2r7TtoIxk8c1knPSWPfz_iEl3TVm3rzME976vTC1ZiNXEfibTgT1S4Xz0FMbXg83lGq7wbTdNf-6qNLLMYk-4oEAq_3teCcn5k05clfMKJotxN=mm,dash", "width": 1920, "height": 1080 }, { "url": "https://lh3.googleusercontent.com/gps-cs-s/APNQkAGHx2X0kv5CrdH8SCzFrRhW7k2r7TtoIxk8c1knPSWPfz_iEl3TVm3rzME976vTC1ZiNXEfibTgT1S4Xz0FMbXg83lGq7wbTdNf-6qNLLMYk-4oEAq_3teCcn5k05clfMKJotxN=mm,hls?ibw=750000", "width": 1920, "height": 1080 } ] } ], "totalPhotos": null } ``` --- ## Google Scholar **Category:** research · **Slug:** `google-scholar` **Detail page:** https://zapi.ink/api/research/google-scholar Pencarian publikasi ilmiah Google Scholar + profil author (sitasi, h-index, daftar publikasi). **Tags:** google-scholar, scholar, akademik, jurnal, sitasi, riset, paper ### Cari Publikasi Cari publikasi ilmiah di Google Scholar (filter tahun, bahasa, paten, sitasi). - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:google-scholar/search` - **Cache TTL:** 3600s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Academic search keyword. Supports operators like author:, source:, intitle:. | | `page` | number | query | no | Page number (10 results per page). Default 1 | | `yearFrom` | number | query | no | Only include results published from this year | | `yearTo` | number | query | no | Only include results published up to this year | | `language` | string | query | no | Interface language code (hl=). Default en | | `patents` | enum(true|false) | query | no | Include patents in results. Default true | | `citations` | enum(true|false) | query | no | Include citation-only (no fulltext) entries. Default true | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:google-scholar/search?query=transformer%20neural%20network&page=1&yearFrom=2018&yearTo=2024&language=en&patents=true&citations=true" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:google-scholar/search?query=transformer%20neural%20network&page=1&yearFrom=2018&yearTo=2024&language=en&patents=true&citations=true", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:google-scholar/search?query=transformer%20neural%20network&page=1&yearFrom=2018&yearTo=2024&language=en&patents=true&citations=true", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "query": "transformer neural network", "hasMore": true, "perPage": 10, "results": [ { "link": "https://homes.esat.kuleuven.be/~konijn/publications/2021/Liu2.pdf", "type": "PDF", "year": 2021, "title": "Transformer in convolutional neural networks", "venue": "arXiv preprint arXiv", "pdfUrl": "https://homes.esat.kuleuven.be/~konijn/publications/2021/Liu2.pdf", "authors": [ "Y Liu", "G Sun", "Y Qiu", "L Zhang" ], "snippet": "… of totally abandoning them as done in recent transformer works [16–20], we aim at introducing a generic framework that could inherit the advantages of both CNNs and transformers . …", "resultId": "Xhupwy48-swJ", "versions": 0, "publisher": "homes.esat.kuleuven.be", "citedByUrl": "https://scholar.google.com/scholar?cites=14770184099463764830&as_sdt=2005&sciodt=0,5&hl=en", "relatedUrl": "https://scholar.google.com/scholar?q=related:Xhupwy48-swJ:scholar.google.com/&scioq=transformer+neural+network&hl=en&as_sdt=0,5", "citedByCount": 112, "authorProfiles": [ { "name": "Y Liu", "authorId": "UB3doCoAAAAJ" }, { "name": "G Sun", "authorId": "qd8Blw0AAAAJ" }, { "name": "L Zhang", "authorId": "61LOyWUAAAAJ" } ], "publicationInfo": "Y Liu , G Sun , Y Qiu, L Zhang … - arXiv preprint arXiv …, 2021 - homes.esat.kuleuven.be" }, { "link": "https://arxiv.org/abs/1907.05572", "type": "PDF", "year": 2019, "title": "R- transformer : Recurrent neural network enhanced transformer", "venue": "arXiv preprint arXiv", "pdfUrl": "https://arxiv.org/pdf/1907.05572", "authors": [ "Z Wang", "Y Ma", "Z Liu", "J Tang" ], "snippet": "… Unlike previously proposed Transformer -like models, R- Transformer in this work leverages the strength of RNN and is able model the local structures effectively without the need of any …", "resultId": "9jQQcRuE-5gJ", "versions": 4, "publisher": "arxiv.org", "citedByUrl": "https://scholar.google.com/scholar?cites=11023549766315291894&as_sdt=2005&sciodt=0,5&hl=en", "relatedUrl": "https://scholar.google.com/scholar?q=related:9jQQcRuE-5gJ:scholar.google.com/&scioq=transformer+neural+network&hl=en&as_sdt=0,5", "citedByCount": 180, "authorProfiles": [ { "name": "Z Wang", "authorId": "nvNEalYAAAAJ" }, { "name": "Y Ma", "authorId": "wf9TTOIAAAAJ" }, { "name": "Z Liu", "authorId": "rRTzNm0AAAAJ" }, { "name": "J Tang", "authorId": "WtzKMWAAAAAJ" } ], "publicationInfo": "Z Wang , Y Ma , Z Liu , J Tang - arXiv preprint arXiv:1907.05572, 2019 - arxiv.org" }, { "link": "https://www.sciencedirect.com/science/article/pii/S136481522200281X", "type": "", "year": 2023, "title": "Transformer neural networks for interpretable flood forecasting", "venue": "… Modelling & Software", "pdfUrl": "", "authors": [ "M Castangia", "LMM Grajales", "A Aliberti", "C Rossi" ], "snippet": "… the applicability of the Transformer neural network to the task … that the Transformer outperforms recurrent neural networks by … Furthermore, the Transformer requires lower computational …", "resultId": "eaSqVjEELZcJ", "versions": 5, "publisher": "Elsevier", "citedByUrl": "https://scholar.google.com/scholar?cites=10893367683633030265&as_sdt=2005&sciodt=0,5&hl=en", "relatedUrl": "https://scholar.google.com/scholar?q=related:eaSqVjEELZcJ:scholar.google.com/&scioq=transformer+neural+network&hl=en&as_sdt=0,5", "citedByCount": 178, "authorProfiles": [ { "name": "M Castangia", "authorId": "RulBKsMAAAAJ" }, { "name": "A Aliberti", "authorId": "A_EadKUAAAAJ" }, { "name": "C Rossi", "authorId": "Wwyz_joAAAAJ" } ], "publicationInfo": "M Castangia , LMM Grajales, A Aliberti , C Rossi … - … Modelling & Software, 2023 - Elsevier" }, { "link": "https://dl.acm.org/doi/abs/10.1145/3388440.3412467", "type": "PDF", "year": 2020, "title": "Transforming the language of life: transformer neural networks for protein prediction tasks", "venue": "Proceedings of the 11th", "pdfUrl": "https://dl.acm.org/doi/pdf/10.1145/3388440.3412467", "authors": [ "A Nambiar", "M Heflin", "S Liu", "S Maslov" ], "snippet": "… We present a Transformer neural network that pre-trains task-agnostic sequence representations. This model is fine-tuned to solve two different protein prediction tasks: protein family …", "resultId": "fS-AVuwxGuAJ", "versions": 9, "publisher": "dl.acm.org", "citedByUrl": "https://scholar.google.com/scholar?cites=16148274305023618941&as_sdt=2005&sciodt=0,5&hl=en", "relatedUrl": "https://scholar.google.com/scholar?q=related:fS-AVuwxGuAJ:scholar.google.com/&scioq=transformer+neural+network&hl=en&as_sdt=0,5", "citedByCount": 198, "authorProfiles": [ { "name": "A Nambiar", "authorId": "cQZWTbMAAAAJ" }, { "name": "S Liu", "authorId": "ktb2fSwAAAAJ" }, { "name": "S Maslov", "authorId": "TOkEuagAAAAJ" } ], "publicationInfo": "A Nambiar , M Heflin, S Liu , S Maslov … - Proceedings of the 11th …, 2020 - dl.acm.org" }, { "link": "https://aclanthology.org/C18-1054/", "type": "PDF", "year": 2018, "title": "A comparison of transformer and recurrent neural networks on multilingual neural machine translation", "venue": "Proceedings of the 27th", "pdfUrl": "https://aclanthology.org/C18-1054.pdf", "authors": [ "SM Lakew", "M Cettolo", "M Federico" ], "snippet": "… investigates the translation quality of two of the currently dominant neural architectures in MT, which are the Recurrent and the Transformer ones; and (iii) quantitatively explores how the …", "resultId": "J8p83ayKPy8J", "versions": 8, "publisher": "aclanthology.org", "citedByUrl": "https://scholar.google.com/scholar?cites=3404592318370335271&as_sdt=2005&sciodt=0,5&hl=en", "relatedUrl": "https://scholar.google.com/scholar?q=related:J8p83ayKPy8J:scholar.google.com/&scioq=transformer+neural+network&hl=en&as_sdt=0,5", "citedByCount": 210, "authorProfiles": [ { "name": "SM Lakew", "authorId": "GEB4LhgAAAAJ" }, { "name": "M Cettolo", "authorId": "5uWajM4AAAAJ" }, { "name": "M Federico", "authorId": "WaGw_qYAAAAJ" } ], "publicationInfo": "SM Lakew , M Cettolo , M Federico - Proceedings of the 27th …, 2018 - aclanthology.org" }, { "link": "https://arxiv.org/abs/2209.15425", "type": "PDF", "year": 2022, "title": "Spikformer: When spiking neural network meets transformer", "venue": "arXiv preprint arXiv", "pdfUrl": "https://arxiv.org/pdf/2209.15425", "authors": [ "Z Zhou", "Y Zhu", "C He", "Y Wang", "S Yan", "Y Tian" ], "snippet": "… We propose Spiking Transformer (Spikformer), which incorporates the self-attention mechanism and Transformer into the spiking neural networks (SNNs) for enhanced learning …", "resultId": "YBqrsf24cakJ", "versions": 4, "publisher": "arxiv.org", "citedByUrl": "https://scholar.google.com/scholar?cites=12209743464525142624&as_sdt=2005&sciodt=0,5&hl=en", "relatedUrl": "https://scholar.google.com/scholar?q=related:YBqrsf24cakJ:scholar.google.com/&scioq=transformer+neural+network&hl=en&as_sdt=0,5", "citedByCount": 684, "authorProfiles": [ { "name": "Z Zhou", "authorId": "4nz-h1QAAAAJ" }, { "name": "Y Zhu", "authorId": "HBp_nuAAAAAJ" }, { "name": "Y Wang", "authorId": "o_DllmIAAAAJ" }, { "name": "S Yan", "authorId": "DNuiPHwAAAAJ" }, { "name": "Y Tian", "authorId": "fn6hJx0AAAAJ" } ], "publicationInfo": "Z Zhou , Y Zhu , C He, Y Wang , S Yan , Y Tian … - arXiv preprint arXiv …, 2022 - arxiv.org" }, { "link": "https://ieeexplore.ieee.org/abstract/document/544265/", "type": "PDF", "year": 1996, "title": "An artificial neural network approach to transformer fault diagnosis", "venue": "IEEE transactions on power", "pdfUrl": "https://vtechworks.lib.vt.edu/bitstreams/9bce9f02-3dc2-4b68-914f-9576c7a6800a/download", "authors": [ "Y Zhang", "X Ding", "Y Liu", "PJ Griffin" ], "snippet": "… This paper presents an artificial neural network (ANN) approach to diagnose and detect faults in oil-filled power transformers based on dissolved gas-in-oil analysis. A twostep ANN …", "resultId": "BpubS3GIt-UJ", "versions": 12, "publisher": "ieeexplore.ieee.org", "citedByUrl": "https://scholar.google.com/scholar?cites=16552848975604718342&as_sdt=2005&sciodt=0,5&hl=en", "relatedUrl": "https://scholar.google.com/scholar?q=related:BpubS3GIt-UJ:scholar.google.com/&scioq=transformer+neural+network&hl=en&as_sdt=0,5", "citedByCount": 612, "authorProfiles": [ { "name": "Y Liu", "authorId": "qHDlIS8AAAAJ" } ], "publicationInfo": "Y Zhang, X Ding, Y Liu , PJ Griffin - IEEE transactions on power …, 1996 - ieeexplore.ieee.org" }, { "link": "https://www.mdpi.com/2076-3417/13/9/5521", "type": "HTML", "year": 2023, "title": "Comparing vision transformers and convolutional neural networks for image classification: A literature review", "venue": "Applied Sciences", "pdfUrl": "https://www.mdpi.com/2076-3417/13/9/5521", "authors": [ "J Maurício", "I Domingues", "J Bernardino" ], "snippet": "… Transformers are models that implement a mechanism of self… Neural Networks for image classification and transformers … Transformers (ViT) and Convolutional Neural Networks . The …", "resultId": "3RtgwJzWuNwJ", "versions": 10, "publisher": "mdpi.com", "citedByUrl": "https://scholar.google.com/scholar?cites=15904698052789672925&as_sdt=2005&sciodt=0,5&hl=en", "relatedUrl": "https://scholar.google.com/scholar?q=related:3RtgwJzWuNwJ:scholar.google.com/&scioq=transformer+neural+network&hl=en&as_sdt=0,5", "citedByCount": 797, "authorProfiles": [ { "name": "J Maurício", "authorId": "qkfnuSAAAAAJ" }, { "name": "I Domingues", "authorId": "wsX09lEAAAAJ" }, { "name": "J Bernardino", "authorId": "EpJW32AAAAAJ" } ], "publicationInfo": "J Maurício , I Domingues , J Bernardino - Applied Sciences, 2023 - mdpi.com" } ], "nextPage": 2, "didYouMean": null, "totalResults": null } ``` --- ### Profil Author Profil author Google Scholar — metrik sitasi, h-index, i10, dan daftar publikasi. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:google-scholar/author` - **Cache TTL:** 3600s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `userId` | string | query | yes | Author profile ID (the `user` param from a profile URL; also returned as `authorProfiles[].authorId` by the search endpoint). | | `page` | number | query | no | Publications page (100 per page). Default 1 | | `sortBy` | enum(cited|year) | query | no | Sort publications by citation count or year. Default cited | | `language` | string | query | no | Interface language (hl=). Default en | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:google-scholar/author?userId=UB3doCoAAAAJ&page=1&sortBy=cited&language=en" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:google-scholar/author?userId=UB3doCoAAAAJ&page=1&sortBy=cited&language=en", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:google-scholar/author?userId=UB3doCoAAAAJ&page=1&sortBy=cited&language=en", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "name": "Yun Liu", "page": 1, "photo": null, "userId": "UB3doCoAAAAJ", "hasMore": false, "metrics": { "hIndexAll": 43, "i10IndexAll": 60, "citationsAll": 12299, "hIndexRecent": 41, "i10IndexRecent": 58, "citationsRecent": 10871 }, "perPage": 100, "interests": [ "Computer Vision" ], "affiliation": "Professor of Computer Science, Nankai University", "emailDomain": "nankai.edu.cn", "publications": [ { "url": "https://scholar.google.com/citations?view_op=view_citation&hl=en&user=UB3doCoAAAAJ&pagesize=100&citation_for_view=UB3doCoAAAAJ:l7t_Zn2s7bgC", "year": 2017, "title": "Structure-measure: A New Way to Evaluate Foreground Maps", "venue": "IEEE International Conference on Computer Vision", "authors": "DP Fan, MM Cheng, Y Liu, T Li, A Borji", "citationId": "UB3doCoAAAAJ:l7t_Zn2s7bgC", "citedByCount": 2486 }, { "url": "https://scholar.google.com/citations?view_op=view_citation&hl=en&user=UB3doCoAAAAJ&pagesize=100&citation_for_view=UB3doCoAAAAJ:dQ2og3OwTAUC", "year": 2019, "title": "Richer Convolutional Features for Edge Detection", "venue": "IEEE Transactions on Pattern Analysis and Machine Intelligence (IEEE CVPR 2017)", "authors": "Y Liu, MM Cheng, X Hu, JW Bian, L Zhang, X Bai, J Tang", "citationId": "UB3doCoAAAAJ:dQ2og3OwTAUC", "citedByCount": 1638 }, { "url": "https://scholar.google.com/citations?view_op=view_citation&hl=en&user=UB3doCoAAAAJ&pagesize=100&citation_for_view=UB3doCoAAAAJ:GtLg2Ama23sC", "year": 2020, "title": "MS-TCN++: Multi-Stage Temporal Convolutional Network for Action Segmentation", "venue": "IEEE Transactions on Pattern Analysis and Machine Intelligence", "authors": "S Li, YA Farha, Y Liu, MM Cheng, J Gall", "citationId": "UB3doCoAAAAJ:GtLg2Ama23sC", "citedByCount": 1251 }, { "url": "https://scholar.google.com/citations?view_op=view_citation&hl=en&user=UB3doCoAAAAJ&pagesize=100&citation_for_view=UB3doCoAAAAJ:W5xh706n7nkC", "year": 2020, "title": "GMS: Grid-based Motion Statistics for Fast, Ultra-robust Feature Correspondence", "venue": "International Journal of Computer Vision", "authors": "JW Bian, WY Lin, Y Liu, L Zhang, SK Yeung, MM Cheng, I Reid", "citationId": "UB3doCoAAAAJ:W5xh706n7nkC", "citedByCount": 962 }, { "url": "https://scholar.google.com/citations?view_op=view_citation&hl=en&user=UB3doCoAAAAJ&pagesize=100&citation_for_view=UB3doCoAAAAJ:e_rmSamDkqQC", "year": 2022, "title": "P2T: Pyramid Pooling Transformer for Scene Understanding", "venue": "IEEE Transactions on Pattern Analysis and Machine Intelligence", "authors": "YH Wu#, Y Liu#, X Zhan, MM Cheng", "citationId": "UB3doCoAAAAJ:e_rmSamDkqQC", "citedByCount": 406 }, { "url": "https://scholar.google.com/citations?view_op=view_citation&hl=en&user=UB3doCoAAAAJ&pagesize=100&citation_for_view=UB3doCoAAAAJ:zLWjf1WUPmwC", "year": 2022, "title": "EDN: Salient Object Detection via Extremely-Downsampled Network", "venue": "IEEE Transactions on Image Processing", "authors": "YH Wu#, Y Liu#, L Zhang, MM Cheng, B Ren", "citationId": "UB3doCoAAAAJ:zLWjf1WUPmwC", "citedByCount": 349 }, { "url": "https://scholar.google.com/citations?view_op=view_citation&hl=en&user=UB3doCoAAAAJ&pagesize=100&citation_for_view=UB3doCoAAAAJ:VOx2b1Wkg3QC", "year": 2018, "title": "Crowd Counting With Deep Negative Correlation Learning", "venue": "IEEE Conference on Computer Vision and Pattern Recognition", "authors": "Z Shi, L Zhang, Y Liu, X Cao, Y Ye, MM Cheng, G Zheng", "citationId": "UB3doCoAAAAJ:VOx2b1Wkg3QC", "citedByCount": 326 }, { "url": "https://scholar.google.com/citations?view_op=view_citation&hl=en&user=UB3doCoAAAAJ&pagesize=100&citation_for_view=UB3doCoAAAAJ:Ug5p-4gJ2f0C", "year": 2023, "title": "LSDIR Dataset: A Large Scale Dataset for Image Restoration", "venue": "IEEE/CVF Conference on Computer Vision and Pattern Recognition, 1775-1787", "authors": "Y Li, K Zhang, J Liang, J Cao, C Liu, R Gong, Y Zhang, H Tang, Y Liu, ...", "citationId": "UB3doCoAAAAJ:Ug5p-4gJ2f0C", "citedByCount": 307 } ], "publicationCount": 90 } ``` --- ## PubMed **Category:** research · **Slug:** `pubmed` **Detail page:** https://zapi.ink/api/research/pubmed NCBI E-utilities across 37 Entrez databases — literature search, summaries, full records, cross-database links, citation metrics and clinical trials. **Tags:** pubmed, ncbi, literature, biomedical, research, citations ### Abstract efetch db=pubmed&rettype=abstract&retmode=text, pre-bound. The payload is one numbered block per record; the split keys each block back to its PMID so the - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/abstract` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Comma-separated PMIDs, max 200 per call | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/abstract?id=33301246%2C32109013" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/abstract?id=33301246%2C32109013", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/abstract?id=33301246%2C32109013", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "db": "pubmed", "count": 2, "items": [ { "pmid": "33301246", "content": "1. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub \n2020 Dec 10.\n\nSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.\n\nPolack FP(1), Thomas SJ(1), Kitchin N(1), Absalon J(1), Gurtman A(1), Lockhart \nS(1), Perez JL(1), Pérez Marc G(1), Moreira ED(1), Zerbini C(1), Bailey R(1), \nSwanson KA(1), Roychoudhury S(1), Koury K(1), Li P(1), Kalina WV(1), Cooper \nD(1), Frenck RW Jr(1), Hammitt LL(1), Türeci Ö(1), Nell H(1), Schaefer A(1), \nÜnal S(1), Tresnan DB(1), Mather S(1), Dormitzer PR(1), Şahin U(1), Jansen \nKU(1), Gruber WC(1); C4591001 Clinical Trial Group.\n\nCollaborators: Aberg J, Addo M, Akhan S, Albertson T, Al-Ibrahim M, Altın S, \nAnderson C, Andrews C, Arora S, Balik I, Barnett E, Bauer G, Baumann-Noss S, \nBerhe M, Bradley P, Brandon D, Brune D, Burgher A, Butcher B, Butuk D, Cannon K, \nCardona J, Cavelli R, Chalhoub F, Christensen S, Christensen T, Chu L, Cox S, \nCrook G, Davis M, Davit R, Denham D, Dever M, Donskey C, Doust M, Dunn M, Earl \nJ, Eder F, Eich A, Ensz D, Essink B, Falcone R, Falsey A, Farrington C, Finberg \nR, Finn D, Fitz-Patrick D, Fortmann S, Fouche L, Fragoso V, Frenck R, Fried D, \nFuller G, Fussell S, Garcia-Diaz J, Gentry A, Glover R, Greenbaum C, Grubb S, \nHammitt L, Harper C, Harper W, Hartman A, Heller R, Hendrix E, Herrington D, \nJennings T, Karabay O, Kaster S, Katzman S, Kingsley J, Klein N, Klein T, Koch \nM, Köksal I, Koren M, Kutner M, Lee M, Leibowitz M, Levin M, Libster R, \nLillestol M, Lucasti C, Luttermann M, Manning MBE, Martin M, Matherne P, \nMcMurray J, Mert A, Middleton R, Mitha E, Morawski E, Moreira E, Mulligan M, \nMurray A, Mussaji M, Musungaie D, Nell H, Odekirk L, Ogbuagu O, Paolino K, Patel \nS, Peterson J, Pickrell P, Polack F, Poretz D, Raad G, Randall W, Rankin B, \nReynolds S, Riesenberg R, Rodriguez H, Rosen J, Rubino J, Rupp R, Saiger S, \nSalata R, Saleh J, Schaefer A, Schear M, Schultz A, Schwartz H, Segall N, Seger \nW, Senders S, Sharp S, Shoffner S, Simsek Yavuz S, Sligh T, Smith W, Stacey H, \nStephens M, Studdard H, Tabak F, Talaat K, Thomas S, Towner W, Tran V, Ünal S, \nUsdan L, Vanchiere J, Varano S, Wadsworth ETL, Walsh W, Walter E, Wappner D, \nWhiles R, Williams H, Wilson J, Winkle P, Winokur P, Wolf T, Yozviak J, Zerbini \nC.\n\nAuthor information:\n(1)From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), \nBuenos Aires; State University of New York, Upstate Medical University, Syracuse \n(S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., \nK.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine \nResearch and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); \nVaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety \nSurveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação \nObras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro \nPaulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global \nProduct Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, \nCincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore \n(L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen \n(A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape \nTown, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and \nWorldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT \n(D.B.T.).\n\nComment in\n N Engl J Med. 2020 Dec 31;383(27):2677-2678. doi: 10.1056/NEJMe2034717.\n Nature. 2020 Dec;588(7838):377-378. doi: 10.1038/d41586-020-03542-4.\n Semergen. 2021 Jan-Feb;47(1):1-3. doi: 10.1016/j.semerg.2020.12.005.\n Panminerva Med. 2022 Mar;64(1):131-132. doi: 10.23736/S0031-0808.21.04286-5.\n Ann Intern Med. 2021 Feb;174(2):JC15. doi: 10.7326/ACPJ202102160-015.\n MMW Fortschr Med. 2021 Feb;163(2):24-25. doi: 10.1007/s15006-021-9577-4.\n N Engl J Med. 2021 Apr 22;384(16):1576-1577. doi: 10.1056/NEJMc2036242.\n N Engl J Med. 2021 Apr 22;384(16):1577. doi: 10.1056/NEJMc2036242.\n N Engl J Med. 2021 Apr 22;384(16):1577-1578. doi: 10.1056/NEJMc2036242.\n Virol Sin. 2021 Oct;36(5):1097-1103. doi: 10.1007/s12250-021-00408-5.\n N Engl J Med. 2022 Mar 24;386(12):1176-1179. doi: 10.1056/NEJMe2202547.\n\nBACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) \ninfection and the resulting coronavirus disease 2019 (Covid-19) have afflicted \ntens of millions of people in a worldwide pandemic. Safe and effective vaccines \nare needed urgently.\nMETHODS: In an ongoing multinational, placebo-controlled, observer-blinded, \npivotal efficacy trial, we randomly assigned persons 16 years of age or older in \na 1:1 ratio to receive two doses, 21 days apart, of either placebo or the \nBNT162b2 vaccine candidate (30 μg per dose). BNT162b2 is a lipid \nnanoparticle-formulated, nucleoside-modified RNA vaccine that encodes a \nprefusion stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. \nThe primary end points were efficacy of the vaccine against laboratory-confirmed \nCovid-19 and safety.\nRESULTS: A total of 43,548 participants underwent randomization, of whom 43,448 \nreceived injections: 21,720 with BNT162b2 and 21,728 with placebo. There were 8 \ncases of Covid-19 with onset at least 7 days after the second dose among \nparticipants assigned to receive BNT162b2 and 162 cases among those assigned to \nplacebo; BNT162b2 was 95% effective in preventing Covid-19 (95% credible \ninterval, 90.3 to 97.6). Similar vaccine efficacy (generally 90 to 100%) was \nobserved across subgroups defined by age, sex, race, ethnicity, baseline \nbody-mass index, and the presence of coexisting conditions. Among 10 cases of \nsevere Covid-19 with onset after the first dose, 9 occurred in placebo \nrecipients and 1 in a BNT162b2 recipient. The safety profile of BNT162b2 was \ncharacterized by short-term, mild-to-moderate pain at the injection site, \nfatigue, and headache. The incidence of serious adverse events was low and was \nsimilar in the vaccine and placebo groups.\nCONCLUSIONS: A two-dose regimen of BNT162b2 conferred 95% protection against \nCovid-19 in persons 16 years of age or older. Safety over a median of 2 months \nwas similar to that of other viral vaccines. (Funded by BioNTech and Pfizer; \nClinicalTrials.gov number, NCT04368728.).\n\nCopyright © 2020 Massachusetts Medical Society.\n\nDOI: 10.1056/NEJMoa2034577\nPMCID: PMC7745181\nPMID: 33301246 [Indexed for MEDLINE]" }, { "pmid": "32109013", "content": "2. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub \n2020 Feb 28.\n\nClinical Characteristics of Coronavirus Disease 2019 in China.\n\nGuan WJ(1), Ni ZY(1), Hu Y(1), Liang WH(1), Ou CQ(1), He JX(1), Liu L(1), Shan \nH(1), Lei CL(1), Hui DSC(1), Du B(1), Li LJ(1), Zeng G(1), Yuen KY(1), Chen \nRC(1), Tang CL(1), Wang T(1), Chen PY(1), Xiang J(1), Li SY(1), Wang JL(1), \nLiang ZJ(1), Peng YX(1), Wei L(1), Liu Y(1), Hu YH(1), Peng P(1), Wang JM(1), \nLiu JY(1), Chen Z(1), Li G(1), Zheng ZJ(1), Qiu SQ(1), Luo J(1), Ye CJ(1), Zhu \nSY(1), Zhong NS(1); China Medical Treatment Expert Group for Covid-19.\n\nCollaborators: Zhong NS, Li LJ, Zeng G, Gao GF, Yuen KY.\n\nAuthor information:\n(1)From the State Key Laboratory of Respiratory Disease, National Clinical \nResearch Center for Respiratory Disease, Guangzhou Institute of Respiratory \nHealth, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., \nJ.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments \nof Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency \nMedicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and \nGuangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the \nState Key Laboratory of Organ Failure Research, Department of Biostatistics, \nGuangdong Provincial Key Laboratory of Tropical Disease Research, School of \nPublic Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan \nJinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, \nHuazhong University of Science and Technology (Yu Hu), the Central Hospital of \nWuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and \nWestern Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital \nAffiliated to Wuhan University of Science and Technology (Jian-ming Wang), and \nthe People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's \nHospital and the Second Affiliated Hospital of Southern University of Science \nand Technology, National Clinical Research Center for Infectious Diseases (L. \nLiu), and the Department of Clinical Microbiology and Infection Control, \nUniversity of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth \nAffiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of \nMedicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), \nand the Department of Microbiology and the Carol Yu Center for Infection, Li Ka \nShing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong \nKong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical \nCollege and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center \nfor Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for \nDiagnosis and Treatment of Infectious Diseases, National Clinical Research \nCenter for Infectious Diseases, First Affiliated Hospital, College of Medicine, \nZhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical \nCenter, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, \nAffiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the \nFirst Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of \nHainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), \nWenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of \nYichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of \nMedicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - \nall in China.\n\nComment in\n N Engl J Med. 2020 May 7;382(19):1859. doi: 10.1056/NEJMc2005203.\n N Engl J Med. 2020 May 7;382(19):1860. doi: 10.1056/NEJMc2005203.\n N Engl J Med. 2020 May 7;382(19):1860. doi: 10.1056/NEJMc2005203.\n N Engl J Med. 2020 May 7;382(19):1860-1861. doi: 10.1056/NEJMc2005203.\n Travel Med Infect Dis. 2020 May - Jun;35:101620. doi: \n10.1016/j.tmaid.2020.101620.\n Diabetes Res Clin Pract. 2020 Apr;162:108132. doi: \n10.1016/j.diabres.2020.108132.\n Int J Cardiol. 2020 Jul 1;310:167-168. doi: 10.1016/j.ijcard.2020.03.074.\n Singapore Med J. 2020 Sep;61(9):460-462. doi: 10.11622/smedj.2020051.\n Br J Haematol. 2020 May;189(4):640-642. doi: 10.1111/bjh.16699.\n Spinal Cord. 2020 Jun;58(6):724-725. doi: 10.1038/s41393-020-0472-0.\n Urology. 2020 Aug;142:42. doi: 10.1016/j.urology.2020.04.069.\n Eur Respir J. 2020 Aug 13;56(2):2001692. doi: 10.1183/13993003.01692-2020.\n Eur Respir J. 2020 Jul 16;56(1):2001234. doi: 10.1183/13993003.01234-2020.\n Med J Malaysia. 2020 May;75(3):309-310.\n Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E197-E202. doi: \n10.1152/ajpendo.00255.2020.\n Rehabilitacion (Madr). 2020 Oct - Dec;54(4):228-230. doi: \n10.1016/j.rh.2020.06.002.\n Hepatology. 2020 Nov;72(5):1509-1513. doi: 10.1002/hep.31522.\n S Afr Med J. 2020 Jun 02;110(7):572-573. doi: \n10.7196/SAMJ.2020.v110i7.14917.\n Signal Transduct Target Ther. 2020 Oct 3;5(1):217. doi: \n10.1038/s41392-020-00333-1.\n Mayo Clin Proc. 2020 Oct;95(10):2062-2064. doi: \n10.1016/j.mayocp.2020.08.012.\n Pulmonology. 2021 Mar-Apr;27(2):91-93. doi: 10.1016/j.pulmoe.2020.11.002.\n Perm J. 2020 Dec;25:1. doi: 10.7812/TPP/20.140.\n\nBACKGROUND: Since December 2019, when coronavirus disease 2019 (Covid-19) \nemerged in Wuhan city and rapidly spread throughout China, data have been needed \non the clinical characteristics of the affected patients.\nMETHODS: We extracted data regarding 1099 patients with laboratory-confirmed \nCovid-19 from 552 hospitals in 30 provinces, autonomous regions, and \nmunicipalities in mainland China through January 29, 2020. The primary composite \nend point was admission to an intensive care unit (ICU), the use of mechanical \nventilation, or death.\nRESULTS: The median age of the patients was 47 years; 41.9% of the patients were \nfemale. The primary composite end point occurred in 67 patients (6.1%), \nincluding 5.0% who were admitted to the ICU, 2.3% who underwent invasive \nmechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a \nhistory of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had \ncontact with residents of Wuhan, including 31.3% who had visited the city. The \nmost common symptoms were fever (43.8% on admission and 88.7% during \nhospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median \nincubation period was 4 days (interquartile range, 2 to 7). On admission, \nground-glass opacity was the most common radiologic finding on chest computed \ntomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of \n877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with \nsevere disease. Lymphocytopenia was present in 83.2% of the patients on \nadmission.\nCONCLUSIONS: During the first 2 months of the current outbreak, Covid-19 spread \nrapidly throughout China and caused varying degrees of illness. Patients often \npresented without fever, and many did not have abnormal radiologic findings. \n(Funded by the National Health Commission of China and others.).\n\nCopyright © 2020 Massachusetts Medical Society.\n\nDOI: 10.1056/NEJMoa2002032\nPMCID: PMC7092819\nPMID: 32109013 [Indexed for MEDLINE]" } ], "format": "text", "provider": "pubmed" } ``` --- ### Annotation Search PubTator3 entity-aware search. Page size is the service's own, not ours — it reports page_size back and ignores any attempt to set it. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/annotation-search` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `text` | string | query | yes | Free text, or a PubTator concept id such as @DISEASE_COVID_19 to search by entity | | `page` | number | query | no | Page number. Default 1 | | `sort` | enum(relevance|date) | query | no | Result order. Default relevance | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/annotation-search?text=covid-19%20vaccine&page=1&sort=relevance" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/annotation-search?text=covid-19%20vaccine&page=1&sort=relevance", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/annotation-search?text=covid-19%20vaccine&page=1&sort=relevance", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "text": "covid-19 vaccine", "count": 10, "items": [ { "doi": "10.14423/SMJ.0000000000001576", "date": "2023-07-01T00:00:00Z", "pmid": "37400094", "issue": "7", "pages": "519-523", "score": 291.16425, "title": "Associations between COVID-19 Death Exposure and COVID-19 Vaccine Hesitancy and Vaccine Uptake.", "volume": "116", "authors": [ "Andersen JA", "Scott AJ", "Rowland B", "Willis DE", "McElfish PA" ], "journal": "South Med J", "highlight": "Associations between @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19 Death@@@ Exposure and COVID-19 Vaccine Hesitancy and Vaccine Uptake.", "citationNlm": "Andersen JA, Scott AJ, Rowland B, Willis DE, McElfish PA. Associations between COVID-19 Death Exposure and COVID-19 Vaccine Hesitancy and Vaccine Uptake. South Med J. 2023 Jul;116(7):519-523. PMID: 37400094", "publishedOn": "2023 Jul", "citationBibTeX": "@article{37400094, title={Associations between COVID-19 Death Exposure and COVID-19 Vaccine Hesitancy and Vaccine Uptake.}, author={Andersen JA and Scott AJ and Rowland B and Willis DE and McElfish PA}, journal={South Med J}, volume={116}, number={7}, pages={519-523}}" }, { "doi": "10.12968/bjon.2021.30.6.344", "date": "2021-03-25T00:00:00Z", "pmid": "33769885", "issue": "6", "pages": "344-349", "score": 290.42218, "title": "COVID-19 vaccines and vaccine administration.", "volume": "30", "authors": [ "Gordon C", "Porteous D", "Unsworth J" ], "journal": "Br J Nurs", "highlight": "@DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ vaccines and vaccine administration.", "citationNlm": "Gordon C, Porteous D, Unsworth J. COVID-19 vaccines and vaccine administration. Br J Nurs. 2021 Mar 25;30(6):344-349. PMID: 33769885", "publishedOn": "2021 Mar 25", "citationBibTeX": "@article{33769885, title={COVID-19 vaccines and vaccine administration.}, author={Gordon C and Porteous D and Unsworth J}, journal={Br J Nurs}, volume={30}, number={6}, pages={344-349}}" }, { "doi": "10.1164/rccm.2021C2", "date": "2021-05-01T00:00:00Z", "pmid": "33759735", "issue": "9", "pages": "P22-P23", "score": 289.14032, "title": "What Are COVID-19 Vaccines?", "volume": "203", "authors": [ "Hartert TV", "Sockrider M" ], "journal": "Am J Respir Crit Care Med", "highlight": "What Are @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ Vaccines?", "citationNlm": "Hartert TV, Sockrider M. What Are COVID-19 Vaccines? Am J Respir Crit Care Med. 2021 May 1;203(9):P22-P23. PMID: 33759735", "publishedOn": "2021 May 1", "citationBibTeX": "@article{33759735, title={What Are COVID-19 Vaccines?}, author={Hartert TV and Sockrider M}, journal={Am J Respir Crit Care Med}, volume={203}, number={9}, pages={P22-P23}}" }, { "doi": "10.32481/djph.2022.03.010", "date": "2022-03-29T00:00:00Z", "pmid": "35402935", "issue": "1", "pages": "68", "score": 289.14032, "title": "Vaccines for COVID-19", "volume": "8", "authors": [ "Eppes SC" ], "journal": "Dela J Public Health", "highlight": "Vaccines for @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@", "citationNlm": "Eppes SC. Vaccines for COVID-19 Dela J Public Health. 2022 Mar;8(1):68. PMID: 35402935", "publishedOn": "2022 Mar", "citationBibTeX": "@article{35402935, title={Vaccines for COVID-19}, author={Eppes SC}, journal={Dela J Public Health}, volume={8}, number={1}, pages={68}}" }, { "doi": "10.1186/s12889-022-13540-y", "date": "2022-06-18T00:00:00Z", "pmid": "35717164", "issue": "1", "pages": "1219", "score": 289.02994, "title": "COVID-19 vaccine hesitancy: a midwifery survey into attitudes towards the COVID-19 vaccine", "volume": "22", "authors": [ "Odejinmi F", "Mallick R", "Neophytou C", "Mondeh K", "Hall M", "Scrivener C", "Tibble K", "Turay-Olusile M" ], "journal": "BMC Public Health", "highlight": "@DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ vaccine hesitancy: a midwifery survey into attitudes towards the @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ vaccine", "citationNlm": "Odejinmi F, Mallick R, Neophytou C, Mondeh K, Hall M, Scrivener C, Tibble K, Turay-Olusile M, Deo N, Oforiwaa D, Osayimwen R. COVID-19 vaccine hesitancy: a midwifery survey into attitudes towards the COVID-19 vaccine BMC Public Health. 2022 Jun 18;22(1):1219. PMID: 35717164", "publishedOn": "2022 Jun 18", "citationBibTeX": "@article{35717164, title={COVID-19 vaccine hesitancy: a midwifery survey into attitudes towards the COVID-19 vaccine}, author={Odejinmi F and Mallick R and Neophytou C and Mondeh K and Hall M and Scrivener C and Tibble K and Turay-Olusile M and Deo N and Oforiwaa D and Osayimwen R}, journal={BMC Public Health}, volume={22}, number={1}, pages={1219}}" }, { "doi": "10.1136/bmj.o2535", "date": "2022-10-21T00:00:00Z", "pmid": "36270640", "issue": "", "pages": "o2535", "score": 288.58517, "title": "What next for covid-19 vaccines?", "volume": "379", "journal": "BMJ", "highlight": "What next for @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@covid-19@@@ vaccines?", "citationNlm": "What next for covid-19 vaccines? BMJ. 2022 Oct 21;379():o2535. PMID: 36270640", "publishedOn": "2022 Oct 21", "citationBibTeX": "@article{36270640, title={What next for covid-19 vaccines?}, journal={BMJ}, volume={379}, pages={o2535}}" }, { "doi": "10.1136/bmj.o2422", "date": "2022-10-20T00:00:00Z", "pmid": "36265866", "issue": "", "pages": "o2422", "score": 288.58517, "title": "What next for covid-19 vaccines?", "volume": "379", "authors": [ "Looi MK", "Mahase E" ], "journal": "BMJ", "highlight": "What next for @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@covid-19@@@ vaccines?", "citationNlm": "Looi MK, Mahase E. What next for covid-19 vaccines? BMJ. 2022 Oct 20;379():o2422. PMID: 36265866", "publishedOn": "2022 Oct 20", "citationBibTeX": "@article{36265866, title={What next for covid-19 vaccines?}, author={Looi MK and Mahase E}, journal={BMJ}, volume={379}, pages={o2422}}" }, { "doi": "10.1016/j.eprac.2021.01.013", "date": "2021-02-01T00:00:00Z", "pmid": "33515760", "issue": "2", "pages": "170-172", "score": 288.58517, "title": "COVID-19 Vaccine", "volume": "27", "authors": [ "Fernandes A", "Chaudhari S", "Jamil N", "Gopalakrishnan G" ], "journal": "Endocr Pract", "highlight": "@DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ Vaccine", "citationNlm": "Fernandes A, Chaudhari S, Jamil N, Gopalakrishnan G. COVID-19 Vaccine Endocr Pract. 2021 Feb;27(2):170-172. PMID: 33515760", "publishedOn": "2021 Feb", "citationBibTeX": "@article{33515760, title={COVID-19 Vaccine}, author={Fernandes A and Chaudhari S and Jamil N and Gopalakrishnan G}, journal={Endocr Pract}, volume={27}, number={2}, pages={170-172}}" } ], "limit": 10, "total": 152737, "facets": { "type": [ { "name": "Journal Article", "count": 137431 }, { "name": "Review", "count": 26305 }, { "name": "Editorial", "count": 4670 }, { "name": "Letter", "count": 4534 }, { "name": "Comment", "count": 2301 } ], "year": [ { "name": "2022", "count": 43790 }, { "name": "2021", "count": 32118 }, { "name": "2023", "count": 31676 }, { "name": "2024", "count": 16725 }, { "name": "2020", "count": 12835 }, { "name": "2025", "count": 12536 }, { "name": "2026", "count": 3019 }, { "name": "2019", "count": 17 } ], "journal": [ { "name": "Vaccines (Basel)", "count": 5035 }, { "name": "PLoS One", "count": 3648 }, { "name": "Front Immunol", "count": 2803 }, { "name": "Sci Rep", "count": 2685 }, { "name": "Front Public Health", "count": 2585 } ] }, "hasMore": true, "nextPage": 2, "provider": "pubmed" } ``` --- ### Annotations PubTator3 BioC-JSON export. The service answers 29 KB of browsable HTML on a default Accept and still says 200, so application/json is not optional here. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/annotations` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `pmids` | string | query | yes | Comma-separated PMIDs, max 100 per call | | `full` | enum(true|false) | query | no | Annotate the full text instead of title and abstract. Default false | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/annotations?pmids=33301246%2C32109013&full=false" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/annotations?pmids=33301246%2C32109013&full=false", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/annotations?pmids=33301246%2C32109013&full=false", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 2, "items": [ { "pmid": "32109013", "year": 2020, "pmcid": "PMC7092819", "authors": "Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS", "journal": "N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub ", "passages": [ { "text": "Clinical Characteristics of Coronavirus Disease 2019 in China.", "type": "title", "offset": 0, "section": null, "annotations": [ { "id": "1", "name": "COVID-19", "text": "Coronavirus Disease 2019", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_COVID_19", "locations": [ { "span": 24, "offset": 28 } ], "identifier": "MESH:D000086382", "normalizedId": "D000086382" } ] }, { "text": "BACKGROUND: Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. METHODS: We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death. RESULTS: The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission. CONCLUSIONS: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.).", "type": "abstract", "offset": 63, "section": null, "annotations": [ { "id": "23", "name": "COVID-19", "text": "coronavirus disease 2019", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_COVID_19", "locations": [ { "span": 24, "offset": 101 } ], "identifier": "MESH:D000086382", "normalizedId": "D000086382" }, { "id": "24", "name": "COVID-19", "text": "Covid-19", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_COVID_19", "locations": [ { "span": 8, "offset": 127 } ], "identifier": "MESH:D000086382", "normalizedId": "D000086382" }, { "id": "25", "name": "9606", "text": "patients", "type": "Species", "biotype": "species", "database": "ncbi_taxonomy", "accession": null, "locations": [ { "span": 8, "offset": 266 } ], "identifier": "9606", "normalizedId": 9606 }, { "id": "26", "name": "9606", "text": "patients", "type": "Species", "biotype": "species", "database": "ncbi_taxonomy", "accession": null, "locations": [ { "span": 8, "offset": 318 } ], "identifier": "9606", "normalizedId": 9606 }, { "id": "27", "name": "COVID-19", "text": "Covid-19", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_COVID_19", "locations": [ { "span": 8, "offset": 353 } ], "identifier": "MESH:D000086382", "normalizedId": "D000086382" }, { "id": "28", "name": "Death", "text": "death", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_Death", "locations": [ { "span": 5, "offset": 598 } ], "identifier": "MESH:D003643", "normalizedId": "D003643" }, { "id": "29", "name": "9606", "text": "patients", "type": "Species", "biotype": "species", "database": "ncbi_taxonomy", "accession": null, "locations": [ { "span": 8, "offset": 636 } ], "identifier": "9606", "normalizedId": 9606 }, { "id": "30", "name": "9606", "text": "patients", "type": "Species", "biotype": "species", "database": "ncbi_taxonomy", "accession": null, "locations": [ { "span": 8, "offset": 672 } ], "identifier": "9606", "normalizedId": 9606 } ] } ], "annotationCount": 22 }, { "pmid": "33301246", "year": 2020, "pmcid": "PMC7745181", "authors": "Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Perez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, Tureci O, Nell H, Schaefer A, Unal S, Tresnan DB, Mather S, Dormitzer PR, Sahin U, Jansen KU, Gruber WC", "journal": "N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub ", "passages": [ { "text": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.", "type": "title", "offset": 0, "section": null, "annotations": [ { "id": "1", "name": "COVID-19", "text": "Covid-19", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_COVID_19", "locations": [ { "span": 8, "offset": 41 } ], "identifier": "MESH:D000086382", "normalizedId": "D000086382" } ] }, { "text": "BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently. METHODS: In an ongoing multinational, placebo-controlled, observer-blinded, pivotal efficacy trial, we randomly assigned persons 16 years of age or older in a 1:1 ratio to receive two doses, 21 days apart, of either placebo or the BNT162b2 vaccine candidate (30 mug per dose). BNT162b2 is a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. The primary end points were efficacy of the vaccine against laboratory-confirmed Covid-19 and safety. RESULTS: A total of 43,548 participants underwent randomization, of whom 43,448 received injections: 21,720 with BNT162b2 and 21,728 with placebo. There were 8 cases of Covid-19 with onset at least 7 days after the second dose among participants assigned to receive BNT162b2 and 162 cases among those assigned to placebo; BNT162b2 was 95% effective in preventing Covid-19 (95% credible interval, 90.3 to 97.6). Similar vaccine efficacy (generally 90 to 100%) was observed across subgroups defined by age, sex, race, ethnicity, baseline body-mass index, and the presence of coexisting conditions. Among 10 cases of severe Covid-19 with onset after the first dose, 9 occurred in placebo recipients and 1 in a BNT162b2 recipient. The safety profile of BNT162b2 was characterized by short-term, mild-to-moderate pain at the injection site, fatigue, and headache. The incidence of serious adverse events was low and was similar in the vaccine and placebo groups. CONCLUSIONS: A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines. (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728.).", "type": "abstract", "offset": 59, "section": null, "annotations": [ { "id": "16", "name": "COVID-19", "text": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_COVID_19", "locations": [ { "span": 70, "offset": 71 } ], "identifier": "MESH:D000086382", "normalizedId": "D000086382" }, { "id": "17", "name": "COVID-19", "text": "coronavirus disease 2019", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_COVID_19", "locations": [ { "span": 24, "offset": 160 } ], "identifier": "MESH:D000086382", "normalizedId": "D000086382" }, { "id": "18", "name": "COVID-19", "text": "Covid-19", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_COVID_19", "locations": [ { "span": 8, "offset": 186 } ], "identifier": "MESH:D000086382", "normalizedId": "D000086382" }, { "id": "19", "name": "Lipids", "text": "lipid", "type": "Chemical", "biotype": "chemical", "database": "ncbi_mesh", "accession": "@CHEMICAL_Lipids", "locations": [ { "span": 5, "offset": 603 } ], "identifier": "MESH:D008055", "normalizedId": "D008055" }, { "id": "20", "name": "Nucleosides", "text": "nucleoside", "type": "Chemical", "biotype": "chemical", "database": "ncbi_mesh", "accession": "@CHEMICAL_Nucleosides", "locations": [ { "span": 10, "offset": 634 } ], "identifier": "MESH:D009705", "normalizedId": "D009705" }, { "id": "21", "name": "S", "text": "spike", "type": "Gene", "biotype": "gene", "database": "ncbi_gene", "accession": "@GENE_S", "locations": [ { "span": 5, "offset": 744 } ], "identifier": "43740568", "normalizedId": 43740568 }, { "id": "22", "name": "COVID-19", "text": "Covid-19", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_COVID_19", "locations": [ { "span": 8, "offset": 840 } ], "identifier": "MESH:D000086382", "normalizedId": "D000086382" }, { "id": "23", "name": "COVID-19", "text": "Covid-19", "type": "Disease", "biotype": "disease", "database": "ncbi_mesh", "accession": "@DISEASE_COVID_19", "locations": [ { "span": 8, "offset": 1030 } ], "identifier": "MESH:D000086382", "normalizedId": "D000086382" } ] } ], "annotationCount": 15 } ], "fullText": false, "provider": "pubmed" } ``` --- ### Citation Export NCBI literature citation exporter. A PMID that does not exist answers 200 with a zero-byte body, so an empty response is a verdict here, not a transport failure. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/citation-export` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | One PMID, or a PMC id when db is pmc | | `db` | enum(pubmed|pmc) | query | no | Source collection. Default pubmed | | `format` | enum(csl|ris|medline) | query | no | csl returns JSON, ris and medline return text. Default csl | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/citation-export?id=33301246&db=pubmed&format=csl" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/citation-export?id=33301246&db=pubmed&format=csl", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/citation-export?id=33301246&db=pubmed&format=csl", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "db": "pubmed", "id": "33301246", "format": "csl", "citation": { "id": "pmid:33301246", "DOI": "10.1056/NEJMoa2034577", "ISSN": "0028-4793", "PMID": "33301246", "page": "2603-2615", "type": "article-journal", "PMCID": "PMC7745181", "issue": "27", "title": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine", "author": [ { "given": "Fernando P", "family": "Polack" }, { "given": "Stephen J", "family": "Thomas" }, { "given": "Nicholas", "family": "Kitchin" }, { "given": "Judith", "family": "Absalon" }, { "given": "Alejandra", "family": "Gurtman" }, { "given": "Stephen", "family": "Lockhart" }, { "given": "John L", "family": "Perez" }, { "given": "Gonzalo", "family": "Pérez Marc" } ], "issued": { "date-parts": [ [ 2020, 12, 31 ] ] }, "source": "PubMed", "volume": "383", "accessed": { "date-parts": [ [ 2026, 8, 29 ] ] }, "epub-date": { "date-parts": [ [ 2020, 12, 10 ] ] }, "container-title": "The New England journal of medicine", "publisher-place": "United States", "container-title-short": "N Engl J Med" }, "provider": "pubmed" } ``` --- ### Citation Match ecitmatch answers plain text, one pipe-delimited line per citation, with the PMID appended after the caller's own key. A miss comes back as NOT_FOUND with a reason - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/citation-match` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `journal` | string | query | yes | Journal title or NLM abbreviation | | `year` | number | query | yes | Publication year | | `volume` | string | query | no | Journal volume | | `firstPage` | string | query | no | First page of the article | | `author` | string | query | no | First author, surname and initials | | `key` | string | query | no | Your own label for this citation, echoed back on the match | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/citation-match?journal=proc%20natl%20acad%20sci%20u%20s%20a&year=1991&volume=88&firstPage=3248&author=mann%20bj&key=ref1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/citation-match?journal=proc%20natl%20acad%20sci%20u%20s%20a&year=1991&volume=88&firstPage=3248&author=mann%20bj&key=ref1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/citation-match?journal=proc%20natl%20acad%20sci%20u%20s%20a&year=1991&volume=88&firstPage=3248&author=mann%20bj&key=ref1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "db": "pubmed", "key": "ref1", "pmid": "2014248", "year": 1991, "author": "mann bj", "volume": "88", "journal": "proc natl acad sci u s a", "provider": "pubmed", "firstPage": "3248" } ``` --- ### Citation Metrics iCite bibliometrics. It inlines cited_by[] and references[] — 841 KB for two PMIDs — so those arrays are opt-in rather than default. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/citation-metrics` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `pmids` | string | query | yes | Comma-separated PMIDs, max 200 per call | | `includeCitationLists` | enum(true|false) | query | no | Include the full citedBy, citedByClinical and references PMID lists. They are large — two PMIDs measured 841 KB. Default false | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/citation-metrics?pmids=33301246%2C32109013&includeCitationLists=false" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/citation-metrics?pmids=33301246%2C32109013&includeCitationLists=false", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/citation-metrics?pmids=33301246%2C32109013&includeCitationLists=false", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 2, "items": [ { "doi": "10.1056/NEJMoa2002032", "pmid": "32109013", "year": 2020, "human": 0.7777777777777778, "title": "Clinical Characteristics of Coronavirus Disease 2019 in China.", "animal": 0, "xCoord": -0.19245008972987523, "yCoord": 0.6666666666666667, "authors": [ { "name": "Guan, Wei-Jie", "lastName": "Guan", "firstName": "Wei-Jie" }, { "name": "Ni, Zheng-Yi", "lastName": "Ni", "firstName": "Zheng-Yi" }, { "name": "Hu, Yu", "lastName": "Hu", "firstName": "Yu" }, { "name": "Liang, Wen-Hua", "lastName": "Liang", "firstName": "Wen-Hua" }, { "name": "Ou, Chun-Quan", "lastName": "Ou", "firstName": "Chun-Quan" }, { "name": "He, Jian-Xing", "lastName": "He", "firstName": "Jian-Xing" }, { "name": "Liu, Lei", "lastName": "Liu", "firstName": "Lei" }, { "name": "Shan, Hong", "lastName": "Shan", "firstName": "Hong" } ], "journal": "N Engl J Med", "isClinical": false, "provisional": false, "citationCount": 18784, "nihPercentile": 100, "citationsPerYear": 3130.6666666666665, "fieldCitationRate": 5.71715931843237, "isResearchArticle": true, "molecularCellular": 0.2222222222222222, "relativeCitationRatio": 1178.3415335154866, "citedByClinicalArticle": true, "expectedCitationsPerYear": 2.656841482389724, "approximatePotentialToTranslate": 0.95 }, { "doi": "10.1056/NEJMoa2034577", "pmid": "33301246", "year": 2020, "human": 0.8571428571428571, "title": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.", "animal": 0, "xCoord": -0.12371791482634836, "yCoord": 0.7857142857142857, "authors": [ { "name": "Polack, Fernando P", "lastName": "Polack", "firstName": "Fernando P" }, { "name": "Thomas, Stephen J", "lastName": "Thomas", "firstName": "Stephen J" }, { "name": "Kitchin, Nicholas", "lastName": "Kitchin", "firstName": "Nicholas" }, { "name": "Absalon, Judith", "lastName": "Absalon", "firstName": "Judith" }, { "name": "Gurtman, Alejandra", "lastName": "Gurtman", "firstName": "Alejandra" }, { "name": "Lockhart, Stephen", "lastName": "Lockhart", "firstName": "Stephen" }, { "name": "Perez, John L", "lastName": "Perez", "firstName": "John L" }, { "name": "Marc, Gonzalo Pérez", "lastName": "Marc", "firstName": "Gonzalo Pérez" } ], "journal": "N Engl J Med", "isClinical": true, "provisional": false, "citationCount": 11647, "nihPercentile": 100, "citationsPerYear": 1941.1666666666667, "fieldCitationRate": 7.0924802409233445, "isResearchArticle": true, "molecularCellular": 0.14285714285714285, "relativeCitationRatio": 606.9075911393454, "citedByClinicalArticle": true, "expectedCitationsPerYear": 3.198455077852168, "approximatePotentialToTranslate": 0.95 } ], "provider": "pubmed", "includeCitationLists": false } ``` --- ### Database Info einfo per-database record: searchable fields, link names, build and record count. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/database-info` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `db` | enum(pubmed|protein|nuccore|ipg|nucleotide|structure|genome|grasp|annotinfo|assembly|bioproject|biosample|blastdbinfo|books|cdd|clinvar|dbvar|gene|gds|geoprofiles|medgen|mesh|nlmcatalog|omim|orgtrack|pmc|proteinclusters|pcassay|protfam|pccompound|pcsubstance|seqannot|snp|sra|taxonomy|biocollections|gtr) | query | yes | Entrez database to describe | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/database-info?db=pubmed" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/database-info?db=pubmed", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/database-info?db=pubmed", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "db": "pubmed", "build": "Build-2026.08.29.12.19", "links": [ { "dbTo": "assembly", "menu": "Assembly", "name": "pubmed_assembly", "description": "Assembly" }, { "dbTo": "bioproject", "menu": "Project Links", "name": "pubmed_bioproject", "description": "Related Projects" }, { "dbTo": "biosample", "menu": "BioSample Links", "name": "pubmed_biosample", "description": "BioSample links" }, { "dbTo": "books", "menu": "Cited in Books", "name": "pubmed_books_refs", "description": "PubMed links associated with Books" }, { "dbTo": "cdd", "menu": "Conserved Domain Links", "name": "pubmed_cdd", "description": "Link to related CDD entry" }, { "dbTo": "clinvar", "menu": "ClinVar", "name": "pubmed_clinvar", "description": "Clinical variations associated with publication" }, { "dbTo": "dbvar", "menu": "dbVar", "name": "pubmed_dbvar", "description": "Link from PubMed to dbVar" }, { "dbTo": "gap", "menu": "dbGaP Links", "name": "pubmed_gap", "description": "Related dbGaP record" } ], "fields": [ { "name": "ALL", "isDate": false, "fullName": "All Fields", "isHidden": false, "hierarchy": false, "termCount": null, "description": "All terms from all searchable fields", "isNumerical": false, "singleToken": false }, { "name": "UID", "isDate": false, "fullName": "UID", "isHidden": true, "hierarchy": false, "termCount": null, "description": "Unique number assigned to publication", "isNumerical": true, "singleToken": true }, { "name": "FILT", "isDate": false, "fullName": "Filter", "isHidden": false, "hierarchy": false, "termCount": null, "description": "Limits the records", "isNumerical": false, "singleToken": true }, { "name": "TITL", "isDate": false, "fullName": "Title", "isHidden": false, "hierarchy": false, "termCount": null, "description": "Words in title of publication", "isNumerical": false, "singleToken": false }, { "name": "MESH", "isDate": false, "fullName": "MeSH Terms", "isHidden": false, "hierarchy": true, "termCount": null, "description": "Medical Subject Headings assigned to publication", "isNumerical": false, "singleToken": true }, { "name": "MAJR", "isDate": false, "fullName": "MeSH Major Topic", "isHidden": false, "hierarchy": true, "termCount": null, "description": "MeSH terms of major importance to publication", "isNumerical": false, "singleToken": true }, { "name": "JOUR", "isDate": false, "fullName": "Journal", "isHidden": false, "hierarchy": false, "termCount": null, "description": "Journal abbreviation of publication", "isNumerical": false, "singleToken": true }, { "name": "AFFL", "isDate": false, "fullName": "Affiliation", "isHidden": false, "hierarchy": false, "termCount": null, "description": "Author's institutional affiliation and address", "isNumerical": false, "singleToken": false } ], "menuName": "PubMed", "provider": "pubmed", "linkCount": 47, "fieldCount": 48, "lastUpdate": "2026/08/29 12:19", "description": "PubMed bibliographic record", "recordCount": 41081950 } ``` --- ### Databases NCBI's 429 body echoes our egress address back inside an `api-key` field. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/databases` - **Cache TTL:** 300s **Parameters:** _No parameters._ **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/databases" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/databases", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/databases", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 37, "items": [ { "db": "pubmed" }, { "db": "protein" }, { "db": "nuccore" }, { "db": "ipg" }, { "db": "nucleotide" }, { "db": "structure" }, { "db": "genome" }, { "db": "grasp" } ], "provider": "pubmed" } ``` --- ### Entity Autocomplete PubTator3 concept suggestions. The `_id` it returns is the accession the search and relations endpoints take, so it is surfaced as `conceptId` rather than dropped. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/entity-autocomplete` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | yes | Partial entity name to complete | | `concept` | enum(gene|disease|chemical|species|variant|cellline) | query | no | Restrict suggestions to one entity type | | `limit` | number | query | no | Maximum suggestions to return. Default 10 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/entity-autocomplete?query=covid&concept=gene&limit=10" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/entity-autocomplete?query=covid&concept=gene&limit=10", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/entity-autocomplete?query=covid&concept=gene&limit=10", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 10, "items": [ { "name": "COVID-19", "biotype": "disease", "database": "ncbi_mesh", "conceptId": "@DISEASE_COVID_19", "matchedOn": "Matched on name COVID-19", "databaseId": "D000086382", "description": null }, { "name": "Post-Acute COVID-19 Syndrome", "biotype": "disease", "database": "ncbi_mesh", "conceptId": "@DISEASE_Post_Acute_COVID_19_Syndrome", "matchedOn": "Multiple matches", "databaseId": "D000094024", "description": null }, { "name": "pediatric multisystem inflammatory disease COVID-19 related", "biotype": "disease", "database": "ncbi_mesh", "conceptId": "@DISEASE_pediatric_multisystem_inflammatory_disease_COVID_19_related", "matchedOn": "Multiple matches", "databaseId": "C000705967", "description": null }, { "name": "adult multisystem inflammatory disease COVID-19 related", "biotype": "disease", "database": "ncbi_mesh", "conceptId": "@DISEASE_adult_multisystem_inflammatory_disease_COVID_19_related", "matchedOn": "Matched on synonyms COVID-19-associated multisystem inflammatory syndrome in adults", "databaseId": "C000718087", "description": null }, { "name": "COVID-19 stress syndrome", "biotype": "disease", "database": "ncbi_mesh", "conceptId": "@DISEASE_COVID_19_stress_syndrome", "matchedOn": "Matched on name COVID-19 stress syndrome", "databaseId": "C000711430", "description": null }, { "name": "COVID-19 post-intensive care syndrome", "biotype": "disease", "database": "ncbi_mesh", "conceptId": "@DISEASE_COVID_19_post_intensive_care_syndrome", "matchedOn": "Matched on name COVID-19 post-intensive care syndrome", "databaseId": "C000711429", "description": null }, { "name": "COVID-19 reinfection", "biotype": "disease", "database": "ncbi_mesh", "conceptId": "@DISEASE_COVID_19_reinfection", "matchedOn": "Matched on name COVID-19 reinfection", "databaseId": "C000722979", "description": null }, { "name": "COVID-19 breakthrough infections", "biotype": "disease", "database": "ncbi_mesh", "conceptId": "@DISEASE_COVID_19_breakthrough_infections", "matchedOn": "Matched on name COVID-19 breakthrough infections", "databaseId": "C000718127", "description": null } ], "query": "covid", "provider": "pubmed" } ``` --- ### Entity Relations PubTator3 curated relations. An unfiltered e1 can answer 158 KB, so the result is capped here and the upstream length is reported alongside it. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/entity-relations` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `e1` | string | query | yes | First concept id, from entity-autocomplete | | `type` | enum(ANY|treat|cause|cotreat|compare|interact|inhibit|stimulate|drug_interact|associate|prevent|positive_correlate|negative_correlate) | query | no | Relation type. Default ANY | | `e2` | string | query | no | Second concept id, to pin both ends of the relation | | `limit` | number | query | no | Maximum relations to return. Default 100 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/entity-relations?e1=%40CHEMICAL_Doxorubicin&type=treat&e2=%40DISEASE_Neoplasms&limit=100" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/entity-relations?e1=%40CHEMICAL_Doxorubicin&type=treat&e2=%40DISEASE_Neoplasms&limit=100", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/entity-relations?e1=%40CHEMICAL_Doxorubicin&type=treat&e2=%40DISEASE_Neoplasms&limit=100", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "e1": "@CHEMICAL_Doxorubicin", "e2": "@DISEASE_Neoplasms", "type": "treat", "count": 1, "items": [ { "type": "treat", "source": "@CHEMICAL_Doxorubicin", "target": "@DISEASE_Neoplasms", "publications": 14872 } ], "limit": 3, "total": 1, "provider": "pubmed" } ``` --- ### Fetch Records efetch: full records. The payload is XML, MEDLINE text or FASTA depending on rettype — never JSON — so it is handed back verbatim rather than half-parsed. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/fetch-records` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Comma-separated UIDs, max 200 per call | | `db` | enum(pubmed|protein|nuccore|ipg|nucleotide|structure|genome|grasp|annotinfo|assembly|bioproject|biosample|blastdbinfo|books|cdd|clinvar|dbvar|gene|gds|geoprofiles|medgen|mesh|nlmcatalog|omim|orgtrack|pmc|proteinclusters|pcassay|protfam|pccompound|pcsubstance|seqannot|snp|sra|taxonomy|biocollections|gtr) | query | no | Entrez database. Default pubmed | | `rettype` | enum(abstract|medline|uilist|fasta|gb|gp|docsum|full|native|xml) | query | no | Record type. Valid values depend on the database | | `retmode` | enum(xml|text|asn.1) | query | no | Payload encoding. Default xml | | `retstart` | number | query | no | Offset into the record set when fetching from history | | `retmax` | number | query | no | Maximum records to return. Upstream caps at 10000 | | `strand` | enum(1|2) | query | no | Sequence strand, 1 plus and 2 minus. Sequence databases only | | `seqStart` | number | query | no | First sequence base to retrieve. Sequence databases only | | `seqStop` | number | query | no | Last sequence base to retrieve. Sequence databases only | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/fetch-records?id=33301246%2C32109013&db=pubmed&rettype=medline&retmode=xml&retstart=0&retmax=100&strand=1&seqStart=1&seqStop=200" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/fetch-records?id=33301246%2C32109013&db=pubmed&rettype=medline&retmode=xml&retstart=0&retmax=100&strand=1&seqStart=1&seqStop=200", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/fetch-records?id=33301246%2C32109013&db=pubmed&rettype=medline&retmode=xml&retstart=0&retmax=100&strand=1&seqStart=1&seqStop=200", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "db": "pubmed", "ids": [ "33301246", "32109013" ], "type": "medline", "bytes": 206336, "format": "xml", "content": "\n\n\n333012462021011220260518
1533-4406383272020Dec31The New England journal of medicineN Engl J MedSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.260326152603-2615NEJMoa203457710.1056/NEJMoa2034577Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently.In an ongoing multinational, placebo-controlled, observer-blinded, pivotal efficacy trial, we randomly assigned persons 16 years of age or older in a 1:1 ratio to receive two doses, 21 days apart, of either placebo or the BNT162b2 vaccine candidate (30 μg per dose). BNT162b2 is a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. The primary end points were efficacy of the vaccine against laboratory-confirmed Covid-19 and safety.A total of 43,548 participants underwent randomization, of whom 43,448 received injections: 21,720 with BNT162b2 and 21,728 with placebo. There were 8 cases of Covid-19 with onset at least 7 days after the second dose among participants assigned to receive BNT162b2 and 162 cases among those assigned to placebo; BNT162b2 was 95% effective in preventing Covid-19 (95% credible interval, 90.3 to 97.6). Similar vaccine efficacy (generally 90 to 100%) was observed across subgroups defined by age, sex, race, ethnicity, baseline body-mass index, and the presence of coexisting conditions. Among 10 cases of severe Covid-19 with onset after the first dose, 9 occurred in placebo recipients and 1 in a BNT162b2 recipient. The safety profile of BNT162b2 was characterized by short-term, mild-to-moderate pain at the injection site, fatigue, and headache. The incidence of serious adverse events was low and was similar in the vaccine and placebo groups.A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines. (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728.).Copyright © 2020 Massachusetts Medical Society.PolackFernando PFPFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).ThomasStephen JSJFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).KitchinNicholasNFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).AbsalonJudithJFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).GurtmanAlejandraAFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).LockhartStephenSFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).PerezJohn LJLFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).Pérez MarcGonzaloGFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).MoreiraEdson DEDFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).ZerbiniCristianoCFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).BaileyRuthRFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).SwansonKena AKAFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).RoychoudhurySatrajitSFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).KouryKennethKFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).LiPingPFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).KalinaWarren VWVFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).CooperDavidDFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).FrenckRobert WRWJrFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).HammittLaura LLLFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).TüreciÖzlemÖFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).NellHayleneHFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).SchaeferAxelAFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).ÜnalSerhatSFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).TresnanDina BDBFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).MatherSusanSFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).DormitzerPhilip RPRFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).ŞahinUğurUFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).JansenKathrin UKUFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).GruberWilliam CWCFrom Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) - both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children's Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) - both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); Hacettepe University, Ankara, Turkey (S.Ü.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).C4591001 Clinical Trial GroupengClinicalTrials.govNCT04368728Clinical Trial, Phase IIClinical Trial, Phase IIIJournal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov't20201210
United StatesN Engl J Med02555620028-47930BNT162 Vaccine0COVID-19 Vaccines0Vaccines, Synthetic0mRNA VaccinesIMN Engl J Med. 2020 Dec 31;383(27):2677-2678. doi: 10.1056/NEJMe2034717.33301245Nature. 2020 Dec;588(7838):377-378. doi: 10.1038/d41586-020-03542-4.33311629Semergen. 2021 Jan-Feb;47(1):1-3. doi: 10.1016/j.semerg.2020.12.005.33478841Panminerva Med. 2022 Mar;64(1):131-132. doi: 10.23736/S0031-0808.21.04286-5.33480519Ann Intern Med. 2021 Feb;174(2):JC15. doi: 10.7326/ACPJ202102160-015.33524290MMW Fortschr Med. 2021 Feb;163(2):24-25. doi: 10.1007/s15006-021-9577-4.33527275N Engl J Med. 2021 Apr 22;384(16):1576-1577. doi: 10.1056/NEJMc2036242.33596348N Engl J Med. 2021 Apr 22;384(16):1577. doi: 10.1056/NEJMc2036242.33596349N Engl J Med. 2021 Apr 22;384(16):1577-1578. doi: 10.1056/NEJMc2036242.33596350Virol Sin. 2021 Oct;36(5):1097-1103. doi: 10.1007/s12250-021-00408-5.34061319N Engl J Med. 2022 Mar 24;386(12):1176-1179. doi: 10.1056/NEJMe2202547.35196425AdolescentAdultAgedBNT162 VaccineCOVID-19immunologyprevention & controlCOVID-19 Vaccinesadministration & dosageadverse effectsimmunologyFatigueetiologyFemaleHeadacheetiologyHumansImmunization, SecondaryMaleMiddle AgedSARS-CoV-2geneticsSingle-Blind MethodTreatment OutcomeVaccines, SyntheticYoung AdultmRNA VaccinesAbergJudithJAddoMarylynMAkhanSılaSAlbertsonTimothyTAl-IbrahimMohamedMAltınSedatSAndersonCoreyCAndrewsCharlesCAroraSamirSBalikIsmailIBarnettElizabethEBauerGeorgeGBaumann-NossSybilleSBerheMezgebeMBradleyPaulPBrandonDonaldDBruneDanielDBurgherAbramAButcherBainBButukDavidDCannonKevinKCardonaJoseJCavelliRachaelRChalhoubFadiFChristensenShaneSChristensenTomTChuLaurenceLCoxStevenSCrookGretchenGDavisMatthewMDavitRajeshRDenhamDouglasDDeverMichaelMDonskeyCurtisCDoustMatthewMDunnMichaelMEarlJohnJEderFrankFEichAndreasAEnszDavidDEssinkBrandonBFalconeRobertRFalseyAnnAFarringtonCecilCFinbergRobertRFinnDanielDFitz-PatrickDavidDFortmannStephenSFoucheLeonLFragosoVeronicaVFrenckRobertRFriedDavidDFullerGregoryGFussellSuzanneSGarcia-DiazJuliaJGentryAndrewAGloverRichardRGreenbaumCarlaCGrubbStephenSHammittLauraLHarperCharlesCHarperWayneWHartmanAaronAHellerRobertRHendrixErnestEHerringtonDarrellDJenningsTimothyTKarabayOğuzOKasterStevenSKatzmanStevenSKingsleyJeffreyJKleinNicolaNKleinTracyTKochMarkMKöksalIftaharIKorenMichaelMKutnerMarkMLeeMarcusMLeibowitzMarkMLevinMichaelMLibsterRominaRLillestolMichaelMLucastiChristopherCLuttermannMatthiasMManningMary Beth EarlMBEMartinMartinMMathernePaulPMcMurrayJamesJMertAliAMiddletonRandleRMithaEssackEMorawskiEmilyEMoreiraEdsonEMulliganMarkMMurrayAlexanderAMussajiMurtazaMMusungaieDanyDNellHayleneHOdekirkLarryLOgbuaguOnyemaOPaolinoKristopherKPatelSuchetSPetersonJamesJPickrellPaulPPolackFernandoFPoretzDonaldDRaadGeorgeGRandallWilliamWRankinBruceBReynoldsStevenSRiesenbergRobertRRodriguezHectorHRosenJeffreyJRubinoJohnJRuppRichardRSaigerSalmaSSalataRobertRSalehJamshidJSchaeferAxelASchearMartinMSchultzArminASchwartzHowardHSegallNathanNSegerWilliamWSendersShellySSharpStephanSShoffnerSylviaSSimsek YavuzSerapSSlighTeresaTSmithWilliamWStaceyHelenHStephensMichaelMStuddardHarryHTabakFehmiFTalaatKawsarKThomasStephenSTownerWilliamWTranVanVÜnalSerhatSUsdanLisaLVanchiereJohnJVaranoSusannSWadsworthEdward Tyler LETLWalshWalshWWalterEmmanuelEWappnerDiegoDWhilesRickRWilliamsHayesHWilsonJonathanJWinklePeterPWinokurPatriciaPWolfThomasTYozviakJosephJZerbiniCristianoC
202012116020211136020201210122020201217ppublish33301246PMC774518110.1056/NEJMoa2034577Johns Hopkins University Coronavirus Resource Center. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. 2020 (https://coronavirus.jhu.edu/map.html).World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 — 11 March 2020 (https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020).Centers for Disease Control and Prevention. COVID-19 information page (https://www.cdc.gov/coronavirus/2019-ncov/index.html).Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. DOI: 10.1056/NEJMoa2027906.10.1056/NEJMoa2027906PMC758369733053279Pardi N, Tuyishime S, Muramatsu H, et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J Control Release 2015;217:345-351.PMC462404526264835Karikó K, Muramatsu H, Welsh FA, et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther 2008;16:1833-1840.PMC277545118797453Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020;367:1260-1263.PMC716463732075877Sahin U, Muik A, Vogler I, et al. \nBNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans. December 11, 2020 (https://www.medrxiv.org/content/10.1101/2020.12.09.20245175v1). preprint.Food and Drug Administration. Guidance for industry: emergency use authorization for vaccines to prevent COVID-19. October 2020 (https://www.fda.gov/media/142749/download).Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 2020;172:577-582.PMC708117232150748Haynes BF, Corey L, Fernandes P, et al. Prospects for a safe COVID-19 vaccine. Sci Transl Med 2020;12(568):eabe0948-eabe0948.33077678Cowling BJ, Perera RAPM, Valkenburg SA, et al. Comparative immunogenicity of several enhanced influenza vaccine options for older adults: a randomized, controlled trial. Clin Infect Dis 2020;71:1704-1714.PMC728965831828291Food and Drug Administration. Shringrix (zoster vaccine recombinant, adjuvanted) product information. 2019 (https://www.fda.gov/vaccines-blood-biologics/vaccines/shingrix).
321090132020050520260518
1533-4406382182020Apr30The New England journal of medicineN Engl J MedClinical Characteristics of Coronavirus Disease 2019 in China.170817201708-1720NEJMoa200203210.1056/NEJMoa2002032Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients.We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death.The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission.During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.).Copyright © 2020 Massachusetts Medical Society.GuanWei-JieWJ0000-0001-5463-391XFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.NiZheng-YiZYFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.HuYuYFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.LiangWen-HuaWHFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.OuChun-QuanCQFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.HeJian-XingJXFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.LiuLeiLFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.ShanHongHFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.LeiChun-LiangCLFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.HuiDavid S CDSCFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.DuBinBFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.LiLan-JuanLJFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.ZengGuangGFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.YuenKwok-YungKYFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.ChenRu-ChongRCFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.TangChun-LiCLFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.WangTaoTFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.ChenPing-YanPYFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.XiangJieJFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.LiShi-YueSYFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.WangJin-LinJLFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.LiangZi-JingZJFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.PengYi-XiangYXFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.WeiLiLFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.LiuYongYFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.HuYa-HuaYHFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.PengPengPFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.WangJian-MingJMFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.LiuJi-YangJYFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.ChenZhongZFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.LiGangGFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.ZhengZhi-JianZJFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.QiuShao-QinSQFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.LuoJieJFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.YeChang-JiangCJFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.ZhuShao-YongSYFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.ZhongNan-ShanNSFrom the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.China Medical Treatment Expert Group for Covid-19engJournal ArticleResearch Support, Non-U.S. Gov't20200228
United StatesN Engl J Med02555620028-4793IMN Engl J Med. 2020 May 7;382(19):1859. doi: 10.1056/NEJMc2005203.32220202N Engl J Med. 2020 May 7;382(19):1860. doi: 10.1056/NEJMc2005203.32220203N Engl J Med. 2020 May 7;382(19):1860. doi: 10.1056/NEJMc2005203.32220204N Engl J Med. 2020 May 7;382(19):1860-1861. doi: 10.1056/NEJMc2005203.32220205Travel Med Infect Dis. 2020 May - Jun;35:101620. doi: 10.1016/j.tmaid.2020.101620.32222421Diabetes Res Clin Pract. 2020 Apr;162:108132. doi: 10.1016/j.diabres.2020.108132.32234504Int J Cardiol. 2020 Jul 1;310:167-168. doi: 10.1016/j.ijcard.2020.03.074.32276773Singapore Med J. 2020 Sep;61(9):460-462. doi: 10.11622/smedj.2020051.32279480Br J Haematol. 2020 May;189(4):640-642. doi: 10.1111/bjh.16699.32298461Spinal Cord. 2020 Jun;58(6):724-725. doi: 10.1038/s41393-020-0472-0.32317765Urology. 2020 Aug;142:42. doi: 10.1016/j.urology.2020.04.069.32343996Eur Respir J. 2020 Aug 13;56(2):2001692. doi: 10.1183/13993003.01692-2020.32430410Eur Respir J. 2020 Jul 16;56(1):2001234. doi: 10.1183/13993003.01234-2020.32430433Med J Malaysia. 2020 May;75(3):309-310.32467553Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E197-E202. doi: 10.1152/ajpendo.00255.2020.32501731Rehabilitacion (Madr). 2020 Oct - Dec;54(4):228-230. doi: 10.1016/j.rh.2020.06.002.32723577Hepatology. 2020 Nov;72(5):1509-1513. doi: 10.1002/hep.31522.32794597S Afr Med J. 2020 Jun 02;110(7):572-573. doi: 10.7196/SAMJ.2020.v110i7.14917.32880323Signal Transduct Target Ther. 2020 Oct 3;5(1):217. doi: 10.1038/s41392-020-00333-1.33011738Mayo Clin Proc. 2020 Oct;95(10):2062-2064. doi: 10.1016/j.mayocp.2020.08.012.33012336Pulmonology. 2021 Mar-Apr;27(2):91-93. doi: 10.1016/j.pulmoe.2020.11.002.33303350Perm J. 2020 Dec;25:1. doi: 10.7812/TPP/20.140.33635771AdolescentAdultAgedBetacoronavirusCOVID-19ChildChinaepidemiologyCoronavirus InfectionscomplicationsdiagnosisepidemiologytherapyDisease OutbreaksFemaleFeveretiologyHumansMaleMiddle AgedPandemicsPatient AcuityPneumonia, ViralcomplicationsdiagnosisepidemiologytherapySARS-CoV-2Young AdultZhongNan-ShanNSLiLan-JuanLJZengGuangGGaoGeorge FuGFYuenKwok-YungKY
202022960202056602020229602020324ppublish32109013PMC709281910.1056/NEJMoa2002032Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.PMC715929931986264Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-574.PMC715908632007145Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-733.PMC709280331978945Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514-523.PMC715928631986261Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. DOI: 10.1056/NEJMc2001272.10.1056/NEJMc2001272PMC712142831991079Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. DOI: 10.1056/NEJMc2001468.10.1056/NEJMc2001468PMC712097032003551Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020. January 31 (Epub ahead of print).PMC715927132014114Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. DOI: 10.1056/NEJMoa2001316.10.1056/NEJMoa2001316PMC712148431995857World Health Organization. Coronavirus disease (COVID-19) outbreak (https://www.who.int).Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. DOI: 10.1056/NEJMoa2001191.10.1056/NEJMoa2001191PMC709280232004427National Health Commission of the People’s Republic of China home page (http://www.nhc.gov.cn).PMC839294634594648Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-513.PMC713507632007143Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. February 7 (Epub ahead of print).PMC704288132031570World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. January 28, 2020. (https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf).Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America. Am J Respir Crit Care Med 2019;200(7):e45-e67.PMC681243731573350Gao H-N, Lu H-Z, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013;368:2277-2285.23697469World Health Organization. Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance).Lei H, Li Y, Xiao S, et al. Routes of transmission of influenza A H1N1, SARS CoV, and norovirus in air cabin: comparative analyses. Indoor Air 2018;28:394-403.PMC716581829244221Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect 2016;92:235-250.PMC711492126597631Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet 2015;386:995-1007.PMC472157826049252Minodier L, Charrel RN, Ceccaldi PE, et al. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? Virol J 2015;12:215-215.PMC467682026651485Leung WK, To KF, Chan PK, et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 2003;125:1011-1017.PMC712698214517783Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013;369:407-416.PMC402910523782161World Health Organization. Coronavirus disease (COVID-2019) situation reports (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/).
", "provider": "pubmed" } ``` --- ### Gene Report NCBI Datasets v2 gene record. A symbol that does not exist answers 200 with an empty object, so an empty body is the not-found signal. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/gene-report/:symbol/:taxon` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `symbol` | string | path | yes | Official gene symbol | | `taxon` | string | path | no | NCBI taxonomy id or organism name. Default 9606, human | | `includeGeneOntology` | enum(true|false) | query | no | Include the full GO term set, which dominates the payload. Default false | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/gene-report/:symbol/:taxon?includeGeneOntology=false" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/gene-report/:symbol/:taxon?includeGeneOntology=false", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/gene-report/:symbol/:taxon?includeGeneOntology=false", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "type": "PROTEIN_CODING", "query": "TP53", "taxId": "9606", "taxon": "9606", "geneId": "7157", "symbol": "TP53", "omimIds": [ "191170" ], "summary": [ { "source": null, "description": "This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]" } ], "taxName": "Homo sapiens", "provider": "pubmed", "synonyms": [ "P53", "BCC7", "LFS1", "BMFS5", "TRP53" ], "commonName": "human", "geneGroups": [ { "id": "7157", "method": "NCBI Ortholog" } ], "matchCount": 1, "annotations": [ { "releasedOn": "2025-08-01", "assemblyName": "GRCh38.p14", "annotationName": "GCF_000001405.40-RS_2025_08", "genomicLocations": [ { "sequenceName": "17", "accessionVersion": "NC_000017.11" } ], "assemblyAccession": "GCF_000001405.40" }, { "releasedOn": "2025-08-01", "assemblyName": "T2T-CHM13v2.0", "annotationName": "GCF_009914755.1-RS_2025_08", "genomicLocations": [ { "sequenceName": "17", "accessionVersion": "NC_060941.1" } ], "assemblyAccession": "GCF_009914755.1" } ], "chromosomes": [ "17" ], "description": "tumor protein p53", "orientation": "minus", "mapLocations": [ { "type": "Cytogenetic", "value": "17p13.1" } ], "proteinCount": 25, "alternateNames": [ "antigen NY-CO-13", "cellular tumor antigen p53", "mutant tumor protein 53", "phosphoprotein p53", "transformation-related protein 53", "tumor protein 53", "tumor supressor p53" ], "ensemblGeneIds": [ "ENSG00000141510" ], "nomenclatureId": "HGNC:11998", "transcriptCount": 26, "referenceStandards": [ { "type": "REFSEQ_GENE", "range": [ { "end": "24149", "begin": "5001", "orientation": "plus" } ], "accessionVersion": "NG_017013.2" } ], "swissProtAccessions": [ "P04637" ], "transcriptTypeCounts": [ { "type": "PROTEIN_CODING", "count": 25 }, { "type": "NON_CODING", "count": 1 } ], "nomenclatureAuthority": "HGNC" } ``` --- ### Id Convert PMC ID converter. It rejects a mixed batch with a 400, so the id type is declared and every value checked against it before the call. Its `email is missing` warning - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/id-convert` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `ids` | string | query | yes | Comma-separated ids, all of the same type, max 200 | | `idtype` | enum(pmid|pmcid|doi|mid) | query | yes | Type of every id in the batch — mixed types are rejected | | `versions` | enum(true|false) | query | no | Include every PMC version of the record. Default false | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/id-convert?ids=33301246%2C32109013&idtype=pmid&versions=false" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/id-convert?ids=33301246%2C32109013&idtype=pmid&versions=false", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/id-convert?ids=33301246%2C32109013&idtype=pmid&versions=false", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 2, "items": [ { "doi": "10.1056/NEJMoa2034577", "mid": null, "pmid": "33301246", "pmcid": "PMC7745181", "reason": null, "status": null, "requestedId": "33301246" }, { "doi": "10.1056/NEJMoa2002032", "mid": null, "pmid": "32109013", "pmcid": "PMC7092819", "reason": null, "status": null, "requestedId": "32109013" } ], "idType": "pmid", "provider": "pubmed" } ``` --- ### Link Check elink acheck/ncheck/lcheck: which link types exist for a UID, without pulling the links themselves. acheck answers with a per-id catalogue, ncheck and lcheck - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/link-check` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Comma-separated source UIDs, max 100 per call | | `dbfrom` | enum(pubmed|protein|nuccore|ipg|nucleotide|structure|genome|grasp|annotinfo|assembly|bioproject|biosample|blastdbinfo|books|cdd|clinvar|dbvar|gene|gds|geoprofiles|medgen|mesh|nlmcatalog|omim|orgtrack|pmc|proteinclusters|pcassay|protfam|pccompound|pcsubstance|seqannot|snp|sra|taxonomy|biocollections|gtr) | query | no | Source database. Default pubmed | | `cmd` | enum(acheck|ncheck|lcheck) | query | no | acheck lists every link type, ncheck reports whether related records exist, lcheck whether external LinkOut providers exist. Default acheck | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/link-check?id=33301246%2C32109013&dbfrom=pubmed&cmd=acheck" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/link-check?id=33301246%2C32109013&dbfrom=pubmed&cmd=acheck", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/link-check?id=33301246%2C32109013&dbfrom=pubmed&cmd=acheck", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "cmd": "acheck", "ids": [ "33301246", "32109013" ], "count": 2, "items": [ { "id": "33301246", "count": 13, "links": [ { "dbTo": "books", "htmlTag": "Cited in Books", "menuTag": "Cited in Books", "linkName": "pubmed_books_refs", "priority": 185 }, { "dbTo": "medgen", "htmlTag": "MedGen", "menuTag": "MedGen", "linkName": "pubmed_medgen", "priority": 128 }, { "dbTo": "pmc", "htmlTag": null, "menuTag": "PMC Links", "linkName": "pubmed_pmc", "priority": 175 }, { "dbTo": "pmc", "htmlTag": "Free in PMC", "menuTag": null, "linkName": "pubmed_pmc_local", "priority": 175 }, { "dbTo": "pmc", "htmlTag": "Cited in PMC", "menuTag": "Cited in PMC", "linkName": "pubmed_pmc_refs", "priority": 180 }, { "dbTo": "pubmed", "htmlTag": "Similar articles", "menuTag": "Similar articles", "linkName": "pubmed_pubmed", "priority": 1 }, { "dbTo": "pubmed", "htmlTag": "Cited In", "menuTag": "Cited In", "linkName": "pubmed_pubmed_citedin", "priority": 128 }, { "dbTo": "pubmed", "htmlTag": "Combined set of related Articles and Reviews", "menuTag": "Combined set of related Articles and Reviews", "linkName": "pubmed_pubmed_combined", "priority": 1 } ] }, { "id": "32109013", "count": 12, "links": [ { "dbTo": "books", "htmlTag": "Cited in Books", "menuTag": "Cited in Books", "linkName": "pubmed_books_refs", "priority": 185 }, { "dbTo": "pmc", "htmlTag": null, "menuTag": "PMC Links", "linkName": "pubmed_pmc", "priority": 175 }, { "dbTo": "pmc", "htmlTag": "Free in PMC", "menuTag": null, "linkName": "pubmed_pmc_local", "priority": 175 }, { "dbTo": "pmc", "htmlTag": "Cited in PMC", "menuTag": "Cited in PMC", "linkName": "pubmed_pmc_refs", "priority": 180 }, { "dbTo": "pubmed", "htmlTag": "Similar articles", "menuTag": "Similar articles", "linkName": "pubmed_pubmed", "priority": 1 }, { "dbTo": "pubmed", "htmlTag": "Cited In", "menuTag": "Cited In", "linkName": "pubmed_pubmed_citedin", "priority": 128 }, { "dbTo": "pubmed", "htmlTag": "Combined set of related Articles and Reviews", "menuTag": "Combined set of related Articles and Reviews", "linkName": "pubmed_pubmed_combined", "priority": 1 }, { "dbTo": "pubmed", "htmlTag": "Five most related Articles", "menuTag": "Five most related Articles", "linkName": "pubmed_pubmed_five", "priority": 1 } ] } ], "dbFrom": "pubmed", "provider": "pubmed" } ``` --- ### Link Provider elink llinks/prlinks: LinkOut provider URLs. Icon paths come back host-relative, so they are resolved against NCBI's own host to stay usable. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/link-provider` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Comma-separated source UIDs, max 100 per call | | `dbfrom` | enum(pubmed|protein|nuccore|ipg|nucleotide|structure|genome|grasp|annotinfo|assembly|bioproject|biosample|blastdbinfo|books|cdd|clinvar|dbvar|gene|gds|geoprofiles|medgen|mesh|nlmcatalog|omim|orgtrack|pmc|proteinclusters|pcassay|protfam|pccompound|pcsubstance|seqannot|snp|sra|taxonomy|biocollections|gtr) | query | no | Source database. Default pubmed | | `cmd` | enum(llinks|prlinks) | query | no | llinks returns every LinkOut provider, prlinks only the publisher full-text links. Default llinks | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/link-provider?id=33301246&dbfrom=pubmed&cmd=llinks" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/link-provider?id=33301246&dbfrom=pubmed&cmd=llinks", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/link-provider?id=33301246&dbfrom=pubmed&cmd=llinks", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "cmd": "llinks", "ids": [ "33301246" ], "count": 1, "items": [ { "id": "33301246", "count": 9, "links": [ { "url": "https://www.nejm.org/doi/10.1056/NEJMoa2034577?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub 0pubmed", "iconUrl": "https://www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.nejm.org-pb-assets-images-editorial-icons-nejm-full-text.gif", "linkName": null, "attributes": [ "subscription/membership/fee required" ], "categories": [ "Full Text Sources" ], "providerId": "4487", "providerAbbr": "ATYPON", "providerName": "Atypon" }, { "url": "https://clinicaltrials.gov/search?term=AREA%5BReferencePMID%5D33301246", "iconUrl": null, "linkName": null, "attributes": [ "free resource" ], "categories": [ "Medical" ], "providerId": "3654", "providerAbbr": "CTgov", "providerName": "ClinicalTrials.gov" }, { "url": "https://medlineplus.gov/covid19vaccines.html", "iconUrl": "https://www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--medlineplus.gov-images-linkout_sm.gif", "linkName": "COVID-19 Vaccines", "attributes": [ "free resource" ], "categories": [ "Medical" ], "providerId": "3162", "providerAbbr": "MEDPLUS", "providerName": "MedlinePlus Health Information" }, { "url": "https://www.ovid.com/33301246.pmid", "iconUrl": "https://www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--tools.ovid.com-images-ovidlogo.jpg", "linkName": null, "attributes": [ "subscription/membership/fee required" ], "categories": [ "Full Text Sources" ], "providerId": "3682", "providerAbbr": "Ovid", "providerName": "Ovid Technologies, Inc." }, { "url": "https://pmc.ncbi.nlm.nih.gov/articles/pmid/33301246/", "iconUrl": "https://www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--cdn.ncbi.nlm.nih.gov-pmc-cms-images-pmc_linkout.png", "linkName": null, "attributes": [ "free resource" ], "categories": [ "Full Text Sources" ], "providerId": "3494", "providerAbbr": "PMC", "providerName": "PubMed Central" }, { "url": "https://europepmc.org/abstract/MED/33301246", "iconUrl": "https://www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--www.ncbi.nlm.nih.gov-corehtml-pmc-pmcgifs-EPMC.gif", "linkName": null, "attributes": [ "free resource" ], "categories": [ "Full Text Sources" ], "providerId": "6082", "providerAbbr": "UKPMC", "providerName": "Europe PMC" }, { "url": "https://assays.cancer.gov/CPTAC-438", "iconUrl": null, "linkName": null, "attributes": [ "free resource" ], "categories": [ "Miscellaneous" ], "providerId": "8855", "providerAbbr": "assaysnci", "providerName": "NCI CPTAC Assay Portal" }, { "url": "https://facultyopinions.com/pubmed/33301246", "iconUrl": "https://www.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--s3.eu-west-1.amazonaws.com-cdn.science-now.com-images-FObadge128x28.png", "linkName": "See the articles recommended by the Faculty of more than 8,000 leading experts in Biology and Medicine.", "attributes": [ "subscription/membership/fee required" ], "categories": [ "Other Literature Sources" ], "providerId": "3533", "providerAbbr": "fopinions", "providerName": "H1 Connect - Access expert opinions and insights on biomedical research." } ] } ], "dbFrom": "pubmed", "provider": "pubmed" } ``` --- ### Link elink neighbour modes. cmd=neighbor_score returned 310 KB for a single PMID, so maxLinks caps each link array before the payload rather than after it. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/link` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Comma-separated source UIDs, max 100 per call | | `dbfrom` | enum(pubmed|protein|nuccore|ipg|nucleotide|structure|genome|grasp|annotinfo|assembly|bioproject|biosample|blastdbinfo|books|cdd|clinvar|dbvar|gene|gds|geoprofiles|medgen|mesh|nlmcatalog|omim|orgtrack|pmc|proteinclusters|pcassay|protfam|pccompound|pcsubstance|seqannot|snp|sra|taxonomy|biocollections|gtr) | query | no | Source database. Default pubmed | | `db` | enum(pubmed|protein|nuccore|ipg|nucleotide|structure|genome|grasp|annotinfo|assembly|bioproject|biosample|blastdbinfo|books|cdd|clinvar|dbvar|gene|gds|geoprofiles|medgen|mesh|nlmcatalog|omim|orgtrack|pmc|proteinclusters|pcassay|protfam|pccompound|pcsubstance|seqannot|snp|sra|taxonomy|biocollections|gtr) | query | no | Target database. Defaults to dbfrom | | `cmd` | enum(neighbor|neighbor_score|neighbor_history) | query | no | Link mode. neighbor_score adds a relatedness score. Default neighbor | | `linkname` | string | query | no | Restrict to one named link set | | `maxLinks` | number | query | no | Cap on links kept per link set. Default 200 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/link?id=33301246&dbfrom=pubmed&db=pmc&cmd=neighbor&linkname=pubmed_pmc&maxLinks=200" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/link?id=33301246&dbfrom=pubmed&db=pmc&cmd=neighbor&linkname=pubmed_pmc&maxLinks=200", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/link?id=33301246&dbfrom=pubmed&db=pmc&cmd=neighbor&linkname=pubmed_pmc&maxLinks=200", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "db": "pmc", "cmd": "neighbor", "ids": [ "33301246" ], "count": 1, "items": [ { "dbTo": "pmc", "count": 1, "links": [ { "id": "7745181" } ], "dbFrom": "pubmed", "linkName": "pubmed_pmc", "sourceIds": [ "33301246" ], "truncated": false } ], "dbFrom": "pubmed", "webEnv": null, "maxLinks": 3, "provider": "pubmed" } ``` --- ### Post epost stores a UID set on the history server and answers XML. The webEnv and queryKey it returns are what search, summary and fetch chain against for sets - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/post` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Comma-separated UIDs to store, max 5000 per call | | `db` | enum(pubmed|protein|nuccore|ipg|nucleotide|structure|genome|grasp|annotinfo|assembly|bioproject|biosample|blastdbinfo|books|cdd|clinvar|dbvar|gene|gds|geoprofiles|medgen|mesh|nlmcatalog|omim|orgtrack|pmc|proteinclusters|pcassay|protfam|pccompound|pcsubstance|seqannot|snp|sra|taxonomy|biocollections|gtr) | query | no | Entrez database. Default pubmed | | `webEnv` | string | query | no | Append to an existing history session | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/post?id=33301246%2C32109013&db=pubmed&webEnv=MCID_6a93083700b9b9ef110c4022" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/post?id=33301246%2C32109013&db=pubmed&webEnv=MCID_6a93083700b9b9ef110c4022", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/post?id=33301246%2C32109013&db=pubmed&webEnv=MCID_6a93083700b9b9ef110c4022", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "db": "pubmed", "ids": [ "33301246", "32109013" ], "count": 2, "webEnv": "MCID_6a93083700b9b9ef110c4022", "provider": "pubmed", "queryKey": "1", "invalidIds": [] } ``` --- ### Search esearch: term -> UID list. The 10,000-record window is upstream's, not ours; past it the history server (usehistory + epost) is the only way through. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/search` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `term` | string | query | yes | Entrez query. Supports field tags such as [au], [ti], [mesh] and boolean operators | | `db` | enum(pubmed|protein|nuccore|ipg|nucleotide|structure|genome|grasp|annotinfo|assembly|bioproject|biosample|blastdbinfo|books|cdd|clinvar|dbvar|gene|gds|geoprofiles|medgen|mesh|nlmcatalog|omim|orgtrack|pmc|proteinclusters|pcassay|protfam|pccompound|pcsubstance|seqannot|snp|sra|taxonomy|biocollections|gtr) | query | no | Entrez database. Default pubmed | | `page` | number | query | no | Page number. Default 1 | | `limit` | number | query | no | UIDs per page. Default 20, max 500 | | `sort` | enum(relevance|pubDate|author|journalName|mostRecent) | query | no | Sort order. Default is the database default | | `field` | string | query | no | Limit the whole term to one search field | | `datetype` | enum(pdat|edat|mdat) | query | no | Date field the range applies to | | `mindate` | string | query | no | Range start, YYYY/MM/DD | | `maxdate` | string | query | no | Range end, YYYY/MM/DD | | `reldate` | number | query | no | Limit to the last N days instead of a range | | `usehistory` | enum(true|false) | query | no | Store the result set on the history server and return webEnv/queryKey | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/search?term=covid-19%20vaccine&db=pubmed&page=1&limit=20&sort=relevance&field=title&datetype=pdat&mindate=2020%2F01%2F01&maxdate=2021%2F12%2F31&reldate=30&usehistory=true" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/search?term=covid-19%20vaccine&db=pubmed&page=1&limit=20&sort=relevance&field=title&datetype=pdat&mindate=2020%2F01%2F01&maxdate=2021%2F12%2F31&reldate=30&usehistory=true", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/search?term=covid-19%20vaccine&db=pubmed&page=1&limit=20&sort=relevance&field=title&datetype=pdat&mindate=2020%2F01%2F01&maxdate=2021%2F12%2F31&reldate=30&usehistory=true", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "db": "pubmed", "page": 1, "term": "covid-19 vaccine", "count": 0, "items": [], "limit": 3, "total": 0, "webEnv": "MCID_6a937c9f6cbc51515203019e", "hasMore": false, "nextPage": null, "provider": "pubmed", "queryKey": "1", "warnings": [ "No items found." ], "translations": [], "queryTranslation": "\"covid-19\"[Title] AND \"vaccine\"[Title] AND 2020/01/01:2021/12/31[Date - Publication] AND 2026/07/30:2026/08/29[Date - Publication]" } ``` --- ### Spell espell is XML-only: retmode=json answers HTTP 500 with a zero-byte body, so the response is parsed by regex rather than asked for in another format. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/spell` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `term` | string | query | yes | Query to spell-check against the database index | | `db` | enum(pubmed|protein|nuccore|ipg|nucleotide|structure|genome|grasp|annotinfo|assembly|bioproject|biosample|blastdbinfo|books|cdd|clinvar|dbvar|gene|gds|geoprofiles|medgen|mesh|nlmcatalog|omim|orgtrack|pmc|proteinclusters|pcassay|protfam|pccompound|pcsubstance|seqannot|snp|sra|taxonomy|biocollections|gtr) | query | no | Entrez database. Default pubmed | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/spell?term=fiberblast%20cell%20grwth&db=pubmed" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/spell?term=fiberblast%20cell%20grwth&db=pubmed", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/spell?term=fiberblast%20cell%20grwth&db=pubmed", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "db": "pubmed", "term": "fiberblast cell grwth", "items": [ { "text": "", "type": "original" }, { "text": "fibroblast", "type": "replaced" }, { "text": " cell ", "type": "original" }, { "text": "growth", "type": "replaced" } ], "provider": "pubmed", "corrected": true, "correctedTerm": "fibroblast cell growth", "replacementCount": 2 } ``` --- ### Summary esummary: document summaries by UID. NCBI's summary keys are all-lowercase and db-specific, so the whole record is renamed rather than cherry-picked — dropping - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/summary` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `id` | string | query | yes | Comma-separated UIDs, max 200 per call | | `db` | enum(pubmed|protein|nuccore|ipg|nucleotide|structure|genome|grasp|annotinfo|assembly|bioproject|biosample|blastdbinfo|books|cdd|clinvar|dbvar|gene|gds|geoprofiles|medgen|mesh|nlmcatalog|omim|orgtrack|pmc|proteinclusters|pcassay|protfam|pccompound|pcsubstance|seqannot|snp|sra|taxonomy|biocollections|gtr) | query | no | Entrez database. Default pubmed | | `version` | enum(1.0|2.0) | query | no | Summary schema version. Default 2.0 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/summary?id=33301246%2C32109013&db=pubmed&version=2.0" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/summary?id=33301246%2C32109013&db=pubmed&version=2.0", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/summary?id=33301246%2C32109013&db=pubmed&version=2.0", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "db": "pubmed", "count": 2, "items": [ { "uid": "33301246", "essn": "1533-4406", "issn": "0028-4793", "issue": "27", "pages": "2603-2615", "title": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.", "medium": "", "source": "N Engl J Med", "volume": "383", "authors": [ { "name": "Polack FP", "authType": "Author", "clusterId": "" }, { "name": "Thomas SJ", "authType": "Author", "clusterId": "" }, { "name": "Kitchin N", "authType": "Author", "clusterId": "" }, { "name": "Absalon J", "authType": "Author", "clusterId": "" }, { "name": "Gurtman A", "authType": "Author", "clusterId": "" }, { "name": "Lockhart S", "authType": "Author", "clusterId": "" }, { "name": "Perez JL", "authType": "Author", "clusterId": "" }, { "name": "Pérez Marc G", "authType": "Author", "clusterId": "" } ], "chapter": "", "docDate": "", "docType": "citation", "edition": "", "history": [ { "date": "2020/12/11 06:00", "pubStatus": "pubmed" }, { "date": "2021/01/13 06:00", "pubStatus": "medline" }, { "date": "2020/12/10 12:20", "pubStatus": "entrez" }, { "date": "2020/12/17 00:00", "pubStatus": "pmc-release" } ], "pubDate": "2020 Dec 31", "srcDate": "", "bookName": "", "ePubDate": "2020 Dec 10", "pubTypes": [ "Clinical Trial, Phase II", "Clinical Trial, Phase III", "Journal Article", "Multicenter Study", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't" ], "bookTitle": "", "languages": [ "eng" ], "pubStatus": "256", "sortTitle": "safety and efficacy of the bnt162b2 mrna covid 19 vaccine", "articleIds": [ { "value": "33301246", "idType": "pubmed", "idTypeNum": 1 }, { "value": "PMC7745181", "idType": "pmc", "idTypeNum": 8 }, { "value": "pmc-id: PMC7745181;", "idType": "pmcid", "idTypeNum": 5 }, { "value": "10.1056/NEJMoa2034577", "idType": "doi", "idTypeNum": 3 } ], "attributes": [ "Has Abstract" ], "lastAuthor": "Gruber WC", "references": [ { "note": "", "pmid": 33301245, "refType": "Comment in", "refSource": "N Engl J Med. 2020 Dec 31;383(27):2677-2678. doi: 10.1056/NEJMe2034717." }, { "note": "", "pmid": 33311629, "refType": "Comment in", "refSource": "Nature. 2020 Dec;588(7838):377-378. doi: 10.1038/d41586-020-03542-4." }, { "note": "", "pmid": 33478841, "refType": "Comment in", "refSource": "Semergen. 2021 Jan-Feb;47(1):1-3. doi: 10.1016/j.semerg.2020.12.005." }, { "note": "", "pmid": 33480519, "refType": "Comment in", "refSource": "Panminerva Med. 2022 Mar;64(1):131-132. doi: 10.23736/S0031-0808.21.04286-5." }, { "note": "", "pmid": 33524290, "refType": "Comment in", "refSource": "Ann Intern Med. 2021 Feb;174(2):JC15. doi: 10.7326/ACPJ202102160-015." }, { "note": "", "pmid": 33527275, "refType": "Comment in", "refSource": "MMW Fortschr Med. 2021 Feb;163(2):24-25. doi: 10.1007/s15006-021-9577-4." }, { "note": "", "pmid": 33596348, "refType": "Comment in", "refSource": "N Engl J Med. 2021 Apr 22;384(16):1576-1577. doi: 10.1056/NEJMc2036242." }, { "note": "", "pmid": 33596349, "refType": "Comment in", "refSource": "N Engl J Med. 2021 Apr 22;384(16):1577. doi: 10.1056/NEJMc2036242." } ], "eLocationId": "doi: 10.1056/NEJMoa2034577", "nlmUniqueId": "0255562", "pmcRefCount": 13, "sortPubDate": "2020/12/31 00:00", "recordStatus": "PubMed - indexed for MEDLINE", "reportNumber": "", "locationLabel": "", "publisherName": "", "fullJournalName": "The New England journal of medicine", "sortFirstAuthor": "Polack FP", "vernacularTitle": "", "availableFromUrl": "", "publisherLocation": "" }, { "uid": "32109013", "essn": "1533-4406", "issn": "0028-4793", "issue": "18", "pages": "1708-1720", "title": "Clinical Characteristics of Coronavirus Disease 2019 in China.", "medium": "", "source": "N Engl J Med", "volume": "382", "authors": [ { "name": "Guan WJ", "authType": "Author", "clusterId": "" }, { "name": "Ni ZY", "authType": "Author", "clusterId": "" }, { "name": "Hu Y", "authType": "Author", "clusterId": "" }, { "name": "Liang WH", "authType": "Author", "clusterId": "" }, { "name": "Ou CQ", "authType": "Author", "clusterId": "" }, { "name": "He JX", "authType": "Author", "clusterId": "" }, { "name": "Liu L", "authType": "Author", "clusterId": "" }, { "name": "Shan H", "authType": "Author", "clusterId": "" } ], "chapter": "", "docDate": "", "docType": "citation", "edition": "", "history": [ { "date": "2020/02/29 06:00", "pubStatus": "pubmed" }, { "date": "2020/05/06 06:00", "pubStatus": "medline" }, { "date": "2020/02/29 06:00", "pubStatus": "entrez" }, { "date": "2020/03/24 00:00", "pubStatus": "pmc-release" } ], "pubDate": "2020 Apr 30", "srcDate": "", "bookName": "", "ePubDate": "2020 Feb 28", "pubTypes": [ "Journal Article", "Research Support, Non-U.S. Gov't" ], "bookTitle": "", "languages": [ "eng" ], "pubStatus": "256", "sortTitle": "clinical characteristics of coronavirus disease 2019 in china", "articleIds": [ { "value": "32109013", "idType": "pubmed", "idTypeNum": 1 }, { "value": "PMC7092819", "idType": "pmc", "idTypeNum": 8 }, { "value": "pmc-id: PMC7092819;", "idType": "pmcid", "idTypeNum": 5 }, { "value": "10.1056/NEJMoa2002032", "idType": "doi", "idTypeNum": 3 } ], "attributes": [ "Has Abstract" ], "lastAuthor": "Zhong NS", "references": [ { "note": "", "pmid": 32220202, "refType": "Comment in", "refSource": "N Engl J Med. 2020 May 7;382(19):1859. doi: 10.1056/NEJMc2005203." }, { "note": "", "pmid": 32220203, "refType": "Comment in", "refSource": "N Engl J Med. 2020 May 7;382(19):1860. doi: 10.1056/NEJMc2005203." }, { "note": "", "pmid": 32220204, "refType": "Comment in", "refSource": "N Engl J Med. 2020 May 7;382(19):1860. doi: 10.1056/NEJMc2005203." }, { "note": "", "pmid": 32220205, "refType": "Comment in", "refSource": "N Engl J Med. 2020 May 7;382(19):1860-1861. doi: 10.1056/NEJMc2005203." }, { "note": "", "pmid": 32222421, "refType": "Comment in", "refSource": "Travel Med Infect Dis. 2020 May - Jun;35:101620. doi: 10.1016/j.tmaid.2020.101620." }, { "note": "", "pmid": 32234504, "refType": "Comment in", "refSource": "Diabetes Res Clin Pract. 2020 Apr;162:108132. doi: 10.1016/j.diabres.2020.108132." }, { "note": "", "pmid": 32276773, "refType": "Comment in", "refSource": "Int J Cardiol. 2020 Jul 1;310:167-168. doi: 10.1016/j.ijcard.2020.03.074." }, { "note": "", "pmid": 32279480, "refType": "Comment in", "refSource": "Singapore Med J. 2020 Sep;61(9):460-462. doi: 10.11622/smedj.2020051." } ], "eLocationId": "doi: 10.1056/NEJMoa2002032", "nlmUniqueId": "0255562", "pmcRefCount": 24, "sortPubDate": "2020/04/30 00:00", "recordStatus": "PubMed - indexed for MEDLINE", "reportNumber": "", "locationLabel": "", "publisherName": "", "fullJournalName": "The New England journal of medicine", "sortFirstAuthor": "Guan WJ", "vernacularTitle": "", "availableFromUrl": "", "publisherLocation": "" } ], "provider": "pubmed" } ``` --- ### Trials Detail One ClinicalTrials.gov v2 study. The single-study record carries 140 scalar paths across four sections; the heavy repeated blocks (arms, outcomes, locations) are - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/trials-detail/:nctId` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `nctId` | string | path | yes | ClinicalTrials.gov registry id | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/trials-detail/:nctId" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/trials-detail/:nctId", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/trials-detail/:nctId", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "sex": "ALL", "nctId": "NCT04280705", "phases": [ "PHASE3" ], "status": "COMPLETED", "acronym": null, "masking": "DOUBLE", "keywords": [ "Adaptive", "COVID-19", "Efficacy", "Multicenter", "novel coronavirus", "Safety", "ACTT" ], "provider": "pubmed", "armGroups": [ { "type": "PLACEBO_COMPARATOR", "label": "Placebo", "description": "200 mg of Remdesivir placebo administered intravenously on Day 1, followed by a 100 mg once-daily maintenance dose of Remdesivir placebo while hospitalized for up to a 10 days total course. n=286.", "interventionNames": [ "Other: Placebo" ] }, { "type": "EXPERIMENTAL", "label": "Remdesivir", "description": "200 mg of Remdesivir administered intravenously on Day 1, followed by a 100 mg once-daily maintenance dose of Remdesivir while hospitalized for up to a 10 days total course. n=286.", "interventionNames": [ "Drug: Remdesivir" ] } ], "locations": [ { "zip": "35233", "city": "Birmingham", "state": "Alabama", "status": null, "country": "United States", "facility": "University of Alabama at Birmingham School of Medicine - Infectious Disease", "latitude": 33.52066, "longitude": -86.80249 }, { "zip": "29037", "city": "La Jolla", "state": "California", "status": null, "country": "United States", "facility": "University of California San Diego Health - Jacobs Medical Center", "latitude": 32.84727, "longitude": -117.2742 }, { "zip": "90095", "city": "Los Angeles", "state": "California", "status": null, "country": "United States", "facility": "University of California Los Angeles Medical Center - Westwood Clinic", "latitude": 34.05223, "longitude": -118.24368 }, { "zip": "92868-3298", "city": "Orange", "state": "California", "status": null, "country": "United States", "facility": "University of California Irvine Medical Center - Infectious Disease", "latitude": 33.78779, "longitude": -117.85311 }, { "zip": "94304-1207", "city": "Palo Alto", "state": "California", "status": null, "country": "United States", "facility": "VA Palo Alto Health Care System - Infectious Diseases", "latitude": 37.44188, "longitude": -122.14302 }, { "zip": "95817-1460", "city": "Sacramento", "state": "California", "status": null, "country": "United States", "facility": "University of California Davis Medical Center - Internal Medicine - Infectious Disease", "latitude": 38.58157, "longitude": -121.4944 }, { "zip": "92314", "city": "San Diego", "state": "California", "status": null, "country": "United States", "facility": "Naval Medical Center San Diego - Infectious Disease Clinic", "latitude": 32.71571, "longitude": -117.16472 }, { "zip": "94110-2859", "city": "San Francisco", "state": "California", "status": null, "country": "United States", "facility": "University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine", "latitude": 37.77493, "longitude": -122.41942 } ], "startDate": "2020-02-21", "studyType": "INTERVENTIONAL", "whoMasked": [ "PARTICIPANT", "INVESTIGATOR" ], "allocation": "RANDOMIZED", "briefTitle": "Adaptive COVID-19 Treatment Trial (ACTT)", "conditions": [ "COVID-19" ], "enrollment": 1062, "hasResults": true, "ipdSharing": null, "maximumAge": "99 Years", "minimumAge": "18 Years", "orgStudyId": "20-0006", "references": [ { "pmid": "38657001", "type": "DERIVED", "citation": "Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Clifford Lane H, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir. J Infect Dis. 2024 Sep 23;230(3):624-634. doi: 10.1093/infdis/jiae198." }, { "pmid": "38618926", "type": "DERIVED", "citation": "Lin DY, Wang J, Gu Y, Zeng D. Evaluating treatment efficacy in hospitalized COVID-19 patients, with applications to Adaptive COVID-19 Treatment Trials. Clin Trials. 2024 Aug;21(4):500-506. doi: 10.1177/17407745241238443. Epub 2024 Apr 15." }, { "pmid": "37466213", "type": "DERIVED", "citation": "Hedskog C, Rodriguez L, Roychoudhury P, Huang ML, Jerome KR, Hao L, Ireton RC, Li J, Perry JK, Han D, Camus G, Greninger AL, Gale M Jr, Porter DP. Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1). J Infect Dis. 2023 Nov 2;228(9):1263-1273. doi: 10.1093/infdis/jiad270." }, { "pmid": "36695483", "type": "DERIVED", "citation": "Grundeis F, Ansems K, Dahms K, Thieme V, Metzendorf MI, Skoetz N, Benstoem C, Mikolajewska A, Griesel M, Fichtner F, Stegemann M. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014962. doi: 10.1002/14651858.CD014962.pub2." }, { "pmid": "36442063", "type": "DERIVED", "citation": "Potter GE, Bonnett T, Rubenstein K, Lindholm DA, Rapaka RR, Doernberg SB, Lye DC, Mularski RA, Hynes NA, Kline S, Paules CI, Wolfe CR, Frank MG, Rouphael NG, Deye GA, Sweeney DA, Colombo RE, Davey RT Jr, Mehta AK, Whitaker JA, Castro JG, Amin AN, Colombo CJ, Levine CB, Jain MK, Maves RC, Marconi VC, Grossberg R, Hozayen S, Burgess TH, Atmar RL, Ganesan A, Gomez CA, Benson CA, Lopez de Castilla D, Ahuja N, George SL, Nayak SU, Cohen SH, Lalani T, Short WR, Erdmann N, Tomashek KM, Tebas P. Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. Ann Intern Med. 2022 Dec;175(12):1716-1727. doi: 10.7326/M22-2116. Epub 2022 Nov 29." }, { "pmid": "34473343", "type": "DERIVED", "citation": "Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2." }, { "pmid": "34350582", "type": "DERIVED", "citation": "Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8(8):CD014962. doi: 10.1002/14651858.CD014962." }, { "pmid": "33240091", "type": "DERIVED", "citation": "Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifiro G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020." } ], "whyStopped": null, "leadSponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "briefSummary": "This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in up to approximately 100 sites globally. The study will compare different investigational therapeutic agents to a control arm. There will be interim monitoring to introduce new arms and allow early stopping for futility, efficacy, or safety. If one therapy proves to be efficacious, then this treatment may become the control arm for comparison(s) with new experimental treatment(s). Any such change would be accompanied by an updated sample size. Because background standards of supportive care may evolve/improve over time as more is learned about successful management of COVID-19, comparisons of safety and efficacy will be based on data from concurrently randomized subjects. An independent Data and Safety Monitoring Board (DSMB) will actively monitor interim data to make recommendations about early study closure or changes to study arms. To evaluate the clinical efficacy, as assessed by time to recovery, of different investigational therapeutics as compared to the control arm.", "organization": "National Institute of Allergy and Infectious Diseases (NIAID)", "secondaryIds": [], "standardAges": [ "ADULT", "OLDER_ADULT" ], "collaborators": [], "firstPostedOn": "2020-02-21", "interventions": [ { "name": "Placebo", "type": "OTHER", "description": "The supplied placebo lyophilized formulation is identical in physical appearance to the active lyophilized formulation and contains the same inactive ingredients. Alternatively, a placebo of normal saline of equal volume may be given if there are limitations on matching placebo supplies.", "armGroupLabels": [ "Placebo" ] }, { "name": "Remdesivir", "type": "DRUG", "description": "Drug Remdesivir is a single diastereomer monophosphoramidate prodrug designed for the intracellular delivery of a modified adenine nucleoside analog GS-441524. In addition to the active ingredient, the lyophilized formulation of Remdesivir contains the following inactive ingredients: water for injection, sulfobutylether beta-cyclodextrin sodium (SBECD), and hydrochloric acid and/or sodium hydroxide.", "armGroupLabels": [ "Remdesivir" ] } ], "lastUpdatedOn": "2022-03-14", "locationCount": 60, "officialTitle": "A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults", "otherOutcomes": [], "completionDate": "2020-05-21", "enrollmentType": "ACTUAL", "meshConditions": [ { "id": "D000086382", "term": "COVID-19" } ], "primaryPurpose": "TREATMENT", "oversightHasDmc": null, "primaryOutcomes": [ { "measure": "Time to Recovery", "timeFrame": "Day 1 through Day 29", "description": "Day of recovery is defined as the first day on which the subject satisfies one of the following three categories from the ordinal scale: 1) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 2) Not hospitalized, limitation on activities and/or requiring home oxygen; 3) Not hospitalized, no limitations on activities." }, { "measure": "Time to Recovery by Race", "timeFrame": "Day 1 through Day 29", "description": "Day of recovery is defined as the first day on which the subject satisfies one of the following three categories from the ordinal scale: 1) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 2) Not hospitalized, limitation on activities and/or requiring home oxygen; 3) Not hospitalized, no limitations on activities." }, { "measure": "Time to Recovery by Ethnicity", "timeFrame": "Day 1 through Day 29", "description": "Day of recovery is defined as the first day on which the subject satisfies one of the following three categories from the ordinal scale: 1) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 2) Not hospitalized, limitation on activities and/or requiring home oxygen; 3) Not hospitalized, no limitations on activities." }, { "measure": "Time to Recovery by Sex", "timeFrame": "Day 1 through Day 29", "description": "Day of recovery is defined as the first day on which the subject satisfies one of the following three categories from the ordinal scale: 1) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 2) Not hospitalized, limitation on activities and/or requiring home oxygen; 3) Not hospitalized, no limitations on activities." } ], "leadSponsorClass": "NIH", "responsibleParty": "SPONSOR", "statusVerifiedOn": "2020-04", "healthyVolunteers": false, "interventionModel": "PARALLEL", "meshInterventions": [ { "id": "C000606551", "term": "remdesivir" } ], "organizationClass": "NIH", "secondaryOutcomes": [ { "measure": "Change From Baseline in Alanine Transaminase (ALT)", "timeFrame": "Days 1, 3, 5, 8, 11, 15 and 29", "description": "Blood to evaluate ALT was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge." }, { "measure": "Change From Baseline in Aspartate Transaminase (AST)", "timeFrame": "Days 1, 3, 5, 8, 11, 15 and 29", "description": "Blood to evaluate AST was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge." }, { "measure": "Change From Baseline in Creatinine", "timeFrame": "Days 1, 3, 5, 8, 11, 15 and 29", "description": "Blood to evaluate serum creatinine was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge." }, { "measure": "Change From Baseline in Glucose", "timeFrame": "Days 1, 3, 5, 8, 11, 15 and 29", "description": "Blood to evaluate serum glucose was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge." }, { "measure": "Change From Baseline in Hemoglobin", "timeFrame": "Days 1, 3, 5, 8, 11, 15 and 29", "description": "Blood to evaluate hemoglobin was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge." }, { "measure": "Change From Baseline in Platelets", "timeFrame": "Days 1, 3, 5, 8, 11, 15 and 29", "description": "Blood to evaluate platelets was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge." }, { "measure": "Change From Baseline in Prothrombin Time (PT)", "timeFrame": "Days 1, 3, 5, 8, 11, 15 and 29", "description": "Blood to evaluate PT was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge." }, { "measure": "Change From Baseline in Total Bilirubin", "timeFrame": "Days 1, 3, 5, 8, 11, 15 and 29", "description": "Blood to evaluate total bilirubin was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge." } ], "isFdaRegulatedDrug": true, "detailedDescription": "This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in up to approximately 100 sites globally. The study will compare different investigational therapeutic agents to a control arm. There will be interim monitoring to introduce new arms and allow early stopping for futility, efficacy, or safety. If one therapy proves to be efficacious, then this treatment may become the control arm for comparison(s) with new experimental treatment(s). Any such change would be accompanied by an updated sample size. Because background standards of supportive care may evolve/improve over time as more is learned about successful management of COVID-19, comparisons of safety and efficacy will be based on data from concurrently randomized subjects. An independent Data and Safety Monitoring Board (DSMB) will actively monitor interim data to make recommendations about early study closure or changes to study arms.\n\nThe initial sample size is projected to be 572 subjects to achieve 400 subjects with a \"recovered\" status (per the primary objective). The primary analysis will be based on those subjects enrolled in order to 400 recoveries. An additional analysis of the moderate severity subgroup (those with baseline status of \"Hospitalized, requiring supplemental oxygen\" or \"Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care\") is also of public health importance. Hence, enrollment will be permitted until the date of April 20, 2020 to ensure 400 recoveries and provide additional data about this important subgroup. With recent enrollment rates, the total sample size may be 600 to over 800.\n\nSubjects will be assessed daily while hospitalized. If the subjects are discharged from the hospital, they will have a study visit at Days 15, 22, and 29 as an outpatient. For discharged subjects, it is preferred that the Day 15 and 29 visits are in person to obtain safety laboratory tests and OP swab and blood (serum only) samples for secondary research as well as clinical outcome data. However, infection control or other restrictions may limit the ability of the subject to return to the clinic. In this case, Day 15 and 29 visits may be conducted by phone, and only clinical data will be obtained. The Day 22 visit does not have laboratory tests or collection of samples and may also be conducted by phone.\n\nAll subjects will undergo a series of efficacy, safety, and laboratory assessments. Safety laboratory tests and blood (serum and plasma) research samples and oropharyngeal (OP) swabs will be obtained on Days 1 (prior to infusion) and Days 3, 5, 8, and 11 (while hospitalized). OP swabs and blood (serum only) plus safety laboratory tests will be collected on Day 15 and 29 (if the subject attends an in-person visit or are still hospitalized).\n\nThe primary outcome is time to recovery by Day 29. A key secondary outcome evaluates treatment-related improvements in the 8-point ordinal scale at Day 15. As little is known about the clinical course of COVID-19, a pilot study will be used for a blinded sample size reassessment.\n\nContacts:\n\n20-0006 Central Contact\n\nTelephone: 1 (301) 7617948\n\nEmail: DMIDClinicalTrials@niaid.nih.gov", "eligibilityCriteria": "Inclusion Criteria:\n\n1. Admitted to a hospital with symptoms suggestive of COVID-19 infection.\n2. Subject (or legally authorized representative) provides informed consent prior to initiation of any study procedures.\n3. Subject (or legally authorized representative) understands and agrees to comply with planned study procedures.\n4. Male or non-pregnant female adult \\> / = 18 years of age at time of enrollment.\n5. Has laboratory-confirmed SARS-CoV-2 infection as determined by polymerase chain reaction (PCR) or other commercial or public health assay in any specimen, as documented by either or the following:\n\n 1. PCR positive in sample collected \\< 72 hours prior to randomization; OR\n\n Exclusion Criteria:\n 2. PCR positive in sample collected \\>/= 72 hours prior to randomization, documented inability to obtain a repeat sample (e.g. due to lack of testing supplies, limited testing capacity, results taking \\>24 hours, etc.) AND progressive disease suggestive of ongoing SARS-CoV-2 infection.\n6. Illness of any duration, and at least one of the following:\n\n 1. Radiographic infiltrates by imaging (chest x-ray, CT scan, etc.), OR\n 2. SpO2 \\< / = 94% on room air, OR\n 3. Requiring supplemental oxygen, OR\n 4. Requiring mechanical ventilation.\n7. Women of childbearing potential must agree to either abstinence or use at least one primary form of contraception not including hormonal contraception from the time of screening through Day 29.\n8. Agrees to not participate in another clinical trial for the treatment of COVID-19 or SARS-CoV-2 through Day 29.\n\nExclusion Criteria:\n\n1. Alanine Transaminase (ALT) or Aspartate Transaminase (AST) \\> 5 times the upper limit of normal.\n2. Estimated glomerular filtration rate (eGFR) \\< 30 ml/min (including patients receiving hemodialysis or hemofiltration).\n3. Pregnancy or breast feeding.\n4. Anticipated discharge from the hospital or transfer to another hospital which is not a study site within 72 hours.\n5. Allergy to any study medication.", "isFdaRegulatedDevice": false, "resultsFirstPostedOn": "2020-09-25", "primaryCompletionDate": "2020-05-21" } ``` --- ### Trials Search ClinicalTrials.gov v2 study search. v2 paginates by an opaque token, not a page number, so the cursor is passed through instead of being faked into a page index. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:pubmed/trials-search` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `condition` | string | query | no | Condition or disease being studied | | `term` | string | query | no | Free-text terms matched across the whole record | | `status` | enum(NOT_YET_RECRUITING|RECRUITING|ENROLLING_BY_INVITATION|ACTIVE_NOT_RECRUITING|SUSPENDED|TERMINATED|COMPLETED|WITHDRAWN|AVAILABLE|NO_LONGER_AVAILABLE|TEMPORARILY_NOT_AVAILABLE|APPROVED_FOR_MARKETING|WITHHELD|UNKNOWN) | query | no | Restrict to one recruitment status | | `limit` | number | query | no | Studies per page. Default 20, max 100 | | `cursor` | string | query | no | Page token from nextCursor of a previous call | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:pubmed/trials-search?condition=covid-19&term=remdesivir&status=RECRUITING&limit=20&cursor=ZVt07cGHkvI2wRk2CJf6" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:pubmed/trials-search?condition=covid-19&term=remdesivir&status=RECRUITING&limit=20&cursor=ZVt07cGHkvI2wRk2CJf6", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:pubmed/trials-search?condition=covid-19&term=remdesivir&status=RECRUITING&limit=20&cursor=ZVt07cGHkvI2wRk2CJf6", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "term": null, "count": 3, "items": [ { "nctId": "NCT01128829", "phases": [ "NA" ], "status": "COMPLETED", "acronym": "SIR", "masking": "NONE", "keywords": [ "obesity", "diabetes", "artificial sweeteners" ], "startDate": "2010-05", "studyType": "INTERVENTIONAL", "allocation": "RANDOMIZED", "briefTitle": "Sugar-replacement Sweeteners, and Blood Sugar Control", "conditions": [ "Obesity" ], "enrollment": 17, "hasResults": true, "leadSponsor": "Washington University School of Medicine", "briefSummary": "Several sugar-replacement sweeteners are currently on the market, including saccharine (ex. Sweet'N Low), aspartame (ex. Equal), and sucralose (ex. Splenda). The purpose of this study is to examine wether non caloric sweeteners affects how well the body works to control blood sugar. The study includes detailed blood sugar testing after drinking liquids that may contain sucralose. The investigators hypothesize that drinking liquids with sucralose will effect the amounts of specific appetite-affecting substances naturally produced by the body.", "organization": "Washington University School of Medicine", "firstPostedOn": "2010-05-24", "lastUpdatedOn": "2014-12-22", "officialTitle": "Regulation of Incretin Release by Non-nutritive Sweeteners in Humans", "completionDate": "2012-10", "enrollmentType": "ACTUAL", "primaryPurpose": "BASIC_SCIENCE", "leadSponsorClass": "OTHER", "statusVerifiedOn": "2014-12", "interventionModel": "CROSSOVER", "primaryCompletionDate": "2012-02" }, { "nctId": "NCT06186102", "phases": [ "PHASE2" ], "status": "COMPLETED", "acronym": "PolyCAD", "masking": "QUADRUPLE", "keywords": [ "Spermidine", "Dietary supplement", "Polyamine", "Prevention", "Treatment", "Lifestyle", "Coronary artery disease", "Ischemic heart disease" ], "startDate": "2024-01-01", "studyType": "INTERVENTIONAL", "allocation": "RANDOMIZED", "briefTitle": "Polyamine Treatment in Elderly Patients With Coronary Artery Disease", "conditions": [ "Ischemic Heart Disease", "Myocardial Infarction", "Cardiovascular Diseases", "Hypertensive Heart Disease", "Hypertension", "Diastolic Dysfunction", "Obesity", "Metabolic Syndrome" ], "enrollment": 187, "hasResults": false, "leadSponsor": "University of Aarhus", "briefSummary": "The present study is testing spermidine treatment in elderly patients with coronary artery disease. The study is a randomized, double-blind, placebo-controlled, two-armed, parallel-group, single centre, clinical study.", "organization": "University of Aarhus", "collaborators": [ "Sygesikringen Danmark", "Aarhus University Hospital", "Danish Diabetes Academy", "Danish Cardiovascular Academy (DCA)", "Eva and Henry Frænkels Mindefond", "DoNotAge.org" ], "firstPostedOn": "2023-12-29", "lastUpdatedOn": "2026-07-01", "officialTitle": "Polyamine Treatment in Elderly Patients With Coronary Artery Disease - a Randomized Controlled Trial", "completionDate": "2026-06-29", "enrollmentType": "ACTUAL", "primaryPurpose": "TREATMENT", "leadSponsorClass": "OTHER", "statusVerifiedOn": "2026-04", "interventionModel": "PARALLEL", "primaryCompletionDate": "2026-06-29" }, { "nctId": "NCT01947595", "phases": [ "NA" ], "status": "COMPLETED", "acronym": "PLIS", "masking": "NONE", "keywords": [ "diabetes mellitus type 2", "impaired glucose tolerance", "lifestyle intervention", "body fat distribution", "prevention" ], "startDate": "2012-03", "studyType": "INTERVENTIONAL", "allocation": "RANDOMIZED", "briefTitle": "Individualized Lifestyle Intervention in Subjects With Prediabetes", "conditions": [ "Diabetes Mellitus Type 2" ], "enrollment": 1145, "hasResults": false, "leadSponsor": "University Hospital Tuebingen", "briefSummary": "The purpose of this prospective randomized multicenter intervention study is to determine whether in the prevention of Diabetes an intensified lifestyle intervention is superior to a conventional lifestyle intervention in high risk non-Responder subjects. Further, the intensive phenotyping to determine subgroups with an increased risk for diabetes enables an individualized prevention and therapy of type 2 diabetes mellitus.", "organization": "University Hospital Tuebingen", "collaborators": [ "German Diabetes-Center, Leibniz-Institut in Düsseldorf", "Endocrinology and Metabolic Diseases, Charité Berlin", "German Institute of Human Nutrition", "University Hospital Carl Gustav Carus", "LMU Klinikum", "University Hospital Heidelberg" ], "firstPostedOn": "2013-09-20", "lastUpdatedOn": "2017-08-23", "officialTitle": "Prediabetes Lifestyle Intervention Study", "completionDate": "2017-08", "enrollmentType": "ACTUAL", "primaryPurpose": "PREVENTION", "leadSponsorClass": "OTHER", "statusVerifiedOn": "2017-08", "interventionModel": "PARALLEL", "primaryCompletionDate": "2017-08" } ], "limit": 3, "total": 15144, "cursor": null, "status": "COMPLETED", "hasMore": true, "provider": "pubmed", "condition": "diabetes", "nextCursor": "ZVt07cGHkvI2wRk2CJf6_LLt25GeMN8wd7KrgP4Ymj2e" } ``` --- ## SINTA **Category:** research · **Slug:** `sinta` **Detail page:** https://zapi.ink/api/research/sinta Science and Technology Index — Indonesian researchers, affiliations, departments, accredited journals, books, IPR and Scopus/Scholar output with SINTA scores. **Tags:** sinta, indonesia, peneliti, afiliasi, jurnal ### Affiliation Departments SINTA — one institution's study programmes (/affiliations/departments/{id}/{code}). Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/affiliation-departments/:affiliationId/:affiliationCode` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `affiliationId` | string | path | yes | SINTA affiliation id, the `affiliationId` returned by the affiliations endpoint | | `affiliationCode` | string | path | no | Institution code, the `code` returned by the affiliations endpoint. Resolved automatically when omitted | | `query` | string | query | no | Free-text programme search within this institution | | `page` | number | query | no | Page number, 10 programmes per page. Default 1 | | `sort` | enum(score3yr|scoreOverall|alphabetical) | query | no | Ranking order. Default score3yr | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/affiliation-departments/:affiliationId/:affiliationCode?query=kedokteran&page=1&sort=score3yr" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/affiliation-departments/:affiliationId/:affiliationCode?query=kedokteran&page=1&sort=score3yr", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/affiliation-departments/:affiliationId/:affiliationCode?query=kedokteran&page=1&sort=score3yr", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "sort": "score3yr", "count": 10, "items": [ { "url": "https://sinta.kemdiktisaintek.go.id/departments/profile/384/001001/11201", "name": "Kedokteran", "level": "S1", "authors": [ { "name": "BAGAS SURYO BINTORO", "authorId": "6788835" }, { "name": "ETI NURWENING SHOLIKHAH", "authorId": "6012080" }, { "name": "BAYU SATRIA WIRATAMA", "authorId": "6191183" }, { "name": "DWI ARIS AGUNG NUGRAHANINGSIH", "authorId": "6035754" }, { "name": "KRISTY ISKANDAR", "authorId": "6099361" } ], "metrics": { "sintaScore3Yr": 39541, "sintaScoreOverall": 109563 }, "departmentCode": "11201" }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/profile/384/001001/54261", "name": "Kedokteran Hewan", "level": "S1", "authors": [ { "name": "IDA FITRIANA", "authorId": "5985331" }, { "name": "HEVI WIHADMADYATAMI", "authorId": "44009" }, { "name": "YUDHI RATNA NUGRAHENI", "authorId": "6091895" }, { "name": "DWI LILIEK KUSINDARTA", "authorId": "43975" }, { "name": "RINI WIDAYANTI", "authorId": "6024868" } ], "metrics": { "sintaScore3Yr": 21992, "sintaScoreOverall": 55014 }, "departmentCode": "54261" }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/profile/384/001001/11001", "name": "Doktor Ilmu Kedokteran dan Kesehatan", "level": "S3", "authors": [ { "name": "SOFIA MUBARIKA HARJANA", "authorId": "6013959" }, { "name": "FITRI HARYANTI", "authorId": "6011533" }, { "name": "ADI UTARINI", "authorId": "6013867" }, { "name": "MAE SRI HARTATI WAHYUNINGSIH", "authorId": "6011535" }, { "name": "AHMAD HAMIM SADEWA", "authorId": "6004283" } ], "metrics": { "sintaScore3Yr": 4300, "sintaScoreOverall": 35565 }, "departmentCode": "11001" }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/profile/384/001001/12201", "name": "Kedokteran Gigi", "level": "S1", "authors": [ { "name": "RINI WIDYANINGRUM", "authorId": "5985910" }, { "name": "REZMELIA SARI", "authorId": "6156995" }, { "name": "TETIANA HANIASTUTI", "authorId": "6013845" }, { "name": "HERIATI SITOSARI", "authorId": "6015382" }, { "name": "SRI LARNANI", "authorId": "6014294" } ], "metrics": { "sintaScore3Yr": 3880, "sintaScoreOverall": 11285 }, "departmentCode": "12201" }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/profile/384/001001/12001", "name": "Doktor Ilmu Kedokteran Gigi", "level": "S3", "authors": [ { "name": "IKA DEWI ANA", "authorId": "260243" }, { "name": "WIDOWATI SISWOMIHARDJO", "authorId": "6022995" }, { "name": "NUNUK PURWANTI", "authorId": "6007906" }, { "name": "SUPRIATNO", "authorId": "42453" }, { "name": "HERIBERTUS DEDY KUSUMA YULIANTO", "authorId": "6644352" } ], "metrics": { "sintaScore3Yr": 3827, "sintaScoreOverall": 21968 }, "departmentCode": "12001" }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/profile/384/001001/11104", "name": "Magister Ilmu Kedokteran Tropis", "level": "S2", "authors": [ { "name": "RIRIS ANDONO AHMAD", "authorId": "6005583" }, { "name": "YANRI WIJAYANTI SUBRONTO", "authorId": "6676686" }, { "name": "IDA SAFITRI LAKSANAWATI", "authorId": "6197829" }, { "name": "TRI BASKORO TUNGGUL SATOTO", "authorId": "6035347" }, { "name": "E. ELSA HERDIANA MURHANDARWATI", "authorId": "6017251" } ], "metrics": { "sintaScore3Yr": 3388, "sintaScoreOverall": 20783 }, "departmentCode": "11104" }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/profile/384/001001/12102", "name": "Magister Ilmu Kedokteran Gigi Klinis", "level": "S2", "authors": [ { "name": "ARCHADIAN NURYANTI", "authorId": "6014472" }, { "name": "RETNO ARDHANI", "authorId": "6008545" }, { "name": "DEWI AGUSTINA", "authorId": "6013865" }, { "name": "SURYONO", "authorId": "43213" }, { "name": "RYNA DWI YANUARYSKA", "authorId": "5978096" } ], "metrics": { "sintaScore3Yr": 3170, "sintaScoreOverall": 10739 }, "departmentCode": "12102" }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/profile/384/001001/11109", "name": "Magister Ilmu Pendidikan Kedokteran dan Kesehatan", "level": "S2", "authors": [ { "name": "MORA CLARAMITA", "authorId": "6007248" }, { "name": "YOYO SUHOYO", "authorId": "5985469" }, { "name": "GANDES RETNO RAHAYU", "authorId": "6036070" }, { "name": "WIDYANDANA", "authorId": "6013878" }, { "name": "RR TITI SAVITRI PRIHATININGSIH", "authorId": "6007240" } ], "metrics": { "sintaScore3Yr": 2460, "sintaScoreOverall": 10902 }, "departmentCode": "11109" } ], "limit": 10, "query": "kedokteran", "total": 14, "hasMore": true, "nextPage": 2, "provider": "sinta", "affiliationId": "384", "affiliationCode": "001001", "affiliationName": "Universitas Gadjah Mada" } ``` --- ### Affiliation SINTA — one institution's profile (/affiliations/profile/{id}), with its indexed output. Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/affiliation/:affiliationId` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `affiliationId` | string | path | yes | SINTA affiliation id, the `affiliationId` returned by the affiliations endpoint | | `view` | enum(scopus|garuda|googleScholar|researches|services|iprs|books) | query | no | Which output tab to read. Default scopus | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/affiliation/:affiliationId?view=scopus" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/affiliation/:affiliationId?view=scopus", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/affiliation/:affiliationId?view=scopus", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "url": "https://sinta.kemdiktisaintek.go.id/affiliations/profile/404", "code": "001019", "name": "Universitas Brawijaya", "view": "scopus", "count": 10, "items": [ { "doi": null, "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-105035910996&origin=resultslist", "year": 2027, "title": "HABITAT TYPE EFFECTS ON INSECT POLLINATOR SPECIES RICHNESS AND ABUNDANCE IN JAMBI OIL PALM PLANTATIONS", "authors": "Jihadi A.", "quartile": "Q4 Journal", "authorOrder": null, "citedByCount": 0, "publicationUrl": "https://www.scopus.com/sourceid/21101041703", "publicationName": "Indian Journal of Entomology" }, { "doi": null, "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-105042998323&origin=resultslist", "year": 2027, "title": "Occupational Mismatch and Income Effects in Indonesia’s Gig Economy: A Gender Perspective", "authors": "Setyanti A.M.", "quartile": "Q2 Journal", "authorOrder": null, "citedByCount": 0, "publicationUrl": "https://www.scopus.com/sourceid/21100855500", "publicationName": "Journal of Population and Social Studies" }, { "doi": null, "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-105046260648&origin=resultslist", "year": 2027, "title": "Interpretability TabNet: Enhancing Tabular Deep Learning with Entmax Stability Masking", "authors": "Yudistira N.", "quartile": "Q3 Journal", "authorOrder": null, "citedByCount": 0, "publicationUrl": "https://www.scopus.com/sourceid/25674", "publicationName": "Lecture Notes in Computer Science" }, { "doi": null, "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-105046356390&origin=resultslist", "year": 2027, "title": "Enhancing Stability and Convergence in Graph-Based Chess Reinforcement Learning Using Adaptive Optimization Strategies", "authors": "Yudistira N.", "quartile": "Q3 Journal", "authorOrder": null, "citedByCount": 0, "publicationUrl": "https://www.scopus.com/sourceid/25674", "publicationName": "Lecture Notes in Computer Science" }, { "doi": null, "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-105046181520&origin=resultslist", "year": 2027, "title": "Adaptive Conformal Prediction for Reliable and Explainable Medical Image Classification", "authors": "Octadion O.", "quartile": "Q3 Journal", "authorOrder": null, "citedByCount": 0, "publicationUrl": "https://www.scopus.com/sourceid/25674", "publicationName": "Lecture Notes in Computer Science" }, { "doi": null, "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-105038287714&origin=resultslist", "year": 2026, "title": "Dynamic Behavior of Caputo Fractional-Order Model of Forest Biomass, Human Population, and Atmospheric Carbon Dioxide", "authors": "Huda M.N.", "quartile": "Q3 Journal", "authorOrder": null, "citedByCount": 1, "publicationUrl": "https://www.scopus.com/sourceid/21101068591", "publicationName": "Communication in Biomathematical Sciences" }, { "doi": null, "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-105042373527&origin=resultslist", "year": 2026, "title": "Euler Scheme for a Predator-Prey Model Incorporating Predator Cannibalism and Refuge", "authors": "Rayungsari M.", "quartile": "Q4 Journal", "authorOrder": null, "citedByCount": 0, "publicationUrl": "https://www.scopus.com/sourceid/26916", "publicationName": "Aip Conference Proceedings" }, { "doi": null, "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-105044206229&origin=resultslist", "year": 2026, "title": "NUMERICAL SIMULATIONS OF SOLITON PROPAGATION IN KERR NONLINEAR MEDIA WITH LINEAR REFRACTIVE INDEX VARIATION AND NONLINEAR DIFFRACTION", "authors": "Beta M.A.", "quartile": "Q4 Journal", "authorOrder": null, "citedByCount": 0, "publicationUrl": "https://www.scopus.com/sourceid/17900156722", "publicationName": "Far East Journal of Mathematical Sciences" } ], "metrics": { "authors": 2686, "indexes": { "garuda": { "citations": 707, "documents": 47499, "citedDocuments": 450, "citationsPerResearcher": 0.31 }, "scopus": { "citations": 143868, "documents": 19242, "citedDocuments": 13925, "citationsPerResearcher": 62.31 }, "webOfScience": { "citations": 1849, "documents": 555, "citedDocuments": 266, "citationsPerResearcher": 0.8 }, "googleScholar": { "citations": 1124352, "documents": 148198, "citedDocuments": 86473, "citationsPerResearcher": 486.94 } }, "journals": 104, "departments": 208, "sintaScore3Yr": 887455, "sintaScoreOverall": 2300397, "sintaScoreProductivity": 1083, "sintaScoreProductivity3Yr": 418 }, "imageUrl": "https://sinta-document-650498682909-ap-southeast-3-an.s3.ap-southeast-3.amazonaws.com/public/affiliation/404.png", "location": "KOTA MALANG - JAWA TIMUR, ID", "provider": "sinta", "abbreviation": "UB", "affiliationId": "404", "indexUpdatedAt": "2026-07-06 11:51:18" } ``` --- ### Affiliations SINTA — affiliation listing (/affiliations?q=&page=), the Indonesian institution index. Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/affiliations` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text institution search. Omit for the full ranked index | | `page` | number | query | no | Page number, 10 institutions per page. Default 1 | | `sort` | enum(score3yr|scoreOverall|alphabetical) | query | no | Ranking order. Default score3yr | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/affiliations?query=universitas&page=1&sort=score3yr" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/affiliations?query=universitas&page=1&sort=score3yr", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/affiliations?query=universitas&page=1&sort=score3yr", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "sort": "score3yr", "count": 10, "items": [ { "url": "https://sinta.kemdiktisaintek.go.id/affiliations/profile/384", "code": "001001", "name": "Universitas Gadjah Mada", "metrics": { "authors": 3674, "departments": 294, "sintaScore3Yr": 1610976, "sintaScoreOverall": 5411955 }, "imageUrl": "https://sinta-document-650498682909-ap-southeast-3-an.s3.ap-southeast-3.amazonaws.com/public/affiliation/384.jpg", "location": "KAB. SLEMAN - DAERAH ISTIMEWA YOGYAKARTA, ID", "abbreviation": "UGM", "affiliationId": "384" }, { "url": "https://sinta.kemdiktisaintek.go.id/affiliations/profile/380", "code": "001004", "name": "Universitas Airlangga", "metrics": { "authors": 2240, "departments": 194, "sintaScore3Yr": 1334044, "sintaScoreOverall": 3624707 }, "imageUrl": "https://sinta-document-650498682909-ap-southeast-3-an.s3.ap-southeast-3.amazonaws.com/public/affiliation/380.jpg", "location": "KOTA SURABAYA - JAWA TIMUR, ID", "abbreviation": "UNAIR", "affiliationId": "380" }, { "url": "https://sinta.kemdiktisaintek.go.id/affiliations/profile/6", "code": "001008", "name": "Universitas Diponegoro", "metrics": { "authors": 1970, "departments": 162, "sintaScore3Yr": 1059768, "sintaScoreOverall": 2588832 }, "imageUrl": "https://sinta-document-650498682909-ap-southeast-3-an.s3.ap-southeast-3.amazonaws.com/public/affiliation/6.jpg", "location": "KOTA SEMARANG - JAWA TENGAH, ID", "abbreviation": "UNDIP", "affiliationId": "6" }, { "url": "https://sinta.kemdiktisaintek.go.id/affiliations/profile/430", "code": "001002", "name": "Universitas Indonesia", "metrics": { "authors": 3152, "departments": 270, "sintaScore3Yr": 1016969, "sintaScoreOverall": 3608694 }, "imageUrl": "https://sinta-document-650498682909-ap-southeast-3-an.s3.ap-southeast-3.amazonaws.com/public/affiliation/430.jpg", "location": "KOTA ADM. JAKARTA PUSAT - DKI JAKARTA, ID", "abbreviation": "UI", "affiliationId": "430" }, { "url": "https://sinta.kemdiktisaintek.go.id/affiliations/profile/404", "code": "001019", "name": "Universitas Brawijaya", "metrics": { "authors": 2686, "departments": 208, "sintaScore3Yr": 887455, "sintaScoreOverall": 2300397 }, "imageUrl": "https://sinta-document-650498682909-ap-southeast-3-an.s3.ap-southeast-3.amazonaws.com/public/affiliation/404.png", "location": "KOTA MALANG - JAWA TIMUR, ID", "abbreviation": "UB", "affiliationId": "404" }, { "url": "https://sinta.kemdiktisaintek.go.id/affiliations/profile/476", "code": "031015", "name": "Universitas Tarumanagara", "metrics": { "authors": 477, "departments": 33, "sintaScore3Yr": 812038, "sintaScoreOverall": 1372193 }, "imageUrl": "https://sinta-document-650498682909-ap-southeast-3-an.s3.ap-southeast-3.amazonaws.com/public/affiliation/476.png", "location": "KOTA ADM. JAKARTA BARAT - DKI JAKARTA, ID", "abbreviation": "UNTAR", "affiliationId": "476" }, { "url": "https://sinta.kemdiktisaintek.go.id/affiliations/profile/414", "code": "001034", "name": "Universitas Pendidikan Indonesia", "metrics": { "authors": 1898, "departments": 176, "sintaScore3Yr": 810579, "sintaScoreOverall": 1793913 }, "imageUrl": "https://sinta-document-650498682909-ap-southeast-3-an.s3.ap-southeast-3.amazonaws.com/public/affiliation/414.jpg", "location": "KOTA BANDUNG - JAWA BARAT, ID", "abbreviation": "UPI", "affiliationId": "414" }, { "url": "https://sinta.kemdiktisaintek.go.id/affiliations/profile/385", "code": "001005", "name": "Universitas Hasanuddin", "metrics": { "authors": 2321, "departments": 240, "sintaScore3Yr": 808573, "sintaScoreOverall": 2034670 }, "imageUrl": "https://sinta-document-650498682909-ap-southeast-3-an.s3.ap-southeast-3.amazonaws.com/public/affiliation/385.jpg", "location": "KOTA MAKASSAR - SULAWESI SELATAN, ID", "abbreviation": "UNHAS", "affiliationId": "385" } ], "limit": 10, "query": "universitas", "total": 1015, "hasMore": true, "nextPage": 2, "provider": "sinta" } ``` --- ### Author SINTA — one researcher's profile (/authors/profile/{id}), mirroring the category's author shape: identity flat at the top, every number under `metrics`, the output list last. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/author/:authorId` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `authorId` | string | path | yes | SINTA author id, the `authorId` returned by the authors endpoint | | `view` | enum(scopus|garuda|googleScholar|rama|researches|services|iprs|books) | query | no | Which output tab to read. Default scopus | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/author/:authorId?view=googleScholar" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/author/:authorId?view=googleScholar", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/author/:authorId?view=googleScholar", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "url": "https://sinta.kemdiktisaintek.go.id/authors/profile/6005167", "name": "REFNI YULIA", "view": "googleScholar", "count": 10, "items": [ { "doi": null, "url": "https://scholar.google.com/scholar?q=+intitle:'TECHNICAL GUIDANCE IN WRITING THE HISTORY OF NAGARI GUNUNG MEDAN DISTRICT DHARMASRAYA'", "year": 2024, "title": "TECHNICAL GUIDANCE IN WRITING THE HISTORY OF NAGARI GUNUNG MEDAN DISTRICT DHARMASRAYA", "authors": "R Nazmi, Z Zulfa, L Husnita, R Yulia, M Meldawati, J Jamurin", "quartile": null, "authorOrder": null, "citedByCount": 2, "publicationUrl": null, "publicationName": "Human: Journal of Community and Public Service 3 (1), 2024" }, { "doi": null, "url": "https://scholar.google.com/scholar?q=+intitle:'Perkembangan Sektor Pertanian Kabupaten Kerinci 2009-2019'", "year": 2024, "title": "Perkembangan Sektor Pertanian Kabupaten Kerinci 2009-2019", "authors": "I Pratama, R Yulia, JK Junaidi", "quartile": null, "authorOrder": null, "citedByCount": 0, "publicationUrl": null, "publicationName": "Jurnal Pendidikan Tambusai 8 (1), 2296-2302, 2024" }, { "doi": null, "url": "https://scholar.google.com/scholar?q=+intitle:'Memori Kolektif Masyarakat dalam Peristiwa Gempa di Kabupaten Pasaman'", "year": 2024, "title": "Memori Kolektif Masyarakat dalam Peristiwa Gempa di Kabupaten Pasaman", "authors": "S Amelia, Z Zulfa, R Yulia", "quartile": null, "authorOrder": null, "citedByCount": 0, "publicationUrl": null, "publicationName": "Jurnal Pendidikan Tambusai 8 (2), 19118-19128, 2024" }, { "doi": null, "url": "https://scholar.google.com/scholar?q=+intitle:'WANITA INSPIRATIF: BIOGRAFI SUMIYATI KHILYATUN HASANAH 1997-2023'", "year": 2024, "title": "WANITA INSPIRATIF: BIOGRAFI SUMIYATI KHILYATUN HASANAH 1997-2023", "authors": "R Farantika, M Erawati, R Yulia", "quartile": null, "authorOrder": null, "citedByCount": 0, "publicationUrl": null, "publicationName": "Pendas: Jurnal Ilmiah Pendidikan Dasar 9 (03), 249-258, 2024" }, { "doi": null, "url": "https://scholar.google.com/scholar?q=+intitle:'Perkembangan Desa Apar Menjadi Desa Wisata Tahun 2002-2021'", "year": 2023, "title": "Perkembangan Desa Apar Menjadi Desa Wisata Tahun 2002-2021", "authors": "N Nadia, Z Zulfa, R Yulia", "quartile": null, "authorOrder": null, "citedByCount": 2, "publicationUrl": null, "publicationName": "Jurnal Pendidikan Tambusai 7 (3), 20921-20927, 2023" }, { "doi": null, "url": "https://scholar.google.com/scholar?q=+intitle:'How to Discourse on Character Education Values in the Pullagajat Liat Tradition in Mentawai, Indonesia'", "year": 2023, "title": "How to Discourse on Character Education Values in the Pullagajat Liat Tradition in Mentawai, Indonesia", "authors": "Z Zulfa, R Yulia, L Husnita, M Meldawati", "quartile": null, "authorOrder": null, "citedByCount": 10, "publicationUrl": null, "publicationName": "Journal of Pragmatics and Discourse Research 3 (1), 81-92, 2023" }, { "doi": null, "url": "https://scholar.google.com/scholar?q=+intitle:'Biografi Erma Yulnita: Pengusaha Songket Pandai Sikek di Kecamatan X Koto, Kabupaten Tanah Datar Tahun 1985–2019'", "year": 2023, "title": "Biografi Erma Yulnita: Pengusaha Songket Pandai Sikek di Kecamatan X Koto, Kabupaten Tanah Datar Tahun 1985–2019", "authors": "T Bonita, L Husnita, R Yulia", "quartile": null, "authorOrder": null, "citedByCount": 0, "publicationUrl": null, "publicationName": "Jurnal Pendidikan Tambusai 7 (3), 22658-22662, 2023" }, { "doi": null, "url": "https://scholar.google.com/scholar?q=+intitle:'AKTIVITAS TAMBANG TIMAH DI DESA SEKUNING KABUPATEN BINTAN DAN DAMPAKNYA TERHADAP MASYARAKAT (2010-2020)'", "year": 2023, "title": "AKTIVITAS TAMBANG TIMAH DI DESA SEKUNING KABUPATEN BINTAN DAN DAMPAKNYA TERHADAP MASYARAKAT (2010-2020)", "authors": "P Oktaviani, M Erawati, R Yulia", "quartile": null, "authorOrder": null, "citedByCount": 1, "publicationUrl": null, "publicationName": "Kalpataru: Jurnal Sejarah dan Pembelajaran Sejarah 9 (1), 54-60, 2023" } ], "metrics": { "indexes": { "scopus": { "gIndex": 0, "hIndex": 0, "articles": 0, "i10Index": 0, "citations": 0, "citedDocuments": 0 }, "webOfScience": { "gIndex": null, "hIndex": null, "articles": 0, "i10Index": null, "citations": 0, "citedDocuments": 0 }, "googleScholar": { "gIndex": 2, "hIndex": 5, "articles": 34, "i10Index": 2, "citations": 98, "citedDocuments": 17 } }, "sintaScore3Yr": 181, "affiliationScore": 544, "sintaScoreOverall": 544, "affiliationScore3Yr": 181 }, "authorId": "6005167", "imageUrl": "https://scholar.googleusercontent.com/citations?view_op=view_photo&user=hHkSmMoAAAAJ&citpid=1", "provider": "sinta", "subjects": [ { "name": "History", "subjectId": "13474" }, { "name": "Humaniora", "subjectId": "15100" } ], "affiliationId": "4479", "departmentName": "S1 - Sejarah", "affiliationName": "Universitas Pertahanan" } ``` --- ### Authors SINTA — researcher listing (/authors?q=&page=), the Indonesian scholar index. Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/authors` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text researcher search. Omit for the full ranked index | | `page` | number | query | no | Page number, 10 researchers per page. Default 1 | | `sort` | enum(score3yr|scoreOverall|scopusHIndex|googleScholarHIndex|wosHIndex) | query | no | Ranking order. Default score3yr | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/authors?query=budi&page=1&sort=score3yr" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/authors?query=budi&page=1&sort=score3yr", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/authors?query=budi&page=1&sort=score3yr", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "sort": "score3yr", "count": 10, "items": [ { "url": "https://sinta.kemdiktisaintek.go.id/authors/profile/6020372", "name": "MOCHAMAD ARIEF BUDIHARDJO", "metrics": { "wosHIndex": 11, "scopusHIndex": 19, "sintaScore3Yr": 1282, "sintaScoreOverall": 5607, "googleScholarHIndex": 24 }, "authorId": "6020372", "imageUrl": "https://scholar.googleusercontent.com/citations?view_op=view_photo&user=HeCykBgAAAAJ&citpid=1", "subjects": [], "affiliationId": "6", "departmentName": "Teknik Lingkungan (S2)", "affiliationName": "Universitas Diponegoro", "googleScholarId": "HeCykBgAAAAJ" }, { "url": "https://sinta.kemdiktisaintek.go.id/authors/profile/42858", "name": "ARIEF BUDIMAN", "metrics": { "wosHIndex": 0, "scopusHIndex": 23, "sintaScore3Yr": 1273, "sintaScoreOverall": 7034, "googleScholarHIndex": 28 }, "authorId": "42858", "imageUrl": "https://scholar.googleusercontent.com/citations?view_op=view_photo&user=KhtD2iwAAAAJ&citpid=1", "subjects": [ { "name": "Process system engineering", "subjectId": "29491" }, { "name": "Microalgae biorefinery", "subjectId": "90858" }, { "name": "Energy & exergy analysis", "subjectId": "3317" }, { "name": "Biodiesel", "subjectId": "8367" }, { "name": "Biomass to energy", "subjectId": "9179" } ], "affiliationId": "384", "departmentName": "Magister Teknik Sistem (S2)", "affiliationName": "Universitas Gadjah Mada", "googleScholarId": "KhtD2iwAAAAJ" }, { "url": "https://sinta.kemdiktisaintek.go.id/authors/profile/6092782", "name": "BUDIMAN", "metrics": { "wosHIndex": 0, "scopusHIndex": 3, "sintaScore3Yr": 1251, "sintaScoreOverall": 4365, "googleScholarHIndex": 10 }, "authorId": "6092782", "imageUrl": "https://scholar.googleusercontent.com/citations?view_op=view_photo&user=EdLQIy8AAAAJ&citpid=1", "subjects": [ { "name": "Machine Learning", "subjectId": "45831" }, { "name": "Data Science", "subjectId": "17159" }, { "name": "Deep Learning", "subjectId": "17431" }, { "name": "Algorithm", "subjectId": "2548" }, { "name": "Software Development", "subjectId": "38727" } ], "affiliationId": "1433", "departmentName": "Informatika (S1)", "affiliationName": "Universitas Informatika Dan Bisnis Indonesia", "googleScholarId": "EdLQIy8AAAAJ" }, { "url": "https://sinta.kemdiktisaintek.go.id/authors/profile/6028041", "name": "BAMBANG BUDI WIYONO", "metrics": { "wosHIndex": 0, "scopusHIndex": 18, "sintaScore3Yr": 1210, "sintaScoreOverall": 4435, "googleScholarHIndex": 38 }, "authorId": "6028041", "imageUrl": "https://scholar.googleusercontent.com/citations?view_op=view_photo&user=a_nzrJUAAAAJ&citpid=1", "subjects": [ { "name": "Educational Management", "subjectId": "52337" } ], "affiliationId": "438", "departmentName": "Manajemen Pendidikan (S3)", "affiliationName": "Universitas Negeri Malang", "googleScholarId": "a_nzrJUAAAAJ" }, { "url": "https://sinta.kemdiktisaintek.go.id/authors/profile/48991", "name": "SETIA BUDI", "metrics": { "wosHIndex": 9, "scopusHIndex": 15, "sintaScore3Yr": 1154, "sintaScoreOverall": 3945, "googleScholarHIndex": 22 }, "authorId": "48991", "imageUrl": "https://scholar.googleusercontent.com/citations?view_op=view_photo&user=5LDGJ74AAAAJ&citpid=1", "subjects": [ { "name": "Nanomaterials & Thin Film", "subjectId": "36544" } ], "affiliationId": "435", "departmentName": "Kimia (S1)", "affiliationName": "Universitas Negeri Jakarta", "googleScholarId": "5LDGJ74AAAAJ" }, { "url": "https://sinta.kemdiktisaintek.go.id/authors/profile/6145946", "name": "BUDI UTOMO", "metrics": { "wosHIndex": 5, "scopusHIndex": 9, "sintaScore3Yr": 1149, "sintaScoreOverall": 6801, "googleScholarHIndex": 16 }, "authorId": "6145946", "imageUrl": "https://scholar.googleusercontent.com/citations?view_op=view_photo&user=QirafxMAAAAJ&citpid=1", "subjects": [ { "name": "Public Health", "subjectId": "45887" }, { "name": "Medical Epidemiology", "subjectId": "47336" } ], "affiliationId": "380", "departmentName": "Ilmu Kesehatan Reproduksi (S2)", "affiliationName": "Universitas Airlangga", "googleScholarId": "QirafxMAAAAJ" }, { "url": "https://sinta.kemdiktisaintek.go.id/authors/profile/28781", "name": "GELAR BUDIMAN", "metrics": { "wosHIndex": 3, "scopusHIndex": 10, "sintaScore3Yr": 1142, "sintaScoreOverall": 3689, "googleScholarHIndex": 14 }, "authorId": "28781", "imageUrl": "https://scholar.googleusercontent.com/citations?view_op=view_photo&user=CnrgPgEAAAAJ&citpid=1", "subjects": [ { "name": "Electrical Engineering", "subjectId": "45837" }, { "name": "Wireless Communication", "subjectId": "45195" }, { "name": "Multimedia System", "subjectId": "36082" }, { "name": "Signal Processing", "subjectId": "36661" }, { "name": "Watermarking", "subjectId": "44990" } ], "affiliationId": "1093", "departmentName": "Teknik Telekomunikasi (S1)", "affiliationName": "Universitas Telkom", "googleScholarId": "CnrgPgEAAAAJ" }, { "url": "https://sinta.kemdiktisaintek.go.id/authors/profile/6024751", "name": "BUDI ASTUTI", "metrics": { "wosHIndex": 1, "scopusHIndex": 6, "sintaScore3Yr": 1123, "sintaScoreOverall": 2857, "googleScholarHIndex": 22 }, "authorId": "6024751", "imageUrl": "https://scholar.googleusercontent.com/citations?view_op=view_photo&user=a0zE3PYAAAAJ&citpid=1", "subjects": [ { "name": "Bimbingan dan Konseling Pribadi Sosial", "subjectId": "8025" } ], "affiliationId": "381", "departmentName": "Bimbingan dan Konseling (S3)", "affiliationName": "Universitas Negeri Yogyakarta", "googleScholarId": "a0zE3PYAAAAJ" } ], "limit": 10, "query": "budi", "total": 3545, "hasMore": true, "nextPage": 2, "provider": "sinta" } ``` --- ### Books SINTA — academic book listing (/books?q=&page=). Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id and sinta.ristekbrin.go.id are DEAD names — a 0-19ms connect failure there is DNS, not a WAF. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/books` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text title search. Omit for the full index | | `page` | number | query | no | Page number, 10 books per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/books?query=kimia&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/books?query=kimia&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/books?query=kimia&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "city": "YOGYAKARTA", "isbn": "9786022290230", "year": 2001, "title": "Kimia Komputasi: Molecular Docking Plants (Protein-Ligand-Ant-System)", "source": "MANUAL", "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/public/images/books/_9786022290230.jpg", "claimedBy": [ { "name": "HARI PURNOMO", "authorId": "6012096" } ], "publisher": "Pustaka Pelajar", "authorNames": "Hari Purnomo" }, { "city": "YOGYAKARTA", "isbn": "9786022291923", "year": 2001, "title": "Kimia Komputasi untuk Farmasi dan Ilmu Terkait", "source": "MANUAL", "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/public/images/books/_9786022291923.jpg", "claimedBy": [ { "name": "HARI PURNOMO", "authorId": "6012096" } ], "publisher": "Pustaka Pelajar", "authorNames": "Hari Purnomo" }, { "city": "Jakarta", "isbn": "9786022021995", "year": 2016, "title": "Dasar Dasar Fitokimia Untuk Diploma III Farmasi", "source": "MANUAL", "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/public/images/books/_9786022021995.jpg", "claimedBy": [ { "name": "MHD RIZA MARJONI", "authorId": "259320" } ], "publisher": "CV. Trans Info Media", "authorNames": "Mhd Riza Marjoni, S.Si, M.Farm, Apt" }, { "city": "Yogyakarta", "isbn": "9786025775253", "year": 2018, "title": "Kimia dan Pengetahuan Lingkungan Industri", "source": "MANUAL", "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/public/images/books/_9786025775253.jpg", "claimedBy": [ { "name": "ATEP AFIA HIDAYAT", "authorId": "6003684" } ], "publisher": "Penerbit WR", "authorNames": "Atep Afia Hidayat, Muhammad Kholil" }, { "city": "BOGOR", "isbn": "9786026408600", "year": 2018, "title": "BUKU REFERENSI MAHONI : Kandungan Kimia Dan Pemanfaatannya Sebagai Termisida Alami", "source": "MANUAL", "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/public/images/books/_9786026408600.jpg", "claimedBy": [ { "name": "LENY HELIAWATI", "authorId": "6650849" } ], "publisher": "ALQAPRINT JATINANGOR – Anggota Ikapi", "authorNames": "Dr. Leny Heliawati, M.Si" }, { "city": "Malang", "isbn": "9786027705413", "year": 2012, "title": "Petunjuk Praktikum Kimia Dasar I", "source": "MANUAL", "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/public/images/books/_9786027705413.jpg", "claimedBy": [ { "name": "OKTAVIA SULISTINA", "authorId": "5977434" } ], "publisher": "Bayu Media Publishing", "authorNames": "Dra. Hj. Tri Maryami, M.Pd, Evi Susanti, S.Si., M.Si., Eli Hendrik Sanjaya, S.Si., M.Si., Oktavia Sulistina, S.Pd., M.Pd., Laurent Octaviana, S.Pd., M.Si" }, { "city": "Makassar", "isbn": "9786237045571", "year": 2019, "title": "KIMIA ORGANIK (Pengantar, Sifat, Struktur Molekul, Tata Nama, Reaksi, Sintesis, dan Kegunaan)", "source": "MANUAL", "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/public/images/books/_9786237045571_.jpg", "claimedBy": [], "publisher": "Leisyah", "authorNames": "Prof. Dr. Ruslin Hadanu, S.Pd., M.Si" }, { "city": "Jakarta", "isbn": "9786237518129", "year": 2019, "title": "UNIT PEMBELAJARAN STEAM TERINTEGRASI PBL PBL, SMA KELAS XI PADA LINTAS MATA PELAJARAN BIOLOGI, FISIKA, KIMIA “Pembuatan Alat Penentu Kalor BBM Hemat Energi”", "source": "MANUAL", "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/public/images/books/_9786237518129.jpg", "claimedBy": [], "publisher": "UNJ Press", "authorNames": "Lambas, Sularso Budilaksono, Eko Hadi Prayitno, Ahmad Rosadi, Muhammad Anno Suwarno, Atep Kartiansyah." } ], "limit": 10, "query": "kimia", "total": 3335, "hasMore": true, "nextPage": 2, "provider": "sinta" } ``` --- ### Community Services SINTA — community-service records (/comservices?q=&page=), the "pengabdian kepada masyarakat" ledger. Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/community-services` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text search of the global index. Not accepted alongside authorId or affiliationId | | `page` | number | query | no | Page number for the global index, 10 records per page. Default 1 | | `authorId` | string | query | no | Read one researcher's community-service records instead of the global index | | `affiliationId` | string | query | no | Read one institution's community-service records instead of the global index | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/community-services?query=kesehatan&page=1&authorId=42858&affiliationId=384" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/community-services?query=kesehatan&page=1&authorId=42858&affiliationId=384", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/community-services?query=kesehatan&page=1&authorId=42858&affiliationId=384", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "year": 2026, "title": "KOLABORASI SDGS INDONESIA - VIETNAM UNTUK PERTANIAN MASA DEPAN : PEMANFAATAN LIMBAH ORGANIK DAN KONSORSIUM MIKROORGANISME LOKAL (MOL) BAGI PRODUKSI PANGAN SEHAT BERKELANJUTAN DI DA NANG BERSAMA UNIVERSITY OF SCIENCE AND EDUCATION - THE UNIVERSITY OF DA NA", "leader": "Sudarma Dita Wijayanti", "scheme": "PENELITIAN PNBP ( INT SDGS )", "source": null, "status": null, "personnel": [ { "name": "Elok Waziiroh", "authorId": "6035529" }, { "name": "Budi Waluyo", "authorId": "35463" } ], "fundAmount": 70000000 }, { "year": 2026, "title": "PEMBERDAYAAN UMKM PRONOJIWO MELALUI INTEGRITAS BUDIDAYA JAMUR DAN PENGOLAHAN SALAK BERBASIS KELOMPOK TANI DALAM RANGKA PENGUATAN LEGALITAS USAHA", "leader": "Dhiana Puspitawati", "scheme": "PENELITIAN PNBP ( DM 2026 )", "source": null, "status": null, "personnel": [ { "name": "Asti Amelia Novita", "authorId": "6000884" }, { "name": "Mujibur Rahman Khairul Muluk", "authorId": "6029338" } ], "fundAmount": 35000000 }, { "year": 2026, "title": "PENGEMBANGAN SISTEM INFORMASI MANAJEMEN BANTUAN HUKUM UNTUK PENGUATAN AKSES KEADILAN MASYARAKAT MISKIN MELALUI PARALEGAL LPBH NU KOTA MALANG", "leader": "Fachrizal Afandi", "scheme": "PENELITIAN PNBP ( DM 2026 )", "source": null, "status": null, "personnel": [ { "name": "Hagus Tarno", "authorId": "5988420" }, { "name": "Ilhamuddin", "authorId": "6019920" } ], "fundAmount": 30000000 }, { "year": 2026, "title": "PEMBERDAYAAN MASYARAKAT MELALUI PELATIHAN PRODUKSI BERAS GRANUL BERBASIS KOMODITAS LOKAL UNTUK PENCEGAHAN STUNTING DI DESA TUBLOPO KABUPATEN TIMOR TENGAH SELATAN, NTT", "leader": "Widya Dwi Rukmi Putri", "scheme": "PENELITIAN PNBP ( DM 2026 )", "source": null, "status": null, "personnel": [ { "name": "Nur Hidayat", "authorId": "260289" }, { "name": "Nurul Muslihah", "authorId": "6009295" } ], "fundAmount": 70000000 }, { "year": 2026, "title": "EKORIPARIAN MELALUI OLAH LIMBAH TAHU DAN INTEGRATED FARMING DI DUSUN TEGALPASANGAN PAKIS KEMBAR KABUPATEN MALANG", "leader": "Nur Hidayat", "scheme": "PENELITIAN PNBP ( LIVING LAB )", "source": null, "status": null, "personnel": [ { "name": "Asus Maizar Suryanto H", "authorId": "6123425" }, { "name": "Lia Nihlah Najwah", "authorId": "6683860" } ], "fundAmount": 55000000 }, { "year": 2026, "title": "DESA BATU MEKAR AREN MANDIRI BERDAYA: DISEMINASI INOVASI TEKNOLOGI PRODUKSI GULA AREN DAN PENGUATAN KELEMBAGAAN MENUJU SENTRA AGROINDUSTRI BERKELANJUTAN DI LOMBOK BARAT", "leader": "Siti Asmaul Mustaniroh", "scheme": "PENELITIAN PNBP ( DM 2026 )", "source": null, "status": null, "personnel": [ { "name": "Fitria Dina Riana", "authorId": "6668535" }, { "name": "Rini Yulianingsih", "authorId": "5978481" } ], "fundAmount": 60000000 }, { "year": 2026, "title": "DIVERSIFIKASI PRODUK TALAS BENENG BERBASIS TEKNOLOGI DAN MANAJEMEN BERKELANJUTAN DI BUMDES SUMBER MULYO, KECAMATAN DOKO, KABUPATEN BLITAR", "leader": "Suprayogi", "scheme": "PENELITIAN PNBP ( DM 2026 )", "source": null, "status": null, "personnel": [ { "name": "Aulia Nur Mustaqiman", "authorId": "6688699" }, { "name": "Mochammad Syamsul Hadi", "authorId": "5993617" } ], "fundAmount": 35000000 }, { "year": 2026, "title": "EVALUASI PROSES PRODUKSI SPPG DAN TINGKAT KEPUASAN PENERIMA MANFAAT UNTUK MENINGKATKAN ASPEK KEHALALAN, KEAMANAN, DAN GIZI PROGRAM MBG", "leader": "Sucipto", "scheme": "PENELITIAN PNBP ( LIVING LAB )", "source": null, "status": null, "personnel": [ { "name": "Eva Putri Arfiani", "authorId": "6165089" }, { "name": "Anas Budiharjo", "authorId": "6689286" } ], "fundAmount": 50000000 } ], "limit": 10, "query": null, "scope": "affiliation", "total": null, "hasMore": false, "scopeId": "404", "nextPage": null, "provider": "sinta" } ``` --- ### Departments SINTA — study-programme listing (/departments?q=&page=), grouped by national programme code. Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/departments` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text programme search. Omit for the full index | | `page` | number | query | no | Page number, 10 programmes per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/departments?query=teknik&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/departments?query=teknik&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/departments?query=teknik&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "url": "https://sinta.kemdiktisaintek.go.id/departments/affiliations/41001", "name": "Doktor Ilmu Teknik Pertanian", "level": "S3", "affiliations": [ { "name": "Institut Pertanian Bogor", "affiliationId": "428" }, { "name": "Universitas Gadjah Mada", "affiliationId": "384" } ], "departmentCode": "41001", "affiliationCount": 2 }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/affiliations/28101", "name": "Ilmu Dan Teknik Material", "level": "S2", "affiliations": [ { "name": "Universitas Sriwijaya", "affiliationId": "440" }, { "name": "Institut Teknologi Bandung", "affiliationId": "379" }, { "name": "Universitas Indonesia", "affiliationId": "430" } ], "departmentCode": "28101", "affiliationCount": 3 }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/affiliations/28001", "name": "Ilmu Dan Teknik Material", "level": "S3", "affiliations": [ { "name": "Institut Teknologi Bandung", "affiliationId": "379" }, { "name": "Universitas Indonesia", "affiliationId": "430" } ], "departmentCode": "28001", "affiliationCount": 2 }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/affiliations/20003", "name": "Ilmu Teknik", "level": "S3", "affiliations": [ { "name": "Universitas Negeri Yogyakarta", "affiliationId": "381" }, { "name": "Universitas Udayana", "affiliationId": "433" }, { "name": "Universitas Syiah Kuala", "affiliationId": "442" } ], "departmentCode": "20003", "affiliationCount": 3 }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/affiliations/38001", "name": "Ilmu Teknik Kelautan", "level": "S3", "affiliations": [ { "name": "Institut Teknologi Sepuluh Nopember", "affiliationId": "417" }, { "name": "Institut Pertanian Bogor", "affiliationId": "428" } ], "departmentCode": "38001", "affiliationCount": 2 }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/affiliations/41401", "name": "Keteknikan Pertanian", "level": "D3", "affiliations": [ { "name": "Politeknik Enjiniring Pertanian Indonesia", "affiliationId": "8244486" }, { "name": "Politeknik Palu", "affiliationId": "2885" }, { "name": "Politeknik Gorontalo", "affiliationId": "2884" }, { "name": "Politeknik Gorontalo", "affiliationId": "2884" }, { "name": "Politeknik Kelautan dan Perikanan Sorong", "affiliationId": "4409" } ], "departmentCode": "41401", "affiliationCount": 8 }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/affiliations/22105", "name": "Magister Teknik Pengelolaan Bencana Alam", "level": "S2", "affiliations": [ { "name": "Universitas Pembangunan Nasional Veteran Yogyakarta", "affiliationId": "526" }, { "name": "Universitas Gadjah Mada", "affiliationId": "384" } ], "departmentCode": "22105", "affiliationCount": 2 }, { "url": "https://sinta.kemdiktisaintek.go.id/departments/affiliations/24103", "name": "Magister Teknik Pengendalian Pencemaran Industrial", "level": "S2", "affiliations": [ { "name": "Universitas Gadjah Mada", "affiliationId": "384" } ], "departmentCode": "24103", "affiliationCount": 1 } ], "limit": 10, "query": "teknik", "total": 330, "hasMore": true, "nextPage": 2, "provider": "sinta" } ``` --- ### Google Scholar SINTA — Google Scholar-sourced article records (/google?q=&page=). Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/google-scholar` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text search of the global index. Not accepted alongside authorId or affiliationId | | `page` | number | query | no | Page number for the global index, 10 records per page. Default 1 | | `authorId` | string | query | no | Read one researcher's Scholar-indexed articles instead of the global index | | `affiliationId` | string | query | no | Read one institution's Scholar-indexed articles instead of the global index | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/google-scholar?query=malaria&page=1&authorId=42858&affiliationId=384" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/google-scholar?query=malaria&page=1&authorId=42858&affiliationId=384", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/google-scholar?query=malaria&page=1&authorId=42858&affiliationId=384", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "url": "https://scholar.google.com/scholar?q=+intitle:'Penerapan Pengaturan Victim Impact Statement Pada Perkara Tindak Pidana Lingkungan Hidup Dalam Memenuhi Perlindungan Korban'", "year": 2035, "title": "Penerapan Pengaturan Victim Impact Statement Pada Perkara Tindak Pidana Lingkungan Hidup Dalam Memenuhi Perlindungan Korban", "authors": "FAK Aji, LR Bagaskoro", "citedByCount": 0, "publicationUrl": null, "publicationName": "RechtJiva, 2035" }, { "url": "https://scholar.google.com/scholar?q=+intitle:'STUDI PERENCANAAN SISTEM PENYEDIAAN AIR BERSIH DI KECAMATAN SITUBONDO KABUPATEN SITUBONDO'", "year": 2029, "title": "STUDI PERENCANAAN SISTEM PENYEDIAAN AIR BERSIH DI KECAMATAN SITUBONDO KABUPATEN SITUBONDO", "authors": "AW Okyuvan, R Asmaranto, R Haribowo", "citedByCount": 0, "publicationUrl": null, "publicationName": null }, { "url": "https://scholar.google.com/scholar?q=+intitle:'Occupational Mismatch and Income Effects in Indonesia’s Gig Economy: A Gender Perspective'", "year": 2027, "title": "Occupational Mismatch and Income Effects in Indonesia’s Gig Economy: A Gender Perspective", "authors": "AM Setyanti, K Ashar, DB Santoso, N Badriyah", "citedByCount": 0, "publicationUrl": null, "publicationName": "Journal of Population and Social Studies 35, 432-452, 2027" }, { "url": "https://scholar.google.com/scholar?q=+intitle:'Unraveling the Molecular Evolution and Structural Landscape of Klebsiella pneumoniae Carbapenemase Variants'", "year": 2027, "title": "Unraveling the Molecular Evolution and Structural Landscape of Klebsiella pneumoniae Carbapenemase Variants", "authors": "MY Airlangga, RS Maharani, AR Putri, MT Andriasari, BSSF Cuhada, ...", "citedByCount": 0, "publicationUrl": null, "publicationName": "Current Applied Science and Technology 27 (3), 2027" }, { "url": "https://scholar.google.com/scholar?q=+intitle:'Protein Targets and the Roles of Natural Compounds in the Treatment and Management of Hypercholesterolemia: A Comprehensive Review'", "year": 2027, "title": "Protein Targets and the Roles of Natural Compounds in the Treatment and Management of Hypercholesterolemia: A Comprehensive Review", "authors": "J Umar, T Turhadi, TA Wihastuti, F Fatchiyah", "citedByCount": 0, "publicationUrl": null, "publicationName": "Current Applied Science and Technology, 2027" }, { "url": "https://scholar.google.com/scholar?q=+intitle:'Effectiveness, Sequence Characterization, and DNA QR Code of Internal Transcribed Spacer 1 (ITS1) in Identification of Scopellaria marginata (Cucurbitaceae)'", "year": 2027, "title": "Effectiveness, Sequence Characterization, and DNA QR Code of Internal Transcribed Spacer 1 (ITS1) in Identification of Scopellaria marginata (Cucurbitaceae)", "authors": "BN Sudarjayanti, B Rahardi, EL Arumingtyas, T Turhadi", "citedByCount": 0, "publicationUrl": null, "publicationName": "Current Applied Science and Technology, 2027" }, { "url": "https://scholar.google.com/scholar?q=+intitle:'Unraveling the Molecular Evolution and Structural Landscape of Klebsiella pneumoniae Carbapenemase Variants'", "year": 2027, "title": "Unraveling the Molecular Evolution and Structural Landscape of Klebsiella pneumoniae Carbapenemase Variants", "authors": "MY Airlangga, RS Maharani, AR Putri, MT Andriasari, BSSF Cuhada, ...", "citedByCount": 0, "publicationUrl": null, "publicationName": "Current Applied Science and Technology 27 (3), 2027" }, { "url": "https://scholar.google.com/scholar?q=+intitle:'Protein Targets and the Roles of Natural Compounds in the Treatment and Management of Hypercholesterolemia: A Comprehensive Review'", "year": 2027, "title": "Protein Targets and the Roles of Natural Compounds in the Treatment and Management of Hypercholesterolemia: A Comprehensive Review", "authors": "J Umar, T Turhadi, TA Wihastuti, F Fatchiyah", "citedByCount": 0, "publicationUrl": null, "publicationName": "Current Applied Science and Technology, 2027" } ], "limit": 10, "query": null, "scope": "affiliation", "total": null, "hasMore": false, "scopeId": "404", "nextPage": null, "provider": "sinta" } ``` --- ### Insight SINTA — national aggregate statistics. Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id and sinta.ristekbrin.go.id are DEAD names — a 0-19ms connect failure there is DNS, not a WAF. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/insight` - **Cache TTL:** 300s **Parameters:** _No parameters._ **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/insight" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/insight", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/insight", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "authors": 335086, "journals": 16774, "provider": "sinta", "departments": 2481, "affiliations": 5562 } ``` --- ### Iprs SINTA — intellectual-property listing (/iprs?q=&page=), patents, copyrights and industrial designs. Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/iprs` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text search. The upstream index returns nothing for most terms | | `page` | number | query | no | Page number, 10 records per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/iprs?query=bambu&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/iprs?query=bambu&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/iprs?query=bambu&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 0, "items": [], "limit": 10, "query": "bambu", "total": null, "hasMore": false, "nextPage": null, "provider": "sinta" } ``` --- ### Journals SINTA — accredited journal listing (/journals?q=&page=). Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id and sinta.ristekbrin.go.id are DEAD names — a 0-19ms connect failure there is DNS, not a WAF. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/journals` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text journal search. Omit for the full ranked index | | `page` | number | query | no | Page number, 10 journals per page. Default 1 | | `sort` | enum(impact|h5Index|hIndex|citations|citations5Yr) | query | no | Ranking order. Default impact | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/journals?query=kedokteran&page=1&sort=impact" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/journals?query=kedokteran&page=1&sort=impact", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/journals?query=kedokteran&page=1&sort=impact", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "sort": "impact", "count": 10, "items": [ { "url": "https://sinta.kemdiktisaintek.go.id/journals/profile/2137", "name": "Jurnal Kedokteran dan Kesehatan Indonesia", "metrics": { "impact": 1.06, "h5Index": 20, "citations": 2380, "citations5Yr": 1678 }, "coverUrl": "https://scholar.googleusercontent.com/citations?view_op=medium_photo&user=McBFJloAAAAJ&citpid=2", "editorUrl": "https://journal.uii.ac.id/JKKI/about/editorialTeam", "garudaUrl": "https://garuda.kemdiktisaintek.go.id/journal/view/26021", "journalId": "2137", "printIssn": "20854145", "websiteUrl": "https://journal.uii.ac.id/JKKI", "subjectAreas": [ "Health", "Science" ], "accreditation": "S1", "publisherName": "Fakultas Kedokteran, Universitas Islam Indonesia", "electronicIssn": "25272950", "googleScholarUrl": "https://scholar.google.co.id/citations?user=McBFJloAAAAJ&hl=en", "publisherAffiliationId": "382" }, { "url": "https://sinta.kemdiktisaintek.go.id/journals/profile/9042", "name": "JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga", "metrics": { "impact": 1.41, "h5Index": 8, "citations": 377, "citations5Yr": 373 }, "coverUrl": "https://scholar.googleusercontent.com/citations?view_op=medium_photo&user=U_6hsW8AAAAJ&citpid=2", "editorUrl": "https://e-journal.unair.ac.id/JUXTA/about/editorialTeam", "garudaUrl": "https://garuda.kemdiktisaintek.go.id/journal/view/16223", "journalId": "9042", "printIssn": "19073623", "websiteUrl": "https://e-journal.unair.ac.id/JUXTA", "subjectAreas": [], "accreditation": "S2", "publisherName": "Universitas Airlangga", "electronicIssn": "26849453", "googleScholarUrl": "https://scholar.google.co.id/citations?user=U_6hsW8AAAAJ&hl=en", "publisherAffiliationId": "380" }, { "url": "https://sinta.kemdiktisaintek.go.id/journals/profile/1111", "name": "Dentino : Jurnal Kedokteran Gigi", "metrics": { "impact": 1, "h5Index": 16, "citations": 2550, "citations5Yr": 1748 }, "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/img/journal/", "editorUrl": "https://ppjp.ulm.ac.id/journal/index.php/dentino/about/editorialTeam", "garudaUrl": "https://garuda.kemdiktisaintek.go.id/journal/view/9342", "journalId": "1111", "printIssn": "23375310", "websiteUrl": "https://ppjp.ulm.ac.id/journal/index.php/dentino/", "subjectAreas": [ "Health" ], "accreditation": "S2", "publisherName": "Fakultas Kedokteran Gigi Universitas Lambung Mangkurat", "electronicIssn": "25274937", "googleScholarUrl": null, "publisherAffiliationId": "439" }, { "url": "https://sinta.kemdiktisaintek.go.id/journals/profile/934", "name": "Dental Journal (Majalah Kedokteran Gigi)", "metrics": { "impact": 0.92, "h5Index": 19, "citations": 6409, "citations5Yr": 3510 }, "coverUrl": "https://scholar.googleusercontent.com/citations?view_op=medium_photo&user=eiKFibAAAAAJ&citpid=2", "editorUrl": "https://e-journal.unair.ac.id/MKG/about/editorialTeam", "garudaUrl": "https://garuda.kemdiktisaintek.go.id/journal/view/9640", "journalId": "934", "printIssn": "19783728", "websiteUrl": "https://e-journal.unair.ac.id/MKG/index", "subjectAreas": [ "Health" ], "accreditation": "S2", "publisherName": "Universitas Airlangga", "electronicIssn": "24429740", "googleScholarUrl": "https://scholar.google.co.id/citations?user=eiKFibAAAAAJ&hl=en", "publisherAffiliationId": "380" }, { "url": "https://sinta.kemdiktisaintek.go.id/journals/profile/4044", "name": "Mutiara Medika: Jurnal Kedokteran dan Kesehatan", "metrics": { "impact": 0.85, "h5Index": 20, "citations": 2644, "citations5Yr": 2279 }, "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/img/journal/", "editorUrl": "https://journal.umy.ac.id/index.php/mm/about/editorialTeam", "garudaUrl": "https://garuda.kemdiktisaintek.go.id/journal/view/8108", "journalId": "4044", "printIssn": "14118033", "websiteUrl": "https://journal.umy.ac.id/index.php/mm/index", "subjectAreas": [ "Health" ], "accreditation": "S2", "publisherName": "Universitas Muhammadiyah Yogyakarta", "electronicIssn": "26140101", "googleScholarUrl": null, "publisherAffiliationId": "1872" }, { "url": "https://sinta.kemdiktisaintek.go.id/journals/profile/9992", "name": "Interdental Jurnal Kedokteran Gigi (IJKG)", "metrics": { "impact": 0.72, "h5Index": 11, "citations": 527, "citations5Yr": 501 }, "coverUrl": "https://scholar.googleusercontent.com/citations?view_op=medium_photo&user=mJEMPkkAAAAJ&citpid=2", "editorUrl": "https://e-journal.unmas.ac.id/index.php/interdental/about/editorialTeam", "garudaUrl": "https://garuda.kemdiktisaintek.go.id/journal/view/15889", "journalId": "9992", "printIssn": "19799144", "websiteUrl": "https://e-journal.unmas.ac.id/index.php/interdental/about", "subjectAreas": [], "accreditation": "S2", "publisherName": "Fakultas Kedokteran Gigi Universitas Mahasaraswati", "electronicIssn": "26855208", "googleScholarUrl": "https://scholar.google.co.id/citations?user=mJEMPkkAAAAJ&hl=en", "publisherAffiliationId": "2365" }, { "url": "https://sinta.kemdiktisaintek.go.id/journals/profile/4029", "name": "Jurnal Kedokteran Gigi Universitas Padjadjaran", "metrics": { "impact": 0.67, "h5Index": 10, "citations": 483, "citations5Yr": 468 }, "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/img/journal/", "editorUrl": "http://jurnal.unpad.ac.id/jkg/about/editorialTeam", "garudaUrl": "https://garuda.kemdiktisaintek.go.id/journal/view/9990", "journalId": "4029", "printIssn": "08546002", "websiteUrl": "http://jurnal.unpad.ac.id/jkg", "subjectAreas": [ "Health" ], "accreditation": "S2", "publisherName": "Fakultas Kedokteran Gigi Universitas Padjadjaran", "electronicIssn": "25496514", "googleScholarUrl": null, "publisherAffiliationId": "481" }, { "url": "https://sinta.kemdiktisaintek.go.id/journals/profile/902", "name": "Majalah Kedokteran Gigi Indonesia", "metrics": { "impact": 0.32, "h5Index": 19, "citations": 1806, "citations5Yr": 1579 }, "coverUrl": "https://sinta.kemdiktisaintek.go.id/authorverification/img/journal/", "editorUrl": "https://jurnal.ugm.ac.id/mkgi/about/editorialTeam", "garudaUrl": "https://garuda.kemdiktisaintek.go.id/journal/view/7843", "journalId": "902", "printIssn": "24600164", "websiteUrl": "https://jurnal.ugm.ac.id/mkgi/index", "subjectAreas": [ "Health" ], "accreditation": "S2", "publisherName": "Fakultas Kedokteran Gigi Universitas Gadjah Mada", "electronicIssn": "24422576", "googleScholarUrl": null, "publisherAffiliationId": "384" } ], "limit": 10, "query": "kedokteran", "total": 81, "hasMore": true, "nextPage": 2, "provider": "sinta" } ``` --- ### Researches SINTA — funded research records (/researches?q=&page=). Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id and sinta.ristekbrin.go.id are DEAD names — a 0-19ms connect failure there is DNS, not a WAF. - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/researches` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text search of the global index. Not accepted alongside authorId or affiliationId | | `page` | number | query | no | Page number for the global index, 10 records per page. Default 1 | | `authorId` | string | query | no | Read one researcher's funded research records instead of the global index | | `affiliationId` | string | query | no | Read one institution's funded research records instead of the global index | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/researches?query=kesehatan&page=1&authorId=42858&affiliationId=384" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/researches?query=kesehatan&page=1&authorId=42858&affiliationId=384", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/researches?query=kesehatan&page=1&authorId=42858&affiliationId=384", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "year": 2026, "title": "Aplikasi Berbasis Data Smartwatch untuk Deteksi Dini Gangguan Kardiovaskuler dan Optimalisasi Gizi sebagai Penunjang Terapi", "leader": "Erna Susanti", "scheme": "Penelitian Kompetitif Nasional ( PFR )", "source": null, "status": null, "personnel": [ { "name": "Nour Athiroh Abdoes Sjakoer", "authorId": "5977563" }, { "name": "Endang Susilowati", "authorId": "6699891" }, { "name": "Aryo Pinandito", "authorId": "5993073" }, { "name": "Herman Tolle", "authorId": "32930" } ], "fundAmount": 112210000 }, { "year": 2026, "title": "Pengembangan Model Sistem Simulasi Visual Digital Ruang Terbuka Perkotaan Berbasis AI untuk Smart City Kota Malang", "leader": "Herry Santosa", "scheme": "Penelitian Kompetitif Nasional ( PT-LM )", "source": null, "status": null, "personnel": [ { "name": "Jenny Ernawati", "authorId": "6023159" }, { "name": "Agung Setia Budi", "authorId": "6687913" }, { "name": "Adipandang Yudono", "authorId": "6032093" }, { "name": "Herman Tolle", "authorId": "32930" } ], "fundAmount": 199880000 }, { "year": 2026, "title": "PERBANDINGAN AKURASI SKOR RISIKO TIMI DAN GRACE SEBAGAI PREDIKTOR PROGNOSIS PADA PASIEN STEMI DI RUMAH SAKIT dr. SAIFUL ANWAR PROVINSI JAWA TIMUR", "leader": "Titin Andri Wihastuti", "scheme": "Penelitian Kompetitif Nasional ( PPS-PTM )", "source": null, "status": null, "personnel": [ { "name": "Laily Yuliatun", "authorId": "6667999" } ], "fundAmount": 33440000 }, { "year": 2026, "title": "DETEKSI DAN REDUKSI PREMATURE AGING SEL PEMBULUH DARAH AKIBAT PAPARAN NIKOTIN PADA POPULASI PEROKOK", "leader": "Kumboyono", "scheme": "Penelitian Kompetitif Nasional ( PFR )", "source": null, "status": null, "personnel": [ { "name": "Titin Andri Wihastuti", "authorId": "35299" }, { "name": "Yuliana Ratna Kumala", "authorId": "5996193" } ], "fundAmount": 142170000 }, { "year": 2026, "title": "Rekonstruksi Tata Kelola Air Bersih Terpadu Berbasis Environmental Economic Governance dan Nature-based Solution Dalam Mewujudkan Keadilan Lingkungan", "leader": "Dhiana Puspitawati", "scheme": "Penelitian Kompetitif Nasional ( PFR )", "source": null, "status": null, "personnel": [ { "name": "Rizka Novembrianto", "authorId": "6762558" }, { "name": "Nyoman Diah Utari Dewi", "authorId": "5994010" }, { "name": "Fransiska Ayulistya Susanto", "authorId": "6752339" } ], "fundAmount": 147020000 }, { "year": 2026, "title": "Harmoni Lautan: Kajian kompleksitas dinamika ekosistem dalam pengelolaan sumberdaya ikan ekor kuning untuk keberlanjutan perikanan tangkap di Perairan Karimunjawa", "leader": "Aida Sartimbul", "scheme": "Penelitian Kompetitif Nasional ( PPS-PMDSU )", "source": null, "status": null, "personnel": [ { "name": "Abu Bakar Sambah", "authorId": "6184412" }, { "name": "Setyo Tri Wahyudi", "authorId": "5976049" } ], "fundAmount": 60000000 }, { "year": 2026, "title": "Pola kebiasaan makan ikan pelagis dalam hubungannya dengan faktor oseanografi dan pola musim di Perairan Jawa Timur dan sekitarnya", "leader": "Aida Sartimbul", "scheme": "Penelitian Kompetitif Nasional ( PPS-PMDSU )", "source": null, "status": null, "personnel": [ { "name": "Feni Iranawati", "authorId": "6004163" }, { "name": "Defri Yona", "authorId": "6001793" } ], "fundAmount": 60000000 }, { "year": 2026, "title": "Psychometric Credit Scoring Berbasis Sustainability-Oriented Personality untuk Mitigasi Risiko Kredit pada PT BPR Jwalita Trenggalek (Perseroda)", "leader": "Arif Widyatama", "scheme": "Penelitian Kompetitif Nasional ( PT-LM )", "source": null, "status": null, "personnel": [ { "name": "Salnan Ratih Asriningtias", "authorId": "6820632" }, { "name": "San Rudiyanto", "authorId": "6689108" } ], "fundAmount": 186920000 } ], "limit": 10, "query": null, "scope": "affiliation", "total": null, "hasMore": false, "scopeId": "404", "nextPage": null, "provider": "sinta" } ``` --- ### Scopus SINTA — Scopus-sourced article listing (/scopus?q=&page=). Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/scopus` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text article search. Omit for the full index | | `page` | number | query | no | Page number, 10 articles per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/scopus?query=malaria&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/scopus?query=malaria&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/scopus?query=malaria&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-0020731723&origin=resultslist", "year": 1983, "title": "The role of village malaria workers as village surveillance agents in Bekasi Regency, Indonesia.", "creator": "Lapau B.", "quartile": "Q3 Journal", "scopusId": "0020731723", "citedByCount": 3, "publicationUrl": null, "publicationName": "The Southeast Asian journal of tropical medicine and public health" }, { "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-0021190679&origin=resultslist", "year": 1984, "title": "Corticosteroid in the treatment of cerebral malaria.", "creator": "Rampengan T.", "quartile": "no-Q Journal", "scopusId": "0021190679", "citedByCount": 0, "publicationUrl": null, "publicationName": "Paediatrica Indonesiana" }, { "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-0022124307&origin=resultslist", "year": 1985, "title": "Malaria transmission studies in Jepara and Wonosobo regencies Central Java, Indonesia, during 1981-82.", "creator": "Kirnowardoyo S.", "quartile": "Q4 Journal", "scopusId": "0022124307", "citedByCount": 2, "publicationUrl": null, "publicationName": "Journal of Communicable Diseases" }, { "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-0027018660&origin=resultslist", "year": 1992, "title": "Seroepidemiological studies of malaria in different endemic areas of Indonesia.", "creator": "Sutanto I.", "quartile": "Q3 Journal", "scopusId": "0027018660", "citedByCount": 2, "publicationUrl": null, "publicationName": "The Southeast Asian journal of tropical medicine and public health" }, { "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-0027058337&origin=resultslist", "year": 1992, "title": "Epidemiological study of malaria in north sulawesi, indonesia by fluorescence and giemsa staining", "creator": "Syafruddin", "quartile": "no-Q Journal", "scopusId": "0027058337", "citedByCount": 7, "publicationUrl": null, "publicationName": "Japanese Journal of Medical Science and Biology" }, { "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-0027230340&origin=resultslist", "year": 1993, "title": "Antimalarial effects of purified and ?-tocopherol-fortified n-3 polyunsaturated fatty acids", "creator": "Fujikawa M.", "quartile": "Q1 Journal", "scopusId": "0027230340", "citedByCount": 7, "publicationUrl": null, "publicationName": "The Journal of Nutritional Biochemistry" }, { "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-0027339971&origin=resultslist", "year": 1993, "title": "The roles of Ca2+/calmodulin- and cGMP-dependent pathways in gametogenesis of a rodent malaria parasite, Plasmodium berghei", "creator": "Kawamoto F.", "quartile": "Q1 Journal", "scopusId": "0027339971", "citedByCount": 55, "publicationUrl": null, "publicationName": "European Journal of Cell Biology" }, { "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-0029056637&origin=resultslist", "year": 1995, "title": "Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia", "creator": "Baird J.K.", "quartile": "Q1 Journal", "scopusId": "0029056637", "citedByCount": 75, "publicationUrl": null, "publicationName": "American Journal of Tropical Medicine and Hygiene" } ], "limit": 10, "query": "malaria", "total": null, "hasMore": true, "nextPage": 2, "provider": "sinta" } ``` --- ### Subjects SINTA — subject taxonomy (/subjects?q=&page=), the research fields authors claim. Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/subjects` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `query` | string | query | no | Free-text subject search. Omit for the full taxonomy | | `page` | number | query | no | Page number, 10 subjects per page. Default 1 | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/subjects?query=biology&page=1" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/subjects?query=biology&page=1", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/subjects?query=biology&page=1", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "page": 1, "count": 10, "items": [ { "url": "https://sinta.kemdiktisaintek.go.id/subjects/detail/45828", "name": "Microbiology", "authors": [ { "name": "MUHAMMAD MIFTAHUSSURUR", "authorId": "6031037" }, { "name": "EFRI MARDAWATI", "authorId": "5980776" }, { "name": "KARTIKA AFRIDA FAUZIA", "authorId": "6728405" }, { "name": "KATTY HENDRIANA PRISCILIA RIWU", "authorId": "6874649" }, { "name": "ANDRI FREDIANSYAH", "authorId": "6666503" } ], "subjectId": "45828", "authorCount": 1509 }, { "url": "https://sinta.kemdiktisaintek.go.id/subjects/detail/45517", "name": "Biology", "authors": [ { "name": "ETTY RIANI", "authorId": "6042420" }, { "name": "RUDY AGUNG NUGROHO", "authorId": "5973879" }, { "name": "DWI KUSUMA WAHYUNI", "authorId": "6644946" }, { "name": "MOHAMAD NURZAMAN", "authorId": "6024501" }, { "name": "DINA MAULINA", "authorId": "6039806" } ], "subjectId": "45517", "authorCount": 1454 }, { "url": "https://sinta.kemdiktisaintek.go.id/subjects/detail/35378", "name": "Molecular Biology", "authors": [ { "name": "FAHRUL NURKOLIS", "authorId": "6739132" }, { "name": "ARIF NUR MUHAMMAD ANSORI", "authorId": "6733821" }, { "name": "CITRAWATI DYAH KENCONO WUNGU", "authorId": "6171434" }, { "name": "SYAFRUDDIN ILYAS", "authorId": "56650" }, { "name": "REGGIE SURYA", "authorId": "6760337" } ], "subjectId": "35378", "authorCount": 459 }, { "url": "https://sinta.kemdiktisaintek.go.id/subjects/detail/30764", "name": "Marine Biology", "authors": [ { "name": "NUR FADLI", "authorId": "5973233" }, { "name": "MUCHLISIN Z A", "authorId": "256923" }, { "name": "BUNTORA PASARIBU", "authorId": "6828776" }, { "name": "SAPTO ANDRIYONO", "authorId": "5982504" }, { "name": "BEGINER SUBHAN", "authorId": "5975635" } ], "subjectId": "30764", "authorCount": 148 }, { "url": "https://sinta.kemdiktisaintek.go.id/subjects/detail/8842", "name": "Food Microbiology", "authors": [ { "name": "SRI MULYANI", "authorId": "6683617" }, { "name": "R. HARYO BIMO SETIARTO", "authorId": "6156599" }, { "name": "GEMILANG LARA UTAMA SARIPUDIN", "authorId": "5975431" }, { "name": "ENDANG SUTRISWATI RAHAYU", "authorId": "29966" }, { "name": "ASEP AWALUDIN PRIHANTO", "authorId": "5998786" } ], "subjectId": "8842", "authorCount": 120 }, { "url": "https://sinta.kemdiktisaintek.go.id/subjects/detail/14675", "name": "Conservation Biology", "authors": [ { "name": "LILIK BUDI PRASETYO", "authorId": "5980445" }, { "name": "MUHAMMAD ALI IMRON", "authorId": "259768" }, { "name": "HUSAIN LATUCONSINA", "authorId": "218232" }, { "name": "HADI SUSILO ARIFIN", "authorId": "5976974" }, { "name": "ENDANG ARISOESILANINGSIH", "authorId": "5998149" } ], "subjectId": "14675", "authorCount": 95 }, { "url": "https://sinta.kemdiktisaintek.go.id/subjects/detail/39372", "name": "oral biology", "authors": [ { "name": "BASRI", "authorId": "6187877" }, { "name": "ELZA IBRAHIM AUERKARI", "authorId": "5986261" }, { "name": "IRA ARUNDINA", "authorId": "6049068" }, { "name": "NURLINDAH HAMRUN", "authorId": "6029500" }, { "name": "ARMELIA SARI WIDYARMAN", "authorId": "5984651" } ], "subjectId": "39372", "authorCount": 73 }, { "url": "https://sinta.kemdiktisaintek.go.id/subjects/detail/26167", "name": "Pharmaceutical biology", "authors": [ { "name": "TRIANA HERTIANI", "authorId": "5972830" }, { "name": "MUHAMMAD FAUZAN LUBIS", "authorId": "6738535" }, { "name": "KUSTIARIYAH", "authorId": "36165" }, { "name": "RIKA HARTATI", "authorId": "6032164" }, { "name": "FERRY FERDIANSYAH SOFIAN", "authorId": "6007342" } ], "subjectId": "26167", "authorCount": 46 } ], "limit": 10, "query": "biology", "total": 494, "hasMore": true, "nextPage": 2, "provider": "sinta" } ``` --- ### Wcu SINTA — World Class University indicators (/wcu), the national research-performance series. Live host is sinta.kemdiktisaintek.go.id after the 2024 ministry split; sinta.kemdikbud.go.id - **Method:** `GET` - **Endpoint:** `https://api.zapi.ink/v1/research:sinta/wcu` - **Cache TTL:** 300s **Parameters:** | Name | Type | Location | Required | Description | |------|------|----------|----------|-------------| | `indicator` | string | query | no | Return only this indicator. Omit for every indicator on the page | **cURL:** ```bash curl "https://api.zapi.ink/v1/research:sinta/wcu?indicator=research_output2" \ -H "x-api-key: YOUR_API_KEY" ``` **JavaScript / TypeScript:** ```javascript const res = await fetch("https://api.zapi.ink/v1/research:sinta/wcu?indicator=research_output2", { headers: { "x-api-key": process.env.ZAPI_KEY } }); const data = await res.json(); ``` **Python:** ```python import requests r = requests.get("https://api.zapi.ink/v1/research:sinta/wcu?indicator=research_output2", headers={"x-api-key": "YOUR_API_KEY"}) data = r.json() ``` **Example response:** ```json { "count": 1, "items": [ { "title": "Paper Per Lecturer Per year", "series": [ { "name": "Overall", "points": [ { "year": 2016, "value": 77.75 }, { "year": 2017, "value": 103.54 }, { "year": 2018, "value": 153.92 }, { "year": 2019, "value": 166.54 }, { "year": 2020, "value": 165.33 }, { "year": 2021, "value": 157.65 }, { "year": 2022, "value": 139.13 }, { "year": 2023, "value": 1165.79 } ] } ], "indicator": "research_output2" } ], "provider": "sinta" } ``` ---